0001062993-23-010706.txt : 20230511 0001062993-23-010706.hdr.sgml : 20230511 20230510200338 ACCESSION NUMBER: 0001062993-23-010706 CONFORMED SUBMISSION TYPE: 20-F PUBLIC DOCUMENT COUNT: 108 CONFORMED PERIOD OF REPORT: 20221130 FILED AS OF DATE: 20230511 DATE AS OF CHANGE: 20230510 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Plymouth Rock Technologies Inc. CENTRAL INDEX KEY: 0001639142 STANDARD INDUSTRIAL CLASSIFICATION: GOLD & SILVER ORES [1040] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1130 FILING VALUES: FORM TYPE: 20-F SEC ACT: 1934 Act SEC FILE NUMBER: 000-55509 FILM NUMBER: 23908400 BUSINESS ADDRESS: STREET 1: 700-1199 WEST HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6E 3T5 BUSINESS PHONE: 1-888-509-1353 MAIL ADDRESS: STREET 1: 700-1199 WEST HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6E 3T5 FORMER COMPANY: FORMER CONFORMED NAME: ALEXANDRA CAPITAL CORP. DATE OF NAME CHANGE: 20150409 20-F 1 form20f.htm FORM 20-F Plymouth Rock Technologies Inc.: Form 20-F - Filed by newsfilecorp.com
0001639142 false FY No No No No 0001639142 prt:PaycheckProtectionProgramLoanMember 2020-05-04 0001639142 2021-12-01 2022-11-30 0001639142 prt:PaycheckProtectionProgramLoanMember 2020-05-01 2020-05-04 0001639142 ifrs-full:IssuedCapitalMember 2022-11-30 0001639142 ifrs-full:IssuedCapitalMember 2021-11-30 0001639142 2014-11-01 2014-11-12 0001639142 2020-09-01 2020-09-30 0001639142 srt:DirectorMember 2020-09-01 2020-09-30 0001639142 2020-09-01 2020-09-24 0001639142 2020-09-01 2020-09-22 0001639142 srt:DirectorMember 2020-08-01 2020-08-21 0001639142 2020-08-01 2020-08-13 0001639142 2020-07-01 2020-07-03 0001639142 2020-05-01 2020-05-15 0001639142 2020-04-02 2020-04-24 0001639142 2020-08-13 0001639142 2020-07-03 0001639142 2020-09-30 0001639142 2020-09-24 0001639142 2020-09-22 0001639142 prt:SharePurchaseWarrantMember 2020-09-01 2020-09-30 0001639142 prt:AerowaveCorporationMember 2020-09-01 2020-09-30 0001639142 prt:NonBrokeredPrivatePlacementFinancingMember 2020-02-01 2020-02-04 0001639142 2021-01-01 2021-01-29 0001639142 prt:SharePurchaseWarrantMember 2021-11-30 0001639142 prt:SharePurchaseWarrantMember 2020-12-01 2021-11-30 0001639142 ifrs-full:BottomOfRangeMember prt:SharePurchaseWarrantMember 2020-12-01 2021-11-30 0001639142 ifrs-full:TopOfRangeMember prt:SharePurchaseWarrantMember 2020-12-01 2021-11-30 0001639142 srt:DirectorMember 2020-12-01 2021-11-30 0001639142 2021-11-30 0001639142 2020-12-01 2021-11-30 0001639142 ifrs-full:BottomOfRangeMember 2020-12-01 2021-11-30 0001639142 ifrs-full:TopOfRangeMember 2020-12-01 2021-11-30 0001639142 prt:SharePurchaseWarrantMember 2018-04-01 2018-04-25 0001639142 prt:AerowaveCorporationMember 2018-04-01 2018-04-25 0001639142 prt:BrokerWarrantsMember 2021-01-01 2021-01-29 0001639142 2020-11-30 0001639142 2022-11-30 0001639142 prt:ExercisePriceZeroPointSixZeroMember prt:ExpiryDateOfStockOptionsJanuaryOneFiveTwoZeoTwoFourMember 2022-11-30 0001639142 prt:ExercisePriceZeroPointSixZeroMember prt:ExpiryDateOfStockOptionsJanuaryOneFiveTwoZeoTwoFourMember 2021-12-01 2022-11-30 0001639142 prt:ExercisePriceZeroPointSixZeroOneMember prt:ExpiryDateOfStockOptionsMarchTwoZeroTwoZeroTwoFourMember 2022-11-30 0001639142 prt:ExercisePriceZeroPointSixZeroOneMember prt:ExpiryDateOfStockOptionsMarchTwoZeroTwoZeroTwoFourMember 2021-12-01 2022-11-30 0001639142 prt:ExercisePriceZeroPointFiveZeroMember prt:ExpiryDateOfStockOptionsNovemberTwoEightTwoZeroTwoFourMember 2022-11-30 0001639142 prt:ExercisePriceZeroPointFiveZeroMember prt:ExpiryDateOfStockOptionsNovemberTwoEightTwoZeroTwoFourMember 2021-12-01 2022-11-30 0001639142 prt:ExercisePriceZeroPointSevenFiveMember prt:ExpiryDateOfStockOptionsJanuaryTwoOneTwoZeroTwoSixMember 2022-11-30 0001639142 prt:ExercisePriceZeroPointSevenFiveMember prt:ExpiryDateOfStockOptionsJanuaryTwoOneTwoZeroTwoSixMember 2021-12-01 2022-11-30 0001639142 prt:ExercisePriceZeroPointFiveZeroMember prt:ExpiryDateOfStockOptionsJuneOneZeroTwoZeroTwoSixMember 2022-11-30 0001639142 prt:ExercisePriceZeroPointFiveZeroMember prt:ExpiryDateOfStockOptionsJuneOneZeroTwoZeroTwoSixMember 2021-12-01 2022-11-30 0001639142 prt:AugustNineTwoZeroTwoSixMember 2022-11-30 0001639142 prt:AugustNineTwoZeroTwoSixMember 2021-12-01 2022-11-30 0001639142 prt:JanuaryTwentyNineTwoZeroTwoSixMember 2022-11-30 0001639142 prt:JanuaryTwentyNineTwoZeroTwoSixMember 2021-12-01 2022-11-30 0001639142 2019-11-30 0001639142 2019-12-01 2020-11-30 0001639142 prt:NonBrokeredPrivatePlacementFinancingMember 2020-09-01 2020-09-30 0001639142 prt:NonBrokeredPrivatePlacementFinancingMember 2020-05-01 2020-05-15 0001639142 prt:NonBrokeredPrivatePlacementFinancingMember 2020-04-02 2020-04-24 0001639142 prt:SharePurchaseWarrantMember 2021-01-01 2021-01-29 0001639142 prt:SharePurchaseWarrantMember 2021-08-01 2021-08-09 0001639142 prt:PrivatePlacementsMember 2021-08-01 2021-08-09 0001639142 prt:PrivatePlacementsMember 2021-08-09 0001639142 prt:PrivatePlacementsMember 2021-01-01 2021-01-29 0001639142 prt:PrivatePlacementsMember 2021-01-29 0001639142 prt:ConsultantAndDirectorMember 2020-12-01 2021-11-30 0001639142 prt:ConsultantAndDirectorMember 2019-12-01 2020-11-30 0001639142 prt:DirectorsOfficersEmployeeAndConsultantsMember 2021-01-01 2021-01-21 0001639142 prt:DirectorsOfficersEmployeeAndConsultantsMember 2021-01-21 0001639142 prt:ConsultantMember 2021-06-10 0001639142 prt:ConsultantMember 2021-06-01 2021-06-10 0001639142 prt:PrivatePlacementsMember 2020-04-02 2020-04-24 0001639142 prt:PrivatePlacementsMember 2020-05-01 2020-05-15 0001639142 prt:FindersFeesMember 2021-01-01 2021-01-29 0001639142 2021-08-01 2022-08-09 0001639142 prt:SharePurchaseWarrantMember 2021-08-01 2022-08-09 0001639142 prt:FindersFeesMember 2021-08-01 2022-08-09 0001639142 prt:BrokerWarrantsMember 2021-08-01 2022-08-09 0001639142 prt:SharePurchaseWarrantMember 2019-12-01 2020-11-30 0001639142 prt:NonBrokeredPrivatePlacementFinancingMember 2020-12-01 2021-11-30 0001639142 prt:PrivatePlacementsMember 2020-12-01 2021-11-30 0001639142 prt:ProfessionalFeesPayableMember 2021-11-30 0001639142 prt:ProfessionalFeesPayableMember 2022-11-30 0001639142 prt:FundsToBeReturnedToInvestorsMember 2021-11-30 0001639142 prt:FundsToBeReturnedToInvestorsMember 2022-11-30 0001639142 prt:AdvertisingCostsMember 2021-11-30 0001639142 prt:AdvertisingCostsMember 2022-11-30 0001639142 prt:DevelopmentCostsMember 2021-11-30 0001639142 prt:DevelopmentCostsMember 2022-11-30 0001639142 prt:OtherPayableMember 2021-11-30 0001639142 prt:OtherPayableMember 2022-11-30 0001639142 prt:DueToFormerShareholderOfTetraMember 2021-11-30 0001639142 prt:DueToFormerShareholderOfTetraMember 2022-11-30 0001639142 prt:PayrollMember 2021-11-30 0001639142 prt:PayrollMember 2022-11-30 0001639142 prt:BankOverdraftMember 2021-11-30 0001639142 prt:BankOverdraftMember 2022-11-30 0001639142 prt:VATPayableMember 2021-11-30 0001639142 prt:VATPayableMember 2022-11-30 0001639142 prt:PurchasesMember 2021-11-30 0001639142 prt:PurchasesMember 2022-11-30 0001639142 prt:RentMember 2021-11-30 0001639142 prt:RentMember 2022-11-30 0001639142 prt:TetraDronesLimitedMember 2021-12-01 2022-11-30 0001639142 prt:DirectorsOfficersEmployeesAndConsultantsMember 2022-03-01 2022-03-03 0001639142 srt:DirectorMember 2023-03-01 2023-03-16 0001639142 prt:NonBrokeredPrivatePlacementFinancingMember 2023-02-01 2023-02-22 0001639142 prt:PrivatePlacementsMember 2023-03-01 2023-03-30 0001639142 prt:FurnitureMember 2022-11-30 0001639142 ifrs-full:ComputerEquipmentMember 2022-11-30 0001639142 prt:FurnitureMember 2021-11-30 0001639142 ifrs-full:ComputerEquipmentMember 2021-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember prt:FurnitureMember 2022-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:ComputerEquipmentMember 2022-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember prt:FurnitureMember 2021-12-01 2022-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:ComputerEquipmentMember 2021-12-01 2022-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember prt:FurnitureMember 2021-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:ComputerEquipmentMember 2021-11-30 0001639142 ifrs-full:GrossCarryingAmountMember prt:FurnitureMember 2022-11-30 0001639142 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerEquipmentMember 2022-11-30 0001639142 ifrs-full:GrossCarryingAmountMember prt:FurnitureMember 2021-12-01 2022-11-30 0001639142 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerEquipmentMember 2021-12-01 2022-11-30 0001639142 ifrs-full:GrossCarryingAmountMember prt:FurnitureMember 2021-11-30 0001639142 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerEquipmentMember 2021-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember prt:FurnitureMember 2020-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:ComputerEquipmentMember 2020-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember prt:FurnitureMember 2020-12-01 2021-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:ComputerEquipmentMember 2020-12-01 2021-11-30 0001639142 ifrs-full:GrossCarryingAmountMember prt:FurnitureMember 2020-11-30 0001639142 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerEquipmentMember 2020-11-30 0001639142 ifrs-full:GrossCarryingAmountMember prt:FurnitureMember 2020-12-01 2021-11-30 0001639142 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerEquipmentMember 2020-12-01 2021-11-30 0001639142 ifrs-full:GrossCarryingAmountMember ifrs-full:VehiclesMember 2020-11-30 0001639142 ifrs-full:GrossCarryingAmountMember ifrs-full:VehiclesMember 2020-12-01 2021-11-30 0001639142 ifrs-full:GrossCarryingAmountMember ifrs-full:VehiclesMember 2021-11-30 0001639142 ifrs-full:GrossCarryingAmountMember ifrs-full:VehiclesMember 2021-12-01 2022-11-30 0001639142 ifrs-full:GrossCarryingAmountMember ifrs-full:VehiclesMember 2022-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:VehiclesMember 2020-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:VehiclesMember 2020-12-01 2021-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:VehiclesMember 2021-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:VehiclesMember 2021-12-01 2022-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:VehiclesMember 2022-11-30 0001639142 ifrs-full:VehiclesMember 2021-11-30 0001639142 ifrs-full:VehiclesMember 2022-11-30 0001639142 ifrs-full:GrossCarryingAmountMember ifrs-full:LeaseholdImprovementsMember 2020-11-30 0001639142 ifrs-full:GrossCarryingAmountMember ifrs-full:LeaseholdImprovementsMember 2020-12-01 2021-11-30 0001639142 ifrs-full:GrossCarryingAmountMember ifrs-full:LeaseholdImprovementsMember 2021-11-30 0001639142 ifrs-full:GrossCarryingAmountMember ifrs-full:LeaseholdImprovementsMember 2021-12-01 2022-11-30 0001639142 ifrs-full:GrossCarryingAmountMember ifrs-full:LeaseholdImprovementsMember 2022-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:LeaseholdImprovementsMember 2020-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:LeaseholdImprovementsMember 2020-12-01 2021-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:LeaseholdImprovementsMember 2021-12-01 2022-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:LeaseholdImprovementsMember 2022-11-30 0001639142 ifrs-full:LeaseholdImprovementsMember 2021-11-30 0001639142 ifrs-full:LeaseholdImprovementsMember 2022-11-30 0001639142 ifrs-full:GrossCarryingAmountMember prt:DemoEquipmentMember 2020-11-30 0001639142 ifrs-full:GrossCarryingAmountMember prt:DemoEquipmentMember 2020-12-01 2021-11-30 0001639142 ifrs-full:GrossCarryingAmountMember prt:DemoEquipmentMember 2021-11-30 0001639142 ifrs-full:GrossCarryingAmountMember prt:DemoEquipmentMember 2021-12-01 2022-11-30 0001639142 ifrs-full:GrossCarryingAmountMember prt:DemoEquipmentMember 2022-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember prt:DemoEquipmentMember 2020-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember prt:DemoEquipmentMember 2020-12-01 2021-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember prt:DemoEquipmentMember 2021-12-01 2022-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember prt:DemoEquipmentMember 2022-11-30 0001639142 prt:DemoEquipmentMember 2021-11-30 0001639142 prt:DemoEquipmentMember 2022-11-30 0001639142 ifrs-full:GrossCarryingAmountMember 2020-11-30 0001639142 ifrs-full:GrossCarryingAmountMember 2020-12-01 2021-11-30 0001639142 ifrs-full:GrossCarryingAmountMember 2021-11-30 0001639142 ifrs-full:GrossCarryingAmountMember 2021-12-01 2022-11-30 0001639142 ifrs-full:GrossCarryingAmountMember 2022-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember 2020-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember 2020-12-01 2021-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember 2021-12-01 2022-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember 2022-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:LeaseholdImprovementsMember 2021-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember prt:DemoEquipmentMember 2021-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember 2021-11-30 0001639142 srt:DirectorMember 2020-03-30 2020-04-01 0001639142 prt:PlymouthRockUsaMember 2018-11-01 2018-11-30 0001639142 prt:PlymouthRockUsaMember 2022-11-30 0001639142 exch:BPLC 2021-12-01 2022-11-30 0001639142 2023-02-04 0001639142 srt:DirectorMember 2020-04-01 0001639142 ifrs-full:CurrencyRiskMember 2021-12-01 2022-11-30 0001639142 ifrs-full:CurrencyRiskMember 2022-11-30 0001639142 ifrs-full:CurrencyRiskMember 2021-11-30 0001639142 ifrs-full:CurrencyRiskMember 2020-11-30 0001639142 country:CA 2021-12-01 2022-11-30 0001639142 country:US 2021-12-01 2022-11-30 0001639142 country:GB 2021-12-01 2022-11-30 0001639142 country:CA 2020-12-01 2021-11-30 0001639142 country:US 2020-12-01 2021-11-30 0001639142 country:GB 2020-12-01 2021-11-30 0001639142 country:CA 2019-12-01 2020-11-30 0001639142 country:US 2019-12-01 2020-11-30 0001639142 country:GB 2019-12-01 2020-11-30 0001639142 ifrs-full:SellingGeneralAndAdministrativeExpenseMember 2021-12-01 2022-11-30 0001639142 ifrs-full:SellingGeneralAndAdministrativeExpenseMember 2020-12-01 2021-11-30 0001639142 ifrs-full:SellingGeneralAndAdministrativeExpenseMember 2019-12-01 2020-11-30 0001639142 prt:ResearchAndDevelopmentExpensesMember 2021-12-01 2022-11-30 0001639142 prt:ResearchAndDevelopmentExpensesMember 2020-12-01 2021-11-30 0001639142 prt:ResearchAndDevelopmentExpensesMember 2019-12-01 2020-11-30 0001639142 ifrs-full:GrossCarryingAmountMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2022-11-30 0001639142 ifrs-full:CustomerrelatedIntangibleAssetsMember 2021-12-01 2022-11-30 0001639142 ifrs-full:GrossCarryingAmountMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2020-11-30 0001639142 ifrs-full:GrossCarryingAmountMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2021-11-30 0001639142 ifrs-full:GrossCarryingAmountMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2020-12-01 2021-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2020-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2021-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2020-12-01 2021-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2021-12-01 2022-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2022-11-30 0001639142 ifrs-full:CustomerrelatedIntangibleAssetsMember 2021-11-30 0001639142 ifrs-full:CustomerrelatedIntangibleAssetsMember 2022-11-30 0001639142 prt:TetraDronesLimitedMember 2022-11-30 0001639142 prt:TetraDronesLimitedMember 2022-10-01 2022-10-25 0001639142 prt:ThirdPartyMember 2022-11-30 0001639142 prt:ThirdPartyMember 2021-12-01 2022-11-30 0001639142 prt:AnotherThirdPartyMember 2021-12-01 2022-11-30 0001639142 prt:AnotherThirdPartyMember 2022-11-30 0001639142 srt:ChiefFinancialOfficerMember 2021-11-30 0001639142 srt:ChiefExecutiveOfficerMember 2021-11-30 0001639142 srt:DirectorMember 2022-11-30 0001639142 ifrs-full:RelatedPartiesMember 2019-12-01 2020-11-30 0001639142 ifrs-full:RelatedPartiesMember 2020-12-01 2021-11-30 0001639142 ifrs-full:RelatedPartiesMember 2021-12-01 2022-11-30 0001639142 srt:ChiefFinancialOfficerMember 2022-11-30 0001639142 srt:ChiefExecutiveOfficerMember 2022-11-30 0001639142 srt:DirectorMember 2021-11-30 0001639142 prt:CompanyControlledByCorporateSecretaryMember 2022-11-30 0001639142 prt:CompanyControlledByCorporateSecretaryMember 2021-11-30 0001639142 srt:ChiefExecutiveOfficerMember 2021-12-01 2022-11-30 0001639142 srt:ChiefExecutiveOfficerMember 2020-12-01 2021-11-30 0001639142 srt:ChiefExecutiveOfficerMember 2019-12-01 2020-11-30 0001639142 prt:FormerCfoMember 2021-12-01 2022-11-30 0001639142 prt:FormerCfoMember 2020-12-01 2021-11-30 0001639142 prt:FormerCfoMember 2019-12-01 2020-11-30 0001639142 srt:DirectorMember 2021-12-01 2022-11-30 0001639142 srt:DirectorMember 2019-12-01 2020-11-30 0001639142 prt:CompanyControlledByFormerCorporateSecretaryMember 2021-12-01 2022-11-30 0001639142 prt:CompanyControlledByFormerCorporateSecretaryMember 2020-12-01 2021-11-30 0001639142 prt:CompanyControlledByFormerCorporateSecretaryMember 2019-12-01 2020-11-30 0001639142 srt:ChiefFinancialOfficerMember 2019-12-01 2020-11-30 0001639142 srt:ChiefFinancialOfficerMember 2020-12-01 2021-11-30 0001639142 srt:ChiefFinancialOfficerMember 2021-12-01 2022-11-30 0001639142 prt:TetraDronesLimitedMember 2021-06-04 0001639142 prt:TetraDronesLimitedMember prt:WithinSevenDaysMember 2021-06-04 0001639142 prt:TetraDronesLimitedMember prt:WithinTwentyOneDaysMember 2021-06-04 0001639142 prt:TetraDronesLimitedMember prt:WithinOneTwentyDaysMember 2021-06-04 0001639142 prt:TetraDronesLimitedMember prt:WithinOneTwentyDaysOfThirdInstalmentMember 2021-06-04 0001639142 dei:BusinessContactMember 2021-12-01 2022-11-30 0001639142 prt:Year2038Member 2022-11-30 0001639142 prt:Year2039Member 2022-11-30 0001639142 prt:YearTwoZeroFourZeroMember 2022-11-30 0001639142 ifrs-full:BottomOfRangeMember 2021-12-01 2022-11-30 0001639142 ifrs-full:TopOfRangeMember 2021-12-01 2022-11-30 0001639142 prt:YearTwoZeroFourOneMember 2022-11-30 0001639142 ifrs-full:BottomOfRangeMember 2020-12-01 2021-11-30 0001639142 ifrs-full:TopOfRangeMember 2020-12-01 2021-11-30 0001639142 prt:YearTwoZeroFourTwoMemberMember 2022-11-30 0001639142 ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember 2021-11-30 0001639142 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember 2021-11-30 0001639142 prt:PlymouthRockUsaMember 2019-11-30 0001639142 prt:PlymouthRockUsaMember 2020-11-30 0001639142 prt:PlymouthRockUsaMember 2021-11-30 0001639142 ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember 2021-11-30 0001639142 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember 2022-11-30 0001639142 ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember 2022-11-30 0001639142 ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember 2022-11-30 0001639142 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2020-11-30 0001639142 ifrs-full:RetainedEarningsMember 2020-11-30 0001639142 ifrs-full:AdditionalPaidinCapitalMember 2020-11-30 0001639142 ifrs-full:IssuedCapitalMember 2020-11-30 0001639142 ifrs-full:RetainedEarningsMember 2019-11-30 0001639142 ifrs-full:AdditionalPaidinCapitalMember 2019-11-30 0001639142 ifrs-full:IssuedCapitalMember 2019-12-01 2020-11-30 0001639142 ifrs-full:RetainedEarningsMember 2019-12-01 2020-11-30 0001639142 ifrs-full:AdditionalPaidinCapitalMember 2019-12-01 2020-11-30 0001639142 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2019-12-01 2020-11-30 0001639142 prt:SharesToBeIssuedMember 2019-12-01 2020-11-30 0001639142 prt:SharesToBeIssuedMember 2019-11-30 0001639142 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2019-11-30 0001639142 ifrs-full:IssuedCapitalMember 2019-11-30 0001639142 ifrs-full:RetainedEarningsMember 2020-12-01 2021-11-30 0001639142 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2020-12-01 2021-11-30 0001639142 ifrs-full:IssuedCapitalMember 2020-12-01 2021-11-30 0001639142 ifrs-full:AdditionalPaidinCapitalMember 2020-12-01 2021-11-30 0001639142 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2021-11-30 0001639142 ifrs-full:RetainedEarningsMember 2021-11-30 0001639142 ifrs-full:AdditionalPaidinCapitalMember 2021-11-30 0001639142 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2022-11-30 0001639142 ifrs-full:RetainedEarningsMember 2022-11-30 0001639142 ifrs-full:AdditionalPaidinCapitalMember 2022-11-30 0001639142 ifrs-full:RetainedEarningsMember 2021-12-01 2022-11-30 0001639142 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2021-12-01 2022-11-30 0001639142 ifrs-full:IssuedCapitalMember 2021-12-01 2022-11-30 0001639142 prt:SubscriptionsReceivedMember 2019-11-30 0001639142 prt:SubscriptionsReceivedMember 2020-11-30 0001639142 prt:SubscriptionsReceivedMember 2021-11-30 0001639142 prt:SubscriptionsReceivedMember 2022-11-30 0001639142 prt:SubsidiaryMember 2021-12-01 2022-11-30 0001639142 ifrs-full:ComputerEquipmentMember 2021-12-01 2022-11-30 0001639142 ifrs-full:FixturesAndFittingsMember 2021-12-01 2022-11-30 0001639142 ifrs-full:LeaseholdImprovementsMember 2021-12-01 2022-11-30 0001639142 ifrs-full:OfficeEquipmentMember 2021-12-01 2022-11-30 0001639142 ifrs-full:VehiclesMember 2021-12-01 2022-11-30 0001639142 prt:SubsidiaryOneMember 2021-12-01 2022-11-30 0001639142 prt:SubsidiaryTwoMember 2021-12-01 2022-11-30 0001639142 prt:AdvertisingAndPromotionsMember 2021-11-30 0001639142 prt:RentMember 2021-11-30 0001639142 prt:OthersMember 2021-11-30 0001639142 prt:AdvertisingAndPromotionsMember 2022-11-30 0001639142 prt:RentMember 2022-11-30 0001639142 prt:OthersMember 2022-11-30 0001639142 prt:TransferAgentAndFilingFeesMember 2021-11-30 0001639142 prt:TransferAgentAndFilingFeesMember 2022-11-30 0001639142 prt:InsuranceMember 2021-11-30 0001639142 prt:InsuranceMember 2022-11-30 iso4217:CAD iso4217:CAD xbrli:shares iso4217:CAD prt:Unit prt:Finder iso4217:GBP iso4217:USD prt:Year xbrli:pure prt:share xbrli:shares

 

  UNITED STATES OMB APPROVAL
  SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0288
  Washington, D.C. 20549 Expires: October 31, 2023
    Estimated average burden hours per....2629.68
     
     
     

FORM 20-F 

[ ]    REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934

OR

[X]     ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended November 30, 2022  

OR

[ ]     TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ______________________to ______________________

Commission file number _______________________________

PLYMOUTH ROCK TECHNOLOGIES INC.
(Exact name of Registrant as specified in its charter)

_______________________________________
(Translation of Registrant's name into English)

British Columbia, Canada 
(Jurisdiction of incorporation or organization)

Suite 700 - 1199 West Hastings Street, Vancouver, British Columbia, Canada V6E 3T5
(Address of principal executive offices)

Contact Person: Philip Lancaster, Tel: (250) 863-3038, Email: phil@plyrotech.com
Suite 700 - 1199 West Hastings Street, Vancouver, British Columbia, Canada V6E 3T5
(Name, telephone, e-mail and/or facsimile number and Address of Company Contact Person)


2

Securities registered or to be registered pursuant to Section 12(b) of the Act.

Title of each class

Name of each exchange on which registered

 

 

None

Not applicable

Securities registered or to be registered pursuant to Section 12(g) of the Act.

Common Stock
(Title of Class)

Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act.

None
(Title of Class)

Indicate the number of outstanding shares of each of the issuer's capital or common stock as of the close period covered by the annual report.

On November 30, 2022, there were a total of 59,317,461 common shares issued and outstanding.

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
  ]  YES  [X]    NO

If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
[
   ]  YES  [   ]  NO

Note - Checking the box above will not relieve any registrant required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 from their obligations under those Sections.

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
[
   ]  YES  [X]  NO

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
[
   ]  YES  [X]  NO

Indicateby check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of "accelerated filer and large accelerated filer" in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer  [   ] Accelerated filer  [   ] Non-accelerated filer  [X]
    Emerging Growth Company [X]

If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards† provided pursuant to Section 13(a) of the Exchange Act. [ ]
† The term "new or revised financial accounting standard" refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.


3

Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:

U.S. GAAP  [   ] International Financial Reporting Standards as issued
by the International Accounting Standards Board [X]
Other  [   ]

If "Other" has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow.
[   ]    ITEM  17  [   ]  ITEM 18

If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
[   ]  YES  [X]  NO

4

TABLE OF CONTENTS

PART I   7
     
  Item 1. Identity of Directors, Senior Management and Advisers 7
     
  Item 2. Offer Statistics and Expected Timetable 7
     
  Item 3. Key Information 7
     
  Item 4. Information on the Company 23
     
  Item 4A. Unresolved Staff Comments 34
     
  Item 5. Operating and Financial Review and Prospects 34
     
  Item 6. Directors, Senior Management and Employees 38
     
  Item 7. Major Shareholders and Related Party Transactions 49
     
  Item 8. Financial Information 51
     
  Item 9. The Offering and Listing 52
     
  Item 10. Additional Information 52
     
  Item 11. Quantitative and Qualitative Disclosures About Market Risk 60
     
  Item 12. Description of Securities Other than Equity Securities 61
     
PART II   61
     
  Item 13. Defaults, Dividend Arrearages and Delinquencies 61
     
  Item 14. Material Modifications to the Rights of Security Holders and Use of Proceeds. 61
     
  Item 15. Controls and Procedures 61
     
  Item 16A. Audit Committee Financial Expert 63
     
  Item 16B. Code of Ethics 63
     
  Item 16C. Principal Accountant Fees and Services 64
     
  Item 16D. Exemptions from the Listing Standards for Audit Committees 64
     
  Item 16E. Purchases of Equity Securities by the Issuer and Affiliated Purchasers 64
     
  Item 16F: Change in Registrant's Certifying Accountant 64
     
PART III   65
     
  Item 17. Financial Statements 65
     
  Item 18. Financial Statements 65
     
  Item 19. Exhibits 67
 

5

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

This annual report on Form 20-F ("Annual Report") contains forward-looking statements, meaning statements that reflect our current expectations and views of future events and future financial performance. These forward-looking statements are made under the applicable safe-harbor provisions of United States and Canadian securities laws. In some cases, you can identify forward-looking statements by terminology such as "estimate", "project", "believe", "anticipate", "intend", "expect", "plan", "predict", "may", "should", "potential", or "continue", the negative thereof or other variations thereon or comparable terminology.

These forward-looking statements include, but are not limited to, statements about:

  • our strategies for the development of our technology, software and hardware;
  • our future business development, financial conditions and results of operations;
  • the expect growth of the industry that we operate in;
  • our expectations regarding demand for and market acceptance of our products and services;
  • competition in our industry;
  • our expectations regarding our ability to design, develop, manufacture and deliver our products in fulfilment of our contractual commitments;
  • our expectations regarding our relationships with distributors, customers, component suppliers, strategic partners and other stakeholders; and
  • assumptions underlying or related to any of the foregoing.

Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of our Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. There can be no assurance that the forward-looking statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements.

Known and unknown risks, uncertainties and other factors include, but are not limited to:

  • our plans and ability to develop and commercialize product candidates and the timing of these development programs;
  • our establishment and maintenance of intellectual property rights, including licenses involving third-parties, in connection with our product candidates;
  • our need for additional financing and our estimates regarding our capital requirements and future revenues and profitability;
  • our ability to achieve strategic goals from acquisitions of businesses and the risks associated with the integration of such businesses; and
  • differences in anticipated and actual program performance

Accordingly, shareholders and prospective investors should not place undue reliance on forward-looking statements. The forward-looking statements in this Annual Report speak only as to the date hereof. Except as required by applicable law, including the securities laws of the United States and Canada, we do not intend to update any of the forward-looking statements to conform these statements to actual results.


6

REPORTING CURRENCY

In this Annual Report, unless otherwise stated, all dollar amounts are expressed in Canadian dollars. The financial statements and summaries of financial information contained in this Annual Report are also reported in Canadian dollars unless otherwise stated.

IMPORTANT INFORMATION ABOUT IFRS AND NON-IFRS FINANCIAL MEASURES

Our financial statements are prepared in accordance with International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board, unless expressly stated otherwise. The Company makes references to certain non-IFRS measures, including Adjusted EBITDA. These measures are not recognized measures under IFRS, do not have a standardized meaning prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other companies. Rather, these measures are provided as additional information to complement those IFRS measures by providing a further understanding of the Company's results of operations from management's perspective. Accordingly, they should not be considered in isolation nor as a substitute for the analysis of the Company's financial information reported under IFRS.

FREQUENTLY USED TERMS

As used in this Annual Report, unless the context otherwise requires or indicates otherwise, references to "we", "us", "our", "our Company" and "the Company" refer to Plymouth Rock Technologies Inc., a British Columbia corporation, and its wholly owned subsidiaries, Plymouth Rock Technologies Inc., a Delaware corporation ("Plymouth Rock USA"), Plymouth Rock Technologies Inc, incorporated in England and Wales ("Plymouth Rock UK"), and Tetra Drones Ltd. ("Tetra" or "Tetra Drones"), incorporated in England and Wales, unless otherwise stated.

In this Annual Report:

"AI" means artificial intelligence.

"Abicom International" means Abicom International Ltd.

"BCBCA" means British Columbia Business Corporations Act.

"CODA" refers to the Company's Cognitive Object Detection Apparatus, a compact modular radar utilized for a variety of applications, from aircraft to weapon detection.

"CPC" means a capital pool company CPC.

"CSE" means the Canadian Securities Exchange.

"DTC" means the U.S. Depository Trust Corporation, a subsidiary of the Depository Trust & Clearing Corporation, a U.S. company that manages the electronic clearing and settlement of publicly-traded companies.

"EMEA" means Europe, the Middle East and Africa.

"Exchange Act" means the U.S. Securities Exchange Act of 1934, as amended.

"FCC" means the U.S Federal Communications Commission.

"FCPA" means the U.S. Foreign Corrupt Practices Act.

"IASB" means the International Accounting Standards Board.

"IFRS" means International Financial Reporting Standards.

"IRS" means the U.S. Internal Revenue Service.

"Investment Act" means the Investment Canada Act.

"JOBS Act" Refers to the Jumpstart Our Business Startups Act.

"KBR" means Kellogg Brown & Root.

"MiRIAD" means Millimeter Remote Imaging from Airborne Drone, designed for use on UAVs.

"MMU" means Manchester Metropolitan University.

"NASA" means the U.S. National Aeronautics and Space Administration.

"NASDAQ" means National Association of Securities Dealers Automated Quotations. NASDAQ System refers to a sophisticated electronic marketplace and trading system that facilitates the buying and selling of securities, including stocks, options, and other financial instruments.

"NATO" refers to the North Atlantic Treaty Organization.

"non-resident holder" means a holder of our common shares who is a resident of the United States, who is not, will not be and will not be deemed to be a resident of Canada for purposes of the Canadian Income Tax Act and any applicable tax treaty and who does not use or hold, and is not deemed to use or hold, his, her or its common shares in the capital of our Company in connection with carrying on a business in Canada.


7

"OTCQB" means the OTCQB Venture Market electronic quotation facility operated by OTC Markets Group.

"QEF" means a "qualified electing fund" in which case the U.S. Holder would be taxed currently, for each taxable year that we are a PFIC, on its pro rata share of our ordinary earnings and net capital gain (subject to a separate election to defer payment of taxes, which deferral is subject to an interest charge).

"PCAOB" means the U.S. Public Company Accounting Oversight Board.

"PFIC" means a passive foreign investment company.

"Qualifying Transaction" means a transaction where a CPC acquires Significant Assets, as defined by TSXV Policy 2.4, by way of purchase, amalgamation, merger or arrangement with another company or by other means.

"SEC" means the U.S. Securities and Exchange Commission.

"Securities Act" means the U.S. Securities Act of 1933, as amended.

"SSCI" means Scientific Systems Company Inc.

"SS1" or "Shoe Scanner" refers to the Company's compact microwave radar system for scanning shoes.

"TSA ITF" means the U.S. Transport Security Administration's Innovation Task Force.

"TSXV" means the TSX Venture Exchange.

"Treaty" means the Canada-United States Tax Convention as amended by the Protocols thereto.

"UAS" means unmanned aircraft systems.

"UAVs" means unmanned aerial vehicles.

"Wi-Ti" or "Wireless Threat Indication" means a wall or portal mounted sensor system that will detect high-risk concealed threat items over an extended coverage area.

"WTO" means the World Trade Organization.

References to "USD" and "US$" are to U.S. dollars, references to "CAD" and "$" are to Canadian dollars, and references to "GBP" and "£" are to the British pound. This Annual Report includes certain trademarks, service marks and trade names that we own or otherwise have the right to use, such as "Plymouth Rock Technologies", which are protected under applicable intellectual property laws.

PART I

ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISORS

Not applicable to Form 20-F filed as an annual report.

ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE

Not applicable to Form 20-F filed as an annual report.

ITEM 3. KEY INFORMATION

A. [Reserved]

B. Capitalization and Indebtedness

Not applicable to Form 20-F filed as an annual report.

C. Reason for the Offer and Use of Proceeds

Not applicable to Form 20-F filed as an annual report.


8

D. Risk Factors

An investment in our securities carries a significant degree of risk. In addition to the other information presented in this Annual Report, the following should be considered carefully in evaluating our Company and its business, including our consolidated financial statements and related notes included herein, in connection with your ownership our securities. This Annual Report contains forward-looking statements and information within the meaning of U.S. and Canadian securities laws that involve risks and uncertainties. The Company's actual results may differ materially from the results discussed in the forward-looking statements and information. Factors that might cause such differences include those discussed below and elsewhere in this Annual Report.

If any of the events described below occur, our business and financial results could be materially adversely affected. This could cause the trading price of our securities to decline, perhaps significantly, and you therefore may lose all or part of your investment. The risks set out below are not exhaustive and do not comprise all of the risks associated with an investment in the Company. Additional risks and uncertainties not currently known to us or which we currently deem immaterial may also have a material adverse effect on our business, financial condition and results of operations.

Summary of Risk Factors

The following summarizes some, but not all, of the risks provided below. Please carefully consider all of the information discussed in this Item 3.D. "Risk Factors" for a more thorough description of these and other risks:

Risks Associated with Our Business

  • There is substantial doubt as to whether we will continue operations. If we discontinue operations, you could lose your investment.
  • We have a limited operating history. If we fail to generate sufficient revenues to operate profitability, or if we are unable to fund our continuing losses, you could lose all or part of your investment.
  • We will require substantial capital and liquidity to develop, manufacture and market our products. If we do not raise sufficient funds, our plan of operation will be delayed until such time as we raise sufficient funds, provided we are able to do so.
  • Failure to comply with applicable regulatory requirements may have a material adverse impact on the business, financial condition and operating results of the Company.
  • Our technology platform may not perform in line with customer specifications or expectations.
  • We may be compelled to undertake product recalls or take other actions, which could adversely affect our brand image and results of operations.
  • We may become subject to product liability claims or warranty claims, which could harm our financial condition and liquidity if we are not able to successfully defend or insure against such claims.
  • If we fail to successfully develop and commercialize new products, services and technologies that are well received by customers, our operating results may be materially and adversely affected.
  • There can be no assurance that the Company will be able to obtain adequate financing in the future, on favorable terms or at all. Additional capital will be raised through the issuance of additional equity, which will result in dilution to the Company's shareholders.
  • An accident involving a UAV/ UAS provided by us, or another manufacturer could harm the UAS industry.
  • We rely on some third-party distributors for sales, marketing and distribution activities relating to our products.
  • Our operations may be interrupted by production difficulties or delays due to mechanical failures, utility shortages or stoppages, fire, natural disaster or other calamities at or near our facilities.
  • Our consumers may experience service failures or interruptions due to defects in the software, infrastructure, components or engineering system that compromise our products and services, or due to errors in product installation, any of which could harm our business.
  • Our business and prospects depend significantly on our ability to build our brand.
  • Any deterioration of our relationship with our strategic business partners could have a material adverse effect on our operating results.

9

  • We are subject to risks associated with strategic alliances or acquisitions. If we cannot manage the growth of our business or execute our strategies effectively, our business and prospects may be materially and adversely affected.
  • We rely on external suppliers for raw materials and certain components and parts used in our UAS, and have limited control over the quality of these components and parts.
  • We rely on third-party logistics providers to deliver our domestic sales orders and certain overseas orders. Inadequate third-party logistics services or failure to mitigate the risks of damage or disruption to our distribution logistics could adversely affect our business.
  • If our business partners, contractors, suppliers, sales agents, dealers or third-party logistics services providers fail to use ethical business practices and comply with applicable laws and regulations, our brand image could be harmed due to negative publicity beyond our own control.
  • If customers modify or misuse our UAS or operating systems, the UAS may not operate properly, which may cause damage, create negative publicity and harm our business.
  • An inability to secure or defend intellectual property rights and protections for our technologies may negatively impact our business or financial position.
  • We have limited insurance coverage, which could subject us to significant costs and business disruption.
  • We are subject to anti-corruption, anti-bribery, anti-money laundering, financial and economic sanctions and similar laws, and noncompliance with such laws can subject us to administrative, civil and criminal fines and penalties, collateral consequences, remedial measures and legal expenses, all of which could adversely affect our business, results of operations, financial condition and reputation.
  • Conflicts of interest may arise as a result of our directors and officers being directors and officers of other technology companies.
  • We have granted, and may continue to grant, stock options under our stock option plan, which may result in increased share-based compensation expenses.
  • Any complaint or litigation proceedings we may be involved in from time to time could incur substantial judgments, fines, legal fees or other costs and have a material adverse effect on our business, financial condition, results of operations and cash flows.
  • Epidemics and pandemics, such as the COVID-19 pandemic, could materially disrupt the Company's business and have a negative impact on the Company's financial results and financial condition.

Risks Associated with our Common Shares

  • If our Company's business is unsuccessful, our shareholders may lose their entire investment.
  • The price of our common shares has been and may continue to be volatile.
  • If we fail to implement and maintain an effective system of internal controls to remediate our material weaknesses over financial reporting, we may be unable to accurately report our results of operations, meet our reporting obligations or prevent fraud, and investor confidence in our Company and the market price of our common shares may be materially and adversely affected.
  • As a "foreign private issuer", our Company is exempt from certain sections of the Exchange Act which results in shareholders having less complete and timely data than if the Company were a domestic U.S. issuer.
  • We are an emerging growth company within the meaning of the Securities Act and may take advantage of certain reduced reporting requirements.
  • We will incur increased costs after we cease to qualify as an "emerging growth company."
  • Investors' interests in our Company will be diluted and investors may suffer dilution in their net book value per share if our Company issues additional shares or raise funds through the sale of equity securities.
  • Our Company does not intend to pay dividends on any investment in our common shares.
  • The risks associated with penny stock classification could affect the marketability of our common shares and shareholders could find it difficult to sell their shares.

Risks Relating to Management

  • We depend on key personnel to operate our business effectively in the competitive Aerospace & Defense and UAV/ UAS Industries.
  • Since certain of our officers and directors are located in Canada, it may be difficult to enforce any United States judgment for claims brought against such officers and directors.

10

  • Our management is free to devote time to other ventures and shareholders may not agree with their allocation of time.

Risks Associated with Our Business

There is substantial doubt as to whether we will continue operations. If we discontinue operations, you could lose your investment.

Our financial statements have been prepared on the going concern basis, which assumes that we will be able to realize our assets and discharge our liabilities in the normal course of business. However, as at November 30, 2022, we have not generated significant revenue or cash flow from operations since inception. As at November 30, 2022, the Company has a working capital deficiency of $2,025,673 and an accumulated deficit of $16,535,760. We anticipate that we will incur increased expenses and there is a risk we will not realize sufficient revenues to offset those expenses. Our ability to continue our operations is dependent on obtaining additional financing and generating future revenues, and no assurance can be given that we will successfully be able to do so. Accordingly, our financial statements contain disclosure regarding the auditor's substantial doubt about our ability to continue as a going concern. Importantly, the inclusion in our financial statements of a going concern reference may negatively impact our ability to raise future financing and achieve future revenue. The reference regarding the substantial doubt about our ability to continue as a going concern will be removed only when, in the opinion of our auditor, our revenues have reached a level that is able to sustain our business operations, or we have raised substantial additional funds through our financing efforts.

Limited Operating History

The Company has a limited amount of business income in the last two years and had generated limited revenue since its inception in 2011. We have incurred operating and net losses in each year of our existence. We experienced a net loss of $2,667,798 for the year ended November 30, 2022, compared to a net loss of $4,974,834 for the year ended November 30, 2021. The Company is subject to all of the business risks and uncertainties associated with any new business enterprise, including the risk that it will not achieve its growth objective. We expect to incur substantial and increasing losses for the foreseeable future as we research, develop and commercialize our products. If our products do not achieve market acceptance, we may never generate any revenue. We also cannot assure you that we will be profitable even if we successfully commercialize our products. The Company anticipates that it may take several years to achieve positive cash flow from operations. If we fail to generate sufficient revenues to operate profitability, or if we are unable to fund our continuing losses, you could lose all or part of your investment.

Substantial Capital Requirements and Liquidity

We will require substantial funds to develop, manufacture and market our products. If we do not raise sufficient funds, our plan of operation will be delayed until such time as we raise sufficient funds, provided we are able to do so. Further, the cost of carrying out our operating activities and development activities is not fixed, and our cash levels may at any time prove to be insufficient to finance them. Our financing needs may change substantially because a number of factors which are difficult to predict, or which may be outside of our control. These include increased competition, the costs of inventory and protecting rights to our proprietary technology and the time required to obtain required licenses.

We intend to seek additional funding through strategic alliances or through public or private sales of our equity securities, and we may also obtain equipment leases and pursue opportunities to obtain debt financing in the future. We may not succeed in raising the additional funds that we require because such funds may not be available to us on acceptable terms, if at all. If we are unable to obtain sufficient funding on a timely basis, we may be forced to significantly curtail or cease our operations.


11

Regulatory Requirements

We operate in an industry which is highly regulated and is evolving rapidly. Sometimes new risks emerge, and management may not be able to predict all of them or be able to predict how they may cause actual results to be different from those contained in any forward-looking statements. Failure to comply with the requirements of the State licensing agencies within which we operate would have a material adverse impact on the business, financial condition and operating results of the Company.

We will incur ongoing costs and obligations related to regulatory compliance. Failure to comply with regulations may result in additional costs for corrective measures, penalties or in restrictions of our operations. In addition, changes in regulations, more vigorous enforcement thereof or other unanticipated events could require extensive changes to our operations, increased compliance costs or give rise to material liabilities, which could have a material adverse effect on the business, results of operations and financial condition of the Company.

The industry is subject to extensive controls and regulations, which may significantly affect the financial condition of market participants. The marketability of any product may be affected by numerous factors that are beyond our control and which cannot be predicted, such as changes to government regulations, including those relating to taxes and other government levies which may be imposed. Changes in government levies, including taxes, could reduce the Company's earnings and could make future capital investments or the Company's operations uneconomic. The industry is also subject to numerous legal challenges, which may significantly affect the financial condition of market participants, and which cannot be reliably predicted.

Our technology platforms may not perform in line with customer specifications or expectations.

Our technology platforms, consisting of our Aerospace & Defense and UAV / UAS technologies, may not perform in line with customers' expectations. For example, our technologies may not be as easy to operate or maintain as customers expect. Customers may require performance specifications that we are unable to deliver. Some of these target specifications, such as those dependent on battery technology, are constrained by the pace of general technological advancement and the capabilities of our suppliers, which are largely beyond our control.

Our technology platform may contain design or manufacturing defects that result in unsatisfactory performance or require repair. Our technology platform uses a substantial amount of algorithms and software to operate. Software products are inherently complex and often contain defects and errors, especially when first introduced. While we have performed extensive internal testing on our UAS software and hardware systems, we have a limited frame of reference by which to evaluate the long-term performance of our technology platform. There can be no assurance that we will be able to detect and fix any defects in our technology platform before we sell products and services to customers.

If our technology platform is defective or otherwise fails to perform as expected or in accordance with prescribed technical specifications and timetable, our UAS may experience accidents and we may suffer adverse publicity, order cancellations, revenue declines, delivery delays, product recalls, product liability claims, and significant warranty and other expenses. These consequences could have a material adverse impact on our business, financial condition, operating results and prospects.

We may be compelled to undertake product recalls or take other actions, which could adversely affect our brand image and results of operations.

Our UASs may not perform in line with customers' expectations. Any product defects, accidents or any other failure of our UASs to perform as expected could harm our reputation and result in adverse publicity, revenue loss, delivery delays and product recalls, which could harm our brand and reputation. Any product recall or lawsuit seeking significant monetary damages either in excess of or outside of our insurance coverage may have a material adverse effect on our business and financial condition. In the future, we may, voluntarily or involuntarily, initiate a recall if any of our UASs, including any systems or components sourced from our suppliers, prove to be defective or noncompliant with applicable laws and regulations. Such recalls, whether voluntary or involuntary and whether caused by systems or components engineered or manufactured by us or our suppliers, could incur significant expenses and adversely affect our brand image in our target markets. They may also inhibit or prevent commercialization of our current and future product candidates.


12

We may become subject to product liability claims or warranty claims, which could harm our financial condition and liquidity if we are not able to successfully defend or insure against such claims.

We may be exposed to significant product liability claims if our UASs do not perform as expected or malfunction. Any defects, errors, or failures in our products or the misuse of our UASs, operating systems and infrastructure could also result in injury, death or property damage. Our risks in this area are particularly pronounced given we have limited field experience in the operation of our UASs. A successful product liability claim against us could require us to pay a substantial monetary award. Moreover, a product liability claim could generate substantial negative publicity about our UASs and business and inhibit or prevent commercialization of our current and future UAS models. Our insurance coverage might not be sufficient to cover all potential product liability claims. In addition, the same level of insurance coverage may not be available in the future at economical prices, or at all. Even if we are fully insured as it relates to a claim, the claim could nevertheless diminish our brand and divert management's attention and resources, which could have a negative impact on our business, financial condition and result of operations.

If we fail to successfully develop and commercialize new products, services and technologies that are well received by customers, our operating results may be materially and adversely affected.

Our future growth depends on whether we can continually develop and introduce new generations of our existing product lines and update our operating systems and infrastructure with enhanced functionalities and value-added services. This is particularly important in the current industry landscape where technologies and consumer preferences evolve rapidly, which may shorten the lifecycles of our existing products. We plan to upgrade our current UAS models and introduce new models in order to continue to provide UASs with the latest technologies. As technological advancements can be complex and costly, we could experience delays in the development and introduction of new products and services in the future.

Our ability to roll out new and innovative products and services depends on a number of factors, including significant investments in research and development, quality control of our products and services and effective management of our supply chain. We may need to devote more resources to the research and development of new or enhanced products, services and technologies, which may reduce our profitability. In addition, our research and development efforts may not yield the benefits we expect to achieve in a timely manner, or at all. To the extent that we are unable to execute our strategy of continuously introducing new and innovative products, diversifying our product portfolio and satisfying consumers' changing preferences, we may not be able to grow our user base, and our competitive position and results of operations may be adversely affected. Even if we are able to keep up with technological changes and develop new models, our prior models may as a result become obsolete sooner than expected, potentially reducing our return on investment.

Financing Risks and Dilution to Shareholders

The Company will have limited financial resources, no operations, and no revenues. There can be no assurance that the Company will be able to obtain adequate financing in the future or that such financing will be available on favorable terms or at all. It is likely such additional capital will be raised through the issuance of additional equity, which will result in dilution to the Company's shareholders.

Competition

The global market for Aerospace & Defense is highly fragmented and intensely competitive. We compete principally in the market for UAV / UAS. Some of our competitors and potential competitors have greater research, development, financial and personnel resources, including governmental support, as well as established greater penetration into certain vertical markets or geographical market segments. We cannot assure you that we will be able to compete effectively relative to our competitors or continue to develop and market new products effectively. Continued competitive pressures could cause us to lose significant market share or erode profitability margins.


13

An accident involving a UAV / UAS provided by us, or another manufacturer could harm the UAS industry.

An accident involving a UAV / UAS provided by us, or another manufacturer could cause regulatory agencies around the world to tighten restrictions on the use of UAVs / UASs, particularly overpopulated areas and could cause the public to lose confidence in our products and UAVs / UASs generally. There are risks associated with autopilot, flight control, communications and other advanced technologies, and, from time to time, there have been accidents associated with these technologies. The safety of certain cutting-edge technologies depends in part on user interaction, and users may not be accustomed to using such technologies. We could face unfavorable and tightened regulatory control and intervention on the use of autopilot and other advanced technologies and be subject to liability and government scrutiny to the extent accidents associated with our autonomous navigation systems occur. Should a high-profile accident occur resulting in substantial casualty or damages, either involving our UASs or products offered by other companies, public confidence in and regulatory attitudes toward UASs could deteriorate. Any of the foregoing could materially and adversely affect our results of operations, financial condition and growth prospects.

We rely on some third-party distributors for sales, marketing and distribution activities relating to our products.

Some of our business partners are acting as third-party distributors that sell, market and distribute our products to their customers. Accordingly, we may be subject to a number of risks associated with third-party distributors, including a lack of day-to-day control over the activities of third-party distributors selling or using our products and solutions; third-party distributors may terminate their arrangements with us on limited or no notice, or may change the terms of these arrangements in a manner that is unfavorable to us for reasons outside of our control; and any disagreements with our third party distributors could lead to costly and time-consuming litigation or arbitration. If we fail to establish and maintain satisfactory relationships with our third-party distributors, we may not be able to sell, market and distribute our products according to our internal budget and plans, our future revenues and market share may not grow at a pace that we expect, and we could be subject to increases in sales and marketing and other costs which would harm our results of operations and financial condition.

Our operations may be interrupted by production difficulties or delays due to mechanical failures, utility shortages or stoppages, fire, natural disaster or other calamities at or near our facilities.

Production difficulties, such as capacity constraints, mechanical and systems failures and the need for equipment upgrades, may suspend our production and/or reduce our output. There can be no assurance that we will not experience problems with our production facilities in the future or that we will be able to address any such problems in a timely manner. Problems with key equipment in one or more of our production facilities may affect our ability to produce our products or cause us to incur significant expenses to repair or replace such equipment. Scheduled and unscheduled maintenance programs may affect our production output. Any of these could have a material adverse effect on our business, financial condition, results of operations and prospects.

We depend on a continuous supply of utilities, such as electricity and water, to operate our production facilities. Any disruption to the supply of electricity or other utilities may disrupt our production or cause the deterioration or loss of our inventory. This could adversely affect our ability to fulfill our sales orders and consequently may have an adverse effect on our business and results of operations. In addition, fire, natural disasters, pandemics or extreme weather, including droughts, floods, typhoons or other storms, or excessive cold or heat, could cause power outages, fuel shortages, water shortages, damage to our production, processing or distribution facilities or disruption of transportation channels, any of which could impair or interfere with our operations. We cannot assure you that such events will not happen in the future or that we will be able to take adequate measures to mitigate the likelihood or potential impact of such events, or to effectively respond to such events if they occur.


14

Our consumers may experience service failures or interruptions due to defects in the software, infrastructure, components or engineering system that compromise our products and services, or due to errors in product installation, any of which could harm our business.

Our products and services may contain undetected defects in the software, infrastructure, components or engineering system. Sophisticated software and applications, such as those adopted and offered by us, often contain "bugs" that can unexpectedly interfere with the software and applications' intended operations. Our internet services may from time-to-time experience outages, service slowdowns or errors. Defects may also occur in components or processes used in our products or for our services.

There can be no assurance that we will be able to detect and fix all defects in the hardware, software and services we offer. Failure to do so could result in decreases in sales of our products and services, lost revenues, significant warranty and other expenses, decreases in customer confidence and loyalty, losing market share to our competitors, and harm to our reputation.

Our business and prospects depend significantly on our ability to build our brand.

Our business and prospects are heavily dependent on our ability to build, maintain and strengthen our brand. If we do not continue to establish, maintain and strengthen our brand, we may lose the opportunity to build a critical mass of customers. Promoting and positioning our brand will likely depend significantly on our ability to provide high-quality products and engage with our customers as intended. In addition, we expect that our ability to develop, maintain and strengthen our brand will also depend heavily on the success of our user development and branding efforts. Such efforts mainly include building a community of engaged online and offline users as well as other branding initiatives, such as UAS shows and events. To promote our brand, we may be required to change our user development and branding practices, which could result in substantially increased expenses. If we do not develop and maintain a strong brand, our business, prospects, financial condition and operating results will be materially and adversely impacted.

Our brand could be subject to adverse publicity if incidents related to our products occur or are perceived to have occurred, whether or not we are at fault. In particular, given the popularity of social media, any negative publicity, regardless of its truthfulness, could quickly proliferate and harm consumer perceptions of and confidence in our brand. Furthermore, we may be affected by adverse publicity related to our manufacturing or other partners, whether or not such publicity is related to their collaboration with us. Our ability to successfully position our brand could also be adversely affected by perceptions of the quality of our partners' products and services. In addition, from time to time, our products are evaluated and reviewed by third parties. Any unfavorable reviews could adversely affect consumer perceptions of our products.

Any deterioration of our relationship with our strategic business partners could have a material adverse effect on our operating results.

We collaborate with various business partners to promote our products. For example, we collaborate with companies including Air Data Systems and Environmental Resources Management (ERM) / KBR. There can be no guarantee that those business partners will continue to collaborate with us in the future. If we are unable to maintain good relationships with our business partners, or the business of our business partners declines, the reach of our products and services may be adversely affected and our ability to maintain and expand our user base may decrease.

Most of the agreements with our business partners do not prohibit them from working with our competitors or from offering competing services. If our partners change their standard terms and conditions in a manner that is detrimental to our business, or if our business partners decide not to continue working with us, or choose to devote more resources to supporting our competitors or their own competing products, we may not be able to find a substitute on commercially favorable terms, or at all, and our competitive advantages may diminish.


15

We are subject to risks associated with strategic alliances or acquisitions. If we cannot manage the growth of our business or execute our strategies effectively, our business and prospects may be materially and adversely affected.

We have entered into strategic alliances with various business partners including SSCI and Hummingbird Drones' Fire AI, and may in the future enter into joint research and development agreements or co-branding agreements with third parties to further our business purpose from time to time. These alliances could subject us to a number of risks, including risks associated with sharing proprietary information, non-performance by the third parties and increased expenses in establishing new strategic alliances, any of which may materially and adversely affect our business. We may have limited ability to monitor or control the actions of these third parties. If any of these strategic third parties suffer negative publicity or harm to their reputation from events relating to their business, we may also suffer negative publicity or harm to our reputation by virtue of our association with any such third party.

Although we currently do not have any specific acquisition plans, if appropriate opportunities arise, we may acquire additional assets, products, technologies or businesses that are complementary to our existing business. In addition to any required shareholders' approval, we may also have to obtain approvals and licenses from relevant government authorities for the acquisitions and to comply with any applicable laws and regulations, which could result in delays and increased costs, and may derail our business strategy if we fail to do so. Furthermore, past and future acquisitions and the subsequent integration of new assets and businesses into our own require significant attention from our management and could result in a diversion of resources from our existing business, which in turn could have an adverse effect on our business operations. Acquired assets or businesses may not generate the financial results we expect. Acquisitions could result in the use of substantial amounts of cash, potentially dilutive issuances of equity securities, the occurrence of significant goodwill impairment charges, amortization expenses for other intangible assets and exposure to potential unknown liabilities of the acquired business. Moreover, the costs of identifying and consummating acquisitions may be significant.

We rely on external suppliers for raw materials and certain components and parts used in our UAS, and have limited control over the quality of these components and parts.

We purchase certain key components and raw materials, such as computers chips, batteries, motors and electronic displays, from external suppliers for use in our operations and production of UASs. A continuous and stable supply of components and raw materials that meet our standards is crucial to our operations and production. We cannot assure you that we will be able to maintain our existing relationships with our suppliers and continue to be able to stably source key components and raw materials at reasonable prices, or at all. We have integrated our suppliers' technologies within our products such that having to change to an alternative supplier may cause significant disruption to our operations. The supply of key components could be interrupted for any reason, or there could be significant increases in the prices of these key components. Additionally, changes in business conditions, force majeure, governmental changes and other factors beyond our control, or that we do not presently anticipate, could also affect our suppliers' ability to deliver components to us on a timely basis. If any of these events occurs, our business, financial condition, results of operations and prospects may be materially and adversely affected.

We cannot guarantee that the quality of components and parts manufactured by external suppliers will be consistent and maintained at a high standard. Any defects of or quality issues with these components or any noncompliance incidents associated with these third-party suppliers could result in quality issues with our UASs and hence compromise our brand image and results of operations. In extreme situations, we may be exposed to liabilities as a result of significant damages caused by certain components from external suppliers and we cannot assure you that we will be able to obtain sufficient insurance coverage at an acceptable cost in the future. A successful claim brought against us in excess of our available insurance coverage may have a material adverse effect on our business, financial condition and operating results.

We rely on third-party logistics providers to deliver our domestic sales orders and certain overseas orders. Inadequate third-party logistics services or failure to mitigate the risks of damage or disruption to our distribution logistics could adversely affect our business.

Our ability to transport and sell our UASs is critical to our success across our operations. We typically rely on third-party logistics service providers to deliver our domestic sales orders and certain overseas orders. Damage or disruption to our distribution logistics due to disputes, weather, natural disasters, fire, explosions, terrorism, pandemics or labor strikes could impair our ability to distribute or sell our UASs. Inadequate third-party logistics services could also potentially disrupt our distribution and sales and compromise our business reputation. Failure to take adequate steps to mitigate the likelihood or potential impact of such events, or to effectively manage such events if they occur, could adversely affect our business, financial condition and results of operations, as well as require additional resources to restore our supply chain.


16

If our business partners, contractors, suppliers, sales agents, dealers or third-party logistics services providers fail to use ethical business practices and comply with applicable laws and regulations, our brand image could be harmed due to negative publicity beyond our own control.

Our reputation is sensitive to allegations of unethical business practices. We do not control the business practices of our business partners, independent contractors and suppliers, sales agents, dealers or third-party logistics services providers. Accordingly, we cannot guarantee their compliance with ethical business practices, such as environmental responsibilities, fair wage practices, and compliance with child labor laws, among others. A lack of demonstrated compliance could lead us to seek alternative business partners, independent contractors, suppliers, sales agents or dealers, which could increase our costs and result in delayed delivery of our products, product shortages or other disruptions of our operations. Violation of labor or other laws by our independent contractors, suppliers, business partners, sales agent, dealers or third-party logistics services suppliers or the divergence of their labor or other practices from those generally accepted as ethical in the markets in which we do business could also attract negative publicity, diminish our brand image and reduce demand for our UASs and UAS products.

If customers modify or misuse our UASs or operating systems, the UASs may not operate properly, which may cause damage, create negative publicity and harm our business.

Our customers may try to modify our UASs or operating systems for various reasons, which could compromise the performance and safety of our UASs, as well as the safety of the users. During such modifications, they may use third-party parts that may not be compatible with our products. We do not test, nor do we endorse, such modification. In addition, the use of improper external cabling or unsafe charging outlets can expose our customers to injury from UAS malfunctioning. Any injuries or damages resulting from such modifications or misuses could result in adverse publicity, which would negatively affect our brand and harm our business, prospects, financial condition and operating results.

An inability to secure or defend intellectual property rights and protections for our technologies may negatively impact our business or financial position.

We have developed security screening technologies that are adequate to counter various threats. We may be unable to prevent competitors from independently developing or selling products similar to or duplicate of our technology, and there can be no assurance that the resources invested by us to protect our Intellectual Property will be sufficient. We may be unable to secure or retain ownership or rights. In addition, we may be the target of aggressive and opportunistic enforcement of patents by third parties, including non-practicing entities. Regardless of the merit of such claims, responding to infringement claims can be expensive and time-consuming. If we are found to infringe any third-party rights, we could be required to pay substantial damages or we could be enjoined from offering some of products and services. Also, there can be no assurances that we will be able to obtain or renew from third parties the licenses we need in the future, and there is no assurance that such licenses can be obtained on reasonable terms.

In addition, the rights granted under any issued patents may not provide us with proprietary protection or competitive advantages. The claims under any patents that issue from our patent applications may not be broad enough to prevent others from developing technologies that are similar or that achieve results similar to ours. It is also possible that the intellectual property rights of others could bar us from licensing and exploiting any patents that are issued from our pending applications. Numerous patents and pending patent applications owned by others exist in the fields in which we have developed and are developing our technology. These patents and patent applications might have priority over our patent applications and could subject our patent applications to invalidation. Finally, in addition to those who may claim priority, any of our existing or pending patents may also be challenged by others on the basis that they are otherwise invalid or unenforceable.


17

We have limited insurance coverage, which could subject us to significant costs and business disruption.

We have limited liability insurance coverage for our products and business operations. We may not be able to secure additional product liability insurance coverage on acceptable terms or at reasonable costs when needed. A successful liability claim against us due to injuries or damages suffered by our users could materially and adversely affect our financial conditions, results of operations and reputation. Even if unsuccessful, such a claim could cause us adverse publicity, require substantial costs to defend, and divert the time and attention of our management. In addition, we do not have any business disruption insurance. Any business disruption could result in substantial cost to us and diversion of our resources. Furthermore, the United States, Canada or any other jurisdiction relevant to our business may impose requirements for maintaining certain minimum liability or other insurance relating to the operation of UASs. Such insurance policies could be costly, which would reduce the demand for our UASs. Alternatively, certain insurance products that would be desirable to UAS operators may not be commercially available, which would increase the risks of operating our UASs and also reduce the demand for them.

We are subject to anti-corruption, anti-bribery, anti-money laundering, financial and economic sanctions and similar laws, and noncompliance with such laws can subject us to administrative, civil and criminal fines and penalties, collateral consequences, remedial measures and legal expenses, all of which could adversely affect our business, results of operations, financial condition and reputation.

We are subject to anti-corruption, anti-bribery, anti-money laundering, financial and economic sanctions and similar laws and regulations in various jurisdictions in which we conduct our business or sell our products, including the Canadian Corruption of Foreign Public Officials Act, the FCPA, and other anti-corruption laws and regulations. These anti-corruption laws prohibit us and our officers, directors, employees and business partners acting on our behalf, including agents, from corruptly offering, promising, authorizing or providing anything of value to a "foreign official" for the purposes of influencing official decisions or obtaining or retaining business or otherwise obtaining favorable treatment. The FCPA also requires companies to make and keep books, records and accounts that accurately reflect transactions and dispositions of assets and to maintain a system of adequate internal accounting controls. A violation of these laws or regulations could adversely affect our business, results of operations, financial condition and reputation.

We have direct or indirect interactions with officials and employees of government agencies and state-owned affiliated entities in the ordinary course of business. We have also entered into joint ventures and/or other business partnerships with government agencies and state-owned or affiliated entities. These interactions subject us to an increased level of compliance-related concerns. We are in the process of implementing policies and procedures designed to ensure compliance by us and our directors, officers, employees, representatives, consultants, agents and business partners with applicable anti-corruption, anti-bribery, anti-money laundering, financial and economic sanctions and similar laws and regulations. However, our policies and procedures may not be sufficient, and our directors, officers, employees, representatives, consultants, agents, and business partners could engage in improper conduct for which we may be held responsible.

Non-compliance with anti-corruption, anti-bribery, anti-money laundering or financial and economic sanctions laws could subject us to whistleblower complaints, adverse media coverage, investigations, and severe administrative, civil and criminal sanctions, collateral consequences, remedial measures and legal expenses, all of which could materially and adversely affect our business, results of operations, financial condition and reputation. In addition, changes in economic sanctions laws in the future could adversely impact our business and investments in our shares.

Conflicts of interest may arise as a result of our directors and officers being directors and officers of other technology companies.

Certain directors and officers of the Company will be engaged in, and will continue to engage in, other business activities on their own behalf and on behalf of other companies and, as a result of these and other activities, such directors and officers of the Company may become subject to conflicts of interest. The BCBCA provides that in the event that a director or senior officer has a material interest in a contract or proposed contract or agreement that is material to the issuer, the director or senior officer must disclose his interest in such contract or agreement. A director who has a material interest in a contract or proposed contract or agreement that is material to the issuer must refrain from voting on any matter in respect of such contract or agreement, subject to and in accordance with the BCBCA. To the extent that conflicts of interest arise, such conflicts will be resolved in accordance with the provisions of the BCBCA. We cannot assure you that such conflicts will resolve in our favor.


18

We have granted, and may continue to grant, stock options under our stock option plan, which may result in increased share-based compensation expenses.

We adopted a stock option plan in 2016 (the "2016 Plan"), to incentivize our employees, directors and consultants and align their interests with ours. We recognize expenses in our consolidated statement of loss in accordance with IFRS. Under the 2016 Plan, we were authorized to grant stock options to purchase up to 10% of our Company's issued and outstanding common shares. As of November 30, 2022, there were 4,025,000 stock options outstanding. As of November 30, 2022, our unrecognized share-based compensation expenses relating to unvested awards, amounted to $Nil.

On October 17, 2022 we adopted a long-term equity incentive plan (the "2022 Plan") which replaced the 2016 Plan. All options granted under the 2016 Plan remain in full force and effect. The 2022 Plan provides for the grant of Awards with Awards including options to purchase shares, deferred share units, restricted share units, stock appreciation rights and other share-based awards that may be granted pursuant to the 2022 Plan. The aggregate number of common shares to be reserved for issuance upon the exercise or redemption of all Awards granted under the 2022 Plan is ten percent (10%) of the issued and outstanding common shares at the time of granting of Awards (on a non-diluted basis).

We believe the granting of share-based awards is of significant importance to our ability to attract and retain key personnel and employees, and we will continue to grant share-based awards to employees in the future. However, the number of shares reserved for issuance under our share incentive plan may not be sufficient to recruit new employees and to compensate existing employees. Furthermore, prospective candidates and existing employees often consider the value of the equity awards they receive in connection with their employment. Thus, our ability to attract or retain highly skilled employees may be adversely affected by declines in the perceived value of our equity or equity awards. To attract and retain qualified employees, our expenses associated with share-based compensation may increase, which may have an adverse effect on our results of operations.

Litigation

The Company and/or its directors may be subject to a variety of civil or other legal proceedings, with or without merit. We may be the subject of complaints or litigation from customers, employees or other third parties for various actions. The damages sought against us in some of these litigation proceedings could be substantial. We cannot assure you that we will always have meritorious defenses to the plaintiffs' claims. While the ultimate effect of these legal actions cannot be predicted with certainty, our reputation and the result of operations could be negatively impacted. The proceedings we may be involved in from time to time could incur substantial judgments, fines, legal fees or other costs and have a material adverse effect on our business, financial condition, results of operations and cash flows.

Epidemics and pandemics, such as the COVID-19 pandemic, could materially disrupt the Company's business and have a negative impact on the Company's financial results and financial condition.

We are vulnerable to the general economic effects of epidemics, pandemics and other public health crises, such as the COVID-19 pandemic. Due to the recent outbreak of COVID-19, there has been a substantial curtailment of travel and business activities, which is causing significant disruptions to the global economy. The extent to which COVID-19 impacts our results will depend primarily on future developments, which are highly uncertain and cannot be predicted with confidence, including the severity and duration of the crisis, the speed and effectiveness of vaccine and treatment developments and deployment, potential mutations of COVID-19, and the impact of actions taken and that will be taken to contain COVID-19 or treat its impact, among others. For example, if COVID-19 continues to spread, we may need to limit operations or implement additional restrictions as a result of widespread government restrictions.


19

We have been affected in a number of ways, such as the way in which we deal with our researchers and their activities, and planning for and carrying out clinical trials, all of which have experienced some short-term disruption and may suffer long-term changes in the way we will do business. Actions such as government lock downs have slowed or, in some cases, temporarily stopped research and development activities and clinical trials. Various safety protocols for personal interactions may hamper research and development activities. To date, since we are mostly focused on the activities related to research and development, we have not experienced the larger adverse economics of a slowed economy; however, we do expect that timelines for our research and development, clinical trials, regulatory approvals and bringing our products to market will cause our operational costs to be greater than anticipated in this current fiscal year and going forward. The financial effect will be that our development expenses will increase, and we will have to obtain additional capital funding. Any required additional equity funding will be dilutive to the equity of our investors and debt financing will have restrictive covenants that could adversely affect our business plans and operational objectives. Any further funding that we may need may not be available or even if available it may not be on terms that are acceptable to the Company.

Our future results of operations and liquidity could be adversely impacted by delays in payments of outstanding receivable amounts beyond normal payment terms, supply chain disruptions and operational challenges faced by our customers. Continued outbreaks of COVID-19 could result in a widespread health crisis that could adversely affect the economies and financial markets of many countries, resulting in an economic downturn or a global recession that could cause significant volatility or decline in the trading price of our securities, affect our ability to execute strategic business activities, affect demand for our products and likely impact our operating results. These may further limit or restrict our ability to access capital on favorable terms, or at all, lead to consolidation that negatively impacts our business, weaken demand, increase competition, cause us to reduce our capital spend further, or otherwise disrupt our business.

Risks Relating to the Common Shares

If our Company's business is unsuccessful, our shareholders may lose their entire investment.

Although shareholders will not be bound by or be personally liable for our Company's expenses, liabilities or obligations beyond their total original capital contributions, should our Company suffer a deficiency in funds with which to meet our obligations, the shareholders as a whole may lose their entire investment in our Company.

The price of our common shares has been and may continue to be volatile.

The trading price for our common stock on the CSE (where our stock has traded since March 10, 2016) has been and is likely to continue to be highly volatile. Although our common shares are currently quoted on the OTCQB, there is no active market for our common shares, and no significant U.S. market may develop. If such a market develops, prices on that market are also likely to be highly volatile. As a result, an investor may find it difficult to sell, or to obtain accurate quotations of the price of our common shares.

Factors that could adversely affect the price of our common shares include:

 fluctuations in our operating results;

 changes to governmental regulation;

 litigation;

 general stock market and economic conditions;

 number of shares available for trading (float); and

 inclusion in or dropping from stock indexes.


20

If we fail to implement and maintain an effective system of internal controls to remediate our material weaknesses over financial reporting, we may be unable to accurately report our results of operations, meet our reporting obligations or prevent fraud, and investor confidence in our Company and the market price of our common shares may be materially and adversely affected.

Prior to the public listing of our common shares, we were a private company with limited accounting and financial reporting personnel and other resources to address our internal control over financial reporting. In connection with the audit of our consolidated financial statements as of and for the year ended November 30, 2022, we and our independent registered public accounting firm identified two material weaknesses in our internal control over financial reporting. As defined in the standards established by the PCAOB, a "material weakness" is a deficiency, or combination of deficiencies in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis.

The material weaknesses that have been identified relate to our lack of sufficient accounting and financial reporting personnel with requisite knowledge of and experience in application of IFRS rules, and lack of financial reporting policies and procedures that are commensurate with IFRS and SEC reporting and compliance requirements. We are in the process of implementing a number of measures to address the material weaknesses and deficiencies that have been identified. See "Item 15. Controls and Procedures." However, we cannot assure you that these measures may fully address the material weaknesses and deficiencies in our internal control over financial reporting or that we may conclude that they have been fully remediated.

We are subject to the Sarbanes-Oxley Act of 2002. Section 404 of the Sarbanes-Oxley Act, or Section 404, requires that we include a report from management on the effectiveness of our internal control over financial reporting in our annual report on Form 20-F. In addition, once we cease to be an "emerging growth company" as such term is defined in the JOBS Act, our independent registered public accounting firm must attest to and report on the effectiveness of our internal control over financial reporting. Moreover, even if our management concludes that our internal control over financial reporting is effective, our independent registered public accounting firm, after conducting its own independent testing, may issue an adverse opinion on the effectiveness of internal control over financial reporting because of the existence of a material weakness if it is not satisfied with our internal controls or the level at which our controls are documented, designed, operated or reviewed, or if it interprets the relevant requirements differently from us. In addition, after we become a public company, our reporting obligations may place a significant strain on our management, operational and financial resources and systems for the foreseeable future. We may be unable to timely complete our evaluation testing and any required remediation.

During the course of documenting and testing our internal control procedures, in order to satisfy the requirements of Section 404, we may identify other weaknesses and deficiencies in our internal control over financial reporting. If we fail to maintain the adequacy of our internal control over financial reporting, as these standards are modified, supplemented or amended from time to time, we may not be able to conclude on an ongoing basis that we have effective internal control over financial reporting in accordance with Section 404. Generally speaking, if we fail to achieve and maintain an effective internal control environment, it could result in material misstatements in our financial statements and could also impair our ability to comply with applicable financial reporting requirements and related regulatory filings on a timely basis. As a result, our businesses, financial condition, results of operations and prospects, as well as the trading price of our common shares, may be materially and adversely affected. Additionally, ineffective internal control over financial reporting could expose us to increased risk of fraud or misuse of corporate assets and subject us to potential delisting from the stock exchange on which we list, regulatory investigations and civil or criminal sanctions. We may also be required to restate our financial statements from prior periods.

As a "foreign private issuer", our Company is exempt from certain sections of the Exchange Act which results in shareholders having less complete and timely data than if the Company were a domestic U.S. issuer.

Because we are a foreign private issuer under the Exchange Act, we are exempt from certain provisions of the securities rules and regulations in the United States that are applicable to U.S. domestic issuers, including:

 the rules under the Exchange Act requiring the filing of quarterly reports on Form 10-Q or current reports on Form 8-K with the SEC;


21

 the sections of the Exchange Act, including Section 14, regulating the solicitation of proxies, consents, or authorizations in respect of a security registered under the Exchange Act;

 the sections of the Exchange Act requiring insiders to file public reports of their stock ownership and trading activities and liability for insiders who profit from trades made in a short period of time; and

 the selective disclosure rules by issuers of material nonpublic information under Regulation FD.

We are required to file an annual report on Form 20-F within four months of the end of each fiscal year. In addition, we publish our material events through press releases, distributed pursuant to the rules and regulations of the CSE. Press releases relating to material events will also be furnished to the SEC on Form 6-K. However, the information we are required to file with or furnish to the SEC will be less extensive and less timely compared to that required to be filed with the SEC by U.S. domestic issuers. As a result, you may not be afforded the same protections or information which would be made available to you were you investing in a U.S. domestic issuer.

In addition, due to the Company's status as a foreign private issuer, the officers, directors and principal shareholders of our Company are exempt from the short-swing insider disclosure and profit recovery provisions of Section 16 of the Exchange Act. Therefore, these officers, directors and principal shareholders are exempt from short-swing profits which apply to insiders of U.S. issuers. The foregoing exemption results in shareholders having less data in this regard than is available with respect to U.S. issuers.

We are an emerging growth company within the meaning of the Securities Act and may take advantage of certain reduced reporting requirements.

We are an "emerging growth company," as defined in the JOBS Act, and we may take advantage of certain exemptions from requirements applicable to other public companies that are not emerging growth companies including, most significantly, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002 for so long as we remain an emerging growth company. As a result, if we elect not to comply with such auditor attestation requirements, our investors may not have access to certain information they may deem important.

The JOBS Act also provides that an emerging growth company does not need to comply with any new or revised financial accounting standards until such date that a private company is otherwise required to comply with such new or revised accounting standards.

We will incur increased costs after we cease to qualify as an "emerging growth company."

We are a public company and continue to incur significant legal, accounting and other expenses and costs associated with our public company reporting obligations. The Sarbanes-Oxley Act of 2002, as well as rules subsequently implemented by the SEC, impose various requirements on the corporate governance practices of public companies. As a company with less than US$1.07 billion in revenues for our last fiscal year, we qualify as an "emerging growth company" pursuant to the JOBS Act. An emerging growth company may take advantage of specified reduced reporting and other requirements that are otherwise applicable generally to public companies. These provisions include exemption from the auditor attestation requirement under Section 404 of the Sarbanes-Oxley Act of 2002 in the assessment of the emerging growth company's internal control over financial reporting.

We may be disqualified from being considered as an emerging growth company pursuant to the JOBS Act if we no longer meet the definition of an emerging growth company based on our total annual gross revenues. Specifically, we will cease to be an emerging growth company as of the end of the fiscal year in which we exceed $1.07 billion in total annual gross revenues. After we are no longer an "emerging growth company," we expect to incur significant expenses and devote substantial management effort toward ensuring compliance with the requirements of Section 404 of the Sarbanes-Oxley Act of 2002 and the other rules and regulations of the SEC. We are currently evaluating and monitoring developments with respect to these rules and regulations, and we cannot predict or estimate with any degree of certainty the amount of additional costs we may incur or the timing of such costs.


22

Investors' interests in our Company will be diluted and investors may suffer dilution in their net book value per share if our Company issues additional shares or raise funds through the sale of equity securities.

Our constating documents currently authorize the issuance of an unlimited number of common shares without par value. If we are required to issue any additional shares or enter into private placements to raise financing through the sale of equity securities, investors' interests in our Company will be diluted and investors may suffer dilution in their net book value per share depending on the price at which such securities are sold. If we issue any such additional shares, such issuances also will cause a reduction in the proportionate ownership and voting power of all other shareholders. Further, any such issuance may result in a change in control of our Company.

Our Company does not intend to pay dividends on any investment in our common shares.

We have never paid any cash dividends and currently do not intend to pay any dividends for the foreseeable future. To the extent that we require additional funding currently not provided for in our financing plan, our funding sources may prohibit the payment of a dividend. Because we do not intend to declare dividends, any gain on an investment in our Company will need to come through an increase in the market price of our common shares. This may never happen, and investors may lose all of their investment in our Company.

The risks associated with penny stock classification could affect the marketability of our common shares and shareholders could find it difficult to sell their shares.

Our common shares are subject to "penny stock" rules as defined in Rule 3a51-1 of the Exchange Act. The SEC adopted rules that regulate broker-dealer practices in connection with transactions in penny stocks. Transaction costs associated with purchases and sales of penny stocks are likely to be higher than those for other securities. Penny stocks generally are equity securities with a price of less than $5.00 (other than securities registered on certain national securities exchanges or quoted on the NASDAQ system, provided that current price and volume information with respect to transactions in such securities is provided by the exchange or system).

The penny stock rules require a broker-dealer, prior to a transaction in a penny stock not otherwise exempt from the rules, to deliver a standardized risk disclosure document that provides information about penny stocks and the nature and level of risks in the penny stock market. The broker-dealer also must provide the customer with current bid and offer quotations for the penny stock, the compensation of the broker-dealer and its salesperson in the transaction, and monthly account statements showing the market value of each penny stock held in the customer's account. The bid and offer quotations, and the broker-dealer and salesperson compensation information, must be given to the customer orally or in writing prior to effecting the transaction and must be given to the customer in writing before or with the customer's confirmation.

In addition, the penny stock rules require that prior to a transaction in a penny stock not otherwise exempt from such rules, the broker-dealer must make a special written determination that the penny stock is a suitable investment for the purchaser and receive the purchaser's written agreement to the transaction. These disclosure requirements may have the effect of reducing the level of trading activity in the secondary market for our common shares in the United States and shareholders may find it more difficult to sell their shares.

Risks Relating to Management

We depend on key personnel to operate our business effectively in the competitive Aerospace & Defense and UAV / UAS technology industries.

Our success largely depends upon on the performance of the directors and officers and our continuing ability to attract and retain highly qualified personnel. The loss of the services of these persons, or the failure to attract highly qualified personnel in the future, may have a material adverse effect on our business and prospects. Moreover, our competitors may hire and gain access to the expertise of our former employees, or our former employees may compete with us. There is no assurance that we will be successful in attracting, integrating, motivating, and retaining key personnel or that former employees will not compete with in the future. If we are unable to retain our key personnel and attract additional qualified personnel as and when needed, our business may be adversely affected.


23

Since certain of our officers and directors are located in Canada and the United Kingdom, it may be difficult to enforce any United States judgment for claims brought against such officers and directors.

Our Company is organized under the laws of the Province of British Columbia, Canada and certain of our officers and directors are residents of Canada. While a cross border treaty exists between the United States and Canada relating to the enforcement of foreign judgments, the enforcement process is cumbersome and, in some cases, has prevented the enforcement of judgments. As a result, while actions may be brought in Canada, it may be impossible to affect service of process within the United States on the Company's officers and directors or to enforce against these persons any judgments in civil and commercial matters, including judgments under United States federal securities laws. In addition, a Canadian court may not permit an original action in Canada or enforce in Canada a judgment of a United States court based on civil liability provisions of United States federal securities laws.

Our management is free to devote time to other ventures and shareholders may not agree with their allocation of time.

Our officers and directors devote a substantial amount of their time to the management and operation of the Company's business. Management is not however, contractually required to manage or direct the Company as their sole and exclusive function and they may have other business interests and engage in other activities in addition to those relating to the Company. This includes rendering advice or services of any kind to and creating or managing other businesses, including other businesses in the fiber optic industry. Our officers and directors are required by law to act honestly and in good faith with a view to the best interests of the Company and to disclose any interests, which they may have in any project or opportunity of the Company. If a conflict of interest arises, at a meeting of the board of directors of our Company, any director with a conflict is required to disclose their interest in the matter and to abstain from voting on such matter.

As certain of the Company's officers have other outside business activities and, thus, may not be in a position to devote all of their professional time to the Company, the Company's operations may be sporadic, which may result in periodic interruptions or suspensions.

ITEM 4. INFORMATION ON THE COMPANY

A. History and Development of the Company

The Company was incorporated as Alexandra Capital Corp. under the BCBCA on October 17, 2011. The head office, principal address and registered and records office of the Company are located at Suite 700 - 1199 West Hastings Street, Vancouver, British Columbia V6E 3T5. We have three wholly owned subsidiaries, Plymouth Rock Technologies Inc., a Delaware corporation, Plymouth Rock Technologies Inc., incorporated in England and Wales, and Tetra Drones Ltd., incorporated in England and Wales.

Former listing on the TSXV

On May 2, 2012, the Company was listed on the TSXV as a CPC. On August 11, 2014, the Company completed its Qualifying Transaction with arm's length vendor Eastland Management Limited, whereby the Company was granted an option to acquire a 100% interest in Eastland's Southern Belle exploration project.

Transition to listing on the Canadian Securities Exchange

On March 10, 2016, the Company was listed on the CSE and voluntarily delisted from the TSXV.


24

Business acquisition of Plymouth Rock USA and name change

On October 31, 2018, the Company completed its business acquisition of Plymouth Rock USA and changed its name from Alexandra Capital Corp. to Plymouth Rock Technologies Inc. and changed its trading symbol on the CSE to "PRT" (See "Business Acquisition" section of this report).

Commencement of trading on the Frankfurt Stock Exchange in Germany

On January 8, 2019, the Company's common shares commenced trading on the Frankfurt Stock Exchange in Germany under the Symbol: 4XA, WKN# - A2N8RH.

Depositary Trust Company eligibility

On February 12, 2019, the Company's common shares became eligible for electronic clearing and settlement through the DTC. DTC eligibility is expected to simplify the process of trading and enhance liquidity of the Company's common shares.

Commencement of trading on the facilities of the OTCQB

Effective August 27, 2019, the Company's common shares commenced trading on the OTCQB under the symbol: PLRTF.

The SEC maintains an Internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC at http://www.sec.gov. Our website address is www.plyrotech.com.

Historical Development of our Business

Entry into Defense Technology Industry by Acquisition of Plymouth Rock USA as a CSE Listed Company

Pursuant to an arm's length share purchase agreement dated June 21, 2018, with Plymouth Rock USA and its three shareholders, the Company acquired all of the issued and outstanding common shares of Plymouth Rock USA in consideration of the issuance of 3,000,000 common shares of the Company. As a result of the acquisition of Plymouth Rock USA, the Company's principal business activity, through its subsidiary Plymouth Rock USA, was changed from mineral exploration to developing technologies related to remotely detecting assault firearms and suicide bombs concealed on the person or a carry bag. The Company focuses on detection methods with and without the need for a checkpoint of the suspect who is being screened. The Company's planned products encompass the very latest radar, imaging, and UAS technologies for quickly detecting, locating and identifying the presence of threats and for search and rescue missions for law enforcement.

On March 26, 2021, the Company incorporated a new subsidiary in United Kingdom, Plymouth Rock Technologies UK Limited. The purpose of PRT UK is to augment the Company's existing research and development of the X-1 and X-V for the U.S. and EMEA markets. Many of the UK consultants of the Company became direct employees of the Company.

Acquisition of Tetra Drones

On June 4, 2021, the Company announced that it had completed the arm's length acquisition of Tetra Drones, a developer of custom-made, high-performance and niche UAS, which the Company had closely collaborated on sensor technology. Tetra Drones is a private company subsisting under the laws of England and Wales, which carries on the business of producing drones and was founded in 2017 in the UK. The acquisition of Tetra Drones provides the Company with a U.K. based production and sales team with experience selling to leading universities, law enforcement and environmental agencies for mission-specific UAS.


25

The Company acquired all of the then issued and outstanding shares of Tetra Drones, 100 ordinary shares held by the sole Shareholder, Mr. Ben Pickard. Pursuant to the share purchase agreement, the Company acquired Tetra Drones for the sum of £350,000 GBP ($579,682), payable on an installment basis as follows:

 An amount of £35,000 ($60,021) within 7 days after the execution and delivery of the definitive agreement by all parties, paid on June 12, 2021;

 An amount of £35,000 ($60,479) (paid) within 21 days of the initial payment as described in instalment 1 above, paid on July 9, 2021;

 An amount of £140,000 ($236,411) (paid) within 120 days of the second instalment as described above, paid on November 8, 2021 ("the third payment"); and

 £140,000 ($222,771) within 120 days of the third payment. Upon the acquisition of Tetra Drones, the Company assumed Tetra Drones' outstanding loan of £13,000, the collateral of which loan was a leased vehicle. The loan amount outstanding as at November 30, 2022 was £13,253. On October 25, 2022, the loan and the vehicle were released to Mr. Pickard. The remaining acquisition cost of £140,000 was forgiven by Mr. Pickard in return of the full release of the leased vehicle to him and allowing Mr. Pickard to pursue a new venture within the industry. Thus, as of November 30, 2022, the Company's liabilities in the vehicle and the remaining balance in the acquisition cost had been extinguished.

As a result of the acquisition, the Company now owns all outstanding shares of Tetra Drones and assumed Tetra Drones' existing liabilities. The principal owner of Tetra Drones became part of the Company's management and shall be paid a monthly salary along with bonus shares or other equity instruments at the discretion of the board. All expenses related to the transaction were paid by the Company.

The Company sought an independent valuation for Tetra's net assets as of June 4, 2021. Tetra's working capital were all valued based on their carrying values as carrying value was deemed to approximate fair value as at June 4, 2021.

The fair value of net liabilities of Tetra amounted to $77,412 as at the date of acquisition. The Company applied the optional concentration test permitted under IFRS 3 to the acquisition which resulted in the acquired assets being accounted for as an asset acquisition. As such the purchase price was allocated to the identifiable assets and liabilities based on their fair values at the date of acquisition.

Since the transaction was deemed as an asset acquisition, all remaining amounts after deducting the net liabilities from consideration is allocated to Tetra's identifiable intangible asset (customer relationship total of $657,094). This will be amortized over a period of three years from date of acquisition.

B. Business Overview

Our Company

We are an Aerospace & Defense UAV / UAS technology company. We were formed by highly experienced scientists, engineers and business executives to develop and commercialize combined sensory and intelligence products. Our current activities are focused on the design, development and manufacture of UAV / UAS solutions for a variety of markets, from civil and commercial, to government and military. The Company's planned products encompass UAS technologies for quickly detecting, locating and identifying the presence of threats and for other applications such as, search and rescue missions for law enforcement, environmental and humanitarian missions for global government agencies, and inspection of infrastructure for structural damage. The decision to pivot the company to primarily be a designer and manufacturer of UAVs / UASs was due to the monumental potential the UAV market holds, with more and more organizations realizing the possibilities and potential of drones in order to improve their day-to-day operations, as well as reducing costs and increasing safety for employees and individuals.


26

Our Strategy

The Company's objective is to maximize the value of the Company for our shareholders, and our strategy to obtain this result is to focus on project evaluations and project generation. To proceed with this strategy, additional financings may be required during the current fiscal year.

The Company is currently at the inflection point of moving from design/development of prototypes to Low-Rate- Initial-Production. Commercializing the products is a major step in the Company's strategic growth. The marketing spend will also increase to accommodate this growth and sales strategy.

Our Industry

We operate in the Aerospace & Defense and Unmanned Aerial Vehicle (UAV) / Unmanned Aircraft Systems (UAS) industries. The UAV Market is projected to grow from USD $26.2 billion in 2022 to USD $38.3 Billion by 2027, at a CAR of 7.9% from 2022 to 2027.

The use of UAVs has been prevalent among defense forces worldwide for a long time. However, in recent times, several investments have been made by public and private sector organizations to develop new and sophisticated UAVs according to their requirements. The potential of UAVs to be used in several prospective applications in the civil and commercial sectors has led to advancements in them. The civil & commercial application segment of the UAV market is projected to grow significantly in the next 10 years.1

Our Technologies

The Company's core technologies have changed and its current focus is on the XV Unmanned Aerial Systems.

The Wi-Ti, SS-1 Shoescanner and CODA threat detection radar technology development have been put on hold so the Company can concentrate on the above related products.

The Company operates a small Aerospace & Defense component business, Aerowave, that was acquired in 2019. This design and manufacturing business is based in Plymouth MA USA. It supplies components to the US government, scientific communities and commercial businesses.

1. X1 and XV Unmanned Aerial Systems Updates

The X1 multirotor aircraft has become a special-order aircraft. The users of this aircraft will use experimental and defense payloads. Almost all requests for the acquisition of these heavy lift aircraft involve an alteration to mount a sensor instrument or kinetic delivery device. The X1 to date has never sold in its basic configuration. This is testimony to the modularity and payload capability envisaged as its unique proposition.

The XV and XV-L is a Medium altitude long endurance fixed-wing UAS platform with the added capability of vertical take-off and landing. (VTOL) This capability allows operations in from a small open space to allow users long range operations without the requirement for a runway. The XV can launch from an area as small as 8 square meters autonomously and operate for up to 7 hours. Due to ongoing events in Taiwan, Eastern Europe, almost all requests on significant interest with are continually updating the XV platform. The modular architecture of the XV aircraft allows for significant adaption to take place; this includes a hybrid or all electric propulsion system.

We are also currently developing XMR - a 'super-heavy-lift' UAS for Military, Casualty / Medical Evacuation, and Cargo Transportation. The XMR is classified as a 'super heavy lift' UAS due to its capability of lifting up to 330 lbs. making it ideal solution for tasks that require higher than normal payloads. The Company with sufficient R&D funding expects to complete initial flight tests in Q3 2023.

_____________________________
1
See: https://www.marketsandmarkets.com/Market-Reports/unmanned-aerial-vehicles-uav-market-662.html


27

On October 15, 2019, the Company announced the launch of the X1 to address the global requirement for a multi-role, state-of-the-art aerial platform. As of the end of November 2022, the X1 was starting its low-rate demonstration phase.

On May 6, 2020, the Company announced that its pilots had received Permission for Commercial Operations (PfCO) from the UK Civil Aviation Authority, to operate small, unmanned aircraft and small unmanned surveillance aircraft. The Company can now utilize its X1 platform for commercial operations, allowing our operators to demonstrate threat detection and surveillance in civilian airspace to both clients and potential partners. This also enables the Company to offer technical reconnaissance and non-destructive testing services for both civil and military applications.

On May 14, 2020, the Company announced that the X1 platform would be used in a series of airborne tests for the UK National Health Service (NHS) ambulance service for emergency apparatus delivery in collaboration with Hoverworks. This will involve several test scenarios, using PRT pilots, that if successful could lead to on-scene delivery of defibrillators and other critical trauma assistance technologies.

On June 10, 2020, the Company announced that it had signed a Letter of Intent with SDS Group Australia Pty Ltd., a leading provider of best of breed products and equipment to the Australian security and defense securities, to position X1 for procurement-focused evaluations following initial consultation with members of the Australian Government. The focus of the partnership is primarily centered around the need for the early detection and identification of remote wildfires.

On July 16, 2020, the Company began a strategic alliance with Hummingbird Drones' Fire AI division for wildfire analysis from the Company's X1 and XV platforms, to get analytics to the fire fighters as close to real time as possible. Hummingbird Drones is an infrared service provider in Canada, and their Fire AI data analytics service has been used as a hotspot detection platform for wildfires for since 2017.

On August 25, 2020, the Company announced that it signed a re-seller and purchase agreement with Michigan-based Trendset Communications Group, a leading technology provider to the security, telecommunications, and technology sector.

On February 3, 2021, the Company announced the addition of MediMod to its X1 and XV UAV payload systems. MediMod is an active insulated refrigerated storage module that will have multiple medical uses and advantages, including assisting with the immediate need for rapid deployment of COVID-19 vaccine transportation to remote sites or between medical facilities as part of multiple national campaigns for mass vaccination. The transportation module will be dual-use and can be set for warm or cool state for the transportation of blood, human transplant organs and various vaccines across cities and remote destinations. On February 24, 2021, the Company announced the launch of XV-S, a fixed-wing UAS platform with the added capability of vertical take-off and landing. This capability removes the requirement for a large runway or expensive launch catapult and recovery nets, which are usually required by most fixed-wing drones.

On June 24, 2021, the Company announced that its first X1-H model UAS had been sold and delivered to Aardvark LLP, to perform long range oil pipeline security and environmental operations in remote locations.

On July 13, 2021, the Company announced it closed a contract for the sale and delivery of UAS to the Durrell Wildlife Conservation Trust to perform critical environmental operations in Madagascar. The Durrell Wildlife Conservation Trust will use the Company's drone-based thermal infrared cameras as a new way of monitoring lemurs and identifying any potential poachers.

On September 2, 2021, the Company announced the sale of custom drones to Survey-AR, delivering a drone swarm test capability. The project assessed an autonomous drone swarm system to optimize weather and air quality monitoring in atmospheric boundary layer environments with particular importance in urban and industrial areas. The Company supplied a fleet of UAS to autonomously operate together and formed a 'swarm'.


28

On October 26, 2021, the Company announced the delivery of several new orders for environmental monitoring and Petrochemical inspection. Environmental monitoring was be carried out with X-Lite series drones, equipped with a winch and collection cup for deep water sampling to study plastic particulates in water and other microbiological impact. The drones were operated by Swiss university, ETH Zürich. The UAS for petrochemical inspection were used in Saudi Arabia for essential ultrasound testing of infrastructure at some of the world's highest volume petrochemical plants which included those owned by Saudi Aramco oil. The petrochemical sale was in collaboration with the Company's partner Tritex NDT UK.

On October 31, 2021, the Company also announced that it began a digital and marketing awareness campaign with Capital Analytica of Vancouver BC, Media Relations Inc of Burnsville MN and Think Inc Marketing of Huntington Beach CA. The campaign included press initiatives, advertising, publicity services and social media. These marketing and awareness programs include engagements with arm's length parties for an aggregate gross expenditure of CDN$120,000 over a 6-month period and USD $100,000 over a 3-month period. No stock-based compensation was provided.

On May 13, 2022, the Company received an order to manufacture a testing drone for Aspira Aerial Applications. The total value for this order was £6,095.00 GBP, with an additional 20% in VAT, bringing the total to £7,314 GBP. Final payment was received on June 1, 2022.

On May 23, 2022, the Company received an order for software upgrade work for a fleet of light show drones owned by FlightShows Ltd. The total value for this order was £9,125.00 GBP, with an additional 20% in VAT, bringing the total to £10,950.00 GBP. Final payment was received on August 16, 2022.

On July 1, 2022, the Company received an order for supply of drone upgrade and services for light shows from SkyShows Aerial Ltd. The total value for this order was £7,500.00 GBP, with an additional 20% in VAT, bringing the total to £9,000.00 GBP. Final payment was received on August 16, 2022.

On August 16, 2022, the Company received a follow up order to upgrade a fleet of light show drones from FlightShows Ltd. The total value for this order was £19,086.44 GBP, with an additional 20% in VAT, bringing the total to £22,903.73 GBP. Final payment was received on November 11, 2022.

On August 17, 2022, the Company received an order to build a large fixed-wing UAS, and perform service and refurbish an existing drone platform for Air Data Systems Ltd. The total value for this order was £93,848.34 GBP, with an additional 20% in VAT, bringing the total to £112,618.01. Final payment was received on December 22, 2022.

On September 26, 2022, the Company received an order for supply of drones for light shows from SkyShows Aerial Ltd. The total value for this order was £7,500.00 GBP, with an additional 20% in VAT, bringing the total to £9,000.00 GBP. Final payment was received on August 16, 2022.  

On October 3, 2022, the Company received a follow up from Aspira Aerial Applications for modifications.. The total value for this order was £9,495.00 GBP, with an additional 20% in VAT, bringing the total to £11,394.00 GBP. Final payment was received on October 31, 2022.

2. MiRIAD -Millimeter Remote Imaging from Airborne Drone Update

MiRIAD is a prototype compact sensor package that is specifically designed for use on UAS. The sensor is being designed to support a variety of functions, from the primary function of detecting assault weapons and person-borne improvised explosive devices, alongside a whole spectrum of other uses, such as detecting breaks in power cables, solar farm efficiencies, structure degradation and external corrosion. The sensor uses completely passive techniques, which means there are no emissions and therefore no regulatory issues.

MiRIAD uses a unique ultra-lightweight antenna to capture radar images of target subjects within a wide field of view. The captured radar image data, along with high resolution video is then backhauled wirelessly over a high-capacity data link to a central processing center for data analysis. Using algorithm based digital signal processing techniques the radar signature is analyzed and overlaid onto the video imagery to display a real time image of the video capture that includes an indication of any concealed threat item. The technology uses both artificial intelligence and augmented reality techniques to positively identify a threat and its exact location on subjects within its field of view. Multiple MiRIAD equipped UAVs can be supported by a single data processing facility to cover large areas.


29

MiRIAD's primary intended applications are outdoor public event crowd screening, special police and security service operations, and forward operating base protection. Other planned applications include remote infrastructure inspection and analysis; oil and gas pipeline inspection, and search and rescue (land and sea).

On August 31, 2020, the Company announced that it had produced definitive images of infrastructure corrosion utilizing its prototype MiRIAD Sensor system. This will provide a new and more importantly, low-cost capability for detecting civil and military aircraft fatigue, tanker and naval vessel corrosion, pipeline safety for oil and gas installations and infrastructure/bridge fatigue. The Company also believes that safe, passive detection will ultimately be applied to medical skin analysis for burns and next generation walk through detection for modern airport.

In Q1 2021 the Company updated the design of the MiRIAD sensors with digital signal processors to process the image data received from the sensors.

Due to funding issues from late 2021 until the current year ended November 30, 2022 the MiRIAD sensor development was put on hold. Management believes there is value to complete the product development when funding becomes available.

3. Wi-Ti Updates

Wi-Ti is a wall or portal mounted sensor system that will detect concealed threat items over an extended coverage area. It is ideal for covertly screening unstructured crowds to widen the security perimeter in public places.

The past four years have seen significant advances in the monitoring of Wi-Fi radio wave analysis. This includes Wi-Fi used to track and trace the movements of people in real time through walls. Similar techniques have used Wi-Fi radio waves to detect subtle changes in breathing and heart rates. The Company's Wi-Ti technology advances that analysis to concealed threat detection. Unlike other emerging screening technologies, Wi-Ti can be used in airport concourse areas, stadiums, and open spaces at stand-off distances. Our unique radar imaging and signal processing technology allows for non-intrusive screening of crowds in real time. Further, with Wi-Ti, there are no radio emissions, so this method of detection can be freely used in any Wi-Fi enabled environment without special license or regulatory approval.

On February 19, 2019, the Company signed a memorandum of understanding with Abicom International, a Qualcomm authorized design partner, to assist in the continued development of the Wi-Ti system and prototype. Abicom International has worked with many prominent security and technology companies, including Bosch Security, Siemens Transportation, QinetiQ, Harris Systems and Northern Light Technologies. Abicom International's status as a Qualcomm design center is an assurance of excellence that is granted to less than eleven companies globally". The partnership between Plymouth Rock and Abicom International is about the drive to continuously expand the realm of possibilities for Wi-Fi based technologies.

During December 2020, the Company prepared and filed a trademark application for the mark Wi-Ti Class 009 - System for detecting threats, such as concealed weaponry, within a Wi-Fi enabled environment and electronic filing of the same with the USPTO (United States Patent and Trademark Office).

Due to other priorities, the Wi-Ti R&D has been put on hold until funding is available. On October 10, 2022, the trademark application was marked as abandoned by the USPTO.

4. Shoe Scanner - SS1 Footwear Imaging Radar Technology

The SS1 is a floor-mounted 3D imaging system that uses harmless millimeter-wave imaging techniques to inspect footwear to determine if it has been altered or is being used to transport concealed items, such as weaponry, substances, compounds or electronic items. The SS1 can be used at security and identification checkpoints to eliminate the need for footwear removal, streamlining the security screening process and reducing bottle necks.


30

The Shoe Scanner allows for the rapid screening of footwear without necessitating removal of shoes. With a screening time of 30 persons per minute the Millimeter Wave Shoe Scanner is ideal for airport terminals, prisons/correctional facilities, public events and other high throughput, screening applications.

On March 12, 2019, Manchester Metropolitan University assigned the Millimeter Wave Shoe Scanning technology IP to the Company for the consideration of $30,000. The Millimeter Wave Shoe Scanner is a floor-mounted 3D imaging system that uses harmless millimeter-wave imaging techniques to inspect footwear. The scanner is then able to identify if the footwear has been altered or is being used to transport concealed items, such as weaponry, substances, compounds, or electronic items. As of October 8, 2019, the IP and patent transfer for this technology was completed.

On October 29, 2020, the Company received a "Notice of Allowance" by the US Patent and Trademark Office of patent application No. 16/560,480 for the "Method and System for Determining Dielectric Properties of an Object". The invention uses millimeter wave ("MMW") shoe-scanning technologies for fast, contactless screening of passengers' footwear in highly secure environments such as airports, prisons, border points of entry and government buildings On February 16, 2021, the Company was granted US Patent No.: 10,921,428 B1.

On February 22, 2022, Plymouth been awarded a CRADA for its SS1 Shoe Scanner system by the US department of homeland security. A CRADA is a written agreement that facilitates R&D collaboration between one or more federal laboratories and one or more non-federal entities.

Due to other priorities, the Shoe Scanner has been put on hold until funding is available.

Principal Markets

The Company's principal business activity through its subsidiary, Plymouth Rock USA ("PRT USA"), focused on developing technologies related to remotely detecting assault firearms and suicide bombs concealed on the person or a carry bag. The Company focuses on detection methods with and without the need for a checkpoint of the suspect who is being screened. The Company's planned products encompass the very latest radar, imaging, and Unmanned Aerial System ("UAS") technologies for quickly detecting, locating and identifying the presence of threats and for search and rescue missions for law enforcement.

The Company operates in one business segment, focusing on developing technologies. The Company's revenues were generated in the US and UK were mostly composed of sales of engineering design services and radar components to well-known government agencies and prime contractors. All the long-lived assets are located in the US as of November 30, 2022, 2021 and 2020. The following table summarizes the revenue by geographical location:


31

 
      Canada     USA     UK     Total  
For the year ended November 30, 2022                        
  Revenues $ -   $ 154,625   $ 452,734   $ 607,359  
  Gross Profit   -     97,115     319,069     416,184  
For the year ended November 30, 2021                        
  Revenues $ -   $ 79,795   $ 104,601   $ 184,396  
  Gross Profit   -     27,703     53,584     81,287  
For the year ended November 30, 2020                        
  Revenues $ -   $ 70,931   $ -   $ 70,931  
  Gross Profit   -     39,615     -     39,615  

The Company serves the Aerospace component market in North America( Dana please fill in ) The global millimeter wave technology market size was valued at USD 700 million in 2021 and is estimated to reach an expected value of USD 8.84 billion by 2030, registering a CAGR of 37.3% during the forecast period (2020 - 2030).2

The Company also serves the Military and Defense Unmanned Aircraft Systems market. The global military drone market size was valued at USD 10.25 billion in 2021 and is projected to grow from USD 11.73 billion in 2022 to USD 30.86 billion by 2029, exhibiting a CAGR of 14.82% during the forecast period.3

Seasonality

The Company's business is not effected by seasonality.

Sources and Availability of Raw Materials 

We do not require or anticipate requiring any uncommon raw materials for manufacturing of our planned products. Our planned products will rely on common electronic components and materials which are not subject to significant price volatility.

Marketing Channels

The Company has a consultative sales model. Our philosophy is rooted in building a relationship. We develop a holistic and nuanced understanding of our clients' needs and aim to fulfill those needs with a customized solution.

Patents and Licenses

In conducting our business operations, we are dependent on certain proprietary or licensed technology, designs, and other intellectual property. We currently hold the United Kingdom patent for the Shoe Scanner technology for a term of 15 years. The patent number is GB2516410.

In October 2020, we received a Notice of Allowance by U.S. Patent and Trademark Office of patent application No. 16/560,480 for the "Method and System for Determining Dielectric Properties of an Object" used for the Shoe Scanner. We have not obtained any other patents, patents applications or trademarks in connection with our products or planned products and have no plans to do so in the immediate future. We intend to protect our intellectual property primarily through a combination of trade secrets, license restrictions, and copyright.

Our business or profitability are not dependent on the above patent and patent application related to the Shoe Scanner technology

Economic Dependence on Industrial Commercial and Financial Contracts; and New Manufacturing Processes

_____________________________
2
See: https://straitsresearch.com/report/millimeter-wave-technology-market

3 See: https://www.fortunebusinessinsights.com/military-drone-market-102181


32

The Company is economically dependent on its ability to win military, government, law enforcement and industrial commercial contracts. This includes third party contracts with government prime contractors and federal procurement companies. Our ability to win these contracts is a function of maintaining our technical competitive edge, specifically in regard to new materials and the techniques to utilize them, in relation to our competitors.

For summary information regarding our specific contracts, see "Our Technologies" in Item 4.B. above.

Competition

We are an Aerospace & Defense and UAV / UAS technology company. We compete with other technology companies for financing and for market share in our fields of specialization. Many of the companies with whom we compete have greater financial and technical resources than those available to us. Accordingly, these competitors may be able to spend greater amounts on the acquisition, development, and commercialization of technologies of merit. In addition, they may be able to afford more scientific or engineering expertise in the development of their technologies. This competition could result in competitors offering products of greater quality and interest to prospective investors who may finance additional development and commercialization. This competition could adversely impact on our ability to finance further product development and to achieve the financing necessary for us to develop our business. Where we differ from large aerospace companies is that we design, develop, and rapidly prototypes fully autonomous unmanned aircraft with a singular focus on delivering mission ready autonomous capabilities. Our key differentiator is the ability to understand the mission and deliver complete purposeful aerospace capabilities on a rapid / just in time basis. (JIT)

In recent tenders issued by the United States Department of Defense (DoD) and the UK Ministry of Defense (MoD), The UK Home Office and the US Federal Government, our technologies and technical services have been chosen for trial, purchase or are in final selection for larger scale projects. Our competitive position is that we offer truly autonomous technologies as opposed to the legacy Remote Piloted Aircraft Systems (RPAS) that the many NATO coalition defense forces currently use.

Compliance with Government Regulation

Our business is subject to laws and regulations governing the production, sale and use of UAV, UAS, surveillance, threat detection and security technology, including but not limited to regulation regarding public safety, personal privacy, public transportation, criminal law, consumer protection, exports, taxes, labor standards, occupational health, waste disposal, toxic substances, environmental protection, and other matters. Legislation such as the U.S. Airport Security Federalization Act, the U.S. Aviation and Transportation Security Act and the Canadian Aviation Security Act and their respective associated regulations, and all other applicable Federal, State, Provincial and municipal laws. The testing, marketing, and sale of our current and future products may require permissions or permits from various governmental and nongovernmental authorities. There can be no assurance, however, that all permissions or permits will be obtainable or achievable on reasonable terms or that compliance with such laws and regulations would not have an adverse effect on the profitability of any product that we may develop or seek to market.

In the U.S., the Federal Aviation Administration, or the FAA, one of several modal organizations within the Department of Transportation, or the DOT, is the regulatory agency with authority to oversee the safety of aircraft operations in the national airspace system of the United States, or the NAS. By statute, the U.S. Congress has vested the FAA with authority to regulate airspace use, management and efficiency, air traffic control, safety, navigational facilities, and aircraft. By contrast, the DOT retains regulatory control over all economic authority granted to commercial operations of aircraft. Thus, in addition to any FAA approvals and authorization required for operation of aircraft within the NAS, each aircraft operator conducting commercial operations must also be issued and hold economic authority (or an exemption) from the DOT. UAS are considered a category of aircraft for purposes of regulation by the FAA and the DOT. Our UAS and their operations are therefore subject to the approval by both the FAA and the DOT.

With respect to UAS operations in the NAS, the FAA currently has the authority to promulgate and enforce restrictions regarding (i) the types of flights that may be conducted; (ii) the equipment that may be used to conduct those flights; and (iii) the training required. The regulatory framework applicable to a particular UAS operation is determined by whether (a) the UAS is used by a government agency, for commercial purposes, or as a model aircraft; and (b) whether at takeoff the UAS (including any attachments) weighs less than 55 pounds (Small UAS), or equal to or more than 55 pounds (Large UAS). As a result of this regulation, commercial use and delivery of our UAS is and in the near future is expected to continue to be subject to an uncertain or lengthy approval process. We are unable to estimate the average length of time required to obtain the applicable regulatory approvals due to the nascent nature of UAS regulations and the lack of relevant precedents. We cannot predict when these regulations will change, and any new regulations may impose onerous requirements and restrictions.


33

Failure to comply with applicable laws, regulations and permitting requirements may result in enforcement actions thereunder, including orders issued by regulatory or judicial authorities causing the marketing, sale, or use of our products to be curtailed.

Amendments to current laws, regulations and permits governing the intended use of our technologies, or more stringent implementation thereof, could have a material adverse impact on our business and cause increases in capital expenditures or production costs, or require abandonment or delays in development of new products.

We are committed to complying with and are, to our knowledge, in compliance with, all governmental regulations applicable to our Company and our planned products.

C. Organizational Structure

The following table sets out the Company's subsidiaries as of the date of this Annual Report.

Entity Country of Incorporation Ownership Interest
Plymouth Rock Technologies Inc. USA 100%
Plymouth Rock Technologies UK Limited UK 100%
Tetra Drones Ltd. UK 100%

Plymouth Rock USA was incorporated under the General Corporation Law of the State of Delaware on March 22, 2018. Plymouth Rock UK was incorporated under the General Corporation Law for England and Wales on March 26, 2021. Tetra Drones was incorporated under the General Corporation Law for England and Wales on August 8, 2017. 

D. Property, Plants and Equipment

Our Company's operating office is located in an office space in Plymouth, Massachusetts. In November 2018, Plymouth Rock USA entered into a two-year lease agreement for leased premises in Plymouth, Massachusetts, commencing December 1, 2018, and ended on November 30, 2020. The minimum base rent was US$2,917 per month for the period from December 1, 2018, to November 30, 2019, and US$3,005 per month from December 1, 2019, to November 30, 2020.

Effective December 1, 2020, the Company exercised its option to renew the lease for three additional years. After renewal, the minimum base rent is US$3,095 per month for the period from December 1, 2020, to November 30, 2021, US$3,188 per month from December 1, 2021, to November 30, 2022, and US$3,284 per month from December 1, 2022, to December 30, 2022. On December 31, 2022, the Company terminated the lease as per mutual agreement with landlord.

In February 2021, we located a UK facility for the manufacture of multirotor drones. On May 1, 2021 the company entered into a 3 year lease for a facility in Kings Lynn, Norfolk UK for the sum of £1,000 GBP per month with additional utilities that vary, due to the fact it was located in a 55 acre field, we negotiated as part of the lease with the Landlord for the sum of £1,500 per annum for a flying license allowing us to test and demonstrate drones at the facility, this is billed monthly and paid alongside the lease for a sum of £125 GBP per month. We intend to continue with this lease as it fits the requirements of the business.


34

Upon the acquisition of Tetra Drones Limited, we inherited a facility in Lincoln, Lincolnshire UK, for the primary purpose of R&D and Low-Rate Initial Production (LRIP) of small to large fixed-wing drones. The facility lease was transferred in 2022 to PRT and is currently on a month-by-month basis at a minimum rental of £700 GBP and a £268 GBP a quarter for service fees, with additional utilities that vary.

We believe that our existing facilities are adequate to meet our needs for the foreseeable future, unless applicable United States governmental authorities require us to manufacture our UAVs exclusively in the United States.  

ITEM 4A. UNRESOLVED STAFF COMMENTS

Not applicable.

ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS

The following discussion and analysis of our financial condition and results of operations for the fiscal year ended November 30, 2022, should be read in conjunction with our financial statements and related notes included in this Annual Report in accordance with "Item 8 - Financial Information"). Our financial statements for the fiscal year ended November 30, 2022, were prepared in accordance with IFRS and are expressed in Canadian Dollars.

A. Operating Results

Year Ended November 30, 2022

During the year ended November 30, 2022, the Company had a comprehensive loss of $2,739,060 compared to a comprehensive loss of $4,944,231for the year ended November 30, 2021. The decrease in comprehensive losses were primarily driven by the following:

  • Sales during the year ended November 30, 2022, amounted to $607,359 (November 30, 2021 - $184,396) with gross profit of $416,184 (November 30, 2021 - $81,287) resulting in a gross margin of 69% (November 30, 2021 - 44%). The Company's sales for the year include waveguide components and sale of services for drone builds. The increase in gross margin resulted from lower cost of sales relating to improving product yields by creating new process control documentation and by the higher gross margins of the newly acquired subsidiary stemming from efficient processes and economies of scale.
  • Accounting and audit fees of $223,247 (November 30, 2021 - $80,162). The amount increased in the current period due to the additional fees to auditors and accountants for the 2021year end financial audit which spilled over through the first two quarters of the year due to complexities brought about by the set-up of a new company and the acquisition of a new subsidiary as well as additional accounting fees for the UK subsidiary.
  • Amortization in the amount of $286,743 (November 30, 2021 - $143,783) pertains mostly to amortization of customer relationships acquired from Tetra Drones, equipment and right-of-use asset due to the recognition of the Company's leased premises in accordance with IFRS 16.
  • Selling expenses of $177,428 (November 30, 2021 - $709,010) decreased due to timing of various business development initiatives. In the current and prior period, the main selling expenditures were on native ad campaigns.
  • Consulting fees of $143,539 (November 30, 2021 - $456,296) decreased during the period due to transition of a previous officer who now acts as a consultant for the Company.
  • Consulting fees related to research and development of $182,774 (November 30, 2021 - $930,269) decreased mainly due to general administrative this year.
  • General office expenses of $153,403 (November 30, 2021 - $205,710) were slightly lower as a result of fewer activities during the third and fourth quarter of this year.

35

  • Legal fees of $77,011 (November 30, 2021 - $191,686) decreased as in previous period due to the decline in legal fees relating to the acquisition of Tetra Drones, the absence of the set-up fees for the new subsidiary in the UK partially offset by fees relating to the MCTO and other legal consultations.
  • Management fees of $311,535 (November 30, 2021 - $118,000) increased due to management changes during the year.
  • Rent of $47,317 (November 30, 2021 - $42,822) is slightly high due to the additional rent brought by the acquisition of Tetra Drones in the previous year.
  • Stock-based compensation of $Nil (November 30, 2021 - $1,144,342) refers to the portion of the value of the stock options granted by the Company which are expensed during the period. No stock options were granted during the year.
  • Transfer agent and filing fees of $59,385 (November 30, 2021 - $82,825) decreased since there were no issuance of shares, closing of a private placement and related compliance which were done in the same period last year.
  • Wages, salaries and benefits of $985,916 (November 30, 2021 - $817,858) is higher because of expansion of company business overall and acquisition of UK subsidiaries.
  • Foreign currency translation loss of $71,358 (November 30, 2021 - gain of $30,603) recognized in other comprehensive income is the result of translating assets, liabilities and equity of the Company's US and UK entity to Canadian dollars for consolidated financial reporting purposes. The increase in loss was due to unfavorable foreign exchange movements during the year.

B. Liquidity and Capital Resources

The Company's approach to managing its liquidity is to ensure that it has sufficient resources to meet its liabilities as they come due and have sufficient working capital to fund operations for the ensuing fiscal year. Financing of operations has been achieved solely by equity financing. The Company anticipates that it will require significant funds from either equity or debt financing for the development of its technologies and to support general administrative expenses.

At year ended November 30, 2022, the Company had $62,202 in current assets (November 30, 2021 - $632,538) and $2,087,875 in current liabilities (November 30, 2021 - $706,666) for a working capital deficiency of $2,025,673 compared to a working capital deficiency of $74,128 as at November 30, 2021. The increase in working capital deficit is mostly driven by the operating cash outflows and the increase in accounts payable and amounts due to related parties.

As at November 30, 2022, the Company had a share capital balance of $11,851,771 (November 30, 2021 - $11,834,582) and an accumulated deficit of $16,535,760 (November 30, 2021 - $13,867,962). The increase in share capital is only due to the shares issued for consulting services during the quarter.

Financing of operations has been achieved solely by loans and equity financing. However, the Company expects to generate profitable revenue in the coming years with adequate investment to support adding experienced manufacturing personnel and capital equipment. Currently the Company is primarily reliant upon the sale of equity securities, loans and some product sales in order to fund future operations. Since inception, the Company has funded limited operations through the issuance of equity securities on a private placement basis. The Company's ability to raise funds through the issuance of equity will depend on economic, market and commodity prices at the time of financing.

The Company expects to generate similar losses quarter over quarter for the next fiscal year in relation to the Company's development, administration, and promotion of its technologies. As of report date, management anticipates that the funds raised to date will be sufficient to sustain operations and the development of the Companies technologies for the next fiscal year.

Detailed discussions related to the Company's cash flows during the year ended November 30, 2022

Cash balances decreased by a total of $343,724 during the year ended November 30, 2022 (November 30, 2021 - increased by $311,997). In the previous period, the cash increased due to the issuance of shares through private placement and shares issued in relation to warrants exercised and options exercised. This year, the decline in cash balance resulted mainly from operating expenditures (see "Operating Results" above).


36

During the year ended November 30, 2022, cash used in operating activities was $414,023 compared to cash used in operating activities of $3,441,102 during the year ended November 30, 2021. The decrease in cash used came mostly from a lower loss in 2022 resulting from lower business development expenditures, offset by debt forgiveness, and an increase in accounts payable and due to related party balance.

Cash used in investing activities during the year ended November 30, 2022, was $Nil (November 30, 2021 - $573,343). There wasn't a business acquisition in 2022 nor was there any additional equipment purchased during the period.

Cash used in financing activities during the year ended November 30, 2022, was $70,299 compared to cash provided by financing activities of $4,326,442 during the year ended November 30, 2021. The decrease was primarily due to the absence of private placement completed during the current year in addition to option and warrant exercises which were present last year. This was reduced by lease payments and increased from some loan received during the year.

The effect of foreign exchange rates on cash during the year ended November 30, 2022 amounted to a gain of $18,195 (November 30, 2021 loss - $38,336).

C. Research and Development, Patents and Licenses, etc.

The Company has acquired its technology and intellectual property through acquisition. The following table sets out research and development expenditures during the fiscal years ended November 30, 2022, November 30, 2021 and November 30, 2020:

    Year ended November  
Research and Development   2022     2021     2020  
Labor $ 182,774   $ 930,269   $ 386,044  
Materials   50,491     54,737     -  
Total $ 233,265   $ 985,006   $ 386,044  
 
    For the years ended November 30,        
    2022     2021     2020  
Research and Development by Technology   $     $     $  
Aerowave   17,138     57,181     1,452  
X-1   78,887     484,850     184,634  
XV   31,186     129,352     -  
Shoe Scanner   35,959     232,501     73,493  
CODA   70,095     75,816     2,632  
MiRIAD   -     5,306     100,887  
Wi-Ti   -     -     22,946  
Total   233,265     985,006     386,044  

The following table provides a breakdown by technology of the Company's expenditures on its developing technologies recognized in R&D expenses for the fiscal years ended November 30, 2022, November 30, 2021 and November 30, 2020:

  For the year ended November 30, 2022 
Demo Equipment Capitalized Cost - USD Cost - GBP Cost - CAD
  $ £ $
X1 - 1 51,869 9,876 86,057
X1 - 2 21,957 - 29,660
X1 - 3 2,435 - 3,289
X1 - 4 2,435 - 3,289
X1 - 5 2,435 - 3,289
X1 - 6 2,435 - 3,289
XV 26,068 48,675 114,032
Impairment of demo equipment (109,634) (58,551) (236,677)
Foreign currency translation adjustment - - (6,228)
Total - - -
 

37

The R&D expenses incurred for the X1/XV and shoe-scanner were primarily design and process documentation related. The CODA expenses were related to testing of prototypes and software discovery and upgrades. Tetra expense was for the transfer of "know-how" of the Tetra products and the MiRIAD expense was for NDT (Non- Destructive Testing) of various infrastructure for structural integrity. The Company determined that the demo equipment is unable to generate economic benefit as at November 30, 2022 and recorded an impairment loss of $236,667.

The Company has a continuous improvement program in the UK in regard to its aerospace products. This research and development is heavily dependent on key personnel and their abilities to utilise the latest capabilities in design, Computational Fluid Dynamics, rapid prototyping and a deep expertise in technical aeronautical knowledge, satcom and wireless technologies, machine learning and neural networks.

D. Trend Information

Other than as disclosed elsewhere in this Annual Report and specifically in "Item 4.B. Business Overview," we are not aware of any trends, uncertainties, demands, commitments or events that are reasonably likely to have a material effect on our net revenues, income from operations, profitability, liquidity or capital resources, or that would cause the disclosed financial information to be not necessarily indicative of future operating results or financial condition.

The following table summarizes selected financial data for our Company for the fiscal years ended November 30, 2022, 2021, 2020, 2019, and 2018, respectively, prepared in accordance with IFRS as issued by the IASB. The information in the table is expressed in Canadian Dollars was extracted from the detailed financial statements and related notes included in this Annual Report and should be read in conjunction with such financial statements.

Selected Financial Data

(CAD$)

Consolidated Statements of (Loss)
Income Data
Year Ended
November 30
2022 
(audited) 
($)
2021 
(audited) 
($)
2020 
(audited) 
($)
2019 
(audited) 
($)
2018 
(audited) 
($)
Revenues 607,359 184,396 70,931 28,257 Nil
Operating Expenses (2,756,673) (5,014,097) (3,064,180) (3,044,810) (681,655)
Comprehensive Loss (2,739,060) (4,944,231) (2,904,690) (4,320,563) (986,901)
Loss Per Share Basic and (0.05) (0.09) (0.08) (0.14) (0.04)
Common Shares Outstanding 59,310,826 59,239,336 42,762,264 32,796,600 31,761,300
 
Consolidated Statements of
Financial Position Data
As at November 30
2022 
(audited) 
($)
2021 
(audited) 
($)
2020 
(audited) 
($)
2019 
(audited) 
($)
2018 
(audited) 
($)
Current Assets 62,202 632,538 79,919 727,526 2,811,971
Current Liabilities 2,087,875 706,666 322,738 227,058 166,941
Working Capital (Deficit) (2,025,673) (74,128) (242,819) 500,468 2,645,030
Total Liabilities and Shareholders' Equity 148,201 1,549,139 261,385 739,990 3,893,973
Deficit (16,535,760) (13,867,962) (8,893,128) (5,968,892) (1,602,085)
 

38

E. Critical Accounting Estimates

The Company's financial statements included in this Annual Report were prepared in accordance with IFRS and as issued by the IASB. For a description of critical accounting estimates and other significant accounting policies please refer to the notes to the Company's audited financial statements included under Item 18 Financial Statements in this Annual Report.

ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES

A. Directors and senior management

The following table sets forth our current directors and senior management as well as our directors and senior management as at financial year-end November 30, 2022:

Name Position(s) Held with Company Principal Business Activities and Other 
Principal Directorships
Carl Cagliarini Interim Chief Executive Officer and Director
 
Interim CEO since February 3, 2023, and Director since January 22, 2022 Co-Founder of the Company. Chief Strategy Officer of the Company since 2018. 
Dana Wheeler President and Chief Executive Officer (until February 3, 2023)
Director
President, Chief Executive Officer of Plymouth Rock Technologies Inc. from October 30, 2018, until February 3, 2023, Director since October 30, 2018; Business Development Advisor, Serco, Inc. from
June 2017 to June 2018; Chief Executive Officer and managing director, Radio Physics Solutions, October 2009 to
December 2016.
Susan J Gardner Chief Financial Officer (since January 13, 2022) Chief Financial Officer of the Company since 2022; VP, Controller & Treasurer of Boston Mutual Life Insurance Co. from Jun 2005 to Aug 2021.
Zara Kanji Chief Financial Officer (until November 22, 2021)
Director (since April 10, 2023)
Owner, Zara Kanji & Associates, CPA, 2003 to present; Chief Financial Officer of Megastar Development Corp., September 2011 to present; Chief Financial Officer of World Class Extractions October 2018 to present; Chief Financial Officer of INEO Tech Corp January 2019 to present; Chief Financial Officer of TechX Technologies Inc. March 2021 to present.
Philip Lancaster President, Secretary, and Director
 
Director since June 6, 2022, and President and Secretary since February 3, 2023. Director West Riding Consultancy 2020. 2016-2020 SVP Patriot One Technologies.
Vivian Katsuris Secretary and Director (until March 16, 2022)
Interim Chief Financial Officer (from November 22, 2021 until January 13, 2022)
Secretary of the Company from August 2014 to March 2022; President and Founder of Vivkor Holdings Inc. since August 2014; Director and Corporate Secretary of ArcPacific Resources Corp. (formerly Plate Resources Inc.) from January 2014 to July 2016 and CFO from June 2015 to July 2016; Investment Advisor at Global Securities Corporation from 2003 to 2013; Director of KAPA Capital Inc., February 2018 to August 2022, and Corporate Secretary until May 2022; Director of Brascan Gold Inc, September 2020 to February 2023: Director of Zenith Capital Corporation, December 2019 to Present; Director of ACME Lithium Inc. November 2020 to present; Director of Colossus Resources Corp from October 2020 to present.
 

39

 
Name Position(s) Held with Company Principal Business Activities and Other 
Principal Directorships
Douglas Smith Chairman and Director Managing Director at Kent Strategies LLC and Executive Vice President for MWW Group LLC. In the past he occupied the position of Managing Partner at T-Street Capital LLC and Assistant Secretary at United States Homeland Security Council. Douglas A. Smith received an undergraduate degree from Beloit College and an undergraduate degree from SIT Graduate Institute.
Khalid M. Al-Ali Director Founder of Grupo Senseta, Inc. and Silicon Valley Space Business Roundtable, Khalid Al-Ali is Executive Chairman for Grupo Senseta, Inc. and Chairman for Silicon Valley Space Business Roundtable.
Thomas Nash Director (until March 31, 2023) Founder of Xalles Holdings, Inc., Thomas W. Nash presently is Chairman, President, CEO, CFO & Secretary at this company and President for Xalles Technology, Inc., President at Xalles Financial Services, Inc. and President & Director at Co-Owners Rewards, Inc. (which are all subsidiaries of Xalles Holdings, Inc.). Mr. Nash is also on the board of 5 other companies. Thomas W. Nash previously was Chief Operating Officer of Three2N International, Inc.
Angelos Kostopoulos Director (until July 19, 2022) Partner with Nakou & Associates Law Firm from March 2004 to Present focusing on tax and financial compliance; Director of Blue White Capital LLC from August 2011 to Present; Manager for Enron Wind from October 1998 to December 2001; Manager for GE Wind from January 2002 to February 2004; COO for UPC Renewables from July 2006 to January 2009.
Timothy Crowhurst Director (until January 5, 2022) President of Sea Level Communications Ltd., and a former Administrative Tribunal Judge of the Immigration Appeal Division of Canada's Immigration and Refugee Board

Carl Cagliarini- Interim Chief Executive Officer, Director (Age: 51)

Carl Cagliarini has been a director of our Company since January 13, 2022, our Chief Strategy Officer since 2018, Mr. Cagliarini has been the primary lead on product acquisition since the company inception and currently leads the company technical direction and is the primary liaison with defense agencies, government prime contractors and drives organic sales. Mr. Cagliarini was appointed Interim CEO on February 3, 2023.


40

Mr. Cagliarini serves as a pro bono Chairman and Governor for the UK department of Education and Northwest Academies Trust Ltd., The education establishments he governs were recognized for excellence in Special Educational Needs by the UK Government review 2017. Mr. Cagliarini also works closely with the UK Department of Industry and Trade on the promotion of UK and Commonwealth defense and security technologies, which includes working with the UK Home Office and several UK universities on counter terror technology spin out. Mr. Cagliarini is classed as subject matter expert in the unmanned systems and laser-based technologies industry and is a co-author on patents application relating to drone swarming technologies for electronic warfare and synthetic aperture radar. From 2012 to 2016 he served as the industrial lead on a failing UK government program for counter terror which after several months of his input delivered as a working prototype, and a year later a working product.

Prior to this Mr. Cagliarini was an innovator and business development specialist in wireless communication programs for major vendors which included multi-million-dollar technology sales to cellular companies which enabled the 3G / 4G / 5G data revolution. Mr Cagliarini's work is recorded in peer reviews including the ITU Birth of Broadband, which records networks designed and built by Mr. Cagliarini as first of their kind. Prior to this he worked on managing military communication scopes incuding laser programs including the NASA STRV / STRV-2 projects.

Dana Wheeler-Director, Former President and Chief Executive Officer (Age: 62)

Dana Wheeler has been a director since October 30, 2018 and was the President and Chief Executive Officer of our Company from October 30, 2018 to February 3, 2023.

Mr. Wheeler is a customer focused executive with over 35 years of experience in hands-on leadership and engineering roles including CEO, COO, and VP of Engineering. His extensive background includes helping technology start-ups and growth companies launch/establish engineering operations, raise capital, and develop products specialties. In 2009 he co-founded Radio Physics Solutions Inc., a threat detection technology company where he served as president until 2016. From 1997 to 2008, he served as Chief Operating Officer of Terabeam-HXI, a wireless data equipment company. Currently, in addition to his role at Plymouth Rock, he is the principal of Wheeler Engineering Services, a firm providing engineering and business consulting services to the Microwave and Millimeter-Wave industry. Mr. Wheeler holds a Bachelor of Science in Electronics Engineering Technology from the University of Massachusetts Dartmouth.

Susan J Gardner-Chief Financial Officer (Age: 64)

Susan J Gardner was appointed Chief Financial Officer of the Company on January 13, 2022.

Ms. Gardner has over 40 years in the accounting industry. She was previously VP, Controller & Treasurer of Boston Mutual Life Insurance Co. from June 2005 to August 2021.

Zara Kanji-Director (Age: 52)

Zara Kanji has been a director since April 10, 2023, and was CFO of the Company from January 15, 2018 until November 22, 2021.

Ms. Kanji is the founder of Zara Kanji & Associates, CPA and is experienced in financial reporting and compliance for junior listed companies, including taxation, general accounting, financial reporting, and value-added advisory services. She has served as board director and Chief Financial Officer for several listed issuers, where she provided reporting and compliance services for financing and acquisitions. Furthermore, Ms. Kanji is a member of the Chartered Professional Accountants of British Columbia and Canada, as well as a member of Certified General Accountants Association since August 2003. She holds a Bachelor of Technology in Accounting (Honours) and a Diploma in Corporate Finance (Honours) from the British Columbia Institute of Technology. 

Philip Lancaster - President, Secretary, Director (Age: 53)


41

Philip Lancaster has been a director since June 6, 2022, and has also been President and Secretary since February 3, 2023.

Phil Lancaster brings several years of public company experience from his several years of tenure as SVP Business Development & Government Relations at Patriot One Technologies. Prior to this role Phil worked internationally as a British Police Officer in VIP close protection, as well as international service in British Overseas Territories. Throughout his career, Phil received several notable awards for his efforts in the UK and overseas. Through Phil's work in diplomatic protection, and Patriot One Technologies, he has established an extensive global network of contacts that range from government to law enforcement agencies. Phil has written several journal articles focused on the future of soft target hardening and innovation. In addition to his role as a director, Phil will also be taking a management role, assisting in the commercial exploitation of the company's technologies to law enforcement and state security agencies.

Vivian Katsuris-Former Secretary, Director (Age: 58)

Vivian Katsuris was Secretary from August 11, 2014 until March 16, 2022, and director from January 13, 2022 to March 16, 2022.

Ms. Katsuris was appointed Chief Financial Officer and Secretary on August 11, 2014. On November 20, 2017, she resigned as CFO and was appointed President, Chief Executive Officer, and as a director. On October 31, 2018, she resigned as President, CEO and director, but remained Secretary until March 16, 2022. On November 22, 2021, Ms. Katsuris acted as interim Chief Financial Officer, in addition to her role as Secretary, from November 22, 2021, until January 13, 2022 and was a director of the Company from January 13, 2022 until March 16, 2022.

Ms. Katsuris has over 30 years of experience in the brokerage industry, the North American capital markets & public financings. She was an Investment Advisor at Global Securities Corporation from 2003 to 2013 and worked at Canaccord Capital Corp. (Canada and U.S. divisions) from 1993 to 2003. Ms. Katsuris has served on the board as an officer and director of Universal Ventures Inc (TSX-UN) and Plate Resources Inc (TSX-PLR), Kapa Capital Inc. (TSXV-KAPA.P), Brascan Gold Inc. (CSE-BRAS) and also current serves as a director of Zenith Capital Corporation Inc (TSXV-ZENI.P), ACME Lithium Inc (CSE-ACME), and officer and director of Colossus Resources Corp (TSXV-CLUS).

Douglas Smith-Chairman, Director (Age: 55)

Douglas Smith has been a director since April 29, 2020, and Chairman of the Board of Directors since May 13, 2020.

Mr. Smith is the former Assistant Secretary for the U.S. Department of Homeland Security. Douglas is currently the Managing Partner of Kent Strategies and brings over two decades of international experience in business development, communications, coalition building, public policy, and creating and managing public-private partnerships among Federal, State and local governments, and private industry. He has managed large-scale special projects and initiatives both within and outside of government. Douglas is a frequent public speaker both domestically and internationally and regularly appears on national television as an expert on national security and managing crisis.

Khalid M. Al-- Director (Age: 52)

Dr. Khalid M. Al-Ali has been a director of our Company since July 8, 2020.

Dr. Al-Ali brings deep experience and expertise to his roles in various organizations, having spent much of his career in Silicon Valley. He is the Co-Founder and Executive Chairman of Senseta, a world leader in mission-critical big data fusion, artificial intelligence and drone-powered deep technologies. He is the Co-Founder and Chairman of the Silicon Valley Space Business Roundtable. He was the Executive Director of the University of California Office for NASA Partnerships and the University Affiliated Research Center. Dr. Al-Ali was the advisor to the Board of Directors of Qatar Foundation and CEO of the Qatar Science and Technology Park Project. He was a founding member of both Qatar's Information Technology and Communication Committee and the Steering Committee of the Information Technology and Communication Project. Dr. Al-Ali is the principal inventor of U.S. and worldwide-patented technologies, along with a multitude of disclosed inventions not yet patented. He holds a Ph.D. in Mechanical and Electrical Engineering from the University of California at Berkeley and dual B.S. degrees in Mechanical and Aerospace Engineering from the University of Colorado at Boulder.


42

Thomas Nash-Former Director (Age: 57)

Thomas W. Nash was a director of our Company from July 31, 2020 to March 31, 2023.

Mr. Nash is the Chairman and CEO of Xalles Holdings Inc., a Fintech holding company. Mr. Nash has provided strategic business advice to more than 200 firms worldwide from small firms to large organizations such as U.S. Bank, MasterCard, and Citibank. He also led the implementation of financial systems within the U.S. Government's Department of Defense and Department of Homeland Security as well as helped launch successful startup ventures in the payment, eCommerce and IT fields.

Angelos Kostopoulos-Former Director (Age: 65)

Angelos Kostopoulos was a director of our Company from November 20, 2018 to July 19, 2022.

Mr. Kostopoulos is a Registered Tax Return Preparer as designated by the Internal Revenue Service, and has been a tax adviser listed by the U.S. Embassy in Athens since 1992. Currently he is a partner at Nakou & Associates Law Firm (Athens, Greece), and Strati & Partner (Tirana, Albania), where he advised clients on a wide range tax and financial compliance matters. Since 2011 he has served as the president of Blue White Capital LLC a privately held, climate-friendly project developer, integrator, principal and boutique advisory firm. Mr. Kostopoulos holds a Bachelor of Arts (History) from Arizona State University, a Master of Arts (International Relations) from Indiana University Bloomington, a Master of Science (Military Science) from the Hellenic Army Supreme War College, and a Master of Laws (International Business) from the University of Cumbria.

Tim Crowhurst - Former Director (Age: 56)

Tim Crowhurst was a director of our Company from July 13, 2019, to January 5, 2022. He was also a director of our Company from October 17, 2011 to July 30, 2013.

Mr. Crowhurst is President of Sea Level Communications Ltd., and a former Administrative Tribunal Judge of the Immigration Appeal Division of Canada's Immigration and Refugee Board. He brings to Plymouth a long history in managing public companies, as well as a strong understanding of border security measures and international immigration movements. Prior to commencing a successful issue and crisis management consultancy in 1993, he was an advisor to several Canadian Cabinet Ministers.

Family Relationships

There are no family relationships among any of our directors and senior management listed above.

B. Compensation

During the years ended November 30, 2022 and November 30, 2021, compensation was paid (which includes contingent or deferred compensation accrued for the year, even if the compensation is payable at a later date) to our directors and officers as follows:


43

 
COMPENSATION TABLE
Name
and Principal
Position
Year Salary
($)
Bonus
($)
Stock
Awards
($)
Option
Awards
($)
Non-Equity
Incentive
Plan
Compensation
($)
Change in
Pension
Value and
Nonqualified
Deferred

Compensation
Earnings
($)
All
Other
Compensation
($)
Total
($)
Carl Cagliarini
Interim CEO and Director(1)
2022
2021
243,387
Nil
 
Nil
Nil

 
Nil
Nil

 
Nil
Nil

 
Nil
Nil

 
Nil
Nil
Nil
Nil
243,387
Nil

 
Dana Wheeler
Director
Former President and CEO(2) 
2022
2021
 

 
330,337
313,626
 
Nil
Nil

 
Nil
Nil

 
Nil
133,276
Nil
Nil

 
Nil
Nil
Nil
Nil
330,337
446,902

 
Susan J Gardner
Chief Financial Officer(3)
2022
2021
 
68,148
Nil
Nil
Nil
Nil
Nil
Nil
Nil
 
Nil
Nil
Nil
Nil
Nil
Nil
68,148
Nil
 
Zara Kanji
Director
Former Chief Financial Officer(4)
2022
2021
 
Nil
55,000
 
Nil
Nil
Nil
Nil
Nil
33,319
 
Nil
Nil
Nil
Nil
69,486
41,202(5)
 
69,486
129,521
 
Philip Lancaster
President, Secretary
Director (6)
2022
2021
 
75,000
Nil
Nil
Nil
Nil
Nil
Nil
Nil
Nil
Nil
Nil
Nil
Nil
Nil
75,000
Nil
 
Vivian Katsuris
Former Secretary and Director(7)
2022
2021
60,000
63,000
 
Nil
Nil
Nil
Nil
Nil
33,319
 
Nil
Nil
Nil
Nil
Nil
Nil
60,000
96,319
Douglas Smith
Chairman and Director
2022
2021
 
Nil
Nil
Nil
Nil
17,188(8)
307,734(8)
Nil
1,536
 
Nil
Nil
Nil
Nil
Nil
Nil
 
17,188
309,270
 
Khalid M. Al-Ali
Director
2022
2021
Nil
Nil
Nil
Nil
Nil
Nil
Nil
99,000
Nil
Nil
Nil
Nil
Nil
Nil
Nil
99,000
Thomas Nash
Former Director(9)
2022
2021
Nil
Nil
Nil
Nil
Nil
Nil
Nil
99,000
Nil
Nil
Nil
Nil
Nil
Nil
Nil
99,000
Angelos Kostopoulos
Former
Director(10)
2022
2021
 
Nil
Nil
Nil
Nil
Nil
Nil
Nil
479
Nil
Nil
Nil
Nil
Nil
Nil
Nil
479
 
Tim Crowhurst
Former Director(11)
2022
2021
Nil
Nil
Nil
Nil
Nil
Nil
Nil
10,204
Nil
Nil
Nil
Nil
Nil
Nil
Nil
10,204
 

Notes:

(1) Carl Cagliarini was appointed as interim CEO effective February 3, 2023.


44

(2) Dana Wheeler ceased to be President and Chief Executive Officer effective February 3, 2023.

(3) Susan Gardner was appointed as Chief Financial Officer effective January 13, 2022.

(4) Zara Kanji ceased to be Chief Financial Officer on November 22, 2021. Ms. Kanji was appointed as a director effective April 10, 2023.

(5) This refers to accounting fees and rent paid to a company controlled by Ms. Kanji.

(6) Philip Lancaster was appointed as President and Secretary effective February 3, 2023.

(7) Vivian Katsuris previously acted as interim CFO for the Company from November 22, 2021, to January 13, 2022, and was a director from January 13, 2022 to March 16, 2022.

(8) This refers to 656,250 shares issued with a total fair value of $307,734 paid to Douglas Smith as compensation pursuant to the consulting agreement with Mr. Smith for the fiscal year ended November 30, 2021. Further, additional 78,125 shares issued with a fair value of $17,188 as payment to his consulting services rendered for the fiscal year ended November 30, 2022.

(9) Thomas Nash ceased to be a director on March 31, 2023.

(10) Angelos Kostopoulos ceased to be a director on July 19, 2022.

(11) Tim Crowhurst ceased to be a director on January 13, 2022.

There are no arrangements or plans in which we provide pension, retirement or similar benefits for directors or executive officers. Our directors and executive officers may receive share options at the discretion of our board of directors in the future. We do not have any material bonus or profit-sharing plans pursuant to which cash or non-cash compensation is or may be paid to our directors or executive officers, except that share options may be granted at the discretion of our board of directors.

Written Management Agreements

Carl Cagliarini, Interim CEO, has a consulting agreement with the Company for compensation of $16,500 per month with a 180- day notice of termination.

Dana Wheeler, director and former CEO, has a services agreement with the Company. The agreement is to pay for services at US$20,000 per month. The CEO can terminate the agreement with a 6 month notice. The Company has to give 6 months' notice for any termination without cause. Mr. Wheeler's resignation as President & CEO was effective on February 3, 2023 but he remains a director of the Company.

Susan J. Gardner, CFO, has a consulting agreement with the Company for compensation of US$5,000 per month.

Philip Lancaster, Director, President, and Secretary has a consulting agreement with the Company for compensation of $12,500 per month with a 45-day notice of termination.

Vivian Katsuris, former Secretary, has a consulting agreement with the Company for compensation of $2,625 per month with a 30-day notice of termination. Until February 28, 2023, compensation payable under the agreement was $5,250 per month. As of March 1, 2023, the amount of compensation payable was reduced to $2,625 per month.

Douglas Smith, Chairman of the Board of Directors, entered into a consulting agreement with Plymouth Rock USA dated April 1, 2020, for consulting services to the Company. Pursuant to the agreement the Company pays Mr. Smith $250,000 per annum, which is payable at the Company's option by the issuance of 1,000,000 common shares of the Company in four equal quarterly instalments in arrears. If the agreement is terminated for any reason before the completion of a full year, the number of common shares to be issued will be reduced in proportion to the period of engagement. On July 8, 2020, our shareholders approved of the issuance of the 1,000,000 common shares to Mr. Smith. The consulting agreement was cancelled by mutual agreement between Mr. Smith and the Company effective March 31, 2022. As of March 31, 2022, 1,204,975 shares had been issued to Mr. Smith pursuant to the agreement. No termination benefits were or are payable to Mr. Smith under the agreement.


45

Long-Term Equity Incentive Plan

On October 17, 2022 we adopted a long-term equity incentive plan (the "2022 Plan") which replaced our 2016 stock option plan. All options granted under our 2016 stock option plan remain in full force and effect.

The purpose of our 2022 Plan is to attract and motivate directors, senior officers, employees, management company employees, consultants and others providing services to our Company and its subsidiaries, and thereby advance our interests, by affording such persons with an opportunity to acquire an equity interest in our Company through the grant of Awards. Awards as defined in the 2022 Plan include options to purchase shares, deferred share units, restricted share units, stock appreciation rights and other share-based awards that may be granted pursuant to the 2022 Plan.

Our 2022 Plan is a "rolling" plan whereby 10% of the issued and outstanding common shares of the Company at the time of granting of Awards (on a non-diluted basis) may be reserved for issuance upon the exercise or redemption of all Awards granted under the 2022 Plan.

The following is a summary of some of our 2022 Plan's provisions:

 the 2022 Plan shall not, together with all other security-based compensation arrangements of the Company, result, at any time, in (a) the number of common shares issuable to insiders exceeding ten percent (10%) of the issued and outstanding common shares (on a non-diluted basis); or (b) the issuance to insiders, within a one-year period, of a number of common shares exceeding ten percent (10%) of the issued and outstanding common shares (on a non-diluted basis) excluding common shares issued to such insider under the 2022 Plan or any other share compensation arrangement over the preceding one year period; or (c) the issuance to any one insider and such insider's associates within a one year period, of a number of common shares exceeding five percent (5%) of the issued and outstanding common shares (on a non-diluted basis), excluding common shares issued to such insider under the 2022 Plan or any other share compensation arrangement over the preceding one year period;

 the maximum number of Awards which may be reserved for issuance to any one person under the 2022 Plan in any 12 month period shall be 5% of the common shares outstanding at the time of the grant (on a non-diluted basis) less the aggregate number of common shares reserved for issuance to such person under any other option to purchase common shares from treasury granted as a compensation or incentive mechanism.

 the number of options granted to any one consultant, or to persons involved in investor relations activities in a 12 month period under the 2022 Plan shall not exceed 2% of the common shares outstanding at the time of grant (on a non-diluted basis), less the aggregate number of common shares reserved for issuance to consultants or such persons pursuant to any other share compensation arrangement, unless the consent of the applicable stock exchange is first obtained;

 an Award is personal to the participant and is non-assignable and non-transferable, except with the prior written consent of the Company and any required consent of the applicable stock exchange and any other applicable regulatory authority;

 Awards may only be granted to employees, officers, director, management company employees or consultants of the Company or of any affiliate;

 Awards are subject to specific termination provisions including upon the participant ceasing to be eligible or in the event of the death of a participant;

 the term of an option to purchase shares shall be five (5) years from the date of the grant;

 other than options to purchase shares granted to consultants providing investor relations services, options to purchase shares shall vest in instalments, with 1/3 of such options exercisable in whole or in part on or after the first anniversary following the grant of the option, and a further 1/3 vesting and becoming exercisable on each of the second and third anniversaries following the grant of the option;

 options to purchase shares granted to consultants providing investor relations services shall vest at a minimum over a period of 12 months with no more than 1/4 of such options vesting in any three (3) month period;

The full text of our 2022 Plan is attached hereto as Exhibit 4.2


46

Option-Based Awards

During the year ended November 30, 2022, the Company granted no new stock options to officers and directors (2021 - 800,000). No stock options were exercised.

As at November 30, 2022, 1,650,000 options were held by the CEO, former CFO, Former Corporate Secretary, Chairman, and the Company's directors, current and former. During the year ended November 30, 2022, the Company recognized $Nil (2021 - $410,132) related to the options held by the officers and directors.

On March 3, 2023 2,100,000 options were held by the Company's officers and directors (current and former) were surrendered and cancelled. An additional 150,000 options were surrendered and cancelled on March 16, 2023.

The following table sets forth the option-based awards for each of directors and officers of the Company outstanding as at March 31, 2023.

Name Option Based Awards
Number of 
securities 
underlying 
unexercised options 
(#)
Option exercise 
price 
($)
Option expiration 
date
Value of unexercised 
in-the-money 
options 
($)(1)
  Nil
 
n/a n/a Nil

Termination and Change of Control Benefits

Except as previously disclosed, we have no plans or arrangements in respect of remuneration received or that may be received by our directors and senior management in respect of compensating such person in the event of termination of employment (as a result of resignation, retirement, change of control, etc.) or a change in responsibilities.

Pension, Retirement or Similar Benefits

We have not set aside or accrued any amounts to provide pension, retirement or similar benefit for our directors or senior management during the fiscal year ended November 30, 2022.

C. Board Practices

Term of Office

Each director of our Company holds office until the next annual general meeting of our Company or until his successor is elected or appointed, unless his office is earlier vacated in accordance with the articles of our Company or the provisions of the BCBCA. Each member of our senior management is appointed to serve at the discretion of our Board, subject to the terms of the employment agreements described above.

Service Contracts

Other than as disclosed herein, we do not have any service contracts with directors which provide for benefits upon termination of employment.


47

Committees

The audit committee is our only committee at this time. Our Company does not have a remuneration committee.

Audit Committee

The members of our audit committee are Philip Lancaster, Khalid M. Al-Ali and Zara Kanji. All members are financially literate, meaning that they have the ability to read and understand a set of financial statements that present a breadth of complexity of accounting issues that are generally comparable to the breadth and complexity of the issues that can reasonably be expected to be raised by our financial statements.

We have adopted a charter for our audit committee, which is listed as Exhibit 11.1 to this Form 20-F and is incorporated by reference to our Form 20-F filed on March 31, 2021. The audit committee is responsible for review of both interim and annual financial statements for our Company. For the purposes of performing their duties, the members of the audit committee have the right at all times, to inspect all the books and financial records of our Company and any subsidiaries and to discuss with management and the external auditors of our Company any accounts, records and matters relating to the financial statements of our Company. The audit committee members meet periodically with management and annually with the external auditors. Our audit committee has the overall duties and responsibilities to:

  review the financial reporting process to ensure the accuracy of the financial statements of our Company;
  assist the Board to properly and fully discharge its responsibilities;
  strengthen the role of the Board by facilitating in depth discussions between directors, management and external auditors;
  evaluate the independent auditor's qualifications, performance and independence;
  facilitate the independence of the independent auditor;
  assess the processes relating to the determination and mitigation of risks and the maintenance of an effective control environment; and
  review the processes to monitor compliance with laws and regulations.

D. Employees

As of November 30, 2022, we had nine employees. As of the date of this report, we have seven full-time employees. All seven are at the level of our UK subsidiary, Plymouth Rock UK. Our directors and certain contracted individuals play an important role in the running of our Company. We do not expect any material changes in the number of employees over the next 12-month period. We do and will continue to outsource contract employment as needed.

We engage contractors from time to time to consult with us on specific corporate affairs or to perform specific tasks in connection with the development of our products.

E. Share Ownership

As at April 30, 2023, our directors and senior management beneficially owned the following common shares and stock options of our Company:

Name and Office Held Number of Common Shares Owned 
and 
Percent of Total Outstanding Common Shares
Options(2) Owned
# of Shares % of Class(1)
Carl Cagliarini
Interim CEO and Director(3)
525,000
 
0.56% Nil
 
 

48

 
Name and Office Held Number of Common Shares Owned 
and 
Percent of Total Outstanding Common Shares
Options(2) Owned
# of Shares % of Class(1)
Dana Wheeler
Director; former President and Chief Executive Officer(4)
1,350,000 1.45% Nil
 
Susan Gardner
CFO(5)
Nil Nil Nil
Zara Kanji
Director; former Chief Financial Officer(6) 
Nil Nil Nil
Philip Lancaster
President, Secretary, Director(7)
1,000,000(8) 1.08% Nil
Vivian Katsuris
Former Secretary and Director(9)
600,000 0.65% Nil
Douglas Smith
Chairman and Director
1,204,975 1.30% Nil
Khalid M. Al-Ali
Director
Nil Nil Nil
Thomas Nash
Former Director(10)
Nil Nil Nil
Angelos Kostopoulos
Former Director(11)
Nil Nil Nil
Tim Crowhurst
Former Director(12)
Nil Nil Nil

Notes:

(1) Based on 92,997,461common shares issued and outstanding as at April 30, 2023.

(2) Options are exercisable into common shares on a one-for-one basis. Options vest on the grant date unless otherwise resolved by the directors when granting options.

(3) Carl Cagliarini was appointed as interim CEO effective February 3, 2023.

(4) Dana Wheeler ceased to be President and Chief Executive Officer effective February 3, 2023.

(5) Susan Gardner was appointed as Chief Financial Officer effective January 13, 2022.

(6) Zara Kanji ceased to be Chief Financial Officer on November 22, 2021. Ms. Kanji was appointed as a director effective April 10, 2023.

(7) Philip Lancaster was appointed as President and Secretary effective February 3, 2023.

(8) Held indirectly through 1274677 B.C. Ltd.

(9) Vivian Katsuris previously acted as interim CFO for the Company from November 22, 2021, to January 13, 2022, and was a director from January 13, 2022 to March 16, 2022.

(10) Thomas Nash ceased to be a director on March 31, 2023.

(11) Angelos Kostopoulos ceased to be a director on July 19, 2022.

(12) Tim Crowhurst ceased to be a director on January 13, 2022.

The voting rights attached to the common shares owned by our directors and senior management do not differ from those voting rights attached to shares owned by people who are not directors or senior management of our Company.


49

ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS

A. Major Shareholders

To the best of our knowledge, there are no persons or companies who beneficially own, directly or indirectly, or exercise control or direction over, securities carrying more than 5% of the voting rights attached to any class of voting securities of the Company.

Major Shareholder Voting Rights

The voting rights of our major shareholders do not differ from the voting rights of holders of our common shares who are not our major shareholders.

Residency of Shareholders

As at March 31, 2023, the registrar and transfer agent for our Company reported that there were 92,997,461 common shares of our Company issued and outstanding. Of the 92,997,461 common shares issued and outstanding, 85,602,605 were registered to Canadian residents (17 recorded shareholders), 4,888,356 were registered to residents of the United States (39 recorded shareholders), and 2,506,500 were registered to non-United States or Canadian residents (9 recorded shareholders).

As of March 31, 2023, our shareholder register indicates that our common shares are held as follows:

Location Number of Common
Shares
Percentage of Total
Common Shares
Number of Registered
Shareholders of
Record
United States 4,888,356 5.26% 39
Canada 85,602,605 92.05% 17
Other 2,506,500 2.70% 9
Total 92,997,461 100% 65

Control and Control Arrangements

To the best of our knowledge, our Company is not directly or indirectly owned or controlled by another corporation, by any foreign government or by any other natural or legal person severally or jointly, except as disclosed in the above table regarding our major shareholders. 

There are no arrangements known to us, the operation of which may at a subsequent date result in a change in control of our Company.

B. Related Party Transactions

The Company recorded the following transactions with related parties during the period from the beginning of the Company's last financial year up to February 28, 2023.

The amounts due to and from related parties are due to the directors and officers of the Company. The balances are unsecured, non-interest bearing and due on demand. These transactions are in the normal course of operations and have been valued in these consolidated financial statements at the exchange amount, which is the amount of consideration established and agreed to by the related parties.

As at February 28, 2023, and as at November 30, 2022, the following amounts were due to directors and officers of the Company:


50

 
    February 28, 2023     November 30, 2022  
Company controlled by CFO $ 74,850   $ 67,540  
CEO of the Company   311,241     250,179  
Director   505,838     387,953  
  $ 891,929   $ 705,672  

As at February 28, 2023, and as at November 30, 2022, the prepaid to directors and officers of the Company were $nil for both periods.

During the three-month period ended February 28, 2023, and during the year ended November 30, 2022, the Company entered into the following transactions with related parties:

    February 28, 2023     November 30, 2022  
Management fees $ 87,081   $ 311,535  
Consulting fees   37,500     135,000  
Salaries and benefits   81,006     330,337  
  $ 205,587   $ 776,872  

During the three-month period ended February 28, 2023, no options were vested, and no stock-based compensation was recognized in profit or loss.

During the three-month period ended February 28, 2023, 1,850,000 options expired, and no stock-based compensation was recognized in profit or loss.

During the year ended November 30, 2022, no options were vested, and stock-based compensation amounting to $Nil was recognized in profit or loss; of which $Nil was for the Company's officers and directors as set out above.

On June 10, 2021, the Company granted 150,000 incentive stock options to a consultant, options vested on October 10, 2021 and with an exercise price of $0.50 per share for a period of five years from the date of grant.

On January 21, 2021, the Company granted 1,550,000 incentive stock options to directors, consultants, and employees with an exercise price of $0.75 per share for a period of five years from the date of grant.

During the three-month period ended February 28, 2023, and during the year ended November 30, 2022, management fees consisted of the following:

    February 28, 2023     November 30, 2022  
Company controlled by CEO $ 66,830   $ 243,387  
Company controlled by CFO   20,251     68,148  
  $ 87,081   $ 311,535  

Douglas Smith, our Chairman, entered into a consulting agreement with Plymouth Rock USA dated April 1, 2020, for consulting services to the Company. Pursuant to the agreement the Company will pay Mr. Smith $250,000 per annum, which is payable at the Company's option by the issuance of 1,000,000 common shares of the Company in four equal quarterly instalments in arrears. If the agreement is terminated for any reason before the completion of a full year, the number of common shares to be issued will be reduced in proportion to the period of engagement. The consulting agreement was cancelled by mutual agreement between Mr. Smith and the Company effective March 31, 2022. As of March 31, 2022, 1,204,975 shares had been issued to Mr. Smith pursuant to the agreement. No termination benefits were or are payable to Mr. Smith under the agreement.


51

Compensation

For information regarding compensation for our directors and senior management, see Item 6.B - Compensation.

C. Interests of Experts and Counsel

Not applicable

ITEM 8. FINANCIAL INFORMATION

A. Financial Statements and Other Financial Information

Our financial statements (included as Item 18 of this Form 20-F) are stated in Canadian dollars and are prepared in accordance with IFRS, as issued by the IASB.

The following financial statements and notes thereto are filed with and incorporated herein as part of this Annual Report:

  (a) Audited consolidated financial statements for the years ended November 30, 2022 and November 30, 2021, including: report of independent registered accounting firm by Reliant CPA PC, consolidated statements of financial position, consolidated statements of loss and comprehensive loss, consolidate statements of cash flows and consolidated statements of changes in shareholders' equity (deficiency), and notes to consolidated financial statements.

These financial statements can be found under "Item 18 - Financial Statements" below.

Legal Proceedings

There have not been any legal or arbitration proceedings, including those relating to bankruptcy, receivership or similar proceedings, those involving any third party, and governmental proceedings pending or known to be contemplated, which may have, or have had in the recent past, significant effect our financial position or profitability.

There have been no material proceedings in which any director, any member of senior management, or any of our affiliates is either a party adverse to our Company or our subsidiaries or has a material interest adverse to our Company or our subsidiaries.

Policy on Dividend Distributions

We have not declared any dividends since our inception and do not anticipate that we will do so in the foreseeable future. We currently intend to retain future earnings, if any, to finance the development of our business. Any future payment of dividends or distributions will be determined by our Board on the basis of our earnings, financial requirements and other relevant factors.

B. Significant Changes

We are not aware of any significant change that has occurred since November 30, 2022, and that has not been disclosed elsewhere in this Annual Report.


52

ITEM 9. THE OFFER AND LISTING

A. Offer and Listing Details

Our common shares are listed for trading on the CSE under the symbol "PRT", on the OTCQB under the symbol "PLRTF" and on the Frankfurt Stock Exchange under the symbol "4XA".

B. Plan of Distribution

Not applicable to Form 20-F filed as an annual report.

C. Markets

Our common shares are traded on the CSE under the symbol "PRT", on the OTCQB under the symbol "PLRTF" and on the Frankfurt Stock Exchange under the symbol "4XA".

D. Selling Shareholders

Not applicable to Form 20-F filed as an annual report.

E. Dilution

Not applicable to Form 20-F filed as an annual report.

F. Expenses of the Issue

Not applicable to Form 20-F filed as an annual report.

ITEM 10. ADDITIONAL INFORMATION

A. Share Capital

Not applicable to Form 20-F filed as an annual report.

B. Memorandum and Articles of Association

Incorporation

We are incorporated under the BCBCA. Our British Columbia incorporation number is BC0922905.

Objects and Purposes of Our Company

Our articles do not contain a description of our objects and purposes.

Voting on Proposals. Arrangements, Contracts or Compensation by Directors

Other than as disclosed below, our articles do not restrict directors' power to (a) vote on a proposal, arrangement or contract in which the directors are materially interested or (b) to vote compensation to themselves or any other members of their body in the absence of an independent quorum.


53

The BCBCA does, however, contain restrictions in this regard. The BCBCA provides that a director who holds a disclosable interest in a contract or transaction into which we have entered or proposes to enter is not entitled to vote on any directors' resolution to approve that contract or transaction, unless all the directors have a disclosable interest in that contract or transaction, in which case any or all of those directors may vote on such resolution. A director who holds a disclosable interest in a contract or transaction into which we have entered or proposes to enter and who is present at the meeting of directors at which the contract or transaction is considered for approval may be counted in the quorum at the meeting whether or not the director votes on any or all of the resolutions considered at the meeting. A director or senior officer generally holds a disclosable interest in a contract or transaction if (a) the contract or transaction is material to our Company; (b) we have entered, or proposed to enter, into the contract or transaction, and (c) either (i) the director or senior officer has a material interest in the contract or transaction or (ii) the director or senior officer is a director or senior officer of, or has a material interest in, a person who has a material interest in the contract or transaction. A director or senior officer does not hold a disclosable interest in a contract or transaction merely because the contract or transaction relates to the remuneration of the director or senior officer in that person's capacity as director, officer, employee or agent of our Company or of an affiliate of our Company.

Borrowing Powers of Directors

Our articles provide that we, if authorized by our directors, may:

  borrow money in the manner and amount, on the security, from the sources and on the terms and conditions that they consider appropriate;
  issue bonds, debentures and other debt obligations either outright or as security for any liability or obligation of our Company or any other person and at such discounts or premiums and on such other terms as they consider appropriate;
  guarantee the repayment of money by any other person or the performance of any obligation of any other person; and
  mortgage, charge, whether by way of specific or floating charge, grant a security interest in, or give other security on, the whole or any part of the present and future assets and undertaking of our Company.

Qualifications of Directors 

Under our articles, a director is not required to hold a share in the capital of the Company as qualification for his or her office but must be qualified as required by the BCBCA to become, act or continue to act as a director.

Share Rights

All holders of common shares are entitled to receive dividends out of assets legally available therefore at such times and in such amounts as the board of directors may from time to time determine. All holders of common shares will share equally on a per share basis in any dividend declared by the board of directors. The dividend entitlement time limit will be fixed by the board of directors at the time any such dividend is declared. Each outstanding common share is entitled to one vote on all matters submitted to a vote of our shareholders in general meeting. There are no cumulative voting rights attached to any of our shares and, accordingly, the holders of more than half of the shares represented at a general meeting can elect all of the directors to be elected in a general meeting. All directors stand for re-election annually. Upon any liquidation, dissolution or winding up, all common shareholders are entitled to share ratably in all net assets available for distribution after payment to creditors. The common shares are not convertible or redeemable and have no preemptive, subscription or conversion rights. In the event of a merger or consolidation, all common shareholders will be entitled to receive the same per share consideration.

Procedures to Change the Rights of Shareholders

Our articles state that the Company may by resolution of its directors or Company shareholders: (a) create one or more classes or series of shares or, if none of the shares of a class or series of shares are allotted or issued, eliminate that class or series of shares; (b) increase, reduce or eliminate the maximum number of shares that the Company is authorized to issue out of any class or series of shares or establish a maximum number of shares that the Company is authorized to issue out of any class or series of shares for which no maximum is established; (c) if the Company is authorized to issue shares of a class of shares with par value: (i) decrease the par value of those shares, (ii) if none of the shares of that class of shares are allotted or issued, increase the par value of those shares, (iii) subdivide all or any of its unissued or fully paid issued shares with par value into shares of smaller par value, or (iv) consolidate all or any of its unissued or fully paid issued shares with par value into shares of larger par value; (d) subdivide all or any of its unissued or fully paid issued shares without par value; (e) change all or any of its unissued or fully paid issued shares with par value into shares without par value or all or any of its unissued shares without par value into shares with par value; (f) alter the identifying name of any of its shares; (g) consolidate all or any of its unissued or fully paid issued shares without par value; (h) create special rights or restrictions for, and attach those special rights or restrictions to, the shares of any class or series of shares, whether or not any or all of those shares have been issued; (i) vary or delete any special rights or restrictions attached to the shares of any class or series of shares, whether or not any or all of those shares have been issued; (j) change the name of the Company; or (k) otherwise alter its shares or authorized share structure when required or permitted to do so by the BCBCA.


54

An amendment of our articles by shareholders would require the approval of holders of two-thirds of the votes of the Company's common shares cast at a duly called special meeting.

Meetings

Each director holds office until our next annual general meeting or until his office is earlier vacated in accordance with our articles or with the provisions of the BCBCA. A director appointed or elected to fill a vacancy on our board also holds office until our next annual general meeting.

Our articles and the BCBCA provide that our annual meetings of shareholders must be held at such time in each calendar year and not more than 15 months after the last annual general meeting and at such place as our Board may from time to time determine. Our directors may, at any time, call a meeting of our shareholders.

The holders of not less than five percent of our issued shares that carry the right to vote at a meeting may requisition our directors to call a meeting of shareholders for the purposes stated in the requisition.

Under our articles, the quorum for the transaction of business at a meeting of our shareholders is one or more persons who are, present in person or by proxy, shareholders who, in the aggregate hold at least 1% of the issued shares entitled to be voted at the meeting.

Our articles state that in addition to those persons who are entitled to vote at a meeting of our shareholders, the only other persons entitled to be present at the meeting are the directors, the president (if any), the secretary (if any), any lawyer or auditor for our Company, any persons invited to be present at the meeting by our directors or by the chair of the meeting and any person entitled or required under the BCBCA or our articles to be present at the meeting.

Limitations on Ownership of Securities

No share may be issued until it is fully paid.

Neither Canadian law nor our articles limit the right of a non-resident to hold or vote common shares of the Company, other than as provided in the Canadian Investment Act, as amended by the Canadian WTO Act. The purpose of the Canadian Investment Act is to provide for the review of significant investments in Canada by non-Canadians in a manner that encourages investment, economic growth and employment opportunities in Canada and to provide for the review of investments in Canada by non-Canadians that could be injurious to national security. The Canadian Investment Act generally prohibits implementation of a direct reviewable investment (based on certain thresholds) by an individual, government or agency thereof, corporation, partnership, trust or joint venture that is not a "Canadian," as defined in the Investment Act, unless, after review, the minister responsible for the Investment Act is satisfied that the investment is likely to be of net benefit to Canada. An investment in common shares of the Company by a WTO investor (or by a non-Canadian other than a WTO investor if, immediately prior to the implementation of the investment the Company was controlled by WTO investors) would be reviewable under the Canadian Investment Act if it were an investment to acquire direct control of the Company and the value of the assets of the Company equaled or exceeded certain threshold amounts determined on an annual basis.


55

The threshold for a pre-closing net benefit review depends on whether the purchaser is: (a) controlled by a person or entity from a member of the WTO; (b) a state-owned enterprise; or (c) from a country considered a "Trade Agreement Investor" under the Canadian Investment Act. A different threshold also applies if the Canadian business carries on a cultural business. The 2021 threshold for WTO investors that are state-owned enterprises is $415 million based on the book value of the Canadian business' assets. The 2021 thresholds for review for direct acquisitions of control of Canadian businesses by private sector investor WTO investors that are not state-owned enterprises is $1 billion (unless the WTO member is a party to one of a list of certain free trade agreements, in which case the amount is $1.5 billion), also based on the "enterprise value" of the Canadian business being acquired.

A non-Canadian, whether a WTO investor or otherwise, would be deemed to acquire control of the Company for purposes of the Canadian Investment Act if he or she acquired a majority of the common shares of the Company. The acquisition of less than a majority, but at least one-third of the shares, would be presumed to be an acquisition of control of the Company, unless it could be established that the Company is not controlled in fact by the acquirer through the ownership of the shares. In general, an individual is a WTO investor if he or she is a "national" of a country (other than Canada) that is a member of the WTO or has a right of permanent residence in a country (other than Canada) that is a member of the WTO. A corporation or other entity will be a "WTO investor" if it is a "WTO investor-controlled entity," pursuant to detailed rules set out in the Canadian Investment Act. The U.S. is a WTO member. Certain transactions involving our common shares would be exempt from the Canadian Investment Act, including:

  an acquisition of the shares if the acquisition were made in the ordinary course of that person's business as a trader or dealer in securities;
  an acquisition of control of the Company in connection with the realization of a security interest granted for a loan or other financial assistance and not for any purpose related to the provisions of the Investment Act; and
  an acquisition of control of the Company by reason of an amalgamation, merger, consolidation or corporate reorganization, following which the ultimate direct or indirect control in fact of the Company, through the ownership of voting interests, remains unchanged.

Change in Control

There are no provisions in our articles or in the BCBCA that would have the effect of delaying, deferring, or preventing a change in control of our Company, and that would operate only with respect to a merger, acquisition or corporate restructuring involving our Company or our subsidiaries.

Ownership Threshold

Our articles or the BCBCA do not contain any provisions governing the ownership threshold above which shareholder ownership must be disclosed. Securities legislation in Canada, however, requires every person or company who acquires beneficial ownership of, or control or direction over, voting or our common shares (or securities convertible into such securities) which, together with the acquiror's previously acquired securities, represents 10% or more of the outstanding securities of that class to file, subject to certain exceptions, a press release and an early warning report, each of which contain certain prescribed information (including the acquiror's identity, intention and extent of holdings). In addition, such acquiror must make further disclosures where:

  (i) such acquiror or any person acting jointly or in concert with such acquiror, acquires or disposes beneficial ownership of, or acquires or ceases to have control or direction over securities (or securities convertible into such securities) in an amount equal to 2% or more of the outstanding securities of the class of securities that was the subject of such acquiror's most recent early warning report;
 

56

 
  (ii) such acquiror's beneficial ownership of, or control or direction over, the outstanding securities of the class of securities that was the subject of the acquiror's most recent early warning report decreases to less than 10%; or
     
  (iii) there is a change in a material fact contained in the acquiror's most recent early warning report.

Securities legislation in Canada also requires insiders of the Company to file reports disclosing information about transactions involving securities of the Company (or related financial instruments) held by such insider. Insiders of the Company include, among others, the Chief Executive Officer, Chief Financial Officer and Chief Operating Officer of the Company, directors of the Company and persons or companies that have beneficial ownership of, or control or direction over (or a combination thereof), whether direct or indirect, common shares of the Company carrying more than 10% of the voting rights attached to all of the Company's outstanding voting securities. This threshold is higher than the 5% threshold under U.S. securities legislation at which shareholders must report their share ownership.

C. Material Contracts

Except for contracts entered into by the Company in the ordinary course of business, the only material contracts entered into by the Company in the two years preceding the date of this Form 20-F are the following:

a) Acquisition agreement with Tetra dated June 4, 2021. The Company acquired all the outstanding Tetra shares for the sum of £350,000 payable in installments and satisfied in cash. Out of £350,000; £210,000 was paid by cash and the remaining £140,000 was waived or forgiven by former shareholder in exchange of full release of vehicle to him and allowing him to continue working within the industry.

D. Exchange Controls

There are no government laws, decrees or regulations in Canada which restrict the export or import of capital or which affect the remittance of dividends, interest or other payments to non-resident holders of our common shares. Any remittances of dividends to United States residents and to other non-residents are, however, subject to withholding tax. See "Taxation" below.

E. Taxation

Certain Canadian Federal Income Taxation 

We consider that the following general summary fairly describes the principal Canadian federal income tax consequences applicable to a non-resident holder. This summary is based upon the current provisions of the Canadian Income Tax Act, the regulations thereunder, the current publicly announced administrative and assessing policies of the Canada Revenue Agency and the Treaty. This summary also takes into account the amendments to the Canadian Income Tax Act and the regulations publicly announced by the Canadian Minister of Finance prior to the date hereof and assumes that all such amendments or regulations will be enacted in their present form. However, no assurances can be given that such amendments or regulations will be enacted in the form proposed, or at all. This summary is not exhaustive of all possible Canadian federal income tax consequences applicable to a holder of our common shares and, except for the foregoing, this summary does not take into account or anticipate any changes in law, whether by legislative, administrative or judicial decision or action, nor does it take into account provincial, territorial or foreign income tax legislation or considerations, which may differ from the Canadian federal income tax consequences described herein.

This summary is of a general nature only and is not intended to be, and should not be construed to be, legal, business or tax advice to any particular holder or prospective holder of our common shares, and no opinion or representation with respect to the tax consequences to any holder or prospective holder of our common shares is made. Accordingly, holders and prospective holders of our common shares should consult their own tax advisors with respect to the income tax consequences of purchasing, owning and disposing of our common shares in their particular circumstances.


57

Dividends

Dividends paid on our common shares to a non-resident holder will be subject under the Canadian Income Tax Act to withholding tax at a rate of 25% subject to a reduction under the provisions of an applicable tax treaty, which tax is deducted at source by our Company. The Treaty provides that the Canadian Income Tax Act  standard 25% withholding tax rate is reduced to 15% on dividends paid on shares of a corporation resident in Canada (such as our Company) to residents of the United States, and also provides for a further reduction of this rate to 5% where the beneficial owner of the dividends is a corporation resident in the United States that owns at least 10% of the voting shares of the corporation paying the dividend.

Capital Gains

A non-resident holder is not subject to tax under the Canadian Income Tax Act in respect of a capital gain realized upon the disposition of a common share of our Company unless such share represents "taxable Canadian property", as defined in the Canadian Income Tax Act, to the holder thereof. Our common shares generally will be considered taxable Canadian property to a non-resident holder if:

  the non-resident holder;
  persons with whom the non-resident holder did not deal at arm's length; or
  the non-resident holder and persons with whom such non-resident holder did not deal at arm's length,

owned, or had an interest in an option in respect of, not less than 25% of the issued shares of any class of our capital stock at any time during the 60-month period immediately preceding the disposition of such shares. In the case of a non-resident holder to whom shares of our Company represent taxable Canadian property and who is resident in the United States, no Canadian taxes will generally be payable on a capital gain realized on such shares by reason of the Treaty unless the value of such shares is derived principally from real property situated in Canada.

United States Federal Income Taxation 

The following is a general discussion of certain material United States federal foreign income tax matters under current law, generally applicable to a U.S. Holder (as defined below) of our common shares who holds such shares as capital assets. This discussion does not address all aspects of United States federal income tax matters and does not address consequences peculiar to persons subject to special provisions of federal income tax law, such as those described below as excluded from the definition of a U.S. Holder. In addition, this discussion does not cover any state, local or foreign tax consequences. See "Certain Canadian Federal Income Tax Consequences" above.

The following discussion is based upon the Internal Revenue Code of 1986, as amended, U.S. Department of the Treasury regulations, published IRS rulings, published administrative positions of the IRS and court decisions that are currently applicable, any or all of which could be materially and adversely changed, possibly on a retroactive basis, at any time. In addition, this discussion does not consider the potential effects, both adverse and beneficial, of any recently proposed legislation which, if enacted, could be applied, possibly on a retroactive basis, at any time. No assurance can be given that the IRS will agree with such statements and conclusions, or will not take, or a court will not adopt, a position contrary to any position taken herein.

Holders and prospective holders of common shares should consult their own tax advisors with respect to federal, state, local, and foreign tax consequences of purchasing, owning and disposing of our common shares.


58

U.S. Holders

As used herein, a "U.S. Holder" includes a holder of less than 10% of our common shares who is a citizen or resident of the United States, a corporation created or organized in or under the laws of the United States or of any political subdivision thereof, any entity which is taxable as a corporation for U.S. tax purposes and any other person or entity whose ownership of our common shares is effectively connected with the conduct of a trade or business in the United States. A U.S. Holder does not include persons subject to special provisions of federal income tax law, such as tax-exempt organizations, qualified retirement plans, financial institutions, insurance companies, real estate investment trusts, regulated investment companies, broker-dealers, non-resident alien individuals or foreign corporations whose ownership of our common shares is not effectively connected with the conduct of a trade or business in the United States and shareholders who acquired their shares through the exercise of employee stock options or otherwise as compensation.

Distributions

The gross amount of a distribution paid to a U.S. Holder will generally be taxable as dividend income to the U.S. Holder for U.S. federal income tax purposes to the extent paid out of our current or accumulated earnings and profits, as determined under U.S. federal income tax principles. Distributions which are taxable dividends and which meet certain requirements will be "unqualified dividend income" and taxed to U.S. Holders at a maximum U.S. federal rate of 15%. Distributions in excess of our current and accumulated earnings and profits will be treated first as a tax-free return of capital to the extent of the U.S. Holder's tax basis in the common shares and, to the extent in excess of such tax basis, will be treated as a gain from a sale or exchange of such shares.

Capital Gains

In general, upon a sale, exchange or other disposition of common shares, a U.S. Holder will generally recognize a capital gain or loss for U.S. federal income tax purposes in an amount equal to the difference between the amount realized on the sale or other distribution and the U.S. Holder's adjusted tax basis in such shares. Such gain or loss will be U.S. source gain or loss and will be treated as a long-term capital gain or loss if the U.S. Holder's holding period of the shares exceeds one year. If the U.S. Holder is an individual, any capital gain will generally be subject to U.S. federal income tax at preferential rates if specified minimum holding periods are met. The deductibility of capital losses is subject to significant limitations.

Foreign Tax Credit

A U.S. Holder who pays (or has had withheld from distributions) Canadian income tax with respect to the ownership of our common shares may be entitled, at the option of the U.S. Holder, to either a deduction or a tax credit for such foreign tax paid or withheld. Generally, it will be more advantageous to claim a credit because a credit reduces United States federal income taxes on a dollar-for-dollar basis, while a deduction merely reduces the taxpayer's income subject to tax. This election is made on a year-by-year basis and generally applies to all foreign income taxes paid by (or withheld from) the U.S. Holder during that year. There are significant and complex limitations which apply to the tax credit, among which are an ownership period requirement and the general limitation that the credit cannot exceed the proportionate share of the U.S. Holder's United States income tax liability that the U.S. Holder's foreign source income bears to his or its worldwide taxable income. In determining the application of this limitation, the various items of income and deduction must be classified into foreign and domestic sources. Complex rules govern this classification process. There are further limitations on the foreign tax credit for certain types of income such as "passive income", "high withholding tax interest", "financial services income", "shipping income", and certain other classifications of income. The availability of the foreign tax credit and the application of these complex limitations on the tax credit are fact specific and holders and prospective holders of our common shares should consult their own tax advisors regarding their individual circumstances.


59

Passive Foreign Investment Company Status

We would be a PFIC if (taking into account certain "look-through" rules with respect to the income and assets of our corporate subsidiaries in which we own 25 percent (by value) of the stock) either (i) 75 percent or more of our gross income for the taxable year was passive income or (ii) the average percentage (by value) of our total assets that are passive assets during the taxable year was at least 50 percent.

If we were a PFIC, each U.S. Holder would (unless it made one of the elections discussed below on a timely basis) be taxable on gain recognized from the disposition of our common shares (including gain deemed recognized if the common shares are used as security for a loan) and upon receipt of certain "excess distributions" (generally, distributions that exceed 125% of the average amount of distributions in respect to such common shares received during the preceding three taxable years or, if shorter, during the U.S. Holder's holding period prior to the distribution year) with respect to our common shares as if such income had been recognized ratably over the U.S. Holder's holding period for the common shares. The U.S. Holder's income for the current taxable year would include (as ordinary income) amounts allocated to the current taxable year and to any taxable year period prior to the first day of the first taxable year for which we were a PFIC. Tax would also be computed at the highest ordinary income tax rate in effect for each other taxable year period to which income is allocated, and an interest charge on the tax as so computed would also apply. Additionally, if we were a PFIC, U.S. Holders who acquire our common shares from decedents (other than non-resident aliens) would be denied the normally available step-up in basis for such shares to fair market value at the date of death and, instead, would have a tax basis in such shares equal to the decedent's basis, if lower.

As an alternative to the tax treatment described above, a U.S. Holder could elect to treat us as a "qualified electing fund", in which case the U.S. Holder would be taxed currently, for each taxable year that we are a PFIC, on its pro rata share of our ordinary earnings and net capital gain (subject to a separate election to defer payment of taxes, which deferral is subject to an interest charge). Special rules apply if a U.S. Holder makes a QEF election after the first taxable year in its holding period in which we are a PFIC. In the event that we conclude that we will be classified as a PFIC, we will make a determination at such time as to whether we will be able to provide U.S. Holders with the information that is necessary to make a QEF election. Amounts includable in income as a result of a QEF election will be determined without regard to our prior year losses or the amount of cash distributions, if any, received from us. A U.S. Holder's basis in its common shares will increase by any amount included in income and decrease by any amounts not included in income when distributed because such amounts were previously taxed under the QEF rules. So long as a U.S. Holder's QEF election is in effect with respect to the entire holding period for its common shares, any gain or loss realized by such holder on the disposition of its common shares held as a capital asset ordinarily will be capital gain or loss. Such capital gain or loss ordinarily would be long-term if such U.S. Holder had held such common shares for more than one year at the time of the disposition. For non-corporate U.S. Holders, long-term capital gain is generally subject to a maximum U.S. federal income tax rate of 15% for taxable years beginning on or before November 30, 2012. The QEF election is made on a shareholder-by-shareholder basis, applies to all common shares held or subsequently acquired by an electing U.S. Holder and can be revoked only with the consent of the IRS.

As an alternative to making the QEF election, a U.S. Holder of PFIC stock which is publicly traded may in certain circumstances avoid certain of the tax consequences generally applicable to holders of a PFIC by electing to mark the stock to market and recognizing as ordinary income or loss, each taxable year that we are a PFIC, an amount equal to the difference as of the close of the taxable year between the fair market value of the PFIC stock and the U.S. Holder's adjusted tax basis in the PFIC stock. Special rules apply if a U.S. Holder makes a mark-to-market election after the first taxable year in its holding period in which we are a PFIC. Losses would be allowed only to the extent of net mark-to-market gain previously included by the U.S. Holder under the election for prior taxable years. This election is available for so long as the Company's common shares constitute "marketable stock," which includes stock of a PFIC that is "regularly traded" on a "qualified exchange or other market." Generally, a "qualified exchange or other market" includes a national market system established pursuant to Section 11A of the Exchange Act, or a foreign securities exchange that is regulated or supervised by a governmental authority of the country in which the market is located and that has certain characteristics. A class of stock that is traded on one or more qualified exchanges or other markets is "regularly traded" on an exchange or market for any calendar year during which that class of stock is traded, other than in de minimis quantities, on at least 15 days during each calendar quarter, subject to special rules relating to an initial public offering. It is not entirely clear whether either the OTCQB or TSXV are qualified exchanges or other markets, or whether there will be sufficient trading volume with respect to the Company's common shares, and accordingly, whether the common shares will be "marketable stock" for these purposes. Furthermore, there can be no assurances that the Company's common shares will continue to trade on any of the exchanges listed above.


60

We believe we were not a PFIC for the year ending November 30, 2022, and do not expect to be classified as a PFIC for the year ending November 30, 2022. However, PFIC status is determined as of the end of each taxable year and is dependent on a number of factors, including the value of our passive assets, the amount and type of our gross income, and our market capitalization. Therefore, there can be no assurance that we will not become a PFIC for the current taxable year ending November 30, 2023, or in a future taxable year. We will notify U.S. Holders in the event we conclude that we will be treated as a PFIC for any taxable year.

F. Dividends and Paying Agents

There is no dividend restriction; however, we have not declared any dividends since our inception and do not anticipate that we will do so in the foreseeable future. We currently intend to retain future earnings, if any, to finance the development of our business. Any future payment of dividends or distributions will be determined by our Board on the basis of our earnings, financial requirements and other relevant factors. There is no special procedure for nonresident holders to claim dividends. Any remittances of dividends to United States residents and to other nonresidents are, however, subject to withholding tax. See "Taxation" above.

G. Statements by Experts

The financial statements of our Company for the year ended November 30, 2022 included in this Annual Report have been audited by Reliant CPA PC, Certified Public Accountants, with a business address at 895 Dove Street, Suite 300, #300180, New Port Beach, CA 92660 US, as stated in their report appearing in this Annual Report and have been so included in reliance upon the reports of such firm given their authority as experts in accounting and auditing.

H. Documents on Display

We are subject to the informational requirements of the Exchange Act, and we file reports and other information with the Securities and Exchange Commission. You may read and copy any of our reports and other information at, and obtain copies upon payment of prescribed fees from, the Public Reference Room maintained by the SEC at 100 F Street, N.E., Room 1024, Washington, DC, 20549. In addition, the Securities and Exchange Commission maintains a web site that contains reports and other information regarding registrants that file electronically with the Securities and Exchange Commission at http://www.sec.gov. The public may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. 

The documents concerning our Company referred to in this Form 20-F may be viewed at our offices, Suite -06 - 1045 West 8th Avenue, Vancouver, British Columbia V6H 1C3, or you may request them by calling our office at 604-729-2500. Copies of our financial statements and other continuous disclosure documents required under securities rules are available for viewing on the internet at www.sedar.com.

I. Subsidiary Information

Refer to the notes to the consolidated financial statements under Item 18.

ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Financial instruments are agreements between two parties that result in promises to pay or receive cash or equity instruments. The Company classifies its financial instruments as follows: cash and short-term investments are classified as a financial asset at FVTPL, other receivables are classified as loans and receivables, and accounts payable is classified as other financial liabilities, which are measured at amortized cost. The carrying value of these instruments approximates their fair values due to their short term to maturity.


61

The Company has exposure to the following risks from its use of financial instruments:

  Credit risk;
  Liquidity risk; and
  Interest rate risk.

Credit Risk 

Credit risk is the risk of financial loss to our Company if a customer or counterparty to a financial instrument fails to meet its contractual obligations. Our Company reduces its credit risk on cash by placing these instruments with institutions of high credit worthiness.

Liquidity Risk

Liquidity risk is the risk that the Company will not be able to meet its financial obligations when they become due. The Company ensures, as far as reasonably possible, it will have sufficient capital in order to meet short-term business requirements, after taking into account cash flows from operations and the Company's holdings of cash. As at November 30, 2022, the Company has cash balance of $13,127 (November 30, 2021 - $ 375,046) to settle current liabilities of $2,087,875 (November 30, 2021 - $706,666). The Company's future financial success will be dependent upon the ability to monetize its technologies or obtain necessary financing to meet its contractual obligations.

Interest Rate Risk 

Interest rate risk is the risk that future cash flows will fluctuate as a result of changes in market interest rates. The Company is exposed to risks associated with the effects of fluctuations in the prevailing levels of market interest rates. The Company has no significant interest rate risk.

ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES

Not applicable to Form 20-F filed as an annual report.

PART II

ITEM 13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES

Not applicable.

ITEM 14. MATERIAL MO DIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS

Not applicable.

ITEM 15. CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

The phrase "disclosure controls and procedures" refers to controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act, such as this Annual Report, is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the U.S. Securities and Exchange Commission, or SEC. Disclosure controls and procedures are also designed to ensure that such information is accumulated and communicated to our management, including our chief executive officer, or CEO, and chief financial officer, or CFO, as appropriate to allow timely decision regarding required disclosure.


62

Our management, with the participation of our CEO and CFO, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), as of November 30, 2022, the end of the period covered by this Annual Report. Based on such evaluation, our CEO and CFO have concluded that as of November 30, 2022, our disclosure controls and procedures were designed at a reasonable assurance level and were effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the rules and forms of the SEC, and that such information is accumulated and communicated to our management, including our CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure.

Management's Annual Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of consolidated financial statements for external purposes in accordance with generally accepted accounting principles.

Our management, with the participation of our CEO and CFO, has assessed the effectiveness of the internal control over financial reporting as of November 30, 2022. In making this assessment, our management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control - Integrated Framework (2013 Framework). Based on this evaluation, our management has concluded that the internal control over financial reporting has the following material weakness and significant deficiency in internal controls as of November 30, 2021:

1) The Company does not have a formal policy on closing the general ledger at fiscal year-end which resulted into cut-off errors in the expenses and accounts payable balances.

2) The Company does not have proper review in place to ensure all the significant transactions and balances are accounted for in the financial statements, in accordance with IFRS, including revenues, asset impairment, and the deferred tax balance.

3) The Company, due to its size, lacks proper segregation of duties in the accounting department.

4) The Company does not maintain proper corporate records regarding the minutes for Board of Director meetings.

This Annual Report does not include an attestation report of our registered public accounting firm on our internal control over financial reporting due to an exemption established by the JOBS Act for "emerging growth companies."

As a result of the material weakness and significant deficiency noted above, the Company will adopt the following measures:

1) The Company will develop formal closing procedures that should include a checklist to document who will perform each procedure, when completion of each procedure is due, and when it was accomplished.

2) The Company will develop formal review processes related to the accounting treatment for the significant non-routine transactions to ensure all the transactions are properly accounted for in accordance with IFRS.

3) The Company will undertake a review to ensure that it has compensating controls where possible. The Company will also adopt formal review procedures by management to reduce the risk of errors.

4) The Company will document the minutes of director meetings in writing.

Attestation Report of the Registered Accounting Firm

This Annual Report does not include an attestation report of our registered public accounting firm on our internal control over financial reporting. Management's report is not subject to attestation by the Company's registered public accounting firm pursuant to rules of the Securities and Exchange Commission that permit the Company to provide only management's report in this Annual Report.


63

Changes in Internal Controls over Financial Reporting

During the period ended November 30, 2022, there were no changes in our internal control over financial reporting that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Limitations on Effectiveness of Controls and Procedures

In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs.

ITEM 16A. AUDIT COMMITTEE FINANCIAL EXPERT

The members of our audit committee are Philip Lancaster, Khalid M. Al-Ali and Zara Kanji. All members are financially literate, meaning that they have the ability to read and understand a set of financial statements that present a breadth of complexity of accounting issues that are generally comparable to the breadth and complexity of the issues that can reasonably be expected to be raised by our financial statements.

We have adopted a charter for our audit committee. The audit committee is responsible for review of both interim and annual financial statements for our Company. For the purposes of performing their duties, the members of the audit committee have the right at all times, to inspect all the books and financial records of our Company and any subsidiaries and to discuss with management and the external auditors of our Company any accounts, records and matters relating to the financial statements of our Company. The audit committee members meet periodically with management and annually with the external auditors. Our audit committee has the overall duties and responsibilities to:

  review the financial reporting process to ensure the accuracy of the financial statements of our Company;
  assist the Board to properly and fully discharge its responsibilities;
  strengthen the role of the Board by facilitating in depth discussions between directors, management and external auditors;
  evaluate the independent auditor's qualifications, performance and independence;
  facilitate the independence of the independent auditor;
  assess the processes relating to the determination and mitigation of risks and the maintenance of an effective control environment; and
  review the processes to monitor compliance with laws and regulations.

The Board of Directors has determined that Philip Lancaster, Khalid M. Al-Ali and Zara Kanji, who are independent directors, are audit committee financial experts as such term is defined in Rule 10A-3(b)(1) under the Exchange Act.

ITEM 16B. CODE OF ETHICS

Our Company has not adopted a Code of Ethics that applies to our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions because we do not believe that, given our small size and limited operations, a code of ethics is warranted. As our Company grows, we may adopt a Code of Ethics in the future.


64

ITEM 16C. PRINCIPAL ACCOUNTANT FEES AND SERVICES

Audit Fees

The following table sets forth the fees billed by Reliant CPA PC, Certified Public Accountants, for professional audit services for the audit of the Company's annual financial statements for the fiscal year ended November 30, 2022, and for other services rendered during the fiscal year 2022, and the fees billed by Manning Elliott LLP, Chartered Professional Accountants for professional audit services for the audit of the Company's annual financial statements for the fiscal year ended November 30, 2021, and for other services rendered during the fiscal year 2021.

  Fiscal 2022 Fiscal 2021
Audit Fees $122,916 $37,000
Audit Related Fees (1) Nil Nil
Tax Fees (2) Nil Nil
All Other Fees Nil Nil
Total $122,916 $47,000

Notes:

(1) Includes fees associated with assurance and related services that are reasonably related to the performance of the audit or review of the Company's financial statement. This category includes fees related to consultation regarding generally accepted accounting principles.

(2) Tax Fees consist of fees for tax compliance, tax advice and tax planning. The fee includes the preparation of the Company's income tax returns, franchise tax reports, and other tax filings.

Our audit committee pre-approves all audit and non-audit services provided to the Company.

ITEM 16D. EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES

Not Applicable.

ITEM 16E. PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS

Not Applicable.

ITEM 16F. CHANGE IN REGISTRANT'S CERTIFYING ACCOUNTANT

Effective July 26, 2022, Manning Elliott LLP resigned as the Company's independent registered public accounting firm.

Effective January 18, 2023, the Company appointed Reliant CPA PC to serve as its independent registered public accounting firm. The engagement of Reliant CPA PC was approved by the Company's Board of Directors.

The report of Manning Elliott LLP on the Company's financial statements as of and for the fiscal year ended November 30, 2021, did not contain an adverse opinion or disclaimer of opinion, or qualification or modification as to uncertainty, audit scope, or accounting principles.

During the Company's fiscal year ended November 30, 2021 and the subsequent interim period from December 1, 2021 to July 26, 2022, (i) there were no disagreements, resolved or not, between the Company and Manning Elliott LLP on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of Manning Elliott LLP, would have caused Manning Elliott LLP to make reference to the subject matter of such disagreements in connection with its report on the Company's financial statements for such year, and (ii) there were no reportable events within the meaning of Item 16F(a)(1)(v) of Form 20-F.


65

During the Company's fiscal year ended November 30, 2021 and through July 26, 2022, the Company did not consult with Reliance CPA PC on either (i) the application of accounting principles to a specified transaction, either completed or proposed; or the type of audit opinion that may be rendered on our financial statements, and Reliant CPA PC did not provide either a written report or oral advice to us that Reliant CPA PC concluded was an important factor considered by the Company in reaching a decision as to the accounting, auditing or financial reporting issue; or (ii) any matter that was either the subject of a disagreement, as defined in Item 16F(a)(1)(v) of Form 20-F and the related instructions, or a reportable event, as defined in Item 16F(a)(1)(v) of Form 20-F.

The Company provided Manning Elliott LLP with a copy of the disclosures in Item 16F of this Form 20-F and requested that Manning Elliott LLP furnish the Company with a letter addressed to the Securities and Exchange Commission stating whether or not Manning Elliott LLP agrees with the statements in this Item 16F, and if not, stating the respects with which it does not agree. A copy of the letter provided from Manning Elliott LLP is filed as Exhibit 15.1 to this Form 20-F.

The Company provided Reliant CPA PC with a copy of the disclosures in Item 16F of this Form 20-F and requested that Reliant CPA PC furnish the Company with a letter addressed to the Securities and Exchange Commission stating whether or not Reliant CPA PC agrees with the statements in this Item 16F, and if not, stating the respects with which it does not agree. A copy of the letter provided from Reliant CPA PC is filed as Exhibit 15.2 to this Form 20-F.

PART III

ITEM 17. FINANCIAL STATEMENTS

See "Item 18 - Financial Statements".

ITEM 18. FINANCIAL STATEMENTS

Our financial statements are stated in Canadian dollars and are prepared in accordance with IFRS, as issued by the IASB.

The following financial statements and notes thereto are filed with and incorporated herein as part of this Annual Report:

  (a) Audited consolidated financial statements for the years ended November 30, 2022, and November 30, 2021, including: report of independent registered accounting firm by Reliant CPA PC, consolidated statements of financial position, consolidated statements of loss and comprehensive loss, consolidated statements of cash flows and consolidated statements of changes in shareholders' equity (deficiency), and notes to consolidated financial statements.
 

 

 

tmp-finx001.jpg

 

 

CONSOLIDATED FINANCIAL STATEMENTS

For the Years Ended November 30, 2022, 2021 and 2020

(Expressed in Canadian Dollars)


REPORT OF INDEPENDENT REGISTERED ACCOUNTING FIRM

To the Shareholders and Directors of Plymouth Rock Technologies Inc.

Opinion on the Consolidated Financial Statements

We have audited the accompanying consolidated financial statements of Plymouth Rock Technologies Inc. and its subsidiaries (the "Company"), which comprise the consolidated statement of financial position as at November 30, 2022, and the consolidated statements of loss and comprehensive loss, changes in shareholders' equity (deficiency), and cash flows for the year ended November 30, 2022, and the related notes, including a summary of significant accounting policies and other explanatory information (collectively referred to as the "consolidated financial statements").

In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as at November 30, 2022, and its financial performance and its cash flows for the year ended November 30, 2022 in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board.

Material Uncertainty Related to Going Concern

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As described in Note 1 the Company has not generated revenue or cash flow from operations since inception. As at November 30, 2022, the Company has an accumulated deficit of $16,535,760 and incurred a comprehensive loss of $2,739,060 for the year ended November 30, 2022. These conditions raise substantial doubt about the Company's ability to continue as a going concern. Management's plans in regard to these matters are also described in Note 1. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Critical Audit Matter

As described in Note 3 to the consolidated financial statements, the Company acquired 100% of the issued and outstanding ordinary shares of Tetra Drones Ltd. ("Tetra Drones") which resulted in the recognition of an intangible asset related to customer relationships. Management assesses whether any indication of impairment exists at the end of each reporting period with respect to finite life intangible assets. In this assessment, management applies significant judgement to assess the existence of impairment indicators that could give rise to the requirement to conduct a formal impairment test. Due to the judgements and assumptions involved in the making this assessment, we identified this area as critical audit matter.

We have determined that the assessment of existence of impairment indicators for the customer relationships is a critical audit matter primarily due to the application of judgment in assessing specific factors such as (a) the high degree of auditor judgement and subjectivity in performing procedures relating to the assessment of indicators of impairment, (b) significant changes with an adverse effect on the use of the intangible asset and (c) current period cash flow or operating losses, combined with very little history of operations associated with the use of the customer relationships. This led to a high degree of auditor judgment, subjectivity and effort in performing procedures to evaluate audit evidence relating to the judgements made by management in their assessment.

Addressing the critical audit matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. Our audit procedures included amongst others, (a) evaluating the reasonableness of management's assessment of indicators of impairment with respect to the customer relationships, (b) completion of our own assessment of impairment indicators, (c) a review of matters that impact the Company's ability to continue operations, and (d) evaluating whether there were adverse economic changes in the Company's industry by considering external observable market inputs.

- 2 -


Basis for Opinion

These consolidated financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these consolidated financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.

Our audit included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audit provides a reasonable basis for our opinion.

Other Matter

The consolidated financial statements as at November 30, 2021 and for the years ended November 30, 2021 and 2020, which are presented for comparative purposes, were audited by another auditor who expressed an unmodified opinion on those consolidated financial statements on May 2, 2022.

/s/ Reliant CPA PC

CERTIFIED PUBLIC ACCOUNTANTS

Newport Beach, California  6906

March 30, 2023

We have served as the Company's auditor since 2023.

- 3 -


PLYMOUTH ROCK TECHNOLOGIES INC.

Consolidated Statements of Financial Position

(Expressed in Canadian dollars)

As at   Note     November 30, 2022     November 30, 2021  
                   
ASSETS                  
                   
Current assets                  
Cash       $ 13,127   $ 375,046  
Accounts receivable         6,870     11,848  
Sales tax receivable         9,083     56,237  
Inventories         2,175     11,086  
Prepaid expenses   4     30,947     178,321  
Total current assets         62,202     632,538  
                   
Non-current assets                  
Equipment   5     24,801     294,188  
Right of use asset   17     61,198     72,734  
Intangible assets   6     -     549,679  
Total assets       $ 148,201   $ 1,549,139  
                   
LIABILITIES                  
                   
Current liabilities                  
Accounts payable   7   $ 1,063,863   $ 608,385  
Deferred revenue   8     124,918     -  
Lease liabilities   17     66,403     39,221  
Current portion of loans payable   11     127,019     6,332  
Due to related parties   9     705,672     52,728  
Total current liabilities         2,087,875     706,666  
                   
Non-current liabilities                  
Lease liabilities   17     9,394     47,125  
Loan payable   11     -     22,545  
Total liabilities         2,097,269     776,336  
                   
SHAREHOLDERS' EQUITY (DEFICIT)                  
Share capital   13     11,851,771     11,834,582  
Contributed surplus   9,13     2,709,790     2,709,790  
Accumulated other comprehensive income         25,131     96,393  
Deficit         (16,535,760 )   (13,867,962 )
                   
Total shareholders' equity (deficit)         (1,949,068 )   772,803  
                   
Total liabilities and shareholders' equity (deficit)       $ 148,201   $ 1,549,139  

Going concern - Note 1
Commitments - Note 16
Subsequent events - Note 22

These consolidated financial statements are authorized for issuance by the Board of Directors on March 28, 2023.

Approved on behalf of the Board:

"Thomas Nash"  "Khalid Al-Ali"
Thomas Nash, Director Khalid Al-Ali, Director

The accompanying notes are an integral part of these consolidated financial statements.

- 4 -


PLYMOUTH ROCK TECHNOLOGIES INC.

Consolidated Statements of Loss and Comprehensive Loss

(Expressed in Canadian dollars)

          Years Ended November 30   
    Note     2022     2021     2020  
Sales   20   $ 607,359   $ 184,396   $ 70,931  
Cost of sales         191,175     103,109     31,316  
Gross profit         416,184     81,287     39,615  
                         
OPERATING EXPENSES                        
General and administrative   18     2,345,980     3,320,081     1,596,658  
Selling   18     177,428     709,010     1,081,478  
Research and development   18     233,265     985,006     386,044  
Total expenses         2,756,673     5,014,097     3,064,180  
                         
OTHER INCOME (EXPENSES)                        
Gain on debt forgiveness   19     234,303     -     -  
Impairment loss of intangible asset   6     (330,650 )   -     -  
Impairment loss of demo equipment   5     (236,677 )   -     -  
Interest income         -     -     193  
Interest expense         -     -     (165 )
Paycheck protection program   10     -     -     100,818  
Other Income         5,042     -     -  
Foreign exchange loss         673     (42,024 )   (517 )
NET LOSS BEFORE INCOME TAX         (2,667,798 )   (4,974,834 )   (2,924,236 )
                         
NET LOSS         (2,667,798 )   (4,974,834 )   (2,924,236 )
                         
OTHER COMPREHENSIVE INCOME                        
Foreign currency translation gain (loss)         (71,262 )   30,603     19,546  
                         
TOTAL COMPREHENSIVE LOSS       $ (2,739,060 ) $ (4,944,231 ) $ (2,904,690 )
                         
LOSS PER SHARE, basic and diluted       $ (0.05 ) $ (0.09 ) $ (0.08 )
                         
WEIGHTED AVERAGE NUMBER OF COMMON
SHARES OUTSTANDING, basic and diluted
        59,310,826     53,075,143     37,525,451  

The accompanying notes are an integral part of these consolidated financial statements.

- 5 -


PLYMOUTH ROCK TECHNOLOGIES INC.

Consolidated Statements of Changes in Shareholders' Equity (Deficit)

(Expressed in Canadian dollars)

                                        Accumulated
other
comprehensive
losses
       
    Share capital (Note 13)     Shares to
be issued
(Note 13)
                         
    Number of
shares
    Amount     Subscriptions
received
    Contributed
Surplus
    Deficit     Total  
                                                 
Balance, November 30, 2019   32,796,600   $ 5,676,498   $ 22,811   $ -   $ 736,271   $ (5,968,892 ) $ 46,244   $ 512,932  
                                                 
Net loss for the year   -     -     -     -     -     (2,924,236 )   -     (2,924,236 )
Shares issued for warrants exercised   1,233,334     246,667     -     -     -     -     -     246,667  
Private placements   8,232,330     1,367,325     (22,811 )   -     83,109     -     -     1,427,623  
Share issuance costs   -     (38,727 )   -     -     -     -     -     (38,727 )
Shares issued as compensation   500,000     125,000     -     -     -     -     -     125,000  
Stock-based compensation   -     -     -     -     479,107     -     -     479,107  
Foreign currency translation   -     -     -     -     -     -     19,546     19,546  
Balance, November 30, 2020   42,762,264   $ 7,376,763   $ -   $ -   $ 1,298,487   $ (8,893,128 ) $ 65,790   $ (152,088 )
                                                 
Net loss for the period   -     -     -     -     -     (4,974,834 )   -     (4,974,834 )
Foreign currency translation loss   -     -     -     -     -     -     30,603     30,603  
Shares issued for warrants exercised   6,129,572     1,332,727     -     -     -     -     -     1,332,727  
Fair value of warrants exercised   -     36,859     -     -     (36,859 )   -     -     -  
Shares issued for options exercised   425,000     222,500     -     -     -     -     -     222,500  
Fair value of options exercised   -     158,106     -     -     (158,106 )   -     -     -  
Private placements   8,930,000     2,749,000     -     -     287,499     -     -     3,036,499  
Fair value of broker warrants granted   -     (174,427 )   -     -     174,427     -     -     -  
Shares issued to finders   336,250     (100,500 )   -     -     -     -     -     (100,500 )
Finders' fees   -     (74,180 )   -     -     -     -     -     (74,180 )
Shares issued as compensation   656,250     307,734     -     -     -     -     -     307,734  
Stock-based compensation   -     -     -     -     1,144,342     -     -     1,144,342  
Balance, November 30, 2021   59,239,336   $ 11,834,582   $ -   $ -   $ 2,709,790   $ (13,867,962 ) $ 96,393   $ 772,803  
                                                 
Net loss for the period   -     -     -     -     -     (2,667,798 )   -     (2,667,798 )
Foreign currency translation loss   -     -     -     -     -     -     (71,262 )   (71,262 )
Shares issued from services   78,125     17,189     -     -     -     -     -     17,189  
Balance, November 30, 2022   59,317,461     11,851,771   $ -   $ -   $ 2,709,790     (16,535,760 ) $ 25,131   $ (1,949,068 )

The accompanying notes are an integral part of these consolidated financial statements

- 6 -


PLYMOUTH ROCK TECHNOLOGIES INC.

Consolidated Statements of Cash Flows

(Expressed in Canadian dollars)

    Year ended November 30  
    2022     2021     2020  
                   

Cash Provided By (Used In)

                 
                   

Operating Activities

                 

Net loss for the period

$ (2,667,798 ) $ (4,974,834 ) $ (2,924,236 )
                   

Items not affecting cash:

                 

Stock based compensation

  -     1,144,342     479,107  

Amortization expense

  286,745     143,783     41,201  

Foreign exchange (gain) loss

  (71,262 )   -     -  

Interest accretion

  18,877     14,760     20,449  

Impairment of development assets

  -     -     3,576  

Impairment of demo equipment

  236,677     -     -  

Gain on debt forgiveness

  (234,303 )   -     -  

Impairment of intangible asset

  330,650     -     -  

Shares issued for services

  17,189     307,734     125,000  
                   

Changes in non-cash working capital:

                 

Sales tax receivable

  47,154     (51,583 )   2,993  

Accounts receivable

  4,978     (9,062 )   (1,334 )

Inventories

  8,911     8,609     (19,695 )

Prepaid expenses

  147,374     (140,868 )   77,590  

Deferred revenue

  124,918     -     -  

Due from related parties

  -     2,500     (22,570 )

Due to related parties

  652,944     (8,894 )   36,320  

Accounts payable and accrued liabilities

  682,923     122,411     67,084  

Net cash used in operating activities

  (414,023 )   (3,441,102 )   (2,114,515 )
                   

Investing Activities

                 

Purchase of equipment

  -     (204,305 )   (57,518 )

Development expenses on Intangible assets

  -     -     (3,576 )

Acquisition of business

  -     (369,038 )   -  

Net cash provided by (used in) investing activities

  -     (573,343 )   (61,094 )
                   

Financing Activities

                 

Common shares issued for cash, options and warrants exercised, net of share issuance costs

  -     4,417,047     1,635,564  

Lease payments

  (34,701 )   (48,175 )   (48,473 )

Loan payable

  105,000     (42,430 )   -  

Net cash provided by financing activities

  70,299     4,326,442     1,587,091  
                   

Increase (decrease) in cash

  (343,724 )   311,997     (588,518 )

Effect of foreign exchange rate changes on cash

  (18,195 )   38,336     30,112  

Cash, beginning of the period

  375,046     24,713     583,119  
                   

Cash, end of the period

$ 13,127   $ 375,046   $ 24,713  

 

Supplemental cash flow information - Note 15

 

The accompanying notes are an integral part of these consolidated financial statements.

 

- 7 -


PLYMOUTH ROCK TECHNOLOGIES INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the year ended November 30, 2022, 2021 and 2020
(Expressed in Canadian Dollars)

1. NATURE OF OPERATIONS AND ABILITY TO CONTINUE AS A GOING CONCERN

Plymouth Rock Technologies Inc. (the "Company") was incorporated under the Business Corporations Act of British Columbia on October 17, 2011. The head office, principal address and registered and records office of the Company are located at 700 - 1199 West Hastings Street, Vancouver, B.C., V6E 3T5.

The Company's common shares are listed on the CSE and on Frankfurt Stock Exchange in Germany under the Symbol: 4XA, WKN# - A2N8RH. The Company's common shares are also on the OTC Markets Group ("OTCQB") under the symbol: PLRTF.

The Company's principal business activity through its subsidiary, Plymouth Rock USA ("PRT USA"), focused on developing technologies related to remotely detecting assault firearms and suicide bombs concealed on the person or a carry bag. The Company focuses on detection methods with and without the need for a checkpoint of the suspect who is being screened. The Company's planned products encompass the very latest radar, imaging, and Unmanned Aerial System ("UAS") technologies for quickly detecting, locating and identifying the presence of threats and for search and rescue missions for law enforcement.

On March 26, 2021, the Company incorporated a subsidiary in United Kingdom, Plymouth Rock Technologies UK Limited ("PRT UK"). The purpose of PRT UK is to augment the Company's existing research and development of its drone technologies for the US and EMEA markets.

On June 4, 2021, the Company completed its acquisition of Tetra Drones Limited ("Tetra") (Note 3). The acquisition of Tetra provides the Company with drones production line in the United Kingdom.

Going Concern

These consolidated financial statements are prepared on a going concern basis, which contemplates that the Company will continue in operation for the foreseeable future and will be able to realize its assets and discharge its liabilities in the normal course of business. At present, the Company's operations do not generate cash flows from operations. The Company has incurred losses since inception and has a comprehensive loss of $2,739,060 for the year ended November 30, 2022 (2021 - $4,944,231; 2020 - $2,904,690) and had an accumulated deficit of $16,535,760 (2021 - $13,867,962). The ability of the Company to continue as a going concern is dependent on achieving profitable operations, commercializing its technologies, and obtaining the necessary financing in order to develop these technologies further. The outcome of these matters cannot be predicted at this time. The Company will continue to review the prospects of raising additional debt and equity financing to support its operations until such time that its operations become self-sustaining, to fund its research and development activities and to ensure the realization of its assets and discharge of its liabilities. While the Company is expanding its best efforts to achieve the above plans, there is no assurance that any such activity will generate sufficient funds for future operations. These factors and uncertainty casts significant doubt about the Company's ability to continue as a going concern and therefore it may be unable to realize its assets and discharge its liabilities in the normal course of business.

The Company is not expected to be profitable during the ensuing 12 months, and therefore, must rely on securing additional funds from either issuance of debt or equity financing for cash consideration. During the year ended November 30, 2022, the Company received net cash proceeds of $70,299 (2021 - 4,326,442; 2020 - 1,587,091) pursuant to financing activities. Management has been successful in raising capital through periodic private placements of the Company's common shares in the past, however there is no certainty that financing will be available in the future, or certainty that management's planned actions to address this situation will be successful.

- 33 -


PLYMOUTH ROCK TECHNOLOGIES INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the year ended November 30, 2022, 2021 and 2020
(Expressed in Canadian Dollars)

1. NATURE OF OPERATIONS AND ABILITY TO CONTINUE AS A GOING CONCERN (continued)

These consolidated financial statements have been prepared in accordance with International Financial Reporting Standards ("IFRS") with the assumption that the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future rather than a process of forced liquidation. These consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue in existence. Such adjustments could be material.

2. SIGNIFICANT ACCOUNTING POLICIES

Basis of presentation

These consolidated financial statements ("Financial Statements") have been prepared in accordance with IFRS as issued by the International Accounting Standard Board ("IASB") and interpretations of the International Financial Reporting Interpretations Committee ("IFRIC").

These Financial Statements are authorized for issue by the Board of Directors on March 28, 2023.

These Financial Statements have been prepared on the historical cost basis. In addition, these Financial Statements have been prepared using the accrual basis of accounting.

These Financial Statements are presented in Canadian dollars, which is the Company's functional currency. The functional currency of PRT USA is U.S. Dollars and the functional currency of PRT UK and Tetra is British Pound Sterling ("£"). The assets and liabilities of PRT USA, PRT UK and Tetra are translated into Canadian dollars at the rate of exchange prevailing at the reporting date and their income and expense items are translated at average exchange rates for the period. Exchange differences arising on the translation are recognized in other comprehensive income.

Significant accounting judgments, estimates and assumptions

The preparation of these Financial Statements in conformity with IFRS requires management to make judgments and estimates and form assumptions that affect the reported amounts of assets and liabilities at the date of the Financial Statements and reported amounts of income and expenses during the period. Actual results could differ from these estimates.

Significant estimates used in preparing the Financial Statements include, but are not limited to the following:

a. Deferred taxes

The calculation of deferred tax is based on the ability of the Company to generate future taxable income, the estimation of which is subject to significant uncertainty as to the amount and timing. The calculation of deferred tax is also based on assumptions, which are subject to uncertainty as to timing and which tax rates are expected to apply when temporary differences reverse. Deferred tax recorded is also subject to uncertainty regarding the magnitude on non-capital losses available for carry forward and of the balances in various tax pools as the corporate tax returns have not been prepared as of the date of financial statement preparation.

- 34 -


PLYMOUTH ROCK TECHNOLOGIES INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the year ended November 30, 2022, 2021 and 2020
(Expressed in Canadian Dollars)

2. SIGNIFICANT ACCOUNTING POLICIES (continued)

Significant accounting judgments, estimates and assumptions (continued)

b. Stock-based payments

The fair value of stock options and finders' warrants issued are subject to the limitations of the Black-Scholes option pricing model that incorporates market data and involves uncertainty in estimates used by management in the assumptions. Because the Black-Scholes option pricing model requires the input of highly subjective assumptions, including the expected lift, volatility of share prices, risk-free rate and dividend yield, changes in subjective input assumptions can materially affect the fair value estimate.

c. Impairment of non-financial assets

Impairment exists when the carrying value of an asset or cash generating unit ("CGU") exceeds its recoverable amount, which is the higher of its fair value less costs to sell and its value in use. The fair value less costs to sell calculation is based on available data from binding sales transactions in an arm's length transaction of similar assets or observable market prices less incremental costs for disposing of the asset. The value in use calculation is based on a discounted cash flow model.

d. Leases

Management uses estimation in determining the incremental borrowing rate used to measure the lease liability, specific to the asset, underlying currency and geographic location.

Significant judgments used in the preparation of these Financial Statements include, but are not limited to the following:

(i) Going concern

Management has applied judgements in the assessment of the Company's ability to continue as a going concern when preparing its Financial Statements for the year ended November 30, 2022. Management prepares the Financial Statements on a going concern basis unless management either intends to liquidate the entity or to cease trading or has no realistic alternative but to do so.

In assessing whether the going concern assumption is appropriate, management accounts for all available information about the future, which is at least, but is not limited to, twelve months from the end of the reporting period.

(ii) Business combinations

Determination of whether a set of assets acquired and liabilities assumed constitute the acquisition of a business or asset may require the Company to make certain judgments as to whether or not the assets acquired and liabilities assumed include the inputs, processes and outputs necessary to constitute a business as defined in IFRS 3 - Business Combinations. Based on an assessment of the relevant facts and circumstances, the Company concluded that the acquisition disclosed in Note 3 met the criteria for accounting as a business combination.

(iii) Intangible assets

Intangible assets can be capitalized only if development costs can be measured reliably, the product or process is technically and commercially feasible, future economic benefits are probable, and the Company intends to and has sufficient resources to complete development and to use or sell the asset. To determine if the future economic benefit is probable depends on the successful commercialization of its technologies and that in turn depends on the management's judgement and knowledge. As at November 30, 2022, the development costs are not capitalized as management was unable to demonstrate the future economic benefits to be generated from the utilization of the associated expenditures.

- 35 -


PLYMOUTH ROCK TECHNOLOGIES INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the year ended November 30, 2022, 2021 and 2020
(Expressed in Canadian Dollars)

2. SIGNIFICANT ACCOUNTING POLICIES (continued)

Cash

Cash consists of amounts held in banks and highly liquid investments with limited interest and credit risk.

Consolidation

The Financial Statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances, transactions and any unrealized gains and losses arising from intercompany transactions, have been eliminated. The Company's subsidiary is presented in the table below. Plymouth Rock USA was incorporated under the General Corporation Law of the State of Delaware on March 22, 2018. Plymouth Rock UK was incorporated under the General Corporation Law for England and Wales on March 26, 2021.Tetra Drones was incorporated under the General Corporation Law for England and Wales and was acquired by the Company on June 4, 2021.

Entity Country of Incorporation Effective Economic
Interest
     
Plymouth Rock Technologies Inc.
("Plymouth Rock USA")
USA 100%
     
Plymouth Rock Technologies Inc.
("PRT UK")
UK 100%
     
Tetra Drones Ltd. ("Tetra Drones") UK 100%

Intangible assets

Intangible assets that are reflected in the consolidated statements of financial position consist of assets acquired through business combinations. Intangible assets acquired in a business combination are recognized separately from goodwill and are initially recognized at their fair value at the acquisition date (which is regarded as their cost). An intangible asset is regarded as having an indefinite useful life when, based on all relevant factors, there is no foreseeable limit to the period over which the asset is expected to generate net cash inflows. Accordingly, the Company does not amortize these intangible assets, but reviews them for impairment, annually or more frequently if events or changes in circumstances indicate that the assets might be impaired.

Development costs for internally-generated intangible assets are capitalized when all of the following conditions are met:

  • technical feasibility can be demonstrated;
  • management has the intention to complete the intangible asset and use it;
  • management can demonstrate the ability to use the intangible asset;
  • it is probable that the intangible asset will generate future economic benefits;
  • the Company can demonstrate the availability of adequate technical, financial and other resources to complete the development and to use the intangible asset; and
  • costs attributable to the asset can be measured reliably.

The amount initially recognized for internally-generated intangible assets is the sum of the expenditures incurred from the date when the intangible asset first meets the recognition criteria listed above. Where no internally-generated intangible asset can be recognized, development expenditures are charged to the consolidated statements of loss and comprehensive loss in the period in which they are incurred.

Customer relationships acquired through the acquisition of subsidiary, Tetra Drones, are amortized for a period of three years from acquisition date.

- 36 -


PLYMOUTH ROCK TECHNOLOGIES INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the year ended November 30, 2022, 2021 and 2020
(Expressed in Canadian Dollars)

2. SIGNIFICANT ACCOUNTING POLICIES (continued)

Equipment

Recognition and measurement

On initial recognition, equipment is valued at cost, being the purchase price and directly attributable cost of acquisition or construction required to bring the asset to the location and condition necessary to be capable of operating in the manner intended by the Company, including appropriate borrowing costs and the estimated present value of any future unavoidable costs of dismantling and removing the items. The corresponding liability is recognized within provisions.

Equipment is subsequently measured at cost less accumulated depreciation, less any accumulated impairment losses.

When parts of an item of equipment have different useful lives, they are accounted for as separate items (major components) of equipment.

Gains and losses

Gains and losses on disposal of an item of equipment are determined by comparing the proceeds from disposal with the carrying amount and are recognized net within other income in profit or loss.

Depreciation

Half of the normal depreciation is taken in the year of acquisition for equipment with declining balance method. The depreciation rates applicable to each category of property and equipment are as follows:

Computer equipment    55% declining balance Vehicles                             30% declining balance
Furniture                       20% declining balance Leasehold improvements  30% declining balance
Demo equipment          20% declining balance  

Inventories

The Company values inventories at the lower of cost and net realizable value. Cost includes the costs of purchases net of vendor allowances plus other costs, such as transportation, that are directly incurred to bring the inventories to their present location and condition.

Business combinations

Business combinations are accounted for using the acquisition method. The cost of the acquisition is measured at the aggregate of the fair values at the date of acquisition, of assets transferred, liabilities incurred or assumed, and equity instruments issued by the Company. The acquiree's identifiable assets and liabilities assumed are recognized at their fair value at the acquisition date. Acquisition-related costs are recognized in profit or loss as incurred. The excess of consideration over the fair value of the net identifiable assets and liabilities acquired is recorded as goodwill. Any gain on a bargain purchase is recorded in profit or loss immediately. Transaction costs are expensed as incurred, except if related to the issue of debt or equity securities. Any goodwill that arises is tested annually for impairment.

Share capital

The Company records proceeds from the issuance of its common shares as equity. Proceeds received on the issuance of units, consisting of common shares and warrants, are allocated between the common share and warrant component. The Company has adopted a residual value method with respect to the measurement of shares and warrants issued as private placement units. The residual value method first allocates value to the most easily measurable component based on fair value and then the residual value, if any, to the less easily measurable component.

- 37 -


PLYMOUTH ROCK TECHNOLOGIES INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the year ended November 30, 2022, 2021 and 2020
(Expressed in Canadian Dollars)

2. SIGNIFICANT ACCOUNTING POLICIES (continued)

Share capital (continued)

The fair value of the common shares issued in the private placement was determined to be the more easily measurable component and were valued at their fair value, as determined by the closing quoted price on the issuance date. The remaining proceeds, if any, are allocated to the attached warrants. Any fair value attributed to the warrants is recorded as warrant reserve. Management does not expect to record a value to the warrant in most equity issuances as unit private placements are commonly priced at market or at a permitted discount to market. If the warrants are issued as share issuance costs, the fair value of agent's warrants are measured using the Black-Scholes option pricing model and recognized in equity as a deduction from the proceeds.

If the warrants are exercised, the related amount is reclassified as share capital. If the warrants expire unexercised, the related amount remains in warrant reserve.

Incremental costs directly attributable to the issue of new common shares are shown in equity as a deduction, net of tax, from the proceeds. Common shares issued for consideration other than cash are valued based on their market value at the date that shares are issued.

Stock-based payment

The Company recognizes share-based payment expense for the estimated fair value of equity-based instruments granted to both employees and non-employees. Compensation expense is recognized when the options are granted with the same amount being recorded as contributed surplus. The expense is determined using an option pricing model that accounts for the exercise price, the term of the option, the current share price, the expected volatility of the underlying shares, the expected dividend yield, and the risk-free interest rate for the term of the option. If the options are exercised, the contributed surplus will be reduced by the applicable amount. Share-based payment calculations have no effect in the Company's cash position.

Earnings (loss) per share

Basic earnings (loss) per share are calculated using the weighted average number of common shares outstanding during the period. Diluted earnings (loss) per share are calculated using the treasury stock method. This method assumes that common shares are issued for the exercise of options, warrants and convertible securities and that the assumed proceeds from the exercise of options, warrants and convertible securities are used to purchase common shares at the average market price during the period. The difference between the number of shares assumed issued and the number of shares assumed purchased is then added to the basic weighted average number of shares outstanding to determine the fully diluted number of common shares outstanding. No exercise or conversion is assumed during the periods in which a net loss is incurred as the effect is anti-dilutive.

Financial instruments

Financial assets

The Company recognizes financial assets when it becomes party to the contractual provisions of the instrument. Financial assets are measured initially at their fair value plus, in the case of financial assets not subsequently measured at fair value through profit or loss, transaction costs that are directly attributable to their acquisition. Transaction costs attributable to the acquisition of financial assets subsequently measured at fair value through profit or loss are expensed in profit or loss when incurred.

Subsequent to initial recognition, all financial assets are classified and subsequently measured at amortized cost. Interest income is calculated using the effective interest method and gains or losses arising from impairment, foreign exchange and derecognition are recognized in profit or loss. Financial assets measured at amortized cost are comprised of cash, accounts receivable and due from related parties.

- 38 -


PLYMOUTH ROCK TECHNOLOGIES INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the year ended November 30, 2022, 2021 and 2020
(Expressed in Canadian Dollars)

2. SIGNIFICANT ACCOUNTING POLICIES (continued)

Financial assets (continued)

The Company reclassifies debt instruments only when its business model for managing those financial assets has changed. Reclassifications are applied prospectively from the reclassification date and any previously recognized gains, losses or interest are not restated.

The Company recognizes a loss allowance for the expected credit losses associated with its financial assets. Expected credit losses are measured to reflect a probability-weighted amount, the time value of money, and reasonable and supportable information regarding past events, current conditions and forecasts of future economic conditions.

The Company applies the simplified approach for accounts receivable that do not contain a significant financing component. Using the simplified approach, the Company records a loss allowance equal to the expected credit losses resulting from all possible default events over the assets' contractual lifetime.

Financial assets are written off when the Company has no reasonable expectations of recovering all or any portion thereof.

The Company derecognizes a financial asset when its contractual rights to the cash flows from the financial asset expire.

Financial liabilities

The Company recognizes a financial liability when it becomes party to the contractual provisions of the instrument. At initial recognition, the Company measures financial liabilities at their fair value plus transaction costs that are directly attributable to their issuance, with the exception of financial liabilities subsequently measured at fair value through profit or loss for which transaction costs are immediately recorded in profit or loss.

Subsequent to initial recognition, all financial liabilities are measured at amortized cost using the effective interest rate method. Interest, gains, and losses relating to a financial liability are recognized in profit or loss. Financial liabilities measured at amortized cost are comprised of accounts payable, lease liability, and due to related parties.

The Company derecognizes a financial liability only when its contractual obligations are discharged, cancelled or expire.

Interest

Interest income and expense are recognized in profit or loss using the effective interest method.

The 'effective interest rate' is the rate that exactly discounts estimated future cash payments over the expected life of the financial instrument to the gross carrying amount of the financial asset or the amortized cost of the financial liability. The effective interest rate is calculated considering all contractual terms of the financial instruments, except for the expected credit losses of financial assets.

The 'amortized cost' of a financial asset or financial liability is the amount at which the instrument is measured on initial recognition minus principal repayments, plus or minus any cumulative amortization using the effective interest method of any difference between the initial amount and maturity amount and adjusted for any expected credit loss allowance. The 'gross carrying amount' of a financial asset is the amortized cost of a financial asset before adjusting for any expected credit losses.

- 39 -


PLYMOUTH ROCK TECHNOLOGIES INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the year ended November 30, 2022, 2021 and 2020
(Expressed in Canadian Dollars)

2. SIGNIFICANT ACCOUNTING POLICIES (continued)

Interest (continued)

Interest income and expense is calculated by applying the effective interest rate to the gross carrying amount of the financial asset (when the asset is not credit-impaired) or the amortized cost of the financial liability.

Where a financial asset has become credit-impaired subsequent to initial recognition, interest income is calculated in subsequent periods by applying the effective interest method to the amortized cost of the financial asset. If the asset subsequently ceases to be credit-impaired, calculation of interest income reverts to the gross basis.

Offsetting

Financial assets and financial liabilities are offset, with the net amount presented in the statement of financial position, when, and only when, the Company has a current and legally enforceable right to set off the recognized amounts and intends either to settle on a net basis or realize the asset and settle the liability simultaneously.

Income and expenses are presented on a net basis only when permitted under IFRS, or when arising from a group of similar transactions if the resulting income and expenses are not material.

Revenue recognition

Revenue is recognized by applying the five-step model under IFRS 15. The Company recognizes revenue when, or as the goods or services are transferred to the control of the customer and performance obligations are satisfied. The Company's revenue is comprised of sales of its radar systems, radar components and engineering design and development services. The Company's revenue is recognized when control of the goods has been transferred, being when the goods are delivered to customers and when all performance obligations have been fulfilled. The amounts recognized as revenue represent the fair values of the considerations received or receivable from third parties on the sales of goods to customers, net of goods and services taxes and less returns, and discounts, at which time there are no conditions for the payment to become due other than the passage of time. For its engineering design and development services, revenue is recognized when the service has been rendered.

Government Grants

Government grants are recognized at fair value once there is reasonable assurance that the Company will comply with the conditions attached to the grants and that the grants will be received. Government grants are recognized in profit or loss on a systematic basis over the periods in which the Company recognizes as expenses the related costs for which the grants are intended to compensate. A forgivable loan from government is treated as a government grant when there is reasonable assurance that the entity will meet the terms for forgiveness of the loan.

Income taxes

Income tax is recognized in profit or loss except to the extent that it relates to equity items, in which case it is recognized in equity. Current tax expense is the expected tax payable on the taxable income for the year, using tax rates enacted at period end, adjusted for amendments to tax payable with regards to previous years. Deferred tax is recorded using the liability method, providing for temporary differences, between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for taxation purposes. The following temporary differences do not result in deferred tax assets or liabilities: goodwill not deductible for tax purposes; the initial recognition of assets or liabilities that affect neither accounting profit (loss) nor taxable profit (loss); and differences relating to investments in subsidiaries to the extent that they will probably not reverse in the foreseeable future. The amount of deferred tax provided is based on the expected manner of realization or settlement of the carrying amount of assets and liabilities, using tax rates enacted or substantively enacted at the financial position date.

- 40 -


PLYMOUTH ROCK TECHNOLOGIES INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the year ended November 30, 2022, 2021 and 2020
(Expressed in Canadian Dollars)

2. SIGNIFICANT ACCOUNTING POLICIES (continued)

Income taxes (continued)

A deferred tax asset is recognized only to the extent that it is probable that future taxable profits will be available against which the asset can be utilized. Deferred tax assets and liabilities are offset when there is a legally enforceable right to set off current tax assets against current tax liabilities and when they relate to income taxes levied by the same taxation authority and the Company intends to settle its current tax assets and liabilities on a net basis.

Related party transactions

Parties are considered to be related if one party has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions.

Parties are also considered to be related if they are subject to common control and related parties may be individuals or corporate entities. A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties.

Leases

The company adopted IFRS 16 effective December 1, 2019. The Company chose to adopt the modified retrospective approach on transition to IFRS 16 and has chosen not to restate comparative information in accordance with the transitional provisions in IFRS 16. As a result, the comparative information continues to be presented in accordance with the Company's previous accounting policies. The adoption of IFRS 16 resulted in the recognition of a right-of-use asset and a lease liability measured at the present value of the future lease payments on the consolidated statements of financial position. An amortization expense on the right-of-use asset and an interest expense on the lease liability has replaced the operating lease expense. IFRS 16 has changed the presentation of cash flows relating to leases in the Company's consolidated statements of cash flows, however, it does not cause a difference in the amount of cash transferred between the parties of the lease.

Accounting standards, amendments and interpretations not yet effective

Certain new standards, interpretations and amendments to existing standards have been issued by the IASB or the IFRIC during the period but are not yet effective. Some updates that are not applicable or are not consequential to the Company may have been excluded from the list below.

IAS 1 - Presentation of Financial Statements ("IAS 1") - Classification of Liabilities as Current or Noncurrent were amended to clarify that the classification of liabilities as current or non-current is based on rights that are in existence at the end of the reporting period, specify that classification is unaffected by expectations about whether an entity will exercise its right to defer settlement of a liability, explain that rights are in existence if covenants are complied with at the end of the reporting period, and introduce a definition of 'settlement' to make clear that settlement refers to the transfer to the counterparty of cash, equity instruments, other assets or services. The amendments are effective for annual reporting periods beginning on or after January 1, 2023. Earlier adoption is permitted.

 

IAS 16 - Property, Plant and Equipment - Proceeds before Intended Use - The amendments prohibit deducting from the cost of an item of property, plant and equipment any proceeds from selling items produced before that asset is available for use, i.e. proceeds while bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management. Consequently, an entity recognizes such sales proceeds and related costs in profit or loss. The entity measures the cost of those items in accordance with IAS 2 Inventories. The amendments are effective for annual reporting periods beginning on or after January 1, 2022. Earlier adoption is permitted.

These new and amended standards are not expected to have a material impact on the Company's Financial Statements

- 41 -


PLYMOUTH ROCK TECHNOLOGIES INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the year ended November 30, 2022, 2021 and 2020
(Expressed in Canadian Dollars)

3. ACQUISITION

On June 4, 2021, the Company acquired the 100% issued and outstanding ordinary shares of Tetra from two arm's length parties for £350,000. Tetra was a privately held UK-based company which develops custom-made, Unmanned Aircraft Systems ("UAS"). The consideration of £350,000 ($579,682) is payable as follows:

1) An amount of £35,000 ($60,021) within 7 days after the execution and delivery of the definitive agreement by all parties, paid on June 12, 2021;

2) An amount of £35,000 ($60,479) (paid) within 21 days of the initial payment as described in instalment 1 above, paid on July 9, 2021;

3) An amount of £140,000 ($236,411) (paid) within 120 days of the second instalment as described above, paid on November 8, 2021 ("the third payment"); and

4) The remaining balance of £140,000 ($222,771) (see Note 19 - Gain on debt forgiveness) within 120 days of the third payment, forgiven in return of the full release of the leased vehicle and allowing the former sole shareholder of Tetra to continue working within the industry.

The Company applied the optional concentration test permitted under IFRS 3 to the acquisition which resulted in the acquired assets being accounted for as an asset acquisition. As such the purchase price was allocated to the identifiable assets and liabilities based on their fair values at the date of acquisition.

The allocation of the consideration for the purposes of the consolidated statements of financial position is as follows:

Total Consideration      
Cash $ 579,682  
       
Net assets acquired (liabilities assumed)      
Cash indebtedness $ (12,127 )
Equipment   27,799  
Prepaid expenses   11,131  
Due to a related party   (13,699 )
Bank loan   (40,447 )
Accounts payable   (19,210 )
Vehicle loan   (30,859 )
Net assets acquired (liabilities assumed) $ (77,412 )
       
Purchase price allocation      
Net identifiable assets acquired $ (77,412 )
Customer relationships   657,094  
  $ 579,682  
4. PREPAID EXPENSES

As at November 30, 2022 and 2021, the Company's prepaid expenses consist of the following:

    November 30, 2022     November 30, 2021  
             
Advertising and promotions $ 113   $ 127,664  
Rent   8,247     11,211  
Transfer agent and filing fees   13,748     13,020  
Insurance   8,839     8,382  
Others   -     18,044  
  $ 30,947   $ 178,321  

- 42 -


PLYMOUTH ROCK TECHNOLOGIES INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the year ended November 30, 2022, 2021 and 2020
(Expressed in Canadian Dollars)

4. PREPAID EXPENSES (continued)

The prepayments for advertising include prepayments for marketing and awareness programs handled by an arms' length parties for a six to twelve-month period.

Others include prepayments for some office expenses.

As at November 30, 2022, others include $Nil prepayment to related parties (2021 - $5,513) (Note 9).

5. EQUIPMENT

    Computer     Furniture     Vehicles     Leasehold
Improvement
    Demo
Equipment
    Total  
    $     $     $     $     $     $  
Cost:                                    
Balance at November 30, 2020   1,684     12,151     -     -     57,518     71,353  
Additions   22,664     7,244     16,243     3,881     184,484     234,516  
Foreign currency translation adjustment   (320 )   (124 )   (229 )   (55 )   (2,255 )   (2,983 )
Balance at November 30, 2021   24,028     19,271     16,014     3,826     239,747     302,886  
    Disposal   -     -     (16,243 )   -     -     (16,243 )
Foreign currency translation adjustment   (997 )   190     229     (182 )   3,158     2,398  
Balance at November 30, 2022   23,031     19,461     -     3,644     242,905     289,041  
                                     
Accumulated Depreciation:                                    
Balance at November 30, 2020   1,134     3,401     -     -     -     4,535  
Amortization   561     2,055     1,201     287     -     4,104  
Foreign currency translation adjustment   21     17     17     4     -     59  
Balance at November 30, 2021   1,716     5,473     1,218     291     -     8,698  
Amortization   9,236     2,688     4,210     1,006     -     17,140  
Disposal   -     -     (5,375 )   -     -     (5,375 )
Impairment                           236,677     236,677  
Foreign currency translation adjustment   642     296     (53 )   (13 )   6,228     7,100  
Balance at November 30, 2022   11,594     8,457     -     1,284     242,905     264,240  
                                     
Net Book Value:                                    
At November 30, 2021   22,312     13,798     14,796     3,535     239,747     294,188  
At November 30, 2022   11,437     11,004     -     2,360     -     24,801  

- 43 -


PLYMOUTH ROCK TECHNOLOGIES INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the year ended November 30, 2022, 2021 and 2020
(Expressed in Canadian Dollars)

6. INTANGIBLE ASSETS

During the year ended November 30, 2021, the Company acquired Tetra (Note 3).Included in the acquisition is the identifiable intangible asset, customer relationships valued at $657,094.The intangible asset is being amortized over its estimated useful life of three years. For the year ended November 30, 2022, the Company determined that the intangible asset is fully impaired as there is no future economic benefits will derived from this asset.

Cost:   Customer relationship  
Balance at November 30, 2020 $ -  
    Additions   657,094  
Balance at November 30, 2021 and November 30, 2022   657,094  
       
Accumulated amortization:      
Balance at November 30, 2020   -  
    Amortization   (107,415 )
Balance at November 30, 2021   (107,415 )
    Amortization   (219,029 )
    Impairment   (330,650 )
Balance at November 30, 2022   (657,094 )
Net book value      
Balance at November 30, 2021 $ 549,679  
Balance at November 30, 2022 $ -  

7. ACCOUNTS PAYABLE

As at November 30, 2022 and 2021, the Company's accounts payable consist of the following:

    November 30, 2022     November 30, 2021  
             
Professional fees $ 382,805   $ 92,078  
Funds to be returned to investors   43,046     43,046  
Due to former shareholder of Tetra (Note 3, 19)   -     222,771  
Advertising costs   34,705     42,241  
Payroll   268,610     33,173  
Development costs   168,925     123,334  
Bank overdraft   16,036     -  
VAT Payable   61,262     4,735  
Purchases   2,121     -  
Rent   1,822     -  
Others   84,531     47,007  
  $ 1,063,863   $ 608,385  

8. Deferred Revenue

As at November 30, 2022 and 2021, the Company received an advance payment from their customers as consideration for the Company's products and services to be rendered in the future date amounting to $124,918 (2021 - $nil).

- 44 -


PLYMOUTH ROCK TECHNOLOGIES INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the year ended November 30, 2022, 2021 and 2020
(Expressed in Canadian Dollars)

9.    RELATED PARTY TRANSACTIONS AND BALANCES

Key management compensation

The amounts due to and from related parties are due to the directors and officers of the Company. The balances are unsecured, non-interest bearing and due on demand. These transactions are in the normal course of operations and have been valued in these consolidated financial statements at the exchange amount, which is the amount of consideration established and agreed to by the related parties. Key management is comprised of directors and officers of the Company

As at November 30, 2022, $Nil (2021 - $5,513) prepayment to directors and officers of the Company.

As at November 30, 2022, $705,672 (2021 - $52,728) was due to directors and officers of the Company:

    November 30, 2022     November 30, 2021  
Company controlled by the CFO $ 67,540   $ -  
Company controlled by the Corporate Secretary   -     10,500  
CEO of the Company   250,179     561  
Director   387,953     41,667  
  $ 705,672   $ 52,728  

During the years ended November 30, 2022 and 2021 and 2020, the Company entered into the following transactions with related parties:

    November 30, 2022     November 30, 2021     November 30, 2020  
Management fees $ 311,535   $ 118,000   $ 114,125  
Consulting fees   135,000     307,734     166,667  
Accounting fees   -     36,202     22,852  
Rent   -     5,000     20,000  
Share-based payments   -     410,132     271,993  
Salaries and benefits to CEO   330,337     313,626     133,387  
  $ 776,872   $ 1,190,694   $ 729,024  
 

Management fees consisted of the following:

 
    November 30, 2022     November 30, 2021     November 30, 2020  
Company controlled by CEO $ 243,387   $ 63,000   $ 55,125  
Company controlled by the Former CFO   -     55,000     59,000  
Company controlled by the CFO   68,148     -     -  
  $ 311,535   $ 118,000   $ 114,125  

Consulting fees consisted of the following:

    November 30, 2022     November 30, 2021     November 30, 2020  
Company controlled by the Former Corporate Secretary $ 60,000   $ -   $ -  
Directors   75,000     307,734     166,667  
  $ 135,000   $ 307,734   $ 166,667  

- 45 -


PLYMOUTH ROCK TECHNOLOGIES INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the year ended November 30, 2022, 2021 and 2020
(Expressed in Canadian Dollars)

9. RELATED PARTY TRANSACTIONS AND BALANCES (continued)

During the year ended November 30, 2022, the Company had 1,650,000 (2021 -1,725,000) stock options held by the CEO, Former CFO, the Former Corporate Secretary, and the Company's directors. The amount recognized as expense for these options for the years ended November 30, 2022, 2021 and 2020 are as follows:

    November 30, 2022     November 30, 2021     November 30, 2020  
    Number of
Options
held
    Expense
for the year
(vested)
    Number of
options held
    Expense for
the year
(vested)
    Number of
Options held
    Expense
for the year
(vested)
 
CEO   600,000   $ -     600,000   $ 133,275     400,000   $ 44,455  
Former CFO   150,000     -     150,000     33,319     100,000     11,113  
Former Corporate Secretary   150,000     -     150,000     33,319     100,000     11,113  
Directors   750,000     -     825,000     210,219     1,050,000     205,312  
    1,650,000   $ -     1,725,000   $ 410,132     1,650,000   $ 271,993  

 

During the year ended November 30, 2022, the Company also issued 78,125 (2021 -  656,250 and 2020- 500,000) common shares as compensation for consulting fees to a director valued at a total of $17,189 (2021 - $307,734 and 2020 - $125,000) (Note 13).

10. GOVERMENT ASSISTANCE RECEIVED

On May 4, 2020, the Company received a CARES Act Paycheck Protection Program Loan ("PPP Loan") of USD$75,000. The PPP Loan bears interest at 1% per annum and is repayable monthly staring on December 4, 2020. The loan is forgivable if PRT USA meets the requirements outlined below.

i) The loan proceeds are used to cover payroll costs, and most mortgage interest, rent, and utility costs over the 24-week period after the loan is made; and

ii) Employee and compensation levels are maintained. Payroll costs are capped at $100,000 on an annualized basis for each employee.

During the year ended November 30, 2021, it was determined that the Company met the requirements for loan forgiveness, and Company received notice of loan forgiveness on March 16, 2021, therefore there was no loan recognized. As such, the PPP Loan was treated as a government grant and was offset against operating expenses on the consolidated statement of loss and comprehensive loss for the year ended November 30, 2021.

11. LOANS PAYABLE

Upon acquisition of Tetra Drones (Note 3, 19), the Company assumed the latter's outstanding loan of £13,253 ($21,461) as of November 30, 2022. The collateral of this loan is a vehicle. On October 25, 2022, the loan and the vehicle were released to former shareholder of Tetra Drones in exchange of forgoing the remaining acquisition cost of £140,000 ($222,771). Thus, for the year ended November 30, 2022, the Company's liabilities in the vehicle and the remaining balance in the acquisition cost were extinguished.

For the year ended November 30, 2022, the current loan payable of $127,019 consisted of $75,000 plus interest of $4,019 payable to a third party, which is equal to 12% interest per annum payable on demand. This includes as well the $30,000 plus interest of $3,000, a 10% interest payable to another third party for four calendar months from the date of promissory note. As of the year ended November 30, 2022, the company is now liable to pay total interest of $18,000 including the $3,000 interest as they are considered in default. Total proceeds of $105,000 was received by the Company for these loans.

- 46 -


PLYMOUTH ROCK TECHNOLOGIES INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the year ended November 30, 2022, 2021 and 2020
(Expressed in Canadian Dollars)

12. CAPITAL MANAGEMENT

The Company considers its capital structure to include net residual equity of all assets, less liabilities. The Company's objectives when managing capital are to (i) maintain financial flexibility in order to preserve its ability to meet financial obligations and continue as a going concern; (ii) maintain a capital structure that allows the Company to pursue the development of its projects and products; and (iii) optimize the use of its capital to provide an appropriate investment return to its shareholders commensurate with risk.

The Company's financial strategy is formulated and adapted according to market conditions in order to maintain a flexible capital structure that is consistent with its objectives and the risk characteristics of its underlying assets. The Company manages its capital structure and adjusts it in light of changes in economic conditions and the risk characteristics of its underlying assets. To maintain or adjust the capital structure, the Company may attempt to issue new shares or acquire or dispose of assets.

13.  SHARE CAPITAL

(a) Common Shares

Authorized: Unlimited number of common shares without par value

As at November 30, 2022, there were 59,317,461 common shares issued and outstanding
(2021 - 59,239,336).

During the year ended November 30, 2022:

On December 31, 2021, the Company issued 78,125 common shares as compensation for consulting fees to a director valued at a total of $17,189.

During the year ended November 30, 2021:

On August 9, 2021, the Company issued 5,750,000 Units at $0.40 per unit for proceeds of $2,300,000. Each unit comprised one common share and one full non-transferable common share purchase warrant, with each warrant entitling the holder to purchase one additional common share at a price of $0.50 for five years. The Company paid cash of $63,700, issued 166,250 finders' Units with a fair value of $66,500 and 325,750 broker warrants as finder's fees. Each finders' Unit comprised of one common share and one full non-transferable common share purchase warrant, with exercise price of $0.50 per share for five years. The broker warrants are exercisable at $0.50 per share for five years. .

On January 29, 2021, the Company issued 3,180,000 Units at $0.20 per unit for proceeds of $636,000. Each unit comprised one common share and one full non-transferable common share purchase warrant, with each warrant entitling the holder to purchase one additional common share at a price of $0.25 for five years. The Company paid cash of $10,480, issued 170,000 finders' Units with a fair value of $34,000 and 222,400 broker warrants as finder's fees. Each finder's Unit comprised of one common share and one full non-transferable common share purchase warrant with exercise price of $0.25 per share for five years. The broker warrants are exercisable at $0.25 per share for five years.

- 47 -


PLYMOUTH ROCK TECHNOLOGIES INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the year ended November 30, 2022, 2021 and 2020
(Expressed in Canadian Dollars)

13.   SHARE CAPITAL (continued)

(a)   Common Shares (continued)

During the year ended November 30, 2021, the Company issued 425,000 common shares for gross proceeds of $222,500 from the exercise of 425,000 stock options at $0.50 to $0.60 per share.

During the year ended November 30, 2021, the Company issued 6,129,573 common shares for gross proceeds of $1,332,727 from the exercise of 6,129,573 share purchase warrants at $0.20 to $0.50 per share.

During the year ended November 30, 2021, the Company issued 656,250 common shares with total fair value of $307,734 were issued as compensation for consulting fees to a director (Note 9).

During the year ended November 30, 2020:

On September 30, 2020, the Company issued 50,000 common shares pursuant to the exercise of 50,000 share purchase warrants at $0.20 per share.

On September 30, 2020, the Company issued 250,000 common shares were issued as compensation for consulting fees to a director (Note 9) valued at a total of $62,500.

On September 30, 2020, the Company issued an aggregate of 1,335,165 units at a price of $0.30 per unit for gross proceeds of $400,550. Each Unit consists of one common share and one-half of one non-transferable common share purchase warrant (a "Warrant"). Each whole Warrant entitles the holder to purchase one additional common share at a price of $0.50 for two years until September 30, 2022. The fair value of the warrants is determined to be $40,055.

On September 30, 2020, the Company issued 50,000 units at a fair value of $22,811 pursuant to the binding agreement with Aerowave Corporation. Each Unit consists of one common share and one-half of one non-transferable common share purchase warrant (a "Warrant"). Each whole Warrant entitles the holder to purchase one additional common share at a price of $0.50 for two years until September 30, 2022. The fair value of the warrants is determined to be $1,500.

On September 24, 2020, the Company issued 100,000 common shares pursuant to the exercise of 100,000 share purchase warrants at $0.20 per share.

On September 22, 2020, the Company issued 100,000 common shares pursuant to the exercise of 100,000 share purchase warrants at $0.20 per share.

On August 21, 2020, the Company issued 250,000 common shares were issued as compensation for consulting fees to a Director (Note 9) valued at a total of $62,500.

On August 13, 2020, the Company issued 483,334 common shares pursuant to the exercise of 483,334 share purchase warrants at $0.20 per share.

On July 3, 2020, the Company issued 500,000 common shares pursuant to the exercise of 500,000 share purchase warrants at $0.20 per share.

- 48 -


PLYMOUTH ROCK TECHNOLOGIES INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the year ended November 30, 2022, 2021 and 2020
(Expressed in Canadian Dollars)

13.  SHARE CAPITAL (continued)

(a)   Common Shares (continued)

On May 15, 2020, the Company issued an aggregate of 3,718,831 units at a price of $0.15 per unit for gross proceeds of $557,825. Each unit consists of one common share in the capital of the Company and one whole transferable common share purchase warrant (a "Warrant"). Each whole Warrant is exercisable to acquire one common share at an exercise price of $0.20 per share until May 15, 2022.

On April 24, 2020, the Company issued an aggregate of 3,128,334 units at a price of $0.15 per unit for gross proceeds of $469,250. Each unit consists of one common share in the capital of the Company and one whole transferable common share purchase warrant (a "Warrant"). Each whole Warrant is exercisable to acquire one common share at an exercise price of $0.20 per share until April 24, 2022.

In connection with the April 24, 2020 and May 15, 2020 private placements, the Company paid $38,727 in share issuance costs.

On February 4, 2020, the Company arranged a non-brokered private placement financing of up to 10,000,000 units of securities at a price of $0.40 per unit for aggregate gross proceeds of up to $4,000,000 (the "Offering"). Each unit will be comprised of one common share and one-half of one non-transferable common share purchase warrant, with each whole warrant entitling the holder to purchase one additional common share at a price of $0.80 for two years from closing of the Offering. On March 16, 2020, due to the instability in the financial markets caused by the COVID-19 pandemic, the Company cancelled this private placement. And paid $4,400 to investors in connection with this cancelled private placement.

(b) Stock Options

The Company maintains an incentive stock option plan (the "Option Plan") which provides that the Board of Directors of the Company may from time to time, in its discretion, and in accordance with the Exchange requirements, grant to directors, officers, employees, and consultants to the Company, non-transferable options to purchase common shares, provided that the number of common shares reserved for issuance will not exceed 10% of the issued and outstanding common shares in the capital of the Company at the time of granting of options.

During the year ended November 30, 2022:

125,000 stock options with an exercise price of $0.50 were cancelled.

75,000 stock options with an exercise price of $0.50 expired unexercised.

During the year ended November 30, 2021:


On June 10, 2021, the Company granted 150,000 incentive stock options to a consultant with an exercise price of $0.50 per share for a period of five years from the date of grant. The fair value was estimated using the Black-Scholes pricing model with estimated, stock price of $0.485, volatility 100%, risk-free rate 0.82%, dividend yield 0%, and expected life of 5 years. With these assumptions, the fair value of options was determined to be $53,677, and the amount was recognized on the consolidated statements of loss and comprehensive loss for the year ended November 30, 2021

On January 21, 2021, the Company granted 1,550,000 incentive stock options to directors, consultants, and employees with an exercise price of $0.75 per share for a period of five years from the date of grant. The fair value was estimated using the Black-Scholes pricing model with estimated, stock price of $0.75, volatility 100%, risk-free rate 0.43%, dividend yield 0%, and expected life of 5 years. With these assumptions, the fair value of options was determined to be $1,022,995, and the amount was recognized on the consolidated statements of loss and comprehensive loss for the year ended November 30, 2021.

- 49 -


PLYMOUTH ROCK TECHNOLOGIES INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the year ended November 30, 2022, 2021 and 2020
(Expressed in Canadian Dollars)

 

13. SHARE CAPITAL (continued)

(b)   Stock Options (continued)

During the year ended November 30, 2020:

During the year ended November 30, 2020, 200,000 (2019 - 150,000) options issued to a director and a consultant were cancelled before vesting.

Stock-based compensation recognized in profit or loss for the year ended November 30, 2022 amounted to

$Nil (2021 - $1,144,342; 2020 - 479,107).

Stock option transactions and the number of stock options outstanding as at November 30, 2022, 2021 and 2020 are summarized as follows:

    Number of     Weighted Average  
  Options     Exercise Price  
Balance, November 30, 2020   2,950,000   $ 0.58  
Granted   1,700,000     0.73  
Exercised   (425,000 )   0.52  
Balance, November 30, 2021   4,225,000   $ 0.65  
Expired   (75,000 )   0.50  
Cancelled   (125,000 )   0.50  
Balance, November 30, 2022   4,025,000   $ 0.66  

The following summarizes the stock options outstanding at November 30, 2022:

Expiry Date Exercise
Price
  Numbers of
options
outstanding
    Numbers of
options
exercisable
    Weighted average
remaining
contractual life (year)
    Weighted
average
exercise price
 
  $                     $  
January 15, 2024 0.60   2,050,000     2,050,000     0.57     0.31  
March 20, 2024 0.60   150,000     150,000     0.05     0.02  
November 28, 2024 0.50   125,000     125,000     0.06     0.02  
January 21, 2026 0.75   1,550,000     1,550,000     1.21     0.29  
June 10, 2026 0.50   150,000     150,000     0.13     0.02  
      4,025,000     4,025,000     2.03     0.66  

(c)   Share purchase warrants

During the year ended November 30, 2022

561,081 warrants with exercise price of $0.20 expired unexercised.

During the year ended November 30, 2021

On August 9, 2021, the Company issued 5,916,250 common share purchase warrants as part of the private placement. Each warrant is exercisable to purchase one common share at an exercise price of $0.50 per share until August 9, 2026.

On August 9, 2021, the Company also granted 325,750 warrants to finder's warrants as described in note 13(a) in connection with the private placement. Each warrant is exercisable to purchase one common share at an exercise price of $0.50 per share until August 9, 2026. The fair value was estimated using the Black-Scholes pricing model with estimated, stock price of $0.35, volatility 100%, risk-free rate 0.88%, dividend yield 0%, and expected life of 5 years. With these assumptions, the fair value of options was determined to be $79,032.

- 50 -


PLYMOUTH ROCK TECHNOLOGIES INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the year ended November 30, 2022, 2021 and 2020
(Expressed in Canadian Dollars)

13. SHARE CAPITAL (continued)

(c)   Share purchase warrants (continued)

On January 29, 2021, the Company granted 3,350,000 common share purchase warrants as part of a non-brokered private placement. Each warrant is exercisable to acquire one common share at an exercise price of $0.25 per share until January 29, 2026. During the year ended November 30, 2021, 30,000 warrants were exercised at $0.25 per share.

On January 29, 2021, the Company also granted 222,400 warrants to finders in connection with the private placement. Each warrant is exercisable to acquire one common share at an exercise price of $0.50 per share until August 9, 2026. During the year ended November 30, 2021, 4,240 warrants were exercised at $0.25 per share. The fair value was estimated using the Black-Scholes pricing model with estimated, stock price of $0.52, volatility 100%, risk-free rate 0.43%, dividend yield 0%, and expected life of 5 years. With these assumptions, the fair value of options was determined to be $95,395.

During the year ended November 30, 2020

On September 30, 2020, the Company granted 692,583 common share purchase warrants as part of a non-brokered private placement and binding agreement with Aerowave Corporation. Each warrant is exercisable to acquire one common share at an exercise price of $0.50 per share until September 30, 2022. On February 28, 2021, 292,000 warrants were exercised at $0.50 per share.

On May 15, 2020, the Company granted 3,718,831 common share purchase warrants as part of a non-brokered private placement. Each warrant is exercisable to acquire one common share at an exercise price of $0.20 per share until May 15, 2022. On February 28, 2021, 3,208,333 warrants were exercised at $0.20 per share.

On April 24, 2020, the Company granted 3,128,334 common share purchase warrants as part of a non-brokered private placement. Each warrant is exercisable to acquire one common share at an exercise price of $0.20 per share until April 24, 2022. On February 28, 2021, 2,145,000 warrants were exercised at $0.20 per share.

Share purchase warrant transactions and the number of share purchase warrants outstanding as of November 30, 2022, 2021 and 2020 are summarized as follows:

    Number of Warrants     Weighted Average Exercise Price  
Balance, November 30, 2019   -   $ -  
Warrants granted   7,539,748     0.90  
Warrants exercised   (1,233,334 )   0.11  
Balance, November 30, 2020   6,306,414     0.23  
Warrants granted   9,814,400     0.08  
Warrants exercised   (6,129,573 )   0.01  
Balance, November 30, 2021   9,991,241     0.42  
Warrants expired   (561,081 )   0.20  
Balance, November 30, 2022   9,430,160   $ 0.41  

The following summarizes the stock warrants outstanding at November 30, 2022:

Expiry Date   Exercise
Price
$
    Number of Warrants
outstanding and
exercisable
    Weighted average
remaining
contractual life (year)
    Weighted average
exercise price
$
 
January 29, 2026   0.25     3,188,160     1.07     0.08  
      August 9, 2026   0.50     6,242,000     2.17     0.33  
          9,430,160     3.17     0.41  

- 51 -


PLYMOUTH ROCK TECHNOLOGIES INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the year ended November 30, 2022, 2021 and 2020
(Expressed in Canadian Dollars)

14. FINANCIAL RISK MANAGEMENT

The Company's financial assets consist of cash, and due from related parties. The estimated fair values of cash, subscription receivable, and due from related parties approximate their respective carrying values due to the short period to maturity.

Financial instruments measured at fair value are classified into one of three levels in the fair value hierarchy according to the relative reliability of the inputs used to estimate the fair values. The three levels of the fair value hierarchy are:

a. Level 1 - unadjusted quoted prices in active markets for identical assets or liabilities;

b. Level 2 - inputs other than quoted prices that are observable for the asset or liability either directly or indirectly; and

c. Level 3 - inputs that are not based on observable market data.

For the years ended November 30, 2022, and 2021, the fair value of the cash, accounts receivable, accounts payable, and due to and from related parties approximate the book value due to the short-term nature.

The Company is exposed to a variety of financial instrument-related risks. The Board approves and monitors the risk management processes, inclusive of counterparty limits, controlling and reporting structures. The type of risk exposure and the way in which such exposure is managed is provided as follows:

Liquidity Risk

Liquidity risk is the risk that the Company will not be able to meet its financial obligations when they become due. The Company ensures, as far as reasonably possible, it will have sufficient capital in order to meet short-term business requirements, after taking into account cash flows from operations and the Company's holdings of cash. The Company believes that these sources will be sufficient to cover the likely short-term cash requirements.

The Company's cash is currently invested in business accounts which is available on demand by the Company for its operations.

Interest Rate Risk

Interest rate risk is the risk that future cash flows will fluctuate as a result of changes in market interest rates. The Company has no significant interest rate risk due to the short-term nature of its interest generating assets.

Credit Risk

Credit risk is the risk of a loss when a counterparty to a financial instrument fails to meet its contractual obligations. The Company's exposure to credit risk is limited to its cash. The Company limits its exposure to credit risk by holding its cash in deposits with high credit quality Canadian financial institutions.

Foreign Currency Risk

The Company is exposed to foreign currency risk on fluctuations related to cash, leases, due from related parties and accounts payable and accrued liabilities that are denominated in US dollars. 10% fluctuations in the US dollar and UK Sterling Pound against the Canadian dollar have affected comprehensive loss for the year by approximately $81,052 (2021 - $1,200 and 2020 - $7,085).

- 52 -


PLYMOUTH ROCK TECHNOLOGIES INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the year ended November 30, 2022, 2021 and 2020
(Expressed in Canadian Dollars)

15. SUPPLEMENTAL CASH FLOW INFORMATION

During the year ended November 30, 2022, 2021 and 2020, the Company has the following non-cash investing and financing activities:

    November 30,
2022
    November 30,
2021
    November 30,
2020
 
Non-cash financing activities:                  
Fair value of options exercised   -     158,106     -  
Fair value of warrants granted   -     174,427     83,109  
Fair value of warrants exercised   -     36,859     -  
Shares issued for finders   -     100,500     -  
Non-cash investing activities:                  
Shares to be issued to acquisition of inventory   -     -     22,800  

16. COMMITMENTS AND CONTINGENCIES

As at November 30, 2022, the Company has the following commitments:

The Company entered into lease agreement with arm's length party on September 9, 2021. The term commenced on May 1, 2021 and will set to expire on April 30, 2024 and with annual lease fee of £12,000 or £1,000 per month with interest of 4% per annum above Barclays Bank PLC base rate in case of default (Note 17). Further, on the same date, the Company entered into separate agreement with the same arm's length party for drone flying permission over the land without restriction in exchange of £1,500 annual fee. The term commenced on May 1, 2021 and expire on April 30, 2024 as well.

In November 2018, the Company entered into two-year lease agreement for leased premises in Plymouth, Massachusetts, commenced December 1, 2018 and ended on November 30, 2020. On December 31, 2020, the Company renewed this lease agreement to November 30, 2023. The minimum base rent for the remaining lease term are: US$3,188 per month from December 1, 2021 to November 30, 2022; and US$3,284 per month from December 1, 2022 to November 30, 2023 (Note 17).

The Company has certain commitments related to key management compensation for $35,875 per month with no specific expiry of terms (Note 9).

On February 4, 2023, the Company received a disputed claim from former consultant on the unpaid fees for the month of November 2022, December 2022 and January 2023 with an aggregate liability of $30,000. As of the reporting date, the Company is still waiting for the court order and plans to take a legal course of action as well. Management cannot determine the outcome as of the date of this report.

On April 1, 2020 the Company entered into an agreement with a Director of the Company to provide consulting services. In line with this, the Company shall pay $250,000 annually either through cash in 12 monthly installments at the end of each calendar month or through the issuance of 1,000,000 common shares of the Company in four equal quarterly installments, in arrears.

17. RIGHT-OF-USE ASSETS AND LEASE LIABILITY

Right-of-use assets

In November 2018, the Company entered into two-year lease agreement for leased premises in Plymouth, Massachusetts, commencing December 1, 2018 and ending on November 30, 2020. On December 31, 2020, the Company renewed this lease agreement to November 30, 2023. The minimum base rent for the remaining lease term are: USD$3,005 ($3,726) per month from December 1, 2019 to November 01, 2020; USD$3,095 ($3,838) per month from December 1, 2020 to November 30, 2021; USD$3,188 ($3,953) per month from December 1, 2021 to November 30, 2022; and USD$3,284 ($4,072) per month from December 1, 2022 to November 30, 2023 (Note 16).

- 53 -


PLYMOUTH ROCK TECHNOLOGIES INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the year ended November 30, 2022, 2021 and 2020
(Expressed in Canadian Dollars)

17.  RIGHT-OF-USE ASSETS AND LEASE LIABILITY (continued)

Right-of-use assets (continued)

On September 9, 2021, the Company entered into lease agreement with arm's length party to use the premises known as The Old Workshop, Estuary Road, King's Lynn, Norfolk from May 1, 2021 and will set to expire on April 30, 2024, with annual lease fee of £12,000 or £1,000 per month with interest of 4% per annum above Barclays Bank PLC base rate in case of default (Note 16).

The following is the continuity of the cost and accumulated depreciation of right-of-use assets, for the year ended November 30, 2022 and 2021:

Balance, November 30, 2020 $ 114,648  
Amortization expense   (35,654 )
Cumulative translation adjustment   (6,260 )
Balance, November 30, 2021 $ 72,734  
Additions   38,027  
Amortization expense   (50,571 )
Cumulative translation adjustment   1,008  
Balance, November 30, 2022 $ 61,198  

Lease liability

The following is the continuity of lease liability, for the year ended November 30, 2022 and 2021:

Balance, November 30, 2020 $ 113,340  
Lease payments   (48,175 )
Interest on lease liability   14,760  
Cumulative translation adjustment   (5,079 )
Balance, November 30, 2021 $ 86,346  
Additions   38,027  
Lease payments   (72,727 )
Interest on lease liability   18,877  
Cumulative translation adjustment   5,274  
Balance, November 30, 2022 $ 75,797  
Current Portion $ 66,403  
Long-term portion $ 9,394  

As at November 30, 2022 and 2021, the minimum lease payments for the lease liabilities are as follows:

    November 30,
2022
    November 30,
2021
 
Year ending:            
2022 $ -   $ 48,943  
2023   72,664     50,403  
2024   9,716     -  
    82,380     99,346  
Less: Interest expense on lease liabilities   (6,583 )   (13,000 )
Total present value of minimum lease payments $ 75,797   $ 86,346  

 

- 54 -


PLYMOUTH ROCK TECHNOLOGIES INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the year ended November 30, 2022, 2021 and 2020
(Expressed in Canadian Dollars)

18. BREAKDOWN OF EXPENSES

          Year ended November 30,  
General and Administrative Expenses   Note     2022     2021     2020  
Accounting and audit fees   9   $ 223,247   $ 80,162   $ 67,282  
Amortization   5, 6, 17     286,743     143,783     41,201  
Consulting fees   9     143,539     456,296     275,182  
General office expenses         153,403     205,710     111,394  
Insurance         39,007     21,837     11,928  
Interest and accretion   17     18,877     14,760     20,449  
Legal fees         77,011     191,686     74,528  
Management fees   9     311,535     118,000     110,125  
Rent         47,317     42,822     35,325  
Stock-based compensation   9, 13     -     1,144,342     479,107  
Transfer agent and filing fees   13     59,385     82,825     77,919  
Wages, salaries and benefits   9     985,916     817,858     292,218  
Total       $ 2,345,980   $ 3,320,081   $ 1,596,658  
                         
Research and Development         2022     2021     2020  
Labor       $ 182,774   $ 930,269   $ 386,044  
Materials         50,491     54,737     -  
Total       $ 233,265   $ 985,006   $ 386,044  

Selling expenses consist of business development expenses amounting to $177,428 (2021 - $709,010; 2020 - $1,081,478).

19. GAIN ON DEBT FORGIVENESS

For the year ended November 30, 2022, the Company recognized gain on debt forgiveness amounting to $234,303 (2021 - $nil; 2020 - $nil). This composed of remaining £140,000 ($222,771) acquisition cost of Tetra Drones that was forgiven by former shareholder and the £7,155 ($11,532) excess of the net book value of vehicle and related loan released to him (Note 11).

20. SEGMENTED INFORMATION

The Company operates in one business segment, focusing on developing technologies as described in Note 1.

The Company's revenues were generated in the US and UK were mostly composed of sales of engineering design services and radar components to well-known government agencies and prime contractors. All the long-lived assets are located in the US as of November 30, 2022, 2021 and 2020. The following table summarizes the revenue by geographical location:

      Canada     USA     UK     Total  
For the year ended November 30, 2022                        
  Revenues $ -   $ 154,625   $ 452,734   $ 607,359  
  Gross Profit   -     97,115     319,069     416,184  
For the year ended November 30, 2021                        
  Revenues $ -   $ 79,795   $ 104,601   $ 184,396  
  Gross Profit   -     27,703     53,584     81,287  
For the year ended November 30, 2020                        
  Revenues $ -   $ 70,931   $ -   $ 70,931  
  Gross Profit   -     39,615     -     39,615  

- 55 -


PLYMOUTH ROCK TECHNOLOGIES INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the year ended November 30, 2022, 2021 and 2020
(Expressed in Canadian Dollars)

21. INCOME TAXES

The following table reconciles the expected income taxes expense (recovery) at the Canadian statutory income tax rates to the amounts recognized in the statement of operations and comprehensive loss for the years ended November 30, 2022, 2021 and 2020:

    2022     2021     2020  
Net loss before tax and comprehensive loss   (2,667,798 )   (4,944,231 ) $ (2,924,236 )
Combined statutory tax rate   19% to 27%     19% to 29.7%     27.00%  
Expected income tax (recovery) $ (720,000 ) $ (1,278,990 ) $ (789,544 )
Permanent differences   138,000     310,228     -  
Non-deductible items and others   1,618,000     19,811     44,866  
Change in deferred tax assets not recognized   (1,036,000 )   948,951     744,678  
Income tax expense (recovery) $ -   $ -   $ -  

Significant components of the Company's unrecognized deferred tax assets (liabilities) for the years ended November 30, 2022 and 2021 are shown below:

    2022     2021  
Non-capital losses $ 1,657,000   $ 2,641,159  
Capital losses   21,000     21,062  
Equipment   -     1,511  
Share issuance costs   48,000     29,036  
Intangible assets   -     397,156  
Others   -     13,498  
Net deferred tax assets $ 1,726,000   $ 3,103,422  

Non-capital losses carryforward

The Company has non-capital loss carryforwards and net operating losses, for which no deferred tax asset has been recognized of approximately $10,971,723 (2021 - $9,703,024) which may be carried forward to apply against future income for Canadian, USA and United Kingdom income tax purposes, subject to the final determination by taxation authorities, expiring in the following years:

Expiry   2022  
2038   675,203  
2039   2,350,798  
2040   2,443,638  
2041   3,591,486  
2042   1,910,598  
TOTAL $ 10,971,723  

 

- 56 -


PLYMOUTH ROCK TECHNOLOGIES INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the year ended November 30, 2022, 2021 and 2020
(Expressed in Canadian Dollars)

22.  SUBSEQUENT EVENTS

On February 22, 2023, the Company announced a non-brokered private placement financing of up to 30,000,000 units (the "Units") of securities at a price of $0.05 per Unit for aggregate gross proceeds of up to $1,500,000. Each Unit will be comprised of one common share and one full transferable common share purchase warrant, with each whole warrant entitling the holder to purchase one additional common share at a price of $0.10 for three years from closing of the private placement. On March 30, 2023, the Company completed the first tranche of the private placement by issuing 7,200,000 units for gross proceeds of $360,000.

On March 3, 2022, 2,100,000 share options issued to directors, officers, employees, and consultants were surrendered and cancelled. Further, on March 16, 2023, another 150,000 share options issued to director were surrendered and cancelled.

 
- 32 -

 

MANAGEMENT'S DISCUSSION AND ANALYSIS

For the Years Ended November 30, 2022 and 2021


INTRODUCTION

The following information, prepared as of March 30, 2023, should be read in conjunction with the audited consolidated financial statements of Plymouth Rock Technologies Inc. ("the Company" or "Plymouth Rock" or "PRT") for the year ended November 30, 2022 as well as the audited consolidated financial statements of the Company for the year ended November 30, 2021 ("Financial Statements"); including the notes thereto. The Financial Statements and financial data contained in this discussion and analysis are presented in accordance with International Financial Reporting Standards ("IFRS"). The reporting currency is the Canadian dollar.

The following discussion and analysis provide information that management believes is relevant to the assessment and understanding of the Company's results of operations and financial condition. Certain statements herein contain forward-looking statements relating to the operations or to the environment in which we operate, which are based on our operations, forecasts, and projections. Forward-looking statements are not guaranteed of future performance. They involve risks, uncertainties and assumptions; and actual results may differ materially from those anticipated in these forward-looking statements. The risks include those outlined under the "Risk Factors" section of this management discussion and analysis ("MD&A") and elsewhere in the Company's public disclosure documents. Included in the risk factors is the public health crisis caused by the pandemic, COVID-19 which caused disruptions in global supply chain, business operations and financial markets. As of report date, the crisis has not altered the ability of the Company to progress and test its technologies.

BUSINESS OVERVIEW AND OVERALL PERFORMANCE

The Company was incorporated under the Business Corporations Act of British Columbia on October 17, 2011. The head office, principal address and registered and records office of the Company are located at
700 - 1199 West Hastings Street, Vancouver, B.C., V6E 3T5.

The Company's common shares are listed on the CSE under the symbol "PRT", on the Frankfurt Stock Exchange under the Symbol: 4XA, WKN# - A2N8RH and on the OTC Markets Group ("OTCQB") under the symbol: PLRTF.

The Company's principal business activity through its subsidiary, Plymouth Rock USA ("PRT USA") is developing technologies related to remotely detecting assault firearms and suicide bombs concealed on the person or a carry bag. The Company focuses on detection methods with and without the need for a checkpoint of the suspect who is being screened. The Company's planned products encompass the very latest radar, imaging, and Unmanned Aerial System ("UAS") technologies for quickly detecting, locating and identifying the presence of threats and for search and rescue missions for law enforcement.

On January 28, 2021, the Company supplied its first Unmanned Aerial Vehicle ("UAV") to the United Nations ("UN") aspart of the United Nations Assistance Mission in Somalia ("UNSOM") under the United Nations Environment Program ("UNEP") for a tree-reseeding mission (See DEVELOPING TECHNOLOGIES).

On February 10, 2021, during UNSOM, a PRT drone broke the existing beyond visual line of sight ("BVLOS") drone delivery record, and also is believed to have set an additional new record for complete 'round trip' autonomous delivery capability. UN observers and aviation officials that monitor scheduled UN flights have agreed to supply the recorded flight data and witness statements required for the official recognition by adjudicators of Guinness World Records. To date the Company had not received this recognition.

On March 26, 2021, the Company incorporated a subsidiary in United Kingdom, Plymouth Rock Technologies UK Limited ("PRT UK"). The purpose of PRT UK is to augment the Company's existing research and development ("R&D") of the X-1 and X-V for the US and EMEA markets. Many of the UK consultants of the Company have since become direct employees as the Company expands its operations globally.

2

Effective February 1, 2021, Dr. Gianluca De Novi was appointed to VP of Engineering. Dr. De Novi is a Harvard Faculty member, Director of the Medical Device and Simulation Laboratory at the Imaging Department of the Massachusetts General Brigham Hospital and CEO at XSurgical Robotics. Dr. De Novi, was formerly a Scientific Advisor and then transitioned to VP of Engineering when the Company began accelerating the market deployment of its shoe scanner and CODA-1 threat detection systems.

On September 2, 2021, the Company sold custom drones to Survey-AR to deliver a drone swarm test capability. The project will assess an autonomous drone swarm system to optimize weather and air quality monitoring in atmospheric boundary layer environments with particular importance in urban and industrial areas.

On September 9, 2021, the Company completed the qualification for ISO 9001:2015 and became accredited under certificate 377662021. ISO is one of the most rigorous and well-regarded standards in the world. The implementation and application of ISO reinforces our Company's focus on creating products and services, measured against global benchmarks of industry excellence.

On February 9, 2022, the Company secured a contract for Large, Long-range Unmanned Aircraft Systems to be used for BVLOS operations. The end use for the aircraft is for long range natural resource monitoring. Initial deliveries took place in April 2022. The UAS were based on the PRT XV-L platform, with several 'client-specified' modifications. These large all-environment UAS were designed to be deployed for land and maritime operations at BVLOS distances, capable of operating for up to 7 hours. These were installed with the latest SATCOM (Satellite Communication) technologies, alongside enhanced military grade COFDM (Coded Orthogonal Frequency-Division Multiplexing) communications technologies for secure, high-quality data feeds for sub sixty-mile communication scenarios. The total value for this order was £175,454.58 ($301,430.97) with an additional 20% in VAT, bringing the total to £ 210,545.50 ($361,717.17). Final payment for the order was received on April 12, 2022.

On February 16, 2022, Plymouth Rock received an order for an UAS for BVLOS operations. The purpose of this was to acquire a UAS for assessment in conjunction with The UK National Police Air Service (NPAS), which provides air support to 46 police forces, who are leading the Home Office funded research to "better understand the capabilities that Beyond Visual Line of Sight (BVLOS) drones may provide to police aviation in the future". The total value for this order was £49,500.00 ($85,269), with an additional 20% in VAT, bringing the total to £59,400.00 ($102,322). Full payment for the order was received by the company on April 4, 2022. The XV-H remains a PRT asset and remains at the Company's Norfolk facility, of which Norfolk Constabulary have access to in order to perform assessments as and when required.

On February 22, 2022 Plymouth was awarded a cooperative research and development agreement ("CRADA") for its SS1 Shoe Scanner system by the US department of homeland security. A CRADA is a written agreement that facilitates R&D collaboration between one or more federal laboratories and one or more non-federal entities.

On March 8, 2022, Plymouth joined the Naval Aviation Systems Consortium ("NASC"). NASC was formed to support the technology needs of the Naval Air Warfare Centers ("NAWCs") and the Naval Air Systems Command ("NAVAIR") using Other Transaction ("OT") Authority. NASC is an agile, collaborative, and enduring enterprise with world-class capabilities that provides the Navy with broad reach, robust competition and a comprehensive range of technology solutions. Through its unique structure, consortium members are able to work with the Government to identify opportunities, target their technology offerings, expand into new markets and grow their businesses.

On March 8, 2022, the Company launched a new, customer focused website. The site was designed to offer a more user-friendly experience with improved navigation and functionality while allowing visitors to see our full fleet of UAS. Created with simplicity and usability in mind, the site includes many new features to help users quickly and easily identify the product they need, whilst providing specification downloads and videos of our UAS.

3

On March 31, 2022 the British Columbia Securities Commission ("BCSC") issued a temporary management cease trade order ("MCTO") under National Policy 12-203 Management Cease Trade Orders, made at the request of the Company. This MCTO (citation: 2022 BCSECOM 103) prohibited the Company's insiders from trading in the securities of the Company until such time as the annual audited financial statements for the year ended November 30, 2021, the management's discussion and analysis, and the related Chief Executive Officer and Chief Financial Officer certificates ("the Required Filings") and all continuous disclosure requirements have been filed by the Company, and the MCTO has been lifted. The Company's inability to file the Required Filings before the required March 30, 2022 filing deadline is a result of Covid-19 related and other delays in obtaining information with respect to a U.K. subsidiary acquired during the fiscal period. The Company has applied for, and has been granted a MCTO by the BCSC.

On May 13, 2022, the Company filed the Required Filings and the BCSC lifted the MCTO on May 16, 2022.

On June 15, 2022, the Company shipped a total of 16 production units at a value of $3,107 (US$2,450) each under a subcontract to Electro Enterprises Inc., an authorized Boeing re-seller. The units are "Liquid Cooled High Power Loads" and are used on the US Army Phased Array Tracking Radar to Intercept of Target (PATRIOT) Advanced Capability - 3 (PAC -3) Program. The PATRIOT Advanced Capability - 3 (PAC-3) is the Army's premier guided air and missile defense (AMD) system providing highly reactive hit-to-kill capability in both range and altitude while operating in all environments.

Business Acquisition

On June 4, 2021, the Company signed a definitive acquisition agreement outlining the terms and conditions with respect to an acquisition of Tetra Drones Ltd. ("Tetra Drones" or "Tetra"), an arm's length, privately held, UK-based company a developer of custom-made, high-performance and niche UAS. The acquisition of Tetra provides Plymouth with a U.K. based production and sales team with a record of success.

The Company acquired all of the then issued and outstanding shares of Tetra Drones. Tetra Drones has issued and outstanding share capital of 100 ordinary shares held by the sole Shareholder, Mr. Ben Pickard.

Pursuant to the share purchase agreement, the Company acquired Tetra for the sum of £350,000 ($581,367 CAD), payable on an installment basis as follows:

  • £35,000 ($60,021 CAD) within 7 days after the execution and delivery of the definitive agreement by all parties, paid on June 12, 2021;
  • £35,000 ($60,479 CAD) within 21 days of the initial payment as described in instalment 1 above, paid on July 9, 2021;
  • £140,000 ($236,411 CAD) within 120 days of the second instalment as described above, paid on November 8, 2021 ("the third payment"); and
  • £140,000 ($222,771 CAD) within 120 days of the third payment, this was forgiven in return of the full release of the leased vehicle and allowing the former sole shareholder of Tetra to continue working within the industry.

As a result of the acquisition, the Company now owns all outstanding shares of Tetra and will assume Tetra's existing liabilities. The principal owner of Tetra became part of the Company's management and shall be paid a monthly salary along with bonus shares or other equity instruments at the discretion of the board. All expenses related to the transaction were paid by the Company.

The fair value of net liabilities of Tetra amounted to $77,412 as at the date of acquisition. The Company applied the optional concentration test permitted under IFRS 3 to the acquisition which resulted in the acquired assets being accounted for as an asset acquisition. As such the purchase price was allocated to the identifiable assets and liabilities based on their fair values at the date of acquisition.

4

During the period ended November 30, 2022, Mr. Pickard, the former sole shareholder of Tetra resigned from the Company. In exchange for the Company allowing Mr. Pickard to continue working within the industry and providing a full release of the leased vehicle, Mr. Pickard forgave the outstanding balance of £140,000 ($222,771) which was part of the consideration for acquiring Tetra. As of the date of release, the Company has no liabilities for this vehicle.

DEVELOPING TECHNOLOGIES

The Company's core technologies have changed to include: (1) X1 and XV Unmanned Aerial Systems and (2) MiRIAD - Millimeter Remote Imaging from Airborne Drone.

The Wi-Ti, SS-1 Shoescanner and CODA threat detection radar technology development have been put on hold so the Company can concentrate on the above related products.

The Company operates a small Aerospace & Defense component business, Aerowave, that was acquired in 2019. This design and manufacturing business is based in Plymouth MA USA. It supplies components to the US government, scientific communities and commercial businesses.

X1 and XV Unmanned Aerial Systems Updates

The X1 is a purpose built coaxial multirotor UAS designed with the direct input of law enforcement, intelligence agencies, military, and rescue services. Using co-axial heavy lift motors, the X1 improves performance over traditional co-axial propeller designs and increases motor torque by 40%, delivering powerful propulsion and high power to weight capability.

As at the year ended November 30, 2022, X1 demonstration units have been sold to customers for various applications such as oil and natural gas pipeline inspection/security and agriculture/environmental missions.

The XV is a fixed-wing UAS platform with the added capability of vertical take-off and landing. This unique capability allows operators to extend their operational range while removing the requirement for a large runway. The XV can launch from an area as small as 8 square meters fully autonomously and operate for up to 7 hours.

We are also currently developing XMR - a 'super-heavy-lift' UAS for Military, Casualty / Medical Evacuation, and Cargo Transportation. The XMR is classified as a 'super heavy lift' UAS due to its capability of lifting up to 330 lbs. making it ideal solution for tasks that require higher than normal payloads. The Company expects to complete initial flight tests in Q3 2023.

On October 15, 2019, the Company announced the launch of the X1 to address the global requirement for a multi-role, state-of-the-art aerial platform. As of the end of November 2022, the X1 was starting its low-rate demonstration phase. Currently, the Company is procuring materials to begin production of additional demonstration units. X1 systems will be manufactured for various applications and targeted customers.

On May 6, 2020, the Company announced that it has received permission to operate drone platforms in UK airspace, the Permission for Commercial Operations from the UK Civil Aviation Authority, to operate small unmanned aircraft and small unmanned surveillance aircraft. The Company can now utilize its X1 platform for commercial operations, allowing our operators to demonstrate threat detection and surveillance in civilian airspace to both clients and potential partners. This also enables the Company to offer technical reconnaissance and non-destructive testing services for both civil and military applications. 

On May 14, 2020, the Company announced that the X1 platform would be used in a series of airborne tests for the UK National Health Service (NHS) for emergency apparatus delivery. This will involve several test scenarios, that if successful will lead to on-scene delivery of defibrillators and other critical trauma assistance technologies. 

5

On June 10, 2020, the Company announced that it had signed a Letter of Intent with SDS Group Australia Pty Ltd., a leading provider of best of breed products and equipment to the Australian security and defense securities, to position X1 for procurement-focused evaluations following initial consultation with members of the Australian Government. The focus of the partnership is primarily centered around the need for the early detection and identification of remote wildfires.

On July 16, 2020, the Company began a strategic alliance with Hummingbird Drones' Fire AI division for wildfire analysis from the Company's X1 and XV platforms, to get analytics to the fire fighters as close to real time as possible. Hummingbird Drones is an infrared service provider in Canada, and their Fire AI data analytics service has been used as a hotspot detection platform for wildfires for since 2017.

On August 25, 2020, the Company announced that it signed a re-seller and purchase agreement with Michigan-based Trendset Communications Group, a leading technology provider to the security, telecommunications, and technology sector.

On February 3, 2021, the Company announced the addition of MediMod to its X1 and XV UAV payload systems. MediMod is an active insulated refrigerated storage module that will have multiple medical uses and advantages, including assisting with the immediate need for rapid deployment of COVID-19 vaccine transportation to remote sites or between medical facilities as part of multiple national campaigns for mass vaccination. The transportation module will be dual-use and can be set for warm or cool state for the transportation of blood, human transplant organs and various vaccines across cities and remote destinations. On February 24, 2021, the Company announced the launch of XV-S, a fixed-wing UAS platform with the added capability of vertical take-off and landing. This capability removes the requirement for a large runway or expensive launch catapult and recovery nets, which are usually required by most fixed-wing drones.

On June 24, 2021, the Company announced that its first X1-H model UAS had been sold and delivered to Aardvark LLP, to perform long range oil pipeline security and environmental operations in remote locations.

On July 13, 2021, the Company announced it closed a contract for the sale and delivery of UAS to the Durrell Wildlife Conservation Trust to perform critical environmental operations in Madagascar. The Durrell Wildlife Conservation Trust will use the Company's drone-based thermal infrared cameras as a new way of monitoring lemurs and identifying any potential poachers.

On September 2, 2021, the Company announced the sale of custom drones to Survey-AR, delivering a drone swarm test capability. The project assessed an autonomous drone swarm system to optimize weather and air quality monitoring in atmospheric boundary layer environments with particular importance in urban and industrial areas. The Company supplied a fleet of UAS to autonomously operate together and formed a 'swarm'.

On October 26, 2021, the Company announced the delivery of several new orders for environmental monitoring and Petrochemical inspection. Environmental monitoring was be carried out with X-Lite series drones, equipped with a winch and collection cup for deep water sampling to study plastic particulates in water and other microbiological impact. The drones were operated by Swiss university, ETH Zürich. The UAS for petrochemical inspection were used in Saudi Arabia for essential ultrasound testing of infrastructure at some of the world's highest volume petrochemical plants which included those owned by Saudi Aramco oil. The petrochemical sale is in collaboration with the Company's partner Tritex NDT UK.

On October 31, 2021, the Company announced that its partner, Aardvark, had placed an order to use PRT XV-L VTOL UAS for long-range security and environmental operations in remote locations.

On October 31, 2021, the Company also announced that it began a digital and marketing awareness campaign with Capital Analytica of Vancouver BC, Media Relations Inc of Burnsville MN and Think Inc Marketing of Huntington Beach CA. The campaign included press initiatives, advertising, publicity services and social media. These marketing and awareness programs include engagements with arm's length parties for an aggregate gross expenditure of CDN$120,000 over a 6-month period and USD $100,000 over a 3-month period. No stock-based compensation was provided.

6

On February 25, 2022 the Company received a final balancing payment for an order taken on under Tetra Drones Limited from Quantum Aviation. The balancing payment for this order was £2,361.68, with an additional 20% in VAT, bringing the total to £2,834.02.

On March 9, 2022, the Company received payment for electrical engineering work for a system owned by Red Engineering. The total value for this order was £600.00, with an additional 20% in VAT, bringing the total to £720.00.

On April 12, 2022, the Company received a final balancing payment for an order taken on under Tetra Drones Limited from SkyShows Aerial Limited. The balancing payment for this order was £700.00, with an additional 20% in VAT, bringing the total to £840.00.

On May 13, 2022, the Company received an order to manufacture a testing drone for Aspira Aerial Applications. The total value for this order was £6,095.00, with an additional 20% in VAT, bringing the total to £7,314. Final payment was received on June 1, 2022.

On May 23, 2022, the Company received an order for upgrade work for a fleet of light show drones owned by FlightShows Ltd. The total value for this order was £9,125.00, with an additional 20% in VAT, bringing the total to £10,950.00. Final payment was received on August 16, 2022.

On May 24, 2022, the Company received payment for repair work for systems owned by Quantum Aviation. The total value for this order was £460.00, with an additional 20% in VAT, bringing the total to £552.00.

On July 1, 2022, the Company received an order for supply of drones for light shows from SkyShows Aerial Ltd. The total value for this order was £7,500.00, with an additional 20% in VAT, bringing the total to £9,000.00. Final payment was received on August 16, 2022.

On August 16, 2022, the Company received a follow up order to upgrade a fleet of light show drones from FlightShows Ltd. The total value for this order was £19,086.44, with an additional 20% in VAT, bringing the total to £22,903.73. Final payment was received on November 11, 2022.

On August 17, 2022, the Company received an order to build a large fixed-wing UAS, and perform service and refurbish an existing drone platform for Air Data Systems Ltd. The total value for this order was £93,848.34, with an additional 20% in VAT, bringing the total to £112,618.01. Final payment was received on December 22, 2022.

On September 26, 2022, the Company received an order for supply of drones for light shows from SkyShows Aerial Ltd. The total value for this order was £7,500.00, with an additional 20% in VAT, bringing the total to £9,000.00. Final payment was received on August 16, 2022.

On October 3, 2022, the Company received a follow up from Aspira Aerial Applications. The total value for this order was £9,495.00, with an additional 20% in VAT, bringing the total to £11,394.00. Final payment was received on October 31, 2022.

MiRIAD -Millimeter Remote Imaging from Airborne Drone Updates

MiRIAD is a prototype compact sensor package that is specifically designed for use on UAS. The sensor is being designed to support a variety of functions, from the primary function of detecting assault weapons and person-borne improvised explosive devices, alongside a whole spectrum of other uses, such as detecting breaks in power cables, solar farm efficiencies, structure degradation and external corrosion. The sensor uses completely passive techniques, which means there are no emissions and therefore no regulatory issues.

7

MiRIAD uses a unique ultra-lightweight antenna to capture radar images of target subjects within a wide field of view. The captured radar image data, along with high resolution video is then backhauled wirelessly over a high-capacity data link to a central processing center for data analysis. Using algorithm based digital signal processing techniques the radar signature is analyzed and overlaid onto the video imagery to display a real time image of the video capture that includes an indication of any concealed threat item. The technology uses both artificial intelligence and augmented reality techniques to positively identify a threat and its exact location on subjects within its field of view. Multiple MiRIAD equipped UAVs can be supported by a single data processing facility to cover large areas.

MiRIAD's primary intended applications are outdoor public event crowd screening, special police and security service operations, and forward operating base protection. Other planned applications include remote infrastructure inspection and analysis; oil and gas pipeline inspection, and search and rescue (land and sea).

On August 31, 2020, the Company announced that it had produced definitive images of infrastructure corrosion utilizing its prototype MiRIAD Sensor system. This will provide a new and more importantly, low-cost capability for detecting civil and military aircraft fatigue, tanker and naval vessel corrosion, pipeline safety for oil and gas installations and infrastructure/bridge fatigue. The Company also believes that safe, passive detection will ultimately be applied to medical skin analysis for burns and next generation walk through.

In Q1 2021 the Company updated the design of the MiRIAD sensors with digital signal processors to process the image data received from the sensors.

Due to funding issues from late 2021 until the current year ended November 30, 2022 the MiRIAD sensor development was put on hold. Management believes there is value to complete the product development when funding becomes available.

Wi-Ti Updates

Wi-Ti is a wall or portal mounted sensor system that will detect concealed threat items over an extended coverage area. It is ideal for covertly screening unstructured crowds to widen the security perimeter in public places.

The past four years have seen significant advances in the monitoring of Wi-Fi radio wave analysis. This includes Wi-Fi used to track and trace the movements of people in real time through walls. Similar techniques have used Wi-Fi radio waves to detect subtle changes in breathing and heart rates. The Company's Wi-Ti technology advances that analysis to concealed threat detection. Unlike other emerging screening technologies, Wi-Ti can be used in airport concourse areas, stadiums, and open spaces at stand-off distances. Our unique radar imaging and signal processing technology allows for non-intrusive screening of crowds in real time. Further, with Wi-Ti, there are no radio emissions, so this method of detection can be freely used in any Wi-Fi enabled environment without special license or regulatory approval.

On February 19, 2019, the Company signed a memorandum of understanding with Abicom International, a Qualcomm authorized design partner, to assist in the continued development of the Wi-Ti system and prototype. Abicom International has worked with many prominent security and technology companies, including Bosch Security, Siemens Transportation, QinetiQ, Harris Systems and Northern Light Technologies. Abicom International's status as a Qualcomm design center is an assurance of excellence that is granted to less than eleven companies globally". The partnership between Plymouth Rock and Abicom International is about the drive to continuously expand the realm of possibilities for Wi-Fi based technologies.

8

During December 2020, the Company prepared and filed a trademark application for the mark Wi-Ti Class 009 - System for detecting threats, such as concealed weaponry, within a Wi-Fi enabled environment and electronic filing of the same with the USPTO (United States Patent and Trademark Office).

Due to other priorities, the Wi-Ti R&D has been put on hold until funding is available.

Shoe Scanner - SS1 Footwear Imaging Radar Technology

The SS1 is a floor-mounted 3D imaging system that uses harmless millimeter-wave imaging techniques to inspect footwear to determine if it has been altered or is being used to transport concealed items, such as weaponry, substances, compounds or electronic items. The SS1 can be used at security and identification checkpoints to eliminate the need for footwear removal, streamlining the security screening process and reducing bottle necks.

The Shoe Scanner allows for the rapid screening of footwear without necessitating removal of shoes. With a screening time of 30 persons per minute the Millimeter Wave Shoe Scanner is ideal for airport terminals, prisons/correctional facilities, public events and other high throughput, screening applications.

On March 12, 2019, Manchester Metropolitan University assigned the Millimeter Wave Shoe Scanning technology IP to the Company for the consideration of $30,000. The Millimeter Wave Shoe Scanner is a floor-mounted 3D imaging system that uses harmless millimeter-wave imaging techniques to inspect footwear. The scanner is then able to identify if the footwear has been altered or is being used to transport concealed items, such as weaponry, substances, compounds, or electronic items. As of October 8, 2019, the IP and patent transfer for this technology was completed.

On October 29, 2020 the Company received a "Notice of Allowance" by the US Patent and Trademark Office of patent application No. 16/560,480 for the "Method and System for Determining Dielectric Properties of an Object". The invention uses millimeter wave ("MMW") shoe-scanning technologies for fast, contactless screening of passengers' footwear in highly secure environments such as airports, prisons, border points of entry and government buildings On February 16, 2021 the Company was granted US Patent No.: 10,921,428 B1.

On February 22, 2022 Plymouth been awarded a CRADA for its SS1 Shoe Scanner system by the US department of homeland security. A CRADA is a written agreement that facilitates R&D collaboration between one or more federal laboratories and one or more non-federal entities.

Due to other priorities, the Shoe Scanner has been put on hold until funding is available.

Mobile Reconfigurable Distributed Aperture Systems and Methods for Remote Sensing

On February 24, 2022 the Company began the process of applying for a patent. (Application No.: 17174637). This patent application relates to synthetic aperture radars and distributed aperture systems referred to as DAS. These DAS can be mounted on UAS. A DAS or DDAS (Drone Distributed Aperture Systems) may be utilized to create a synthetic aperture for transmission or reception of any or both electromagnetic and acoustic waves by reconfigurable formation of an array of transceivers. For example, a DDAS may include individual transceivers or small arrays of transceivers being mounted onto individual drones.

9

The following table shows the Company's expenditures on its Developing Technologies recognized in R&D expenses:

    For the years ended November 30,  
Research and Development by Technology   2022
$
    2021
$
    2020
$
 
Aerowave   17,138     57,181     1,452  
X-1   78,887     484,850     184,634  
XV   31,186     129,352     -  
Shoe Scanner   35,959     232,501     73,493  
CODA   70,095     75,816     2,632  
MiRIAD   -     5,306     100,887  
Wi-Ti   -     -     22,946  
Total   233,265     985,006     386,044  
 
    For the year ended November 30, 2022  
Demo Equipment Capitalized   Cost - USD     Cost - GBP     Cost - CAD  
    $     £     $  
X1 - 1   51,869     9,876     86,057  
X1 - 2   21,957     -     29,660  
X1 - 3   2,435     -     3,289  
X1 - 4   2,435     -     3,289  
X1 - 5   2,435     -     3,289  
X1 - 6   2,435     -     3,289  
XV   26,068     48,675     114,032  
Impairment of demo equipment   (109,634 )   (58,551 )   (236,677 )
Foreign currency translation adjustment   -     -     (6,228 )
Total   -     -     -  

The R&D expenses incurred for the X1/XV and shoe-scanner were primarily design and process documentation related. The CODA expenses were related to testing of prototypes and software discovery and upgrades. Tetra expense was for the transfer of "know-how" of the Tetra products and the MiRIAD expense was for NDT (Non-Destructive Testing) of various infrastructure for structural integrity. The Company determined that the demo equipment is unable to generate economic benefit as at November 30, 2022. Hense an impairment loss of $236,667.

10

RESULTS OF OPERATIONS

The following table provides a brief summary of the Company's financial operations for the last three fiscal years. This information has been presented in accordance with International Financial Reporting Standards ("IFRS"). The reporting currency is the Canadian dollar. For more detailed information, please refer to the November 30, 2022, 2021 and 2020 audited financial statements.

 

Year Ended
November 30, 2022

Year Ended
November 30, 2021

Year Ended
November 30, 2020

Revenues

$ 607,359

$ 184,396

$ 70,931

Interest income

-

-

193

Net loss for the year

(2,667,798)

(4,974,834)

(2,924,236)

Basic and diluted loss per share

(0.05)

(0.09)

(0.08)

Total assets

148,201

1,549,139

261,385

Total long term liabilities

9,394

69,670

90,735

Cash dividends

-

-

-

Years ended November 30, 2022 and 2021

During the year ended November 30, 2022, the Company had a comprehensive loss of $2,739,060 compared to a comprehensive loss of $4,944,231 for the year ended November 30, 2021. The decrease in comprehensive losses were primarily driven by the following:

  • Sales during the year ended November 30, 2022 amounted to $607,359 (November 30, 2021 - $184,396) with gross profit of $416,184 (November 30, 2021 - $81,287) resulting in a gross margin of 69% (November 30, 2021 - 44%). The Company's sales for the year include waveguide components and sale of services for drone builds. The increase in gross margin resulted from lower cost of sales relating to improving product yields by creating new process control documentation and by the higher gross margins of the newly acquired subsidiary stemming from efficient processes and economies of scale.
  • Accounting and audit fees of $223,247 (November 30, 2021 - $80,162). The amount increased in the current period due to the additional fees to auditors and accountants for the 2021year end financial audit which spilled over through the first two quarters of the year due to complexities brought about by the set-up of a new company and the acquisition of a new subsidiary as well as additional accounting fees for the UK subsidiary.
  • Amortization in the amount of $286,743 (November 30, 2021 - $143,783) pertains mostly to amortization of customer relationships acquired from Tetra Drones, equipment and right-of-use asset due to the recognition of the Company's leased premises in accordance with IFRS 16.
  • Selling expenses of $177,428 (November 30, 2021 - $709,010) decreased due to timing of various business development initiatives. In the current and prior period, the main selling expenditures were on native ad campaigns.
  • Consulting fees of $143,539 (November 30, 2021 - $456,296) decreased during the period due to transition of a previous officer who now acts as a consultant for the Company. (See Directors)
  • Consulting fees related to research and development of $182,774 (November 30, 2021 - $930,269) decreased mainly due to general administrative this year.
  • General office expenses of $153,403 (November 30, 2021 - $205,710) were slightly lower as a result of fewer activities during the third and fourth quarter of this year.
  • Legal fees of $77,011 (November 30, 2021 - $191,686) decreased as in previous period due to the decline in legal fees relating to the acquisition of Tetra Drones, the absence of the set-up fees for the new subsidiary in the UK partially offset by fees relating to the MCTO and other legal consultations.
  • Management fees of $311,535 (November 30, 2021 - $118,000) increased due to management changes during the year. (See Transactions with Related Parties)
11

  • Rent of $47,317 (November 30, 2021 - $42,822) is slightly higher due to the additional rent brought by the acquisition of Tetra Drones in the previous year.
  • Stock-based compensation of $Nil (November 30, 2021 - $1,144,342) refers to the portion of the value of the stock options granted by the Company which are expensed during the period (See Capital Stock). No stock options were granted during the year.
  • Transfer agent and filing fees of $59,385 (November 30, 2021 - $82,825) decreased since there were no issuance of shares, closing of a private placement and related compliance which were done in the same period last year.
  • Wages, salaries and benefits of $985,916 (November 30, 2021 - $817,858) is higher because of expansion of company business overall and acquisition of UK subsidiaries.
  • Foreign currency translation loss of $71,262 (November 30, 2021 - gain of $30,603) recognized in other comprehensive income is the result of translating assets, liabilities and equity of the Company's US and UK entity to Canadian dollars for consolidated financial reporting purposes. The increase in loss was due to unfavorable foreign exchange movements during the year.

Fourth quarter ended November 30, 2022 and 2021

During the quarter ended November 30, 2022, the Company had a comprehensive loss of $711,875 compared to a comprehensive loss of $1,674,429 for the quarter ended November 30, 2021. The decrease in comprehensive losses were primarily driven by the following:

  • Sales during the quarter ended November 30, 2022 amounted to $53,819 (November 30, 2021 - $65,372) with gross profit of $42,324 (November 30, 2021 - $36,695) resulting in a gross margin of 79% (November 30, 2021 - 56%). The Company's sales for the quarter include waveguide components and sale of services for drone builds which yielded higher margins.
  • Accounting and audit fees of $ 22,653 (November 30, 2021 - $10,149). The amount increased in the current period due to the timing of fees of auditors and accountants.
  • Business development expenses of $81,337 (November 30, 2021 - $375,014) decreased due to timing of various business development initiatives. In the current and prior period, the main business development expenditures were on native ad campaigns.
  • Consulting fees of $(143,462) (November 30, 2021 - $199,829) decreased during the period due to the reversal of prior period consulting fee accruals in connection with canceled agreements.
  • Legal fees of $8,430 (November 30, 2021 - $38,906) decreased as in previous period due to the absence of legal fees relating to the acquisition of Tetra Drones, the absence of the set-up fees for the new subsidiary in the UK partially offset by fees relating to the MCTO and other legal consultations.
  • Management fees of $78,847 (November 30, 2021 - $36,250) increased due certain research and development consulting fees being reallocated to management fees during the period.
  • Research and development of $(67,229) (November 30, 2021 - $326,529) decreased mainly due to lower expenditures on X-1 technology this year and the funding issues faced by the Company during the start of the year and a reclassification of certain research and development consulting fees to management fees during the quarter.
  • Stock-based compensation of $Nil (November 30, 2021 - $215,134) decreased due to no stock options granted during the first two quarters of this year (See Capital Stock).
  • Transfer agent and filing fees of $9,017 (November 30, 2021 - $24,030) decreased is significantly as there were not much transactions related to issuance of shares during the period.
  • Wages, salaries and benefits of $232,072 (November 30, 2021 - $308,037) is lower due to a decrease in operating activities during the quarter ended November 30, 2022.
  • Foreign currency translation loss of $50,430 (November 30, 2021 gain - $38,936) recognized in other comprehensive income is the result of translating assets, liabilities and equity of the Company's US and UK entity to Canadian dollars for consolidated financial reporting purposes. The reversal of gain to a loss this period was due to unfavorable foreign exchange movements.
12

SUMMARY OF QUARTERLY RESULTS

The following table sets out selected financial data in respect of the last eight quarters of the Company. The data is derived from the financial statements of the Company prepared in accordance with IFRS.

  Qtr4
November
30, 2022
Qtr3
August
31, 2022
Qtr2
May
31, 2022
Qtr1
February
28, 2022
Total Revenues, including interest income $ 53,819 $ 56,878 $ 332,414 $ 164,248
Net loss (661,445) (778,398) (479,969) (747,986)
Basic and diluted loss per common share (0.05) (0.03) (0.01) (0.01)
         
  Qtr 4
November
30, 2021
Qtr 3
August
31, 2021
Qtr2
May
31, 2021
Qtr1
February
29, 2021
Total Revenues, including interest income $ 65,372 $ 96,484 $ 2,942 $ 19,598
Net loss (1,713,364) (887,777) (1,086,008) (1,287,685)
Basic and diluted loss per common share (0.07) (0.01) (0.02) (0.03)

The lower net loss in quarter ended November 30, 2022, compared with the third quarter of the year was primarily due to the decreased revenue and gross profit, lower G&A and R&D expenses and impairments of intangible assets and demo equipment which was offset against a gain on debt forgiveness in the current quarter. The net loss is higher in the quarters ended 2021 compared with the 2022 quarters was primarily due to increase in research and development and share-based compensation as well as the ramp up of operations in 2021 following the easing of restrictions brought about by the pandemic.

LIQUIDITY AND CAPITAL RESOURCES

The Company's approach to managing its liquidity is to ensure that it has sufficient resources to meet its liabilities as they come due and have sufficient working capital to fund operations for the ensuing fiscal year. Financing of operations has been achieved solely by equity financing. The Company anticipates that it will require significant funds from either equity or debt financing for the development of its technologies and to support general administrative expenses.

As at November 30, 2022, the Company had $62,202 in current assets (November 30, 2021 - $632,538) and $2,087,875 in current liabilities (November 30, 2021 - $706,666) for a working capital deficit of $2,025,673 compared to a working updated deficit of $74,128 as at November 30, 2021. The increase in working capital deficit is mostly driven by the operating cash outflows and the increase in accounts payable and amounts due to related parties.

As at November 30, 2022, the Company had a share capital balance of $11,851,771 (November 30, 2021 - $11,834,582) and an accumulated deficit of $16,535,760 (November 30, 2021 - $13,867,962). The increase in share capital is only due to the shares issued for consulting services during the quarter.

Financing of operations has been achieved solely by loans and equity financing. However, the Company expects to generate profitable revenue in the coming years with adequate investment to support adding experienced manufacturing personnel and capital equipment. Currently the Company is primarily reliant upon the sale of equity securities, loans and some product sales in order to fund future operations. Since inception, the Company has funded limited operations through the issuance of equity securities on a private placement basis. The Company's ability to raise funds through the issuance of equity will depend on economic, market and commodity prices at the time of financing.
The Company expects to generate similar losses quarter over quarter for the next fiscal year in relation to the Company's development, administration and promotion of its technologies. As of report date, management anticipates that the funds raised to date will be sufficient to sustain operations and the development of the Companies technologies for the next fiscal year.

13

Detailed discussions related to the Company's cash flows during the year ended November 30, 2022

Cash balances decreased by a total of $343,724 during the year ended November 30, 2022 (November 30, 2021 - increased by $311,997). In the previous period, the cash increased due to the issuance of shares through private placement and shares issued in relation to warrants exercised and options exercised. This year, the decline in cash balance resulted mainly from operating expenditures (see Results of Operations).

During the year ended November 30, 2022, cash used in operating activities was $414,023 compared to cash used in operating activities of $3,144,102 during the year ended November 30, 2021. The decrease in cash used came mostly from a lower loss in 2022 resulting from lower business development expenditures, offset by debt forgiveness, and an increase in accounts payable and due to related party balance.

Cash used in investing activities during the year ended November 30, 2022, was $Nil (November 30, 2021 - $573,343). There wasn't a business acquisition in 2022 nor was there any additional equipment purchased during the period.

Cash used in financing activities during the year ended November 30, 2022, was $70,299 compared to cash provided by financing activities of $4,326,442 during the year ended November 30, 2021. The decrease was primarily due to the absence of private placement completed during the current year in addition to option and warrant exercises which were present last year. This was reduced by lease payments and increased from some loan received during the year.

The effect of foreign exchange rates on cash during the year ended November 30, 2022 amounted to a gain of $18,195 (November 30, 2021 loss - $38,336).

PROPOSED TRANSACTIONS

On February 22, 2023, the Company announced a non-brokered private placement financing of up to 30,000,000 units (the "Units") of securities at a price of $0.05 per Unit for aggregate gross proceeds of up to $1,500,000. Each Unit will be comprised of one common share and one full transferable common share purchase warrant, with each whole warrant entitling the holder to purchase one additional common share at a price of $0.10 for three years from closing of the private placement. On March 30, 2023, the Company completed the first tranche of the private placement by issuing 7,200,000 units for gross proceeds of $360,000.

OFF-BALANCE SHEET ARRANGEMENTS

To the best of Management's knowledge, there are no off-balance sheet arrangements that have, or are reasonably likely to have, a current or future effect on the results of operations or financial condition of the Company.

CONTRACTUAL COMMITMENTS

The Company entered into lease agreement with arm's length party on September 9, 2021. The term commenced on May 1, 2021 and will set to expire on April 30, 2024 and with annual lease fee of £12,000 or £1,000 per month with interest of 4% per annum above Barclays Bank PLC base rate in case of default. Further, on the same date, the Company entered into separate agreement with the same arm's length party for drone flying permission over the land without restriction in exchange of £1,500 annual fee the term commenced on May 1, 2021 and end on April 30, 2024 as well.

In November 2018, PRT USA entered into two-year lease agreement for leased premises in Plymouth, Massachusetts, commenced December 1, 2018 and ended on November 30, 2020. On December 31, 2020, the Company renewed this lease agreement to November 30, 2023. The minimum base rent for the remaining lease term are: US$3,188 per month from December 1, 2021 to November 30, 2022; and US$3,284 per month from December 1, 2022 to November 30, 2023.

14

The Company has certain commitments related to key management compensation for $35,875 per month with no specific expiry of terms (see Transactions with Related Parties).

On February 4, 2023, the Company received a disputed claim from former consultant on the unpaid fees for the month of November 2022, December 2022 and January 2023 with an aggregate liability of $30,000. As of the reporting date, the Company is still waiting for the court order and plans to take a legal course of action as well. Management cannot determine the outcome as of the date of this report.

On April 1, 2020 the Company entered into an agreement with a Director of the Company to provide consulting services. In line with this, the Company shall pay $250,000 annually either through cash in 12 monthly installments at the end of each calendar month or through the issuance of 1,000,000 common shares of the Company in four equal quarterly installments, in arrears. (see Transactions with Related Parties)

TRANSACTIONS WITH RELATED PARTIES

The amounts due to related parties are due to the directors and officers of the Company. The balances are unsecured, non-interest bearing and due on demand. These transactions are in the normal course of operations and have been valued in these financial statements at the exchange amount, which is the amount of consideration established and agreed to by the related parties.

As at November 30, 2022, $705,672 (November 30, 2021 - $52,728) was due to directors and officers of the Company:

    November 30, 2022     November 30, 2021  
Company controlled by CFO $ 67,540     -  
Company controlled by Company secretary   -     10,500  
CEO of the company   250,179     561  
Director   387,953     41,667  
  $ 705,672   $ 52,728  

As at November 30, 2022, $Nil (November 30, 2021- $5,513) prepayment to directors and officers of the Company:

    November 30, 2022     November 30, 2021  
Company controlled by the Corporate Secretary $ -   $ 5,513  
  $ -   $ 5,513  
 
15

During the years ended November 30, 2022, 2021 and 2020, the Company entered into the following transactions with related parties:

    November 30, 2022     November 30, 2021     November 30, 2020  
Management fees $ 311,535   $ 118,000   $ 114,125  
Consulting fees   135,000     307,734     166,667  
Accounting fees   -     36,202     22,852  
Rent   -     5,000     20,000  
Stock-based compensation   -     410,132     271,993  
Salaries and benefits to CEO   330,337     313,626     133,387  
  $ 776,872   $ 1,190,694   $ 729,024  

Management fees consisted of the following:

    November 30, 2022     November 30, 2021     November 30, 2020  
Company controlled by CEO- Carl Cagliarini $ 243,387   $ 63,000   $ 55,125  
Company controlled by Former CFO- Zara Kanji   -     55,000     59,000  
Company controlled by the CFO- Susan Gardner   68,148     -     -  
  $ 311,535   $ 118,000   $ 114,125  

Consulting fees consisted of the following:

    November 30, 2022     November 30, 2021     November 30, 2020  
Director - Douglas Smith $ -   $ 307,734   $ 166,667  
Director - Philip Lancaster   75,000     -     -  
Company controlled by Former Corporate Secretary- Vivian Katsuris   60,000     -     -  
  $ 135,000   $ 307,734   $ 166,667  

During the year ended November 30, 2022, the Company granted Nil (November 30, 2021 - 1,725,000) options to the CEO, CFO, the Corporate Secretary, and the Company's directors. The amount recognized as expense for these options for the year ended November 30, 2022 is as follows:

    November 30, 2022     November 30, 2021  
    Number of
options held
    Expense for the
period (vested)
    Number of
options held
    Expense for the
period (vested)
 
Dana Wheeler, CEO   600,000   $ -     600,000   $ 133,276  
Zara Kanji, Former CFO   150,000     -     150,000     33,319  
Vivian Katsuris, Former Corporate Secretary   150,000     -     150,000     33,319  
Angelos Kostopoulos, Director   150,000     -     150,000     479  
Tim Crowhurst, Director   -     -     75,000     10,204  
Douglas Smith, Director and Chairman   300,000     -     300,000     1,536  
Dr. Khalid Al-Ali, Director   150,000     -     150,000     99,000  
Thomas Nash, Director   150,000     -     150,000     99,000  
    1,650,000   $ -     1,725,000   $ 410,132  

As at November 30, 2022, 75,000 stock options granted to Tim Crowhurst were cancelled unexercised.

16

SIGNIFICANT ACCOUNTING POLICIES AND CRITICAL ACCOUNTING ESTIMATES

All significant accounting policies and critical accounting estimates are fully disclosed in Note 2 of the Financial Statements for the year ended November 30, 2022 that are available on SEDAR at www.sedar.com.

FINANCIAL RISK MANAGEMENT

The Company's financial assets consist of cash, and due from related parties. The estimated fair values of cash, subscription receivable, and due from related parties approximate their respective carrying values due to the short period to maturity.

Financial instruments measured at fair value are classified into one of three levels in the fair value hierarchy according to the relative reliability of the inputs used to estimate the fair values. The three levels of the fair value hierarchy are:

a. Level 1 - unadjusted quoted prices in active markets for identical assets or liabilities;

b. Level 2 - inputs other than quoted prices that are observable for the asset or liability either directly or indirectly; and

c. Level 3 - inputs that are not based on observable market data.

For the periods ended November 30, 2022, and November 30, 2021, the fair value of the cash, accounts receivable, accounts payable, and due to and from related parties approximate the book value due to the short term nature.

The Company is exposed to a variety of financial instrument related risks. The Board approves and monitors the risk management processes, inclusive of counterparty limits, controlling and reporting structures. The type of risk exposure and the way in which such exposure is managed is provided as follows:

Liquidity Risk

Liquidity risk is the risk that the Company will not be able to meet its financial obligations when they become due. The Company ensures, as far as reasonably possible, it will have sufficient capital in order to meet short-term business requirements, after taking into account cash flows from operations and the Company's holdings of cash. As at November 30, 2022, the Company has cash balance of $13,127 (November 30, 2021 - $ 375,046) to settle current liabilities of $2,087,875 (November 30, 2021 - $706,666). The Company's future financial success will be dependent upon the ability to monetize its technologies or obtain necessary financing to meet its contractual obligations.

Interest Rate Risk

Interest rate risk is the risk that future cash flows will fluctuate as a result of changes in market interest rates. The Company has no significant interest rate risk due to the short-term nature of its interest generating assets.

Credit Risk

Credit risk is the risk of a loss to a counterparty to a financial instrument when it fails to meet its contractual obligations. The Company's exposure to credit risk is limited to its cash. The Company limits its exposure to credit risk by holding its cash in deposits with high credit quality Canadian financial institutions.

17

Foreign Currency Risk

The Company is exposed to foreign currency risk on fluctuations related to cash, due from related parties and accounts payable and accrued liabilities that are denominated in US dollars. 10% fluctuations in the US dollar against the Canadian dollar have affected comprehensive loss for the year by approximately $81,052 (2021 - $1,200 and 2020 - $7,085).

CAPITAL STOCK

The authorized capital of the Company consists of an unlimited number of common shares without par value. As at November 30, 2022 and report date, the following table summarizes the outstanding share capital, stock options, and share purchase warrants of the Company:

    As at  
    November 30, 2022     Report Date  
Common shares   59,317,461     59,317,461  
Stock Options   4,025,000     1,775,000  
Share Purchase Warrants   9,430,160     9,430,160  

Subsequent to the year ended November 30, 2022

On February 22, 2023, the Company announced a non-brokered private placement financing of up to 30,000,000 units (the "Units") of securities at a price of $0.05 per Unit for aggregate gross proceeds of up to $1,500,000. Each Unit will be comprised of one common share and one full transferable common share purchase warrant, with each whole warrant entitling the holder to purchase one additional common share at a price of $0.10 for three years from closing of the private placement. On March 30, 2023, the Company completed the first tranche of the private placement by issuing 7,200,000 units for gross proceeds of $360,000.

On March 3, 2022, 2,100,000 stock options issued to directors, officers, employees, and consultants were surrendered and cancelled. Further, On March 16, 2023, another 150,000 share options issued to director was surrendered and cancelled.

During the year ended November 30, 2022:

On December 31, 2021, the Company issued 78,125 common shares were issued as compensation for consulting fees to a director valued at a total of $17,189.

125,000 stock options with exercise price of $0.50 were cancelled.

75,000 stock options with exercise price of $0.50 expired unexercised.

561,081 warrants with exercise price of $0.20 expired unexercised.

During the year ended November 30, 2021:

During the year ended November 30, 2021, the Company issued 425,000 common shares for gross proceeds of $222,500 from the exercise of 425,000 stock options at $0.50 to $0.60 per share..

During the year ended November 30, 2021, the Company issued 6,129,572 common shares for gross proceeds of $1,332,727 from the exercise of 6,129,572 share purchase warrants at $0.20 to $0.50 per share.

18

During the year ended November 30, 2021, the Company issued 656,250 common shares were issued as compensation for consulting fees to a director (Note 8) valued at a total of $307,734.

On August 9, 2021, the Company issued 5,750,000 Units at $0.40 per unit for proceeds of $2,300,000. Each unit comprised one common share and one full non-transferable common share purchase warrant, with each warrant entitling the holder to purchase one additional common share at a price of $0.50 for five years. The Company paid cash of $63,700, issued 166,250 finders' Units with a fair value of $66,500 and 325,750 broker warrants as finder's fees. Each finders' Unit comprised of one common share and one full non-transferable common share purchase warrant, with exercise price of $0.50 per share for five years. The broker warrants are exercisable at $0.50 per share for five years.

On January 29, 2021, the Company issued 3,180,000 Units at $0.20 per unit for proceeds of $636,000. Each unit comprised one common share and one full non-transferable common share purchase warrant, with each warrant entitling the holder to purchase one additional common share at a price of $0.25 for five years. The Company paid cash of $10,480, issued 170,000 finders' Units with a fair value of $34,000 and 222,400 broker warrants as finder's fees . Each finder's Unit comprised of one common share and one full non-transferable common share purchase warrant with exercise price of $0.25 per share for five years. The broker warrants are exercisable at $0.25 per share for five years.

During the year ended November 30, 2020

On September 30, 2020, the Company issued an aggregate of 1,335,165 units at a price of CDN$0.30 per unit for gross proceeds of $400,550. Each Unit consists of one common share and one-half of one non-transferable common share purchase warrant (a "Warrant"). Each whole Warrant entitles the holder to purchase one additional common share at a price of $0.50 for two years until September 30, 2022. The fair value of the warrants is determined to be $40,055.

On September 30, 2020, the Company issued 250,000 common shares were issued as compensation for consulting fees to a director valued at a total of $62,500.

On September 30, 2020, the Company issued 50,000 units at a fair value of $22,811 pursuant to the binding agreement with Aerowave Corporation. Each Unit consists of one common share and one-half of one non-transferable common share purchase warrant (a "Warrant"). Each whole Warrant entitles the holder to purchase one additional common share at a price of $0.50 for two years until September 30, 2022. The fair value of the warrants is determined to be $1,500.

On August 21, 2020, the Company issued 250,000 common shares were issued as compensation for consulting fees to a Director valued at a total of $62,500.

On August 13, 2020, the Company issued 483,334 common shares pursuant to the exercise of 483,334 share purchase warrants at $0.20 per share.

On July 3, 2020, the Company issued 500,000 common shares pursuant to the exercise of 500,000 share purchase warrants at $0.20 per share.

On May 15, 2020, the Company issued an aggregate of 3,718,831 units at a price of CDN$0.15 per unit for gross proceeds of $557,825 Each unit consists of one common share in the capital of the Company and one whole transferable common share purchase warrant (a "Warrant"). Each whole Warrant is exercisable to acquire one common share at an exercise price of CDN $0.20 per share until May 15, 2022.

On April 24, 2020, the Company issued an aggregate of 3,128,334 units at a price of CDN $0.15 per unit for gross proceeds of $469,250.10. Each unit consists of one common share in the capital of the Company and one whole transferable common share purchase warrant (a "Warrant"). Each whole Warrant is exercisable to acquire one common share at an exercise price of CDN $0.20 per share until April 24, 2022.

19

In connection with the April 24, 2020 and May 15, 2020 private placements, the Company paid $38,238 in share issuance costs.

On February 4, 2020, the Company announced that it has arranged a non-brokered private placement financing of up to 10,000,000 units of securities at a price of $0.40 CAD per Unit for aggregate gross proceeds of up to $4,000,000 CAD (the "Offering").. On March 16, 2020, due to the instability in the financial markets caused by the COVID-19 pandemic, the Company cancelled this private placement.

Stock Options

Stock-based compensation recognized in profit or loss for the year ended November 30, 2022 amounted to $Nil (November 30, 2021 - $1,144,342).

During the year ended November 30, 2022, 125,000 stock options with exercise price of $0.50 were cancelled.

During the year ended November 30, 2022, 75,000 stock options with exercise price of $0.50 expired unexercised.

During the year ended November 30, 2021, 100,000 options were exercised at $0.60 per share and 325,000 options were exercised at $0.50 per share.

On June 10, 2021, the Company granted 150,000 incentive stock options to a consultant, options vested on grant date and with an exercise price of $0.50 per share for a period of five years from the date of grant. The fair value was estimated using the Black-Scholes pricing model with estimated, stock price of $0.485, volatility 100%, risk-free rate 0.82%, dividend yield 0%, and expected life of 5 years. With these assumptions, the fair value of options was determined to be $53,682 and the amount was recognized on the consolidated statements of loss and comprehensive loss for the year ended November 30, 2021.

On January 21, 2021, the Company granted 1,550,000 incentive stock options to directors, consultants, and employees, options vested on grant date and with an exercise price of $0.75 per share for a period of five years from the date of grant. The fair value was estimated using the Black-Scholes pricing model with estimated, stock price of $0.75, volatility 100%, risk-free rate 0.43%, dividend yield 0%, and expected life of 5 years. With these assumptions, the fair value of options was estimated to be $1,022,995 and the amount was recognized on the consolidated statements of loss and comprehensive loss for the year ended November 30, 2021.

Stock option transactions and the number of stock options outstanding as at November 30, 2022, November 30, 2021 and November 30, 2020 are summarized as follows:

    Number of     Weighted Average  
  Options     Exercise Price  
Balance, November 30, 2020   2,950,000   $ 0.58  
Granted   1,700,000     0.75  
Exercised   (425,000 )   0.50  
Balance, November 30, 2021   4,225,000     0.64  
Expired   (75,000 )   0.50  
Cancelled   (125,000 )   0.50  
Balance, November 30, 2022   4,025,000   $ 0.66  
 
20

  
Expiry Date Exercise
Price
  Numbers of
options
outstanding
    Numbers of
options
exercisable
    Weighted
average
remaining
contractual
life (year)
    Weighted average
exercise price
 
  $                     $  
January 15, 2024 0.60   2,050,000     2,050,000     0.57     0.31  
March 20, 2024 0.60   150,000     150,000     0.06     0.02  
November 28, 2024 0.50   125,000     125,000     0.07     0.02  
January 21, 2026 0.75   1,550,000     1,550,000     1.21     0.29  
June 10, 2026 0.50   150,000     150,000     0.13     0.02  
      4,025,000     4,025,000     2.03     0.66  

Share Purchase Warrants

During the year ended November 30, 2022, 561,081 warrants with exercise price of $0.20 expired unexercised.

On August 9, 2021, the Company granted 5,750,000 common share purchase warrants as part of a non-brokered private placement. Each warrant is exercisable to acquire one common share at an exercise price of $0.50 per share until August 9, 2026.

On August 9, 2021, the Company also granted 492,000 warrants to finders in connection with the Private Placement. Each warrant is exercisable to acquire one common share at an exercise price of $0.50 per share until August 9, 2026. The fair value was estimated using the Black-Scholes pricing model with estimated, stock price of $0.35, volatility 100%, risk-free rate 0.88%, dividend yield 0%, and expected life of 5 years. With these assumptions, the fair value of options was determined to be $119,425.

On January 29, 2021, the Company granted 3,350,000 common share purchase warrants as part of a non-brokered private placement. Each warrant is exercisable to acquire one common share at an exercise price of $0.25 per share until January 29, 2026. During the year ended November 30, 2021, 30,000 warrants were exercised at $0.25 per share.

On January 29, 2021, the Company also granted 222,400 warrants to finders in connection with the Private Placement. Each warrant is exercisable to acquire one common share at an exercise price of $0.50 per share until August 9, 2026. During the year ended November 30, 2021, 4,240 warrants were exercised at $0.25 per share. The fair value was estimated using the Black-Scholes pricing model with estimated, stock price of $0.52, volatility 100%, risk-free rate 0.43%, dividend yield 0%, and expected life of 5 years. With these assumptions, the fair value of options was determined to be $95,395.

Share purchase warrant transactions and the number of share purchase warrants outstanding as at November 30, 2022, November 30, 2021 and November 30, 2020 are summarized as follows:

    Number of Warrants     Weighted Average Exercise Price  
Balance, November 30, 2020   6,306,414   $ 0.23  
Warrants granted   9,814,400     0.08  
Warrants exercised   (6,129,573 )   0.01  
Balance, November 30, 2021   9,991,241   $ 0.41  
Warrants expired   (561,081 )   0.20  
Balance, November 30, 2022   9,430,160   $ 0.42  
 
21

  
Expiry Date   Exercise
Price
    Number of
Warrants
outstanding and
exercisable
    Weighted average
remaining
contractual life
(year)
    Weighted average
exercise price
 
    $                 $  
January 29, 2026   0.25     3,188,160     1.07     0.08  
August 9, 2026   0.50     6,242,000     2.10     0.33  
          9,430,161     3.17     0.41  

RISKS RELATED TO OUR BUSINESS

The Company believes that the following risks and uncertainties may materially affect its success.

Limited Operating History

The Company has only started generating revenues in the prior year. The Company was incorporated on October 17, 2011 and has yet to generate a profit from its activities. The Company is subject to all of the business risks and uncertainties associated with any new business enterprise, including the risk that it will not achieve its growth objective. The Company anticipates that it may take several years to achieve positive cash flow from operations.

Substantial Capital Requirements and Liquidity

Substantial additional funds for the establishment of the Company's current and planned operations will be required. No assurances can be given that the Company will be able to raise the additional funding that may be required for such activities, should such funding not be fully generated from operations. Revenues, taxes, transportation costs, capital expenditures, operating expenses and development costs are all factors which will have an impact on the amount of additional capital that may be required. To meet such funding requirements, the Company may be required to undertake additional equity financing, which would be dilutive to shareholders. Debt financing, if available, may also involve restrictions on financing and operating activities. There is no assurance that additional financing will be available on terms acceptable to the Company or at all. If the Company is unable to obtain additional financing as needed, it may be required to reduce the scope of its operations or anticipated expansion and pursue only those development plans that can be funded through cash flows generated from its existing operations.

Regulatory Requirements

The current or future operations of the Company require permits from various governmental authorities, and such operations are and will be governed by laws and regulations governing development, production, taxes, labour standards, occupational health, waste disposal, toxic substances, land use, environmental protection, site safety and other matters. There can be no assurance that all permits which the Company may require for the facilities and conduct of operations will be obtainable on reasonable terms or that such laws and regulation would not have an adverse effect on any development project which the Company might undertake.

Failure to comply with applicable laws, regulations and permitting requirements may result in enforcement actions, including orders issued by regulatory or judicial authorities causing operations to cease or be curtailed, and may include corrective measures requiring capital expenditures, installation of additional equipment or remedial actions. Parties engaged in operations may be required to compensate those suffering losses or damages and may have civil or criminal fines or penalties imposed upon them for violation of applicable laws or regulations. Amendments to current laws, regulation and permits governing operations and activities of companies, or more stringent implementation thereof, could have a material adverse impact on the Company and cause increases in capital expenditures or development costs or require abandonment or delays in the development of new projects.

22

Financing Risks and Dilution to Shareholders

The Company will have limited financial resources, no operations and hardly have revenues. There can be no assurance that the Company will be able to obtain adequate financing in the future or that such financing will be available on favorable terms or at all. It is likely such additional capital will be raised through the issuance of additional equity, which will result in dilution to the Company's shareholders.

Competition

There is competition within the security screening and threat detection market. The Company will compete with other companies, many of which have greater financial, technical and other resources than the Company, as well as for the recruitment and retention of qualified employees and other personnel.

Intellectual Property

The Company has developed security screening technologies that are adequate to counter various threats. The Company may be unable to prevent competitors from independently developing or selling products similar to or duplicate of the Company, and there can be no assurance that the resources invested by the Company to protect the Intellectual Property will be sufficient. The Company may be unable to secure or retain ownership or rights. In addition, the Company may be the target of aggressive and opportunistic enforcement of patents by third parties, including non-practicing entities. Regardless of the merit of such claims, responding to infringement claims can be expensive and time-consuming. If the Company is found to infringe any third-party rights, it could be required to pay substantial damages, or it could be enjoined from offering some of products and services. Also, there can be no assurances that the Company will be able to obtain or renew from third parties the licenses it needs in the future, and there is no assurance that such licenses can be obtained on reasonable terms.

Reliance on Management and Dependence on Key Personnel

The success of the Company will be largely dependent upon on the performance of the directors and officers and the ability to attract and retain key personnel. The loss of the services of these persons may have a material adverse effect on the Company's business and prospects. The Company will compete with numerous other companies for the recruitment and retention of qualified employees and contractors. There is no assurance that the Company can maintain the service of its directors and officers, or other qualified personnel required to operate its business. Failure to do so could have a material adverse effect on the Company and its prospects.

Governmental Regulations and Processing Licenses and Permits

The activities of the Company are subject to various government approvals, various laws governing prospecting, development, land resumptions, production taxes, labor standards and occupational health, toxic substances and other matters. Although the Company believes that its activities are currently carried out in accordance with all applicable rules and regulations, no assurance can be given that new rules and regulations will not be enacted or that existing rules and regulations will not be applied in a manner, which could limit or curtail production or development. Amendments to current laws and regulations governing operations and activities, or more stringent implementation thereof, could have a material adverse impact on the business, operations and financial performance of the Company. Further, the licenses and permits issued in respect of its projects may be subject to conditions that, if not satisfied, may lead to the revocation of such licenses.

Conflicts of Interest

Certain of the directors and officers of the Company will be engaged in, and will continue to engage in, other business activities on their own behalf and on behalf of other companies and, as a result of these and other activities, such directors and officers of the Company may become subject to conflicts of interest. The British Columbia Business Corporations Act ("BCBCA") provides that in the event that a director has a material interest in a contract or proposed contract or agreement that is material to the issuer, the director must disclose his interest in such contract or agreement and refrain from voting on any matter in respect of such contract or agreement, subject to and in accordance with the BCBCA. To the extent that conflicts of interest arise, such conflicts will be resolved in accordance with the provisions of the BCBCA.

23

Litigation

The Company and/or its directors may be subject to a variety of civil or other legal proceedings, with or without merit.

Public Health Crisis

In March 2020, the World Health Organization declared a global pandemic known as COVID-19. The expected impacts on global commerce are expected to be far reaching. This will impact demand for the Company's products and services and its ability to continue developing and testing their technologies in the near term and will impact the Company's supply chains. It may also impact expected credit losses on the Company's receivables. The duration and impact of the COVID-19 outbreak is unknown at this time and it is not possible to reliably estimate the length and severity of these developments and the impact on the financial results and condition of the Company and its subsidiary, in future periods. The management is closely evaluating the impact of COVID-19 on the Company's business.

As certain of the Company's officers have other outside business activities and, thus, may not be in a position to devote all of their professional time to the Company, the Company's operations may be sporadic, which may result in periodic interruptions or suspensions.

FORWARD-LOOKING STATEMENTS

This MD&A may include certain "forward-looking statements" within the meaning of applicable securities legislation. All statements, other than statements of historical facts, included in this MD&A that address activities, events or developments that the Company expects or anticipates will or may occur in the future, including such things as future business strategies competitive strengths, goals, expansion and growth of the Company's businesses, operations, plans and other such matters are forward-looking statements. When used in this MD&A, the words "estimate", "plan", "anticipate", "expect", ''intend'', "believe" and similar expressions are intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, among others, risks that actual results of current exploration activities will differ, changes in project parameters as plans continue to be refined, unavailability of financing, fluctuations in precious and/or base metals prices and other factors, as outlined in the Company's preliminary long form prospectus filed on SEDAR. Although the Company has attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

CAPITAL MANAGEMENT

The Company considers its capital structure to include net residual equity of all assets, less liabilities. The Company's objectives when managing capital are to (i) maintain financial flexibility in order to preserve its ability to meet financial obligations and continue as a going concern; (ii) maintain a capital structure that allows the Company to pursue the development of its projects and products; and (iii) optimize the use of its capital to provide an appropriate investment return to its shareholders commensurate with risk.

24

The Company's financial strategy is formulated and adapted according to market conditions in order to maintain a flexible capital structure that is consistent with its objectives and the risk characteristics of its underlying assets. The Company manages its capital structure and makes adjustments to it in light of changes in economic conditions and the risk characteristics of its underlying assets. To maintain or adjust the capital structure, the Company may attempt to issue new shares or acquire or dispose of assets.

DIRECTORS

Certain directors of the Company are also directors, officers and/or shareholders of other companies that may be engaged in the similar business of developing technologies. Such associations may give rise to conflicts of interest from time to time. The directors of the Company are required to act in good faith with a view to the best interests of the Company and to disclose any interest they may have in any project opportunity of the Company. If a conflict of interest arises at a meeting of the board of directors, any director in a conflict will disclose his/her interest and abstain from voting in the matter(s). In determining whether or not the Company will participate in any project or opportunity, the directors will primarily consider the degree of risk to which the Company may be exposed and its financial position at the time.

On November 22, 2021, Zara Kanji resigned as the Chief Financial Officer and was replaced in the interim by Vivian Katsuris, PRT's Corporate Secretary.

On January 13, 2022, the company appointed Susan Gardner as the company's CFO.

On January 13, 2022, Tim Crowhurst resigned as a Director of the Company.

On March 22, 2022, Vivian Katsuris resigned as the Corporate Secretary of the Company.

On June 9, 2022, the Company appointed Philip Lancaster to its Board of Directors. On February 3, 2023, the Company appointed Philip Lancaster as President and Corporate Secretary, replacing Dana Wheeler as President.

On February 3, 2023, the Company appointed Carl Cagliarini as interim CEO, replacing Dana Wheeler. Dana Wheeler remains on its Board of Directors.

As at the date of this MD&A, the Current Directors and Officers of the Company are as follows:

Carl Cagliarini, Interim CEO

Philip Lancaster, President and Director

Susan Gardner, CFO

Dana Wheeler, Director

Angelos Kostopoulos, Director

Thomas Nash, Director

Douglas Smith, Director and Chairman

Dr. Khalid M. Al-Ali, Director

OUTLOOK

The Company's objective is to maximize the value of the Company for our shareholders, and our strategy to obtain this result is to focus on project evaluations and project generation. To proceed with this strategy, additional financings may be required during the current fiscal year.

The company is currently at the inflection point of moving from design/development of prototypes to Low-Rate-Initial-Production (LRIP). Commercializing the products is a major step in the companies' strategic growth. With the pandemic being on the downturn, this will allow the company to spend appreciably more of its resources to meet with customers directly and start to attend trade shows in person. The marketing spend will also increase to accommodate this growth and sales strategy.

25

The company believes that an increase in revenue will occur in the next 6-12 months due to the forecasted sales pipeline and successful demonstration of the various products.

ADDITIONAL INFORMATION

Additional information relating to the Company can also be found on SEDAR at www.sedar.com.

26


ITEM 19. EXHIBITS
Exhibit No. Exhibit
(3) Articles of Incorporation and Bylaws
3.1 Certificate of Incorporation (incorporated by reference to the Registrant's Form 20FR12G furnished to the Commission on September 11, 2015)
3.2 Notice of Articles (incorporated by reference to the Registrant's Form 20FR12G furnished to the Commission on September 11, 2015)
3.3 Articles (incorporated by reference to the Registrant's Form 20FR12G furnished to the Commission on September 11, 2015)
3.4 Certificate of Change of Name dated October 30, 2018 (incorporated by reference to the Registrant's Form 20-F filed on March 31, 2021)
(4) Material Contracts
4.1 Option Agreement dated February 17, 2014 between Eastland Management Ltd. and Alexandra Capital Corp. (incorporated by reference to the Registrant's Form 20FR12G furnished to the Commission on September 11, 2015)
4.2** Long-Term Employee Incentive Plan dated October 17, 2022
4.3 Amending Letter dated August 15, 2015 between Eastland Management Ltd. and Alexandra Capital Corp. (incorporated by reference to the Registrant's Form 20FR12G furnished to the Commission on November 19, 2015)
4.4 Share Purchase Agreement dated June 21, 2018 with Plymouth Rock USA and the Selling Shareholders of Plymouth Rock USA (incorporated by reference to Form 20-F filed on April 13, 2020)
4.5 Assignment Agreement dated March 5, 2019 with Manchester Metropolitan University (incorporated by reference to Form 20-F filed on April 13, 2020)
4.6 Memorandum of understanding with Abicom International Ltd. dated February 12, 2019 (incorporated by reference to Form 20-F filed on April 13, 2020)
4.7 Letter agreement with Aerowave Corporation dated October 17, 2019 (incorporated by reference to Form 20-F filed on April 13, 2020)
4.8 Consulting Agreement dated April 1, 2020 with Douglas Smith (incorporated by reference to Form 20-F filed on March 31, 2021)
4.9 Acquisition agreement with Tetra Drones Limited dated June 6, 2021 (incorporated by reference to Form 20-F filed om June 3, 2022)
8.1 List of Significant Subsidiaries of the Company (incorporated by reference to Form 20-F filed om June 3, 2022)
11.1 Audit Committee Charter (incorporated by reference to Form 20-F filed on March 31, 2021)
12.1** Section 302 Certification under Sarbanes-Oxley Act of 2002 for Carl Cagliarini
12.2** Section 302 Certification under Sarbanes-Oxley Act of 2002 for Susan J Gardner
13.1** Section 906 Certification under Sarbanes-Oxley Act of 2002 for Carl Cagliarini
13.2** Section 906 Certification under Sarbanes-Oxley Act of 2002 for Susan J Gardner
15.1** Letter from Manning Elliott LLP per Item 16F
15.2** Letter from Reliant CPA PC per Item 16F
101.INS** Inline XBRL Instance Document–the instance document does not appear in the Interactive Data File as its XBRL tags are embedded within the Inline XBRL document
101.SCH** Inline XBRL Taxonomy Extension Schema Document
101.CAL** Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF** Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB** Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE** Inline XBRL Taxonomy Extension Presentation Linkbase Document
104** Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

** Filed herewith.


SIGNATURES

The registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this Annual Report on its behalf.

PLYMOUTH ROCK TECHNOLOGIES INC.

(Registrant)

/s/Carl Cagliarini
Carl Cagliarini
Interim Chief Executive Officer
(Principal Executive Officer)
 
/s/ Susan J Gardner
Susan J Gardner
Chief Financial Officer
(Principal Financial Officer)

Date: Date May 10, 2023


EX-4.2 2 exhibit4-2.htm EXHIBIT 4.2 Plymouth Rock Technologies Inc.: Exhibit 4.2 - Filed by newsfilecorp.com

LONG-TERM EQUITY INCENTIVE PLAN

PLYMOUTH ROCK TECHNOLOGIES INC.

ARTICLE 1
PURPOSE

1.1 Purpose. The purpose of this long-term equity compensation plan of the Corporation is to advance the interests of the Corporation and its Affiliates by (a) attracting, rewarding and retaining highly competent persons as Employees, Directors, and Consultants; (b) providing additional incentives to Employees, Directors, and Consultants as determined by the Board by aligning their interests with those of the Corporation's shareholders; and (c) promoting the success of the Corporation's business.

1.2 Effective Date and Replacement. The Plan shall become effective upon the receipt of all required board and regulatory approvals (the "Effective Time") and will replace the "Stock Option Plan" of the Corporation (the "Prior Plan"). All awards granted under the Prior Plan and which remain outstanding at the Effective Time, and will remain in full force and effect in accordance with their terms, however, following the Effective time, no additional grants shall be made under the Prior Plan.

ARTICLE 2
DEFINED TERMS

2.1 Definitions. The following terms used herein shall have the following meanings:

"Affiliate" means an entity which is an "affiliate" of the Corporation for the purposes of the Securities Act;

"Award" means an Option, Stock Appreciation Right, Restricted Share Unit, Deferred Share Unit or other Share-based Award granted pursuant to the Plan;

"Black-Out Period" means a time when, pursuant to any policies of the Corporation, any securities of the Corporation may not be traded by certain persons as designated by the Corporation, including any holder of an Award;

"Board" means the board of directors of the Corporation or, if established and duly authorized to act in respect of the Plan, a committee of the board of directors of the Corporation;

"Business Day" means any day, other than a Saturday or a Sunday, on which the Exchange is open for trading;

"Change of Control" means the occurrence of any of the following:


2

(i) the sale by the Corporation of all of the assets of the Corporation or substantially all of the assets of the Corporation;

(ii) the acquisition by any Person (whether from the Corporation or from any other Person) of Shares or other securities of the Corporation having rights of purchase, conversion or exchange into Shares which together with securities of the Corporation held by such Person, either alone or together with Persons "acting jointly or in concert" (as such phrase is defined by the Securities Act) with such Person, exceeds 50% of the issued and outstanding Shares, (assuming for this test the purchase, conversion or exchange of such other securities, whether then purchasable, convertible or exchangeable or not, into the highest number of Shares, such Person or Persons would be entitled to);

(iii) the amalgamation of the Corporation with or into any one or more other corporations (other than: (a) an amalgamation of the Corporation with or into a subsidiary (as such term is defined in the Securities Act) of the Corporation; or (b) an amalgamation or merger of the Corporation unanimously recommended by the Board provided that the former holders of Shares receive, in the aggregate and in their capacities as such, shares of the amalgamated corporation having attached thereto not less than 50% of the votes attached to all shares of such amalgamated or merged corporation);

(iv) the election at a meeting of the Corporation's shareholders of that number of persons which would represent a majority of the Board, who are not included in the slate or election as directors proposed to the Corporation's shareholders by the Corporation; or

(v) the completion of any transaction or the first of a series of transaction which would have the same or similar effect as any transaction or series of transactions referred to in subsections (i), (ii), (iii) referred to above;

"Common Shares" means the common shares of the Corporation;

"Consultant" means an individual who:

(i) provides ongoing consulting, technical, management or other services to the Corporation or an Affiliate under a written contract with the Corporation or an Affiliate;

(ii) possesses technical, business or management expertise of value to the Corporation or an Affiliate;

(iii) in the opinion of the Corporation, spends or will spend a significant amount of time and attention on the business and affairs of the Corporation or an Affiliate;

(iv) has a relationship with the Corporation or an Affiliate that enables the Consultant to be knowledgeable about the business and affairs of the Corporation; and


3

(v) includes a Consultant Company or a Consultant Partnership.

"Consultant Company" means, for an individual Consultant, a company of which the individual consultant is an employee or shareholder;

"Consultant Partnership" means, for an individual Consultant, a partnership of which the individual Consultant is an employee or partner;

"Corporation" means Plymouth Rock Technologies Inc., a corporation incorporated under the laws of the Province of British Columbia, and any successor corporation;

"Deferred Share Units" has the meaning set out in Section 11.1;

"Disinterested Shareholders" means all of the Shareholders of the Corporation except Insiders of the Corporation who are Eligible Persons, and such Insiders' associates;

"Director" means a member of the board of directors of the Corporation or of any of its Affiliates;

"Effective Date" means, for a Grant, the date which the Board determines will be the date on which the Grant will take effect;

"Eligible Person" means, subject to all applicable laws, any employee, Officer, Director, Management Company Employee or Consultant of the Corporation or of any Affiliate;

"Employee" means,

(i) an individual who is considered an employee under the Income Tax Act (i.e. for whom income tax employment insurance and CPP deductions must be made at source);

(ii) an individual who works full-time for the Corporation providing services normally provided by an employee and who is subject to the same control and direction by the Corporation over the details and method of work as an employee of the Corporation, but for whom income tax deductions are not made at source; or

(iii) an individual who works for the Corporation on a continuing and regular basis for a minimum amount of time per week providing services normally proved by an employee and who is subject to the same control and direction by the Corporation over the details and methods of work as an employee of the Corporation, but for whom income tax deductions are not made at source; and

(iv) includes an issuer all of the voting securities of which are owned by one or; more Officers, Directors or employees of the Corporation or an Affiliate;

"Exercise Criteria" means he criteria, if any, established by the Board in relation to a Grant, which criteria are to be achieved during a Grant Period by a Participant in respect of that particular Grant in order that Restricted Share Units will be issued and which criteria may, without limitation, include vesting periods and criteria based on performance of the Shares in the market, financial performance by the Corporation and/or by a specific business unit of the Corporation and other corporate or individual measures;


4

"Exchange" means the Canadian Securities Exchange (CSE) or, if the Shares are not then listed and posted for trading on the CSE, on such stock exchange in Canada on which such Shares are listed and posted for trading as may be selected for such purpose by the Board;

"Fixed Term" means the period of time during which an Option must be exercised pursuant to the terms of the Plan;

"Grant" means the grant of Restricted Share Units allocated to a Participant at any time in accordance with the Plan;

"Grant Period" means the period established by the Board in respect of each Grant, which period shall commence on the Effective Date and end on the date designated by the Board, provided however that such period will not in any case exceed three years;

"Insider" has the meaning given under applicable securities legislation and the policies of the Exchange, as amended or replaced from time to time, and also includes associates and affiliates of such an insider;

"Management Company Employee" means an individual employed by a person providing management services to the Corporation, who is required for the ongoing successful operation of the business enterprise of the Corporation, but excluding a person engaged in investor relations activities;

"Market Price" as at any date means the volume weighted average trading price of the Shares on the Exchange for the five trading days immediately preceding the relevant date, calculated by dividing the total value by the total volume of Shares traded for the relevant period, rounded up to the nearest cent. In the event that the Shares are not then listed and posted for trading on any Exchange, the Market Price in respect thereof shall be the fair market value of such Shares as determined by the reasonable application by the Board of a reasonable valuation method;

"Offer" has the meaning set out in Section 6.1;

"Officer" means a senior officer of the Corporation or an Affiliate;

"Other Awards" has the meaning set out in Section 12.1;

"Option" means an option granted to purchase Shares for the Option Price under the terms of the Plan;

"Option Price" means the price per share at which Shares may be purchased under an Option and based on which the SAR Amount is determined, as the same may be adjusted from time to time in accordance with Article 6 hereof;


5

"Participant" means an Eligible Person who holds an Award under the terms of the Plan;

"Payout Date" in respect of a Deferred Share Unit means ten (10) Business Days following the Termination Date;

"Plan" means this long-term equity incentive plan;

"Release Date" means, in respect of a Grant of Restricted Share Units, unless otherwise determined by the Board, either (i) the date which is ten (10) Business Days following each anniversary of the Effective Date of the Grant, or (ii) the date which is ten (10) Business Days following the third anniversary of the Effective Date of the Grant, as specified in the award agreement;

"Restricted Share Units" has the meaning set out in Section 10.1;

"SAR Amount" has the meaning set out in Section 8.2;

"Securities Act" means the Securities Act (British Columbia) as in force from time to time;

"Share Purchase Program" has the meaning set out in Section 10.1 hereof;

"Shares" mean the common shares of the Corporation as currently constituted or, in the event of an adjustment as contemplated by Article 6, such other shares or securities to which a Participant may be entitled or on which the value of an Award may be based, as a result of such adjustment;

"SPP Eligible Person" means any Eligible Person determined by the Board as eligible to participate in the Share Purchase Program;

"Stock Appreciation Rights" has the meaning set out in Section 8.1;

"Tax Act" means the Income Tax Act (Canada) as amended from time to time;

"Termination Date" means the date a Participant ceases to be (i) in the context of a Deferred Share Unit, an Employee or Director, as the case may be, and (ii) in all other contexts herein, an Eligible Person and, unless otherwise provided herein, does not include any period of statutory, contractual or reasonable notice or any period of salary continuance or deemed employment; and

ARTICLE 3
ADMINISTRATION OF PLAN

3.1 General. This Plan shall be administered by the Board which shall have the power, subject to the specific provisions of the Plan:

(a) to establish policies and to adopt rules and regulations for carrying out the purposes, provisions and administration of the Plan;


6

(b) to interpret and construe the Plan and to determine all questions arising out of the Plan and any Award granted pursuant to the Plan, where every such interpretation, construction or determination made by the Board shall be final, binding and conclusive for all purposes;

(c) to determine the Eligible Persons to whom Awards are granted and to grant Awards;

(d) to determine the number of Awards;

(e) to determine the Exercise Criteria in respect of any Grant;

(f) to determine the Option Price provided that the Option Price shall not be less than the Market Price;

(g) to determine the time or times when Awards will be granted and exercisable or redeemable;

(h) to determine if the Shares that are subject to an Award will be subject to any restrictions upon the exercise or redemption of such Award;

(i) to prescribe the form of the instruments or award agreements relating to the grant, exercise, redemption and other terms of Awards;

(j) to determine whether , to what extent, and under what circumstances an Award may be settled in cash, through a cashless exercise or otherwise;

(k) to correct any defect (including but not limited to amending an award agreement to comply with applicable law), supply any omission, or reconcile any inconsistency in the Plan or any award agreement in the manner and to the extent it shall deem desirable to carry out the purposes of the Plan;

(l) to authorize withholding arrangements pursuant to Section 14.4 of the Plan;

(m) to authorize any person to execute on behalf of the Corporation any instrument required to effect the grant of an Award previously granted by the Board; and

(n) to make all other determinations and take all other actions described in the Plan or as the Board otherwise deems necessary or advisable for administering the Plan and effectuating its purposes.

The powers described in this Section 3.1 shall be exercised in accordance with applicable securities laws and the rules and policies of the Exchange.

3.2 Delegation of Administration. The Board may, from time to time, delegate the administration of all or any part of the Plan to a committee of the Board and shall determine the scope of and may revoke or amend such delegation.


7

3.3 Award Agreement. Each Participant shall execute an award agreement in the form determined by the Board from time to time. In the event of any inconsistency between the terms of any award agreement and this Plan, the terms of this Plan shall govern.

3.4 Awards May be Separate or in Tandem. In the Board's discretion, Awards may be granted alone, in addition to, or in tandem with any other Award or any award granted under another plan of the Corporation or an Affiliate. Awards granted in addition to or in tandem with other awards may be granted either at the same time or at different times.

ARTICLE 4
SHARES SUBJECT TO THE PLAN

4.1 Rolling Plan. Subject to adjustment as provided in Article 6, the Shares to be issued under the Plan shall consist of the Corporation's authorized but unissued Shares. The aggregate number of Shares to be reserved for issuance upon the exercise or redemption of all Awards granted under the Plan shall not exceed ten percent (10%) of the issued and outstanding Shares at the time of granting of Awards (on a non-diluted basis) or such other number or percentage as may be approved by the Exchange and the shareholders of the Corporation from time to time. At all times the Corporation will reserve and keep available a sufficient number of Shares in such manner as it may consider appropriate in order to satisfy the requirements of all outstanding Awards made under the Plan and all other outstanding but unvested Awards made under the Plan that are to be settled in Shares.

4.2 Awards to Insiders. Under no circumstances shall this Plan, together with all other security-based compensation arrangements of the Corporation, result, at any time, in:

(a) the number of Shares issuable to Insiders exceeding ten percent (10%) of the issued and outstanding Shares (on a non-diluted basis); or

(b) the issuance to Insiders, within a one-year period, of a number of Shares exceeding ten percent (10%) of the issued and outstanding Shares (on a non-diluted basis) excluding Common Shares issued to such Insider under the Plan or any other Share Compensation Arrangement over the preceding one year period; or

(c) the issuance to any one Insider and such Insider's Associates within a one year period, of a number of Shares exceeding five percent (5%) of the issued and outstanding Shares (on a non-diluted basis), excluding Common Shares issued to such Insider under the Plan or any other Share Compensation Arrangement over the preceding one year period.

4.3 Maximum Award. The maximum number of Awards which may be reserved for issuance to any one person under the Plan in any 12 month period shall be 5% of the Shares outstanding at the time of the grant (on a non-diluted basis) less the aggregate number of Shares reserved for issuance to such person under any other option to purchase Shares from treasury granted as a compensation or incentive mechanism. The number of options granted to any one Consultant, or to persons involved in investor relations activities in a 12 month period under the Plan shall not exceed 2% of the Shares outstanding at the time of grant (on a non-diluted basis), less the aggregate number of Shares reserved for issuance to Consultants or such persons pursuant to any other Share Compensation arrangement, unless the consent of the Exchange is first obtained.


8

4.4 Exercise or Redemption of Awards. Any exercise of Options or redemption of Awards will make new grants available under the Plan effectively resulting in a re-loading of the number of Shares available to be granted under the Plan.

4.5 Awards That Expire or Terminate. If any Award granted hereunder shall expire or terminate for any reason without having been exercised or redeemed in full, the Shares underlying the Award shall again be available to be granted under the Plan.

4.6 Restrictions on Exercise or Redemption. Notwithstanding any of the provisions contained in the Plan or any Award, the Corporation's obligation to issue Shares to a Participant pursuant to the exercise or redemption of an Award shall be subject to:

(a) the completion of such registration or other qualification of such Shares or the approval of the Exchange or such other regulatory authority as the Corporation shall determine to be necessary or advisable in connection with the authorization, issuance or sale thereof;

(b) the admission of such Shares to listing on the Exchange; and

(c) the receipt from the Participant of such representations, agreements and undertakings, including as to future dealings in such Shares as the Corporation or its counsel determines to be necessary or advisable in order to safeguard against the violation of the securities laws of any jurisdiction.

In this regard, the Corporation shall, the extent necessary, take all reasonable steps to obtain such approvals, registrations and qualifications as may be necessary for the issuance of such Shares in compliance with applicable securities laws and for the listing of such Shares on the Exchange. If any Shares cannot be issued to any Participant for any reason including, without limitation, the failure to obtain necessary shareholder, regulatory or stock exchange approval, then the obligation of the Corporation to issue such Shares shall terminate and any amounts paid by the Participant to the Corporation to exercise or redeem an Award shall be returned to the Participant.

4.7 Non-Assignable. An Award is personal to the Participant and is non-assignable and non- transferable, except with the prior written consent of the Corporation and any required consent of the Exchange and any other applicable regulatory authority. Notwithstanding the foregoing, an Award granted to a Consultant that is a company or partnership, may be assigned to a Management Company Employee of such Consultant.

4.8 Substitute Awards. Subject to Exchange approval, if required, the Board may grant Awards under the Plan in substitution for share and share-based awards held by employees, directors, consultants or advisors of another company (an "Acquired Company") in connection with a merger, consolidation or similar transaction involving such Acquired Company and the Corporation or an Affiliate or the acquisition by the Corporation or an Affiliate of property or stock of the Acquired Company. The board may direct that the substitute Awards be granted on such terms and conditions as the Board considers appropriate in the circumstances.


9

ARTICLE 5
ELIGIBILITY AND CEASING TO BE AN ELIGIBLE PERSON

5.1 Eligible Persons. Awards may only be granted to Eligible Persons.

5.2 Compliance with Laws. Notwithstanding any provision contained in this Plan, no Participant may exercise or redeem any Award granted under this Plan and no Shares may be issued upon exercise or redemption of an Award unless such exercise or redemption and issuance are in compliance with all applicable securities laws or other legislation of the jurisdiction of residence of such person and in compliance with the terms of the Plan. Unless the potential Participant is a resident of Canada, the Corporation may require, as a condition of the grant of an Award, that the potential Participant provide a written acknowledgement that the grant of the Award does not violate any such laws.

5.3 Termination Date. Subject to Section 5.4, 5.5 and 5.6 and any express resolution passed by the Board, all Awards, and all rights to acquire Shares pursuant thereto, granted to an Eligible Person shall expire and terminate immediately upon the Participant's Termination Date.

5.4 Circumstances When Awards are Exercisable. If, before the expiry of an Award in accordance with the terms thereof, a Participant ceases to be an Eligible Person for any reason whatsoever, other than termination by the Corporation for cause (in which case all unexercised or unredeemed Awards (vested or unvested) shall cease immediately), such Awards may, subject to:

(a) the terms set out in the award agreement;

(b) any determination made by the Board to accelerate the vesting of or to extend the expiry of an Award; and

(c) any other terms of the Plan,

be exercised or redeemed, as applicable;

(d) if the Participant is deceased, by the heirs of the Participant or by legal personal representative(s) of the estate of the Participant at any time within six (6) months following the death of the Participant; or

(e) by the Participant at any time within ninety (90) days following the Termination Date.

But, in any case, subject to any determination of the Board, the exercise or redemption of the Award must be: (i) prior to the expiry of the Fixed Term of the Option or the expiry of the Stock Appreciation Right in accordance with the terms thereof, (ii) prior to the expiry of the Grant Period in respect of Restricted Share Units, and (iii) prior to the expiry of the Award in the case of Other Awards under the Plan, and in each case only to the extent that the Award was vested or the Exercise Criteria was satisfied and the Participant was otherwise entitled to exercise the Award at the Termination Date.


10

5.5 Death or Termination of Employment.

(a) Notwithstanding Section 5.4, in the event of the death of a Participant while in the employment of the Corporation or any Affiliate, all Awards granted to that Participant prior to the date of death shall be deemed to be vested in the Participant or to have had the Exercise Criteria relating thereto satisfied on the date of death.

(b) Except as specifically provided for in this Plan or in any award agreement, or as otherwise agreed to or determined by the Board, if the employment of a Participant with the Corporation or any Affiliate is terminated for any reason prior to the exercise or redemption of any Award, then the Participant shall be deemed to have forfeited all right, title and interest with respect to any Award not fully vested or in respect of which the Exercise Criteria has not been satisfied upon that Participant's last day of such employment which shall be considered to be:

(i) if the Participant is terminated for just cause, the actual date of termination; and

(ii) if the Participant is terminated for reasons other than just cause, the date which is the later of: (i) the conclusion of any statutory, contractual or common law period of notice of termination of employment to which that Participant is entitled; and (ii) three (3) months after the Termination Date.

(d) Notwithstanding the foregoing, in the event that a Participant's employment with the Corporation or any Affiliate is terminated without just cause or if the Participant resigns from such employment then, at the sole and unfettered discretion of the Board, all or any portion of the Awards granted to that Participant may be deemed to have vested or to have had the Exercise Criteria relating thereto satisfied on the date of termination or resignation.

5.6 Another Listed Category. Awards shall not be affected in the event the Participant ceases to fall within a listed category contained in the definition of an "Eligible Person" hereunder where such Participant falls within another listed category of such definition.

ARTICLE 6
CERTAIN ADJUSTMENTS

6.1 Offer for Shares. In the event that any formal bid (as defined in the Securities Act) for the Shares is made (an "Offer") all Shares subject to outstanding Options not then exercisable shall thereupon become immediately exercisable. Further, the Participant shall be entitled to include in the written notice of election to exercise all or any part of the Option that such Participant is electing to exercise the Option with the intention of tendering the Shares acquired upon such exercise into the Offer. If such election is made, in the event that the Offer is not completed and the relevant Shares are not taken up and paid for by the offeror under such Offer (or a competing Offer), the Participant shall, upon return of certificates representing such Shares, be deemed not to have exercised the Option with respect to such Shares and the Corporation shall return to the Participant the subscription proceeds therefor and/or take such other actions to enable the parties to re-establish as closely as possible their situations and respective economic positions as they existed prior to the making of the Offer and had no Options become exercisable as a result thereof, while making allowance for taxation, regulatory and other irreversible events and consequences which many have intervened since the making of the Offer.


11

6.2 Changes in Shares. In the event of any stock dividend, stock split, combination or exchange of shares, merger, amalgamation, acquisition, divestiture, consolidation, spin-off or other distribution (other than normal cash dividends) of the Corporation's assets to shareholders, or any other change in the capital of the Corporation affecting Shares, the Board will, subject to Exchange approval, if required, make such proportionate adjustments, if any, as the Board in its discretion may deem appropriate to reflect such change, with respect to (i) the number or kind of Shares or other securities reserved for issuance pursuant to this Plan; (ii) the number or kind of Shares or other securities subject to unexercised or unredeemed Awards previously granted; and (i) the Option Price or the Market Price of a Share at the date of grant, as applicable, of Awards.

6.3 No Fractional Shares. The Corporation will not issue fractional Shares in satisfaction of any of its obligations hereunder.

6.4 Accelerated Exercise or Redemption of Awards. Notwithstanding any other provision of the Plan, the Board may at any time give written notice to all Participants advising that their respective Awards (other than a Deferred Share Unit) are all immediately exercisable or redeemable and may be exercised or redeemed only within 30 days of such written notice or such other period as determined by the Board and not thereafter and that all rights of the Participants under any Awards (other than a Deferred Share Unit) not exercised or redeemed within such period will terminate at the expiration of such period.

6.5 Payment on Change of Control. Notwithstanding any other provisions of the Plan, in the event of the occurrence of a Change of Control of the Corporation or of an Affiliate of which a Participant is an employee, with respect to all Options, Grants of Restricted Share Units, Stock Appreciation Rights and Deferred Share Units that are outstanding for such Participant on the date of the Change of Control (the "CoC Date"), (i) all vesting and Exercise Criteria, if any, applicable to such Options, Grants of Restricted Share Units, Stock Appreciation Rights and Grants of Deferred Share Units shall be deemed to have been satisfied as of the CoC Date and (ii) except as may be otherwise provided under the terms of any other employee benefit plan approved by the Board, each participant who has received any such Options, Grants of Restricted Share Units or Stock Appreciation Rights shall be entitled to receive, in full settlement of such Option, Restricted Share Unit or Stock Appreciation Right, a cash payment equal to (A) in the case of a Restricted Share Unit, the Special Value (as defined below) and, (B) in the case of an Option or a Stock Appreciation Right, the difference between the Special Value and the Option Price in respect of such Option or Stock Appreciation Right, in each case, payable on the date which is ten Business Days following the CoC Date. For greater certainty, the occurrence of a Change of Control will not trigger the right of a Participant to receive a payment in respect of a Deferred Share Unit prior to a Termination Date for such Participant.


12

For the purpose of this Section 6.5, the term "Special Value" means an amount determined as follows: (i) if any Shares are sold as part of the transaction constituting the Change of Control, then the Special Value shall equal the weighted average of the prices paid for those Shares by the acquirer, provided that if any portion of the consideration paid for such Shares by the acquirer is paid in property other than cash, then the Board (as constituted immediately prior to the CoC Date) shall determine the fair market value of such property as of the CoC Date for purposes of determining the Special Value; and (ii) if no Shares are sold as part of the transaction constituting the Change of Control, then the Special Value shall be the Market Price of a Share on the day immediately preceding the CoC Date.

ARTICLE 7
OPTIONS

7.1 Grant of Options. The Board may grant Options to Eligible Persons.

7.2 Option Exercise Term. Options shall be for a Fixed Term and shall be exercisable from time to time as determined in the discretion of the Board at the time of grant, provided that, subject to Section 7.3, no Option shall have a term exceeding ten (10) years (or such shorter period as is permitted by the Exchange from time to time).

7.3 Black-Out Period. Except where not permitted by the Exchange, where an Option would expire during a Black-Out Period or within ten (10) Business Days following the end of a Black- Out Period, the term of such Option shall be automatically extended to the date which is ten (10) Business Days following the end of such Black-Out Period.

7.4 Terms of Options. Subject to this Article, the number of Shares subject to each Option, the Option Price, the expiration date of each Option, the extent to which each Option is exercisable from time to time during the term of the Option and other terms and conditions (including vesting) relating to each such Option shall be determined by the Board; provided, however, that if no specific determination is made by the Board with respect to any of the following matters, each Option shall, subject to any other specific provisions of the Plan, contain the following terms and conditions:

(a) the Fixed Term shall be five (5) years from the date the Option is granted to the Participant;

(b) subject to a minimum of $0.10 per Share, the Option Price shall not be less than the closing price of a Share on the Exchange immediately preceding the day on which the Board grants and provides notice to the Exchange of the Options(s), less the discount to the closing price permitted by the Exchange;

(c) except as provided in (d) below, the Option shall vest in instalments, with 1/3 of such Option exercisable in whole or in part on or after the first anniversary following the grant of the Option, and a further 1/3 vesting and becoming exercisable on each of the second and third anniversaries following the grant of the Option; and


13

(d) Options granted to Consultants providing investor relations services shall vest at a minimum over a period of 12 months with no more than 1/4 of such Options vesting in any three (3) month period.

7.5 Restrictions on Option Price. The Option Price shall in no circumstances be lower than the greater of: (i) $0.10; (ii) the price permitted by any other regulatory body having jurisdiction; and (iii) the closing price of a Share on the Exchange immediately preceding the day on which the Board grants and provides notice to the Exchange of the Options(s), less the discount to the closing price permitted by the Exchange.

7.6 Exercise of Options. Subject to the provisions of the Plan and award agreement, an Option may be exercised from time to time by delivery to the Corporation at its principal office of a written notice of exercise addressed to the Chief Financial Officer of the Corporation in a form approved by the Board from time to time and accompanied by payment in full of the Option Price for the Shares to be purchased. Upon receipt of payment in full and subject to the terms of this Plan, the number of Shares in respect of which the Option is exercised will be duly issued to the Participant as fully paid and non-assessable. Upon the exercise of any Option with a related Stock Appreciation Right, the corresponding portion of the related Stock Appreciation Right shall be surrendered to the Corporation and cancelled.

7.7 Form of Consideration. The Board shall determine the acceptable form of consideration for exercising an Option, including the method of payment. To the extent approved by the Board at the time of the grant of an Option and to the extent provided for in the award agreement relating to such Option and subject to applicable law, the consideration for exercise of an Option may be paid in any one, or any combination, of the forms of consideration set forth in subsections (a), (b), (c) and (d) below.

(a) Cash Equivalent. Consideration may be paid by cash, cheque, electronic transfer of funds, or other cash equivalent approved by the Board.

(b) Broker-Assisted Cashless Exercise. Subject to the Board's approval and further subject to the Shares being actively traded on an Exchange, consideration may be paid by the Participant's (i) irrevocable instructions to the Corporation to deliver the Shares issuable upon exercise of the Option promptly to a broker (acceptable to the Corporation) for the Participant's account, and (ii) irrevocable instructions to the broker to sell Shares sufficient to pay the Option Price (plus any amount required to be withheld by applicable law) and upon such sale to deliver the Option Price (plus any amount required to be withheld by applicable law) to the Corporation.

(c) Other Methods. Consideration may be paid using such other methods of payment as the Board, at its discretion, deems appropriate from time to time.

7.8 Restrictive Legends

Any share certificate issued in connection with the exercise of an Option within four months of the date of its grant shall bear a legend similar to the following:


14

Unless permitted under securities legislation, the holder of this security must not trade this security before four months after the date of grant of the stock options.

AND, if the optionee is a resident of the United States, the following additional legend:

The securities represented hereby have not been and will not be registered under the United States Securities Act of 1933, as amended (the "US Securities Act"). The holder hereof, by purchasing such securities, agrees for the benefit of the Issuer that such securities may be offered, sold, pledged or otherwise transferred only (A) to the Issuer, (B) outside of the United States in accordance with Rule 904 of Regulation S under the US Securities Act if available, (C) inside the United States (1) pursuant to the exemption from the registration requirements under the US Securities Act provided by Rule 144 thereunder, if available, and in accordance with the applicable state securities laws, or (2) in a transaction that does not require registration under the US Securities Act or any applicable State laws and regulations governing the offer and sale of securities, and the holder has prior to such sale furnished to the Issuer an opinion of counsel, of recognized standing, reasonably satisfactory to the Issuer. Delivery of this certificate may not constitute "Good Delivery" in settlement of transactions on stock exchanges in Canada. If the Issuer is a "Foreign Issuer" as that term in defined by Regulation S at the time of sale, a new certificate, bearing no legend, delivery of which will constitute "Good Delivery" may be obtained from the Registrar upon delivery of this certificate and a duly executed declaration, in a form satisfactory to the registrar and the Issuer, to the effect that the sale of the securities represented hereby is being made in compliance with Rule 904 of Regulation S under the US Securities Act. (This legend is valid for one year from the date of issuance of the common shares obtained by exercise of the stock option).

ARTICLE 8
STOCK APPRECIATION RIGHTS

8.1 Grants of Share Appreciation Rights. The Board may grant rights ("Stock Appreciation Rights") to Eligible Persons either on a stand-alone basis or in relation to any Option. Where a Stock Appreciation Right is granted in relation to an Option, it shall be a right in respect of the same number of Shares and shall have the same Option Price as the Option.

8.2 Stock Appreciation Rights. Subject to Sections 8.3 and 8.4, a Stock Appreciation Right is the right to receive a cash payment equal to the excess, if any, of:

(a) the Market Price of a Share on the date such Stock Appreciation Right is exercised over;

(b) the Option price,

multiplied by the number of Shares in respect of which the Stock Appreciation Right is being exercised, less any amount required to be withheld by applicable law (the "SAR Amount").


15

8.3 Terms of Stock Appreciation Rights Granted in Connection with an Option. Stock Appreciation Rights granted in relation to an Option Shall be exercisable only at the same time, by the same persons and to the same extent, that the related Option is exercisable. Upon the exercise of any Stock Appreciation Right related to an Option the corresponding portion of the related Option shall be surrendered to the Corporation and cancelled and upon the exercise of any Option which has an accompanying Stock Appreciation Right, the corresponding portion of the related Stock Appreciation Right shall be surrendered to the Corporation and cancelled. In the sole discretion of the Corporation, the Corporation may elect to satisfy the exercise of a Stock Appreciation Right by issuing to the Participant Shares which have a Market Price as at the date of exercise of the Stock Appreciation Right, equal to the SAR Amount. The Corporation, in its sole discretion, may elect in respect of any payment made upon the exercise of a Stock Appreciation Right related to an Option, that neither the Corporation nor any of its Affiliates will deduct any amount in respect of any such payment in computing its taxes under the Tax Act. Any decision to make such election in connection with any particular payment shall not bind the Corporation to make an election in connection with any other payment made in respect of the exercise of a Stock Appreciation Right.

8.4 Terms of Stock Appreciation Rights Granted on a Stand Alone Basis. Stock Appreciation Rights granted on a stand alone basis shall be granted on such terms as shall be determined by the Board and set out in the award agreement (including any terms pertaining to vesting and settlement), provided that the Option Price shall not be less than the closing price of a Share on the Exchange immediately preceding the day on which the Board grants and provides notice to the Exchange of the Options(s), less the discount to the closing price permitted by the Exchange.

ARTICLE 9
SHARE PURCHASE PROGRAM

9.1 Grant of Options and/or Stock Appreciation Rights for Shares Purchased. The Board may institute a share purchase program (the "Share Purchase Program") for SPP Eligible Persons pursuant to which the Board may grant to each SPP Eligible Person one Option and/or one Stock Appreciation Right for each Share purchased by the SPP Eligible Person up to a maximum number of Options and/or Stock Appreciation Rights for any one SPP Eligible Person as may be determined from time to time by the Board.

9.2 Terms of Grants Pursuant to Share Purchase Program. Options and Stock Appreciation Rights granted pursuant to the Share Purchase Program shall be granted on such terms as shall be determined by the Board and set out in the award agreement but shall otherwise be subject to the provisions of the Plan.

ARTICLE 10
RESTRICTED SHARE UNITS

10.1 Grants of Restricted Share Units. The Board may Grant rights ("Restricted Share Units") to Eligible Persons. The Board shall designate the number of Restricted Share Units granted.


16

10.2 Restricted Share Units. A Restricted Share Unit is the right, subject to the level of achievement of Exercise Criteria or vesting or other criteria determined by the Board at the date of the Grant, to receive one Share issued from treasury for each Restricted Share Unit redeemed or a payment in cash determined in accordance with Section 10.5.

10.3 Terms of Restricted Share Units. Restricted Share Units shall be granted on such terms as shall be determined by the Board and set out in the award agreement. Without limiting the generality of the foregoing, subject to the provisions of the Plan, the Board shall, in its sole discretion and from time to time, determine the Eligible Persons to whom Grants will be made based on its assessment, for each Participant, of the current and potential contribution of such Eligible Person to the success of the Corporation. At such time, the Board shall also determine, in connection with each Grant, the Effective Date thereof, the number of Restricted Share Units to be allocated, the Grant Period applicable thereto and any applicable vesting terms for such Grant, the Exercise Criteria, if any, and such other terms and conditions which the Board considers appropriate to the Grant in question (including any dividend equivalent entitlements), and which terms and conditions need not be identical as between any two Grants, whether or not contemporaneous.

10.4 Redemption of Restricted Share Units. Subject to the provisions of the Plan and award agreement, a Restricted Share Unit shall be redeemed and paid (or Shares issued) on the first Release Date following the satisfaction of the Exercise Criteria in respect of such Restricted Share Unit.

10.5 Redemption in Cash. Any award agreement may provide that a Participant, or that Participant's estate, if applicable, may elect to have some or all of its Restricted Share Units described in such award agreement settled by the payment of cash. Where the Participant is an Employee, the settlement date shall be prior to the third anniversary date of the grant of the Restricted Share Unit. If the award agreement in question does not provide such election right to the Participant thereunder and also does not specify that there will be no election to settle Restricted Share Units by the payment of cash, then the Corporation will have the option to settle some or all of such Restricted Share Units by the payment of cash. Where a Participant is to receive cash in settlement of Restricted Share Units, then that Participant shall receive a cash payment equal to the number of Restricted Share Units being settled, multiplied by the Market Price on the Release Date applicable to such Restricted Share Units.

ARTICLE 11
DEFERRED SHARE UNITS

11.1 Grants of Deferred Share Units. The Board may grant rights ("Deferred Share Units") to Eligible Persons who are Employees. The Board shall designate the number of Deferred Share Units granted.

11.2 Deferred Share Units. A Deferred Share Unit is the right to receive a cash payment equal to the Market Price of a Share on the Termination Date, less any amount required to be withheld by applicable law or, if applicable, one fully paid and non-assessable Share issued from treasury.


17

11.3 Terms of Deferred Share Units. Deferred Share Units shall be granted on such terms as shall be determined by the Board and set out in the award agreement. Without limiting the generality of the foregoing, subject to the provisions of the Plan, the Board shall, in its sole discretion and from time to time, determine the Eligible Persons to whom grants will be made based on its assessment, for each Participant, of the anticipated contribution of such Eligible Person to the success of the Corporation. At such time, the Board shall also determine, in connection with each grant, the effective date thereof, the number of Deferred Share Units to be allocated, and such other terms and conditions which the Board considers appropriate to the grant in question, and which terms and conditions need not be identical as between any two grants, whether or not contemporaneous.

11.4 Redemption of Deferred Share Units. Subject to the provisions of the Plan and award agreement, a Deferred Share Unit held by a Participant shall be redeemed by the Corporation on the Payout Date, unless otherwise agreed to between the Corporation and a Participant.

11.5 Deferred Share Units May be Payable in Cash or Shares. Any award agreement may provide that a Participant, or that Participant's estate, if applicable, may elect to have some or all of its Deferred Share Units described in such award agreement settled by the issuance of Shares. If the award agreement in question does not provide such election right to the Participant thereunder and also does not specify that there will be no election to settle Deferred Share Units by the issuance of Shares, then such Deferred Share Units shall only be settled by the payment of cash. For greater certainty, unless expressly provided in the award agreement, the granting of a Deferred Share Unit does not entitle the holder thereof to acquire or otherwise obtain any rights or interests whatsoever in any Shares (including the right to dividends) or other securities of the Corporation. Participants have no right or ability to exercise, receive or otherwise demand payment of the value of the Deferred Share Units granted to them prior to the Payout Date.

ARTICLE 12
OTHER AWARDS

12.1 Grants of Other Awards. The Board may grant other share-based awards ("Other Awards") to Eligible Persons. Other Awards shall be granted on such terms as shall be determined by the Board and set out in the award agreement and will be subject to the approval of the Exchange.

12.2 Maximum Awards. Notwithstanding any other provision of this Plan, the maximum number of Awards granted to Eligible Persons pursuant to Articles 8 to 12 inclusive, together with any and all outstanding Options, shall not exceed ten percent (10%) of the issued and outstanding Shares (on a non-diluted basis)

ARTICLE 13
AMENDMENT PROCEDURE

13.1 Amendment Procedure. The Corporation retains the right to amend or terminate the terms and conditions of the Plan by resolution of the Board. If required, any amendments shall be subject to the prior consent of any applicable regulatory bodies, including the Exchange. Any amendment to the Plan shall take effect with respect to all outstanding Awards on the date of, and all Awards granted after, the effective date of such amendment, provided that in the event any amendment materially and adversely effects any outstanding Options it may apply to such outstanding Awards only with the mutual consent of the Corporation and the Participant to whom such Awards have been granted. The Board shall have the power and authority to approve amendments relating to the Plan or to Awards, without further approval of the shareholders of the Corporation, including the following non-exhaustive list of such amendments:


18

(a) altering, extending or accelerating the terms and conditions of vesting of any Awards;

(b) amending the termination provisions of an Award, which amendment shall include determining that any provisions of Article 5 concerning the effect of the Participant ceasing to be an Eligible Person shall not apply for any reason acceptable to the Board;

(c) accelerating the expiry of the Fixed Term of an Option;

(d) determining adjustments pursuant to Article 6 hereof;

(e) amending the definitions contained within the Plan, including, but not limited to the definition of "Eligible Person" under the Plan except as provided in Section 13.2(e);

(f) amending or modifying the mechanics of exercise or redemption of the Awards as set forth in the Plan;

(g) effecting amendments of a "housekeeping" nature including, without limited the generality of the foregoing, any amendment for the purpose of curing any ambiguity, error, inconsistency or omission in or from the Plan;

(h) effecting amendments necessary to comply with the provisions of applicable laws (including, without limitation, the rules, regulations and policies of the Exchange);

(i) effecting amendments respecting the administration of the Plan; and

(j) effecting amendments necessary to suspend or terminate the Plan.

13.2 Shareholder Approval. Notwithstanding the foregoing, approval of the shareholders of the Corporation shall be required for the following types of amendments:

(a) increasing the number of Shares issuable under the Plan, except such increase by operation of Section 4.1 and in the event of an adjustment contemplated by Article 6;

(b) amending the Plan which amendment could result in the aggregate number of Shares of the Corporation issued to Insiders within any one (1) year period under the Plan together with any other security-based compensation arrangement, or issuable to Insiders at any time under the Plan together with any other security-based compensation arrangement, exceeding ten percent (10%) of the issued and outstanding Shares;


19

(c) extending the Fixed Term of an Option;

(d) reducing the Option Price of an Option or cancelling an Option and replacing such Option with a lower Option Price under such replacement Option, except as permitted pursuant to Article 6;

(e) amending the listed categories contained in the definition of "Eligible Persons" hereunder which would have the potential of broadening or increasing participation in the Plan by Insiders;

(f) extending the term (fixed or otherwise) of an Option held by an Insider beyond the expiry of the original Fixed Term of the Option;

(g) amending Section 13.1 hereof and this Section 13.2; and

(h) making any amendments required to be approved by shareholders under applicable law (including, without limitation, pursuant to the rules, regulations and policies of the Exchange).

Where required by the policies of the Exchange, the shareholder approval required by this Section 13.2 shall be by the majority vote of the shareholders of the Corporation excluding any votes cast by Insiders who are entitled to participate as Eligible Persons under the Plan or who will specifically benefit from the proposed amendment.

13.3 Conflict. In the event of any conflict between Section 13.1 and Section 13.2, the latter shall prevail to the extent of the conflict.

ARTICLE 14
GENERAL

14.1 No Rights as Shareholder. The holder of an Award shall not have any rights as a shareholder of the Corporation with respect to any Shares covered by such Award until such holder shall have exercised or redeemed such Award and been issued Shares in accordance with the terms of the Plan (including tender of payment in full of the Option Price of the Shares in respect of which an Option is being exercised, together with any required withholdings) and the Corporation shall issue such Shares to the Participant in accordance with the terms of the Plan in those circumstances.

14.2 No Rights Conferred.

(a) Nothing contained in this Plan or any Award shall confer upon any Participant any right with respect to continuance as a Director, Officer, Employee, or Consultant or Management Company Employee of the Corporation or its Affiliates, or interfere in any way with the right of the Corporation of its Affiliates to terminate the Participant's employment at any time.


20

(b) Nothing contained in this Plan or any Award shall confer on any Participant who is not a Director, Officer, Employee, or Consultant or Management Company Employee any right to continue providing ongoing services to the Corporation or its Affiliates or affect in any way the right of the Corporation of its Affiliates to determine to terminate his, her or its contract at any time.

14.3 Tax Consequences. It is the responsibility of the Participant to complete and file any tax returns which may be required under any applicable tax laws within the period specified in those laws as a result of the Participant's participation in the Plan. The Corporation shall not be responsible for any tax consequences to the Participant as a result of the Participant's participation in the Plan. The Participant shall remain responsible at all times for paying any federal, provincial, local and foreign income or employment tax due with respect to any Award, and the Corporation shall not be liable for any interest or penalty that a Participant incurs by failing to make timely payments of tax.

14.4 Withholding Requirements. Prior to the delivery of any Shares or cash pursuant to the grant, exercise, vesting, or settlement of an Award, the Corporation shall have the power and the right to deduct or withhold, or to require a Participant to remit to the Corporation, an amount sufficient to satisfy any federal, provincial, local and foreign taxes that the Corporation determines is required to be withheld to comply with applicable laws. The Corporation shall make any withholdings or deductions in respect of taxes as required by law or the interpretation or administration thereof. The Corporation shall be entitled to make arrangements to sell a sufficient number of Shares to be issued pursuant to the exercise of an Award to fund the payment and remittance of such taxes that are required to be deducted or withheld and any associated costs (including brokerage fees).

14.5 No Representation. The Corporation makes no representation or warranty as to the future market value of any Shares issued in accordance with the provisions of the Plan.

14.6 Black-out Policy Restrictions. Awards shall be subject to the Corporation's insider trading policy as may be in effect from time to time, including any Black-out Period, trading prohibition or requirement to obtain mandatory pre-clearance of a transaction.

14.7 Governing Law. This Plan shall be governed by and construed in accordance with the laws of the Province of Ontario and the laws of Canada applicable therein.

14.8 Severance. If any provision of this Plan or any agreement entered into pursuant to this Plan contravenes any law or any order, policy, by-law or regulation of any regulatory body or Exchange having authority over the Corporation of this Plan then such provision shall be deemed to be amended to the extent required to bring such provision into compliance therewith.


EX-12.1 3 exhibit12-1.htm EXHIBIT 12.1 Plymouth Rock Technologies Inc.: Exhibit 12.1 - Filed by newsfilecorp.com

Exhibit 12.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Carl Cagliarini, certify that:

1. I have reviewed this annual report on Form 20-F of Plymouth Rock Technologies Inc. for the year ended November 30, 2022;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


Date:      May 10, 2023                  

 

"Carl Cagliarini"  
Carl Cagliarini
Interim Chief Executive Officer and Director
(Principal Executive Officer)
Plymouth Rock Technologies Inc.
 


EX-12.2 4 exhibit12-2.htm EXHIBIT 12.2 Plymouth Rock Technologies Inc.: Exhibit 12.2 - Filed by newsfilecorp.com

Exhibit 12.2

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Susan J. Gardner, certify that:

1. I have reviewed this annual report on Form 20-F of Plymouth Rock Technologies Inc. for the year ended November 30, 2022;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


Date:      May 10, 2023                  

 

"Susan J. Gardner"  
Susan J. Gardner
Chief Financial Officer
(Principal Financial Officer and Principal Accounting Officer)
Plymouth Rock Technologies Inc.
 


EX-13.1 5 exhibit13-1.htm EXHIBIT 13.1 Plymouth Rock Technologies Inc.: Exhibit 13.1 - Filed by newsfilecorp.com

Exhibit 13.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Carl Cagliarini, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) the Annual Report on Form 20-F of Plymouth Rock Technologies Inc. for the year ended November 30, 2022 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Plymouth Rock Technologies Inc.

Dated:      May 10, 2023  
   
   
  "Carl Cagliarini"
  Carl Cagliarini
Interim Chief Executive Officer and Director
(Principal Executive Officer)
Plymouth Rock Technologies Inc.

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Plymouth Rock Technologies Inc. and will be retained by Plymouth Rock Technologies Inc. and furnished to the Securities and Exchange Commission or its staff upon request.


EX-13.2 6 exhibit13-2.htm EXHIBIT 13.2 Plymouth Rock Technologies Inc.: Exhibit 13.2 - Filed by newsfilecorp.com

Exhibit 13.2

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Susan J. Gardner, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) the Annual Report on Form 20-F of Plymouth Rock Technologies Inc. for the year ended November 30, 2022 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Plymouth Rock Technologies Inc.

Dated:  May 10, 2023       .    
 
   
   
  "Susan J. Gardner"
  Susan J. Gardner
Chief Financial Officer
(Principal Financial Officer and Principal Accounting Officer)
Plymouth Rock Technologies Inc.

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Plymouth Rock Technologies Inc. and will be retained by Plymouth Rock Technologies Inc. and furnished to the Securities and Exchange Commission or its staff upon request.


EX-15.1 7 exhibit15-1.htm EXHIBIT 15.1 Plymouth Rock Technologies Inc.: Exhibit 15.1 - Filed by newsfilecorp.com


May 8, 2023


Securities and Exchange Commission

Washington, DC 20549 - 0405

U.S.A.

We are the former independent auditors for Plymouth Rock Technologies Inc. (the "Company") and, under the date of May 2, 2022, we reported on the financial statements of the Company as of and for the year ended November 30, 2021. The Company provided us with a copy of the disclosures in its Current Report on Form 20-F and for the year ended November 30, 2022 (the "Form 20-F") and requested that we furnish the Company with a letter addressed to the Securities and Exchange Commission stating whether or not we agree with the statements in Item 16F of the Form 20-F, and if not, stating the respects with which we do not agree.

We have read the Company's disclosure regarding "Change in Registrant's Certifying Accountant" as included in Item 16F of the Form 20-F and are in agreement with the disclosure in that section, insofar as it pertains to our firm.

Yours very truly,

MANNING ELLIOTT LLP


EX-15.2 8 exhibit15-2.htm EXHIBIT 15.2 Plymouth Rock Technologies Inc.: Exhibit 15.2 - Filed by newsfilecorp.com


May 9, 2023

Securities and Exchange Commission

Washington, DC 20549 - 0405

U.S.A.

We are the independent auditors for Plymouth Rock Technologies Inc. (the "Company"). The Company provided us with a copy of the disclosures in its Annual Report on Form 20-F and for the year ended November 30, 2022 (the "Form 20-F") and requested that we furnish the Company with a letter addressed to the Securities and Exchange Commission stating whether or not we agree with the statements in Item 16F of the Form 20-F, and if not, stating the respects with which we do not agree.

We have read the Company's disclosure regarding "Change in Registrant's Certifying Accountant" as included in Item 16F of the Form 20-F and are in agreement with the disclosure in that section, insofar as it pertains to our firm.

Yours very truly,

/s/ Reliant CPA PC

Reliant CPA PC

Certified Public Accountants


EX-101.SCH 9 prt-20221130.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink 0002 - Statement - Consolidated Statements of Financial Position link:presentationLink link:definitionLink link:calculationLink 0003 - Statement - Consolidated Statements of Loss and Comprehensive Loss link:presentationLink link:definitionLink link:calculationLink 0004 - Statement - Consolidated Statements of Changes in Shareholders' Equity (Deficit) link:presentationLink link:definitionLink link:calculationLink 0005 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 0006 - Disclosure - NATURE OF OPERATIONS AND ABILITY TO CONTINUE AS A GOING CONCERN link:presentationLink link:definitionLink link:calculationLink 0007 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:definitionLink link:calculationLink 0008 - Disclosure - ACQUISITION link:presentationLink link:definitionLink link:calculationLink 0009 - Disclosure - PREPAID EXPENSES link:presentationLink link:definitionLink link:calculationLink 0010 - Disclosure - EQUIPMENT link:presentationLink link:definitionLink link:calculationLink 0011 - Disclosure - INTANGIBLE ASSETS link:presentationLink link:definitionLink link:calculationLink 0012 - Disclosure - ACCOUNTS PAYABLE link:presentationLink link:definitionLink link:calculationLink 0013 - Disclosure - Deferred Revenue link:presentationLink link:definitionLink link:calculationLink 0014 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES link:presentationLink link:definitionLink link:calculationLink 0015 - Disclosure - GOVERMENT ASSISTANCE RECEIVED link:presentationLink link:definitionLink link:calculationLink 0016 - Disclosure - LOAN PAYABLE link:presentationLink link:definitionLink link:calculationLink 0017 - Disclosure - CAPITAL MANAGEMENT link:presentationLink link:definitionLink link:calculationLink 0018 - Disclosure - SHARE CAPITAL link:presentationLink link:definitionLink link:calculationLink 0019 - Disclosure - FINANCIAL RISK MANAGEMENT link:presentationLink link:definitionLink link:calculationLink 0020 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION link:presentationLink link:definitionLink link:calculationLink 0021 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:definitionLink link:calculationLink 0022 - Disclosure - RIGHT-OF-USE ASSETS AND LEASE LIABILITY link:presentationLink link:definitionLink link:calculationLink 0023 - Disclosure - BREAKDOWN OF EXPENSES link:presentationLink link:definitionLink link:calculationLink 0024 - Disclosure - GAIN ON DEBT FORGIVENESS link:presentationLink link:definitionLink link:calculationLink 0025 - Disclosure - SEGMENTED INFORMATION link:presentationLink link:definitionLink link:calculationLink 0026 - Disclosure - INCOME TAXES link:presentationLink link:definitionLink link:calculationLink 0027 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:definitionLink link:calculationLink 0028 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:definitionLink link:calculationLink 0029 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:definitionLink link:calculationLink 0030 - Disclosure - ACQUISITION (Tables) link:presentationLink link:definitionLink link:calculationLink 0031 - Disclosure - PREPAID EXPENSES (Tables) link:presentationLink link:definitionLink link:calculationLink 0032 - Disclosure - EQUIPMENT (Tables) link:presentationLink link:definitionLink link:calculationLink 0033 - Disclosure - INTANGIBLE ASSETS (Tables) link:presentationLink link:definitionLink link:calculationLink 0034 - Disclosure - ACCOUNTS PAYABLE (Tables) link:presentationLink link:definitionLink link:calculationLink 0035 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES (Tables) link:presentationLink link:definitionLink link:calculationLink 0036 - Disclosure - LOAN PAYABLE (Tables) link:presentationLink link:definitionLink link:calculationLink 0037 - Disclosure - SHARE CAPITAL (Tables) link:presentationLink link:definitionLink link:calculationLink 0038 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Tables) link:presentationLink link:definitionLink link:calculationLink 0039 - Disclosure - RIGHT-OF-USE ASSETS AND LEASE LIABILITY (Tables) link:presentationLink link:definitionLink link:calculationLink 0040 - Disclosure - BREAKDOWN OF EXPENSES (Tables) link:presentationLink link:definitionLink link:calculationLink 0041 - Disclosure - SEGMENTED INFORMATION (Tables) link:presentationLink link:definitionLink link:calculationLink 0042 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:definitionLink link:calculationLink 0043 - Disclosure - NATURE OF OPERATIONS AND ABILITY TO CONTINUE AS A GOING CONCERN (Narrative) (Details) link:presentationLink link:definitionLink link:calculationLink 0044 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Disclosure of subsidiaries (Details) link:presentationLink link:definitionLink link:calculationLink 0045 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Disclosure of depreciation rates applicable to each category of property and equipment (Detail) link:presentationLink link:definitionLink link:calculationLink 0046 - Disclosure - ACQUISITION (Narrative) (Details) link:presentationLink link:definitionLink link:calculationLink 0047 - Disclosure - ACQUISITION - Disclosure of detailed information about purchase price allocation (Details) link:presentationLink link:definitionLink link:calculationLink 0048 - Disclosure - PREPAID EXPENSES (Narrative) (Details) link:presentationLink link:definitionLink link:calculationLink 0049 - Disclosure - PREPAID EXPENSES - Disclosure of prepaid expenses (Details) link:presentationLink link:definitionLink link:calculationLink 0050 - Disclosure - EQUIPMENT - Disclosure of property, plant and equipment (Details) link:presentationLink link:definitionLink link:calculationLink 0051 - Disclosure - INTANGIBLE ASSETS (Narrative) (Details) link:presentationLink link:definitionLink link:calculationLink 0052 - Disclosure - INTANGIBLE ASSETS - Disclosure of detailed information about Intangible assets (Details) link:presentationLink link:definitionLink link:calculationLink 0053 - Disclosure - ACCOUNTS PAYABLE (Narrative) (Details) link:presentationLink link:definitionLink link:calculationLink 0054 - Disclosure - ACCOUNTS PAYABLE - Disclosure of accounts payable (Details) link:presentationLink link:definitionLink link:calculationLink 0055 - Disclosure - Deferred Revenue (Narrative) (Details) link:presentationLink link:definitionLink link:calculationLink 0056 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES (Narrative) (Details) link:presentationLink link:definitionLink link:calculationLink 0057 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES - Disclosure of amounts due to directors and officers (Details) link:presentationLink link:definitionLink link:calculationLink 0058 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES - Disclosure of transactions between related parties (Details) link:presentationLink link:definitionLink link:calculationLink 0059 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES - Disclosure of information about key management personnel (Details) link:presentationLink link:definitionLink link:calculationLink 0060 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES - Disclosure of consulting fees (Details) link:presentationLink link:definitionLink link:calculationLink 0061 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES - Disclosure of information about options granted to the CEO, CFO, the Corporate Secretary, and the Company's directors (Details) link:presentationLink link:definitionLink link:calculationLink 0062 - Disclosure - GOVERMENT ASSISTANCE RECEIVED (Narrative) (Details) link:presentationLink link:definitionLink link:calculationLink 0063 - Disclosure - LOAN PAYABLE (Narrative) (Details) link:presentationLink link:definitionLink link:calculationLink 0064 - Disclosure - SHARE CAPITAL (Narrative) (Details) link:presentationLink link:definitionLink link:calculationLink 0065 - Disclosure - SHARE CAPITAL - Disclosure of number and weighted average exercise prices of share options (Details) link:presentationLink link:definitionLink link:calculationLink 0066 - Disclosure - SHARE CAPITAL - Disclosure of number and weighted average remaining contractual life of outstanding share options (Details) link:presentationLink link:definitionLink link:calculationLink 0067 - Disclosure - SHARE CAPITAL - Disclosure of share purchase warrant transactions (Details) link:presentationLink link:definitionLink link:calculationLink 0068 - Disclosure - SHARE CAPITAL - Disclosure of number of share purchase warrants outstanding (Details) link:presentationLink link:definitionLink link:calculationLink 0069 - Disclosure - FINANCIAL RISK MANAGEMENT (Narrative) (Details) link:presentationLink link:definitionLink link:calculationLink 0070 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION - Disclosure of supplemental cash flow information (Details) link:presentationLink link:definitionLink link:calculationLink 0071 - Disclosure - COMMITMENTS AND CONTINGENCIES (Narrative) (Details) link:presentationLink link:definitionLink link:calculationLink 0072 - Disclosure - RIGHT-OF-USE ASSETS AND LEASE LIABILITY (Narrative) (Details) link:presentationLink link:definitionLink link:calculationLink 0073 - Disclosure - RIGHT-OF-USE ASSETS AND LEASE LIABILITY - Disclosure of continuity of the cost and accumulated amortization of right-of-use assets (Details) link:presentationLink link:definitionLink link:calculationLink 0074 - Disclosure - RIGHT-OF-USE ASSETS AND LEASE LIABILITY - Disclosure of continuity of lease liability (Details) link:presentationLink link:definitionLink link:calculationLink 0075 - Disclosure - RIGHT-OF-USE ASSETS AND LEASE LIABILITY - Disclosure of minimum lease payments for the lease liabilities (Details) link:presentationLink link:definitionLink link:calculationLink 0076 - Disclosure - BREAKDOWN OF EXPENSES (Narrative) (Details) link:presentationLink link:definitionLink link:calculationLink 0077 - Disclosure - BREAKDOWN OF EXPENSES - Disclosure of breakdown of expenses (Details) link:presentationLink link:definitionLink link:calculationLink 0078 - Disclosure - GAIN ON DEBT FORGIVENESS (Narrative) (Details) link:presentationLink link:definitionLink link:calculationLink 0079 - Disclosure - SEGMENTED INFORMATION - Disclosure of revenue by geographical location (Details) link:presentationLink link:definitionLink link:calculationLink 0080 - Disclosure - INCOME TAXES (Narrative) (Details) link:presentationLink link:definitionLink link:calculationLink 0081 - Disclosure - INCOME TAXES - Disclosure of detailed information about effective income tax expense (recovery) (Details) link:presentationLink link:definitionLink link:calculationLink 0082 - Disclosure - INCOME TAXES - Disclosure of temporary difference, unused tax losses and unused tax credits (Details) link:presentationLink link:definitionLink link:calculationLink 0083 - Disclosure - INCOME TAXES - Disclosure of non-capital loss carryforwards (Details) link:presentationLink link:definitionLink link:calculationLink 0084 - Disclosure - SUBSEQUENT EVENTS (Narrative) (Details) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 10 prt-20221130_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 11 prt-20221130_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 12 prt-20221130_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT EX-101.PRE 13 prt-20221130_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 14 exhibit15-1xu001.jpg GRAPHIC begin 644 exhibit15-1xu001.jpg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exhibit15-1xu002.jpg GRAPHIC begin 644 exhibit15-1xu002.jpg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end GRAPHIC 16 exhibit15-2xu001.jpg GRAPHIC begin 644 exhibit15-2xu001.jpg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form20fxz001.jpg GRAPHIC begin 644 form20fxz001.jpg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end GRAPHIC 18 form20fxz002.jpg GRAPHIC begin 644 form20fxz002.jpg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end GRAPHIC 19 form20fxz003.jpg GRAPHIC begin 644 form20fxz003.jpg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end XML 20 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Document And Entity Information
12 Months Ended
Nov. 30, 2022
shares
Entity Addresses [Line Items]  
Entity Registrant Name PLYMOUTH ROCK TECHNOLOGIES INC.
Entity Central Index Key 0001639142
Document Type 20-F
Document Period End Date Nov. 30, 2022
Current Fiscal Year End Date --11-30
Document Fiscal Period Focus FY
Document Fiscal Year Focus 2022
Amendment Flag false
Document Registration Statement false
Document Annual Report true
Document Transition Report false
Entity Common Stock Shares Outstanding 59,317,461
Entity Incorporation, State or Country Code Z4
Entity Address, Address Line One Suite 700 - 1199 West Hastings Street
Entity Address, City or Town Vancouver
Entity Address, Country CA
Entity Address, State or Province BC
Entity Address, Postal Zip Code V6E 3T5
Entity Well Known Seasoned Issuer No
Entity Current Reporting Status No
Entity Interactive Data Current No
Entity Filer Category Non-accelerated Filer
Entity Voluntary Filers No
Entity Emerging Growth Company true
Entity Ex Transition Period false
Entity Shell Company false
Document Accounting Standard International Financial Reporting Standards
Title of 12(b) Security Common Stock
Auditor Name Reliant CPA PC
Auditor Location Newport Beach, California
Auditor Firm ID 6906
Business Contact [Member]  
Entity Addresses [Line Items]  
Contact Personnel Name Philip Lancaster
Entity Address, Address Line One Suite 700 - 1199 West Hastings Street
Entity Address, City or Town Vancouver
Entity Address, Country CA
Entity Address, State or Province BC
Entity Address, Postal Zip Code V6E 3T5
Local Phone Number 863-3038
City Area Code 250

XML 21 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Financial Position - CAD ($)
Nov. 30, 2022
Nov. 30, 2021
Current assets    
Cash $ 13,127 $ 375,046
Accounts receivable 6,870 11,848
Sales tax receivable 9,083 56,237
Inventories 2,175 11,086
Prepaid expenses 30,947 178,321
Total current assets 62,202 632,538
Non-current assets    
Equipment 24,801 294,188
Right of use asset 61,198 72,734
Intangible assets 0 549,679
Total assets 148,201 1,549,139
Current liabilities    
Accounts payable 1,063,863 608,385
Deferred revenue 124,918 0
Lease liabilities 66,403 39,221
Current portion of loans payable 127,019 6,332
Due to related parties 705,672 52,728
Total current liabilities 2,087,875 706,666
Non-current liabilities    
Lease liabilities 9,394 47,125
Loan payable 0 22,545
Total liabilities 2,097,269 776,336
SHAREHOLDERS' EQUITY (DEFICIT)    
Share capital 11,851,771 11,834,582
Contributed surplus 2,709,790 2,709,790
Accumulated other comprehensive income 25,131 96,393
Deficit (16,535,760) (13,867,962)
Total shareholders' equity (deficit) (1,949,068) 772,803
Total liabilities and shareholders' equity (deficit) $ 148,201 $ 1,549,139
XML 22 R3.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Loss and Comprehensive Loss - CAD ($)
12 Months Ended
Nov. 30, 2022
Nov. 30, 2021
Nov. 30, 2020
Income Statement      
Sales $ 607,359 $ 184,396 $ 70,931
Cost of sales 191,175 103,109 31,316
Gross profit 416,184 81,287 39,615
OPERATING EXPENSES      
General and administrative 2,345,980 3,320,081 1,596,658
Selling 177,428 709,010 1,081,478
Research and development 233,265 985,006 386,044
Total expenses 2,756,673 5,014,097 3,064,180
OTHER INCOME (EXPENSES)      
Gain on debt forgiveness 234,303 0 0
Impairment loss of intangible asset (330,650) 0 0
Impairment loss of demo equipment (236,677) 0 0
Interest income 0 0 193
Interest expense 0 0 (165)
Paycheck protection program 0 0 100,818
Other Income 5,042 0 0
Foreign exchange loss 673 (42,024) (517)
NET LOSS BEFORE INCOME TAX (2,667,798) (4,974,834) (2,924,236)
NET LOSS (2,667,798) (4,974,834) (2,924,236)
OTHER COMPREHENSIVE INCOME      
Foreign currency translation gain (loss) (71,262) 30,603 19,546
TOTAL COMPREHENSIVE LOSS $ (2,739,060) $ (4,944,231) $ (2,904,690)
LOSS PER SHARE, basic and diluted $ (0.05) $ (0.09) $ (0.08)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING, basic and diluted 59,310,826 53,075,143 37,525,451
XML 23 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Changes in Shareholders' Equity (Deficit) - CAD ($)
Share capital [Member]
Shares to be issued [Member]
Subscriptions received [Member]
Contributed Surplus [Member]
Deficit [Member]
Accumulated other comprehensive losses [Member]
Total
Beginning Balance at Nov. 30, 2019 $ 5,676,498 $ 22,811 $ 0 $ 736,271 $ (5,968,892) $ 46,244 $ 512,932
Beginning Balance (Shares) at Nov. 30, 2019 32,796,600            
Statements Line Items              
Net loss for the year         (2,924,236)   (2,924,236)
Shares issued for warrants exercised $ 246,667           246,667
Shares issued for warrants exercised (Shares) 1,233,334            
Private placements $ 1,367,325 $ (22,811)   83,109     1,427,623
Private placements (Shares) 8,232,330            
Share issuance costs $ (38,727)           (38,727)
Shares issued as compensation $ 125,000           125,000
Shares issued as compensation (Shares) 500,000            
Stock-based compensation       479,107     479,107
Foreign currency translation gain (loss)           19,546 19,546
Ending Balance at Nov. 30, 2020 $ 7,376,763   0 1,298,487 (8,893,128) 65,790 (152,088)
Ending Balance (Shares) at Nov. 30, 2020 42,762,264            
Statements Line Items              
Net loss for the year         (4,974,834)   (4,974,834)
Shares issued for warrants exercised $ 1,332,727           1,332,727
Shares issued for warrants exercised (Shares) 6,129,572            
Fair value of warrants exercised $ 36,859     (36,859)      
Shares issued for options exercised $ 222,500           222,500
Shares issued for options exercised (Shares) 425,000            
Private placements $ 2,749,000     287,499     3,036,499
Private placements (Shares) 8,930,000            
Fair value of options exercised $ 158,106     (158,106)      
Fair value of broker warrants granted (174,427)     174,427      
Shares issued to finders $ (100,500)           (100,500)
Shares issued to finders (Shares) 336,250            
Cash paid to finders $ (74,180)           (74,180)
Shares issued as compensation $ 307,734           307,734
Shares issued as compensation (Shares) 656,250            
Stock-based compensation       1,144,342     1,144,342
Foreign currency translation gain (loss)           30,603 30,603
Ending Balance at Nov. 30, 2021 $ 11,834,582   0 2,709,790 (13,867,962) 96,393 772,803
Ending Balance (Shares) at Nov. 30, 2021 59,239,336            
Statements Line Items              
Net loss for the year         (2,667,798)   (2,667,798)
Foreign currency translation gain (loss)           (71,262) (71,262)
Shares issued from services $ 17,189           17,189
Shares issued from services (Shares) 78,125            
Ending Balance at Nov. 30, 2022 $ 11,851,771   $ 0 $ 2,709,790 $ (16,535,760) $ 25,131 $ (1,949,068)
Ending Balance (Shares) at Nov. 30, 2022 59,317,461            
XML 24 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Cash Flows - CAD ($)
12 Months Ended
Nov. 30, 2022
Nov. 30, 2021
Nov. 30, 2020
Cash Provided By (Used In)      
Net loss for the period $ (2,667,798) $ (4,974,834) $ (2,924,236)
Items not affecting cash:      
Stock based compensation 0 1,144,342 479,107
Amortization expense 286,745 143,783 41,201
Foreign exchange (gain) loss (71,262) 0 0
Interest accretion 18,877 14,760 20,449
Impairment of development assets 0 0 3,576
Impairment of demo equipment 236,677 0 0
Gain on debt forgiveness (234,303) (0) 0
Impairment of intangible asset 330,650 0 0
Shares issued for services 17,189 307,734 125,000
Changes in non-cash working capital:      
Sales tax receivable 47,154 (51,583) 2,993
Accounts receivable 4,978 (9,062) (1,334)
Inventories 8,911 8,609 (19,695)
Prepaid expenses 147,374 (140,868) 77,590
Deferred revenue 124,918 0 0
Due from related parties 0 2,500 (22,570)
Due to related parties 652,944 (8,894) 36,320
Accounts payable and accrued liabilities 682,923 122,411 67,084
Net cash used in operating activities (414,023) (3,441,102) (2,114,515)
Investing Activities      
Purchase of equipment 0 (204,305) (57,518)
Development expenses on Intangible assets 0 0 (3,576)
Acquisition of business 0 (369,038) 0
Net cash provided by (used in) investing activities (0) (573,343) (61,094)
Financing Activities      
Common shares issued for cash, options and warrants exercised, net of share issuance costs 0 4,417,047 1,635,564
Lease payments (34,701) (48,175) (48,473)
Loan payable 105,000 (42,430) 0
Net cash provided by financing activities 70,299 4,326,442 1,587,091
Increase (decrease) in cash (343,724) 311,997 (588,518)
Effect of foreign exchange rate changes on cash (18,195) 38,336 30,112
Cash, beginning of the period 375,046 24,713 583,119
Cash, end of the period $ 13,127 $ 375,046 $ 24,713
XML 25 R6.htm IDEA: XBRL DOCUMENT v3.23.1
NATURE OF OPERATIONS AND ABILITY TO CONTINUE AS A GOING CONCERN
12 Months Ended
Nov. 30, 2022
Nature Of Operations And Ability To Continue As Going Concern Abstract  
NATURE OF OPERATIONS AND ABILITY TO CONTINUE AS A GOING CONCERN [Text Block]

1. NATURE OF OPERATIONS AND ABILITY TO CONTINUE AS A GOING CONCERN

Plymouth Rock Technologies Inc. (the "Company") was incorporated under the Business Corporations Act of British Columbia on October 17, 2011. The head office, principal address and registered and records office of the Company are located at 700 - 1199 West Hastings Street, Vancouver, B.C., V6E 3T5.

The Company's common shares are listed on the CSE and on Frankfurt Stock Exchange in Germany under the Symbol: 4XA, WKN# - A2N8RH. The Company's common shares are also on the OTC Markets Group ("OTCQB") under the symbol: PLRTF.

The Company's principal business activity through its subsidiary, Plymouth Rock USA ("PRT USA"), focused on developing technologies related to remotely detecting assault firearms and suicide bombs concealed on the person or a carry bag. The Company focuses on detection methods with and without the need for a checkpoint of the suspect who is being screened. The Company's planned products encompass the very latest radar, imaging, and Unmanned Aerial System ("UAS") technologies for quickly detecting, locating and identifying the presence of threats and for search and rescue missions for law enforcement.

On March 26, 2021, the Company incorporated a subsidiary in United Kingdom, Plymouth Rock Technologies UK Limited ("PRT UK"). The purpose of PRT UK is to augment the Company's existing research and development of its drone technologies for the US and EMEA markets.

On June 4, 2021, the Company completed its acquisition of Tetra Drones Limited ("Tetra") (Note 3). The acquisition of Tetra provides the Company with drones production line in the United Kingdom.

Going Concern

These consolidated financial statements are prepared on a going concern basis, which contemplates that the Company will continue in operation for the foreseeable future and will be able to realize its assets and discharge its liabilities in the normal course of business. At present, the Company's operations do not generate cash flows from operations. The Company has incurred losses since inception and has a comprehensive loss of $2,739,060 for the year ended November 30, 2022 (2021 - $4,944,231; 2020 - $2,904,690) and had an accumulated deficit of $16,535,760 (2021 - $13,867,962). The ability of the Company to continue as a going concern is dependent on achieving profitable operations, commercializing its technologies, and obtaining the necessary financing in order to develop these technologies further. The outcome of these matters cannot be predicted at this time. The Company will continue to review the prospects of raising additional debt and equity financing to support its operations until such time that its operations become self-sustaining, to fund its research and development activities and to ensure the realization of its assets and discharge of its liabilities. While the Company is expanding its best efforts to achieve the above plans, there is no assurance that any such activity will generate sufficient funds for future operations. These factors and uncertainty casts significant doubt about the Company's ability to continue as a going concern and therefore it may be unable to realize its assets and discharge its liabilities in the normal course of business.

The Company is not expected to be profitable during the ensuing 12 months, and therefore, must rely on securing additional funds from either issuance of debt or equity financing for cash consideration. During the year ended November 30, 2022, the Company received net cash proceeds of $70,299 (2021 - 4,326,442; 2020 - 1,587,091) pursuant to financing activities. Management has been successful in raising capital through periodic private placements of the Company's common shares in the past, however there is no certainty that financing will be available in the future, or certainty that management's planned actions to address this situation will be successful.

These consolidated financial statements have been prepared in accordance with International Financial Reporting Standards ("IFRS") with the assumption that the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future rather than a process of forced liquidation. These consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue in existence. Such adjustments could be material.

XML 26 R7.htm IDEA: XBRL DOCUMENT v3.23.1
SIGNIFICANT ACCOUNTING POLICIES
12 Months Ended
Nov. 30, 2022
Disclosure Of Significant Accounting Policies [Abstract]  
SIGNIFICANT ACCOUNTING POLICIES [Text Block]

2. SIGNIFICANT ACCOUNTING POLICIES

Basis of presentation

These consolidated financial statements ("Financial Statements") have been prepared in accordance with IFRS as issued by the International Accounting Standard Board ("IASB") and interpretations of the International Financial Reporting Interpretations Committee ("IFRIC").

These Financial Statements are authorized for issue by the Board of Directors on March 28, 2023.

These Financial Statements have been prepared on the historical cost basis. In addition, these Financial Statements have been prepared using the accrual basis of accounting.

These Financial Statements are presented in Canadian dollars, which is the Company's functional currency. The functional currency of PRT USA is U.S. Dollars and the functional currency of PRT UK and Tetra is British Pound Sterling ("£"). The assets and liabilities of PRT USA, PRT UK and Tetra are translated into Canadian dollars at the rate of exchange prevailing at the reporting date and their income and expense items are translated at average exchange rates for the period. Exchange differences arising on the translation are recognized in other comprehensive income.

Significant accounting judgments, estimates and assumptions

The preparation of these Financial Statements in conformity with IFRS requires management to make judgments and estimates and form assumptions that affect the reported amounts of assets and liabilities at the date of the Financial Statements and reported amounts of income and expenses during the period. Actual results could differ from these estimates.

Significant estimates used in preparing the Financial Statements include, but are not limited to the following:

a. Deferred taxes

The calculation of deferred tax is based on the ability of the Company to generate future taxable income, the estimation of which is subject to significant uncertainty as to the amount and timing. The calculation of deferred tax is also based on assumptions, which are subject to uncertainty as to timing and which tax rates are expected to apply when temporary differences reverse. Deferred tax recorded is also subject to uncertainty regarding the magnitude on non-capital losses available for carry forward and of the balances in various tax pools as the corporate tax returns have not been prepared as of the date of financial statement preparation.

b. Stock-based payments

The fair value of stock options and finders' warrants issued are subject to the limitations of the Black-Scholes option pricing model that incorporates market data and involves uncertainty in estimates used by management in the assumptions. Because the Black-Scholes option pricing model requires the input of highly subjective assumptions, including the expected lift, volatility of share prices, risk-free rate and dividend yield, changes in subjective input assumptions can materially affect the fair value estimate.

c. Impairment of non-financial assets

Impairment exists when the carrying value of an asset or cash generating unit ("CGU") exceeds its recoverable amount, which is the higher of its fair value less costs to sell and its value in use. The fair value less costs to sell calculation is based on available data from binding sales transactions in an arm's length transaction of similar assets or observable market prices less incremental costs for disposing of the asset. The value in use calculation is based on a discounted cash flow model.

d. Leases

Management uses estimation in determining the incremental borrowing rate used to measure the lease liability, specific to the asset, underlying currency and geographic location.

Significant judgments used in the preparation of these Financial Statements include, but are not limited to the following:

(i) Going concern

Management has applied judgements in the assessment of the Company's ability to continue as a going concern when preparing its Financial Statements for the year ended November 30, 2022. Management prepares the Financial Statements on a going concern basis unless management either intends to liquidate the entity or to cease trading or has no realistic alternative but to do so.

In assessing whether the going concern assumption is appropriate, management accounts for all available information about the future, which is at least, but is not limited to, twelve months from the end of the reporting period.

(ii) Business combinations

Determination of whether a set of assets acquired and liabilities assumed constitute the acquisition of a business or asset may require the Company to make certain judgments as to whether or not the assets acquired and liabilities assumed include the inputs, processes and outputs necessary to constitute a business as defined in IFRS 3 - Business Combinations. Based on an assessment of the relevant facts and circumstances, the Company concluded that the acquisition disclosed in Note 3 met the criteria for accounting as a business combination.

(iii) Intangible assets

Intangible assets can be capitalized only if development costs can be measured reliably, the product or process is technically and commercially feasible, future economic benefits are probable, and the Company intends to and has sufficient resources to complete development and to use or sell the asset. To determine if the future economic benefit is probable depends on the successful commercialization of its technologies and that in turn depends on the management's judgement and knowledge. As at November 30, 2022, the development costs are not capitalized as management was unable to demonstrate the future economic benefits to be generated from the utilization of the associated expenditures.

Cash

Cash consists of amounts held in banks and highly liquid investments with limited interest and credit risk.

Consolidation

The Financial Statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances, transactions and any unrealized gains and losses arising from intercompany transactions, have been eliminated. The Company's subsidiary is presented in the table below. Plymouth Rock USA was incorporated under the General Corporation Law of the State of Delaware on March 22, 2018. Plymouth Rock UK was incorporated under the General Corporation Law for England and Wales on March 26, 2021.Tetra Drones was incorporated under the General Corporation Law for England and Wales and was acquired by the Company on June 4, 2021.

Entity Country of Incorporation Effective Economic
Interest
     
Plymouth Rock Technologies Inc.
("Plymouth Rock USA")
USA 100%
     
Plymouth Rock Technologies Inc.
("PRT UK")
UK 100%
     
Tetra Drones Ltd. ("Tetra Drones") UK 100%

Intangible assets

Intangible assets that are reflected in the consolidated statements of financial position consist of assets acquired through business combinations. Intangible assets acquired in a business combination are recognized separately from goodwill and are initially recognized at their fair value at the acquisition date (which is regarded as their cost). An intangible asset is regarded as having an indefinite useful life when, based on all relevant factors, there is no foreseeable limit to the period over which the asset is expected to generate net cash inflows. Accordingly, the Company does not amortize these intangible assets, but reviews them for impairment, annually or more frequently if events or changes in circumstances indicate that the assets might be impaired.

Development costs for internally-generated intangible assets are capitalized when all of the following conditions are met:

  • technical feasibility can be demonstrated;
  • management has the intention to complete the intangible asset and use it;
  • management can demonstrate the ability to use the intangible asset;
  • it is probable that the intangible asset will generate future economic benefits;
  • the Company can demonstrate the availability of adequate technical, financial and other resources to complete the development and to use the intangible asset; and
  • costs attributable to the asset can be measured reliably.

The amount initially recognized for internally-generated intangible assets is the sum of the expenditures incurred from the date when the intangible asset first meets the recognition criteria listed above. Where no internally-generated intangible asset can be recognized, development expenditures are charged to the consolidated statements of loss and comprehensive loss in the period in which they are incurred.

Customer relationships acquired through the acquisition of subsidiary, Tetra Drones, are amortized for a period of three years from acquisition date.

Equipment

Recognition and measurement

On initial recognition, equipment is valued at cost, being the purchase price and directly attributable cost of acquisition or construction required to bring the asset to the location and condition necessary to be capable of operating in the manner intended by the Company, including appropriate borrowing costs and the estimated present value of any future unavoidable costs of dismantling and removing the items. The corresponding liability is recognized within provisions.

Equipment is subsequently measured at cost less accumulated depreciation, less any accumulated impairment losses.

When parts of an item of equipment have different useful lives, they are accounted for as separate items (major components) of equipment.

Gains and losses

Gains and losses on disposal of an item of equipment are determined by comparing the proceeds from disposal with the carrying amount and are recognized net within other income in profit or loss.

Depreciation

Half of the normal depreciation is taken in the year of acquisition for equipment with declining balance method. The depreciation rates applicable to each category of property and equipment are as follows:

Computer equipment    55% declining balance Vehicles                             30% declining balance
Furniture                       20% declining balance Leasehold improvements  30% declining balance
Demo equipment          20% declining balance  

Inventories

The Company values inventories at the lower of cost and net realizable value. Cost includes the costs of purchases net of vendor allowances plus other costs, such as transportation, that are directly incurred to bring the inventories to their present location and condition.

Business combinations

Business combinations are accounted for using the acquisition method. The cost of the acquisition is measured at the aggregate of the fair values at the date of acquisition, of assets transferred, liabilities incurred or assumed, and equity instruments issued by the Company. The acquiree's identifiable assets and liabilities assumed are recognized at their fair value at the acquisition date. Acquisition-related costs are recognized in profit or loss as incurred. The excess of consideration over the fair value of the net identifiable assets and liabilities acquired is recorded as goodwill. Any gain on a bargain purchase is recorded in profit or loss immediately. Transaction costs are expensed as incurred, except if related to the issue of debt or equity securities. Any goodwill that arises is tested annually for impairment.

Share capital

The Company records proceeds from the issuance of its common shares as equity. Proceeds received on the issuance of units, consisting of common shares and warrants, are allocated between the common share and warrant component. The Company has adopted a residual value method with respect to the measurement of shares and warrants issued as private placement units. The residual value method first allocates value to the most easily measurable component based on fair value and then the residual value, if any, to the less easily measurable component.

The fair value of the common shares issued in the private placement was determined to be the more easily measurable component and were valued at their fair value, as determined by the closing quoted price on the issuance date. The remaining proceeds, if any, are allocated to the attached warrants. Any fair value attributed to the warrants is recorded as warrant reserve. Management does not expect to record a value to the warrant in most equity issuances as unit private placements are commonly priced at market or at a permitted discount to market. If the warrants are issued as share issuance costs, the fair value of agent's warrants are measured using the Black-Scholes option pricing model and recognized in equity as a deduction from the proceeds.

If the warrants are exercised, the related amount is reclassified as share capital. If the warrants expire unexercised, the related amount remains in warrant reserve.

Incremental costs directly attributable to the issue of new common shares are shown in equity as a deduction, net of tax, from the proceeds. Common shares issued for consideration other than cash are valued based on their market value at the date that shares are issued.

Stock-based payment

The Company recognizes share-based payment expense for the estimated fair value of equity-based instruments granted to both employees and non-employees. Compensation expense is recognized when the options are granted with the same amount being recorded as contributed surplus. The expense is determined using an option pricing model that accounts for the exercise price, the term of the option, the current share price, the expected volatility of the underlying shares, the expected dividend yield, and the risk-free interest rate for the term of the option. If the options are exercised, the contributed surplus will be reduced by the applicable amount. Share-based payment calculations have no effect in the Company's cash position.

Earnings (loss) per share

Basic earnings (loss) per share are calculated using the weighted average number of common shares outstanding during the period. Diluted earnings (loss) per share are calculated using the treasury stock method. This method assumes that common shares are issued for the exercise of options, warrants and convertible securities and that the assumed proceeds from the exercise of options, warrants and convertible securities are used to purchase common shares at the average market price during the period. The difference between the number of shares assumed issued and the number of shares assumed purchased is then added to the basic weighted average number of shares outstanding to determine the fully diluted number of common shares outstanding. No exercise or conversion is assumed during the periods in which a net loss is incurred as the effect is anti-dilutive.

Financial instruments

Financial assets

The Company recognizes financial assets when it becomes party to the contractual provisions of the instrument. Financial assets are measured initially at their fair value plus, in the case of financial assets not subsequently measured at fair value through profit or loss, transaction costs that are directly attributable to their acquisition. Transaction costs attributable to the acquisition of financial assets subsequently measured at fair value through profit or loss are expensed in profit or loss when incurred.

Subsequent to initial recognition, all financial assets are classified and subsequently measured at amortized cost. Interest income is calculated using the effective interest method and gains or losses arising from impairment, foreign exchange and derecognition are recognized in profit or loss. Financial assets measured at amortized cost are comprised of cash, accounts receivable and due from related parties.

The Company reclassifies debt instruments only when its business model for managing those financial assets has changed. Reclassifications are applied prospectively from the reclassification date and any previously recognized gains, losses or interest are not restated.

The Company recognizes a loss allowance for the expected credit losses associated with its financial assets. Expected credit losses are measured to reflect a probability-weighted amount, the time value of money, and reasonable and supportable information regarding past events, current conditions and forecasts of future economic conditions.

The Company applies the simplified approach for accounts receivable that do not contain a significant financing component. Using the simplified approach, the Company records a loss allowance equal to the expected credit losses resulting from all possible default events over the assets' contractual lifetime.

Financial assets are written off when the Company has no reasonable expectations of recovering all or any portion thereof.

The Company derecognizes a financial asset when its contractual rights to the cash flows from the financial asset expire.

Financial liabilities

The Company recognizes a financial liability when it becomes party to the contractual provisions of the instrument. At initial recognition, the Company measures financial liabilities at their fair value plus transaction costs that are directly attributable to their issuance, with the exception of financial liabilities subsequently measured at fair value through profit or loss for which transaction costs are immediately recorded in profit or loss.

Subsequent to initial recognition, all financial liabilities are measured at amortized cost using the effective interest rate method. Interest, gains, and losses relating to a financial liability are recognized in profit or loss. Financial liabilities measured at amortized cost are comprised of accounts payable, lease liability, and due to related parties.

The Company derecognizes a financial liability only when its contractual obligations are discharged, cancelled or expire.

Interest

Interest income and expense are recognized in profit or loss using the effective interest method.

The 'effective interest rate' is the rate that exactly discounts estimated future cash payments over the expected life of the financial instrument to the gross carrying amount of the financial asset or the amortized cost of the financial liability. The effective interest rate is calculated considering all contractual terms of the financial instruments, except for the expected credit losses of financial assets.

The 'amortized cost' of a financial asset or financial liability is the amount at which the instrument is measured on initial recognition minus principal repayments, plus or minus any cumulative amortization using the effective interest method of any difference between the initial amount and maturity amount and adjusted for any expected credit loss allowance. The 'gross carrying amount' of a financial asset is the amortized cost of a financial asset before adjusting for any expected credit losses.

Interest income and expense is calculated by applying the effective interest rate to the gross carrying amount of the financial asset (when the asset is not credit-impaired) or the amortized cost of the financial liability.

Where a financial asset has become credit-impaired subsequent to initial recognition, interest income is calculated in subsequent periods by applying the effective interest method to the amortized cost of the financial asset. If the asset subsequently ceases to be credit-impaired, calculation of interest income reverts to the gross basis.

Offsetting

Financial assets and financial liabilities are offset, with the net amount presented in the statement of financial position, when, and only when, the Company has a current and legally enforceable right to set off the recognized amounts and intends either to settle on a net basis or realize the asset and settle the liability simultaneously.

Income and expenses are presented on a net basis only when permitted under IFRS, or when arising from a group of similar transactions if the resulting income and expenses are not material.

Revenue recognition

Revenue is recognized by applying the five-step model under IFRS 15. The Company recognizes revenue when, or as the goods or services are transferred to the control of the customer and performance obligations are satisfied. The Company's revenue is comprised of sales of its radar systems, radar components and engineering design and development services. The Company's revenue is recognized when control of the goods has been transferred, being when the goods are delivered to customers and when all performance obligations have been fulfilled. The amounts recognized as revenue represent the fair values of the considerations received or receivable from third parties on the sales of goods to customers, net of goods and services taxes and less returns, and discounts, at which time there are no conditions for the payment to become due other than the passage of time. For its engineering design and development services, revenue is recognized when the service has been rendered.

Government Grants

Government grants are recognized at fair value once there is reasonable assurance that the Company will comply with the conditions attached to the grants and that the grants will be received. Government grants are recognized in profit or loss on a systematic basis over the periods in which the Company recognizes as expenses the related costs for which the grants are intended to compensate. A forgivable loan from government is treated as a government grant when there is reasonable assurance that the entity will meet the terms for forgiveness of the loan.

Income taxes

Income tax is recognized in profit or loss except to the extent that it relates to equity items, in which case it is recognized in equity. Current tax expense is the expected tax payable on the taxable income for the year, using tax rates enacted at period end, adjusted for amendments to tax payable with regards to previous years. Deferred tax is recorded using the liability method, providing for temporary differences, between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for taxation purposes. The following temporary differences do not result in deferred tax assets or liabilities: goodwill not deductible for tax purposes; the initial recognition of assets or liabilities that affect neither accounting profit (loss) nor taxable profit (loss); and differences relating to investments in subsidiaries to the extent that they will probably not reverse in the foreseeable future. The amount of deferred tax provided is based on the expected manner of realization or settlement of the carrying amount of assets and liabilities, using tax rates enacted or substantively enacted at the financial position date.

A deferred tax asset is recognized only to the extent that it is probable that future taxable profits will be available against which the asset can be utilized. Deferred tax assets and liabilities are offset when there is a legally enforceable right to set off current tax assets against current tax liabilities and when they relate to income taxes levied by the same taxation authority and the Company intends to settle its current tax assets and liabilities on a net basis.

Related party transactions

Parties are considered to be related if one party has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions.

Parties are also considered to be related if they are subject to common control and related parties may be individuals or corporate entities. A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties.

Leases

The company adopted IFRS 16 effective December 1, 2019. The Company chose to adopt the modified retrospective approach on transition to IFRS 16 and has chosen not to restate comparative information in accordance with the transitional provisions in IFRS 16. As a result, the comparative information continues to be presented in accordance with the Company's previous accounting policies. The adoption of IFRS 16 resulted in the recognition of a right-of-use asset and a lease liability measured at the present value of the future lease payments on the consolidated statements of financial position. An amortization expense on the right-of-use asset and an interest expense on the lease liability has replaced the operating lease expense. IFRS 16 has changed the presentation of cash flows relating to leases in the Company's consolidated statements of cash flows, however, it does not cause a difference in the amount of cash transferred between the parties of the lease.

Accounting standards, amendments and interpretations not yet effective

Certain new standards, interpretations and amendments to existing standards have been issued by the IASB or the IFRIC during the period but are not yet effective. Some updates that are not applicable or are not consequential to the Company may have been excluded from the list below.

IAS 1 - Presentation of Financial Statements ("IAS 1") - Classification of Liabilities as Current or Noncurrent were amended to clarify that the classification of liabilities as current or non-current is based on rights that are in existence at the end of the reporting period, specify that classification is unaffected by expectations about whether an entity will exercise its right to defer settlement of a liability, explain that rights are in existence if covenants are complied with at the end of the reporting period, and introduce a definition of 'settlement' to make clear that settlement refers to the transfer to the counterparty of cash, equity instruments, other assets or services. The amendments are effective for annual reporting periods beginning on or after January 1, 2023. Earlier adoption is permitted.

 

IAS 16 - Property, Plant and Equipment - Proceeds before Intended Use - The amendments prohibit deducting from the cost of an item of property, plant and equipment any proceeds from selling items produced before that asset is available for use, i.e. proceeds while bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management. Consequently, an entity recognizes such sales proceeds and related costs in profit or loss. The entity measures the cost of those items in accordance with IAS 2 Inventories. The amendments are effective for annual reporting periods beginning on or after January 1, 2022. Earlier adoption is permitted.

These new and amended standards are not expected to have a material impact on the Company's Financial Statements

XML 27 R8.htm IDEA: XBRL DOCUMENT v3.23.1
ACQUISITION
12 Months Ended
Nov. 30, 2022
Disclosure of detailed information about business combination [abstract]  
ACQUISITION [Text Block]

3. ACQUISITION

On June 4, 2021, the Company acquired the 100% issued and outstanding ordinary shares of Tetra from two arm's length parties for £350,000. Tetra was a privately held UK-based company which develops custom-made, Unmanned Aircraft Systems ("UAS"). The consideration of £350,000 ($579,682) is payable as follows:

1) An amount of £35,000 ($60,021) within 7 days after the execution and delivery of the definitive agreement by all parties, paid on June 12, 2021;

2) An amount of £35,000 ($60,479) (paid) within 21 days of the initial payment as described in instalment 1 above, paid on July 9, 2021;

3) An amount of £140,000 ($236,411) (paid) within 120 days of the second instalment as described above, paid on November 8, 2021 ("the third payment"); and

4) The remaining balance of £140,000 ($222,771) (see Note 19 - Gain on debt forgiveness) within 120 days of the third payment, forgiven in return of the full release of the leased vehicle and allowing the former sole shareholder of Tetra to continue working within the industry.

The Company applied the optional concentration test permitted under IFRS 3 to the acquisition which resulted in the acquired assets being accounted for as an asset acquisition. As such the purchase price was allocated to the identifiable assets and liabilities based on their fair values at the date of acquisition.

The allocation of the consideration for the purposes of the consolidated statements of financial position is as follows:

Total Consideration      
Cash $ 579,682  
       
Net assets acquired (liabilities assumed)      
Cash indebtedness $ (12,127 )
Equipment   27,799  
Prepaid expenses   11,131  
Due to a related party   (13,699 )
Bank loan   (40,447 )
Accounts payable   (19,210 )
Vehicle loan   (30,859 )
Net assets acquired (liabilities assumed) $ (77,412 )
       
Purchase price allocation      
Net identifiable assets acquired $ (77,412 )
Customer relationships   657,094  
  $ 579,682  
XML 28 R9.htm IDEA: XBRL DOCUMENT v3.23.1
PREPAID EXPENSES
12 Months Ended
Nov. 30, 2022
Disclosure Of Detail Information About Prepaid Expenses [Abstract]  
PREPAID EXPENSES [Text Block]
4. PREPAID EXPENSES

As at November 30, 2022 and 2021, the Company's prepaid expenses consist of the following:

    November 30, 2022     November 30, 2021  
             
Advertising and promotions $ 113   $ 127,664  
Rent   8,247     11,211  
Transfer agent and filing fees   13,748     13,020  
Insurance   8,839     8,382  
Others   -     18,044  
  $ 30,947   $ 178,321  

The prepayments for advertising include prepayments for marketing and awareness programs handled by an arms' length parties for a six to twelve-month period.

Others include prepayments for some office expenses.

As at November 30, 2022, others include $Nil prepayment to related parties (2021 - $5,513) (Note 9).

XML 29 R10.htm IDEA: XBRL DOCUMENT v3.23.1
EQUIPMENT
12 Months Ended
Nov. 30, 2022
Property, plant and equipment [abstract]  
EQUIPMENT [Text Block]

5. EQUIPMENT

    Computer     Furniture     Vehicles     Leasehold
Improvement
    Demo
Equipment
    Total  
    $     $     $     $     $     $  
Cost:                                    
Balance at November 30, 2020   1,684     12,151     -     -     57,518     71,353  
Additions   22,664     7,244     16,243     3,881     184,484     234,516  
Foreign currency translation adjustment   (320 )   (124 )   (229 )   (55 )   (2,255 )   (2,983 )
Balance at November 30, 2021   24,028     19,271     16,014     3,826     239,747     302,886  
    Disposal   -     -     (16,243 )   -     -     (16,243 )
Foreign currency translation adjustment   (997 )   190     229     (182 )   3,158     2,398  
Balance at November 30, 2022   23,031     19,461     -     3,644     242,905     289,041  
                                     
Accumulated Depreciation:                                    
Balance at November 30, 2020   1,134     3,401     -     -     -     4,535  
Amortization   561     2,055     1,201     287     -     4,104  
Foreign currency translation adjustment   21     17     17     4     -     59  
Balance at November 30, 2021   1,716     5,473     1,218     291     -     8,698  
Amortization   9,236     2,688     4,210     1,006     -     17,140  
Disposal   -     -     (5,375 )   -     -     (5,375 )
Impairment                           236,677     236,677  
Foreign currency translation adjustment   642     296     (53 )   (13 )   6,228     7,100  
Balance at November 30, 2022   11,594     8,457     -     1,284     242,905     264,240  
                                     
Net Book Value:                                    
At November 30, 2021   22,312     13,798     14,796     3,535     239,747     294,188  
At November 30, 2022   11,437     11,004     -     2,360     -     24,801  
XML 30 R11.htm IDEA: XBRL DOCUMENT v3.23.1
INTANGIBLE ASSETS
12 Months Ended
Nov. 30, 2022
Intangible assets and goodwill [abstract]  
INTANGIBLE ASSETS [Text Block]

6. INTANGIBLE ASSETS

During the year ended November 30, 2021, the Company acquired Tetra (Note 3).Included in the acquisition is the identifiable intangible asset, customer relationships valued at $657,094.The intangible asset is being amortized over its estimated useful life of three years. For the year ended November 30, 2022, the Company determined that the intangible asset is fully impaired as there is no future economic benefits will derived from this asset.

Cost:   Customer relationship  
Balance at November 30, 2020 $ -  
    Additions   657,094  
Balance at November 30, 2021 and November 30, 2022   657,094  
       
Accumulated amortization:      
Balance at November 30, 2020   -  
    Amortization   (107,415 )
Balance at November 30, 2021   (107,415 )
    Amortization   (219,029 )
    Impairment   (330,650 )
Balance at November 30, 2022   (657,094 )
Net book value      
Balance at November 30, 2021 $ 549,679  
Balance at November 30, 2022 $ -  
XML 31 R12.htm IDEA: XBRL DOCUMENT v3.23.1
ACCOUNTS PAYABLE
12 Months Ended
Nov. 30, 2022
Disclosure Of Detail Information About Accounts Payable [Abstract]  
ACCOUNTS PAYABLE [Text Block]

7. ACCOUNTS PAYABLE

As at November 30, 2022 and 2021, the Company's accounts payable consist of the following:

    November 30, 2022     November 30, 2021  
             
Professional fees $ 382,805   $ 92,078  
Funds to be returned to investors   43,046     43,046  
Due to former shareholder of Tetra (Note 3, 19)   -     222,771  
Advertising costs   34,705     42,241  
Payroll   268,610     33,173  
Development costs   168,925     123,334  
Bank overdraft   16,036     -  
VAT Payable   61,262     4,735  
Purchases   2,121     -  
Rent   1,822     -  
Others   84,531     47,007  
  $ 1,063,863   $ 608,385  
XML 32 R13.htm IDEA: XBRL DOCUMENT v3.23.1
Deferred Revenue
12 Months Ended
Nov. 30, 2022
Disclosure of disaggregation of revenue from contracts with customers [abstract]  
Deferred Revenue [Text Block]

8. Deferred Revenue

As at November 30, 2022 and 2021, the Company received an advance payment from their customers as consideration for the Company's products and services to be rendered in the future date amounting to $124,918 (2021 - $nil).

XML 33 R14.htm IDEA: XBRL DOCUMENT v3.23.1
RELATED PARTY TRANSACTIONS AND BALANCES
12 Months Ended
Nov. 30, 2022
Related party transactions [abstract]  
RELATED PARTY TRANSACTIONS AND BALANCES [Text Block]

9.    RELATED PARTY TRANSACTIONS AND BALANCES

Key management compensation

The amounts due to and from related parties are due to the directors and officers of the Company. The balances are unsecured, non-interest bearing and due on demand. These transactions are in the normal course of operations and have been valued in these consolidated financial statements at the exchange amount, which is the amount of consideration established and agreed to by the related parties. Key management is comprised of directors and officers of the Company

As at November 30, 2022, $Nil (2021 - $5,513) prepayment to directors and officers of the Company.

As at November 30, 2022, $705,672 (2021 - $52,728) was due to directors and officers of the Company:

    November 30, 2022     November 30, 2021  
Company controlled by the CFO $ 67,540   $ -  
Company controlled by the Corporate Secretary   -     10,500  
CEO of the Company   250,179     561  
Director   387,953     41,667  
  $ 705,672   $ 52,728  

During the years ended November 30, 2022 and 2021 and 2020, the Company entered into the following transactions with related parties:

    November 30, 2022     November 30, 2021     November 30, 2020  
Management fees $ 311,535   $ 118,000   $ 114,125  
Consulting fees   135,000     307,734     166,667  
Accounting fees   -     36,202     22,852  
Rent   -     5,000     20,000  
Share-based payments   -     410,132     271,993  
Salaries and benefits to CEO   330,337     313,626     133,387  
  $ 776,872   $ 1,190,694   $ 729,024  
 

Management fees consisted of the following:

 
    November 30, 2022     November 30, 2021     November 30, 2020  
Company controlled by CEO $ 243,387   $ 63,000   $ 55,125  
Company controlled by the Former CFO   -     55,000     59,000  
Company controlled by the CFO   68,148     -     -  
  $ 311,535   $ 118,000   $ 114,125  

Consulting fees consisted of the following:

    November 30, 2022     November 30, 2021     November 30, 2020  
Company controlled by the Former Corporate Secretary $ 60,000   $ -   $ -  
Directors   75,000     307,734     166,667  
  $ 135,000   $ 307,734   $ 166,667  

During the year ended November 30, 2022, the Company had 1,650,000 (2021 -1,725,000) stock options held by the CEO, Former CFO, the Former Corporate Secretary, and the Company's directors. The amount recognized as expense for these options for the years ended November 30, 2022, 2021 and 2020 are as follows:

    November 30, 2022     November 30, 2021     November 30, 2020  
    Number of
Options
held
    Expense
for the year
(vested)
    Number of
options held
    Expense for
the year
(vested)
    Number of
Options held
    Expense
for the year
(vested)
 
CEO   600,000   $ -     600,000   $ 133,275     400,000   $ 44,455  
Former CFO   150,000     -     150,000     33,319     100,000     11,113  
Former Corporate Secretary   150,000     -     150,000     33,319     100,000     11,113  
Directors   750,000     -     825,000     210,219     1,050,000     205,312  
    1,650,000   $ -     1,725,000   $ 410,132     1,650,000   $ 271,993  

 

During the year ended November 30, 2022, the Company also issued 78,125 (2021 -  656,250 and 2020- 500,000) common shares as compensation for consulting fees to a director valued at a total of $17,189 (2021 - $307,734 and 2020 - $125,000) (Note 13).

XML 34 R15.htm IDEA: XBRL DOCUMENT v3.23.1
GOVERMENT ASSISTANCE RECEIVED
12 Months Ended
Nov. 30, 2022
Government Assistance Received [Abstract]  
GOVERNMENT ASSISTANCE RECEIVED [Text Block]

10. GOVERMENT ASSISTANCE RECEIVED

On May 4, 2020, the Company received a CARES Act Paycheck Protection Program Loan ("PPP Loan") of USD$75,000. The PPP Loan bears interest at 1% per annum and is repayable monthly staring on December 4, 2020. The loan is forgivable if PRT USA meets the requirements outlined below.

i) The loan proceeds are used to cover payroll costs, and most mortgage interest, rent, and utility costs over the 24-week period after the loan is made; and

ii) Employee and compensation levels are maintained. Payroll costs are capped at $100,000 on an annualized basis for each employee.

During the year ended November 30, 2021, it was determined that the Company met the requirements for loan forgiveness, and Company received notice of loan forgiveness on March 16, 2021, therefore there was no loan recognized. As such, the PPP Loan was treated as a government grant and was offset against operating expenses on the consolidated statement of loss and comprehensive loss for the year ended November 30, 2021.

XML 35 R16.htm IDEA: XBRL DOCUMENT v3.23.1
LOAN PAYABLE
12 Months Ended
Nov. 30, 2022
Disclosure of detailed information about borrowings [abstract]  
LOAN PAYABLE [Text Block]

11. LOANS PAYABLE

Upon acquisition of Tetra Drones (Note 3, 19), the Company assumed the latter's outstanding loan of £13,253 ($21,461) as of November 30, 2022. The collateral of this loan is a vehicle. On October 25, 2022, the loan and the vehicle were released to former shareholder of Tetra Drones in exchange of forgoing the remaining acquisition cost of £140,000 ($222,771). Thus, for the year ended November 30, 2022, the Company's liabilities in the vehicle and the remaining balance in the acquisition cost were extinguished.

For the year ended November 30, 2022, the current loan payable of $127,019 consisted of $75,000 plus interest of $4,019 payable to a third party, which is equal to 12% interest per annum payable on demand. This includes as well the $30,000 plus interest of $3,000, a 10% interest payable to another third party for four calendar months from the date of promissory note. As of the year ended November 30, 2022, the company is now liable to pay total interest of $18,000 including the $3,000 interest as they are considered in default. Total proceeds of $105,000 was received by the Company for these loans.

XML 36 R17.htm IDEA: XBRL DOCUMENT v3.23.1
CAPITAL MANAGEMENT
12 Months Ended
Nov. 30, 2022
Capital Management [Abstract]  
CAPITAL MANAGEMENT [Text Block]

12. CAPITAL MANAGEMENT

The Company considers its capital structure to include net residual equity of all assets, less liabilities. The Company's objectives when managing capital are to (i) maintain financial flexibility in order to preserve its ability to meet financial obligations and continue as a going concern; (ii) maintain a capital structure that allows the Company to pursue the development of its projects and products; and (iii) optimize the use of its capital to provide an appropriate investment return to its shareholders commensurate with risk.

The Company's financial strategy is formulated and adapted according to market conditions in order to maintain a flexible capital structure that is consistent with its objectives and the risk characteristics of its underlying assets. The Company manages its capital structure and adjusts it in light of changes in economic conditions and the risk characteristics of its underlying assets. To maintain or adjust the capital structure, the Company may attempt to issue new shares or acquire or dispose of assets.

XML 37 R18.htm IDEA: XBRL DOCUMENT v3.23.1
SHARE CAPITAL
12 Months Ended
Nov. 30, 2022
Disclosure of classes of share capital [abstract]  
SHARE CAPITAL [Text Block]

13.  SHARE CAPITAL

(a) Common Shares

Authorized: Unlimited number of common shares without par value

As at November 30, 2022, there were 59,317,461 common shares issued and outstanding
(2021 - 59,239,336).

During the year ended November 30, 2022:

On December 31, 2021, the Company issued 78,125 common shares as compensation for consulting fees to a director valued at a total of $17,189.

During the year ended November 30, 2021:

On August 9, 2021, the Company issued 5,750,000 Units at $0.40 per unit for proceeds of $2,300,000. Each unit comprised one common share and one full non-transferable common share purchase warrant, with each warrant entitling the holder to purchase one additional common share at a price of $0.50 for five years. The Company paid cash of $63,700, issued 166,250 finders' Units with a fair value of $66,500 and 325,750 broker warrants as finder's fees. Each finders' Unit comprised of one common share and one full non-transferable common share purchase warrant, with exercise price of $0.50 per share for five years. The broker warrants are exercisable at $0.50 per share for five years. .

On January 29, 2021, the Company issued 3,180,000 Units at $0.20 per unit for proceeds of $636,000. Each unit comprised one common share and one full non-transferable common share purchase warrant, with each warrant entitling the holder to purchase one additional common share at a price of $0.25 for five years. The Company paid cash of $10,480, issued 170,000 finders' Units with a fair value of $34,000 and 222,400 broker warrants as finder's fees. Each finder's Unit comprised of one common share and one full non-transferable common share purchase warrant with exercise price of $0.25 per share for five years. The broker warrants are exercisable at $0.25 per share for five years.

During the year ended November 30, 2021, the Company issued 425,000 common shares for gross proceeds of $222,500 from the exercise of 425,000 stock options at $0.50 to $0.60 per share.

During the year ended November 30, 2021, the Company issued 6,129,573 common shares for gross proceeds of $1,332,727 from the exercise of 6,129,573 share purchase warrants at $0.20 to $0.50 per share.

During the year ended November 30, 2021, the Company issued 656,250 common shares with total fair value of $307,734 were issued as compensation for consulting fees to a director (Note 9).

During the year ended November 30, 2020:

On September 30, 2020, the Company issued 50,000 common shares pursuant to the exercise of 50,000 share purchase warrants at $0.20 per share.

On September 30, 2020, the Company issued 250,000 common shares were issued as compensation for consulting fees to a director (Note 9) valued at a total of $62,500.

On September 30, 2020, the Company issued an aggregate of 1,335,165 units at a price of $0.30 per unit for gross proceeds of $400,550. Each Unit consists of one common share and one-half of one non-transferable common share purchase warrant (a "Warrant"). Each whole Warrant entitles the holder to purchase one additional common share at a price of $0.50 for two years until September 30, 2022. The fair value of the warrants is determined to be $40,055.

On September 30, 2020, the Company issued 50,000 units at a fair value of $22,811 pursuant to the binding agreement with Aerowave Corporation. Each Unit consists of one common share and one-half of one non-transferable common share purchase warrant (a "Warrant"). Each whole Warrant entitles the holder to purchase one additional common share at a price of $0.50 for two years until September 30, 2022. The fair value of the warrants is determined to be $1,500.

On September 24, 2020, the Company issued 100,000 common shares pursuant to the exercise of 100,000 share purchase warrants at $0.20 per share.

On September 22, 2020, the Company issued 100,000 common shares pursuant to the exercise of 100,000 share purchase warrants at $0.20 per share.

On August 21, 2020, the Company issued 250,000 common shares were issued as compensation for consulting fees to a Director (Note 9) valued at a total of $62,500.

On August 13, 2020, the Company issued 483,334 common shares pursuant to the exercise of 483,334 share purchase warrants at $0.20 per share.

On July 3, 2020, the Company issued 500,000 common shares pursuant to the exercise of 500,000 share purchase warrants at $0.20 per share.

On May 15, 2020, the Company issued an aggregate of 3,718,831 units at a price of $0.15 per unit for gross proceeds of $557,825. Each unit consists of one common share in the capital of the Company and one whole transferable common share purchase warrant (a "Warrant"). Each whole Warrant is exercisable to acquire one common share at an exercise price of $0.20 per share until May 15, 2022.

On April 24, 2020, the Company issued an aggregate of 3,128,334 units at a price of $0.15 per unit for gross proceeds of $469,250. Each unit consists of one common share in the capital of the Company and one whole transferable common share purchase warrant (a "Warrant"). Each whole Warrant is exercisable to acquire one common share at an exercise price of $0.20 per share until April 24, 2022.

In connection with the April 24, 2020 and May 15, 2020 private placements, the Company paid $38,727 in share issuance costs.

On February 4, 2020, the Company arranged a non-brokered private placement financing of up to 10,000,000 units of securities at a price of $0.40 per unit for aggregate gross proceeds of up to $4,000,000 (the "Offering"). Each unit will be comprised of one common share and one-half of one non-transferable common share purchase warrant, with each whole warrant entitling the holder to purchase one additional common share at a price of $0.80 for two years from closing of the Offering. On March 16, 2020, due to the instability in the financial markets caused by the COVID-19 pandemic, the Company cancelled this private placement. And paid $4,400 to investors in connection with this cancelled private placement.

(b) Stock Options

The Company maintains an incentive stock option plan (the "Option Plan") which provides that the Board of Directors of the Company may from time to time, in its discretion, and in accordance with the Exchange requirements, grant to directors, officers, employees, and consultants to the Company, non-transferable options to purchase common shares, provided that the number of common shares reserved for issuance will not exceed 10% of the issued and outstanding common shares in the capital of the Company at the time of granting of options.

During the year ended November 30, 2022:

125,000 stock options with an exercise price of $0.50 were cancelled.

75,000 stock options with an exercise price of $0.50 expired unexercised.

During the year ended November 30, 2021:


On June 10, 2021, the Company granted 150,000 incentive stock options to a consultant with an exercise price of $0.50 per share for a period of five years from the date of grant. The fair value was estimated using the Black-Scholes pricing model with estimated, stock price of $0.485, volatility 100%, risk-free rate 0.82%, dividend yield 0%, and expected life of 5 years. With these assumptions, the fair value of options was determined to be $53,677, and the amount was recognized on the consolidated statements of loss and comprehensive loss for the year ended November 30, 2021

On January 21, 2021, the Company granted 1,550,000 incentive stock options to directors, consultants, and employees with an exercise price of $0.75 per share for a period of five years from the date of grant. The fair value was estimated using the Black-Scholes pricing model with estimated, stock price of $0.75, volatility 100%, risk-free rate 0.43%, dividend yield 0%, and expected life of 5 years. With these assumptions, the fair value of options was determined to be $1,022,995, and the amount was recognized on the consolidated statements of loss and comprehensive loss for the year ended November 30, 2021.

During the year ended November 30, 2020:

During the year ended November 30, 2020, 200,000 (2019 - 150,000) options issued to a director and a consultant were cancelled before vesting.

Stock-based compensation recognized in profit or loss for the year ended November 30, 2022 amounted to

$Nil (2021 - $1,144,342; 2020 - 479,107).

Stock option transactions and the number of stock options outstanding as at November 30, 2022, 2021 and 2020 are summarized as follows:

    Number of     Weighted Average  
  Options     Exercise Price  
Balance, November 30, 2020   2,950,000   $ 0.58  
Granted   1,700,000     0.73  
Exercised   (425,000 )   0.52  
Balance, November 30, 2021   4,225,000   $ 0.65  
Expired   (75,000 )   0.50  
Cancelled   (125,000 )   0.50  
Balance, November 30, 2022   4,025,000   $ 0.66  

The following summarizes the stock options outstanding at November 30, 2022:

Expiry Date Exercise
Price
  Numbers of
options
outstanding
    Numbers of
options
exercisable
    Weighted average
remaining
contractual life (year)
    Weighted
average
exercise price
 
  $                     $  
January 15, 2024 0.60   2,050,000     2,050,000     0.57     0.31  
March 20, 2024 0.60   150,000     150,000     0.05     0.02  
November 28, 2024 0.50   125,000     125,000     0.06     0.02  
January 21, 2026 0.75   1,550,000     1,550,000     1.21     0.29  
June 10, 2026 0.50   150,000     150,000     0.13     0.02  
      4,025,000     4,025,000     2.03     0.66  

(c)   Share purchase warrants

During the year ended November 30, 2022

561,081 warrants with exercise price of $0.20 expired unexercised.

During the year ended November 30, 2021

On August 9, 2021, the Company issued 5,916,250 common share purchase warrants as part of the private placement. Each warrant is exercisable to purchase one common share at an exercise price of $0.50 per share until August 9, 2026.

On August 9, 2021, the Company also granted 325,750 warrants to finder's warrants as described in note 13(a) in connection with the private placement. Each warrant is exercisable to purchase one common share at an exercise price of $0.50 per share until August 9, 2026. The fair value was estimated using the Black-Scholes pricing model with estimated, stock price of $0.35, volatility 100%, risk-free rate 0.88%, dividend yield 0%, and expected life of 5 years. With these assumptions, the fair value of options was determined to be $79,032.

On January 29, 2021, the Company granted 3,350,000 common share purchase warrants as part of a non-brokered private placement. Each warrant is exercisable to acquire one common share at an exercise price of $0.25 per share until January 29, 2026. During the year ended November 30, 2021, 30,000 warrants were exercised at $0.25 per share.

On January 29, 2021, the Company also granted 222,400 warrants to finders in connection with the private placement. Each warrant is exercisable to acquire one common share at an exercise price of $0.50 per share until August 9, 2026. During the year ended November 30, 2021, 4,240 warrants were exercised at $0.25 per share. The fair value was estimated using the Black-Scholes pricing model with estimated, stock price of $0.52, volatility 100%, risk-free rate 0.43%, dividend yield 0%, and expected life of 5 years. With these assumptions, the fair value of options was determined to be $95,395.

During the year ended November 30, 2020

On September 30, 2020, the Company granted 692,583 common share purchase warrants as part of a non-brokered private placement and binding agreement with Aerowave Corporation. Each warrant is exercisable to acquire one common share at an exercise price of $0.50 per share until September 30, 2022. On February 28, 2021, 292,000 warrants were exercised at $0.50 per share.

On May 15, 2020, the Company granted 3,718,831 common share purchase warrants as part of a non-brokered private placement. Each warrant is exercisable to acquire one common share at an exercise price of $0.20 per share until May 15, 2022. On February 28, 2021, 3,208,333 warrants were exercised at $0.20 per share.

On April 24, 2020, the Company granted 3,128,334 common share purchase warrants as part of a non-brokered private placement. Each warrant is exercisable to acquire one common share at an exercise price of $0.20 per share until April 24, 2022. On February 28, 2021, 2,145,000 warrants were exercised at $0.20 per share.

Share purchase warrant transactions and the number of share purchase warrants outstanding as of November 30, 2022, 2021 and 2020 are summarized as follows:

    Number of Warrants     Weighted Average Exercise Price  
Balance, November 30, 2019   -   $ -  
Warrants granted   7,539,748     0.90  
Warrants exercised   (1,233,334 )   0.11  
Balance, November 30, 2020   6,306,414     0.23  
Warrants granted   9,814,400     0.08  
Warrants exercised   (6,129,573 )   0.01  
Balance, November 30, 2021   9,991,241     0.42  
Warrants expired   (561,081 )   0.20  
Balance, November 30, 2022   9,430,160   $ 0.41  

The following summarizes the stock warrants outstanding at November 30, 2022:

Expiry Date   Exercise
Price
$
    Number of Warrants
outstanding and
exercisable
    Weighted average
remaining
contractual life (year)
    Weighted average
exercise price
$
 
January 29, 2026   0.25     3,188,160     1.07     0.08  
      August 9, 2026   0.50     6,242,000     2.17     0.33  
          9,430,160     3.17     0.41  
XML 38 R19.htm IDEA: XBRL DOCUMENT v3.23.1
FINANCIAL RISK MANAGEMENT
12 Months Ended
Nov. 30, 2022
Disclosure Of Financial Risk Management Explanatory [Abstract]  
FINANCIAL RISK MANAGEMENT [Text Block]

14. FINANCIAL RISK MANAGEMENT

The Company's financial assets consist of cash, and due from related parties. The estimated fair values of cash, subscription receivable, and due from related parties approximate their respective carrying values due to the short period to maturity.

Financial instruments measured at fair value are classified into one of three levels in the fair value hierarchy according to the relative reliability of the inputs used to estimate the fair values. The three levels of the fair value hierarchy are:

a. Level 1 - unadjusted quoted prices in active markets for identical assets or liabilities;

b. Level 2 - inputs other than quoted prices that are observable for the asset or liability either directly or indirectly; and

c. Level 3 - inputs that are not based on observable market data.

For the years ended November 30, 2022, and 2021, the fair value of the cash, accounts receivable, accounts payable, and due to and from related parties approximate the book value due to the short-term nature.

The Company is exposed to a variety of financial instrument-related risks. The Board approves and monitors the risk management processes, inclusive of counterparty limits, controlling and reporting structures. The type of risk exposure and the way in which such exposure is managed is provided as follows:

Liquidity Risk

Liquidity risk is the risk that the Company will not be able to meet its financial obligations when they become due. The Company ensures, as far as reasonably possible, it will have sufficient capital in order to meet short-term business requirements, after taking into account cash flows from operations and the Company's holdings of cash. The Company believes that these sources will be sufficient to cover the likely short-term cash requirements.

The Company's cash is currently invested in business accounts which is available on demand by the Company for its operations.

Interest Rate Risk

Interest rate risk is the risk that future cash flows will fluctuate as a result of changes in market interest rates. The Company has no significant interest rate risk due to the short-term nature of its interest generating assets.

Credit Risk

Credit risk is the risk of a loss when a counterparty to a financial instrument fails to meet its contractual obligations. The Company's exposure to credit risk is limited to its cash. The Company limits its exposure to credit risk by holding its cash in deposits with high credit quality Canadian financial institutions.

Foreign Currency Risk

The Company is exposed to foreign currency risk on fluctuations related to cash, leases, due from related parties and accounts payable and accrued liabilities that are denominated in US dollars. 10% fluctuations in the US dollar and UK Sterling Pound against the Canadian dollar have affected comprehensive loss for the year by approximately $81,052 (2021 - $1,200 and 2020 - $7,085).

XML 39 R20.htm IDEA: XBRL DOCUMENT v3.23.1
SUPPLEMENTAL CASH FLOW INFORMATION
12 Months Ended
Nov. 30, 2022
Supplemental Cash Flows Information Abstract  
SUPPLEMENTAL CASH FLOW INFORMATION [Text Block]

15. SUPPLEMENTAL CASH FLOW INFORMATION

During the year ended November 30, 2022, 2021 and 2020, the Company has the following non-cash investing and financing activities:

    November 30,
2022
    November 30,
2021
    November 30,
2020
 
Non-cash financing activities:                  
Fair value of options exercised   -     158,106     -  
Fair value of warrants granted   -     174,427     83,109  
Fair value of warrants exercised   -     36,859     -  
Shares issued for finders   -     100,500     -  
Non-cash investing activities:                  
Shares to be issued to acquisition of inventory   -     -     22,800  
XML 40 R21.htm IDEA: XBRL DOCUMENT v3.23.1
COMMITMENTS AND CONTINGENCIES
12 Months Ended
Nov. 30, 2022
Commitments And Contingencies [Abstract]  
COMMITMENTS AND CONTINGENCIES [Text Block]

16. COMMITMENTS AND CONTINGENCIES

As at November 30, 2022, the Company has the following commitments:

The Company entered into lease agreement with arm's length party on September 9, 2021. The term commenced on May 1, 2021 and will set to expire on April 30, 2024 and with annual lease fee of £12,000 or £1,000 per month with interest of 4% per annum above Barclays Bank PLC base rate in case of default (Note 17). Further, on the same date, the Company entered into separate agreement with the same arm's length party for drone flying permission over the land without restriction in exchange of £1,500 annual fee. The term commenced on May 1, 2021 and expire on April 30, 2024 as well.

In November 2018, the Company entered into two-year lease agreement for leased premises in Plymouth, Massachusetts, commenced December 1, 2018 and ended on November 30, 2020. On December 31, 2020, the Company renewed this lease agreement to November 30, 2023. The minimum base rent for the remaining lease term are: US$3,188 per month from December 1, 2021 to November 30, 2022; and US$3,284 per month from December 1, 2022 to November 30, 2023 (Note 17).

The Company has certain commitments related to key management compensation for $35,875 per month with no specific expiry of terms (Note 9).

On February 4, 2023, the Company received a disputed claim from former consultant on the unpaid fees for the month of November 2022, December 2022 and January 2023 with an aggregate liability of $30,000. As of the reporting date, the Company is still waiting for the court order and plans to take a legal course of action as well. Management cannot determine the outcome as of the date of this report.

On April 1, 2020 the Company entered into an agreement with a Director of the Company to provide consulting services. In line with this, the Company shall pay $250,000 annually either through cash in 12 monthly installments at the end of each calendar month or through the issuance of 1,000,000 common shares of the Company in four equal quarterly installments, in arrears.

XML 41 R22.htm IDEA: XBRL DOCUMENT v3.23.1
RIGHT-OF-USE ASSETS AND LEASE LIABILITY
12 Months Ended
Nov. 30, 2022
Right Of Use Assets And Lease Liability [Abstract]  
RIGHT-OF-USE ASSETS AND LEASE LIABILITY [Text Block]

17. RIGHT-OF-USE ASSETS AND LEASE LIABILITY

Right-of-use assets

In November 2018, the Company entered into two-year lease agreement for leased premises in Plymouth, Massachusetts, commencing December 1, 2018 and ending on November 30, 2020. On December 31, 2020, the Company renewed this lease agreement to November 30, 2023. The minimum base rent for the remaining lease term are: USD$3,005 ($3,726) per month from December 1, 2019 to November 01, 2020; USD$3,095 ($3,838) per month from December 1, 2020 to November 30, 2021; USD$3,188 ($3,953) per month from December 1, 2021 to November 30, 2022; and USD$3,284 ($4,072) per month from December 1, 2022 to November 30, 2023 (Note 16).

On September 9, 2021, the Company entered into lease agreement with arm's length party to use the premises known as The Old Workshop, Estuary Road, King's Lynn, Norfolk from May 1, 2021 and will set to expire on April 30, 2024, with annual lease fee of £12,000 or £1,000 per month with interest of 4% per annum above Barclays Bank PLC base rate in case of default (Note 16).

The following is the continuity of the cost and accumulated depreciation of right-of-use assets, for the year ended November 30, 2022 and 2021:

Balance, November 30, 2020 $ 114,648  
Amortization expense   (35,654 )
Cumulative translation adjustment   (6,260 )
Balance, November 30, 2021 $ 72,734  
Additions   38,027  
Amortization expense   (50,571 )
Cumulative translation adjustment   1,008  
Balance, November 30, 2022 $ 61,198  

Lease liability

The following is the continuity of lease liability, for the year ended November 30, 2022 and 2021:

Balance, November 30, 2020 $ 113,340  
Lease payments   (48,175 )
Interest on lease liability   14,760  
Cumulative translation adjustment   (5,079 )
Balance, November 30, 2021 $ 86,346  
Additions   38,027  
Lease payments   (72,727 )
Interest on lease liability   18,877  
Cumulative translation adjustment   5,274  
Balance, November 30, 2022 $ 75,797  
Current Portion $ 66,403  
Long-term portion $ 9,394  

As at November 30, 2022 and 2021, the minimum lease payments for the lease liabilities are as follows:

    November 30,
2022
    November 30,
2021
 
Year ending:            
2022 $ -   $ 48,943  
2023   72,664     50,403  
2024   9,716     -  
    82,380     99,346  
Less: Interest expense on lease liabilities   (6,583 )   (13,000 )
Total present value of minimum lease payments $ 75,797   $ 86,346  
XML 42 R23.htm IDEA: XBRL DOCUMENT v3.23.1
BREAKDOWN OF EXPENSES
12 Months Ended
Nov. 30, 2022
Disclosure of attribution of expenses by nature to their function [abstract]  
BREAKDOWN OF EXPENSES [Text Block]

18. BREAKDOWN OF EXPENSES

          Year ended November 30,  
General and Administrative Expenses   Note     2022     2021     2020  
Accounting and audit fees   9   $ 223,247   $ 80,162   $ 67,282  
Amortization   5, 6, 17     286,743     143,783     41,201  
Consulting fees   9     143,539     456,296     275,182  
General office expenses         153,403     205,710     111,394  
Insurance         39,007     21,837     11,928  
Interest and accretion   17     18,877     14,760     20,449  
Legal fees         77,011     191,686     74,528  
Management fees   9     311,535     118,000     110,125  
Rent         47,317     42,822     35,325  
Stock-based compensation   9, 13     -     1,144,342     479,107  
Transfer agent and filing fees   13     59,385     82,825     77,919  
Wages, salaries and benefits   9     985,916     817,858     292,218  
Total       $ 2,345,980   $ 3,320,081   $ 1,596,658  
                         
Research and Development         2022     2021     2020  
Labor       $ 182,774   $ 930,269   $ 386,044  
Materials         50,491     54,737     -  
Total       $ 233,265   $ 985,006   $ 386,044  

Selling expenses consist of business development expenses amounting to $177,428 (2021 - $709,010; 2020 - $1,081,478).

XML 43 R24.htm IDEA: XBRL DOCUMENT v3.23.1
GAIN ON DEBT FORGIVENESS
12 Months Ended
Nov. 30, 2022
Gain On Debt Forgiveness [Abstract]  
GAIN ON DEBT FORGIVENESS [Text Block]

19. GAIN ON DEBT FORGIVENESS

For the year ended November 30, 2022, the Company recognized gain on debt forgiveness amounting to $234,303 (2021 - $nil; 2020 - $nil). This composed of remaining £140,000 ($222,771) acquisition cost of Tetra Drones that was forgiven by former shareholder and the £7,155 ($11,532) excess of the net book value of vehicle and related loan released to him (Note 11).

XML 44 R25.htm IDEA: XBRL DOCUMENT v3.23.1
SEGMENTED INFORMATION
12 Months Ended
Nov. 30, 2022
Disclosure of operating segments [abstract]  
SEGMENTED INFORMATION [Text Block]

20. SEGMENTED INFORMATION

The Company operates in one business segment, focusing on developing technologies as described in Note 1.

The Company's revenues were generated in the US and UK were mostly composed of sales of engineering design services and radar components to well-known government agencies and prime contractors. All the long-lived assets are located in the US as of November 30, 2022, 2021 and 2020. The following table summarizes the revenue by geographical location:

      Canada     USA     UK     Total  
For the year ended November 30, 2022                        
  Revenues $ -   $ 154,625   $ 452,734   $ 607,359  
  Gross Profit   -     97,115     319,069     416,184  
For the year ended November 30, 2021                        
  Revenues $ -   $ 79,795   $ 104,601   $ 184,396  
  Gross Profit   -     27,703     53,584     81,287  
For the year ended November 30, 2020                        
  Revenues $ -   $ 70,931   $ -   $ 70,931  
  Gross Profit   -     39,615     -     39,615  
XML 45 R26.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES
12 Months Ended
Nov. 30, 2022
Income taxes paid (refund) [abstract]  
INCOME TAXES [Text Block]

21. INCOME TAXES

The following table reconciles the expected income taxes expense (recovery) at the Canadian statutory income tax rates to the amounts recognized in the statement of operations and comprehensive loss for the years ended November 30, 2022, 2021 and 2020:

    2022     2021     2020  
Net loss before tax and comprehensive loss   (2,667,798 )   (4,944,231 ) $ (2,924,236 )
Combined statutory tax rate   19% to 27%     19% to 29.7%     27.00%  
Expected income tax (recovery) $ (720,000 ) $ (1,278,990 ) $ (789,544 )
Permanent differences   138,000     310,228     -  
Non-deductible items and others   1,618,000     19,811     44,866  
Change in deferred tax assets not recognized   (1,036,000 )   948,951     744,678  
Income tax expense (recovery) $ -   $ -   $ -  

Significant components of the Company's unrecognized deferred tax assets (liabilities) for the years ended November 30, 2022 and 2021 are shown below:

    2022     2021  
Non-capital losses $ 1,657,000   $ 2,641,159  
Capital losses   21,000     21,062  
Equipment   -     1,511  
Share issuance costs   48,000     29,036  
Intangible assets   -     397,156  
Others   -     13,498  
Net deferred tax assets $ 1,726,000   $ 3,103,422  

Non-capital losses carryforward

The Company has non-capital loss carryforwards and net operating losses, for which no deferred tax asset has been recognized of approximately $10,971,723 (2021 - $9,703,024) which may be carried forward to apply against future income for Canadian, USA and United Kingdom income tax purposes, subject to the final determination by taxation authorities, expiring in the following years:

Expiry   2022  
2038   675,203  
2039   2,350,798  
2040   2,443,638  
2041   3,591,486  
2042   1,910,598  
TOTAL $ 10,971,723  
XML 46 R27.htm IDEA: XBRL DOCUMENT v3.23.1
SUBSEQUENT EVENTS
12 Months Ended
Nov. 30, 2022
Disclosure of non-adjusting events after reporting period [abstract]  
SUBSEQUENT EVENTS [Text Block]

22.  SUBSEQUENT EVENTS

On February 22, 2023, the Company announced a non-brokered private placement financing of up to 30,000,000 units (the "Units") of securities at a price of $0.05 per Unit for aggregate gross proceeds of up to $1,500,000. Each Unit will be comprised of one common share and one full transferable common share purchase warrant, with each whole warrant entitling the holder to purchase one additional common share at a price of $0.10 for three years from closing of the private placement. On March 30, 2023, the Company completed the first tranche of the private placement by issuing 7,200,000 units for gross proceeds of $360,000.

On March 3, 2022, 2,100,000 share options issued to directors, officers, employees, and consultants were surrendered and cancelled. Further, on March 16, 2023, another 150,000 share options issued to director were surrendered and cancelled.

XML 47 R28.htm IDEA: XBRL DOCUMENT v3.23.1
SIGNIFICANT ACCOUNTING POLICIES (Policies)
12 Months Ended
Nov. 30, 2022
Notes to Financial Statements [Abstract]  
Basis of presentation [Policy Text Block]

Basis of presentation

These consolidated financial statements ("Financial Statements") have been prepared in accordance with IFRS as issued by the International Accounting Standard Board ("IASB") and interpretations of the International Financial Reporting Interpretations Committee ("IFRIC").

These Financial Statements are authorized for issue by the Board of Directors on March 28, 2023.

These Financial Statements have been prepared on the historical cost basis. In addition, these Financial Statements have been prepared using the accrual basis of accounting.

These Financial Statements are presented in Canadian dollars, which is the Company's functional currency. The functional currency of PRT USA is U.S. Dollars and the functional currency of PRT UK and Tetra is British Pound Sterling ("£"). The assets and liabilities of PRT USA, PRT UK and Tetra are translated into Canadian dollars at the rate of exchange prevailing at the reporting date and their income and expense items are translated at average exchange rates for the period. Exchange differences arising on the translation are recognized in other comprehensive income.

Significant accounting judgments, estimates and assumptions [Policy Text Block]

Significant accounting judgments, estimates and assumptions

The preparation of these Financial Statements in conformity with IFRS requires management to make judgments and estimates and form assumptions that affect the reported amounts of assets and liabilities at the date of the Financial Statements and reported amounts of income and expenses during the period. Actual results could differ from these estimates.

Significant estimates used in preparing the Financial Statements include, but are not limited to the following:

a. Deferred taxes

The calculation of deferred tax is based on the ability of the Company to generate future taxable income, the estimation of which is subject to significant uncertainty as to the amount and timing. The calculation of deferred tax is also based on assumptions, which are subject to uncertainty as to timing and which tax rates are expected to apply when temporary differences reverse. Deferred tax recorded is also subject to uncertainty regarding the magnitude on non-capital losses available for carry forward and of the balances in various tax pools as the corporate tax returns have not been prepared as of the date of financial statement preparation.

b. Stock-based payments

The fair value of stock options and finders' warrants issued are subject to the limitations of the Black-Scholes option pricing model that incorporates market data and involves uncertainty in estimates used by management in the assumptions. Because the Black-Scholes option pricing model requires the input of highly subjective assumptions, including the expected lift, volatility of share prices, risk-free rate and dividend yield, changes in subjective input assumptions can materially affect the fair value estimate.

c. Impairment of non-financial assets

Impairment exists when the carrying value of an asset or cash generating unit ("CGU") exceeds its recoverable amount, which is the higher of its fair value less costs to sell and its value in use. The fair value less costs to sell calculation is based on available data from binding sales transactions in an arm's length transaction of similar assets or observable market prices less incremental costs for disposing of the asset. The value in use calculation is based on a discounted cash flow model.

d. Leases

Management uses estimation in determining the incremental borrowing rate used to measure the lease liability, specific to the asset, underlying currency and geographic location.

Significant judgments used in the preparation of these Financial Statements include, but are not limited to the following:

(i) Going concern

Management has applied judgements in the assessment of the Company's ability to continue as a going concern when preparing its Financial Statements for the year ended November 30, 2022. Management prepares the Financial Statements on a going concern basis unless management either intends to liquidate the entity or to cease trading or has no realistic alternative but to do so.

In assessing whether the going concern assumption is appropriate, management accounts for all available information about the future, which is at least, but is not limited to, twelve months from the end of the reporting period.

(ii) Business combinations

Determination of whether a set of assets acquired and liabilities assumed constitute the acquisition of a business or asset may require the Company to make certain judgments as to whether or not the assets acquired and liabilities assumed include the inputs, processes and outputs necessary to constitute a business as defined in IFRS 3 - Business Combinations. Based on an assessment of the relevant facts and circumstances, the Company concluded that the acquisition disclosed in Note 3 met the criteria for accounting as a business combination.

(iii) Intangible assets

Intangible assets can be capitalized only if development costs can be measured reliably, the product or process is technically and commercially feasible, future economic benefits are probable, and the Company intends to and has sufficient resources to complete development and to use or sell the asset. To determine if the future economic benefit is probable depends on the successful commercialization of its technologies and that in turn depends on the management's judgement and knowledge. As at November 30, 2022, the development costs are not capitalized as management was unable to demonstrate the future economic benefits to be generated from the utilization of the associated expenditures.

Cash [Policy Text Block]

Cash

Cash consists of amounts held in banks and highly liquid investments with limited interest and credit risk.

Consolidation [Policy Text Block]

Consolidation

The Financial Statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances, transactions and any unrealized gains and losses arising from intercompany transactions, have been eliminated. The Company's subsidiary is presented in the table below. Plymouth Rock USA was incorporated under the General Corporation Law of the State of Delaware on March 22, 2018. Plymouth Rock UK was incorporated under the General Corporation Law for England and Wales on March 26, 2021.Tetra Drones was incorporated under the General Corporation Law for England and Wales and was acquired by the Company on June 4, 2021.

Entity Country of Incorporation Effective Economic
Interest
     
Plymouth Rock Technologies Inc.
("Plymouth Rock USA")
USA 100%
     
Plymouth Rock Technologies Inc.
("PRT UK")
UK 100%
     
Tetra Drones Ltd. ("Tetra Drones") UK 100%
Intangible assets [Policy Text Block]

Intangible assets

Intangible assets that are reflected in the consolidated statements of financial position consist of assets acquired through business combinations. Intangible assets acquired in a business combination are recognized separately from goodwill and are initially recognized at their fair value at the acquisition date (which is regarded as their cost). An intangible asset is regarded as having an indefinite useful life when, based on all relevant factors, there is no foreseeable limit to the period over which the asset is expected to generate net cash inflows. Accordingly, the Company does not amortize these intangible assets, but reviews them for impairment, annually or more frequently if events or changes in circumstances indicate that the assets might be impaired.

Development costs for internally-generated intangible assets are capitalized when all of the following conditions are met:

  • technical feasibility can be demonstrated;
  • management has the intention to complete the intangible asset and use it;
  • management can demonstrate the ability to use the intangible asset;
  • it is probable that the intangible asset will generate future economic benefits;
  • the Company can demonstrate the availability of adequate technical, financial and other resources to complete the development and to use the intangible asset; and
  • costs attributable to the asset can be measured reliably.

The amount initially recognized for internally-generated intangible assets is the sum of the expenditures incurred from the date when the intangible asset first meets the recognition criteria listed above. Where no internally-generated intangible asset can be recognized, development expenditures are charged to the consolidated statements of loss and comprehensive loss in the period in which they are incurred.

Customer relationships acquired through the acquisition of subsidiary, Tetra Drones, are amortized for a period of three years from acquisition date.

Equipment [Policy Text Block]

Equipment

Recognition and measurement

On initial recognition, equipment is valued at cost, being the purchase price and directly attributable cost of acquisition or construction required to bring the asset to the location and condition necessary to be capable of operating in the manner intended by the Company, including appropriate borrowing costs and the estimated present value of any future unavoidable costs of dismantling and removing the items. The corresponding liability is recognized within provisions.

Equipment is subsequently measured at cost less accumulated depreciation, less any accumulated impairment losses.

When parts of an item of equipment have different useful lives, they are accounted for as separate items (major components) of equipment.

Gains and losses

Gains and losses on disposal of an item of equipment are determined by comparing the proceeds from disposal with the carrying amount and are recognized net within other income in profit or loss.

Depreciation

Half of the normal depreciation is taken in the year of acquisition for equipment with declining balance method. The depreciation rates applicable to each category of property and equipment are as follows:

Computer equipment    55% declining balance Vehicles                             30% declining balance
Furniture                       20% declining balance Leasehold improvements  30% declining balance
Demo equipment          20% declining balance  
Inventories [Policy Text Block]

Inventories

The Company values inventories at the lower of cost and net realizable value. Cost includes the costs of purchases net of vendor allowances plus other costs, such as transportation, that are directly incurred to bring the inventories to their present location and condition.

Business combinations [Policy Text Block]

Business combinations

Business combinations are accounted for using the acquisition method. The cost of the acquisition is measured at the aggregate of the fair values at the date of acquisition, of assets transferred, liabilities incurred or assumed, and equity instruments issued by the Company. The acquiree's identifiable assets and liabilities assumed are recognized at their fair value at the acquisition date. Acquisition-related costs are recognized in profit or loss as incurred. The excess of consideration over the fair value of the net identifiable assets and liabilities acquired is recorded as goodwill. Any gain on a bargain purchase is recorded in profit or loss immediately. Transaction costs are expensed as incurred, except if related to the issue of debt or equity securities. Any goodwill that arises is tested annually for impairment.

Share capital [Policy Text Block]

Share capital

The Company records proceeds from the issuance of its common shares as equity. Proceeds received on the issuance of units, consisting of common shares and warrants, are allocated between the common share and warrant component. The Company has adopted a residual value method with respect to the measurement of shares and warrants issued as private placement units. The residual value method first allocates value to the most easily measurable component based on fair value and then the residual value, if any, to the less easily measurable component.

The fair value of the common shares issued in the private placement was determined to be the more easily measurable component and were valued at their fair value, as determined by the closing quoted price on the issuance date. The remaining proceeds, if any, are allocated to the attached warrants. Any fair value attributed to the warrants is recorded as warrant reserve. Management does not expect to record a value to the warrant in most equity issuances as unit private placements are commonly priced at market or at a permitted discount to market. If the warrants are issued as share issuance costs, the fair value of agent's warrants are measured using the Black-Scholes option pricing model and recognized in equity as a deduction from the proceeds.

If the warrants are exercised, the related amount is reclassified as share capital. If the warrants expire unexercised, the related amount remains in warrant reserve.

Incremental costs directly attributable to the issue of new common shares are shown in equity as a deduction, net of tax, from the proceeds. Common shares issued for consideration other than cash are valued based on their market value at the date that shares are issued.

Stock-based payment [Policy Text Block]

Stock-based payment

The Company recognizes share-based payment expense for the estimated fair value of equity-based instruments granted to both employees and non-employees. Compensation expense is recognized when the options are granted with the same amount being recorded as contributed surplus. The expense is determined using an option pricing model that accounts for the exercise price, the term of the option, the current share price, the expected volatility of the underlying shares, the expected dividend yield, and the risk-free interest rate for the term of the option. If the options are exercised, the contributed surplus will be reduced by the applicable amount. Share-based payment calculations have no effect in the Company's cash position.

Earnings (loss) per share [Policy Text Block]

Earnings (loss) per share

Basic earnings (loss) per share are calculated using the weighted average number of common shares outstanding during the period. Diluted earnings (loss) per share are calculated using the treasury stock method. This method assumes that common shares are issued for the exercise of options, warrants and convertible securities and that the assumed proceeds from the exercise of options, warrants and convertible securities are used to purchase common shares at the average market price during the period. The difference between the number of shares assumed issued and the number of shares assumed purchased is then added to the basic weighted average number of shares outstanding to determine the fully diluted number of common shares outstanding. No exercise or conversion is assumed during the periods in which a net loss is incurred as the effect is anti-dilutive.

Financial instruments [Policy Text Block]

Financial instruments

Financial assets

The Company recognizes financial assets when it becomes party to the contractual provisions of the instrument. Financial assets are measured initially at their fair value plus, in the case of financial assets not subsequently measured at fair value through profit or loss, transaction costs that are directly attributable to their acquisition. Transaction costs attributable to the acquisition of financial assets subsequently measured at fair value through profit or loss are expensed in profit or loss when incurred.

Subsequent to initial recognition, all financial assets are classified and subsequently measured at amortized cost. Interest income is calculated using the effective interest method and gains or losses arising from impairment, foreign exchange and derecognition are recognized in profit or loss. Financial assets measured at amortized cost are comprised of cash, accounts receivable and due from related parties.

The Company reclassifies debt instruments only when its business model for managing those financial assets has changed. Reclassifications are applied prospectively from the reclassification date and any previously recognized gains, losses or interest are not restated.

The Company recognizes a loss allowance for the expected credit losses associated with its financial assets. Expected credit losses are measured to reflect a probability-weighted amount, the time value of money, and reasonable and supportable information regarding past events, current conditions and forecasts of future economic conditions.

The Company applies the simplified approach for accounts receivable that do not contain a significant financing component. Using the simplified approach, the Company records a loss allowance equal to the expected credit losses resulting from all possible default events over the assets' contractual lifetime.

Financial assets are written off when the Company has no reasonable expectations of recovering all or any portion thereof.

The Company derecognizes a financial asset when its contractual rights to the cash flows from the financial asset expire.

Financial liabilities

The Company recognizes a financial liability when it becomes party to the contractual provisions of the instrument. At initial recognition, the Company measures financial liabilities at their fair value plus transaction costs that are directly attributable to their issuance, with the exception of financial liabilities subsequently measured at fair value through profit or loss for which transaction costs are immediately recorded in profit or loss.

Subsequent to initial recognition, all financial liabilities are measured at amortized cost using the effective interest rate method. Interest, gains, and losses relating to a financial liability are recognized in profit or loss. Financial liabilities measured at amortized cost are comprised of accounts payable, lease liability, and due to related parties.

The Company derecognizes a financial liability only when its contractual obligations are discharged, cancelled or expire.

Interest

Interest income and expense are recognized in profit or loss using the effective interest method.

The 'effective interest rate' is the rate that exactly discounts estimated future cash payments over the expected life of the financial instrument to the gross carrying amount of the financial asset or the amortized cost of the financial liability. The effective interest rate is calculated considering all contractual terms of the financial instruments, except for the expected credit losses of financial assets.

The 'amortized cost' of a financial asset or financial liability is the amount at which the instrument is measured on initial recognition minus principal repayments, plus or minus any cumulative amortization using the effective interest method of any difference between the initial amount and maturity amount and adjusted for any expected credit loss allowance. The 'gross carrying amount' of a financial asset is the amortized cost of a financial asset before adjusting for any expected credit losses.

Interest income and expense is calculated by applying the effective interest rate to the gross carrying amount of the financial asset (when the asset is not credit-impaired) or the amortized cost of the financial liability.

Where a financial asset has become credit-impaired subsequent to initial recognition, interest income is calculated in subsequent periods by applying the effective interest method to the amortized cost of the financial asset. If the asset subsequently ceases to be credit-impaired, calculation of interest income reverts to the gross basis.

Offsetting

Financial assets and financial liabilities are offset, with the net amount presented in the statement of financial position, when, and only when, the Company has a current and legally enforceable right to set off the recognized amounts and intends either to settle on a net basis or realize the asset and settle the liability simultaneously.

Income and expenses are presented on a net basis only when permitted under IFRS, or when arising from a group of similar transactions if the resulting income and expenses are not material.

Revenue recognition [Policy Text Block]

Revenue recognition

Revenue is recognized by applying the five-step model under IFRS 15. The Company recognizes revenue when, or as the goods or services are transferred to the control of the customer and performance obligations are satisfied. The Company's revenue is comprised of sales of its radar systems, radar components and engineering design and development services. The Company's revenue is recognized when control of the goods has been transferred, being when the goods are delivered to customers and when all performance obligations have been fulfilled. The amounts recognized as revenue represent the fair values of the considerations received or receivable from third parties on the sales of goods to customers, net of goods and services taxes and less returns, and discounts, at which time there are no conditions for the payment to become due other than the passage of time. For its engineering design and development services, revenue is recognized when the service has been rendered.

Government Grants [Policy Text Block]

Government Grants

Government grants are recognized at fair value once there is reasonable assurance that the Company will comply with the conditions attached to the grants and that the grants will be received. Government grants are recognized in profit or loss on a systematic basis over the periods in which the Company recognizes as expenses the related costs for which the grants are intended to compensate. A forgivable loan from government is treated as a government grant when there is reasonable assurance that the entity will meet the terms for forgiveness of the loan.

Income taxes [Policy Text Block]

Income taxes

Income tax is recognized in profit or loss except to the extent that it relates to equity items, in which case it is recognized in equity. Current tax expense is the expected tax payable on the taxable income for the year, using tax rates enacted at period end, adjusted for amendments to tax payable with regards to previous years. Deferred tax is recorded using the liability method, providing for temporary differences, between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for taxation purposes. The following temporary differences do not result in deferred tax assets or liabilities: goodwill not deductible for tax purposes; the initial recognition of assets or liabilities that affect neither accounting profit (loss) nor taxable profit (loss); and differences relating to investments in subsidiaries to the extent that they will probably not reverse in the foreseeable future. The amount of deferred tax provided is based on the expected manner of realization or settlement of the carrying amount of assets and liabilities, using tax rates enacted or substantively enacted at the financial position date.

A deferred tax asset is recognized only to the extent that it is probable that future taxable profits will be available against which the asset can be utilized. Deferred tax assets and liabilities are offset when there is a legally enforceable right to set off current tax assets against current tax liabilities and when they relate to income taxes levied by the same taxation authority and the Company intends to settle its current tax assets and liabilities on a net basis.

Related party transactions [Policy Text Block]

Related party transactions

Parties are considered to be related if one party has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions.

Parties are also considered to be related if they are subject to common control and related parties may be individuals or corporate entities. A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties.

Leases [Policy Text Block]

Leases

The company adopted IFRS 16 effective December 1, 2019. The Company chose to adopt the modified retrospective approach on transition to IFRS 16 and has chosen not to restate comparative information in accordance with the transitional provisions in IFRS 16. As a result, the comparative information continues to be presented in accordance with the Company's previous accounting policies. The adoption of IFRS 16 resulted in the recognition of a right-of-use asset and a lease liability measured at the present value of the future lease payments on the consolidated statements of financial position. An amortization expense on the right-of-use asset and an interest expense on the lease liability has replaced the operating lease expense. IFRS 16 has changed the presentation of cash flows relating to leases in the Company's consolidated statements of cash flows, however, it does not cause a difference in the amount of cash transferred between the parties of the lease.

Accounting standards, amendments and interpretations not yet effective [Policy Text Block]

Accounting standards, amendments and interpretations not yet effective

Certain new standards, interpretations and amendments to existing standards have been issued by the IASB or the IFRIC during the period but are not yet effective. Some updates that are not applicable or are not consequential to the Company may have been excluded from the list below.

IAS 1 - Presentation of Financial Statements ("IAS 1") - Classification of Liabilities as Current or Noncurrent were amended to clarify that the classification of liabilities as current or non-current is based on rights that are in existence at the end of the reporting period, specify that classification is unaffected by expectations about whether an entity will exercise its right to defer settlement of a liability, explain that rights are in existence if covenants are complied with at the end of the reporting period, and introduce a definition of 'settlement' to make clear that settlement refers to the transfer to the counterparty of cash, equity instruments, other assets or services. The amendments are effective for annual reporting periods beginning on or after January 1, 2023. Earlier adoption is permitted.

 

IAS 16 - Property, Plant and Equipment - Proceeds before Intended Use - The amendments prohibit deducting from the cost of an item of property, plant and equipment any proceeds from selling items produced before that asset is available for use, i.e. proceeds while bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management. Consequently, an entity recognizes such sales proceeds and related costs in profit or loss. The entity measures the cost of those items in accordance with IAS 2 Inventories. The amendments are effective for annual reporting periods beginning on or after January 1, 2022. Earlier adoption is permitted.

These new and amended standards are not expected to have a material impact on the Company's Financial Statements

XML 48 R29.htm IDEA: XBRL DOCUMENT v3.23.1
SIGNIFICANT ACCOUNTING POLICIES (Tables)
12 Months Ended
Nov. 30, 2022
Disclosure Of Significant Accounting Policies [Abstract]  
Disclosure of subsidiaries [Table Text Block]
Entity Country of Incorporation Effective Economic
Interest
     
Plymouth Rock Technologies Inc.
("Plymouth Rock USA")
USA 100%
     
Plymouth Rock Technologies Inc.
("PRT UK")
UK 100%
     
Tetra Drones Ltd. ("Tetra Drones") UK 100%
Disclosure of depreciation rates applicable to each category of property and equipment [Table Text Block]
Computer equipment    55% declining balance Vehicles                             30% declining balance
Furniture                       20% declining balance Leasehold improvements  30% declining balance
Demo equipment          20% declining balance  
XML 49 R30.htm IDEA: XBRL DOCUMENT v3.23.1
ACQUISITION (Tables)
12 Months Ended
Nov. 30, 2022
Disclosure of detailed information about business combination [abstract]  
Disclosure of purchase price allocation [Table Text Block]
Total Consideration      
Cash $ 579,682  
       
Net assets acquired (liabilities assumed)      
Cash indebtedness $ (12,127 )
Equipment   27,799  
Prepaid expenses   11,131  
Due to a related party   (13,699 )
Bank loan   (40,447 )
Accounts payable   (19,210 )
Vehicle loan   (30,859 )
Net assets acquired (liabilities assumed) $ (77,412 )
       
Purchase price allocation      
Net identifiable assets acquired $ (77,412 )
Customer relationships   657,094  
  $ 579,682  
XML 50 R31.htm IDEA: XBRL DOCUMENT v3.23.1
PREPAID EXPENSES (Tables)
12 Months Ended
Nov. 30, 2022
Disclosure Of Detail Information About Prepaid Expenses [Abstract]  
Disclosure of prepaid expenses [Table Text Block]
    November 30, 2022     November 30, 2021  
             
Advertising and promotions $ 113   $ 127,664  
Rent   8,247     11,211  
Transfer agent and filing fees   13,748     13,020  
Insurance   8,839     8,382  
Others   -     18,044  
  $ 30,947   $ 178,321  
XML 51 R32.htm IDEA: XBRL DOCUMENT v3.23.1
EQUIPMENT (Tables)
12 Months Ended
Nov. 30, 2022
Property, plant and equipment [abstract]  
Disclosure of property, plant and equipment [Table Text Block]
    Computer     Furniture     Vehicles     Leasehold
Improvement
    Demo
Equipment
    Total  
    $     $     $     $     $     $  
Cost:                                    
Balance at November 30, 2020   1,684     12,151     -     -     57,518     71,353  
Additions   22,664     7,244     16,243     3,881     184,484     234,516  
Foreign currency translation adjustment   (320 )   (124 )   (229 )   (55 )   (2,255 )   (2,983 )
Balance at November 30, 2021   24,028     19,271     16,014     3,826     239,747     302,886  
    Disposal   -     -     (16,243 )   -     -     (16,243 )
Foreign currency translation adjustment   (997 )   190     229     (182 )   3,158     2,398  
Balance at November 30, 2022   23,031     19,461     -     3,644     242,905     289,041  
                                     
Accumulated Depreciation:                                    
Balance at November 30, 2020   1,134     3,401     -     -     -     4,535  
Amortization   561     2,055     1,201     287     -     4,104  
Foreign currency translation adjustment   21     17     17     4     -     59  
Balance at November 30, 2021   1,716     5,473     1,218     291     -     8,698  
Amortization   9,236     2,688     4,210     1,006     -     17,140  
Disposal   -     -     (5,375 )   -     -     (5,375 )
Impairment                           236,677     236,677  
Foreign currency translation adjustment   642     296     (53 )   (13 )   6,228     7,100  
Balance at November 30, 2022   11,594     8,457     -     1,284     242,905     264,240  
                                     
Net Book Value:                                    
At November 30, 2021   22,312     13,798     14,796     3,535     239,747     294,188  
At November 30, 2022   11,437     11,004     -     2,360     -     24,801  
XML 52 R33.htm IDEA: XBRL DOCUMENT v3.23.1
INTANGIBLE ASSETS (Tables)
12 Months Ended
Nov. 30, 2022
Intangible assets and goodwill [abstract]  
Disclosure of intangible assets [Table Text Block]
Cost:   Customer relationship  
Balance at November 30, 2020 $ -  
    Additions   657,094  
Balance at November 30, 2021 and November 30, 2022   657,094  
       
Accumulated amortization:      
Balance at November 30, 2020   -  
    Amortization   (107,415 )
Balance at November 30, 2021   (107,415 )
    Amortization   (219,029 )
    Impairment   (330,650 )
Balance at November 30, 2022   (657,094 )
Net book value      
Balance at November 30, 2021 $ 549,679  
Balance at November 30, 2022 $ -  
XML 53 R34.htm IDEA: XBRL DOCUMENT v3.23.1
ACCOUNTS PAYABLE (Tables)
12 Months Ended
Nov. 30, 2022
Disclosure Of Detail Information About Accounts Payable [Abstract]  
Disclosure of accounts payable [Table Text Block]
    November 30, 2022     November 30, 2021  
             
Professional fees $ 382,805   $ 92,078  
Funds to be returned to investors   43,046     43,046  
Due to former shareholder of Tetra (Note 3, 19)   -     222,771  
Advertising costs   34,705     42,241  
Payroll   268,610     33,173  
Development costs   168,925     123,334  
Bank overdraft   16,036     -  
VAT Payable   61,262     4,735  
Purchases   2,121     -  
Rent   1,822     -  
Others   84,531     47,007  
  $ 1,063,863   $ 608,385  
XML 54 R35.htm IDEA: XBRL DOCUMENT v3.23.1
RELATED PARTY TRANSACTIONS AND BALANCES (Tables)
12 Months Ended
Nov. 30, 2022
Related party transactions [abstract]  
Disclosure of amounts due to directors and officers [Table Text Block]
    November 30, 2022     November 30, 2021  
Company controlled by the CFO $ 67,540   $ -  
Company controlled by the Corporate Secretary   -     10,500  
CEO of the Company   250,179     561  
Director   387,953     41,667  
  $ 705,672   $ 52,728  
Disclosure of transactions between related parties [Table Text Block]
    November 30, 2022     November 30, 2021     November 30, 2020  
Management fees $ 311,535   $ 118,000   $ 114,125  
Consulting fees   135,000     307,734     166,667  
Accounting fees   -     36,202     22,852  
Rent   -     5,000     20,000  
Share-based payments   -     410,132     271,993  
Salaries and benefits to CEO   330,337     313,626     133,387  
  $ 776,872   $ 1,190,694   $ 729,024  
Disclosure of management fees explanatory [Table Text Block]
    November 30, 2022     November 30, 2021     November 30, 2020  
Company controlled by CEO $ 243,387   $ 63,000   $ 55,125  
Company controlled by the Former CFO   -     55,000     59,000  
Company controlled by the CFO   68,148     -     -  
  $ 311,535   $ 118,000   $ 114,125  
Disclosure of consulting fees explanatory [Table Text Block]
    November 30, 2022     November 30, 2021     November 30, 2020  
Company controlled by the Former Corporate Secretary $ 60,000   $ -   $ -  
Directors   75,000     307,734     166,667  
  $ 135,000   $ 307,734   $ 166,667  
Disclosure of information about key management personnel [Table Text Block]
    November 30, 2022     November 30, 2021     November 30, 2020  
    Number of
Options
held
    Expense
for the year
(vested)
    Number of
options held
    Expense for
the year
(vested)
    Number of
Options held
    Expense
for the year
(vested)
 
CEO   600,000   $ -     600,000   $ 133,275     400,000   $ 44,455  
Former CFO   150,000     -     150,000     33,319     100,000     11,113  
Former Corporate Secretary   150,000     -     150,000     33,319     100,000     11,113  
Directors   750,000     -     825,000     210,219     1,050,000     205,312  
    1,650,000   $ -     1,725,000   $ 410,132     1,650,000   $ 271,993  
XML 55 R36.htm IDEA: XBRL DOCUMENT v3.23.1
SHARE CAPITAL (Tables)
12 Months Ended
Nov. 30, 2022
Disclosure of classes of share capital [abstract]  
Disclosure of number and weighted average exercise prices of share options [Table Text Block]
    Number of     Weighted Average  
  Options     Exercise Price  
Balance, November 30, 2020   2,950,000   $ 0.58  
Granted   1,700,000     0.73  
Exercised   (425,000 )   0.52  
Balance, November 30, 2021   4,225,000   $ 0.65  
Expired   (75,000 )   0.50  
Cancelled   (125,000 )   0.50  
Balance, November 30, 2022   4,025,000   $ 0.66  
Disclosure of number and weighted average remaining contractual life of outstanding share options [Table Text Block]
Expiry Date Exercise
Price
  Numbers of
options
outstanding
    Numbers of
options
exercisable
    Weighted average
remaining
contractual life (year)
    Weighted
average
exercise price
 
  $                     $  
January 15, 2024 0.60   2,050,000     2,050,000     0.57     0.31  
March 20, 2024 0.60   150,000     150,000     0.05     0.02  
November 28, 2024 0.50   125,000     125,000     0.06     0.02  
January 21, 2026 0.75   1,550,000     1,550,000     1.21     0.29  
June 10, 2026 0.50   150,000     150,000     0.13     0.02  
      4,025,000     4,025,000     2.03     0.66  
Disclosure of share purchase warrant transactions [Table Text Block]
    Number of Warrants     Weighted Average Exercise Price  
Balance, November 30, 2019   -   $ -  
Warrants granted   7,539,748     0.90  
Warrants exercised   (1,233,334 )   0.11  
Balance, November 30, 2020   6,306,414     0.23  
Warrants granted   9,814,400     0.08  
Warrants exercised   (6,129,573 )   0.01  
Balance, November 30, 2021   9,991,241     0.42  
Warrants expired   (561,081 )   0.20  
Balance, November 30, 2022   9,430,160   $ 0.41  
Disclosure of number of share purchase warrants outstanding [Table Text Block]
Expiry Date   Exercise
Price
$
    Number of Warrants
outstanding and
exercisable
    Weighted average
remaining
contractual life (year)
    Weighted average
exercise price
$
 
January 29, 2026   0.25     3,188,160     1.07     0.08  
      August 9, 2026   0.50     6,242,000     2.17     0.33  
          9,430,160     3.17     0.41  
XML 56 R37.htm IDEA: XBRL DOCUMENT v3.23.1
SUPPLEMENTAL CASH FLOW INFORMATION (Tables)
12 Months Ended
Nov. 30, 2022
Supplemental Cash Flows Information Abstract  
Disclosure of supplemental cash flow information [Table Text Block]
    November 30,
2022
    November 30,
2021
    November 30,
2020
 
Non-cash financing activities:                  
Fair value of options exercised   -     158,106     -  
Fair value of warrants granted   -     174,427     83,109  
Fair value of warrants exercised   -     36,859     -  
Shares issued for finders   -     100,500     -  
Non-cash investing activities:                  
Shares to be issued to acquisition of inventory   -     -     22,800  
XML 57 R38.htm IDEA: XBRL DOCUMENT v3.23.1
RIGHT-OF-USE ASSETS AND LEASE LIABILITY (Tables)
12 Months Ended
Nov. 30, 2022
Right Of Use Assets And Lease Liability [Abstract]  
Disclosure of continuity of the cost and accumulated amortization of right-of-use assets [Table Text Block]
Balance, November 30, 2020 $ 114,648  
Amortization expense   (35,654 )
Cumulative translation adjustment   (6,260 )
Balance, November 30, 2021 $ 72,734  
Additions   38,027  
Amortization expense   (50,571 )
Cumulative translation adjustment   1,008  
Balance, November 30, 2022 $ 61,198  
Disclosure of continuity of lease liability [Table Text Block]
Balance, November 30, 2020 $ 113,340  
Lease payments   (48,175 )
Interest on lease liability   14,760  
Cumulative translation adjustment   (5,079 )
Balance, November 30, 2021 $ 86,346  
Additions   38,027  
Lease payments   (72,727 )
Interest on lease liability   18,877  
Cumulative translation adjustment   5,274  
Balance, November 30, 2022 $ 75,797  
Current Portion $ 66,403  
Long-term portion $ 9,394  
Disclosure of minimum lease payments for the lease liabilities [Table Text Block]
    November 30,
2022
    November 30,
2021
 
Year ending:            
2022 $ -   $ 48,943  
2023   72,664     50,403  
2024   9,716     -  
    82,380     99,346  
Less: Interest expense on lease liabilities   (6,583 )   (13,000 )
Total present value of minimum lease payments $ 75,797   $ 86,346  
XML 58 R39.htm IDEA: XBRL DOCUMENT v3.23.1
BREAKDOWN OF EXPENSES (Tables)
12 Months Ended
Nov. 30, 2022
Disclosure of attribution of expenses by nature to their function [abstract]  
Disclosure of breakdown of expenses [Table Text Block]
          Year ended November 30,  
General and Administrative Expenses   Note     2022     2021     2020  
Accounting and audit fees   9   $ 223,247   $ 80,162   $ 67,282  
Amortization   5, 6, 17     286,743     143,783     41,201  
Consulting fees   9     143,539     456,296     275,182  
General office expenses         153,403     205,710     111,394  
Insurance         39,007     21,837     11,928  
Interest and accretion   17     18,877     14,760     20,449  
Legal fees         77,011     191,686     74,528  
Management fees   9     311,535     118,000     110,125  
Rent         47,317     42,822     35,325  
Stock-based compensation   9, 13     -     1,144,342     479,107  
Transfer agent and filing fees   13     59,385     82,825     77,919  
Wages, salaries and benefits   9     985,916     817,858     292,218  
Total       $ 2,345,980   $ 3,320,081   $ 1,596,658  
                         
Research and Development         2022     2021     2020  
Labor       $ 182,774   $ 930,269   $ 386,044  
Materials         50,491     54,737     -  
Total       $ 233,265   $ 985,006   $ 386,044  
XML 59 R40.htm IDEA: XBRL DOCUMENT v3.23.1
SEGMENTED INFORMATION (Tables)
12 Months Ended
Nov. 30, 2022
Disclosure of operating segments [abstract]  
Disclosure of revenue and long-lived assets by geographical location [Table Text Block]
      Canada     USA     UK     Total  
For the year ended November 30, 2022                        
  Revenues $ -   $ 154,625   $ 452,734   $ 607,359  
  Gross Profit   -     97,115     319,069     416,184  
For the year ended November 30, 2021                        
  Revenues $ -   $ 79,795   $ 104,601   $ 184,396  
  Gross Profit   -     27,703     53,584     81,287  
For the year ended November 30, 2020                        
  Revenues $ -   $ 70,931   $ -   $ 70,931  
  Gross Profit   -     39,615     -     39,615  
XML 60 R41.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES (Tables)
12 Months Ended
Nov. 30, 2022
Income taxes paid (refund) [abstract]  
Disclosure of detailed information about effective income tax expense (recovery) [Table Text Block]
    2022     2021     2020  
Net loss before tax and comprehensive loss   (2,667,798 )   (4,944,231 ) $ (2,924,236 )
Combined statutory tax rate   19% to 27%     19% to 29.7%     27.00%  
Expected income tax (recovery) $ (720,000 ) $ (1,278,990 ) $ (789,544 )
Permanent differences   138,000     310,228     -  
Non-deductible items and others   1,618,000     19,811     44,866  
Change in deferred tax assets not recognized   (1,036,000 )   948,951     744,678  
Income tax expense (recovery) $ -   $ -   $ -  
Disclosure of temporary difference, unused tax losses and unused tax credits [Table Text Block]
    2022     2021  
Non-capital losses $ 1,657,000   $ 2,641,159  
Capital losses   21,000     21,062  
Equipment   -     1,511  
Share issuance costs   48,000     29,036  
Intangible assets   -     397,156  
Others   -     13,498  
Net deferred tax assets $ 1,726,000   $ 3,103,422  
Disclosure of non-capital loss carryforwards [Table Text Block]
Expiry   2022  
2038   675,203  
2039   2,350,798  
2040   2,443,638  
2041   3,591,486  
2042   1,910,598  
TOTAL $ 10,971,723  
XML 61 R42.htm IDEA: XBRL DOCUMENT v3.23.1
NATURE OF OPERATIONS AND ABILITY TO CONTINUE AS A GOING CONCERN (Narrative) (Details) - CAD ($)
12 Months Ended
Nov. 30, 2022
Nov. 30, 2021
Nov. 30, 2020
Nature Of Operations And Ability To Continue As Going Concern Abstract      
Comprehensive loss $ 2,739,060 $ 4,944,231 $ 2,904,690
Accumulated deficit 16,535,760 13,867,962  
Net cash proceeds pursuant to financing activities $ 70,299 $ 4,326,442 $ 1,587,091
XML 62 R43.htm IDEA: XBRL DOCUMENT v3.23.1
SIGNIFICANT ACCOUNTING POLICIES - Disclosure of subsidiaries (Details)
12 Months Ended
Nov. 30, 2022
Plymouth Rock USA [Member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation USA
Effective Economic Interest 100.00%
PRT UK [Member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation UK
Effective Economic Interest 100.00%
Tetra Drones [Member]  
Disclosure of subsidiaries [line items]  
Country of Incorporation UK
Effective Economic Interest 100.00%
XML 63 R44.htm IDEA: XBRL DOCUMENT v3.23.1
SIGNIFICANT ACCOUNTING POLICIES - Disclosure of depreciation rates applicable to each category of property and equipment (Detail)
12 Months Ended
Nov. 30, 2022
Computer equipment [Member]  
Disclosure of detailed information about property, plant and equipment [line items]  
Depreciation method declining balance
Depreciation rates 55.00%
Furniture [Member]  
Disclosure of detailed information about property, plant and equipment [line items]  
Depreciation method declining balance
Depreciation rates 20.00%
Demo equipment [Member]  
Disclosure of detailed information about property, plant and equipment [line items]  
Depreciation method declining balance
Depreciation rates 20.00%
Vehicles [Member]  
Disclosure of detailed information about property, plant and equipment [line items]  
Depreciation method declining balance
Depreciation rates 30.00%
Leasehold Improvement [Member]  
Disclosure of detailed information about property, plant and equipment [line items]  
Depreciation method declining balance
Depreciation rates 30.00%
XML 64 R45.htm IDEA: XBRL DOCUMENT v3.23.1
ACQUISITION (Narrative) (Details) - Tetra [Member]
Jun. 04, 2021
CAD ($)
Jun. 04, 2021
GBP (£)
Disclosure of detailed information about business combination [line items]    
Percentage of interest acquired 100.00% 100.00%
Consideration payable $ 579,682 £ 350,000
Amount (paid) within 7 days [Member]    
Disclosure of detailed information about business combination [line items]    
Consideration payable 60,021 35,000
Amount (paid) within 21 days [Member]    
Disclosure of detailed information about business combination [line items]    
Consideration payable 60,479 35,000
Amount (paid) within 120 days [Member]    
Disclosure of detailed information about business combination [line items]    
Consideration payable 236,411 140,000
Remaining balance [Member]    
Disclosure of detailed information about business combination [line items]    
Consideration payable $ 222,771 £ 140,000
XML 65 R46.htm IDEA: XBRL DOCUMENT v3.23.1
ACQUISITION - Disclosure of detailed information about purchase price allocation (Details) - Jun. 04, 2021 - Tetra [Member]
CAD ($)
GBP (£)
Disclosure of detailed information about business combination [line items]    
Cash $ 579,682  
Net assets acquired (liabilities assumed)    
Cash indebtedness (12,127)  
Equipment 27,799  
Prepaid expenses 11,131  
Due to a related party (13,699)  
Bank loan (40,447)  
Accounts payable (19,210)  
Vehicle loan (30,859)  
Net assets acquired (liabilities assumed) (77,412)  
Net identifiable assets acquired (77,412)  
Customer relationships 657,094  
Total Consideration $ 579,682 £ 350,000
XML 66 R47.htm IDEA: XBRL DOCUMENT v3.23.1
PREPAID EXPENSES (Narrative) (Details) - CAD ($)
Nov. 30, 2022
Nov. 30, 2021
Disclosure Of Detail Information About Prepaid Expenses [Abstract]    
Prepayment to related parties $ 0 $ 5,513
XML 67 R48.htm IDEA: XBRL DOCUMENT v3.23.1
PREPAID EXPENSES - Disclosure of prepaid expenses (Details) - CAD ($)
Nov. 30, 2022
Nov. 30, 2021
Prepaid Expenses [Line Items]    
Prepaid expenses $ 30,947 $ 178,321
Advertising and promotions [Member]    
Prepaid Expenses [Line Items]    
Prepaid expenses 113 127,664
Rent [Member]    
Prepaid Expenses [Line Items]    
Prepaid expenses 8,247 11,211
Transfer agent and filing fees [Member]    
Prepaid Expenses [Line Items]    
Prepaid expenses 13,748 13,020
Insurance [Member]    
Prepaid Expenses [Line Items]    
Prepaid expenses 8,839 8,382
Others [Member]    
Prepaid Expenses [Line Items]    
Prepaid expenses $ 0 $ 18,044
XML 68 R49.htm IDEA: XBRL DOCUMENT v3.23.1
EQUIPMENT - Disclosure of property, plant and equipment (Details) - CAD ($)
12 Months Ended
Nov. 30, 2022
Nov. 30, 2021
Nov. 30, 2020
Disclosure of detailed information about property, plant and equipment [line items]      
Beginning balance $ 294,188    
Impairment (236,677) $ 0 $ 0
Ending balance 24,801 294,188  
Cost [Member]      
Disclosure of detailed information about property, plant and equipment [line items]      
Beginning balance 302,886 71,353  
Disposal (16,243)    
Additions   234,516  
Foreign currency translation adjustment 2,398 (2,983)  
Ending balance 289,041 302,886 71,353
Accumulated Depreciation [Member]      
Disclosure of detailed information about property, plant and equipment [line items]      
Beginning balance (8,698) (4,535)  
Amortization 17,140 4,104  
Disposal (5,375)    
Impairment 236,677    
Foreign currency translation adjustment 7,100 59  
Ending balance (264,240) (8,698) (4,535)
Computer [Member]      
Disclosure of detailed information about property, plant and equipment [line items]      
Beginning balance 22,312    
Ending balance 11,437 22,312  
Computer [Member] | Cost [Member]      
Disclosure of detailed information about property, plant and equipment [line items]      
Beginning balance 24,028 1,684  
Disposal 0    
Additions   22,664  
Foreign currency translation adjustment (997) (320)  
Ending balance 23,031 24,028 1,684
Computer [Member] | Accumulated Depreciation [Member]      
Disclosure of detailed information about property, plant and equipment [line items]      
Beginning balance (1,716) (1,134)  
Amortization 9,236 561  
Disposal 0    
Foreign currency translation adjustment 642 21  
Ending balance (11,594) (1,716) (1,134)
Furniture [Member]      
Disclosure of detailed information about property, plant and equipment [line items]      
Beginning balance 13,798    
Ending balance 11,004 13,798  
Furniture [Member] | Cost [Member]      
Disclosure of detailed information about property, plant and equipment [line items]      
Beginning balance 19,271 12,151  
Disposal 0    
Additions   7,244  
Foreign currency translation adjustment 190 (124)  
Ending balance 19,461 19,271 12,151
Furniture [Member] | Accumulated Depreciation [Member]      
Disclosure of detailed information about property, plant and equipment [line items]      
Beginning balance (5,473) (3,401)  
Amortization 2,688 2,055  
Disposal 0    
Foreign currency translation adjustment 296 17  
Ending balance (8,457) (5,473) (3,401)
Vehicles [Member]      
Disclosure of detailed information about property, plant and equipment [line items]      
Beginning balance 14,796    
Ending balance 0 14,796  
Vehicles [Member] | Cost [Member]      
Disclosure of detailed information about property, plant and equipment [line items]      
Beginning balance 16,014 0  
Disposal (16,243)    
Additions   16,243  
Foreign currency translation adjustment 229 (229)  
Ending balance 0 16,014 0
Vehicles [Member] | Accumulated Depreciation [Member]      
Disclosure of detailed information about property, plant and equipment [line items]      
Beginning balance (1,218) 0  
Amortization 4,210 1,201  
Disposal (5,375)    
Foreign currency translation adjustment (53) 17  
Ending balance (0) (1,218) 0
Leasehold Improvement [Member]      
Disclosure of detailed information about property, plant and equipment [line items]      
Beginning balance 3,535    
Ending balance 2,360 3,535  
Leasehold Improvement [Member] | Cost [Member]      
Disclosure of detailed information about property, plant and equipment [line items]      
Beginning balance 3,826 0  
Disposal 0    
Additions   3,881  
Foreign currency translation adjustment (182) (55)  
Ending balance 3,644 3,826 0
Leasehold Improvement [Member] | Accumulated Depreciation [Member]      
Disclosure of detailed information about property, plant and equipment [line items]      
Beginning balance (291) 0  
Amortization 1,006 287  
Disposal 0    
Foreign currency translation adjustment (13) 4  
Ending balance (1,284) (291) 0
Demo Equipment [Member]      
Disclosure of detailed information about property, plant and equipment [line items]      
Beginning balance 239,747    
Ending balance 0 239,747  
Demo Equipment [Member] | Cost [Member]      
Disclosure of detailed information about property, plant and equipment [line items]      
Beginning balance 239,747 57,518  
Disposal 0    
Additions   184,484  
Foreign currency translation adjustment 3,158 (2,255)  
Ending balance 242,905 239,747 57,518
Demo Equipment [Member] | Accumulated Depreciation [Member]      
Disclosure of detailed information about property, plant and equipment [line items]      
Beginning balance 0 0  
Amortization 0 0  
Disposal 0    
Impairment 236,677    
Foreign currency translation adjustment 6,228 0  
Ending balance $ (242,905) $ 0 $ 0
XML 69 R50.htm IDEA: XBRL DOCUMENT v3.23.1
INTANGIBLE ASSETS (Narrative) (Details) - CAD ($)
12 Months Ended
Nov. 30, 2022
Nov. 30, 2021
Nov. 30, 2020
Disclosure of detailed information about intangible assets [line items]      
Intangible assets other than goodwill $ 0 $ 549,679  
Research and development costs 233,265 985,006 $ 386,044
Customer relationship [Member]      
Disclosure of detailed information about intangible assets [line items]      
Intangible assets other than goodwill $ 0 549,679  
Estimated useful life three years    
Customer relationship [Member] | Cost [Member]      
Disclosure of detailed information about intangible assets [line items]      
Intangible assets other than goodwill $ 657,094 $ 657,094 $ 0
XML 70 R51.htm IDEA: XBRL DOCUMENT v3.23.1
INTANGIBLE ASSETS - Disclosure of detailed information about Intangible assets (Details) - CAD ($)
12 Months Ended
Nov. 30, 2022
Nov. 30, 2021
Disclosure of detailed information about intangible assets [line items]    
Beginning balance $ 549,679  
Ending balance 0 $ 549,679
Customer relationship [Member]    
Disclosure of detailed information about intangible assets [line items]    
Beginning balance 549,679  
Ending balance 0 549,679
Cost [Member] | Customer relationship [Member]    
Disclosure of detailed information about intangible assets [line items]    
Beginning balance 657,094 0
Additions   657,094
Ending balance 657,094 657,094
Accumulated amortization [Member] | Customer relationship [Member]    
Disclosure of detailed information about intangible assets [line items]    
Beginning balance (107,415) 0
Amortization (219,029) (107,415)
Impairment (330,650)  
Ending balance $ (657,094) $ (107,415)
XML 71 R52.htm IDEA: XBRL DOCUMENT v3.23.1
ACCOUNTS PAYABLE - Disclosure of accounts payable (Details) - CAD ($)
Nov. 30, 2022
Nov. 30, 2021
Trade And Other Payable [Line Items]    
Accounts payable $ 1,063,863 $ 608,385
Professional fees [Member]    
Trade And Other Payable [Line Items]    
Accounts payable 382,805 92,078
Funds to be returned to investors [Member]    
Trade And Other Payable [Line Items]    
Accounts payable 43,046 43,046
Due to former shareholder of Tetra [Member]    
Trade And Other Payable [Line Items]    
Accounts payable 0 222,771
Advertising costs [Member]    
Trade And Other Payable [Line Items]    
Accounts payable 34,705 42,241
Payroll [Member]    
Trade And Other Payable [Line Items]    
Accounts payable 268,610 33,173
Development costs [Member]    
Trade And Other Payable [Line Items]    
Accounts payable 168,925 123,334
Bank Overdraft [Member]    
Trade And Other Payable [Line Items]    
Accounts payable 16,036 0
VAT Payable [Member]    
Trade And Other Payable [Line Items]    
Accounts payable 61,262 4,735
Purchases [Member]    
Trade And Other Payable [Line Items]    
Accounts payable 2,121 0
Rent [Member]    
Trade And Other Payable [Line Items]    
Accounts payable 1,822 0
Others [Member]    
Trade And Other Payable [Line Items]    
Accounts payable $ 84,531 $ 47,007
XML 72 R53.htm IDEA: XBRL DOCUMENT v3.23.1
Deferred Revenue (Narrative) (Details) - CAD ($)
12 Months Ended
Nov. 30, 2022
Nov. 30, 2021
Disclosure of disaggregation of revenue from contracts with customers [abstract]    
Deferred Revenue $ 124,918 $ 0
XML 73 R54.htm IDEA: XBRL DOCUMENT v3.23.1
RELATED PARTY TRANSACTIONS AND BALANCES (Narrative) (Details) - CAD ($)
1 Months Ended 12 Months Ended
Sep. 30, 2020
Aug. 21, 2020
Nov. 30, 2022
Nov. 30, 2021
Nov. 30, 2020
Disclosure of transactions between related parties [line items]          
Due from directors and officers     $ 0 $ 5,513  
Due to directors and officers     $ 705,672 $ 52,728  
Common shares issued as compensation for consulting fees     78,125 656,250 500,000
Value of common shares issued as compensation for consulting fees       $ 307,734 $ 125,000
Directors [Member]          
Disclosure of transactions between related parties [line items]          
Due to directors and officers     $ 387,953 41,667  
Value of common shares issued as compensation for consulting fees $ 62,500 $ 62,500 $ 17,189 $ 307,734 $ 125,000
Number of Options held     750,000 825,000 1,050,000
Former CFO [Member]          
Disclosure of transactions between related parties [line items]          
Number of Options held     150,000 150,000 100,000
Related parties [Member]          
Disclosure of transactions between related parties [line items]          
Number of Options held     1,650,000 1,725,000 1,650,000
XML 74 R55.htm IDEA: XBRL DOCUMENT v3.23.1
RELATED PARTY TRANSACTIONS AND BALANCES - Disclosure of amounts due to directors and officers (Details) - CAD ($)
Nov. 30, 2022
Nov. 30, 2021
Disclosure of transactions between related parties [line items]    
Due to directors and officers $ 705,672 $ 52,728
Company controlled by the CFO [Member]    
Disclosure of transactions between related parties [line items]    
Due to directors and officers 67,540 0
Company controlled by the Corporate Secretary [Member]    
Disclosure of transactions between related parties [line items]    
Due to directors and officers 0 10,500
CEO of the Company [Member]    
Disclosure of transactions between related parties [line items]    
Due to directors and officers 250,179 561
Director [Member]    
Disclosure of transactions between related parties [line items]    
Due to directors and officers $ 387,953 $ 41,667
XML 75 R56.htm IDEA: XBRL DOCUMENT v3.23.1
RELATED PARTY TRANSACTIONS AND BALANCES - Disclosure of transactions between related parties (Details) - CAD ($)
12 Months Ended
Nov. 30, 2022
Nov. 30, 2021
Nov. 30, 2020
Disclosure of transactions between related parties [line items]      
Consulting fees $ 135,000 $ 307,734 $ 166,667
Share-based payments 0 1,144,342 479,107
Related parties [Member]      
Disclosure of transactions between related parties [line items]      
Management fees 311,535 118,000 114,125
Consulting fees 135,000 307,734 166,667
Accounting fees 0 36,202 22,852
Rent 0 5,000 20,000
Share-based payments 0 410,132 271,993
Salaries and benefits to CEO 330,337 313,626 133,387
Transactions with related parties $ 776,872 $ 1,190,694 $ 729,024
XML 76 R57.htm IDEA: XBRL DOCUMENT v3.23.1
RELATED PARTY TRANSACTIONS AND BALANCES - Disclosure of information about key management personnel (Details) - CAD ($)
12 Months Ended
Nov. 30, 2022
Nov. 30, 2021
Nov. 30, 2020
Company controlled by CEO [Member]      
Disclosure of transactions between related parties [line items]      
Management fees $ 243,387 $ 63,000 $ 55,125
Company controlled by the Former CFO [Member]      
Disclosure of transactions between related parties [line items]      
Management fees 0 55,000 59,000
Company controlled by the CFO [Member]      
Disclosure of transactions between related parties [line items]      
Management fees 68,148 0 0
Related parties [Member]      
Disclosure of transactions between related parties [line items]      
Management fees $ 311,535 $ 118,000 $ 114,125
XML 77 R58.htm IDEA: XBRL DOCUMENT v3.23.1
RELATED PARTY TRANSACTIONS AND BALANCES - Disclosure of consulting fees (Details) - CAD ($)
12 Months Ended
Apr. 01, 2020
Nov. 30, 2022
Nov. 30, 2021
Nov. 30, 2020
Disclosure of transactions between related parties [line items]        
Consulting fees   $ 135,000 $ 307,734 $ 166,667
Company Controlled By Former Corporate Secretary [Member]        
Disclosure of transactions between related parties [line items]        
Consulting fees   60,000 0 0
Directors [Member]        
Disclosure of transactions between related parties [line items]        
Consulting fees $ 250,000 $ 75,000 $ 307,734 $ 166,667
XML 78 R59.htm IDEA: XBRL DOCUMENT v3.23.1
RELATED PARTY TRANSACTIONS AND BALANCES - Disclosure of information about options granted to the CEO, CFO, the Corporate Secretary, and the Company's directors (Details) - CAD ($)
12 Months Ended
Nov. 30, 2022
Nov. 30, 2021
Nov. 30, 2020
Disclosure of transactions between related parties [line items]      
Expense for the year (vested) $ 0 $ 1,144,342 $ 479,107
Related parties [Member]      
Disclosure of transactions between related parties [line items]      
Number of Options held 1,650,000 1,725,000 1,650,000
Expense for the year (vested) $ 0 $ 410,132 $ 271,993
CEO [Member]      
Disclosure of transactions between related parties [line items]      
Number of Options held 600,000 600,000 400,000
Expense for the year (vested) $ 0 $ 133,275 $ 44,455
Former CFO [Member]      
Disclosure of transactions between related parties [line items]      
Number of Options held 150,000 150,000 100,000
Expense for the year (vested) $ 0 $ 33,319 $ 11,113
Former Corporate Secretary [Member]      
Disclosure of transactions between related parties [line items]      
Number of Options held 150,000 150,000 100,000
Expense for the year (vested) $ 0 $ 33,319 $ 11,113
Directors [Member]      
Disclosure of transactions between related parties [line items]      
Number of Options held 750,000 825,000 1,050,000
Expense for the year (vested) $ 0 $ 210,219 $ 205,312
XML 79 R60.htm IDEA: XBRL DOCUMENT v3.23.1
GOVERMENT ASSISTANCE RECEIVED (Narrative) (Details)
12 Months Ended
May 04, 2020
CAD ($)
Nov. 30, 2022
CAD ($)
Nov. 30, 2021
CAD ($)
Nov. 30, 2020
CAD ($)
May 04, 2020
USD ($)
Disclosure of detailed information about borrowings [line items]          
Paycheck protection program   $ 0 $ 0 $ 100,818  
CARES Act Paycheck Protection Program Loan ("PPP Loan") [Member]          
Disclosure of detailed information about borrowings [line items]          
Loan received         $ 75,000
Borrowings, interest rate         1.00%
Paycheck protection program $ 100,000        
XML 80 R61.htm IDEA: XBRL DOCUMENT v3.23.1
LOAN PAYABLE (Narrative) (Details)
1 Months Ended 12 Months Ended
Oct. 25, 2022
GBP (£)
Oct. 25, 2022
USD ($)
Nov. 30, 2022
CAD ($)
Nov. 30, 2022
GBP (£)
Nov. 30, 2022
USD ($)
Nov. 30, 2022
GBP (£)
Nov. 30, 2022
USD ($)
Loans Payable [Line Items]              
Borrowing costs recognised as expense     $ 18,000        
Interest payable     3,000        
Proceeds from loans receivable     105,000        
Tetra [Member]              
Loans Payable [Line Items]              
Latter of outstanding loan           £ 13,253 $ 21,461
Remaining acquisition related cost £ 140,000 $ 222,771   £ 140,000 $ 222,771    
Third Party [Member]              
Loans Payable [Line Items]              
Current borrowings     127,019        
Borrowing costs recognised as expense     75,000        
Interest payable     $ 4,019        
Borrowings, interest rate     12.00%     12.00% 12.00%
Another Third Party [Member]              
Loans Payable [Line Items]              
Borrowing costs recognised as expense     $ 30,000        
Interest payable     $ 3,000        
Borrowings, interest rate     10.00%     10.00% 10.00%
XML 81 R62.htm IDEA: XBRL DOCUMENT v3.23.1
SHARE CAPITAL (Narrative) (Details)
1 Months Ended 12 Months Ended
Aug. 09, 2021
CAD ($)
Year
share
$ / shares
Jun. 10, 2021
CAD ($)
Year
share
$ / shares
Aug. 13, 2020
$ / shares
shares
Jul. 03, 2020
$ / shares
shares
May 15, 2020
CAD ($)
share
$ / shares
shares
Feb. 04, 2020
CAD ($)
share
$ / shares
Nov. 12, 2014
Mar. 30, 2023
CAD ($)
share
Mar. 16, 2023
share
Feb. 22, 2023
CAD ($)
share
$ / shares
$ / Unit
Jan. 29, 2021
CAD ($)
Year
share
$ / shares
shares
Jan. 21, 2021
CAD ($)
Year
share
$ / shares
Sep. 30, 2020
CAD ($)
share
$ / shares
shares
Sep. 24, 2020
$ / shares
shares
Sep. 22, 2020
$ / shares
shares
Aug. 21, 2020
CAD ($)
shares
Apr. 24, 2020
CAD ($)
share
$ / shares
shares
Apr. 25, 2018
Nov. 30, 2022
CAD ($)
share
$ / shares
shares
Aug. 09, 2022
CAD ($)
$ / shares
shares
Nov. 30, 2021
CAD ($)
share
$ / shares
shares
Nov. 30, 2020
CAD ($)
share
$ / shares
shares
Apr. 01, 2020
shares
Nov. 30, 2019
shares
Disclosure of classes of share capital [line items]                                                
Number of shares issued | shares     483,334 500,000                 50,000 100,000 100,000           425,000      
Number of share purchase warrants exercised | shares     483,334 500,000                 50,000 100,000 100,000           6,129,573 1,233,334    
Weighted average exercise price of warrants exercised | $ / shares     $ 0.2 $ 0.2                 $ 0.2 $ 0.2 $ 0.2           $ 0.01 $ 0.11    
Proceeds from warrants exercised | $                                         $ 1,332,727 $ 246,667    
Number of units issued | shares         3,718,831           3,180,000           3,128,334     5,750,000        
Price per unit issued | $ / shares         0.15           0.2           0.15     0.4        
Proceeds from units issued | $         $ 557,825           $ 636,000           $ 469,250     $ 2,300,000        
Exercise price of warrants granted | $ / shares         $ 0.2                       $ 0.2       $ 0.08 $ 0.9    
Number of share options exercised | share                                         425,000      
Weighted average exercise price, exercised | $ / shares                                         $ 0.52      
Proceeds from exercise of options | $                                         $ 222,500      
Share issue related cost | $                                           $ 38,727    
Number of warrants granted | share                                         9,814,400 7,539,748    
Percentage of common shares reserved for issuance             10.00%                                  
Number of stock options granted | share                                         1,700,000      
Exercise price of stock options granted | $ / shares                                         $ 0.73      
Remaining contractual life of stock option                                     2 years 10 days          
Number of options Expired | share                                     75,000          
Weighted average exercise price, Expired | $ / shares                                     $ 0.5          
Number of options cancelled | share                                     125,000          
Weighted average exercise price, cancelled | $ / shares                                     $ 0.5          
Stock-based compensation recognized in profit or loss | $                                     $ 0   $ 1,144,342 $ 479,107    
Value of common shares issued as compensation for consulting fees | $                                         $ 307,734 125,000    
Bottom of range [Member]                                                
Disclosure of classes of share capital [line items]                                                
Weighted average exercise price, exercised | $ / shares                                         $ 0.5      
Top of range [Member]                                                
Disclosure of classes of share capital [line items]                                                
Weighted average exercise price, exercised | $ / shares                                         $ 0.6      
Share capital [Member]                                                
Disclosure of classes of share capital [line items]                                                
Proceeds from warrants exercised | $                                         $ 1,332,727 246,667    
Share issue related cost | $                                           $ 38,727    
Number of shares issued and outstanding | shares                                     59,317,461   59,239,336 42,762,264   32,796,600
Common shares issued as compensation for consulting fees | shares                                         656,250 500,000    
Value of common shares issued as compensation for consulting fees | $                                         $ 307,734 $ 125,000    
Aerowave Corporation ("Aerowave") [Member]                                                
Disclosure of classes of share capital [line items]                                                
Number of units issued | shares                         50,000                      
Proceeds from units issued | $                         $ 22,811                      
Exercise price of warrants granted | $ / shares                         $ 0.5                      
Warrants granted, estimated fair value | $                         $ 1,500                      
Warrants granted, exercisable period                                   2 years            
Directors Officers Employee And Consultants [Member]                                                
Disclosure of classes of share capital [line items]                                                
Number of stock options granted | share                       1,550,000                        
Exercise price of stock options granted | $ / shares                       $ 0.75                        
Remaining contractual life of stock option                       5 years                        
Stock price | $ / shares                       $ 0.75                        
Volatility                       100.00%                        
Risk-free rate                       0.43%                        
Dividend yield                       0.00%                        
Expected life | Year                       5                        
Fair value of stock option | $                       $ 1,022,995                        
Consultant [Member]                                                
Disclosure of classes of share capital [line items]                                                
Number of stock options granted | share   150,000                                            
Exercise price of stock options granted | $ / shares   $ 0.5                                            
Remaining contractual life of stock option   5 years                                            
Stock price | $ / shares   $ 0.485                                            
Volatility   100.00%                                            
Risk-free rate   0.82%                                            
Dividend yield   0.00%                                            
Expected life | Year   5                                            
Fair value of stock option | $   $ 53,677                                            
Consultant And Director [Member]                                                
Disclosure of classes of share capital [line items]                                                
Number of options cancelled | share                                         200,000 150,000    
Director [Member]                                                
Disclosure of classes of share capital [line items]                                                
Number of shares issued | shares                                             1,000,000  
Number of shares issued for services | shares                                         78,125      
Value of shares issued for services | $                                         $ 17,189      
Number of stock options granted | share                 150,000                              
Stock-based compensation recognized in profit or loss | $                                     $ 0   $ 210,219 $ 205,312    
Common shares issued as compensation for consulting fees | shares                         250,000     250,000         656,250      
Value of common shares issued as compensation for consulting fees | $                         $ 62,500     $ 62,500     $ 17,189   $ 307,734 $ 125,000    
Private Placements [Member]                                                
Disclosure of classes of share capital [line items]                                                
Number of share purchase warrants exercised | shares                                         4,240      
Weighted average exercise price of warrants exercised | $ / shares                                         $ 0.25      
Number of units issued for private placement | share               7,200,000                                
Proceeds from units issued | $               $ 360,000                                
Exercise price of warrants granted | $ / shares $ 0.5                   $ 0.5                          
Share issue related cost | $         $ 38,727                       $ 38,727              
Number of warrants granted | share 325,750                   222,400                          
Stock price | $ / shares $ 0.35                   $ 0.52                          
Volatility 100.00%                   100.00%                          
Risk-free rate 0.88%                   0.43%                          
Dividend yield 0.00%                   0.00%                          
Expected life | Year 5                   5                          
Fair value of stock option | $ $ 79,032                   $ 95,395                          
Finder's Fees [Member]                                                
Disclosure of classes of share capital [line items]                                                
Exercise price of warrants granted | $ / shares                     $ 0.25                 $ 0.5        
Shares issued for finder's fees, shares | shares                     170,000                 166,250        
Shares issued for finder's fees, value | $                     $ 10,480                 $ 63,700        
Fair value of finders units issued | $                     $ 34,000                 $ 66,500        
Warrants granted, exercisable period                     5 years                 5 years        
Non-brokered private placement financing [Member]                                                
Disclosure of classes of share capital [line items]                                                
Number of share purchase warrants exercised | shares         3,208,333               292,000       2,145,000       30,000      
Weighted average exercise price of warrants exercised | $ / shares         $ 0.2               $ 0.5       $ 0.2       $ 0.25      
Number of units issued for private placement | share           10,000,000       30,000,000                            
Price per unit issued           0.4       0.05                            
Proceeds from units issued | $           $ 4,000,000       $ 1,500,000                            
Exercise price of warrants granted | $ / shares         $ 0.2 $ 0.8       $ 0.1     $ 0.5       $ 0.2              
Number of warrants granted | share         3,718,831               692,583       3,128,334              
Cancelled private placement, amount held | $           $ 4,400                                    
Share Purchase Warrant [Member]                                                
Disclosure of classes of share capital [line items]                                                
Number of shares issued | shares                                         6,129,573      
Number of share purchase warrants exercised | shares                                         6,129,573 561,081    
Weighted average exercise price of warrants exercised | $ / shares                                           $ 0.2    
Proceeds from warrants exercised | $                                         $ 1,332,727      
Number of units issued | shares                         1,335,165                      
Price per unit issued | $ / shares                         0.3                      
Proceeds from units issued | $                         $ 400,550                      
Exercise price of warrants granted | $ / shares $ 0.5                   $ 0.25   $ 0.5             $ 0.5        
Warrants granted, estimated fair value | $                         $ 40,055                      
Warrants granted, exercisable period                     5 years             2 years   5 years        
Number of warrants granted | share 5,916,250                   3,350,000                          
Share Purchase Warrant [Member] | Bottom of range [Member]                                                
Disclosure of classes of share capital [line items]                                                
Weighted average exercise price of warrants exercised | $ / shares                                         $ 0.2      
Share Purchase Warrant [Member] | Top of range [Member]                                                
Disclosure of classes of share capital [line items]                                                
Weighted average exercise price of warrants exercised | $ / shares                                         $ 0.5      
Broker Warrants [Member]                                                
Disclosure of classes of share capital [line items]                                                
Exercise price of warrants granted | $ / shares                     $ 0.25                 $ 0.5        
Shares issued for finder's fees, shares | shares                     222,400                 325,750        
Warrants granted, exercisable period                     5 years                 5 years        
XML 82 R63.htm IDEA: XBRL DOCUMENT v3.23.1
SHARE CAPITAL - Disclosure of number and weighted average exercise prices of share options (Details)
12 Months Ended
Nov. 30, 2022
share
$ / shares
Nov. 30, 2021
share
$ / shares
Disclosure of classes of share capital [abstract]    
Number of options outstanding, beginning balance | share 4,225,000 2,950,000
Weighted average exercise price, beginning balance | $ / shares $ 0.65 $ 0.58
Number of Options held | share   1,700,000
Exercise price of stock options granted | $ / shares   $ 0.73
Number of options exercised | share   (425,000)
Weighted average exercise price, exercised | $ / shares   $ 0.52
Number of options Expired | share (75,000)  
Weighted average exercise price, Expired | $ / shares $ 0.5  
Number of options cancelled | share (125,000)  
Weighted average exercise price, cancelled | $ / shares $ 0.5  
Number of options outstanding, ending balance | share 4,025,000 4,225,000
Weighted average exercise price, ending balance | $ / shares $ 0.66 $ 0.65
XML 83 R64.htm IDEA: XBRL DOCUMENT v3.23.1
SHARE CAPITAL - Disclosure of number and weighted average remaining contractual life of outstanding share options (Details)
12 Months Ended
Nov. 30, 2022
share
$ / shares
Nov. 30, 2021
share
Nov. 30, 2020
share
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]      
Numbers of options outstanding 4,025,000 4,225,000 2,950,000
Numbers of options exercisable 4,025,000    
Weighted average remaining contractual life (year) 2 years 10 days    
Weighted average exercise price | $ / shares $ 0.66    
January 15, 2024 [Member] | Exercise Price 0.60 [Member]      
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]      
Exercise Price | $ / shares $ 0.6    
Numbers of options outstanding 2,050,000    
Numbers of options exercisable 2,050,000    
Weighted average remaining contractual life (year) 6 months 25 days    
Weighted average exercise price | $ / shares $ 0.31    
March 20, 2024 [Member] | Exercise Price 0.60 [Member]      
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]      
Exercise Price | $ / shares $ 0.6    
Numbers of options outstanding 150,000    
Numbers of options exercisable 150,000    
Weighted average remaining contractual life (year) 18 days    
Weighted average exercise price | $ / shares $ 0.02    
November 28, 2024 [Member] | Exercise Price 0.50 [Member]      
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]      
Exercise Price | $ / shares $ 0.5    
Numbers of options outstanding 125,000    
Numbers of options exercisable 125,000    
Weighted average remaining contractual life (year) 21 days    
Weighted average exercise price | $ / shares $ 0.02    
January 21, 2026 [Member] | Exercise Price 0.75 [Member]      
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]      
Exercise Price | $ / shares $ 0.75    
Numbers of options outstanding 1,550,000    
Numbers of options exercisable 1,550,000    
Weighted average remaining contractual life (year) 1 year 2 months 15 days    
Weighted average exercise price | $ / shares $ 0.29    
June 10, 2026 [Member] | Exercise Price 0.50 [Member]      
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]      
Exercise Price | $ / shares $ 0.5    
Numbers of options outstanding 150,000    
Numbers of options exercisable 150,000    
Weighted average remaining contractual life (year) 1 month 17 days    
Weighted average exercise price | $ / shares $ 0.02    
XML 84 R65.htm IDEA: XBRL DOCUMENT v3.23.1
SHARE CAPITAL - Disclosure of share purchase warrant transactions (Details)
1 Months Ended 12 Months Ended
Aug. 13, 2020
$ / shares
shares
Jul. 03, 2020
$ / shares
shares
May 15, 2020
$ / shares
Sep. 30, 2020
$ / shares
shares
Sep. 24, 2020
$ / shares
shares
Sep. 22, 2020
$ / shares
shares
Apr. 24, 2020
$ / shares
Nov. 30, 2022
share
$ / shares
Nov. 30, 2021
share
$ / shares
shares
Nov. 30, 2020
share
$ / shares
shares
Disclosure of classes of share capital [abstract]                    
Warrants outstanding, beginning balance | share               9,991,241 6,306,414 0
Weighted average exercise price, beginning balance               $ 0.42 $ 0.23 $ 0
Warrants granted | share                 9,814,400 7,539,748
Weighted average exercise price of warrants granted     $ 0.2       $ 0.2   $ 0.08 $ 0.9
Warrants expired | share               (561,081)    
Weighted average exercise price of warrants expired               $ 0.2    
Warrants exercised | shares (483,334) (500,000)   (50,000) (100,000) (100,000)     (6,129,573) (1,233,334)
Weighted average exercise price of warrants exercised $ 0.2 $ 0.2   $ 0.2 $ 0.2 $ 0.2     $ 0.01 $ 0.11
Warrants outstanding, ending balance | share               9,430,160 9,991,241 6,306,414
Weighted average exercise price, ending balance               $ 0.41 $ 0.42 $ 0.23
XML 85 R66.htm IDEA: XBRL DOCUMENT v3.23.1
SHARE CAPITAL - Disclosure of number of share purchase warrants outstanding (Details)
12 Months Ended
Nov. 30, 2022
share
$ / shares
Nov. 30, 2021
share
$ / shares
Nov. 30, 2020
share
$ / shares
Nov. 30, 2019
share
$ / shares
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]        
Numbers of warrants outstanding | share 9,430,160 9,991,241 6,306,414 0
Weighted average remaining contractual life (year) 3 years 2 months 1 day      
Weighted average exercise price $ 0.41 $ 0.42 $ 0.23 $ 0
January 29, 2026 [Member]        
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]        
Exercise Price $ 0.25      
Numbers of warrants outstanding | share 3,188,160      
Weighted average remaining contractual life (year) 1 year 25 days      
Weighted average exercise price $ 0.08      
August 9, 2026 [Member]        
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]        
Exercise Price $ 0.5      
Numbers of warrants outstanding | share 6,242,000      
Weighted average remaining contractual life (year) 2 years 2 months 1 day      
Weighted average exercise price $ 0.33      
XML 86 R67.htm IDEA: XBRL DOCUMENT v3.23.1
FINANCIAL RISK MANAGEMENT (Narrative) (Details) - Foreign Currency Risk [Member] - CAD ($)
12 Months Ended
Nov. 30, 2022
Nov. 30, 2021
Nov. 30, 2020
Disclosure of nature and extent of risks arising from financial instruments [line items]      
Potential fluctuations in functional currency exchange rate 10.00%    
Comprehensive loss due to fluctuations in US dollar against the Canadian dollar $ 81,052 $ 1,200 $ 7,085
XML 87 R68.htm IDEA: XBRL DOCUMENT v3.23.1
SUPPLEMENTAL CASH FLOW INFORMATION - Disclosure of supplemental cash flow information (Details) - CAD ($)
12 Months Ended
Nov. 30, 2022
Nov. 30, 2021
Nov. 30, 2020
Non-cash financing activities      
Fair value of options exercised $ 0 $ 158,106 $ 0
Fair value of warrants granted 0 174,427 83,109
Fair value of warrants exercised 0 36,859 0
Shares issued for finders 0 100,500 0
Non-cash investing activities:      
Shares to be issued to acquisition of inventory $ 0 $ 0 $ 22,800
XML 88 R69.htm IDEA: XBRL DOCUMENT v3.23.1
COMMITMENTS AND CONTINGENCIES (Narrative) (Details)
1 Months Ended 12 Months Ended
Apr. 01, 2020
CAD ($)
shares
Nov. 30, 2018
Nov. 30, 2022
CAD ($)
Nov. 30, 2022
GBP (£)
Nov. 30, 2021
CAD ($)
shares
Nov. 30, 2020
CAD ($)
Feb. 04, 2023
CAD ($)
Nov. 30, 2022
USD ($)
Nov. 30, 2020
USD ($)
Sep. 30, 2020
shares
Sep. 24, 2020
shares
Sep. 22, 2020
shares
Aug. 13, 2020
shares
Jul. 03, 2020
shares
Nov. 30, 2019
CAD ($)
Nov. 30, 2019
USD ($)
Disclosure Of Commitments [Line Items]                                
Consulting fees     $ 135,000   $ 307,734 $ 166,667                    
Key management compensation     $ 35,875                          
Without restriction in exchange annual fee | £       £ 1,500                        
Aggregate liability             $ 30,000                  
Number of shares issued | shares         425,000         50,000 100,000 100,000 483,334 500,000    
PRT USA [Member]                                
Disclosure Of Commitments [Line Items]                                
Term of lease   2 years                            
Monthly lease payment, next twelve months               $ 3,188             $ 3,726 $ 3,005
Monthly lease payment, year two           3,838   $ 3,284 $ 3,095              
Barclays Bank PLC [Member]                                
Disclosure Of Commitments [Line Items]                                
Annual lease fee | £       £ 12,000                        
Annual interest rate of lease     4.00% 4.00%                        
Monthly lease payment | £       £ 1,000                        
Director [Member]                                
Disclosure Of Commitments [Line Items]                                
Consulting fees $ 250,000   $ 75,000   $ 307,734 $ 166,667                    
Number of shares issued | shares 1,000,000                              
XML 89 R70.htm IDEA: XBRL DOCUMENT v3.23.1
RIGHT-OF-USE ASSETS AND LEASE LIABILITY (Narrative) (Details)
1 Months Ended 12 Months Ended
Nov. 30, 2018
Nov. 30, 2022
GBP (£)
Nov. 30, 2022
CAD ($)
Nov. 30, 2022
USD ($)
Nov. 30, 2021
CAD ($)
Nov. 30, 2021
USD ($)
Nov. 30, 2020
CAD ($)
Nov. 30, 2020
USD ($)
Nov. 30, 2019
CAD ($)
Nov. 30, 2019
USD ($)
PRT USA [Member]                    
Disclosure of maturity analysis of operating lease payments [line items]                    
Term of lease 2 years                  
Monthly lease payment, next twelve months       $ 3,188         $ 3,726 $ 3,005
Monthly lease payment, year two       3,284     $ 3,838 $ 3,095    
Monthly lease payment, year three         $ 3,953 $ 3,188        
Monthly lease payment, year four     $ 4,072 $ 3,284            
BARCLAYS BANK PLC [Member]                    
Disclosure of maturity analysis of operating lease payments [line items]                    
Annual lease fee   £ 12,000                
Monthly lease payment   £ 1,000                
Annual interest rate of lease   4.00%                
XML 90 R71.htm IDEA: XBRL DOCUMENT v3.23.1
RIGHT-OF-USE ASSETS AND LEASE LIABILITY - Disclosure of continuity of the cost and accumulated amortization of right-of-use assets (Details) - CAD ($)
12 Months Ended
Nov. 30, 2022
Nov. 30, 2021
Right Of Use Assets And Lease Liability [Abstract]    
Opening balance $ 72,734 $ 114,648
Additions 38,027  
Amortization expense (50,571) (35,654)
Cumulative translation adjustment 1,008 (6,260)
Closing balance $ 61,198 $ 72,734
XML 91 R72.htm IDEA: XBRL DOCUMENT v3.23.1
RIGHT-OF-USE ASSETS AND LEASE LIABILITY - Disclosure of continuity of lease liability (Details) - CAD ($)
12 Months Ended
Nov. 30, 2022
Nov. 30, 2021
Right Of Use Assets And Lease Liability [Abstract]    
Opening balance $ 86,346 $ 113,340
Additions 38,027  
Lease payment (72,727) (48,175)
Interest on lease liability 18,877 14,760
Cumulative translation adjustment 5,274 (5,079)
Closing balance 75,797 86,346
Current portion 66,403 39,221
Long-term portion $ 9,394 $ 47,125
XML 92 R73.htm IDEA: XBRL DOCUMENT v3.23.1
RIGHT-OF-USE ASSETS AND LEASE LIABILITY - Disclosure of minimum lease payments for the lease liabilities (Details) - CAD ($)
Nov. 30, 2022
Nov. 30, 2021
Nov. 30, 2020
Disclosure of maturity analysis of operating lease payments [line items]      
Minimum lease payments for lease liabilities $ 82,380 $ 99,346  
Less: Interest expense on lease liabilities (6,583) (13,000)  
Total present value of minimum lease payments 75,797 86,346 $ 113,340
2022 [Member]      
Disclosure of maturity analysis of operating lease payments [line items]      
Minimum lease payments for lease liabilities 0 48,943  
2023 [Member]      
Disclosure of maturity analysis of operating lease payments [line items]      
Minimum lease payments for lease liabilities 72,664 50,403  
2024 [Member]      
Disclosure of maturity analysis of operating lease payments [line items]      
Minimum lease payments for lease liabilities $ 9,716 $ 0  
XML 93 R74.htm IDEA: XBRL DOCUMENT v3.23.1
BREAKDOWN OF EXPENSES (Narrative) (Details) - CAD ($)
12 Months Ended
Nov. 30, 2022
Nov. 30, 2021
Nov. 30, 2020
Disclosure of attribution of expenses by nature to their function [abstract]      
Selling expenses $ 177,428 $ 709,010 $ 1,081,478
XML 94 R75.htm IDEA: XBRL DOCUMENT v3.23.1
BREAKDOWN OF EXPENSES - Disclosure of breakdown of expenses (Details) - CAD ($)
12 Months Ended
Nov. 30, 2022
Nov. 30, 2021
Nov. 30, 2020
Disclosure of attribution of expenses by nature to their function [line items]      
Interest and accretion $ 18,877 $ 14,760  
Stock-based compensation 0 1,144,342 $ 479,107
Total 2,345,980 3,320,081 1,596,658
Total 233,265 985,006 386,044
General and Administrative Expenses [Member]      
Disclosure of attribution of expenses by nature to their function [line items]      
Accounting and audit fees 223,247 80,162 67,282
Amortization 286,743 143,783 41,201
Consulting fees 143,539 456,296 275,182
General office expenses 153,403 205,710 111,394
Insurance 39,007 21,837 11,928
Interest and accretion 18,877 14,760 20,449
Legal fees 77,011 191,686 74,528
Management fees 311,535 118,000 110,125
Rent 47,317 42,822 35,325
Stock-based compensation 0 1,144,342 479,107
Transfer agent and filing fees 59,385 82,825 77,919
Wages, salaries and benefits 985,916 817,858 292,218
Total 2,345,980 3,320,081 1,596,658
Research and Development [Member]      
Disclosure of attribution of expenses by nature to their function [line items]      
Labor 182,774 930,269 386,044
Materials 50,491 54,737 0
Total $ 233,265 $ 985,006 $ 386,044
XML 95 R76.htm IDEA: XBRL DOCUMENT v3.23.1
GAIN ON DEBT FORGIVENESS (Narrative) (Details)
1 Months Ended 12 Months Ended
Oct. 25, 2022
GBP (£)
Oct. 25, 2022
USD ($)
Nov. 30, 2022
CAD ($)
Nov. 30, 2022
GBP (£)
Nov. 30, 2022
USD ($)
Nov. 30, 2021
CAD ($)
Nov. 30, 2020
CAD ($)
Gain On Debt Forgiveness [Line Items]              
Gain on debt forgiveness     $ 234,303     $ 0 $ 0
Tetra [Member]              
Gain On Debt Forgiveness [Line Items]              
Remaining acquisition related cost £ 140,000 $ 222,771   £ 140,000 $ 222,771    
Excess net book value of vehicle loan       £ 7,155 $ 11,532    
XML 96 R77.htm IDEA: XBRL DOCUMENT v3.23.1
SEGMENTED INFORMATION - Disclosure of revenue by geographical location (Details) - CAD ($)
12 Months Ended
Nov. 30, 2022
Nov. 30, 2021
Nov. 30, 2020
Disclosure of operating segments [line items]      
Sales $ 607,359 $ 184,396 $ 70,931
Gross Profit 416,184 81,287 39,615
Canada [Member]      
Disclosure of operating segments [line items]      
Sales 0 0 0
Gross Profit 0 0 0
USA [Member]      
Disclosure of operating segments [line items]      
Sales 154,625 79,795 70,931
Gross Profit 97,115 27,703 39,615
UK [Member]      
Disclosure of operating segments [line items]      
Sales 452,734 104,601 0
Gross Profit $ 319,069 $ 53,584 $ 0
XML 97 R78.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES (Narrative) (Details) - CAD ($)
Nov. 30, 2022
Nov. 30, 2021
Income taxes paid (refund) [abstract]    
Non-capital losses carryforwards $ 10,971,723 $ 9,703,024
XML 98 R79.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES - Disclosure of detailed information about effective income tax expense (recovery) (Details) - CAD ($)
12 Months Ended
Nov. 30, 2022
Nov. 30, 2021
Nov. 30, 2020
Disclosure Of Income Taxes [Line Items]      
Net loss before tax and comprehensive loss $ (2,667,798) $ (4,944,231) $ (2,924,236)
Combined statutory tax rate     27.00%
Expected income tax (recovery) (720,000) (1,278,990) $ (789,544)
Permanent differences 138,000 310,228 0
Non-deductible items and others 1,618,000 19,811 44,866
Change in deferred tax assets not recognized (1,036,000) 948,951 744,678
Income tax expense (recovery) $ 0 $ 0 $ 0
Bottom of range [Member]      
Disclosure Of Income Taxes [Line Items]      
Combined statutory tax rate 19.00% 19.00%  
Top of range [Member]      
Disclosure Of Income Taxes [Line Items]      
Combined statutory tax rate 27.00% 29.70%  
XML 99 R80.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES - Disclosure of temporary difference, unused tax losses and unused tax credits (Details) - CAD ($)
Nov. 30, 2022
Nov. 30, 2021
Income taxes paid (refund) [abstract]    
Non-capital loss $ 1,657,000 $ 2,641,159
Capital losses 21,000 21,062
Equipment 0 1,511
Share issuance costs 48,000 29,036
Intangible assets 0 397,156
Others 0 13,498
Net deferred tax assets $ 1,726,000 $ 3,103,422
XML 100 R81.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES - Disclosure of non-capital loss carryforwards (Details) - CAD ($)
Nov. 30, 2022
Nov. 30, 2021
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]    
Non-capital losses carryforwards $ 10,971,723 $ 9,703,024
2038 [Member]    
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]    
Non-capital losses carryforwards 675,203  
2039 [Member]    
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]    
Non-capital losses carryforwards 2,350,798  
2040 [Member]    
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]    
Non-capital losses carryforwards 2,443,638  
2041 [Member]    
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]    
Non-capital losses carryforwards 3,591,486  
2042 [Member]    
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]    
Non-capital losses carryforwards $ 1,910,598  
XML 101 R82.htm IDEA: XBRL DOCUMENT v3.23.1
SUBSEQUENT EVENTS (Narrative) (Details)
1 Months Ended 12 Months Ended
Mar. 03, 2022
share
Aug. 09, 2021
$ / shares
May 15, 2020
CAD ($)
$ / shares
Feb. 04, 2020
CAD ($)
share
$ / shares
Mar. 30, 2023
CAD ($)
share
Mar. 16, 2023
share
Feb. 22, 2023
CAD ($)
share
$ / shares
$ / Unit
Jan. 29, 2021
CAD ($)
$ / shares
Sep. 30, 2020
$ / shares
Apr. 24, 2020
CAD ($)
$ / shares
Aug. 09, 2022
CAD ($)
$ / shares
Nov. 30, 2021
share
$ / shares
Nov. 30, 2020
$ / shares
Disclosure of non-adjusting events after reporting period [line items]                          
Price per unit issued | $ / shares     0.15         0.2   0.15 0.4    
Proceeds from units issued | $     $ 557,825         $ 636,000   $ 469,250 $ 2,300,000    
Weighted average exercise price of warrants granted | $ / shares     $ 0.2             $ 0.2   $ 0.08 $ 0.9
Number of stock options granted                       1,700,000  
Non-brokered private placement financing [Member]                          
Disclosure of non-adjusting events after reporting period [line items]                          
Number of units issued for private placement       10,000,000     30,000,000            
Price per unit issued       0.4     0.05            
Proceeds from units issued | $       $ 4,000,000     $ 1,500,000            
Weighted average exercise price of warrants granted | $ / shares     $ 0.2 $ 0.8     $ 0.1   $ 0.5 $ 0.2      
Private Placements [Member]                          
Disclosure of non-adjusting events after reporting period [line items]                          
Number of units issued for private placement         7,200,000                
Proceeds from units issued | $         $ 360,000                
Weighted average exercise price of warrants granted | $ / shares   $ 0.5           $ 0.5          
Directors, Officers, Employees, And Consultants [Member]                          
Disclosure of non-adjusting events after reporting period [line items]                          
Number of stock options granted 2,100,000                        
Director [Member]                          
Disclosure of non-adjusting events after reporting period [line items]                          
Number of stock options granted           150,000              
XML 102 form20f_htm.xml IDEA: XBRL DOCUMENT 0001639142 prt:PaycheckProtectionProgramLoanMember 2020-05-04 0001639142 2021-12-01 2022-11-30 0001639142 prt:PaycheckProtectionProgramLoanMember 2020-05-01 2020-05-04 0001639142 ifrs-full:IssuedCapitalMember 2022-11-30 0001639142 ifrs-full:IssuedCapitalMember 2021-11-30 0001639142 2014-11-01 2014-11-12 0001639142 2020-09-01 2020-09-30 0001639142 srt:DirectorMember 2020-09-01 2020-09-30 0001639142 2020-09-01 2020-09-24 0001639142 2020-09-01 2020-09-22 0001639142 srt:DirectorMember 2020-08-01 2020-08-21 0001639142 2020-08-01 2020-08-13 0001639142 2020-07-01 2020-07-03 0001639142 2020-05-01 2020-05-15 0001639142 2020-04-02 2020-04-24 0001639142 2020-08-13 0001639142 2020-07-03 0001639142 2020-09-30 0001639142 2020-09-24 0001639142 2020-09-22 0001639142 prt:SharePurchaseWarrantMember 2020-09-01 2020-09-30 0001639142 prt:AerowaveCorporationMember 2020-09-01 2020-09-30 0001639142 prt:NonBrokeredPrivatePlacementFinancingMember 2020-02-01 2020-02-04 0001639142 2021-01-01 2021-01-29 0001639142 prt:SharePurchaseWarrantMember 2021-11-30 0001639142 prt:SharePurchaseWarrantMember 2020-12-01 2021-11-30 0001639142 prt:SharePurchaseWarrantMember ifrs-full:BottomOfRangeMember 2020-12-01 2021-11-30 0001639142 prt:SharePurchaseWarrantMember ifrs-full:TopOfRangeMember 2020-12-01 2021-11-30 0001639142 srt:DirectorMember 2020-12-01 2021-11-30 0001639142 2021-11-30 0001639142 2020-12-01 2021-11-30 0001639142 ifrs-full:BottomOfRangeMember 2020-12-01 2021-11-30 0001639142 ifrs-full:TopOfRangeMember 2020-12-01 2021-11-30 0001639142 prt:SharePurchaseWarrantMember 2018-04-01 2018-04-25 0001639142 prt:AerowaveCorporationMember 2018-04-01 2018-04-25 0001639142 prt:BrokerWarrantsMember 2021-01-01 2021-01-29 0001639142 2020-11-30 0001639142 2022-11-30 0001639142 prt:ExpiryDateOfStockOptionsJanuaryOneFiveTwoZeoTwoFourMember prt:ExercisePriceZeroPointSixZeroMember 2022-11-30 0001639142 prt:ExpiryDateOfStockOptionsJanuaryOneFiveTwoZeoTwoFourMember prt:ExercisePriceZeroPointSixZeroMember 2021-12-01 2022-11-30 0001639142 prt:ExpiryDateOfStockOptionsMarchTwoZeroTwoZeroTwoFourMember prt:ExercisePriceZeroPointSixZeroOneMember 2022-11-30 0001639142 prt:ExpiryDateOfStockOptionsMarchTwoZeroTwoZeroTwoFourMember prt:ExercisePriceZeroPointSixZeroOneMember 2021-12-01 2022-11-30 0001639142 prt:ExpiryDateOfStockOptionsNovemberTwoEightTwoZeroTwoFourMember prt:ExercisePriceZeroPointFiveZeroMember 2022-11-30 0001639142 prt:ExpiryDateOfStockOptionsNovemberTwoEightTwoZeroTwoFourMember prt:ExercisePriceZeroPointFiveZeroMember 2021-12-01 2022-11-30 0001639142 prt:ExpiryDateOfStockOptionsJanuaryTwoOneTwoZeroTwoSixMember prt:ExercisePriceZeroPointSevenFiveMember 2022-11-30 0001639142 prt:ExpiryDateOfStockOptionsJanuaryTwoOneTwoZeroTwoSixMember prt:ExercisePriceZeroPointSevenFiveMember 2021-12-01 2022-11-30 0001639142 prt:ExpiryDateOfStockOptionsJuneOneZeroTwoZeroTwoSixMember prt:ExercisePriceZeroPointFiveZeroMember 2022-11-30 0001639142 prt:ExpiryDateOfStockOptionsJuneOneZeroTwoZeroTwoSixMember prt:ExercisePriceZeroPointFiveZeroMember 2021-12-01 2022-11-30 0001639142 prt:AugustNineTwoZeroTwoSixMember 2022-11-30 0001639142 prt:AugustNineTwoZeroTwoSixMember 2021-12-01 2022-11-30 0001639142 prt:JanuaryTwentyNineTwoZeroTwoSixMember 2022-11-30 0001639142 prt:JanuaryTwentyNineTwoZeroTwoSixMember 2021-12-01 2022-11-30 0001639142 2019-11-30 0001639142 2019-12-01 2020-11-30 0001639142 prt:NonBrokeredPrivatePlacementFinancingMember 2020-09-01 2020-09-30 0001639142 prt:NonBrokeredPrivatePlacementFinancingMember 2020-05-01 2020-05-15 0001639142 prt:NonBrokeredPrivatePlacementFinancingMember 2020-04-02 2020-04-24 0001639142 prt:SharePurchaseWarrantMember 2021-01-01 2021-01-29 0001639142 prt:SharePurchaseWarrantMember 2021-08-01 2021-08-09 0001639142 prt:PrivatePlacementsMember 2021-08-01 2021-08-09 0001639142 prt:PrivatePlacementsMember 2021-08-09 0001639142 prt:PrivatePlacementsMember 2021-01-01 2021-01-29 0001639142 prt:PrivatePlacementsMember 2021-01-29 0001639142 prt:ConsultantAndDirectorMember 2020-12-01 2021-11-30 0001639142 prt:ConsultantAndDirectorMember 2019-12-01 2020-11-30 0001639142 prt:DirectorsOfficersEmployeeAndConsultantsMember 2021-01-01 2021-01-21 0001639142 prt:DirectorsOfficersEmployeeAndConsultantsMember 2021-01-21 0001639142 prt:ConsultantMember 2021-06-10 0001639142 prt:ConsultantMember 2021-06-01 2021-06-10 0001639142 prt:PrivatePlacementsMember 2020-04-02 2020-04-24 0001639142 prt:PrivatePlacementsMember 2020-05-01 2020-05-15 0001639142 prt:FindersFeesMember 2021-01-01 2021-01-29 0001639142 2021-08-01 2022-08-09 0001639142 prt:SharePurchaseWarrantMember 2021-08-01 2022-08-09 0001639142 prt:FindersFeesMember 2021-08-01 2022-08-09 0001639142 prt:BrokerWarrantsMember 2021-08-01 2022-08-09 0001639142 prt:SharePurchaseWarrantMember 2019-12-01 2020-11-30 0001639142 prt:NonBrokeredPrivatePlacementFinancingMember 2020-12-01 2021-11-30 0001639142 prt:PrivatePlacementsMember 2020-12-01 2021-11-30 0001639142 prt:ProfessionalFeesPayableMember 2021-11-30 0001639142 prt:ProfessionalFeesPayableMember 2022-11-30 0001639142 prt:FundsToBeReturnedToInvestorsMember 2021-11-30 0001639142 prt:FundsToBeReturnedToInvestorsMember 2022-11-30 0001639142 prt:AdvertisingCostsMember 2021-11-30 0001639142 prt:AdvertisingCostsMember 2022-11-30 0001639142 prt:DevelopmentCostsMember 2021-11-30 0001639142 prt:DevelopmentCostsMember 2022-11-30 0001639142 prt:OtherPayableMember 2021-11-30 0001639142 prt:OtherPayableMember 2022-11-30 0001639142 prt:DueToFormerShareholderOfTetraMember 2021-11-30 0001639142 prt:DueToFormerShareholderOfTetraMember 2022-11-30 0001639142 prt:PayrollMember 2021-11-30 0001639142 prt:PayrollMember 2022-11-30 0001639142 prt:BankOverdraftMember 2021-11-30 0001639142 prt:BankOverdraftMember 2022-11-30 0001639142 prt:VATPayableMember 2021-11-30 0001639142 prt:VATPayableMember 2022-11-30 0001639142 prt:PurchasesMember 2021-11-30 0001639142 prt:PurchasesMember 2022-11-30 0001639142 prt:RentMember 2021-11-30 0001639142 prt:RentMember 2022-11-30 0001639142 prt:TetraDronesLimitedMember 2021-12-01 2022-11-30 0001639142 prt:DirectorsOfficersEmployeesAndConsultantsMember 2022-03-01 2022-03-03 0001639142 srt:DirectorMember 2023-03-01 2023-03-16 0001639142 prt:NonBrokeredPrivatePlacementFinancingMember 2023-02-01 2023-02-22 0001639142 prt:PrivatePlacementsMember 2023-03-01 2023-03-30 0001639142 prt:FurnitureMember 2022-11-30 0001639142 ifrs-full:ComputerEquipmentMember 2022-11-30 0001639142 prt:FurnitureMember 2021-11-30 0001639142 ifrs-full:ComputerEquipmentMember 2021-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember prt:FurnitureMember 2022-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:ComputerEquipmentMember 2022-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember prt:FurnitureMember 2021-12-01 2022-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:ComputerEquipmentMember 2021-12-01 2022-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember prt:FurnitureMember 2021-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:ComputerEquipmentMember 2021-11-30 0001639142 ifrs-full:GrossCarryingAmountMember prt:FurnitureMember 2022-11-30 0001639142 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerEquipmentMember 2022-11-30 0001639142 ifrs-full:GrossCarryingAmountMember prt:FurnitureMember 2021-12-01 2022-11-30 0001639142 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerEquipmentMember 2021-12-01 2022-11-30 0001639142 ifrs-full:GrossCarryingAmountMember prt:FurnitureMember 2021-11-30 0001639142 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerEquipmentMember 2021-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember prt:FurnitureMember 2020-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:ComputerEquipmentMember 2020-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember prt:FurnitureMember 2020-12-01 2021-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:ComputerEquipmentMember 2020-12-01 2021-11-30 0001639142 ifrs-full:GrossCarryingAmountMember prt:FurnitureMember 2020-11-30 0001639142 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerEquipmentMember 2020-11-30 0001639142 ifrs-full:GrossCarryingAmountMember prt:FurnitureMember 2020-12-01 2021-11-30 0001639142 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerEquipmentMember 2020-12-01 2021-11-30 0001639142 ifrs-full:GrossCarryingAmountMember ifrs-full:VehiclesMember 2020-11-30 0001639142 ifrs-full:GrossCarryingAmountMember ifrs-full:VehiclesMember 2020-12-01 2021-11-30 0001639142 ifrs-full:GrossCarryingAmountMember ifrs-full:VehiclesMember 2021-11-30 0001639142 ifrs-full:GrossCarryingAmountMember ifrs-full:VehiclesMember 2021-12-01 2022-11-30 0001639142 ifrs-full:GrossCarryingAmountMember ifrs-full:VehiclesMember 2022-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:VehiclesMember 2020-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:VehiclesMember 2020-12-01 2021-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:VehiclesMember 2021-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:VehiclesMember 2021-12-01 2022-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:VehiclesMember 2022-11-30 0001639142 ifrs-full:VehiclesMember 2021-11-30 0001639142 ifrs-full:VehiclesMember 2022-11-30 0001639142 ifrs-full:GrossCarryingAmountMember ifrs-full:LeaseholdImprovementsMember 2020-11-30 0001639142 ifrs-full:GrossCarryingAmountMember ifrs-full:LeaseholdImprovementsMember 2020-12-01 2021-11-30 0001639142 ifrs-full:GrossCarryingAmountMember ifrs-full:LeaseholdImprovementsMember 2021-11-30 0001639142 ifrs-full:GrossCarryingAmountMember ifrs-full:LeaseholdImprovementsMember 2021-12-01 2022-11-30 0001639142 ifrs-full:GrossCarryingAmountMember ifrs-full:LeaseholdImprovementsMember 2022-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:LeaseholdImprovementsMember 2020-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:LeaseholdImprovementsMember 2020-12-01 2021-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:LeaseholdImprovementsMember 2021-12-01 2022-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:LeaseholdImprovementsMember 2022-11-30 0001639142 ifrs-full:LeaseholdImprovementsMember 2021-11-30 0001639142 ifrs-full:LeaseholdImprovementsMember 2022-11-30 0001639142 ifrs-full:GrossCarryingAmountMember prt:DemoEquipmentMember 2020-11-30 0001639142 ifrs-full:GrossCarryingAmountMember prt:DemoEquipmentMember 2020-12-01 2021-11-30 0001639142 ifrs-full:GrossCarryingAmountMember prt:DemoEquipmentMember 2021-11-30 0001639142 ifrs-full:GrossCarryingAmountMember prt:DemoEquipmentMember 2021-12-01 2022-11-30 0001639142 ifrs-full:GrossCarryingAmountMember prt:DemoEquipmentMember 2022-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember prt:DemoEquipmentMember 2020-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember prt:DemoEquipmentMember 2020-12-01 2021-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember prt:DemoEquipmentMember 2021-12-01 2022-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember prt:DemoEquipmentMember 2022-11-30 0001639142 prt:DemoEquipmentMember 2021-11-30 0001639142 prt:DemoEquipmentMember 2022-11-30 0001639142 ifrs-full:GrossCarryingAmountMember 2020-11-30 0001639142 ifrs-full:GrossCarryingAmountMember 2020-12-01 2021-11-30 0001639142 ifrs-full:GrossCarryingAmountMember 2021-11-30 0001639142 ifrs-full:GrossCarryingAmountMember 2021-12-01 2022-11-30 0001639142 ifrs-full:GrossCarryingAmountMember 2022-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember 2020-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember 2020-12-01 2021-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember 2021-12-01 2022-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember 2022-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:LeaseholdImprovementsMember 2021-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember prt:DemoEquipmentMember 2021-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember 2021-11-30 0001639142 srt:DirectorMember 2020-03-30 2020-04-01 0001639142 prt:PlymouthRockUsaMember 2018-11-01 2018-11-30 0001639142 prt:PlymouthRockUsaMember 2022-11-30 0001639142 exch:BPLC 2021-12-01 2022-11-30 0001639142 2023-02-04 0001639142 srt:DirectorMember 2020-04-01 0001639142 ifrs-full:CurrencyRiskMember 2021-12-01 2022-11-30 0001639142 ifrs-full:CurrencyRiskMember 2022-11-30 0001639142 ifrs-full:CurrencyRiskMember 2021-11-30 0001639142 ifrs-full:CurrencyRiskMember 2020-11-30 0001639142 country:CA 2021-12-01 2022-11-30 0001639142 country:US 2021-12-01 2022-11-30 0001639142 country:GB 2021-12-01 2022-11-30 0001639142 country:CA 2020-12-01 2021-11-30 0001639142 country:US 2020-12-01 2021-11-30 0001639142 country:GB 2020-12-01 2021-11-30 0001639142 country:CA 2019-12-01 2020-11-30 0001639142 country:US 2019-12-01 2020-11-30 0001639142 country:GB 2019-12-01 2020-11-30 0001639142 ifrs-full:SellingGeneralAndAdministrativeExpenseMember 2021-12-01 2022-11-30 0001639142 ifrs-full:SellingGeneralAndAdministrativeExpenseMember 2020-12-01 2021-11-30 0001639142 ifrs-full:SellingGeneralAndAdministrativeExpenseMember 2019-12-01 2020-11-30 0001639142 prt:ResearchAndDevelopmentExpensesMember 2021-12-01 2022-11-30 0001639142 prt:ResearchAndDevelopmentExpensesMember 2020-12-01 2021-11-30 0001639142 prt:ResearchAndDevelopmentExpensesMember 2019-12-01 2020-11-30 0001639142 ifrs-full:GrossCarryingAmountMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2022-11-30 0001639142 ifrs-full:CustomerrelatedIntangibleAssetsMember 2021-12-01 2022-11-30 0001639142 ifrs-full:GrossCarryingAmountMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2020-11-30 0001639142 ifrs-full:GrossCarryingAmountMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2021-11-30 0001639142 ifrs-full:GrossCarryingAmountMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2020-12-01 2021-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2020-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2021-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2020-12-01 2021-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2021-12-01 2022-11-30 0001639142 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2022-11-30 0001639142 ifrs-full:CustomerrelatedIntangibleAssetsMember 2021-11-30 0001639142 ifrs-full:CustomerrelatedIntangibleAssetsMember 2022-11-30 0001639142 prt:TetraDronesLimitedMember 2022-11-30 0001639142 prt:TetraDronesLimitedMember 2022-10-01 2022-10-25 0001639142 prt:ThirdPartyMember 2022-11-30 0001639142 prt:ThirdPartyMember 2021-12-01 2022-11-30 0001639142 prt:AnotherThirdPartyMember 2021-12-01 2022-11-30 0001639142 prt:AnotherThirdPartyMember 2022-11-30 0001639142 srt:ChiefFinancialOfficerMember 2021-11-30 0001639142 srt:ChiefExecutiveOfficerMember 2021-11-30 0001639142 srt:DirectorMember 2022-11-30 0001639142 ifrs-full:RelatedPartiesMember 2019-12-01 2020-11-30 0001639142 ifrs-full:RelatedPartiesMember 2020-12-01 2021-11-30 0001639142 ifrs-full:RelatedPartiesMember 2021-12-01 2022-11-30 0001639142 srt:ChiefFinancialOfficerMember 2022-11-30 0001639142 srt:ChiefExecutiveOfficerMember 2022-11-30 0001639142 srt:DirectorMember 2021-11-30 0001639142 prt:CompanyControlledByCorporateSecretaryMember 2022-11-30 0001639142 prt:CompanyControlledByCorporateSecretaryMember 2021-11-30 0001639142 srt:ChiefExecutiveOfficerMember 2021-12-01 2022-11-30 0001639142 srt:ChiefExecutiveOfficerMember 2020-12-01 2021-11-30 0001639142 srt:ChiefExecutiveOfficerMember 2019-12-01 2020-11-30 0001639142 prt:FormerCfoMember 2021-12-01 2022-11-30 0001639142 prt:FormerCfoMember 2020-12-01 2021-11-30 0001639142 prt:FormerCfoMember 2019-12-01 2020-11-30 0001639142 srt:DirectorMember 2021-12-01 2022-11-30 0001639142 srt:DirectorMember 2019-12-01 2020-11-30 0001639142 prt:CompanyControlledByFormerCorporateSecretaryMember 2021-12-01 2022-11-30 0001639142 prt:CompanyControlledByFormerCorporateSecretaryMember 2020-12-01 2021-11-30 0001639142 prt:CompanyControlledByFormerCorporateSecretaryMember 2019-12-01 2020-11-30 0001639142 srt:ChiefFinancialOfficerMember 2019-12-01 2020-11-30 0001639142 srt:ChiefFinancialOfficerMember 2020-12-01 2021-11-30 0001639142 srt:ChiefFinancialOfficerMember 2021-12-01 2022-11-30 0001639142 prt:TetraDronesLimitedMember 2021-06-04 0001639142 prt:WithinSevenDaysMember prt:TetraDronesLimitedMember 2021-06-04 0001639142 prt:WithinTwentyOneDaysMember prt:TetraDronesLimitedMember 2021-06-04 0001639142 prt:WithinOneTwentyDaysMember prt:TetraDronesLimitedMember 2021-06-04 0001639142 prt:WithinOneTwentyDaysOfThirdInstalmentMember prt:TetraDronesLimitedMember 2021-06-04 0001639142 dei:BusinessContactMember 2021-12-01 2022-11-30 0001639142 prt:Year2038Member 2022-11-30 0001639142 prt:Year2039Member 2022-11-30 0001639142 prt:YearTwoZeroFourZeroMember 2022-11-30 0001639142 ifrs-full:BottomOfRangeMember 2021-12-01 2022-11-30 0001639142 ifrs-full:TopOfRangeMember 2021-12-01 2022-11-30 0001639142 prt:YearTwoZeroFourOneMember 2022-11-30 0001639142 ifrs-full:BottomOfRangeMember 2020-12-01 2021-11-30 0001639142 ifrs-full:TopOfRangeMember 2020-12-01 2021-11-30 0001639142 prt:YearTwoZeroFourTwoMemberMember 2022-11-30 0001639142 ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember 2021-11-30 0001639142 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember 2021-11-30 0001639142 prt:PlymouthRockUsaMember 2019-11-30 0001639142 prt:PlymouthRockUsaMember 2020-11-30 0001639142 prt:PlymouthRockUsaMember 2021-11-30 0001639142 ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember 2021-11-30 0001639142 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember 2022-11-30 0001639142 ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember 2022-11-30 0001639142 ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember 2022-11-30 0001639142 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2020-11-30 0001639142 ifrs-full:RetainedEarningsMember 2020-11-30 0001639142 ifrs-full:AdditionalPaidinCapitalMember 2020-11-30 0001639142 ifrs-full:IssuedCapitalMember 2020-11-30 0001639142 ifrs-full:RetainedEarningsMember 2019-11-30 0001639142 ifrs-full:AdditionalPaidinCapitalMember 2019-11-30 0001639142 ifrs-full:IssuedCapitalMember 2019-12-01 2020-11-30 0001639142 ifrs-full:RetainedEarningsMember 2019-12-01 2020-11-30 0001639142 ifrs-full:AdditionalPaidinCapitalMember 2019-12-01 2020-11-30 0001639142 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2019-12-01 2020-11-30 0001639142 prt:SharesToBeIssuedMember 2019-12-01 2020-11-30 0001639142 prt:SharesToBeIssuedMember 2019-11-30 0001639142 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2019-11-30 0001639142 ifrs-full:IssuedCapitalMember 2019-11-30 0001639142 ifrs-full:RetainedEarningsMember 2020-12-01 2021-11-30 0001639142 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2020-12-01 2021-11-30 0001639142 ifrs-full:IssuedCapitalMember 2020-12-01 2021-11-30 0001639142 ifrs-full:AdditionalPaidinCapitalMember 2020-12-01 2021-11-30 0001639142 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2021-11-30 0001639142 ifrs-full:RetainedEarningsMember 2021-11-30 0001639142 ifrs-full:AdditionalPaidinCapitalMember 2021-11-30 0001639142 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2022-11-30 0001639142 ifrs-full:RetainedEarningsMember 2022-11-30 0001639142 ifrs-full:AdditionalPaidinCapitalMember 2022-11-30 0001639142 ifrs-full:RetainedEarningsMember 2021-12-01 2022-11-30 0001639142 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2021-12-01 2022-11-30 0001639142 ifrs-full:IssuedCapitalMember 2021-12-01 2022-11-30 0001639142 prt:SubscriptionsReceivedMember 2019-11-30 0001639142 prt:SubscriptionsReceivedMember 2020-11-30 0001639142 prt:SubscriptionsReceivedMember 2021-11-30 0001639142 prt:SubscriptionsReceivedMember 2022-11-30 0001639142 prt:SubsidiaryMember 2021-12-01 2022-11-30 0001639142 ifrs-full:ComputerEquipmentMember 2021-12-01 2022-11-30 0001639142 ifrs-full:FixturesAndFittingsMember 2021-12-01 2022-11-30 0001639142 ifrs-full:LeaseholdImprovementsMember 2021-12-01 2022-11-30 0001639142 ifrs-full:OfficeEquipmentMember 2021-12-01 2022-11-30 0001639142 ifrs-full:VehiclesMember 2021-12-01 2022-11-30 0001639142 prt:SubsidiaryOneMember 2021-12-01 2022-11-30 0001639142 prt:SubsidiaryTwoMember 2021-12-01 2022-11-30 0001639142 prt:AdvertisingAndPromotionsMember 2021-11-30 0001639142 prt:RentMember 2021-11-30 0001639142 prt:OthersMember 2021-11-30 0001639142 prt:AdvertisingAndPromotionsMember 2022-11-30 0001639142 prt:RentMember 2022-11-30 0001639142 prt:OthersMember 2022-11-30 0001639142 prt:TransferAgentAndFilingFeesMember 2021-11-30 0001639142 prt:TransferAgentAndFilingFeesMember 2022-11-30 0001639142 prt:InsuranceMember 2021-11-30 0001639142 prt:InsuranceMember 2022-11-30 iso4217:CAD iso4217:CAD shares iso4217:CAD prt:Unit prt:Finder iso4217:GBP iso4217:USD prt:Year pure prt:share shares 0001639142 false FY No No No No 20-F false true 2022-11-30 --11-30 2022 false PLYMOUTH ROCK TECHNOLOGIES INC. Z4 Suite 700 - 1199 West Hastings Street Vancouver BC CA V6E 3T5 Philip Lancaster 250 863-3038 Suite 700 - 1199 West Hastings Street Vancouver BC CA V6E 3T5 Common Stock 59317461 Non-accelerated Filer true false International Financial Reporting Standards false Reliant CPA PC Newport Beach, California 6906 13127 375046 6870 11848 9083 56237 2175 11086 30947 178321 62202 632538 24801 294188 61198 72734 0 549679 148201 1549139 1063863 608385 124918 0 66403 39221 127019 6332 705672 52728 2087875 706666 9394 47125 0 22545 2097269 776336 11851771 11834582 2709790 2709790 25131 96393 -16535760 -13867962 -1949068 772803 148201 1549139 607359 184396 70931 191175 103109 31316 416184 81287 39615 2345980 3320081 1596658 177428 709010 1081478 233265 985006 386044 2756673 5014097 3064180 234303 0 0 330650 0 0 236677 0 0 0 0 193 0 0 165 0 0 100818 5042 0 0 673 -42024 -517 -2667798 -4974834 -2924236 -2667798 -4974834 -2924236 -71262 30603 19546 -2739060 -4944231 -2904690 -0.05 -0.09 -0.08 59310826 53075143 37525451 32796600 5676498 22811 0 736271 -5968892 46244 512932 -2924236 -2924236 1233334 246667 246667 8232330 1367325 -22811 83109 1427623 38727 38727 500000 125000 125000 479107 479107 19546 19546 42762264 7376763 0 1298487 -8893128 65790 -152088 -4974834 -4974834 30603 30603 6129572 1332727 1332727 36859 -36859 425000 222500 222500 158106 -158106 8930000 2749000 287499 3036499 -174427 174427 336250 -100500 -100500 -74180 -74180 656250 307734 307734 1144342 1144342 59239336 11834582 0 2709790 -13867962 96393 772803 -2667798 -2667798 -71262 -71262 78125 17189 17189 59317461 11851771 0 2709790 -16535760 25131 -1949068 -2667798 -4974834 -2924236 0 1144342 479107 286745 143783 41201 -71262 0 0 18877 14760 20449 0 0 3576 236677 0 0 -234303 -0 0 330650 0 0 17189 307734 125000 47154 -51583 2993 4978 -9062 -1334 8911 8609 -19695 147374 -140868 77590 124918 0 0 0 2500 -22570 652944 -8894 36320 682923 122411 67084 -414023 -3441102 -2114515 0 204305 57518 0 0 3576 0 369038 0 -0 -573343 -61094 0 4417047 1635564 34701 48175 48473 -105000 42430 0 70299 4326442 1587091 -343724 311997 -588518 -18195 38336 30112 375046 24713 583119 13127 375046 24713 <div> <p style="text-align: justify; margin-top: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>1.</b><span style="width: 10pt; text-indent: 0pt; display: inline-block;"> </span><b>NATURE OF OPERATIONS AND ABILITY TO CONTINUE AS A GOING CONCERN</b></span></span></p> <div> <div> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Plymouth Rock Technologies Inc. (the "Company") was incorporated under the Business Corporations Act of British Columbia on October 17, 2011. The head office, principal address and registered and records office of the Company are located at 700 - 1199 West Hastings Street, Vancouver, B.C., V6E 3T5.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The Company's common shares are listed on the CSE and on Frankfurt Stock Exchange in Germany under the Symbol: 4XA, WKN# - A2N8RH. The Company's common shares are also on the OTC Markets Group ("OTCQB") under the symbol: PLRTF.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The Company's principal business activity through its subsidiary, Plymouth Rock USA ("PRT USA"), focused on developing technologies related to remotely detecting assault firearms and suicide bombs concealed on the person or a carry bag. The Company focuses on detection methods with and without the need for a checkpoint of the suspect who is being screened. The Company's planned products encompass the very latest radar, imaging, and Unmanned Aerial System ("UAS") technologies for quickly detecting, locating and identifying the presence of threats and for search and rescue missions for law enforcement.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">On March 26, 2021, the Company incorporated a subsidiary in United Kingdom, Plymouth Rock Technologies UK Limited ("PRT UK"). The purpose of PRT UK is to augment the Company's existing research and development of its drone technologies for the US and EMEA markets.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">On June 4, 2021, the Company completed its acquisition of Tetra Drones Limited ("Tetra") (Note 3). The acquisition of Tetra provides the Company with drones production line in the United Kingdom.</span></span></p> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span style="text-decoration: underline;"><b>Going Concern</b></span></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">These consolidated financial statements are prepared on a going concern basis, which contemplates that the Company will continue in operation for the foreseeable future and will be able to realize its assets and discharge its liabilities in the normal course of business. At present, the Company's operations do not generate cash flows from operations. The Company has incurred losses since inception and has a comprehensive loss of $2,739,060 for the year ended November 30, 2022 (2021 - $4,944,231; 2020 - $2,904,690) and had an accumulated deficit of $16,535,760 (2021 - $13,867,962). The ability of the Company to continue as a going concern is dependent on achieving profitable operations, commercializing its technologies, and obtaining the necessary financing in order to develop these technologies further. The outcome of these matters cannot be predicted at this time. The Company will continue to review the prospects of raising additional debt and equity financing to support its operations until such time that its operations become self-sustaining, to fund its research and development activities and to ensure the realization of its assets and discharge of its liabilities. While the Company is expanding its best efforts to achieve the above plans, there is no assurance that any such activity will generate sufficient funds for future operations. These factors and uncertainty casts significant doubt about the Company's ability to continue as a going concern and therefore it may be unable to realize its assets and discharge its liabilities in the normal course of business. </span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The Company is not expected to be profitable during the ensuing 12 months, and therefore, must rely on securing additional funds from either issuance of debt or equity financing for cash consideration. During the year ended November 30, 2022, the Company received net cash proceeds of $70,299 (2021 - 4,326,442; 2020 - 1,587,091) pursuant to financing activities. Management has been successful in raising capital through periodic private placements of the Company's common shares in the past, however there is no certainty that financing will be available in the future, or certainty that management's planned actions to address this situation will be successful.</span></span></p> <div> </div> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">These consolidated financial statements have been prepared in accordance with International Financial Reporting Standards ("IFRS") with the assumption that the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future rather than a process of forced liquidation. These consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue in existence. Such adjustments could be material. </span></span></p> </div> </div> </div> -2739060 -4944231 -2904690 -16535760 -13867962 70299 4326442 1587091 <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>2.</b><span style="width: 10pt; text-indent: 0pt; display: inline-block;"> </span><b>SIGNIFICANT ACCOUNTING POLICIES </b></span></span></p> <div> <div> <div> <p style="margin-left: 18pt; text-align: justify; margin-top: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Basis of presentation</b></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">These consolidated financial statements ("Financial Statements") have been prepared in accordance with IFRS as issued by the International Accounting Standard Board ("IASB") and interpretations of the International Financial Reporting Interpretations Committee ("IFRIC").</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">These Financial Statements are authorized for issue by the Board of Directors on March 28, 2023.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">These Financial Statements have been prepared on the historical cost basis. In addition, these Financial Statements have been prepared using the accrual basis of accounting.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">These Financial Statements are presented in Canadian dollars, which is the Company's functional currency. The functional currency of PRT USA is U.S. Dollars and the functional currency of PRT UK and Tetra is British Pound Sterling ("£"). The assets and liabilities of PRT USA, PRT UK and Tetra are translated into Canadian dollars at the rate of exchange prevailing at the reporting date and their income and expense items are translated at average exchange rates for the period. Exchange differences arising on the translation are recognized in other comprehensive income.</span></span></p> </div> <div> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Significant accounting judgments, estimates and assumptions</b></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The preparation of these Financial Statements in conformity with IFRS requires management to make judgments and estimates and form assumptions that affect the reported amounts of assets and liabilities at the date of the Financial Statements and reported amounts of income and expenses during the period. Actual results could differ from these estimates.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Significant estimates used in preparing the Financial Statements include, but are not limited to the following:</span></span></p> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">a.<span style="width: 6.11pt; text-indent: 0pt; display: inline-block;"> </span>Deferred taxes</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The calculation of deferred tax is based on the ability of the Company to generate future taxable income, the estimation of which is subject to significant uncertainty as to the amount and timing. The calculation of deferred tax is also based on assumptions, which are subject to uncertainty as to timing and which tax rates are expected to apply when temporary differences reverse. Deferred tax recorded is also subject to uncertainty regarding the magnitude on non-capital losses available for carry forward and of the balances in various tax pools as the corporate tax returns have not been prepared as of the date of financial statement preparation.</span></span></p> <div> </div> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">b.<span style="width: 6.11pt; text-indent: 0pt; display: inline-block;"> </span>Stock-based payments</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The fair value of stock options and finders' warrants issued are subject to the limitations of the Black-Scholes option pricing model that incorporates market data and involves uncertainty in estimates used by management in the assumptions. Because the Black-Scholes option pricing model requires the input of highly subjective assumptions, including the expected lift, volatility of share prices, risk-free rate and dividend yield, changes in subjective input assumptions can materially affect the fair value estimate.</span></span></p> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">c.<span style="width: 6.67pt; text-indent: 0pt; display: inline-block;"> </span>Impairment of non-financial assets</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Impairment exists when the carrying value of an asset or cash generating unit ("CGU") exceeds its recoverable amount, which is the higher of its fair value less costs to sell and its value in use. The fair value less costs to sell calculation is based on available data from binding sales transactions in an arm's length transaction of similar assets or observable market prices less incremental costs for disposing of the asset. The value in use calculation is based on a discounted cash flow model.</span></span></p> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">d.<span style="width: 6.23pt; text-indent: 0pt; display: inline-block;"> </span>Leases</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Management uses estimation in determining the incremental borrowing rate used to measure the lease liability, specific to the asset, underlying currency and geographic location.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Significant judgments used in the preparation of these Financial Statements include, but are not limited to the following:</span></span></p> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(i)<span style="display: inline-block; width: 8.5pt;"> </span>Going concern</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Management has applied judgements in the assessment of the Company's ability to continue as a going concern when preparing its Financial Statements for the year ended November 30, 2022. Management prepares the Financial Statements on a going concern basis unless management either intends to liquidate the entity or to cease trading or has no realistic alternative but to do so.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">In assessing whether the going concern assumption is appropriate, management accounts for all available information about the future, which is at least, but is not limited to, twelve months from the end of the reporting period.</span></span></p> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(ii)<span style="display: inline-block; width: 5pt;"> </span>Business combinations</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Determination of whether a set of assets acquired and liabilities assumed constitute the acquisition of a business or asset may require the Company to make certain judgments as to whether or not the assets acquired and liabilities assumed include the inputs, processes and outputs necessary to constitute a business as defined in IFRS 3 - Business Combinations. Based on an assessment of the relevant facts and circumstances, the Company concluded that the acquisition disclosed in Note 3 met the criteria for accounting as a business combination.</span></span></p> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(iii)<span style="width: 2.67pt; text-indent: 0pt; display: inline-block;"> </span>Intangible assets</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Intangible assets can be capitalized only if development costs can be measured reliably, the product or process is technically and commercially feasible, future economic benefits are probable, and the Company intends to and has sufficient resources to complete development and to use or sell the asset. To determine if the future economic benefit is probable depends on the successful commercialization of its technologies and that in turn depends on the management's judgement and knowledge. As at November 30, 2022, the development costs are not capitalized as management was unable to demonstrate the future economic benefits to be generated from the utilization of the associated expenditures.</span></span></p> </div> <div> </div> <div> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Cash</b></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Cash consists of amounts held in banks and highly liquid investments with limited interest and credit risk.</span></span></p> </div> <div> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Consolidation</b></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The Financial Statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances, transactions and any unrealized gains and losses arising from intercompany transactions, have been eliminated. The Company's subsidiary is presented in the table below. Plymouth Rock USA was incorporated under the General Corporation Law of the State of Delaware on March 22, 2018. Plymouth Rock UK was incorporated under the General Corporation Law for England and Wales on March 26, 2021.Tetra Drones was incorporated under the General Corporation Law for England and Wales and was acquired by the Company on June 4, 2021.</span></span></p> <div style="margin-left: 18pt;"> <div> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt;"> <tr> <td style="width: 39%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>Entity</b></span></span></span></span></td> <td style="width: 27%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>Country of Incorporation</b></span></span></span></span></td> <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><b>Effective Economic</b></span></span></span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><span><span><b>Interest</b></span></span></span></span></span></span></span></span></td> </tr> <tr> <td style="width: 39%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom;"> </td> <td style="width: 27%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom;"> </td> <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Plymouth Rock Technologies Inc.</span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span>("Plymouth Rock USA")</span></span></span></span></td> <td style="width: 27%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; background-color: #e6efff; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"> USA </span></span></td> <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; background-color: #e6efff; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">100%</span></span></td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; padding-left: 5pt;"> </td> <td style="width: 27%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom;"> </td> <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Plymouth Rock Technologies Inc.</span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span>("PRT UK")</span></span></span></span></td> <td style="width: 27%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; background-color: #e6efff; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"> UK </span></span></td> <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; background-color: #e6efff; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">100%</span></span></td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; padding-left: 5pt;"> </td> <td style="width: 27%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom;"> </td> <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Tetra Drones Ltd. ("Tetra Drones")</span></span></td> <td style="width: 27%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; background-color: #e6efff; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"> UK </span></span></td> <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; background-color: #e6efff; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">100%</span></span></td> </tr> </table> </div> </div> </div> <div> <p style="margin-left: 18pt; text-align: justify; margin-top: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Intangible assets</b></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Intangible assets that are reflected in the consolidated statements of financial position consist of assets acquired through business combinations. Intangible assets acquired in a business combination are recognized separately from goodwill and are initially recognized at their fair value at the acquisition date (which is regarded as their cost). An intangible asset is regarded as having an indefinite useful life when, based on all relevant factors, there is no foreseeable limit to the period over which the asset is expected to generate net cash inflows. Accordingly, the Company does not amortize these intangible assets, but reviews them for impairment, annually or more frequently if events or changes in circumstances indicate that the assets might be impaired.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Development costs for internally-generated intangible assets are capitalized when all of the following conditions are met:</span></span></p> <ul style="padding-left: 0pt; list-style-type: disc;"> <li style="text-align: justify; margin-left: 36pt; padding-left: 8.45pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">technical feasibility can be demonstrated;</span></span></li> <li style="margin-left: 36pt; text-align: justify; padding-left: 8.45pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">management has the intention to complete the intangible asset and use it;</span></span></li> <li style="margin-left: 36pt; text-align: justify; padding-left: 8.45pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">management can demonstrate the ability to use the intangible asset;</span></span></li> <li style="margin-left: 36pt; text-align: justify; padding-left: 8.45pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">it is probable that the intangible asset will generate future economic benefits;</span></span></li> <li style="text-align: justify; margin-left: 36pt; padding-left: 8.4pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">the Company can demonstrate the availability of adequate technical, financial and other resources to complete the development and to use the intangible asset; and</span></span></li> <li style="margin-left: 36pt; text-align: justify; padding-left: 8.45pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">costs attributable to the asset can be measured reliably.</span></span></li> </ul> <p style="text-align: justify; margin-left: 18pt; margin-top: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The amount initially recognized for internally-generated intangible assets is the sum of the expenditures incurred from the date when the intangible asset first meets the recognition criteria listed above. Where no internally-generated intangible asset can be recognized, development expenditures are charged to the consolidated statements of loss and comprehensive loss in the period in which they are incurred.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Customer relationships acquired through the acquisition of subsidiary, Tetra Drones, are amortized for a period of three years from acquisition date.</span></span></p> </div> <div> </div> <div> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Equipment</b></span></span></p> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><i>Recognition and measurement</i></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">On initial recognition, equipment is valued at cost, being the purchase price and directly attributable cost of acquisition or construction required to bring the asset to the location and condition necessary to be capable of operating in the manner intended by the Company, including appropriate borrowing costs and the estimated present value of any future unavoidable costs of dismantling and removing the items. The corresponding liability is recognized within provisions.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Equipment is subsequently measured at cost less accumulated depreciation, less any accumulated impairment losses.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">When parts of an item of equipment have different useful lives, they are accounted for as separate items (major components) of equipment.</span></span></p> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><i>Gains and losses</i></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Gains and losses on disposal of an item of equipment are determined by comparing the proceeds from disposal with the carrying amount and are recognized net within other income in profit or loss.</span></span></p> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><i>Depreciation</i></span></span></p> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Half of the normal depreciation is taken in the year of acquisition for equipment with declining balance method. The depreciation rates applicable to each category of property and equipment are as follows:</span></span></p> <div style="margin-left: 18pt;"> <div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-size: 10pt; width: 100%;"> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Computer equipment    55% declining balance</span></span></td> <td style="margin-top: 0pt; margin-bottom: 0pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Vehicles                             30% declining balance</span></span></td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Furniture                       20% declining balance</span></span></td> <td style="margin-top: 0pt; margin-bottom: 0pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Leasehold improvements  30% declining balance</span></span></td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Demo equipment          20% declining balance</span></span></td> <td style="margin-top: 0pt; margin-bottom: 0pt;"> </td> </tr> </table> </div> </div> </div> <div> <p style="margin-left: 18pt; text-align: justify; margin-top: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Inventories</b></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The Company values inventories at the lower of cost and net realizable value. Cost includes the costs of purchases net of vendor allowances plus other costs, such as transportation, that are directly incurred to bring the inventories to their present location and condition.</span></span></p> </div> <div> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Business combinations</b></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Business combinations are accounted for using the acquisition method. The cost of the acquisition is measured at the aggregate of the fair values at the date of acquisition, of assets transferred, liabilities incurred or assumed, and equity instruments issued by the Company. The acquiree's identifiable assets and liabilities assumed are recognized at their fair value at the acquisition date. Acquisition-related costs are recognized in profit or loss as incurred. The excess of consideration over the fair value of the net identifiable assets and liabilities acquired is recorded as goodwill. Any gain on a bargain purchase is recorded in profit or loss immediately. Transaction costs are expensed as incurred, except if related to the issue of debt or equity securities. Any goodwill that arises is tested annually for impairment.</span></span></p> </div> <div> <p style="text-align: justify; margin-left: 18pt; margin-bottom: 0pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Share capital</b></span></span></p> <p style="text-align: justify; margin-left: 18pt; margin-top: 0pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The Company records proceeds from the issuance of its common shares as equity. Proceeds received on the issuance of units, consisting of common shares and warrants, are allocated between the common share and warrant component. The Company has adopted a residual value method with respect to the measurement of shares and warrants issued as private placement units. The residual value method first allocates value to the most easily measurable component based on fair value and then the residual value, if any, to the less easily measurable component.</span></span></p> <div> </div> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The fair value of the common shares issued in the private placement was determined to be the more easily measurable component and were valued at their fair value, as determined by the closing quoted price on the issuance date. The remaining proceeds, if any, are allocated to the attached warrants. Any fair value attributed to the warrants is recorded as warrant reserve. Management does not expect to record a value to the warrant in most equity issuances as unit private placements are commonly priced at market or at a permitted discount to market. If the warrants are issued as share issuance costs, the fair value of agent's warrants are measured using the Black-Scholes option pricing model and recognized in equity as a deduction from the proceeds.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">If the warrants are exercised, the related amount is reclassified as share capital. If the warrants expire unexercised, the related amount remains in warrant reserve.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Incremental costs directly attributable to the issue of new common shares are shown in equity as a deduction, net of tax, from the proceeds. Common shares issued for consideration other than cash are valued based on their market value at the date that shares are issued.</span></span></p> </div> <div> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Stock-based payment</b></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The Company recognizes share-based payment expense for the estimated fair value of equity-based instruments granted to both employees and non-employees. Compensation expense is recognized when the options are granted with the same amount being recorded as contributed surplus. The expense is determined using an option pricing model that accounts for the exercise price, the term of the option, the current share price, the expected volatility of the underlying shares, the expected dividend yield, and the risk-free interest rate for the term of the option. If the options are exercised, the contributed surplus will be reduced by the applicable amount. Share-based payment calculations have no effect in the Company's cash position.</span></span></p> </div> <div> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Earnings (loss) per share</b></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Basic earnings (loss) per share are calculated using the weighted average number of common shares outstanding during the period. Diluted earnings (loss) per share are calculated using the treasury stock method. This method assumes that common shares are issued for the exercise of options, warrants and convertible securities and that the assumed proceeds from the exercise of options, warrants and convertible securities are used to purchase common shares at the average market price during the period. The difference between the number of shares assumed issued and the number of shares assumed purchased is then added to the basic weighted average number of shares outstanding to determine the fully diluted number of common shares outstanding. No exercise or conversion is assumed during the periods in which a net loss is incurred as the effect is anti-dilutive.</span></span></p> </div> <div> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Financial instruments </b></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span style="text-decoration: underline;">Financial assets</span></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The Company recognizes financial assets when it becomes party to the contractual provisions of the instrument. Financial assets are measured initially at their fair value plus, in the case of financial assets not subsequently measured at fair value through profit or loss, transaction costs that are directly attributable to their acquisition. Transaction costs attributable to the acquisition of financial assets subsequently measured at fair value through profit or loss are expensed in profit or loss when incurred.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>Subsequent to initial recognition, all financial assets are classified and subsequently measured at amortized cost. Interest income is calculated using the effective interest method and gains or losses arising from impairment, foreign exchange and derecognition are recognized in profit or loss. Financial assets measured at amortized cost are comprised of cash, accounts receivable and due from related parties.</span></span></span></p> <div> </div> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The Company reclassifies debt instruments only when its business model for managing those financial assets has changed. Reclassifications are applied prospectively from the reclassification date and any previously recognized gains, losses or interest are not restated.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The Company recognizes a loss allowance for the expected credit losses associated with its financial assets. Expected credit losses are measured to reflect a probability-weighted amount, the time value of money, and reasonable and supportable information regarding past events, current conditions and forecasts of future economic conditions.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The Company applies the simplified approach for accounts receivable that do not contain a significant financing component. Using the simplified approach, the Company records a loss allowance equal to the expected credit losses resulting from all possible default events over the assets' contractual lifetime.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Financial assets are written off when the Company has no reasonable expectations of recovering all or any portion thereof.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The Company derecognizes a financial asset when its contractual rights to the cash flows from the financial asset expire.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span style="text-decoration: underline;">Financial liabilities</span></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The Company recognizes a financial liability when it becomes party to the contractual provisions of the instrument. At initial recognition, the Company measures financial liabilities at their fair value plus transaction costs that are directly attributable to their issuance, with the exception of financial liabilities subsequently measured at fair value through profit or loss for which transaction costs are immediately recorded in profit or loss.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Subsequent to initial recognition, all financial liabilities are measured at amortized cost using the effective interest rate method. Interest, gains, and losses relating to a financial liability are recognized in profit or loss. Financial liabilities measured at amortized cost are comprised of accounts payable, lease liability, and due to related parties.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The Company derecognizes a financial liability only when its contractual obligations are discharged, cancelled or expire.</span></span></p> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span style="text-decoration: underline;">Interest</span></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Interest income and expense are recognized in profit or loss using the effective interest method.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The 'effective interest rate' is the rate that exactly discounts estimated future cash payments over the expected life of the financial instrument to the gross carrying amount of the financial asset or the amortized cost of the financial liability. The effective interest rate is calculated considering all contractual terms of the financial instruments, except for the expected credit losses of financial assets.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The 'amortized cost' of a financial asset or financial liability is the amount at which the instrument is measured on initial recognition minus principal repayments, plus or minus any cumulative amortization using the effective interest method of any difference between the initial amount and maturity amount and adjusted for any expected credit loss allowance. The 'gross carrying amount' of a financial asset is the amortized cost of a financial asset before adjusting for any expected credit losses.</span></span></p> <div> </div> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Interest income and expense is calculated by applying the effective interest rate to the gross carrying amount of the financial asset (when the asset is not credit-impaired) or the amortized cost of the financial liability.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Where a financial asset has become credit-impaired subsequent to initial recognition, interest income is calculated in subsequent periods by applying the effective interest method to the amortized cost of the financial asset. If the asset subsequently ceases to be credit-impaired, calculation of interest income reverts to the gross basis.</span></span></p> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span style="text-decoration: underline;">Offsetting</span></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Financial assets and financial liabilities are offset, with the net amount presented in the statement of financial position, when, and only when, the Company has a current and legally enforceable right to set off the recognized amounts and intends either to settle on a net basis or realize the asset and settle the liability simultaneously.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Income and expenses are presented on a net basis only when permitted under IFRS, or when arising from a group of similar transactions if the resulting income and expenses are not material.</span></span></p> </div> <div> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Revenue recognition</b></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Revenue is recognized by applying the five-step model under IFRS 15. The Company recognizes revenue when, or as the goods or services are transferred to the control of the customer and performance obligations are satisfied. The Company's revenue is comprised of sales of its radar systems, radar components and engineering design and development services. The Company's revenue is recognized when control of the goods has been transferred, being when the goods are delivered to customers and when all performance obligations have been fulfilled. The amounts recognized as revenue represent the fair values of the considerations received or receivable from third parties on the sales of goods to customers, net of goods and services taxes and less returns, and discounts, at which time there are no conditions for the payment to become due other than the passage of time. For its engineering design and development services, revenue is recognized when the service has been rendered.</span></span></p> </div> <div> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Government Grants </b></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Government grants are recognized at fair value once there is reasonable assurance that the Company will comply with the conditions attached to the grants and that the grants will be received. Government grants are recognized in profit or loss on a systematic basis over the periods in which the Company recognizes as expenses the related costs for which the grants are intended to compensate. A forgivable loan from government is treated as a government grant when there is reasonable assurance that the entity will meet the terms for forgiveness of the loan.</span></span></p> </div> <div> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Income taxes</b></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Income tax is recognized in profit or loss except to the extent that it relates to equity items, in which case it is recognized in equity. Current tax expense is the expected tax payable on the taxable income for the year, using tax rates enacted at period end, adjusted for amendments to tax payable with regards to previous years. Deferred tax is recorded using the liability method, providing for temporary differences, between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for taxation purposes. The following temporary differences do not result in deferred tax assets or liabilities: goodwill not deductible for tax purposes; the initial recognition of assets or liabilities that affect neither accounting profit (loss) nor taxable profit (loss); and differences relating to investments in subsidiaries to the extent that they will probably not reverse in the foreseeable future. The amount of deferred tax provided is based on the expected manner of realization or settlement of the carrying amount of assets and liabilities, using tax rates enacted or substantively enacted at the financial position date.</span></span></p> <div> </div> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">A deferred tax asset is recognized only to the extent that it is probable that future taxable profits will be available against which the asset can be utilized. Deferred tax assets and liabilities are offset when there is a legally enforceable right to set off current tax assets against current tax liabilities and when they relate to income taxes levied by the same taxation authority and the Company intends to settle its current tax assets and liabilities on a net basis.</span></span></p> </div> <div> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Related party transactions</b></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Parties are considered to be related if one party has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Parties are also considered to be related if they are subject to common control and related parties may be individuals or corporate entities. A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties.</span></span></p> </div> <div> <p style="margin-left: 18pt; margin-bottom: 0pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Leases</b></span></span></p> <p style="text-align: justify; margin-left: 18pt; margin-bottom: 0pt; margin-top: 0pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The company adopted IFRS 16 effective December 1, 2019. The Company chose to adopt the modified retrospective approach on transition to IFRS 16 and has chosen not to restate comparative information in accordance with the transitional provisions in IFRS 16. As a result, the comparative information continues to be presented in accordance with the Company's previous accounting policies. The adoption of IFRS 16 resulted in the recognition of a right-of-use asset and a lease liability measured at the present value of the future lease payments on the consolidated statements of financial position. An amortization expense on the right-of-use asset and an interest expense on the lease liability has replaced the operating lease expense. IFRS 16 has changed the presentation of cash flows relating to leases in the Company's consolidated statements of cash flows, however, it does not cause a difference in the amount of cash transferred between the parties of the lease.</span></span></p> </div> <div> <p style="margin-top: 0pt; margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Accounting standards, amendments and interpretations not yet effective </b></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Certain new standards, interpretations and amendments to existing standards have been issued by the IASB or the IFRIC during the period but are not yet effective. Some updates that are not applicable or are not consequential to the Company may have been excluded from the list below.</span></span></p> <p style="text-align: justify; margin-left: 18pt; margin-bottom: 0pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>IAS 1 - </b>Presentation of Financial Statements ("IAS 1") - <i>Classification of Liabilities as Current or Noncurrent</i> were amended to clarify that the classification of liabilities as current or non-current is based on rights that are in </span></span><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">existence at the end of the reporting period, specify that classification is unaffected by expectations about whether an entity will exercise its right to defer settlement of a liability, explain that rights are in existence if covenants are complied with at the end of the reporting period, and introduce a definition of 'settlement' to make clear that settlement refers to the transfer to the counterparty of cash, equity instruments, other assets or services. The amendments are effective for annual reporting periods beginning on or after January 1, 2023. Earlier adoption is permitted.</span></span></p> <p style="text-align: justify; margin-left: 18pt; margin-bottom: 0pt; margin-top: 10pt;"> </p> <p style="text-align: justify; margin-left: 18pt; margin-top: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>IAS 16 - </b>Property, Plant and Equipment - <i>Proceeds before Intended Use</i> - The amendments prohibit deducting from the cost of an item of property, plant and equipment any proceeds from selling items produced before that asset is available for use, i.e. proceeds while bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management. Consequently, an entity recognizes such sales proceeds and related costs in profit or loss. The entity measures the cost of those items in accordance with IAS 2 Inventories. The amendments are effective for annual reporting periods beginning on or after January 1, 2022. Earlier adoption is permitted.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">These new and amended standards are not expected to have a material impact on the Company's Financial Statements</span></span></p> </div> </div> </div> <div> <p style="margin-left: 18pt; text-align: justify; margin-top: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Basis of presentation</b></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">These consolidated financial statements ("Financial Statements") have been prepared in accordance with IFRS as issued by the International Accounting Standard Board ("IASB") and interpretations of the International Financial Reporting Interpretations Committee ("IFRIC").</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">These Financial Statements are authorized for issue by the Board of Directors on March 28, 2023.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">These Financial Statements have been prepared on the historical cost basis. In addition, these Financial Statements have been prepared using the accrual basis of accounting.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">These Financial Statements are presented in Canadian dollars, which is the Company's functional currency. The functional currency of PRT USA is U.S. Dollars and the functional currency of PRT UK and Tetra is British Pound Sterling ("£"). The assets and liabilities of PRT USA, PRT UK and Tetra are translated into Canadian dollars at the rate of exchange prevailing at the reporting date and their income and expense items are translated at average exchange rates for the period. Exchange differences arising on the translation are recognized in other comprehensive income.</span></span></p> </div> <div> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Significant accounting judgments, estimates and assumptions</b></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The preparation of these Financial Statements in conformity with IFRS requires management to make judgments and estimates and form assumptions that affect the reported amounts of assets and liabilities at the date of the Financial Statements and reported amounts of income and expenses during the period. Actual results could differ from these estimates.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Significant estimates used in preparing the Financial Statements include, but are not limited to the following:</span></span></p> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">a.<span style="width: 6.11pt; text-indent: 0pt; display: inline-block;"> </span>Deferred taxes</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The calculation of deferred tax is based on the ability of the Company to generate future taxable income, the estimation of which is subject to significant uncertainty as to the amount and timing. The calculation of deferred tax is also based on assumptions, which are subject to uncertainty as to timing and which tax rates are expected to apply when temporary differences reverse. Deferred tax recorded is also subject to uncertainty regarding the magnitude on non-capital losses available for carry forward and of the balances in various tax pools as the corporate tax returns have not been prepared as of the date of financial statement preparation.</span></span></p> <div> </div> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">b.<span style="width: 6.11pt; text-indent: 0pt; display: inline-block;"> </span>Stock-based payments</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The fair value of stock options and finders' warrants issued are subject to the limitations of the Black-Scholes option pricing model that incorporates market data and involves uncertainty in estimates used by management in the assumptions. Because the Black-Scholes option pricing model requires the input of highly subjective assumptions, including the expected lift, volatility of share prices, risk-free rate and dividend yield, changes in subjective input assumptions can materially affect the fair value estimate.</span></span></p> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">c.<span style="width: 6.67pt; text-indent: 0pt; display: inline-block;"> </span>Impairment of non-financial assets</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Impairment exists when the carrying value of an asset or cash generating unit ("CGU") exceeds its recoverable amount, which is the higher of its fair value less costs to sell and its value in use. The fair value less costs to sell calculation is based on available data from binding sales transactions in an arm's length transaction of similar assets or observable market prices less incremental costs for disposing of the asset. The value in use calculation is based on a discounted cash flow model.</span></span></p> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">d.<span style="width: 6.23pt; text-indent: 0pt; display: inline-block;"> </span>Leases</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Management uses estimation in determining the incremental borrowing rate used to measure the lease liability, specific to the asset, underlying currency and geographic location.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Significant judgments used in the preparation of these Financial Statements include, but are not limited to the following:</span></span></p> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(i)<span style="display: inline-block; width: 8.5pt;"> </span>Going concern</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Management has applied judgements in the assessment of the Company's ability to continue as a going concern when preparing its Financial Statements for the year ended November 30, 2022. Management prepares the Financial Statements on a going concern basis unless management either intends to liquidate the entity or to cease trading or has no realistic alternative but to do so.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">In assessing whether the going concern assumption is appropriate, management accounts for all available information about the future, which is at least, but is not limited to, twelve months from the end of the reporting period.</span></span></p> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(ii)<span style="display: inline-block; width: 5pt;"> </span>Business combinations</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Determination of whether a set of assets acquired and liabilities assumed constitute the acquisition of a business or asset may require the Company to make certain judgments as to whether or not the assets acquired and liabilities assumed include the inputs, processes and outputs necessary to constitute a business as defined in IFRS 3 - Business Combinations. Based on an assessment of the relevant facts and circumstances, the Company concluded that the acquisition disclosed in Note 3 met the criteria for accounting as a business combination.</span></span></p> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(iii)<span style="width: 2.67pt; text-indent: 0pt; display: inline-block;"> </span>Intangible assets</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Intangible assets can be capitalized only if development costs can be measured reliably, the product or process is technically and commercially feasible, future economic benefits are probable, and the Company intends to and has sufficient resources to complete development and to use or sell the asset. To determine if the future economic benefit is probable depends on the successful commercialization of its technologies and that in turn depends on the management's judgement and knowledge. As at November 30, 2022, the development costs are not capitalized as management was unable to demonstrate the future economic benefits to be generated from the utilization of the associated expenditures.</span></span></p> </div> <div> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Cash</b></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Cash consists of amounts held in banks and highly liquid investments with limited interest and credit risk.</span></span></p> </div> <div> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Consolidation</b></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The Financial Statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances, transactions and any unrealized gains and losses arising from intercompany transactions, have been eliminated. The Company's subsidiary is presented in the table below. Plymouth Rock USA was incorporated under the General Corporation Law of the State of Delaware on March 22, 2018. Plymouth Rock UK was incorporated under the General Corporation Law for England and Wales on March 26, 2021.Tetra Drones was incorporated under the General Corporation Law for England and Wales and was acquired by the Company on June 4, 2021.</span></span></p> <div style="margin-left: 18pt;"> <div> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt;"> <tr> <td style="width: 39%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>Entity</b></span></span></span></span></td> <td style="width: 27%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>Country of Incorporation</b></span></span></span></span></td> <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><b>Effective Economic</b></span></span></span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><span><span><b>Interest</b></span></span></span></span></span></span></span></span></td> </tr> <tr> <td style="width: 39%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom;"> </td> <td style="width: 27%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom;"> </td> <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Plymouth Rock Technologies Inc.</span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span>("Plymouth Rock USA")</span></span></span></span></td> <td style="width: 27%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; background-color: #e6efff; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"> USA </span></span></td> <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; background-color: #e6efff; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">100%</span></span></td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; padding-left: 5pt;"> </td> <td style="width: 27%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom;"> </td> <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Plymouth Rock Technologies Inc.</span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span>("PRT UK")</span></span></span></span></td> <td style="width: 27%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; background-color: #e6efff; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"> UK </span></span></td> <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; background-color: #e6efff; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">100%</span></span></td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; padding-left: 5pt;"> </td> <td style="width: 27%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom;"> </td> <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Tetra Drones Ltd. ("Tetra Drones")</span></span></td> <td style="width: 27%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; background-color: #e6efff; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"> UK </span></span></td> <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; background-color: #e6efff; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">100%</span></span></td> </tr> </table> </div> </div> </div> <div> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt;"> <tr> <td style="width: 39%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>Entity</b></span></span></span></span></td> <td style="width: 27%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>Country of Incorporation</b></span></span></span></span></td> <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><b>Effective Economic</b></span></span></span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><span><span><b>Interest</b></span></span></span></span></span></span></span></span></td> </tr> <tr> <td style="width: 39%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom;"> </td> <td style="width: 27%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom;"> </td> <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Plymouth Rock Technologies Inc.</span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span>("Plymouth Rock USA")</span></span></span></span></td> <td style="width: 27%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; background-color: #e6efff; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"> USA </span></span></td> <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; background-color: #e6efff; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">100%</span></span></td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; padding-left: 5pt;"> </td> <td style="width: 27%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom;"> </td> <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Plymouth Rock Technologies Inc.</span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span>("PRT UK")</span></span></span></span></td> <td style="width: 27%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; background-color: #e6efff; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"> UK </span></span></td> <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; background-color: #e6efff; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">100%</span></span></td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; padding-left: 5pt;"> </td> <td style="width: 27%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom;"> </td> <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Tetra Drones Ltd. ("Tetra Drones")</span></span></td> <td style="width: 27%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; background-color: #e6efff; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"> UK </span></span></td> <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; background-color: #e6efff; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">100%</span></span></td> </tr> </table> </div> USA 1 UK 1 UK 1 <div> <p style="margin-left: 18pt; text-align: justify; margin-top: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Intangible assets</b></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Intangible assets that are reflected in the consolidated statements of financial position consist of assets acquired through business combinations. Intangible assets acquired in a business combination are recognized separately from goodwill and are initially recognized at their fair value at the acquisition date (which is regarded as their cost). An intangible asset is regarded as having an indefinite useful life when, based on all relevant factors, there is no foreseeable limit to the period over which the asset is expected to generate net cash inflows. Accordingly, the Company does not amortize these intangible assets, but reviews them for impairment, annually or more frequently if events or changes in circumstances indicate that the assets might be impaired.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Development costs for internally-generated intangible assets are capitalized when all of the following conditions are met:</span></span></p> <ul style="padding-left: 0pt; list-style-type: disc;"> <li style="text-align: justify; margin-left: 36pt; padding-left: 8.45pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">technical feasibility can be demonstrated;</span></span></li> <li style="margin-left: 36pt; text-align: justify; padding-left: 8.45pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">management has the intention to complete the intangible asset and use it;</span></span></li> <li style="margin-left: 36pt; text-align: justify; padding-left: 8.45pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">management can demonstrate the ability to use the intangible asset;</span></span></li> <li style="margin-left: 36pt; text-align: justify; padding-left: 8.45pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">it is probable that the intangible asset will generate future economic benefits;</span></span></li> <li style="text-align: justify; margin-left: 36pt; padding-left: 8.4pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">the Company can demonstrate the availability of adequate technical, financial and other resources to complete the development and to use the intangible asset; and</span></span></li> <li style="margin-left: 36pt; text-align: justify; padding-left: 8.45pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">costs attributable to the asset can be measured reliably.</span></span></li> </ul> <p style="text-align: justify; margin-left: 18pt; margin-top: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The amount initially recognized for internally-generated intangible assets is the sum of the expenditures incurred from the date when the intangible asset first meets the recognition criteria listed above. Where no internally-generated intangible asset can be recognized, development expenditures are charged to the consolidated statements of loss and comprehensive loss in the period in which they are incurred.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Customer relationships acquired through the acquisition of subsidiary, Tetra Drones, are amortized for a period of three years from acquisition date.</span></span></p> </div> <div> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Equipment</b></span></span></p> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><i>Recognition and measurement</i></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">On initial recognition, equipment is valued at cost, being the purchase price and directly attributable cost of acquisition or construction required to bring the asset to the location and condition necessary to be capable of operating in the manner intended by the Company, including appropriate borrowing costs and the estimated present value of any future unavoidable costs of dismantling and removing the items. The corresponding liability is recognized within provisions.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Equipment is subsequently measured at cost less accumulated depreciation, less any accumulated impairment losses.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">When parts of an item of equipment have different useful lives, they are accounted for as separate items (major components) of equipment.</span></span></p> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><i>Gains and losses</i></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Gains and losses on disposal of an item of equipment are determined by comparing the proceeds from disposal with the carrying amount and are recognized net within other income in profit or loss.</span></span></p> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><i>Depreciation</i></span></span></p> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Half of the normal depreciation is taken in the year of acquisition for equipment with declining balance method. The depreciation rates applicable to each category of property and equipment are as follows:</span></span></p> <div style="margin-left: 18pt;"> <div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-size: 10pt; width: 100%;"> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Computer equipment    55% declining balance</span></span></td> <td style="margin-top: 0pt; margin-bottom: 0pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Vehicles                             30% declining balance</span></span></td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Furniture                       20% declining balance</span></span></td> <td style="margin-top: 0pt; margin-bottom: 0pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Leasehold improvements  30% declining balance</span></span></td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Demo equipment          20% declining balance</span></span></td> <td style="margin-top: 0pt; margin-bottom: 0pt;"> </td> </tr> </table> </div> </div> </div> <div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-size: 10pt; width: 100%;"> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Computer equipment    55% declining balance</span></span></td> <td style="margin-top: 0pt; margin-bottom: 0pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Vehicles                             30% declining balance</span></span></td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Furniture                       20% declining balance</span></span></td> <td style="margin-top: 0pt; margin-bottom: 0pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Leasehold improvements  30% declining balance</span></span></td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Demo equipment          20% declining balance</span></span></td> <td style="margin-top: 0pt; margin-bottom: 0pt;"> </td> </tr> </table> </div> 0.55 declining balance 0.30 declining balance 0.20 declining balance 0.30 declining balance 0.20 declining balance <div> <p style="margin-left: 18pt; text-align: justify; margin-top: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Inventories</b></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The Company values inventories at the lower of cost and net realizable value. Cost includes the costs of purchases net of vendor allowances plus other costs, such as transportation, that are directly incurred to bring the inventories to their present location and condition.</span></span></p> </div> <div> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Business combinations</b></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Business combinations are accounted for using the acquisition method. The cost of the acquisition is measured at the aggregate of the fair values at the date of acquisition, of assets transferred, liabilities incurred or assumed, and equity instruments issued by the Company. The acquiree's identifiable assets and liabilities assumed are recognized at their fair value at the acquisition date. Acquisition-related costs are recognized in profit or loss as incurred. The excess of consideration over the fair value of the net identifiable assets and liabilities acquired is recorded as goodwill. Any gain on a bargain purchase is recorded in profit or loss immediately. Transaction costs are expensed as incurred, except if related to the issue of debt or equity securities. Any goodwill that arises is tested annually for impairment.</span></span></p> </div> <div> <p style="text-align: justify; margin-left: 18pt; margin-bottom: 0pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Share capital</b></span></span></p> <p style="text-align: justify; margin-left: 18pt; margin-top: 0pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The Company records proceeds from the issuance of its common shares as equity. Proceeds received on the issuance of units, consisting of common shares and warrants, are allocated between the common share and warrant component. The Company has adopted a residual value method with respect to the measurement of shares and warrants issued as private placement units. The residual value method first allocates value to the most easily measurable component based on fair value and then the residual value, if any, to the less easily measurable component.</span></span></p> <div> </div> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The fair value of the common shares issued in the private placement was determined to be the more easily measurable component and were valued at their fair value, as determined by the closing quoted price on the issuance date. The remaining proceeds, if any, are allocated to the attached warrants. Any fair value attributed to the warrants is recorded as warrant reserve. Management does not expect to record a value to the warrant in most equity issuances as unit private placements are commonly priced at market or at a permitted discount to market. If the warrants are issued as share issuance costs, the fair value of agent's warrants are measured using the Black-Scholes option pricing model and recognized in equity as a deduction from the proceeds.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">If the warrants are exercised, the related amount is reclassified as share capital. If the warrants expire unexercised, the related amount remains in warrant reserve.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Incremental costs directly attributable to the issue of new common shares are shown in equity as a deduction, net of tax, from the proceeds. Common shares issued for consideration other than cash are valued based on their market value at the date that shares are issued.</span></span></p> </div> <div> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Stock-based payment</b></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The Company recognizes share-based payment expense for the estimated fair value of equity-based instruments granted to both employees and non-employees. Compensation expense is recognized when the options are granted with the same amount being recorded as contributed surplus. The expense is determined using an option pricing model that accounts for the exercise price, the term of the option, the current share price, the expected volatility of the underlying shares, the expected dividend yield, and the risk-free interest rate for the term of the option. If the options are exercised, the contributed surplus will be reduced by the applicable amount. Share-based payment calculations have no effect in the Company's cash position.</span></span></p> </div> <div> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Earnings (loss) per share</b></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Basic earnings (loss) per share are calculated using the weighted average number of common shares outstanding during the period. Diluted earnings (loss) per share are calculated using the treasury stock method. This method assumes that common shares are issued for the exercise of options, warrants and convertible securities and that the assumed proceeds from the exercise of options, warrants and convertible securities are used to purchase common shares at the average market price during the period. The difference between the number of shares assumed issued and the number of shares assumed purchased is then added to the basic weighted average number of shares outstanding to determine the fully diluted number of common shares outstanding. No exercise or conversion is assumed during the periods in which a net loss is incurred as the effect is anti-dilutive.</span></span></p> </div> <div> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Financial instruments </b></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span style="text-decoration: underline;">Financial assets</span></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The Company recognizes financial assets when it becomes party to the contractual provisions of the instrument. Financial assets are measured initially at their fair value plus, in the case of financial assets not subsequently measured at fair value through profit or loss, transaction costs that are directly attributable to their acquisition. Transaction costs attributable to the acquisition of financial assets subsequently measured at fair value through profit or loss are expensed in profit or loss when incurred.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>Subsequent to initial recognition, all financial assets are classified and subsequently measured at amortized cost. Interest income is calculated using the effective interest method and gains or losses arising from impairment, foreign exchange and derecognition are recognized in profit or loss. Financial assets measured at amortized cost are comprised of cash, accounts receivable and due from related parties.</span></span></span></p> <div> </div> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The Company reclassifies debt instruments only when its business model for managing those financial assets has changed. Reclassifications are applied prospectively from the reclassification date and any previously recognized gains, losses or interest are not restated.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The Company recognizes a loss allowance for the expected credit losses associated with its financial assets. Expected credit losses are measured to reflect a probability-weighted amount, the time value of money, and reasonable and supportable information regarding past events, current conditions and forecasts of future economic conditions.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The Company applies the simplified approach for accounts receivable that do not contain a significant financing component. Using the simplified approach, the Company records a loss allowance equal to the expected credit losses resulting from all possible default events over the assets' contractual lifetime.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Financial assets are written off when the Company has no reasonable expectations of recovering all or any portion thereof.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The Company derecognizes a financial asset when its contractual rights to the cash flows from the financial asset expire.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span style="text-decoration: underline;">Financial liabilities</span></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The Company recognizes a financial liability when it becomes party to the contractual provisions of the instrument. At initial recognition, the Company measures financial liabilities at their fair value plus transaction costs that are directly attributable to their issuance, with the exception of financial liabilities subsequently measured at fair value through profit or loss for which transaction costs are immediately recorded in profit or loss.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Subsequent to initial recognition, all financial liabilities are measured at amortized cost using the effective interest rate method. Interest, gains, and losses relating to a financial liability are recognized in profit or loss. Financial liabilities measured at amortized cost are comprised of accounts payable, lease liability, and due to related parties.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The Company derecognizes a financial liability only when its contractual obligations are discharged, cancelled or expire.</span></span></p> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span style="text-decoration: underline;">Interest</span></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Interest income and expense are recognized in profit or loss using the effective interest method.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The 'effective interest rate' is the rate that exactly discounts estimated future cash payments over the expected life of the financial instrument to the gross carrying amount of the financial asset or the amortized cost of the financial liability. The effective interest rate is calculated considering all contractual terms of the financial instruments, except for the expected credit losses of financial assets.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The 'amortized cost' of a financial asset or financial liability is the amount at which the instrument is measured on initial recognition minus principal repayments, plus or minus any cumulative amortization using the effective interest method of any difference between the initial amount and maturity amount and adjusted for any expected credit loss allowance. The 'gross carrying amount' of a financial asset is the amortized cost of a financial asset before adjusting for any expected credit losses.</span></span></p> <div> </div> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Interest income and expense is calculated by applying the effective interest rate to the gross carrying amount of the financial asset (when the asset is not credit-impaired) or the amortized cost of the financial liability.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Where a financial asset has become credit-impaired subsequent to initial recognition, interest income is calculated in subsequent periods by applying the effective interest method to the amortized cost of the financial asset. If the asset subsequently ceases to be credit-impaired, calculation of interest income reverts to the gross basis.</span></span></p> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span style="text-decoration: underline;">Offsetting</span></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Financial assets and financial liabilities are offset, with the net amount presented in the statement of financial position, when, and only when, the Company has a current and legally enforceable right to set off the recognized amounts and intends either to settle on a net basis or realize the asset and settle the liability simultaneously.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Income and expenses are presented on a net basis only when permitted under IFRS, or when arising from a group of similar transactions if the resulting income and expenses are not material.</span></span></p> </div> <div> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Revenue recognition</b></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Revenue is recognized by applying the five-step model under IFRS 15. The Company recognizes revenue when, or as the goods or services are transferred to the control of the customer and performance obligations are satisfied. The Company's revenue is comprised of sales of its radar systems, radar components and engineering design and development services. The Company's revenue is recognized when control of the goods has been transferred, being when the goods are delivered to customers and when all performance obligations have been fulfilled. The amounts recognized as revenue represent the fair values of the considerations received or receivable from third parties on the sales of goods to customers, net of goods and services taxes and less returns, and discounts, at which time there are no conditions for the payment to become due other than the passage of time. For its engineering design and development services, revenue is recognized when the service has been rendered.</span></span></p> </div> <div> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Government Grants </b></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Government grants are recognized at fair value once there is reasonable assurance that the Company will comply with the conditions attached to the grants and that the grants will be received. Government grants are recognized in profit or loss on a systematic basis over the periods in which the Company recognizes as expenses the related costs for which the grants are intended to compensate. A forgivable loan from government is treated as a government grant when there is reasonable assurance that the entity will meet the terms for forgiveness of the loan.</span></span></p> </div> <div> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Income taxes</b></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Income tax is recognized in profit or loss except to the extent that it relates to equity items, in which case it is recognized in equity. Current tax expense is the expected tax payable on the taxable income for the year, using tax rates enacted at period end, adjusted for amendments to tax payable with regards to previous years. Deferred tax is recorded using the liability method, providing for temporary differences, between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for taxation purposes. The following temporary differences do not result in deferred tax assets or liabilities: goodwill not deductible for tax purposes; the initial recognition of assets or liabilities that affect neither accounting profit (loss) nor taxable profit (loss); and differences relating to investments in subsidiaries to the extent that they will probably not reverse in the foreseeable future. The amount of deferred tax provided is based on the expected manner of realization or settlement of the carrying amount of assets and liabilities, using tax rates enacted or substantively enacted at the financial position date.</span></span></p> <div> </div> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">A deferred tax asset is recognized only to the extent that it is probable that future taxable profits will be available against which the asset can be utilized. Deferred tax assets and liabilities are offset when there is a legally enforceable right to set off current tax assets against current tax liabilities and when they relate to income taxes levied by the same taxation authority and the Company intends to settle its current tax assets and liabilities on a net basis.</span></span></p> </div> <div> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Related party transactions</b></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Parties are considered to be related if one party has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Parties are also considered to be related if they are subject to common control and related parties may be individuals or corporate entities. A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties.</span></span></p> </div> <div> <p style="margin-left: 18pt; margin-bottom: 0pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Leases</b></span></span></p> <p style="text-align: justify; margin-left: 18pt; margin-bottom: 0pt; margin-top: 0pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The company adopted IFRS 16 effective December 1, 2019. The Company chose to adopt the modified retrospective approach on transition to IFRS 16 and has chosen not to restate comparative information in accordance with the transitional provisions in IFRS 16. As a result, the comparative information continues to be presented in accordance with the Company's previous accounting policies. The adoption of IFRS 16 resulted in the recognition of a right-of-use asset and a lease liability measured at the present value of the future lease payments on the consolidated statements of financial position. An amortization expense on the right-of-use asset and an interest expense on the lease liability has replaced the operating lease expense. IFRS 16 has changed the presentation of cash flows relating to leases in the Company's consolidated statements of cash flows, however, it does not cause a difference in the amount of cash transferred between the parties of the lease.</span></span></p> </div> <div> <p style="margin-top: 0pt; margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Accounting standards, amendments and interpretations not yet effective </b></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Certain new standards, interpretations and amendments to existing standards have been issued by the IASB or the IFRIC during the period but are not yet effective. Some updates that are not applicable or are not consequential to the Company may have been excluded from the list below.</span></span></p> <p style="text-align: justify; margin-left: 18pt; margin-bottom: 0pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>IAS 1 - </b>Presentation of Financial Statements ("IAS 1") - <i>Classification of Liabilities as Current or Noncurrent</i> were amended to clarify that the classification of liabilities as current or non-current is based on rights that are in </span></span><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">existence at the end of the reporting period, specify that classification is unaffected by expectations about whether an entity will exercise its right to defer settlement of a liability, explain that rights are in existence if covenants are complied with at the end of the reporting period, and introduce a definition of 'settlement' to make clear that settlement refers to the transfer to the counterparty of cash, equity instruments, other assets or services. The amendments are effective for annual reporting periods beginning on or after January 1, 2023. Earlier adoption is permitted.</span></span></p> <p style="text-align: justify; margin-left: 18pt; margin-bottom: 0pt; margin-top: 10pt;"> </p> <p style="text-align: justify; margin-left: 18pt; margin-top: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>IAS 16 - </b>Property, Plant and Equipment - <i>Proceeds before Intended Use</i> - The amendments prohibit deducting from the cost of an item of property, plant and equipment any proceeds from selling items produced before that asset is available for use, i.e. proceeds while bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management. Consequently, an entity recognizes such sales proceeds and related costs in profit or loss. The entity measures the cost of those items in accordance with IAS 2 Inventories. The amendments are effective for annual reporting periods beginning on or after January 1, 2022. Earlier adoption is permitted.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">These new and amended standards are not expected to have a material impact on the Company's Financial Statements</span></span></p> </div> <div> <div> <p style="text-align: justify; margin-top: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>3.<span style="display: inline-block; width: 10pt;"> </span>ACQUISITION</b></span></span></p> <div> <div> <div> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">On June 4, 2021, the Company acquired the 100% issued and outstanding ordinary shares of Tetra from two arm's length parties for £350,000. Tetra was a privately held UK-based company which develops custom-made, Unmanned Aircraft Systems ("UAS"). The consideration of £350,000 ($579,682) is payable as follows:</span></span></p> <p style="text-align: justify; margin-left: 36pt; margin-bottom: 0pt; text-indent: -18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">1)<span style="width: 10pt; text-indent: 0pt; display: inline-block;"> </span>An amount of £35,000 ($60,021) within 7 days after the execution and delivery of the definitive agreement by all parties, paid on June 12, 2021;</span></span></p> <p style="text-align: justify; margin-left: 36pt; margin-bottom: 0pt; text-indent: -18pt; margin-top: 0pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">2)<span style="width: 10pt; text-indent: 0pt; display: inline-block;"> </span>An amount of £35,000 ($60,479) (paid) within 21 days of the initial payment as described in instalment 1 above, paid on July 9, 2021;</span></span></p> <p style="text-align: justify; margin-left: 36pt; margin-bottom: 0pt; text-indent: -18pt; margin-top: 0pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">3)<span style="width: 10pt; text-indent: 0pt; display: inline-block;"> </span>An amount of £140,000 ($236,411) (paid) within 120 days of the second instalment as described above, paid on November 8, 2021 ("the third payment"); and</span></span></p> <p style="text-align: justify; margin-left: 36pt; text-indent: -18pt; margin-top: 0pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">4)<span style="width: 10pt; text-indent: 0pt; display: inline-block;"> </span>The remaining balance of £140,000 ($222,771) (see Note 19 - Gain on debt forgiveness) within 120 days of the third payment, forgiven in return of the full release of the leased vehicle and allowing the former sole shareholder of Tetra to continue working within the industry.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The Company applied the optional concentration test permitted under IFRS 3 to the acquisition which resulted in the acquired assets being accounted for as an asset acquisition. As such the purchase price was allocated to the identifiable assets and liabilities based on their fair values at the date of acquisition.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The allocation of the consideration for the purposes of the consolidated statements of financial position is as follows:</span></span></p> <div style="margin-left: 18pt; margin-bottom: 10pt;"> <div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-size: 10pt; width: 100%; border-color: #000000;"> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span style="text-decoration: underline;"><b>Total Consideration</b></span></span></span></td> <td style="vertical-align: bottom; text-align: right; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="vertical-align: bottom; text-align: right; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Cash</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">579,682</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span style="text-decoration: underline;"><b>Net assets acquired (liabilities assumed)</b></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Cash indebtedness</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(12,127</span></span></td> <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Equipment</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">27,799</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Prepaid expenses</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">11,131</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Due to a related party</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(13,699</span></span></td> <td style="vertical-align: bottom; text-align: left;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Bank loan</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(40,447</span></span></td> <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Accounts payable</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(19,210</span></span></td> <td style="vertical-align: bottom; text-align: left;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Vehicle loan</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(30,859</span></span></td> <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 2.25pt double #000000; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Net assets acquired (liabilities assumed)</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(77,412</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Purchase price allocation</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Net identifiable assets acquired</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(77,412</span></span></td> <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Customer relationships</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">657,094</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 2.25pt double #000000; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">579,682</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> </table> </div> </div> </div> </div> </div> </div> </div> 1 350000 350000 579682 35000 60021 35000 60479 140000 236411 140000 222771 <div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-size: 10pt; width: 100%; border-color: #000000;"> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span style="text-decoration: underline;"><b>Total Consideration</b></span></span></span></td> <td style="vertical-align: bottom; text-align: right; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="vertical-align: bottom; text-align: right; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Cash</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">579,682</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span style="text-decoration: underline;"><b>Net assets acquired (liabilities assumed)</b></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Cash indebtedness</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(12,127</span></span></td> <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Equipment</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">27,799</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Prepaid expenses</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">11,131</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Due to a related party</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(13,699</span></span></td> <td style="vertical-align: bottom; text-align: left;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Bank loan</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(40,447</span></span></td> <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Accounts payable</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(19,210</span></span></td> <td style="vertical-align: bottom; text-align: left;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Vehicle loan</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(30,859</span></span></td> <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 2.25pt double #000000; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Net assets acquired (liabilities assumed)</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(77,412</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Purchase price allocation</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Net identifiable assets acquired</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(77,412</span></span></td> <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Customer relationships</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">657,094</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 2.25pt double #000000; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">579,682</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> </table> </div> 579682 12127 27799 11131 13699 40447 19210 30859 -77412 -77412 657094 579682 <div style="margin-bottom: 0pt; text-align: justify;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span><b>4.<span style="display: inline-block; width: 10pt;"> </span>PREPAID EXPENSES</b></span></span></span></span></span></div> <div> <p style="margin-left: 18pt; text-align: justify; margin-top: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span>As at November 30, 2022 and 2021, the Company's prepaid expenses consist of the following:</span></span></span></span></span></p> <div style="margin-bottom: 11pt;"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-size: 10pt; width: 70%; border-color: #000000; margin-left: auto; margin-right: auto;"> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; vertical-align: bottom;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span><b>November 30, 2022</b></span></span></span></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span>November 30, 2021</span></span></span></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; background-color: #ffffff; text-align: justify;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span><b> </b></span></span></span></span></span></td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; text-align: justify;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; text-align: justify;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; text-align: justify;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: justify; background-color: #e6efff;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span>Advertising and promotions</span></span></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span><b>$</b></span></span></span></span></span></td> <td style="vertical-align: bottom; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span><b>113</b></span></span></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span>$</span></span></span></span></span></td> <td style="vertical-align: bottom; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span>127,664</span></span></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: justify;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span>Rent</span></span></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 22%;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span><b>8,247</b></span></span></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 22%;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span>11,211</span></span></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: justify; background-color: #e6efff;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span>Transfer agent and filing fees</span></span></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span><b>13,748</b></span></span></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span>13,020</span></span></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: justify;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span>Insurance</span></span></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 22%;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span><b>8,839</b></span></span></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 22%;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span>8,382</span></span></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: justify; background-color: #e6efff;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span>Others</span></span></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span><b>-</b></span></span></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span>18,044</span></span></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 2.25pt double #000000; vertical-align: bottom;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span><b>$</b></span></span></span></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 22%;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span><b>30,947</b></span></span></span></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span>$</span></span></span></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 22%;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span>178,321</span></span></span></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%;"> </td> </tr> </table> </div> <div> </div> <p style="text-align: justify; margin-left: 18pt; margin-top: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span>The prepayments for advertising include prepayments for marketing and awareness programs handled by an arms' length parties for a six to twelve-month period.</span></span></span></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span>Others include prepayments for some office expenses.</span></span></span></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span>As at November 30, 2022, others include $Nil prepayment to related parties (2021 - $5,513) (Note 9).</span></span></span></span></span></p> </div> <div style="margin-bottom: 11pt;"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-size: 10pt; width: 70%; border-color: #000000; margin-left: auto; margin-right: auto;"> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; vertical-align: bottom;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span><b>November 30, 2022</b></span></span></span></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span>November 30, 2021</span></span></span></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; background-color: #ffffff; text-align: justify;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span><b> </b></span></span></span></span></span></td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; text-align: justify;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; text-align: justify;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; text-align: justify;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: justify; background-color: #e6efff;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span>Advertising and promotions</span></span></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span><b>$</b></span></span></span></span></span></td> <td style="vertical-align: bottom; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span><b>113</b></span></span></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span>$</span></span></span></span></span></td> <td style="vertical-align: bottom; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span>127,664</span></span></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: justify;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span>Rent</span></span></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 22%;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span><b>8,247</b></span></span></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 22%;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span>11,211</span></span></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: justify; background-color: #e6efff;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span>Transfer agent and filing fees</span></span></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span><b>13,748</b></span></span></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span>13,020</span></span></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: justify;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span>Insurance</span></span></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 22%;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span><b>8,839</b></span></span></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 22%;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span>8,382</span></span></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: justify; background-color: #e6efff;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span>Others</span></span></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span><b>-</b></span></span></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span>18,044</span></span></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 2.25pt double #000000; vertical-align: bottom;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span><b>$</b></span></span></span></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 22%;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span><b>30,947</b></span></span></span></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span>$</span></span></span></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 22%;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span><span>178,321</span></span></span></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%;"> </td> </tr> </table> </div> 113 127664 8247 11211 13748 13020 8839 8382 0 18044 30947 178321 0 5513 <div> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>5.<span style="display: inline-block; width: 10pt;"> </span>EQUIPMENT</b></span></span></p> <div> <div> <div style="margin-bottom: 11pt;"> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;"> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-top: 0.75pt solid #000000; vertical-align: bottom;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; text-align: right;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; white-space: nowrap; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Computer</b></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; white-space: nowrap; text-align: center;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; white-space: nowrap; text-align: center;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; white-space: nowrap; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Furniture</b></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; white-space: nowrap; text-align: center;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; white-space: nowrap; text-align: center;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; white-space: nowrap; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Vehicles</b></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; white-space: nowrap; text-align: center;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; white-space: nowrap; text-align: center;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; white-space: nowrap; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Leasehold </b></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>Improvement</b></span></span></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; white-space: nowrap; text-align: center;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; white-space: nowrap; text-align: center;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; white-space: nowrap; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Demo </b></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>Equipment</b></span></span></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; white-space: nowrap; text-align: center;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; white-space: nowrap; text-align: center;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; white-space: nowrap; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Total</b></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; text-align: center;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: center;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: center; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: center; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: center; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: center; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: center; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: center; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: center;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Cost:</b></span></span></td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Balance at November 30, 2020</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">1,684</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">12,151</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">57,518</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">71,353</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Additions</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">22,664</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">7,244</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">16,243</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">3,881</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">184,484</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">234,516</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td colspan="1" style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-indent: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Foreign currency translation adjustment</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(320</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(124</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(229</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(55</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(2,255</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(2,983</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Balance at November 30, 2021</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">24,028</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">19,271</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">16,014</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">3,826</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">239,747</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">302,886</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">    Disposal</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(16,243</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(16,243</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> </tr> <tr> <td colspan="1" style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-indent: 10pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Foreign currency translation adjustment</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(997</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">190</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">229</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(182</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">3,158</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">2,398</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 2.25pt double #000000; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Balance at November 30, 2022</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>23,031</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>19,461</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>3,644</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>242,905</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>289,041</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Accumulated Depreciation:</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Balance at November 30, 2020</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">1,134</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">3,401</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">4,535</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Amortization</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">561</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">2,055</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">1,201</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">287</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">4,104</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td colspan="1" style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-indent: 10pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Foreign currency translation adjustment</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">21</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">17</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">17</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">4</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">59</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Balance at November 30, 2021</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">1,716</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">5,473</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">1,218</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; width: 1%; text-align: left;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; width: 8%; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">291</span></span></td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; width: 2%; text-align: left;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">8,698</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-top: 0.75pt solid #000000; text-indent: 10pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Amortization</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">9,236</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">2,688</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">4,210</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">1,006</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">17,140</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Disposal</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(5,375</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(5,375</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Impairment</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">236,677</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">236,677</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td colspan="1" style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-indent: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Foreign currency translation adjustment</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">642</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">296</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(53</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(13</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">6,228</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">7,100</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 2.25pt double #000000; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Balance at November 30, 2022</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>11,594</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>8,457</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>1,284</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>242,905</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>264,240</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; padding-left: 5pt;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Net Book Value:</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; padding-left: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">At November 30, 2021</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">22,312</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">13,798</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">14,796</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">3,535</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">239,747</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">294,188</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 2.25pt double #000000; vertical-align: bottom; background-color: #e6efff; padding-left: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>At November 30, 2022</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>11,437</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>11,004</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>2,360</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>24,801</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> </table> </div> </div> </div> </div> <div style="margin-bottom: 11pt;"> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;"> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-top: 0.75pt solid #000000; vertical-align: bottom;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; text-align: right;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; white-space: nowrap; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Computer</b></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; white-space: nowrap; text-align: center;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; white-space: nowrap; text-align: center;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; white-space: nowrap; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Furniture</b></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; white-space: nowrap; text-align: center;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; white-space: nowrap; text-align: center;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; white-space: nowrap; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Vehicles</b></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; white-space: nowrap; text-align: center;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; white-space: nowrap; text-align: center;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; white-space: nowrap; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Leasehold </b></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>Improvement</b></span></span></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; white-space: nowrap; text-align: center;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; white-space: nowrap; text-align: center;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; white-space: nowrap; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Demo </b></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>Equipment</b></span></span></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; white-space: nowrap; text-align: center;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; white-space: nowrap; text-align: center;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; white-space: nowrap; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Total</b></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; text-align: center;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: center;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: center; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: center; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: center; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: center; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: center; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: center; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: center;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Cost:</b></span></span></td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Balance at November 30, 2020</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">1,684</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">12,151</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">57,518</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">71,353</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Additions</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">22,664</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">7,244</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">16,243</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">3,881</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">184,484</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">234,516</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td colspan="1" style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-indent: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Foreign currency translation adjustment</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(320</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(124</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(229</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(55</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(2,255</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(2,983</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Balance at November 30, 2021</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">24,028</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">19,271</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">16,014</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">3,826</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">239,747</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">302,886</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">    Disposal</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(16,243</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(16,243</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> </tr> <tr> <td colspan="1" style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-indent: 10pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Foreign currency translation adjustment</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(997</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">190</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">229</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(182</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">3,158</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">2,398</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 2.25pt double #000000; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Balance at November 30, 2022</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>23,031</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>19,461</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>3,644</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>242,905</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>289,041</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Accumulated Depreciation:</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Balance at November 30, 2020</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">1,134</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">3,401</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">4,535</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Amortization</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">561</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">2,055</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">1,201</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">287</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">4,104</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td colspan="1" style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-indent: 10pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Foreign currency translation adjustment</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">21</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">17</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">17</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">4</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">59</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Balance at November 30, 2021</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">1,716</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">5,473</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">1,218</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; width: 1%; text-align: left;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; width: 8%; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">291</span></span></td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; width: 2%; text-align: left;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">8,698</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-top: 0.75pt solid #000000; text-indent: 10pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Amortization</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">9,236</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">2,688</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">4,210</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">1,006</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">17,140</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Disposal</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(5,375</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(5,375</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Impairment</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">236,677</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">236,677</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td colspan="1" style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-indent: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Foreign currency translation adjustment</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">642</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">296</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(53</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(13</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">6,228</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">7,100</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 2.25pt double #000000; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Balance at November 30, 2022</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>11,594</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>8,457</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>1,284</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>242,905</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>264,240</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; padding-left: 5pt;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Net Book Value:</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 8%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; padding-left: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">At November 30, 2021</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">22,312</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">13,798</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">14,796</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">3,535</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">239,747</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 8%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">294,188</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 2.25pt double #000000; vertical-align: bottom; background-color: #e6efff; padding-left: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>At November 30, 2022</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>11,437</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>11,004</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>2,360</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: right; width: 8%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>24,801</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> </table> </div> 1684 12151 0 0 57518 71353 22664 7244 16243 3881 184484 234516 -320 -124 -229 -55 -2255 -2983 24028 19271 16014 3826 239747 302886 0 0 -16243 0 0 -16243 -997 190 229 -182 3158 2398 23031 19461 0 3644 242905 289041 -1134 -3401 0 0 0 -4535 561 2055 1201 287 0 4104 21 17 17 4 0 59 -1716 -5473 -1218 -291 0 -8698 9236 2688 4210 1006 0 17140 0 0 -5375 0 0 -5375 -236677 -236677 642 296 -53 -13 6228 7100 -11594 -8457 -0 -1284 -242905 -264240 22312 13798 14796 3535 239747 294188 11437 11004 0 2360 0 24801 <div> <div> <div> <p style="text-align: justify; margin-top: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>6.<span style="display: inline-block; width: 10pt;"> </span>INTANGIBLE ASSETS</b></span></span></p> </div> </div> <div> <div> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">During the year ended November 30, 2021, the Company acquired Tetra (Note 3).Included in the acquisition is the identifiable intangible asset, customer relationships valued at $657,094.The intangible asset is being amortized over its estimated useful life of three years. For the year ended November 30, 2022, the Company determined that the intangible asset is fully impaired as there is no future economic benefits will derived from this asset.</span></span></p> <table cellpadding="0" cellspacing="0" style="width: 70%; border-collapse: collapse; font-size: 10pt; border-color: #000000; margin-left: auto; margin-right: auto;"> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-top: 0.75pt solid #000000; vertical-align: bottom;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Cost:</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Customer relationship </b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right;"> </td> </tr> <tr> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; padding-left: 6.1pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Balance at November 30, 2020</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-family: Times New Roman, Times, serif;">-</span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; padding-left: 6.1pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">    Additions</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">657,094</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-left: 6.1pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Balance at November 30, 2021 and November 30, 2022</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>657,094</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; padding-left: 6.1pt;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 12%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-left: 6.1pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Accumulated amortization:</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-left: 6.1pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Balance at November 30, 2020</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-family: Times New Roman, Times, serif;"><b>-</b></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; padding-left: 6.1pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">    Amortization</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(107,415</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> </tr> <tr> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; padding-left: 6.1pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Balance at November 30, 2021</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(107,415</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> </tr> <tr> <td style="vertical-align: bottom; padding-left: 6.1pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">    Amortization</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(219,029</span></span></td> <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> </tr> <tr> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; padding-left: 6.1pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">    Impairment</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(330,650</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> </tr> <tr> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-left: 6.1pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Balance at November 30, 2022</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>(657,094</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>)</b></span></span></td> </tr> <tr> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; padding-left: 6.1pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Net book value</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 12%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; padding-left: 6.1pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Balance at November 30, 2021</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">549,679</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-left: 6.1pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Balance at November 30, 2022</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; width: 12%;"><span style="font-family: Times New Roman, Times, serif;"><b>-</b></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> </table> </div> </div> </div> 657094 three years <table cellpadding="0" cellspacing="0" style="width: 70%; border-collapse: collapse; font-size: 10pt; border-color: #000000; margin-left: auto; margin-right: auto;"> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-top: 0.75pt solid #000000; vertical-align: bottom;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Cost:</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Customer relationship </b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right;"> </td> </tr> <tr> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; padding-left: 6.1pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Balance at November 30, 2020</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-family: Times New Roman, Times, serif;">-</span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; padding-left: 6.1pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">    Additions</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">657,094</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-left: 6.1pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Balance at November 30, 2021 and November 30, 2022</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>657,094</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; padding-left: 6.1pt;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 12%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-left: 6.1pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Accumulated amortization:</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-left: 6.1pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Balance at November 30, 2020</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-family: Times New Roman, Times, serif;"><b>-</b></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; padding-left: 6.1pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">    Amortization</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(107,415</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> </tr> <tr> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; padding-left: 6.1pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Balance at November 30, 2021</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(107,415</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> </tr> <tr> <td style="vertical-align: bottom; padding-left: 6.1pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">    Amortization</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(219,029</span></span></td> <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> </tr> <tr> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; padding-left: 6.1pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">    Impairment</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(330,650</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> </tr> <tr> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-left: 6.1pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Balance at November 30, 2022</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>(657,094</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>)</b></span></span></td> </tr> <tr> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; padding-left: 6.1pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Net book value</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 12%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; padding-left: 6.1pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Balance at November 30, 2021</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">549,679</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-left: 6.1pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Balance at November 30, 2022</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; width: 12%;"><span style="font-family: Times New Roman, Times, serif;"><b>-</b></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> </table> 0 657094 657094 657094 0 107415 -107415 219029 330650 -657094 549679 0 <div> <div> <p style="text-align: justify; margin-top: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><b>7.<span style="display: inline-block; width: 10pt;"> </span>ACCOUNTS PAYABLE</b></span></span></span></p> <div> <div> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>As at November 30, 2022 and 2021, the Company's accounts payable consist of the following:</span></span></span></p> <div style="margin-left: 18pt;"> <div style="margin-bottom: 11pt;"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-size: 10pt; width: 100%; border-color: #000000;"> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; vertical-align: bottom;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><b>November 30, 2022</b></span></span></span></td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>November 30, 2021</span></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; background-color: #ffffff; text-align: justify;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><b> </b></span></span></span></td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; text-align: justify;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; text-align: justify;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; text-align: justify;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: justify; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>Professional fees</span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><b>$</b></span></span></span></td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><b>382,805</b></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>$</span></span></span></td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>92,078</span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>Funds to be returned to investors</span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><b>43,046</b></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>43,046</span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: justify; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>Due to former shareholder of Tetra (Note 3, 19)</span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><b>-</b></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>222,771</span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>Advertising costs</span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><b>34,705</b></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>42,241</span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: justify; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>Payroll</span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><b>268,610</b></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>33,173</span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>Development costs</span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><b>168,925</b></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>123,334</span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: justify; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>Bank overdraft</span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><b>16,036</b></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>-</span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>VAT Payable</span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><b>61,262</b></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>4,735</span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: justify; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>Purchases</span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><b>2,121</b></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>-</span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>Rent</span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><b>1,822</b></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>-</span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: justify; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>Others</span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><b>84,531</b></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>47,007</span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 2.25pt double #000000; vertical-align: bottom;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><b>$</b></span></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><b>1,063,863</b></span></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>$</span></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>608,385</span></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%;"> </td> </tr> </table> </div> </div> </div> </div> </div> </div> <div style="margin-bottom: 11pt;"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-size: 10pt; width: 100%; border-color: #000000;"> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; vertical-align: bottom;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><b>November 30, 2022</b></span></span></span></td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>November 30, 2021</span></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; background-color: #ffffff; text-align: justify;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><b> </b></span></span></span></td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; text-align: justify;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; text-align: justify;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; text-align: justify;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: justify; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>Professional fees</span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><b>$</b></span></span></span></td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><b>382,805</b></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>$</span></span></span></td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>92,078</span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>Funds to be returned to investors</span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><b>43,046</b></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>43,046</span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: justify; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>Due to former shareholder of Tetra (Note 3, 19)</span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><b>-</b></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>222,771</span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>Advertising costs</span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><b>34,705</b></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>42,241</span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: justify; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>Payroll</span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><b>268,610</b></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>33,173</span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>Development costs</span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><b>168,925</b></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>123,334</span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: justify; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>Bank overdraft</span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><b>16,036</b></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>-</span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>VAT Payable</span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><b>61,262</b></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>4,735</span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: justify; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>Purchases</span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><b>2,121</b></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>-</span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>Rent</span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><b>1,822</b></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>-</span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: justify; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>Others</span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><b>84,531</b></span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>47,007</span></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 2.25pt double #000000; vertical-align: bottom;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><b>$</b></span></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><b>1,063,863</b></span></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>$</span></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>608,385</span></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%;"> </td> </tr> </table> </div> 382805 92078 43046 43046 0 222771 34705 42241 268610 33173 168925 123334 16036 0 61262 4735 2121 0 1822 0 84531 47007 1063863 608385 <div> <p style="text-align: justify; margin-top: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>8.<span style="display: inline-block; width: 10pt;"> </span>Deferred Revenue</b></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">As at November 30, 2022 and 2021, the Company received an advance payment from their customers as consideration for the Company's products and services to be rendered in the future date amounting to $124,918 (2021 - $nil).</span></span></p> </div> 124918 0 <div> <div> <div> <p style="text-align: justify; margin-top: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>9.    RELATED PARTY TRANSACTIONS AND BALANCES</b></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Key management compensation</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The amounts due to and from related parties are due to the directors and officers of the Company. The balances are unsecured, non-interest bearing and due on demand. These transactions are in the normal course of operations and have been valued in these consolidated financial statements at the exchange amount, which is the amount of consideration established and agreed to by the related parties. Key management is comprised of directors and officers of the Company</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">As at November 30, 2022, $Nil (2021 - $5,513) prepayment to directors and officers of the Company.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">As at November 30, 2022, $705,672 (2021 - $52,728) was due to directors and officers of the Company:</span></span></p> </div> </div> <div> <div> <div style="margin-left: 18pt;"> <div> <div> <div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-size: 10pt; width: 100%; border-color: #000000;"> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; vertical-align: bottom;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>November 30, 2022</b></span></span></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span>November 30, 2021</span></span></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Company controlled by the CFO</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>67,540</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Company controlled by the Corporate Secretary</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">10,500</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">CEO of the Company</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>250,179</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">561</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Director</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>387,953</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">41,667</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 2.25pt double #000000; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>705,672</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">52,728</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> </table> </div> </div> </div> </div> </div> <p style="text-align: justify; margin-left: 18pt; margin-top: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span>During the years ended November 30, 2022 and 2021 and 2020, the Company entered into the following transactions with related parties:</span></span></span></span></p> <div style="margin-left: 18pt;"> <div> <div> <div> <div> <div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-size: 10pt; width: 100%; border-color: #000000;"> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; vertical-align: bottom;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>November 30, 2022</b></span></span></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span>November 30, 2021</span></span></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span>November 30, 2020</span></span></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Management fees</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>311,535</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">118,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">114,125</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Consulting fees</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>135,000</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">307,734</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">166,667</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Accounting fees</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">36,202</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">22,852</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Rent</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">5,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">20,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Share-based payments</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">410,132</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">271,993</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Salaries and benefits to CEO</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>330,337</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">313,626</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">133,387</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 2.25pt double #000000; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>776,872</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">1,190,694</span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">729,024</span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> </table> </div> </div> </div> </div> </div> </div> </div> <span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span> </span></span></span></span> <p style="margin-bottom: 0pt; margin-top: 0pt; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span>Management fees consisted of the following:</span></span></span></span></p>   <div> <div> <div> <div style="margin-left: 18pt;"> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;"> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; vertical-align: bottom;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><b> </b></span></span></span></span></span></span></td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><b>November 30, 2022</b></span></span></span></span></span></span></td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span>November 30, 2021</span></span></span></span></span></span></td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span>November 30, 2020</span></span></span></span></span></span></td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Company controlled by CEO</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>243,387</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">63,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">55,125</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Company controlled by the Former CFO</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">55,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">59,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Company controlled by the CFO</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>68,148</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 2.25pt double #000000; vertical-align: bottom;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 17%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>311,535</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 17%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">118,000</span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 17%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">114,125</span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> </table> </div> </div> </div> </div> </div> <div> <div> <p style="text-align: justify; margin-left: 18pt; margin-top: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Consulting fees consisted of the following:</span></span></p> <div style="margin-left: 18pt; margin-bottom: 11pt;"> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;"> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; vertical-align: bottom;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b> </b></span></span></span></span></td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>November 30, 2022</b></span></span></span></span></td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span>November 30, 2021</span></span></span></span></td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span>November 30, 2020</span></span></span></span></td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Company controlled by the Former Corporate Secretary</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>60,000</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Directors</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>75,000</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">307,734</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">166,667</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 2.25pt double #000000; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>135,000</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">307,734</span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">166,667</span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> </table> </div> <div> </div> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">During the year ended November 30, 2022, the Company had 1,650,000 (2021 -1,725,000) stock options held by the CEO, Former CFO, the Former Corporate Secretary, and the Company's directors. The amount recognized as expense for these options for the years ended November 30, 2022, 2021 and 2020 are as follows:</span></span></p> </div> </div> <div style="margin-left: 18pt; margin-bottom: 10pt;"> <div> <div> <div> <div> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;"> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; vertical-align: bottom;"> </td> <td colspan="1" style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center;"> </td> <td colspan="4" style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>November 30, 2022</b></span></span></span></span></td> <td colspan="1" style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> <td colspan="1" style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> <td colspan="4" style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>November 30, 2021</b></span></span></span></span></td> <td colspan="1" style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> <td colspan="1" style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> <td colspan="4" style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>November 30, 2020</b></span></span></span></span></td> <td colspan="1" style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; text-align: center;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: center;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>Number of</b></span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><span><span><b>Options</b></span><br/><span><b>held</b></span></span></span></span></span></span></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: right;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: right;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>Expense </b></span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><span><span><b>for the year</b></span></span></span></span></span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><span><span><b>(vested)</b></span></span></span></span></span></span></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: right;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: right;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span>Number of</span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><span><span>options held</span></span></span></span></span></span></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: right;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; white-space: nowrap; text-align: right;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; white-space: nowrap; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span>Expense for</span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><span><span>the year</span></span></span></span></span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><span><span>(vested)</span></span></span></span></span></span></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; white-space: nowrap; text-align: right;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: right;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span>Number of</span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><span><span>Options held</span></span></span></span></span></span></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: right;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; white-space: nowrap; text-align: right;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; white-space: nowrap; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span>Expense</span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><span><span><span><span>for the year</span></span></span></span></span></span></span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><span><span>(vested)</span></span></span></span></span></span></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; text-align: right;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">CEO</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>600,000</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">600,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">133,275</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">400,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">44,455</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Former CFO</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>150,000</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">150,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">33,319</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">100,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">11,113</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Former Corporate Secretary</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>150,000</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">150,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">33,319</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">100,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">11,113</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Directors</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>750,000</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">825,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">210,219</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">1,050,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">205,312</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 2.25pt double #000000; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>1,650,000</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">1,725,000</span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">410,132</span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">1,650,000</span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">271,993</span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> </table> </div> </div> </div> </div> <p style="margin: 0pt;"> </p> <p style="text-align: justify; margin-top: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">During the year ended November 30, 2022, the Company also issued 78,125 (2021 -  656,250 and 2020- 500,000) common shares as compensation for consulting fees to a director valued at a total of $17,189 (2021 - $307,734 and 2020 - $125,000) (Note 13).</span></span></p> </div> 0 5513 705672 52728 <div> <div> <div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-size: 10pt; width: 100%; border-color: #000000;"> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; vertical-align: bottom;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>November 30, 2022</b></span></span></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span>November 30, 2021</span></span></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Company controlled by the CFO</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>67,540</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Company controlled by the Corporate Secretary</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">10,500</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">CEO of the Company</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>250,179</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">561</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Director</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>387,953</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">41,667</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 2.25pt double #000000; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>705,672</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">52,728</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> </table> </div> </div> </div> 67540 0 0 10500 250179 561 387953 41667 705672 52728 <div> <div> <div> <div> <div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-size: 10pt; width: 100%; border-color: #000000;"> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; vertical-align: bottom;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>November 30, 2022</b></span></span></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span>November 30, 2021</span></span></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span>November 30, 2020</span></span></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Management fees</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>311,535</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">118,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">114,125</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Consulting fees</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>135,000</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">307,734</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">166,667</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Accounting fees</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">36,202</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">22,852</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Rent</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">5,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">20,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Share-based payments</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">410,132</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">271,993</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Salaries and benefits to CEO</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>330,337</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">313,626</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">133,387</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 2.25pt double #000000; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>776,872</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">1,190,694</span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">729,024</span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> </table> </div> </div> </div> </div> </div> 311535 118000 114125 135000 307734 166667 0 36202 22852 0 5000 20000 0 410132 271993 330337 313626 133387 776872 1190694 729024 <div> <div> <div> <div style="margin-left: 18pt;"> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;"> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; vertical-align: bottom;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><b> </b></span></span></span></span></span></span></td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><b>November 30, 2022</b></span></span></span></span></span></span></td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span>November 30, 2021</span></span></span></span></span></span></td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span>November 30, 2020</span></span></span></span></span></span></td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Company controlled by CEO</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>243,387</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">63,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">55,125</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Company controlled by the Former CFO</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">55,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">59,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Company controlled by the CFO</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>68,148</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 2.25pt double #000000; vertical-align: bottom;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 17%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>311,535</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 17%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">118,000</span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 17%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">114,125</span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> </table> </div> </div> </div> </div> 243387 63000 55125 0 55000 59000 68148 0 0 311535 118000 114125 <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;"> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; vertical-align: bottom;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b> </b></span></span></span></span></td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>November 30, 2022</b></span></span></span></span></td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span>November 30, 2021</span></span></span></span></td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span>November 30, 2020</span></span></span></span></td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Company controlled by the Former Corporate Secretary</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>60,000</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Directors</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>75,000</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">307,734</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 17%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">166,667</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 2.25pt double #000000; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>135,000</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">307,734</span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 17%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">166,667</span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> </table> 60000 0 0 75000 307734 166667 135000 307734 166667 1650000 1725000 <div> <div> <div> <div> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;"> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; vertical-align: bottom;"> </td> <td colspan="1" style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center;"> </td> <td colspan="4" style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>November 30, 2022</b></span></span></span></span></td> <td colspan="1" style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> <td colspan="1" style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> <td colspan="4" style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>November 30, 2021</b></span></span></span></span></td> <td colspan="1" style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> <td colspan="1" style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> <td colspan="4" style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>November 30, 2020</b></span></span></span></span></td> <td colspan="1" style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; text-align: center;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: center;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>Number of</b></span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><span><span><b>Options</b></span><br/><span><b>held</b></span></span></span></span></span></span></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: right;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: right;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>Expense </b></span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><span><span><b>for the year</b></span></span></span></span></span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><span><span><b>(vested)</b></span></span></span></span></span></span></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: right;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: right;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span>Number of</span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><span><span>options held</span></span></span></span></span></span></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: right;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; white-space: nowrap; text-align: right;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; white-space: nowrap; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span>Expense for</span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><span><span>the year</span></span></span></span></span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><span><span>(vested)</span></span></span></span></span></span></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; white-space: nowrap; text-align: right;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: right;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span>Number of</span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><span><span>Options held</span></span></span></span></span></span></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: right;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; white-space: nowrap; text-align: right;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; white-space: nowrap; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span>Expense</span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><span><span><span><span>for the year</span></span></span></span></span></span></span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><span><span>(vested)</span></span></span></span></span></span></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; text-align: right;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">CEO</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>600,000</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">600,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">133,275</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">400,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">44,455</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Former CFO</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>150,000</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">150,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">33,319</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">100,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">11,113</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Former Corporate Secretary</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>150,000</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">150,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">33,319</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">100,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">11,113</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Directors</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>750,000</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">825,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">210,219</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">1,050,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">205,312</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 2.25pt double #000000; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>1,650,000</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">1,725,000</span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">410,132</span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">1,650,000</span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">271,993</span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> </table> </div> </div> </div> </div> 600000 0 600000 133275 400000 44455 150000 0 150000 33319 100000 11113 150000 0 150000 33319 100000 11113 750000 0 825000 210219 1050000 205312 1650000 0 1725000 410132 1650000 271993 78125 656250 500000 17189 307734 125000 <div> <div> <div> <div> <div> <p style="text-align: justify; margin-top: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><b>10.</b><span style="width: 5.25pt; text-indent: 0pt; display: inline-block;"> </span><b>GOVERMENT ASSISTANCE RECEIVED </b></span></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>On May 4, 2020, the Company received a CARES Act Paycheck Protection Program Loan ("PPP Loan") of USD$75,000. The PPP Loan bears interest at 1% per annum and is repayable monthly staring on December 4, 2020. The loan is forgivable if PRT USA meets the requirements outlined below.</span></span></span></p> <p style="text-align: justify; margin-left: 36pt; margin-bottom: 0pt; text-indent: -18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>i)<span style="display: inline-block; width: 13pt;"> </span>The loan proceeds are used to cover payroll costs, and most mortgage interest, rent, and utility costs over the 24-week period after the loan is made; and</span></span></span></p> <p style="margin-left: 36pt; text-indent: -18pt; margin-top: 0pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>ii)<span style="display: inline-block; width: 10pt;"> </span>Employee and compensation levels are maintained. Payroll costs are capped at $100,000 on an annualized basis for each employee.</span></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>During the year ended November 30, 2021, it was determined that the Company met the requirements for loan forgiveness, and Company received notice of loan forgiveness on March 16, 2021, therefore there was no loan recognized. As such, the PPP Loan was treated as a government grant and was offset against operating expenses on the consolidated statement of loss and comprehensive loss for the year ended November 30, 2021.</span></span></span></p> </div> </div> </div> </div> </div> 75000 0.01 100000 <div> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>11.</b><span style="width: 5.25pt; text-indent: 0pt; display: inline-block;"> </span><b>LOANS PAYABLE</b></span></span></p> <div> <div> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Upon acquisition of Tetra Drones (Note 3, 19), the Company assumed the latter's outstanding loan of £13,253 ($21,461) as of November 30, 2022. The collateral of this loan is a vehicle. On October 25, 2022, the loan and the vehicle were released to former shareholder of Tetra Drones in exchange of forgoing the remaining acquisition cost of £140,000 ($222,771). Thus, for the year ended November 30, 2022, the Company's liabilities in the vehicle and the remaining balance in the acquisition cost were extinguished.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">For the year ended November 30, 2022, the current loan payable of $127,019 consisted of $75,000 plus interest of $4,019 payable to a third party, which is equal to 12% interest per annum payable on demand. This includes as well the $30,000 plus interest of $3,000, a 10% interest payable to another third party for four calendar months from the date of promissory note. As of the year ended November 30, 2022, the company is now liable to pay total interest of $18,000 including the $3,000 interest as they are considered in default. Total proceeds of $105,000 was received by the Company for these loans.</span></span></p> </div> </div> </div> 13253 21461 140000 222771 127019 75000 4019 0.12 30000 3000 0.10 18000 3000 105000 <div> <div> <div> <div> <p style="text-align: justify; margin-top: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>12.</b><span style="width: 5.9pt; text-indent: 0pt; display: inline-block;"> </span><b>CAPITAL MANAGEMENT</b></span></span></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span>The Company considers its capital structure to include net residual equity of all assets, less liabilities. The Company's objectives when managing capital are to (i) maintain financial flexibility in order to preserve its ability to meet financial obligations and continue as a going concern; (ii) maintain a capital structure that allows the Company to pursue the development of its projects and products; and (iii) optimize the use of its capital to provide an appropriate investment return to its shareholders commensurate with risk.</span></span></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span>The Company's financial strategy is formulated and adapted according to market conditions in order to maintain a flexible capital structure that is consistent with its objectives and the risk characteristics of its underlying assets. The Company manages its capital structure and adjusts it in light of changes in economic conditions and the risk characteristics of its underlying assets. To maintain or adjust the capital structure, the Company may attempt to issue new shares or acquire or dispose of assets.</span></span></span></span></p> </div> </div> </div> </div> <div> <div> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>13. </b><span style="width: 5.55pt; text-indent: 0pt; display: inline-block;"> </span><b>SHARE CAPITAL</b></span></span></p> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(a)<span style="width: 8pt; display: inline-block;"> </span>Common Shares</span></span></p> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Authorized: Unlimited number of common shares without par value</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">As at November 30, 2022, there were 59,317,461 common shares issued and outstanding<br/>(2021 - 59,239,336).</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span style="text-decoration: underline;"><i>During the year ended November 30, 2022:</i></span></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">On December 31, 2021, the Company issued 78,125 common shares as compensation for consulting fees to a director valued at a total of $17,189.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span style="text-decoration: underline;"><i>During the year ended November 30, 2021:</i></span></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">On August 9, 2021, the Company issued 5,750,000 Units at $0.40 per unit for proceeds of $2,300,000. Each unit comprised one common share and one full non-transferable common share purchase warrant, with each warrant entitling the holder to purchase one additional common share at a price of $0.50 for five years. The Company paid cash of $63,700, issued 166,250 finders' Units with a fair value of $66,500 and 325,750 broker warrants as finder's fees. Each finders' Unit comprised of one common share and one full non-transferable common share purchase warrant, with exercise price of $0.50 per share for five years. The broker warrants are exercisable at $0.50 per share for five years. .</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">On January 29, 2021, the Company issued 3,180,000 Units at $0.20 per unit for proceeds of $636,000. Each unit comprised one common share and one full non-transferable common share purchase warrant, with each warrant entitling the holder to purchase one additional common share at a price of $0.25 for five years. The Company paid cash of $10,480, issued 170,000 finders' Units with a fair value of $34,000 and 222,400 broker warrants as finder's fees. Each finder's Unit comprised of one common share and one full non-transferable common share purchase warrant with exercise price of $0.25 per share for five years. The broker warrants are exercisable at $0.25 per share for five years.</span></span></p> <div> </div> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">During the year ended November 30, 2021, the Company issued 425,000 common shares for gross proceeds of $222,500 from the exercise of 425,000 stock options at $0.50 to $0.60 per share.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">During the year ended November 30, 2021, the Company issued 6,129,573 common shares for gross proceeds of $1,332,727 from the exercise of 6,129,573 share purchase warrants at $0.20 to $0.50 per share. </span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">During the year ended November 30, 2021, the Company issued 656,250 common shares with total fair value of $307,734 were issued as compensation for consulting fees to a director (Note 9).</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span style="text-decoration: underline;"><i>During the year ended November 30, 2020:</i></span></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">On September 30, 2020, the Company issued 50,000 common shares pursuant to the exercise of 50,000 share purchase warrants at $0.20 per share.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">On September 30, 2020, the Company issued 250,000 common shares were issued as compensation for consulting fees to a director (Note 9) valued at a total of $62,500.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">On September 30, 2020, the Company issued an aggregate of 1,335,165 units at a price of $0.30 per unit for gross proceeds of $400,550. Each Unit consists of one common share and one-half of one non-transferable common share purchase warrant (a "Warrant"). Each whole Warrant entitles the holder to purchase one additional common share at a price of $0.50 for two years until September 30, 2022. The fair value of the warrants is determined to be $40,055.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">On September 30, 2020, the Company issued 50,000 units at a fair value of $22,811 pursuant to the binding agreement with Aerowave Corporation. Each Unit consists of one common share and one-half of one non-transferable common share purchase warrant (a "Warrant"). Each whole Warrant entitles the holder to purchase one additional common share at a price of $0.50 for two years until September 30, 2022. The fair value of the warrants is determined to be $1,500.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">On September 24, 2020, the Company issued 100,000 common shares pursuant to the exercise of 100,000 share purchase warrants at $0.20 per share.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">On September 22, 2020, the Company issued 100,000 common shares pursuant to the exercise of 100,000 share purchase warrants at $0.20 per share.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">On August 21, 2020, the Company issued 250,000 common shares were issued as compensation for consulting fees to a Director (Note 9) valued at a total of $62,500.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">On August 13, 2020, the Company issued 483,334 common shares pursuant to the exercise of 483,334 share purchase warrants at $0.20 per share.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">On July 3, 2020, the Company issued 500,000 common shares pursuant to the exercise of 500,000 share purchase warrants at $0.20 per share.</span></span></p> <div> </div> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">On May 15, 2020, the Company issued an aggregate of 3,718,831 units at a price of $0.15 per unit for gross proceeds of $557,825. Each unit consists of one common share in the capital of the Company and one whole transferable common share purchase warrant (a "Warrant"). Each whole Warrant is exercisable to acquire one common share at an exercise price of $0.20 per share until May 15, 2022.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">On April 24, 2020, the Company issued an aggregate of 3,128,334 units at a price of $0.15 per unit for gross proceeds of $469,250. Each unit consists of one common share in the capital of the Company and one whole transferable common share purchase warrant (a "Warrant"). Each whole Warrant is exercisable to acquire one common share at an exercise price of $0.20 per share until April 24, 2022.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">In connection with the April 24, 2020 and May 15, 2020 private placements, the Company paid $38,727 in share issuance costs<span style="color: #ff0000;">.</span></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">On February 4, 2020, the Company arranged a non-brokered private placement financing of up to 10,000,000 units of securities at a price of $0.40 per unit for aggregate gross proceeds of up to $4,000,000 (the "Offering"). Each unit will be comprised of one common share and one-half of one non-transferable common share purchase warrant, with each whole warrant entitling the holder to purchase one additional common share at a price of $0.80 for two years from closing of the Offering. On March 16, 2020, due to the instability in the financial markets caused by the COVID-19 pandemic, the Company cancelled this private placement. And paid $4,400 to investors in connection with this cancelled private placement.</span></span></p> </div> </div> <div> <div> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(b)<span style="display: inline-block; width: 6pt;"> </span>Stock Options</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The Company maintains an incentive stock option plan (the "Option Plan") which provides that the Board of Directors of the Company may from time to time, in its discretion, and in accordance with the Exchange requirements, grant to directors, officers, employees, and consultants to the Company, non-transferable options to purchase common shares, provided that the number of common shares reserved for issuance will not exceed 10% of the issued and outstanding common shares in the capital of the Company at the time of granting of options.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span style="text-decoration: underline;"><i>During the year ended November 30, 2022:</i></span></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">125,000 stock options with an exercise price of $0.50 were cancelled.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">75,000 stock options with an exercise price of $0.50 expired unexercised.</span></span></p> <p style="text-align: justify; margin-left: 18pt; margin-bottom: 0pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span style="text-decoration: underline;"><i>During the year ended November 30, 2021:</i></span></span></span></p> <p style="text-align: justify; margin-left: 18pt; margin-top: 0pt;"><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">On June 10, 2021, the Company granted 150,000 incentive stock options to a consultant with an exercise price of $0.50 per share for a period of five years from the date of grant. The fair value was estimated using the Black-Scholes pricing model with estimated, stock price of $0.485, volatility 100%, risk-free rate 0.82%, dividend yield 0%, and expected life of 5 years. With these assumptions, the fair value of options was determined to be $53,677, and the amount was recognized on the consolidated statements of loss and comprehensive loss for the year ended November 30, 2021</span></span></p> <p style="text-align: justify; margin-left: 18pt; margin-top: 0pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>On January 21, 2021, the Company granted 1,550,000 incentive stock options to directors, consultants, and employees with an exercise price of $0.75 per share for a period of five years from the date of grant. The fair value was estimated using the Black-Scholes pricing model with estimated, stock price of $0.75, volatility 100%, risk-free rate 0.43%, dividend yield 0%, and expected life of 5 years. With these assumptions, the fair value of options was determined to be $1,022,995, and the amount was recognized on the consolidated statements of loss and comprehensive loss for the year ended November 30, 2021.</span></span></span></p> <div> </div> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span style="text-decoration: underline;"><i>During the year ended November 30, 2020:</i></span></span></span></p> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">During the year ended November 30, 2020, 200,000 (2019 - 150,000) options issued to a director and a consultant were cancelled before vesting.</span></span></p> <p style="margin-left: 18pt; margin-bottom: 0pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Stock-based compensation recognized in profit or loss for the year ended November 30, 2022 amounted to</span></span></p> <p style="margin-top: 0pt; margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$Nil (2021 - $1,144,342; 2020 - 479,107).</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Stock option transactions and the number of stock options outstanding as at November 30, 2022, 2021 and 2020 are summarized as follows:</span></span></p> <div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-size: 10pt; width: 70%; border-color: #000000; margin-left: auto; margin-right: auto;"> <tr> <td rowspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-indent: 40pt;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; text-align: right;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>Number of </b></span></span></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>Weighted Average </b></span></span></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; text-align: right;"> </td> </tr> <tr> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: right;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>Options</b></span></span></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>Exercise Price</b></span></span></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: right;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Balance, November 30, 2020</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">2,950,000</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.58</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Granted</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 22%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">1,700,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 22%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.73</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Exercised</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(425,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.52</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Balance, November 30, 2021</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 22%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">4,225,000</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 22%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.65</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Expired</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(75,000</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.50</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Cancelled</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 22%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(125,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 22%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.50</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 2.25pt double #000000; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Balance, November 30, 2022</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>4,025,000</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>0.66</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> </table> </div> <p style="text-align: justify; margin-left: 18pt; margin-top: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The following summarizes the stock options outstanding at November 30, 2022:</span></span></p> <div> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;"> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; white-space: nowrap; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>Expiry Date</b></span></span></span></span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: center; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>Exercise</b></span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><span><span><b>Price</b></span></span></span></span></span></span></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>Numbers of</b></span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><span><span><b>options</b></span></span></span></span></span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><span><span><b>outstanding</b></span></span></span></span></span></span></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>Numbers of</b></span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><span><span><b>options</b></span></span></span></span><br/><span><span><span><span><b>exercisable </b></span></span></span></span></span></span></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>Weighted average</b></span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><span><span><b>remaining</b></span></span></span></span><br/><span><span><span><span><b>contractual life (year) </b></span></span></span></span></span></span></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>Weighted</b></span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><span><span><b>average</b></span></span></span></span><br/><span><span><span><span><b>exercise price</b></span></span></span></span></span></span></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt;"> </td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right;"> </td> <td style="vertical-align: bottom; text-align: right;"> </td> <td style="vertical-align: bottom; text-align: right;"> </td> <td style="vertical-align: bottom; text-align: right;"> </td> <td style="vertical-align: bottom; text-align: right;"> </td> <td style="vertical-align: bottom; text-align: right;"> </td> <td style="vertical-align: bottom; text-align: right;"> </td> <td style="vertical-align: bottom; text-align: right;"> </td> <td style="vertical-align: bottom; text-align: right;"> </td> <td style="vertical-align: bottom; text-align: right;"> </td> <td style="vertical-align: bottom; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">January 15, 2024</span></span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: center; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.60</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">2,050,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">2,050,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"> 0.57 </span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.31</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">March 20, 2024</span></span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.60</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">150,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">150,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"> 0.05 </span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.02</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">November 28, 2024</span></span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: center; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.50</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">125,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">125,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"> 0.06 </span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.02</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">January 21, 2026</span></span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.75</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">1,550,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">1,550,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"> 1.21 </span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.29</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">June 10, 2026</span></span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: center; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.50</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">150,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">150,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"> 0.13 </span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.02</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>4,025,000</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>4,025,000</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> 2.03 </b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>0.66</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%;"> </td> </tr> </table> </div> </div> </div> <div> <div> <div> <div> <div> <div> <p style="text-align: justify; margin-top: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(c)   Share purchase warrants</span></span></p> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span style="text-decoration: underline;">During the year ended November 30, 2022</span></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">561,081 warrants with exercise price of $0.20 expired unexercised.</span></span></p> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span style="text-decoration: underline;">During the year ended November 30, 2021</span></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">On August 9, 2021, the Company issued 5,916,250 common share purchase warrants as part of the private placement. Each warrant is exercisable to purchase one common share at an exercise price of $0.50 per share until August 9, 2026.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span>On August 9, 2021, the Company also granted 325,750 warrants to finder's warrants as described in note 13(a) in connection with the private placement. Each warrant is exercisable to purchase one common share at an exercise price of $0.50 per share until August 9, 2026. The fair value was estimated using the Black-Scholes pricing model with estimated, stock price of $0.35, volatility 100%, risk-free rate 0.88%, dividend yield 0%, and expected life of 5 years. With these assumptions, the fair value of options was determined to be $79,032.</span></span></span></p> <div> </div> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">On January 29, 2021, the Company granted 3,350,000 common share purchase warrants as part of a non-brokered private placement. Each warrant is exercisable to acquire one common share at an exercise price of $0.25 per share until January 29, 2026. During the year ended November 30, 2021, 30,000 warrants were exercised at $0.25 per share.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">On January 29, 2021, the Company also granted 222,400 warrants to finders in connection with the private placement. Each warrant is exercisable to acquire one common share at an exercise price of $0.50 per share until August 9, 2026. During the year ended November 30, 2021, 4,240 warrants were exercised at $0.25 per share. The fair value was estimated using the Black-Scholes pricing model with estimated, stock price of $0.52, volatility 100%, risk-free rate 0.43%, dividend yield 0%, and expected life of 5 years. With these assumptions, the fair value of options was determined to be $95,395.</span></span></p> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span style="text-decoration: underline;">During the year ended November 30, 2020</span></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">On September 30, 2020, the Company granted 692,583 common share purchase warrants as part of a non-brokered private placement and binding agreement with Aerowave Corporation. Each warrant is exercisable to acquire one common share at an exercise price of $0.50 per share until September 30, 2022. On February 28, 2021, 292,000 warrants were exercised at $0.50 per share.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">On May 15, 2020, the Company granted 3,718,831 common share purchase warrants as part of a non-brokered private placement. Each warrant is exercisable to acquire one common share at an exercise price of $0.20 per share until May 15, 2022. On February 28, 2021, 3,208,333 warrants were exercised at $0.20 per share.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">On April 24, 2020, the Company granted 3,128,334 common share purchase warrants as part of a non-brokered private placement. Each warrant is exercisable to acquire one common share at an exercise price of $0.20 per share until April 24, 2022. On February 28, 2021, 2,145,000 warrants were exercised at $0.20 per share.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Share purchase warrant transactions and the number of share purchase warrants outstanding as of November 30, 2022, 2021 and 2020 are summarized as follows:</span></span></p> <div> <div> <div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-size: 10pt; width: 80%; border-color: #000000; margin-left: auto; margin-right: auto;"> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: right;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><b>Number of Warrants</b></span></span></span></span></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><b>Weighted Average Exercise Price</b></span></span></span></span></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: right;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Balance, November 30, 2019</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Warrants granted</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 22%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">7,539,748</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 22%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.90</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Warrants exercised</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(1,233,334</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.11</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Balance, November 30, 2020</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; width: 22%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">6,306,414</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 22%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.23</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Warrants granted</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">9,814,400</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.08</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Warrants exercised</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 22%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(6,129,573</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 22%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.01</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Balance, November 30, 2021</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">9,991,241</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.42</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Warrants expired</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 22%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(561,081</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 22%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.20</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 2.25pt double #000000; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Balance, November 30, 2022</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>9,430,160</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>0.41</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> </table> </div> </div> </div> <p style="text-align: justify; margin-left: 18pt; margin-top: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The following summarizes the stock warrants outstanding at November 30, 2022:</span></span></p> <div style="margin-left: 18pt;"> <div> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;"> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-indent: 10pt; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>Expiry Date</b></span></span></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: right;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>Exercise</b></span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><span><span><b>Price</b></span></span></span></span></span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>$</b></span></span></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: right;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: right;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>Number of Warrants</b></span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><span><span><span><span><b>outstanding and</b></span></span></span></span></span></span></span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><span><span><b>exercisable </b></span></span></span></span></span></span></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: right;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: right;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>Weighted average</b></span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><span><span><b>remaining</b></span></span></span></span></span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><span><span><b>contractual life (year) </b></span></span></span></span></span></span></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: right;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: right;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>Weighted average</b></span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><span><span><b>exercise price</b></span></span></span></span></span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>$</b></span></span></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: right;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">January 29, 2026</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; width: 10%; background-color: #e6efff; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.25</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">3,188,160</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"> 1.07 </span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.08</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">      August 9, 2026</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; width: 10%; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.50</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">6,242,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"> 2.17 </span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.33</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; padding-right: 5.4pt; padding-left: 5.4pt; border-top: 0.75pt solid #000000; text-align: center; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 10%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>9,430,160</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> 3.17 </b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>0.41</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> </table> </div> </div> </div> </div> </div> </div> </div> </div> 59317461 59239336 78125 17189 5750000 0.4 2300000 0.5 P5Y 63700 166250 66500 325750 0.5 P5Y 0.5 P5Y 3180000 0.2 636000 0.25 P5Y 10480 170000 34000 222400 0.25 P5Y 0.25 P5Y 425000 222500 425000 0.5 0.6 6129573 1332727 6129573 0.2 0.5 656250 307734 50000 50000 0.2 250000 62500 1335165 0.3 400550 0.5 P2Y 40055 50000 22811 0.5 P2Y 1500 100000 100000 0.2 100000 100000 0.2 250000 62500 483334 483334 0.2 500000 500000 0.2 3718831 0.15 557825 0.2 3128334 0.15 469250 0.2 38727 38727 10000000 0.4 4000000 0.8 4400 0.10 125000 0.5 75000 0.5 150000 0.5 P5Y 0.485 1 0.0082 0 5 53677 1550000 0.75 P5Y 0.75 1 0.0043 0 5 1022995 200000 150000 0 1144342 479107 <div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-size: 10pt; width: 70%; border-color: #000000; margin-left: auto; margin-right: auto;"> <tr> <td rowspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-indent: 40pt;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; text-align: right;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>Number of </b></span></span></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>Weighted Average </b></span></span></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; text-align: right;"> </td> </tr> <tr> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: right;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>Options</b></span></span></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>Exercise Price</b></span></span></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: right;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Balance, November 30, 2020</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">2,950,000</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.58</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Granted</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 22%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">1,700,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 22%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.73</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Exercised</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(425,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.52</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Balance, November 30, 2021</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 22%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">4,225,000</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 22%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.65</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Expired</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(75,000</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.50</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Cancelled</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 22%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(125,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 22%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.50</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 2.25pt double #000000; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Balance, November 30, 2022</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>4,025,000</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>0.66</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> </table> </div> 2950000 0.58 1700000 0.73 425000 0.52 4225000 0.65 75000 0.5 125000 0.5 4025000 0.66 <div> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;"> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; white-space: nowrap; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>Expiry Date</b></span></span></span></span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: center; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>Exercise</b></span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><span><span><b>Price</b></span></span></span></span></span></span></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>Numbers of</b></span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><span><span><b>options</b></span></span></span></span></span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><span><span><b>outstanding</b></span></span></span></span></span></span></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>Numbers of</b></span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><span><span><b>options</b></span></span></span></span><br/><span><span><span><span><b>exercisable </b></span></span></span></span></span></span></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>Weighted average</b></span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><span><span><b>remaining</b></span></span></span></span><br/><span><span><span><span><b>contractual life (year) </b></span></span></span></span></span></span></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>Weighted</b></span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><span><span><b>average</b></span></span></span></span><br/><span><span><span><span><b>exercise price</b></span></span></span></span></span></span></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt;"> </td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right;"> </td> <td style="vertical-align: bottom; text-align: right;"> </td> <td style="vertical-align: bottom; text-align: right;"> </td> <td style="vertical-align: bottom; text-align: right;"> </td> <td style="vertical-align: bottom; text-align: right;"> </td> <td style="vertical-align: bottom; text-align: right;"> </td> <td style="vertical-align: bottom; text-align: right;"> </td> <td style="vertical-align: bottom; text-align: right;"> </td> <td style="vertical-align: bottom; text-align: right;"> </td> <td style="vertical-align: bottom; text-align: right;"> </td> <td style="vertical-align: bottom; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">January 15, 2024</span></span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: center; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.60</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">2,050,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">2,050,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"> 0.57 </span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.31</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">March 20, 2024</span></span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.60</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">150,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">150,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"> 0.05 </span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.02</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">November 28, 2024</span></span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: center; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.50</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">125,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">125,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"> 0.06 </span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.02</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">January 21, 2026</span></span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.75</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">1,550,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">1,550,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"> 1.21 </span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.29</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">June 10, 2026</span></span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: center; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.50</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">150,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">150,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"> 0.13 </span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.02</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>4,025,000</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>4,025,000</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> 2.03 </b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>0.66</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%;"> </td> </tr> </table> </div> 0.6 2050000 2050000 P0Y6M25D 0.31 0.6 150000 150000 P0Y18D 0.02 0.5 125000 125000 P0Y21D 0.02 0.75 1550000 1550000 P1Y2M15D 0.29 0.5 150000 150000 P0Y1M17D 0.02 4025000 4025000 P2Y10D 0.66 561081 0.2 5916250 0.5 325750 0.5 0.35 1 0.0088 0 5 79032 3350000 0.25 30000 0.25 222400 0.5 4240 0.25 0.52 1 0.0043 0 5 95395 692583 0.5 292000 0.5 3718831 0.2 3208333 0.2 3128334 0.2 2145000 0.2 <div> <div> <div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-size: 10pt; width: 80%; border-color: #000000; margin-left: auto; margin-right: auto;"> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: right;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><b>Number of Warrants</b></span></span></span></span></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><b>Weighted Average Exercise Price</b></span></span></span></span></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: right;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Balance, November 30, 2019</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Warrants granted</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 22%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">7,539,748</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 22%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.90</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Warrants exercised</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(1,233,334</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.11</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Balance, November 30, 2020</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; width: 22%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">6,306,414</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 22%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.23</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Warrants granted</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">9,814,400</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.08</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Warrants exercised</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 22%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(6,129,573</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 22%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.01</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Balance, November 30, 2021</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">9,991,241</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.42</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Warrants expired</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 22%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(561,081</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 22%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.20</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 2.25pt double #000000; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Balance, November 30, 2022</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>9,430,160</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 22%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>0.41</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> </table> </div> </div> </div> 0 0 7539748 0.9 1233334 0.11 6306414 0.23 9814400 0.08 6129573 0.01 9991241 0.42 561081 0.2 9430160 0.41 <div> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;"> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-indent: 10pt; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>Expiry Date</b></span></span></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: right;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>Exercise</b></span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><span><span><b>Price</b></span></span></span></span></span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>$</b></span></span></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: right;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: right;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>Number of Warrants</b></span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><span><span><span><span><b>outstanding and</b></span></span></span></span></span></span></span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><span><span><b>exercisable </b></span></span></span></span></span></span></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: right;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: right;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>Weighted average</b></span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><span><span><b>remaining</b></span></span></span></span></span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><span><span><b>contractual life (year) </b></span></span></span></span></span></span></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: right;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: right;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>Weighted average</b></span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><span><span><span><span><b>exercise price</b></span></span></span></span></span></span></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>$</b></span></span></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: right;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">January 29, 2026</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; width: 10%; background-color: #e6efff; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.25</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">3,188,160</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"> 1.07 </span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.08</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">      August 9, 2026</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; width: 10%; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.50</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">6,242,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"> 2.17 </span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">0.33</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; padding-right: 5.4pt; padding-left: 5.4pt; border-top: 0.75pt solid #000000; text-align: center; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 10%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>9,430,160</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> 3.17 </b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>0.41</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> </table> </div> 0.25 3188160 P1Y25D 0.08 0.5 6242000 P2Y2M1D 0.33 9430160 P3Y2M1D 0.41 <div> <div> <div> <div> <div> <div> <p style="text-align: justify; margin-top: 0pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>14.</b><span style="width: 6.1pt; text-indent: 0pt; display: inline-block;"> </span><b>FINANCIAL RISK MANAGEMENT </b></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The Company's financial assets consist of cash, and due from related parties. The estimated fair values of cash, subscription receivable, and due from related parties approximate their respective carrying values due to the short period to maturity.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Financial instruments measured at fair value are classified into one of three levels in the fair value hierarchy according to the relative reliability of the inputs used to estimate the fair values. The three levels of the fair value hierarchy are:</span></span></p> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">a.<span style="width: 9.66pt; text-indent: 0pt; display: inline-block;"> </span>Level 1 - unadjusted quoted prices in active markets for identical assets or liabilities;</span></span></p> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">b.<span style="width: 9.66pt; text-indent: 0pt; display: inline-block;"> </span>Level 2 - inputs other than quoted prices that are observable for the asset or liability either directly or indirectly; and</span></span></p> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">c.<span style="width: 10.22pt; text-indent: 0pt; display: inline-block;"> </span>Level 3 - inputs that are not based on observable market data.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">For the years ended November 30, 2022, and 2021, the fair value of the cash, accounts receivable, accounts payable, and due to and from related parties approximate the book value due to the short-term nature.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The Company is exposed to a variety of financial instrument-related risks. The Board approves and monitors the risk management processes, inclusive of counterparty limits, controlling and reporting structures. The type of risk exposure and the way in which such exposure is managed is provided as follows:</span></span></p> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><i>Liquidity Risk</i></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Liquidity risk is the risk that the Company will not be able to meet its financial obligations when they become due. The Company ensures, as far as reasonably possible, it will have sufficient capital in order to meet short-term business requirements, after taking into account cash flows from operations and the Company's holdings of cash. The Company believes that these sources will be sufficient to cover the likely short-term cash requirements.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The Company's cash is currently invested in business accounts which is available on demand by the Company for its operations.</span></span></p> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><i>Interest Rate Risk</i></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Interest rate risk is the risk that future cash flows will fluctuate as a result of changes in market interest rates. The Company has no significant interest rate risk due to the short-term nature of its interest generating assets.</span></span></p> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><i>Credit Risk</i></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Credit risk is the risk of a loss when a counterparty to a financial instrument fails to meet its contractual obligations. The Company's exposure to credit risk is limited to its cash. The Company limits its exposure to credit risk by holding its cash in deposits with high credit quality Canadian financial institutions.</span></span></p> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><i>Foreign Currency Risk</i></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The Company is exposed to foreign currency risk on fluctuations related to cash, leases, due from related parties and accounts payable and accrued liabilities that are denominated in US dollars. 10% fluctuations in the US dollar and UK Sterling Pound against the Canadian dollar have affected comprehensive loss for the year by approximately $81,052 (2021 - $1,200 and 2020 - $7,085).</span></span></p> </div> </div> </div> </div> </div> </div> 0.10 81052 1200 7085 <div> <div> <p style="text-align: justify; margin-top: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>15.</b><span style="width: 6.1pt; text-indent: 0pt; display: inline-block;"> </span><b>SUPPLEMENTAL CASH FLOW INFORMATION</b></span></span></p> <div> <div> <div> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">During the year ended November 30, 2022, 2021 and 2020, the Company has the following non-cash investing and financing activities:</span></span></p> <div> <div style="margin-left: 18pt; margin-bottom: 11pt;"> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;"> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; vertical-align: bottom;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>November 30,</b></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>2022 </b></span></span></span></span></td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">November 30,</span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span>2021</span></span></span></span></td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">November 30,</span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span>2020</span></span></span></span></td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Non-cash financing activities:</span></span></td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Fair value of options exercised</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 15%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 15%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">158,106</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 15%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Fair value of warrants granted</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 15%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 15%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">174,427</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 15%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">83,109</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Fair value of warrants exercised</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 15%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 15%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">36,859</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 15%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Shares issued for finders</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 15%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 15%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">100,500</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 15%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Non-cash investing activities:</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 15%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 15%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 15%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Shares to be issued to acquisition of inventory</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 15%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 15%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 15%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">22,800</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> </table> </div> </div> </div> </div> </div> </div> </div> <div> <div style="margin-left: 18pt; margin-bottom: 11pt;"> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;"> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; vertical-align: bottom;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>November 30,</b></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>2022 </b></span></span></span></span></td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">November 30,</span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span>2021</span></span></span></span></td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">November 30,</span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span>2020</span></span></span></span></td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Non-cash financing activities:</span></span></td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Fair value of options exercised</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 15%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 15%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">158,106</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 15%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Fair value of warrants granted</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 15%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 15%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">174,427</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 15%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">83,109</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Fair value of warrants exercised</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 15%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 15%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">36,859</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 15%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Shares issued for finders</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 15%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 15%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">100,500</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 15%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Non-cash investing activities:</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 15%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 15%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 15%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Shares to be issued to acquisition of inventory</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 15%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 15%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 15%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">22,800</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> </table> </div> </div> 0 158106 0 0 174427 83109 0 36859 0 0 100500 0 0 0 22800 <div> <div> <div> <p style="text-align: justify; margin-top: 0pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>16.</b><span style="width: 6.1pt; text-indent: 0pt; display: inline-block;"> </span><b>COMMITMENTS AND CONTINGENCIES</b></span></span></p> <p style="margin-left: 18pt; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">As at November 30, 2022, the Company has the following commitments: </span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The Company entered into lease agreement with arm's length party on September 9, 2021. The term commenced on May 1, 2021 and will set to expire on April 30, 2024 and with annual lease fee of £12,000 or £1,000 per month with interest of 4% per annum above Barclays Bank PLC base rate in case of default (Note 17). Further, on the same date, the Company entered into separate agreement with the same arm's length party for drone flying permission over the land without restriction in exchange of £1,500 annual fee. The term commenced on May 1, 2021 and expire on April 30, 2024 as well.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">In November 2018, the Company entered into two-year lease agreement for leased premises in Plymouth, Massachusetts, commenced December 1, 2018 and ended on November 30, 2020. On December 31, 2020, the Company renewed this lease agreement to November 30, 2023. The minimum base rent for the remaining lease term are: US$3,188 per month from December 1, 2021 to November 30, 2022; and US$3,284 per month from December 1, 2022 to November 30, 2023 (Note 17).</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The Company has certain commitments related to key management compensation for $35,875 per month with no specific expiry of terms (Note 9).</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">On February 4, 2023, the Company received a disputed claim from former consultant on the unpaid fees for the month of November 2022, December 2022 and January 2023 with an aggregate liability of $30,000. As of the reporting date, the Company is still waiting for the court order and plans to take a legal course of action as well. Management cannot determine the outcome as of the date of this report.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">On April 1, 2020 the Company entered into an agreement with a Director of the Company to provide consulting services. In line with this, the Company shall pay $250,000 annually either through cash in 12 monthly installments at the end of each calendar month or through the issuance of 1,000,000 common shares of the Company in four equal quarterly installments, in arrears.</span></span></p> </div> </div> </div> 12000 1000 0.04 1500 P2Y 3188 3284 35875 30000 250000 1000000 <div> <div> <div> <div> <div> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>17.<span style="display: inline-block; width: 5.55pt;"> </span>RIGHT-OF-USE ASSETS AND LEASE LIABILITY</b></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span style="text-decoration: underline;">Right-of-use assets</span></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">In November 2018, the Company entered into two-year lease agreement for leased premises in Plymouth, Massachusetts, commencing December 1, 2018 and ending on November 30, 2020. On December 31, 2020, the Company renewed this lease agreement to November 30, 2023. The minimum base rent for the remaining lease term are: USD$3,005 ($3,726) per month from December 1, 2019 to November 01, 2020; USD$3,095 ($3,838) per month from December 1, 2020 to November 30, 2021; USD$3,188 ($3,953) per month from December 1, 2021 to November 30, 2022; and USD$3,284 ($4,072) per month from December 1, 2022 to November 30, 2023 (Note 16).</span></span></p> <div> </div> <p style="margin-top: 0pt; margin-bottom: 11pt; font-size: 10pt; font-family: Times New Roman, Times, serif; margin-left: 18pt;">On September 9, 2021, the Company entered into lease agreement with arm's length party to use the premises known as The Old Workshop, Estuary Road, King's Lynn, Norfolk from May 1, 2021 and will set to expire on April 30, 2024, with annual lease fee of £12,000 or £1,000 per month with interest of 4% per annum above Barclays Bank PLC base rate in case of default (Note 16).</p> <p style="text-align: justify; margin-left: 18pt; margin-top: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The following is the continuity of the cost and accumulated depreciation of right-of-use assets, for the year ended November 30, 2022 and 2021:</span></span></p> </div> </div> <div> <div> <div> <table cellpadding="0" cellspacing="0" style="width: 70%; border-collapse: collapse; font-size: 10pt; border-color: #000000; margin-left: auto; margin-right: auto;"> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Balance, November 30, 2020</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">114,648</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5pt; vertical-align: bottom; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Amortization expense</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(35,654</span></span></td> <td style="vertical-align: bottom; text-align: left;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5pt; vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: justify; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Cumulative translation adjustment</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(6,260</span></span></td> <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Balance, November 30, 2021</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">72,734</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Additions</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">38,027</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Amortization expense</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(50,571</span></span></td> <td style="vertical-align: bottom; text-align: left;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Cumulative translation adjustment</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">1,008</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; border-bottom: 2.25pt double #000000; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Balance, November 30, 2022</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>61,198</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%;"> </td> </tr> </table> </div> </div> </div> <p style="text-align: justify; margin-left: 18pt; margin-top: 11pt; margin-bottom: 11pt;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span><span style="text-decoration: underline;">Lease liability</span></span></span></span></p> <p style="margin-left: 18pt; text-align: justify; margin-top: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span>The following is the continuity of lease liability, for the year ended November 30, 2022 and 2021:</span></span></span></p> <div> <div> <div> <table cellpadding="0" cellspacing="0" style="width: 80%; border-collapse: collapse; font-size: 10pt; border-color: #000000; margin-left: auto; margin-right: auto;"> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-top: 0.75pt solid #000000; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Balance, November 30, 2020</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">113,340</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5pt; vertical-align: bottom; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Lease payments</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(48,175</span></span></td> <td style="vertical-align: bottom; text-align: left;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5pt; vertical-align: bottom; text-align: justify; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Interest on lease liability</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">14,760</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5pt; vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Cumulative translation adjustment</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(5,079</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Balance, November 30, 2021</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">86,346</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Additions</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">38,027</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Lease payments</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(72,727</span></span></td> <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Interest on lease liability</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">18,877</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Cumulative translation adjustment</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">5,274</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Balance, November 30, 2022</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>75,797</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Current Portion </b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>66,403</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Long-term portion </b></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>9,394</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> </table> </div> </div> </div> <p style="margin-left: 22pt; margin-top: 11pt;"><span style="font-family: Times New Roman,Times,serif;"><span style="font-size: 10pt;"><span>As at November 30, 2022 and 2021, the minimum lease payments for the lease liabilities are as follows: </span></span></span></p> <div> <div> <div> <table cellpadding="0" cellspacing="0" style="width: 90%; border-collapse: collapse; font-size: 10pt; border-color: #000000; margin-left: auto; margin-right: auto;"> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; vertical-align: bottom;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>November 30, </b></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>2022</b></span></span></span></span></td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>November 30, </b></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>2021</b></span></span></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; background-color: #e6efff; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Year ending:</span></span></td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">2022</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">48,943</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">2023</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>72,664</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">50,403</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-indent: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">2024</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>9,716</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>82,380</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">99,346</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Less: Interest expense on lease liabilities</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>(6,583</b></span></span></td> <td style="vertical-align: bottom; text-align: left;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>)</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(13,000</span></span></td> <td style="vertical-align: bottom; text-align: left;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-indent: 10pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Total present value of minimum lease payments</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>75,797</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>86,346</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> </table> </div> </div> </div> <div> </div> </div> </div> </div> P2Y 3005 3726 3095 3838 3188 3953 3284 4072 12000 1000 0.04 <div> <div> <table cellpadding="0" cellspacing="0" style="width: 70%; border-collapse: collapse; font-size: 10pt; border-color: #000000; margin-left: auto; margin-right: auto;"> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Balance, November 30, 2020</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">114,648</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5pt; vertical-align: bottom; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Amortization expense</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(35,654</span></span></td> <td style="vertical-align: bottom; text-align: left;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5pt; vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: justify; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Cumulative translation adjustment</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(6,260</span></span></td> <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Balance, November 30, 2021</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">72,734</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Additions</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">38,027</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Amortization expense</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(50,571</span></span></td> <td style="vertical-align: bottom; text-align: left;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Cumulative translation adjustment</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">1,008</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; border-bottom: 2.25pt double #000000; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Balance, November 30, 2022</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>61,198</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%;"> </td> </tr> </table> </div> </div> 114648 35654 -6260 72734 38027 50571 1008 61198 <div> <div> <table cellpadding="0" cellspacing="0" style="width: 80%; border-collapse: collapse; font-size: 10pt; border-color: #000000; margin-left: auto; margin-right: auto;"> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-top: 0.75pt solid #000000; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Balance, November 30, 2020</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">113,340</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5pt; vertical-align: bottom; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Lease payments</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(48,175</span></span></td> <td style="vertical-align: bottom; text-align: left;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5pt; vertical-align: bottom; text-align: justify; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Interest on lease liability</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">14,760</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5pt; vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Cumulative translation adjustment</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(5,079</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Balance, November 30, 2021</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">86,346</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Additions</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">38,027</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Lease payments</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(72,727</span></span></td> <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Interest on lease liability</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">18,877</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Cumulative translation adjustment</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">5,274</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Balance, November 30, 2022</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>75,797</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Current Portion </b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>66,403</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Long-term portion </b></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>9,394</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> </table> </div> </div> 113340 48175 14760 -5079 86346 38027 72727 18877 5274 75797 66403 9394 <div> <div> <table cellpadding="0" cellspacing="0" style="width: 90%; border-collapse: collapse; font-size: 10pt; border-color: #000000; margin-left: auto; margin-right: auto;"> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; vertical-align: bottom;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>November 30, </b></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>2022</b></span></span></span></span></td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>November 30, </b></span></span><br/><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span><span><b>2021</b></span></span></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; background-color: #e6efff; text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Year ending:</span></span></td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">2022</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">48,943</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">2023</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>72,664</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">50,403</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-indent: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">2024</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>9,716</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>82,380</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">99,346</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Less: Interest expense on lease liabilities</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>(6,583</b></span></span></td> <td style="vertical-align: bottom; text-align: left;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>)</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(13,000</span></span></td> <td style="vertical-align: bottom; text-align: left;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-indent: 10pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Total present value of minimum lease payments</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>75,797</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>86,346</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> </table> </div> </div> 0 48943 72664 50403 9716 0 82380 99346 6583 13000 75797 86346 <div> <p style="text-align: justify; margin-top: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>18.<span style="display: inline-block; width: 5.55pt;"> </span>BREAKDOWN OF EXPENSES</b></span></span></p> <div> <div> <div> <div style="margin-left: 18pt;"> <div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-size: 10pt; width: 100%; border-color: #000000;"> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; vertical-align: bottom; white-space: nowrap;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; vertical-align: bottom; white-space: nowrap;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; vertical-align: bottom; white-space: nowrap;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; vertical-align: bottom; white-space: nowrap;"> </td> <td colspan="1" style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> <td colspan="7" style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Year ended November 30,</b></span></span></td> <td colspan="1" style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; white-space: nowrap; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>General and Administrative Expenses</b></span></span></td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Note</b></span></span></td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>2022</b></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>2021</b></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>2020</b></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Accounting and audit fees</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; width: 10%; background-color: #e6efff; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">9</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>223,247</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">80,162</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">67,282</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Amortization</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; width: 10%; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">5, 6, 17</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>286,743</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">143,783</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">41,201</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Consulting fees</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; width: 10%; background-color: #e6efff; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">9</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>143,539</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">456,296</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">275,182</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">General office expenses</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; width: 10%; text-align: center;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>153,403</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">205,710</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">111,394</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Insurance</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; width: 10%; background-color: #e6efff; text-align: center;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>39,007</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">21,837</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">11,928</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Interest and accretion</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; width: 10%; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">17</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>18,877</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">14,760</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">20,449</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Legal fees</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; width: 10%; background-color: #e6efff; text-align: center;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>77,011</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">191,686</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">74,528</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Management fees</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; width: 10%; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">9</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>311,535</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">118,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">110,125</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Rent</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; width: 10%; background-color: #e6efff; text-align: center;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>47,317</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">42,822</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">35,325</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Stock-based compensation</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; width: 10%; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">9, 13</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">1,144,342</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">479,107</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Transfer agent and filing fees</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; width: 10%; background-color: #e6efff; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">13</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>59,385</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">82,825</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">77,919</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-indent: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Wages, salaries and benefits</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; width: 10%; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">9</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>985,916</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">817,858</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">292,218</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-bottom: 2.25pt double #000000; text-indent: 10pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Total</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; width: 10%; background-color: #e6efff; text-align: center;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>2,345,980</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">3,320,081</span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">1,596,658</span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-indent: 10pt;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; width: 10%; text-align: center;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Research and Development</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; width: 10%; text-align: center; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 10%; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>2022</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 10%; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>2021</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 10%; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>2020</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Labor</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; width: 10%; text-align: center; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>182,774</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">930,269</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">386,044</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Materials</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; width: 10%; text-align: center;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>50,491</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">54,737</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; padding-right: 5.4pt; padding-left: 5.4pt; border-top: 0.75pt solid #000000; text-indent: 10pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Total</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; width: 10%; text-align: center; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>233,265</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">985,006</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">386,044</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> </table> </div> </div> <p style="text-align: justify; margin-left: 18pt; margin-top: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Selling expenses consist of business development expenses amounting to $177,428 (2021 - $709,010; 2020 - $1,081,478).</span></span></p> </div> </div> </div> </div> <div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-size: 10pt; width: 100%; border-color: #000000;"> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; vertical-align: bottom; white-space: nowrap;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; vertical-align: bottom; white-space: nowrap;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; vertical-align: bottom; white-space: nowrap;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; vertical-align: bottom; white-space: nowrap;"> </td> <td colspan="1" style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> <td colspan="7" style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Year ended November 30,</b></span></span></td> <td colspan="1" style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; white-space: nowrap; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>General and Administrative Expenses</b></span></span></td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Note</b></span></span></td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>2022</b></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>2021</b></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>2020</b></span></span></td> <td style="vertical-align: bottom; background-color: #ffffff; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Accounting and audit fees</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; width: 10%; background-color: #e6efff; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">9</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>223,247</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">80,162</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">67,282</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Amortization</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; width: 10%; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">5, 6, 17</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>286,743</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">143,783</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">41,201</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Consulting fees</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; width: 10%; background-color: #e6efff; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">9</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>143,539</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">456,296</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">275,182</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">General office expenses</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; width: 10%; text-align: center;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>153,403</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">205,710</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">111,394</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Insurance</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; width: 10%; background-color: #e6efff; text-align: center;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>39,007</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">21,837</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">11,928</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Interest and accretion</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; width: 10%; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">17</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>18,877</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">14,760</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">20,449</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Legal fees</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; width: 10%; background-color: #e6efff; text-align: center;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>77,011</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">191,686</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">74,528</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Management fees</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; width: 10%; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">9</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>311,535</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">118,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">110,125</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Rent</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; width: 10%; background-color: #e6efff; text-align: center;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>47,317</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">42,822</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">35,325</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Stock-based compensation</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; width: 10%; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">9, 13</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">1,144,342</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">479,107</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Transfer agent and filing fees</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; width: 10%; background-color: #e6efff; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">13</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>59,385</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">82,825</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">77,919</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-indent: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Wages, salaries and benefits</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; width: 10%; text-align: center;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">9</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>985,916</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">817,858</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">292,218</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-bottom: 2.25pt double #000000; text-indent: 10pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Total</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; width: 10%; background-color: #e6efff; text-align: center;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>2,345,980</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">3,320,081</span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">1,596,658</span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-indent: 10pt;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; width: 10%; text-align: center;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; padding-left: 5pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Research and Development</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; width: 10%; text-align: center; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 10%; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>2022</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 10%; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>2021</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: right; width: 10%; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>2020</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Labor</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; width: 10%; text-align: center; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>182,774</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">930,269</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">386,044</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-indent: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Materials</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; width: 10%; text-align: center;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>50,491</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">54,737</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; padding-right: 5.4pt; padding-left: 5.4pt; border-top: 0.75pt solid #000000; text-indent: 10pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Total</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; width: 10%; text-align: center; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 2.25pt double #000000; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>233,265</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">985,006</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">386,044</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> </table> </div> 223247 80162 67282 286743 143783 41201 143539 456296 275182 153403 205710 111394 39007 21837 11928 18877 14760 20449 77011 191686 74528 311535 118000 110125 47317 42822 35325 0 1144342 479107 59385 82825 77919 985916 817858 292218 2345980 3320081 1596658 182774 930269 386044 50491 54737 0 233265 985006 386044 177428 709010 1081478 <div> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>19.<span style="display: inline-block; width: 6pt;"> </span>GAIN ON DEBT FORGIVENESS</b></span></span></p> <p style="text-align: justify; margin-left: 18pt; margin-bottom: 11pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">For the year ended November 30, 2022, the Company recognized gain on debt forgiveness amounting to $234,303 (2021 - $nil; 2020 - $nil). This composed of remaining £140,000 ($222,771) acquisition cost of Tetra Drones that was forgiven by former shareholder and the £7,155 ($11,532)<b> </b>excess of the net book value of vehicle and related loan released to him (Note 11).</span></span></p> </div> 234303 0 0 140000 222771 7155 11532 <div> <div> <div> <div> <p style="text-align: justify; margin-top: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>20.<span style="display: inline-block; width: 5.5pt;"> </span>SEGMENTED INFORMATION</b></span></span></p> <div> <div> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The Company operates in one business segment, focusing on developing technologies as described in Note 1.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The Company's revenues were generated in the US and UK were mostly composed of sales of engineering design services and radar components to well-known government agencies and prime contractors. All the long-lived assets are located in the US as of November 30, 2022, 2021 and 2020. The following table summarizes the revenue by geographical location:</span></span></p> <div style="margin-left: 18pt;"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-size: 10pt; width: 100%; border-color: #000000;"> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; vertical-align: bottom;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; vertical-align: bottom;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Canada </b></span></span></td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>USA </b></span></span></td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>UK </b></span></span></td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Total </b></span></span></td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> </tr> <tr> <td colspan="2" style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>For the year ended November 30, 2022</b></span></span></td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Revenues</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>154,625</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>452,734</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>607,359</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Gross Profit</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>97,115</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>319,069</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>416,184</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td colspan="2" style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>For the year ended November 30, 2021</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Revenues</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">79,795</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">104,601</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">184,396</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Gross Profit</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">27,703</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">53,584</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">81,287</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td colspan="2" style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>For the year ended November 30, 2020</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Revenues</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">70,931</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">70,931</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Gross Profit</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">39,615</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">39,615</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> </table> </div> </div> </div> </div> </div> </div> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-size: 10pt; width: 100%; border-color: #000000;"> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; vertical-align: bottom;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; vertical-align: bottom;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Canada </b></span></span></td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>USA </b></span></span></td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>UK </b></span></span></td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Total </b></span></span></td> <td style="background-color: #ffffff; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-top: 0.75pt solid #000000; text-align: center; white-space: nowrap;"> </td> </tr> <tr> <td colspan="2" style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>For the year ended November 30, 2022</b></span></span></td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Revenues</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>154,625</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>452,734</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>607,359</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Gross Profit</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>97,115</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>319,069</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>416,184</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td colspan="2" style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>For the year ended November 30, 2021</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Revenues</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">79,795</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">104,601</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">184,396</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom;"> </td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Gross Profit</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">27,703</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">53,584</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">81,287</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td colspan="2" style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>For the year ended November 30, 2020</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: bottom;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Revenues</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">70,931</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">70,931</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b> </b></span></span></td> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; vertical-align: bottom; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Gross Profit</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">39,615</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">39,615</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> </table> 0 154625 452734 607359 0 97115 319069 416184 0 79795 104601 184396 0 27703 53584 81287 0 70931 0 70931 0 39615 0 39615 <div> <div> <p style="text-align: justify; margin-top: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>21.<span style="display: inline-block; width: 6pt;"> </span>INCOME TAXES</b></span></span></p> </div> </div> <div> <div> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The following table reconciles the expected income taxes expense (recovery) at the Canadian statutory income tax rates to the amounts recognized in the statement of operations and comprehensive loss for the years ended November 30, 2022, 2021 and 2020:</span></span></p> <div style="margin-left: 18pt;"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-size: 10pt; width: 100%; border-color: #000000;"> <tr> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-left: 1.05pt;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>2022</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>2021</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">2020</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right;"> </td> </tr> <tr> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; padding-left: 1.05pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Net loss before tax and comprehensive loss</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>(2,667,798</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>)</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>(4,944,231</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>)</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(2,924,236</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> </tr> <tr> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; padding-left: 1.05pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Combined statutory tax rate</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>19% to 27%</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>19% to 29.7%</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">27.00%</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-left: 1.05pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Expected income tax (recovery)</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; text-align: right; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>(720,000</b></span></span></td> <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>)</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; text-align: right; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>(1,278,990</b></span></span></td> <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>)</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(789,544</span></span></td> <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> </tr> <tr> <td style="vertical-align: bottom; padding-left: 1.05pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Permanent differences</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>138,000</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>310,228</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-left: 1.05pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Non-deductible items and others</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>1,618,000</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>19,811</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">44,866</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; padding-left: 1.05pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Change in deferred tax assets not recognized</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>(1,036,000</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>)</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>948,951</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">744,678</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; padding-left: 1.05pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Income tax expense (recovery)</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> </table> </div> <p style="text-align: justify; margin-left: 18pt; margin-top: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Significant components of the Company's unrecognized deferred tax assets (liabilities) for the years ended November 30, 2022 and 2021 are shown below:</span></span></p> <div style="margin-left: 0pt;"> <table cellpadding="0" cellspacing="0" style="width: 80%; border-collapse: collapse; font-size: 10pt; border-color: #000000; margin-left: auto; margin-right: auto;"> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-top: 0.75pt solid #000000; vertical-align: bottom;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>2022</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>2021</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right;"> </td> </tr> <tr> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; padding-left: 1.05pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Non-capital losses</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">1,657,000</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">2,641,159</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-left: 1.05pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Capital losses</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">21,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">21,062</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-left: 1.05pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Equipment</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">1,511</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-left: 1.05pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Share issuance costs</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">48,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">29,036</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-left: 1.05pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Intangible assets</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">397,156</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; padding-left: 1.05pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Others</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">13,498</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-left: 1.05pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Net deferred tax assets</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>1,726,000</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>3,103,422</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> </table> </div> <p style="text-align: justify; margin-left: 18pt; margin-top: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Non-capital losses carryforward</b></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The Company has non-capital loss carryforwards and net operating losses, for which no deferred tax asset has been recognized of approximately $10,971,723 (2021 - $9,703,024) which may be carried forward to apply against future income for Canadian, USA and United Kingdom income tax purposes, subject to the final determination by taxation authorities, expiring in the following years:</span></span></p> <div style="margin-left: 0pt;"> <table cellpadding="0" cellspacing="0" style="width: 70%; border-collapse: collapse; font-size: 10pt; border-color: #000000; margin-left: auto; margin-right: auto;"> <tr> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-left: 1.1pt; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Expiry</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>2022</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-left: 1.1pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">2038</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">675,203</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-left: 1.1pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">2039</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">2,350,798</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-left: 1.1pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">2040</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">2,443,638</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-left: 1.1pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">2041</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">3,591,486</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; padding-left: 1.1pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">2042</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">1,910,598</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-left: 1.1pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">TOTAL</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">10,971,723</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> </table> </div> </div> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-size: 10pt; width: 100%; border-color: #000000;"> <tr> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-left: 1.05pt;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>2022</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>2021</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">2020</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right;"> </td> </tr> <tr> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; padding-left: 1.05pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Net loss before tax and comprehensive loss</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>(2,667,798</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>)</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>(4,944,231</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>)</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(2,924,236</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> </tr> <tr> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; padding-left: 1.05pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Combined statutory tax rate</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>19% to 27%</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>19% to 29.7%</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">27.00%</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-left: 1.05pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Expected income tax (recovery)</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; text-align: right; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>(720,000</b></span></span></td> <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>)</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; text-align: right; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>(1,278,990</b></span></span></td> <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>)</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; text-align: right; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">(789,544</span></span></td> <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">)</span></span></td> </tr> <tr> <td style="vertical-align: bottom; padding-left: 1.05pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Permanent differences</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>138,000</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>310,228</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-left: 1.05pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Non-deductible items and others</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>1,618,000</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>19,811</b></span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">44,866</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; padding-left: 1.05pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Change in deferred tax assets not recognized</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>(1,036,000</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>)</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>948,951</b></span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 10%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">744,678</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; padding-left: 1.05pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Income tax expense (recovery)</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>-</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 10%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> </table> -2667798 -4944231 -2924236 0.19 0.27 0.19 0.297 0.27 -720000 -1278990 -789544 138000 310228 0 1618000 19811 44866 -1036000 948951 744678 0 0 0 <table cellpadding="0" cellspacing="0" style="width: 80%; border-collapse: collapse; font-size: 10pt; border-color: #000000; margin-left: auto; margin-right: auto;"> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-top: 0.75pt solid #000000; vertical-align: bottom;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>2022</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>2021</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right;"> </td> </tr> <tr> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; padding-left: 1.05pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Non-capital losses</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">1,657,000</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">2,641,159</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-left: 1.05pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Capital losses</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">21,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">21,062</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-left: 1.05pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Equipment</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">1,511</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-left: 1.05pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Share issuance costs</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">48,000</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">29,036</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-left: 1.05pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Intangible assets</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">397,156</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; padding-left: 1.05pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Others</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">-</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">13,498</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-left: 1.05pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Net deferred tax assets</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>1,726,000</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>$</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>3,103,422</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> </table> 1657000 2641159 21000 21062 0 1511 48000 29036 0 397156 0 13498 1726000 3103422 10971723 9703024 <table cellpadding="0" cellspacing="0" style="width: 70%; border-collapse: collapse; font-size: 10pt; border-color: #000000; margin-left: auto; margin-right: auto;"> <tr> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-left: 1.1pt; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>Expiry</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>2022</b></span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-left: 1.1pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">2038</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">675,203</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-left: 1.1pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">2039</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">2,350,798</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-left: 1.1pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">2040</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">2,443,638</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-left: 1.1pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">2041</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">3,591,486</span></span></td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; padding-left: 1.1pt; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">2042</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">1,910,598</span></span></td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-left: 1.1pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">TOTAL</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">$</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; width: 12%;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">10,971,723</span></span></td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> </table> 675203 2350798 2443638 3591486 1910598 10971723 <div> <div> <div> <div> <div> <p style="text-align: justify; margin-top: 10pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><b>22.  SUBSEQUENT EVENTS</b></span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">On February 22, 2023, the Company announced a non-brokered private placement financing of up to 30,000,000 units (the "Units") of securities at a price of $0.05 per Unit for aggregate gross proceeds of up to $1,500,000. Each Unit will be comprised of one common share and one full transferable common share purchase warrant, with each whole warrant entitling the holder to purchase one additional common share at a price of $0.10 for three years from closing of the private placement. On March 30, 2023, the Company completed the first tranche of the private placement by issuing 7,200,000 units for gross proceeds of $360,000.</span></span></p> <p style="text-align: justify; margin-left: 18pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">On March 3, 2022, 2,100,000 share options issued to directors, officers, employees, and consultants were surrendered and cancelled. Further, on March 16, 2023, another 150,000 share options issued to director were surrendered and cancelled.</span></span></p> </div> </div> </div> </div> </div> 30000000 0.05 1500000 0.1 7200000 360000 2100000 150000 EXCEL 103 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 104 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 105 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 106 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 317 335 1 false 92 0 false 10 false false R1.htm 0001 - Document - Document And Entity Information Sheet http://plyrotech.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 0002 - Statement - Consolidated Statements of Financial Position Sheet http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition Consolidated Statements of Financial Position Statements 2 false false R3.htm 0003 - Statement - Consolidated Statements of Loss and Comprehensive Loss Sheet http://plyrotech.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss Consolidated Statements of Loss and Comprehensive Loss Statements 3 false false R4.htm 0004 - Statement - Consolidated Statements of Changes in Shareholders' Equity (Deficit) Sheet http://plyrotech.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity Consolidated Statements of Changes in Shareholders' Equity (Deficit) Statements 4 false false R5.htm 0005 - Statement - Consolidated Statements of Cash Flows Sheet http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows Statements 5 false false R6.htm 0006 - Disclosure - NATURE OF OPERATIONS AND ABILITY TO CONTINUE AS A GOING CONCERN Sheet http://plyrotech.com/role/NatureOfOperationsAndAbilityToContinueAsGoingConcern NATURE OF OPERATIONS AND ABILITY TO CONTINUE AS A GOING CONCERN Notes 6 false false R7.htm 0007 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES Sheet http://plyrotech.com/role/SignificantAccountingPolicies SIGNIFICANT ACCOUNTING POLICIES Notes 7 false false R8.htm 0008 - Disclosure - ACQUISITION Sheet http://plyrotech.com/role/BusinessAcquisiton ACQUISITION Notes 8 false false R9.htm 0009 - Disclosure - PREPAID EXPENSES Sheet http://plyrotech.com/role/PrepaidExpenses PREPAID EXPENSES Notes 9 false false R10.htm 0010 - Disclosure - EQUIPMENT Sheet http://plyrotech.com/role/Equipment EQUIPMENT Notes 10 false false R11.htm 0011 - Disclosure - INTANGIBLE ASSETS Sheet http://plyrotech.com/role/IntangibleAssets INTANGIBLE ASSETS Notes 11 false false R12.htm 0012 - Disclosure - ACCOUNTS PAYABLE Sheet http://plyrotech.com/role/AccountsPayable ACCOUNTS PAYABLE Notes 12 false false R13.htm 0013 - Disclosure - Deferred Revenue Sheet http://plyrotech.com/role/DeferredRevenue Deferred Revenue Notes 13 false false R14.htm 0014 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES Sheet http://plyrotech.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS AND BALANCES Notes 14 false false R15.htm 0015 - Disclosure - GOVERMENT ASSISTANCE RECEIVED Sheet http://plyrotech.com/role/GOVERMENTASSITANCERECEIVED GOVERMENT ASSISTANCE RECEIVED Notes 15 false false R16.htm 0016 - Disclosure - LOAN PAYABLE Sheet http://plyrotech.com/role/LOANPAYABLE LOAN PAYABLE Notes 16 false false R17.htm 0017 - Disclosure - CAPITAL MANAGEMENT Sheet http://plyrotech.com/role/CapitalManagement CAPITAL MANAGEMENT Notes 17 false false R18.htm 0018 - Disclosure - SHARE CAPITAL Sheet http://plyrotech.com/role/ShareCapital SHARE CAPITAL Notes 18 false false R19.htm 0019 - Disclosure - FINANCIAL RISK MANAGEMENT Sheet http://plyrotech.com/role/FinancialRiskManagement FINANCIAL RISK MANAGEMENT Notes 19 false false R20.htm 0020 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION Sheet http://plyrotech.com/role/SupplementalCashFlowInformation SUPPLEMENTAL CASH FLOW INFORMATION Notes 20 false false R21.htm 0021 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://plyrotech.com/role/Commitments COMMITMENTS AND CONTINGENCIES Notes 21 false false R22.htm 0022 - Disclosure - RIGHT-OF-USE ASSETS AND LEASE LIABILITY Sheet http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITY RIGHT-OF-USE ASSETS AND LEASE LIABILITY Notes 22 false false R23.htm 0023 - Disclosure - BREAKDOWN OF EXPENSES Sheet http://plyrotech.com/role/BREAKDOWNOFEXPENSES BREAKDOWN OF EXPENSES Notes 23 false false R24.htm 0024 - Disclosure - GAIN ON DEBT FORGIVENESS Sheet http://plyrotech.com/role/GAINONDEBTFORGIVENESS GAIN ON DEBT FORGIVENESS Notes 24 false false R25.htm 0025 - Disclosure - SEGMENTED INFORMATION Sheet http://plyrotech.com/role/SegmentedInformation SEGMENTED INFORMATION Notes 25 false false R26.htm 0026 - Disclosure - INCOME TAXES Sheet http://plyrotech.com/role/IncomeTaxes INCOME TAXES Notes 26 false false R27.htm 0027 - Disclosure - SUBSEQUENT EVENTS Sheet http://plyrotech.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 27 false false R28.htm 0028 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://plyrotech.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 28 false false R29.htm 0029 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://plyrotech.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://plyrotech.com/role/SignificantAccountingPolicies 29 false false R30.htm 0030 - Disclosure - ACQUISITION (Tables) Sheet http://plyrotech.com/role/BUSINESSACQUISITONTables ACQUISITION (Tables) Tables http://plyrotech.com/role/BusinessAcquisiton 30 false false R31.htm 0031 - Disclosure - PREPAID EXPENSES (Tables) Sheet http://plyrotech.com/role/PREPAIDEXPENSESTables PREPAID EXPENSES (Tables) Tables http://plyrotech.com/role/PrepaidExpenses 31 false false R32.htm 0032 - Disclosure - EQUIPMENT (Tables) Sheet http://plyrotech.com/role/EQUIPMENTTables EQUIPMENT (Tables) Tables http://plyrotech.com/role/Equipment 32 false false R33.htm 0033 - Disclosure - INTANGIBLE ASSETS (Tables) Sheet http://plyrotech.com/role/INTANGIBLEASSETSTables INTANGIBLE ASSETS (Tables) Tables http://plyrotech.com/role/IntangibleAssets 33 false false R34.htm 0034 - Disclosure - ACCOUNTS PAYABLE (Tables) Sheet http://plyrotech.com/role/ACCOUNTSPAYABLETables ACCOUNTS PAYABLE (Tables) Tables http://plyrotech.com/role/AccountsPayable 34 false false R35.htm 0035 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES (Tables) Sheet http://plyrotech.com/role/RELATEDPARTYTRANSACTIONSTables RELATED PARTY TRANSACTIONS AND BALANCES (Tables) Tables http://plyrotech.com/role/RelatedPartyTransactions 35 false false R36.htm 0037 - Disclosure - SHARE CAPITAL (Tables) Sheet http://plyrotech.com/role/SHARECAPITALTables SHARE CAPITAL (Tables) Tables http://plyrotech.com/role/ShareCapital 36 false false R37.htm 0038 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Tables) Sheet http://plyrotech.com/role/SUPPLEMENTALCASHFLOWINFORMATIONTables SUPPLEMENTAL CASH FLOW INFORMATION (Tables) Tables http://plyrotech.com/role/SupplementalCashFlowInformation 37 false false R38.htm 0039 - Disclosure - RIGHT-OF-USE ASSETS AND LEASE LIABILITY (Tables) Sheet http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYTables RIGHT-OF-USE ASSETS AND LEASE LIABILITY (Tables) Tables http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITY 38 false false R39.htm 0040 - Disclosure - BREAKDOWN OF EXPENSES (Tables) Sheet http://plyrotech.com/role/BREAKDOWNOFEXPENSESTables BREAKDOWN OF EXPENSES (Tables) Tables http://plyrotech.com/role/BREAKDOWNOFEXPENSES 39 false false R40.htm 0041 - Disclosure - SEGMENTED INFORMATION (Tables) Sheet http://plyrotech.com/role/SEGMENTEDINFORMATIONTables SEGMENTED INFORMATION (Tables) Tables http://plyrotech.com/role/SegmentedInformation 40 false false R41.htm 0042 - Disclosure - INCOME TAXES (Tables) Sheet http://plyrotech.com/role/INCOMETAXESTables INCOME TAXES (Tables) Tables http://plyrotech.com/role/IncomeTaxes 41 false false R42.htm 0043 - Disclosure - NATURE OF OPERATIONS AND ABILITY TO CONTINUE AS A GOING CONCERN (Narrative) (Details) Sheet http://plyrotech.com/role/NATUREOFOPERATIONSANDABILITYTOCONTINUEASAGOINGCONCERNNarrativeDetails NATURE OF OPERATIONS AND ABILITY TO CONTINUE AS A GOING CONCERN (Narrative) (Details) Details http://plyrotech.com/role/NatureOfOperationsAndAbilityToContinueAsGoingConcern 42 false false R43.htm 0044 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Disclosure of subsidiaries (Details) Sheet http://plyrotech.com/role/SignificantAccountingPoliciesDisclosureOfSubsidiariesDetails SIGNIFICANT ACCOUNTING POLICIES - Disclosure of subsidiaries (Details) Details 43 false false R44.htm 0045 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Disclosure of depreciation rates applicable to each category of property and equipment (Detail) Sheet http://plyrotech.com/role/SignificantAccountingPoliciesDisclosureOfDepreciationRatesApplicableToEachCategoryOfPropertyAndEquipmentDetail SIGNIFICANT ACCOUNTING POLICIES - Disclosure of depreciation rates applicable to each category of property and equipment (Detail) Details 44 false false R45.htm 0046 - Disclosure - ACQUISITION (Narrative) (Details) Sheet http://plyrotech.com/role/BUSINESSACQUISITONNarrativeDetail ACQUISITION (Narrative) (Details) Details http://plyrotech.com/role/BUSINESSACQUISITONTables 45 false false R46.htm 0047 - Disclosure - ACQUISITION - Disclosure of detailed information about purchase price allocation (Details) Sheet http://plyrotech.com/role/DisclosureOfDetailedInformationAboutPurchasePriceAllocationDetails ACQUISITION - Disclosure of detailed information about purchase price allocation (Details) Details 46 false false R47.htm 0048 - Disclosure - PREPAID EXPENSES (Narrative) (Details) Sheet http://plyrotech.com/role/PREPAIDEXPENSESNarrativeDetails PREPAID EXPENSES (Narrative) (Details) Details http://plyrotech.com/role/PREPAIDEXPENSESTables 47 false false R48.htm 0049 - Disclosure - PREPAID EXPENSES - Disclosure of prepaid expenses (Details) Sheet http://plyrotech.com/role/PREPAIDEXPENSESDisclosureOfPrepaidExpensesDetails PREPAID EXPENSES - Disclosure of prepaid expenses (Details) Details 48 false false R49.htm 0050 - Disclosure - EQUIPMENT - Disclosure of property, plant and equipment (Details) Sheet http://plyrotech.com/role/EQUIPMENTDisclosureOfEquipmentDetails EQUIPMENT - Disclosure of property, plant and equipment (Details) Details 49 false false R50.htm 0051 - Disclosure - INTANGIBLE ASSETS (Narrative) (Details) Sheet http://plyrotech.com/role/INTANGIBLEASSETSDetails INTANGIBLE ASSETS (Narrative) (Details) Details http://plyrotech.com/role/INTANGIBLEASSETSTables 50 false false R51.htm 0052 - Disclosure - INTANGIBLE ASSETS - Disclosure of detailed information about Intangible assets (Details) Sheet http://plyrotech.com/role/IntangibleAssetsDisclosureOfDetailedInformationAboutIntangibleAssetsDetails INTANGIBLE ASSETS - Disclosure of detailed information about Intangible assets (Details) Details 51 false false R52.htm 0054 - Disclosure - ACCOUNTS PAYABLE - Disclosure of accounts payable (Details) Sheet http://plyrotech.com/role/ACCOUNTSPAYABLEDetails ACCOUNTS PAYABLE - Disclosure of accounts payable (Details) Details 52 false false R53.htm 0055 - Disclosure - Deferred Revenue (Narrative) (Details) Sheet http://plyrotech.com/role/DeferredRevenueNarrativeDetails Deferred Revenue (Narrative) (Details) Details http://plyrotech.com/role/DeferredRevenue 53 false false R54.htm 0056 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES (Narrative) (Details) Sheet http://plyrotech.com/role/RelatedPartyTransactionsNarrativeDetails RELATED PARTY TRANSACTIONS AND BALANCES (Narrative) (Details) Details http://plyrotech.com/role/RELATEDPARTYTRANSACTIONSTables 54 false false R55.htm 0057 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES - Disclosure of amounts due to directors and officers (Details) Sheet http://plyrotech.com/role/RelatedPartyTransactionsDisclosureOfAmountsDueToOfficersDetails RELATED PARTY TRANSACTIONS AND BALANCES - Disclosure of amounts due to directors and officers (Details) Details 55 false false R56.htm 0058 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES - Disclosure of transactions between related parties (Details) Sheet http://plyrotech.com/role/RelatedPartyTransactionsDisclosureOfTransactionsBetweenRelatedPartiesDetails RELATED PARTY TRANSACTIONS AND BALANCES - Disclosure of transactions between related parties (Details) Details 56 false false R57.htm 0059 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES - Disclosure of information about key management personnel (Details) Sheet http://plyrotech.com/role/RELATEDPARTYTRANSACTIONSANDBALANCESDisclosureOfInformationAboutKeyManagementPersonnelDetails RELATED PARTY TRANSACTIONS AND BALANCES - Disclosure of information about key management personnel (Details) Details 57 false false R58.htm 0060 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES - Disclosure of consulting fees (Details) Sheet http://plyrotech.com/role/RELATEDPARTYTRANSACTIONSANDBALANCESConsultingFeesDetails RELATED PARTY TRANSACTIONS AND BALANCES - Disclosure of consulting fees (Details) Details 58 false false R59.htm 0061 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES - Disclosure of information about options granted to the CEO, CFO, the Corporate Secretary, and the Company's directors (Details) Sheet http://plyrotech.com/role/RELATEDPARTYTRANSACTIONSANDBALANCESDisclosureOfInformationAboutOptionsGrantedToTheCEOCFOTheCorporateSecretaryAndTheCompanysDirectorsDetails RELATED PARTY TRANSACTIONS AND BALANCES - Disclosure of information about options granted to the CEO, CFO, the Corporate Secretary, and the Company's directors (Details) Details 59 false false R60.htm 0062 - Disclosure - GOVERMENT ASSISTANCE RECEIVED (Narrative) (Details) Sheet http://plyrotech.com/role/GOVERMENTASSITANCERECEIVEDDetailTextuals GOVERMENT ASSISTANCE RECEIVED (Narrative) (Details) Details http://plyrotech.com/role/GOVERMENTASSITANCERECEIVED 60 false false R61.htm 0063 - Disclosure - LOAN PAYABLE (Narrative) (Details) Sheet http://plyrotech.com/role/LOANPAYABLENarrativeDetails LOAN PAYABLE (Narrative) (Details) Details http://plyrotech.com/role/LOANPAYABLE 61 false false R62.htm 0064 - Disclosure - SHARE CAPITAL (Narrative) (Details) Sheet http://plyrotech.com/role/SHARECAPITALNarrativeDetails SHARE CAPITAL (Narrative) (Details) Details http://plyrotech.com/role/SHARECAPITALTables 62 false false R63.htm 0065 - Disclosure - SHARE CAPITAL - Disclosure of number and weighted average exercise prices of share options (Details) Sheet http://plyrotech.com/role/ShareCapitalDisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsDetails SHARE CAPITAL - Disclosure of number and weighted average exercise prices of share options (Details) Details 63 false false R64.htm 0066 - Disclosure - SHARE CAPITAL - Disclosure of number and weighted average remaining contractual life of outstanding share options (Details) Sheet http://plyrotech.com/role/ShareCapitalDisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsDetails SHARE CAPITAL - Disclosure of number and weighted average remaining contractual life of outstanding share options (Details) Details 64 false false R65.htm 0067 - Disclosure - SHARE CAPITAL - Disclosure of share purchase warrant transactions (Details) Sheet http://plyrotech.com/role/ShareCapitalDisclosureOfSharePurchaseWarrantTransactionsDetails SHARE CAPITAL - Disclosure of share purchase warrant transactions (Details) Details 65 false false R66.htm 0068 - Disclosure - SHARE CAPITAL - Disclosure of number of share purchase warrants outstanding (Details) Sheet http://plyrotech.com/role/SHARECAPITALDetails SHARE CAPITAL - Disclosure of number of share purchase warrants outstanding (Details) Details 66 false false R67.htm 0069 - Disclosure - FINANCIAL RISK MANAGEMENT (Narrative) (Details) Sheet http://plyrotech.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails FINANCIAL RISK MANAGEMENT (Narrative) (Details) Details http://plyrotech.com/role/FinancialRiskManagement 67 false false R68.htm 0070 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION - Disclosure of supplemental cash flow information (Details) Sheet http://plyrotech.com/role/DisclosureOfDetailedInformationAboutSupplementalCashFlowInformationDetails SUPPLEMENTAL CASH FLOW INFORMATION - Disclosure of supplemental cash flow information (Details) Details 68 false false R69.htm 0071 - Disclosure - COMMITMENTS AND CONTINGENCIES (Narrative) (Details) Sheet http://plyrotech.com/role/COMMITMENTSNarrativeDetail COMMITMENTS AND CONTINGENCIES (Narrative) (Details) Details http://plyrotech.com/role/Commitments 69 false false R70.htm 0072 - Disclosure - RIGHT-OF-USE ASSETS AND LEASE LIABILITY (Narrative) (Details) Sheet http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetailTextuals RIGHT-OF-USE ASSETS AND LEASE LIABILITY (Narrative) (Details) Details http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYTables 70 false false R71.htm 0073 - Disclosure - RIGHT-OF-USE ASSETS AND LEASE LIABILITY - Disclosure of continuity of the cost and accumulated amortization of right-of-use assets (Details) Sheet http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetails RIGHT-OF-USE ASSETS AND LEASE LIABILITY - Disclosure of continuity of the cost and accumulated amortization of right-of-use assets (Details) Details 71 false false R72.htm 0074 - Disclosure - RIGHT-OF-USE ASSETS AND LEASE LIABILITY - Disclosure of continuity of lease liability (Details) Sheet http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetails1 RIGHT-OF-USE ASSETS AND LEASE LIABILITY - Disclosure of continuity of lease liability (Details) Details 72 false false R73.htm 0075 - Disclosure - RIGHT-OF-USE ASSETS AND LEASE LIABILITY - Disclosure of minimum lease payments for the lease liabilities (Details) Sheet http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetails2 RIGHT-OF-USE ASSETS AND LEASE LIABILITY - Disclosure of minimum lease payments for the lease liabilities (Details) Details 73 false false R74.htm 0076 - Disclosure - BREAKDOWN OF EXPENSES (Narrative) (Details) Sheet http://plyrotech.com/role/BREAKDOWNOFEXPENSESDetailTextuals BREAKDOWN OF EXPENSES (Narrative) (Details) Details http://plyrotech.com/role/BREAKDOWNOFEXPENSESTables 74 false false R75.htm 0077 - Disclosure - BREAKDOWN OF EXPENSES - Disclosure of breakdown of expenses (Details) Sheet http://plyrotech.com/role/BREAKDOWNOFEXPENSESDetails BREAKDOWN OF EXPENSES - Disclosure of breakdown of expenses (Details) Details 75 false false R76.htm 0078 - Disclosure - GAIN ON DEBT FORGIVENESS (Narrative) (Details) Sheet http://plyrotech.com/role/GAINONDEBTFORGIVENESSNarrativeDetails GAIN ON DEBT FORGIVENESS (Narrative) (Details) Details http://plyrotech.com/role/GAINONDEBTFORGIVENESS 76 false false R77.htm 0079 - Disclosure - SEGMENTED INFORMATION - Disclosure of revenue by geographical location (Details) Sheet http://plyrotech.com/role/SEGMENTEDINFORMATIONDetails SEGMENTED INFORMATION - Disclosure of revenue by geographical location (Details) Details 77 false false R78.htm 0080 - Disclosure - INCOME TAXES (Narrative) (Details) Sheet http://plyrotech.com/role/INCOMETAXESDetails INCOME TAXES (Narrative) (Details) Details http://plyrotech.com/role/INCOMETAXESTables 78 false false R79.htm 0081 - Disclosure - INCOME TAXES - Disclosure of detailed information about effective income tax expense (recovery) (Details) Sheet http://plyrotech.com/role/DisclosureOfDetailedInformationAboutReconcilesTheExpectedIncomeTaxesExpenseDetails INCOME TAXES - Disclosure of detailed information about effective income tax expense (recovery) (Details) Details 79 false false R80.htm 0082 - Disclosure - INCOME TAXES - Disclosure of temporary difference, unused tax losses and unused tax credits (Details) Sheet http://plyrotech.com/role/DisclosureOfDetailedInformationAboutUnrecognizedDeductibleTemporaryDifferencesDetails INCOME TAXES - Disclosure of temporary difference, unused tax losses and unused tax credits (Details) Details 80 false false R81.htm 0083 - Disclosure - INCOME TAXES - Disclosure of non-capital loss carryforwards (Details) Sheet http://plyrotech.com/role/IncomeTaxesDisclosureOfNonCapitalLossCarryforwardsDetails INCOME TAXES - Disclosure of non-capital loss carryforwards (Details) Details 81 false false R82.htm 0084 - Disclosure - SUBSEQUENT EVENTS (Narrative) (Details) Sheet http://plyrotech.com/role/SUBSEQUENTEVENTSNarrativeDetail SUBSEQUENT EVENTS (Narrative) (Details) Details http://plyrotech.com/role/SubsequentEvents 82 false false All Reports Book All Reports [dq-0547-EntityFileNumber-Missing] Submission type 20-F should have a non-empty value for EntityFileNumber in the Required Context. form20f.htm [dq-0549-DocumentAnnualReport, DocumentTransitionReport, DocumentShellCompanyReport-Exclusive-Values] In submission type 20-F, exactly one of DocumentAnnualReport, DocumentTransitionReport, DocumentShellCompanyReport should have the value "true" and the others should have the value "false". form20f.htm exhibit12-1.htm exhibit12-2.htm exhibit13-1.htm exhibit13-2.htm exhibit15-1.htm exhibit15-2.htm exhibit4-2.htm prt-20221130.xsd prt-20221130_cal.xml prt-20221130_def.xml prt-20221130_lab.xml prt-20221130_pre.xml form20fxz001.jpg form20fxz002.jpg form20fxz003.jpg http://xbrl.sec.gov/dei/2022 https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full true true JSON 109 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form20f.htm": { "axisCustom": 7, "axisStandard": 17, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 39, "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full": 749 }, "contextCount": 317, "dts": { "calculationLink": { "local": [ "prt-20221130_cal.xml" ] }, "definitionLink": { "local": [ "prt-20221130_def.xml" ] }, "inline": { "local": [ "form20f.htm" ] }, "labelLink": { "local": [ "prt-20221130_lab.xml" ] }, "presentationLink": { "local": [ "prt-20221130_pre.xml" ] }, "schema": { "local": [ "prt-20221130.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/currency/2022/currency-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/exch/2022/exch-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd", "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" ] } }, "elementCount": 675, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 7, "total": 7 }, "keyCustom": 113, "keyStandard": 222, "memberCustom": 61, "memberStandard": 28, "nsprefix": "prt", "nsuri": "http://plyrotech.com/20221130", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "span", "p", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001 - Document - Document And Entity Information", "menuCat": "Cover", "order": "1", "role": "http://plyrotech.com/role/DocumentAndEntityInformation", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "span", "p", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0010 - Disclosure - EQUIPMENT", "menuCat": "Notes", "order": "10", "role": "http://plyrotech.com/role/Equipment", "shortName": "EQUIPMENT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0011 - Disclosure - INTANGIBLE ASSETS", "menuCat": "Notes", "order": "11", "role": "http://plyrotech.com/role/IntangibleAssets", "shortName": "INTANGIBLE ASSETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0012 - Disclosure - ACCOUNTS PAYABLE", "menuCat": "Notes", "order": "12", "role": "http://plyrotech.com/role/AccountsPayable", "shortName": "ACCOUNTS PAYABLE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0013 - Disclosure - Deferred Revenue", "menuCat": "Notes", "order": "13", "role": "http://plyrotech.com/role/DeferredRevenue", "shortName": "Deferred Revenue", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0014 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES", "menuCat": "Notes", "order": "14", "role": "http://plyrotech.com/role/RelatedPartyTransactions", "shortName": "RELATED PARTY TRANSACTIONS AND BALANCES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfGovernmentGrantsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0015 - Disclosure - GOVERMENT ASSISTANCE RECEIVED", "menuCat": "Notes", "order": "15", "role": "http://plyrotech.com/role/GOVERMENTASSITANCERECEIVED", "shortName": "GOVERMENT ASSISTANCE RECEIVED", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfGovernmentGrantsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfBorrowingsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0016 - Disclosure - LOAN PAYABLE", "menuCat": "Notes", "order": "16", "role": "http://plyrotech.com/role/LOANPAYABLE", "shortName": "LOAN PAYABLE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfBorrowingsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0017 - Disclosure - CAPITAL MANAGEMENT", "menuCat": "Notes", "order": "17", "role": "http://plyrotech.com/role/CapitalManagement", "shortName": "CAPITAL MANAGEMENT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfIssuedCapitalExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0018 - Disclosure - SHARE CAPITAL", "menuCat": "Notes", "order": "18", "role": "http://plyrotech.com/role/ShareCapital", "shortName": "SHARE CAPITAL", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfIssuedCapitalExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0019 - Disclosure - FINANCIAL RISK MANAGEMENT", "menuCat": "Notes", "order": "19", "role": "http://plyrotech.com/role/FinancialRiskManagement", "shortName": "FINANCIAL RISK MANAGEMENT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "b", "span", "span", "span", "td", "tr", "table", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20221130", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:CashAndCashEquivalents", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0002 - Statement - Consolidated Statements of Financial Position", "menuCat": "Statements", "order": "2", "role": "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition", "shortName": "Consolidated Statements of Financial Position", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "b", "span", "span", "span", "td", "tr", "table", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20221130", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:CashAndCashEquivalents", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0020 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION", "menuCat": "Notes", "order": "20", "role": "http://plyrotech.com/role/SupplementalCashFlowInformation", "shortName": "SUPPLEMENTAL CASH FLOW INFORMATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfCommitmentsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0021 - Disclosure - COMMITMENTS AND CONTINGENCIES", "menuCat": "Notes", "order": "21", "role": "http://plyrotech.com/role/Commitments", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfCommitmentsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "prt:DisclosureOfRightOfUseAssetsAndLeaseLiabilityExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0022 - Disclosure - RIGHT-OF-USE ASSETS AND LEASE LIABILITY", "menuCat": "Notes", "order": "22", "role": "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITY", "shortName": "RIGHT-OF-USE ASSETS AND LEASE LIABILITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "prt:DisclosureOfRightOfUseAssetsAndLeaseLiabilityExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfExpensesByNatureExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0023 - Disclosure - BREAKDOWN OF EXPENSES", "menuCat": "Notes", "order": "23", "role": "http://plyrotech.com/role/BREAKDOWNOFEXPENSES", "shortName": "BREAKDOWN OF EXPENSES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfExpensesByNatureExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "prt:DisclosureOfGainOnDebtForgivenessTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0024 - Disclosure - GAIN ON DEBT FORGIVENESS", "menuCat": "Notes", "order": "24", "role": "http://plyrotech.com/role/GAINONDEBTFORGIVENESS", "shortName": "GAIN ON DEBT FORGIVENESS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "prt:DisclosureOfGainOnDebtForgivenessTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0025 - Disclosure - SEGMENTED INFORMATION", "menuCat": "Notes", "order": "25", "role": "http://plyrotech.com/role/SegmentedInformation", "shortName": "SEGMENTED INFORMATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0026 - Disclosure - INCOME TAXES", "menuCat": "Notes", "order": "26", "role": "http://plyrotech.com/role/IncomeTaxes", "shortName": "INCOME TAXES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0027 - Disclosure - SUBSEQUENT EVENTS", "menuCat": "Notes", "order": "27", "role": "http://plyrotech.com/role/SubsequentEvents", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "div", "div", "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "prt:DescriptionOfAccountingPolicyForBasisOfPresentationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0028 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)", "menuCat": "Policies", "order": "28", "role": "http://plyrotech.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies", "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "div", "div", "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "prt:DescriptionOfAccountingPolicyForBasisOfPresentationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "div", "div", "prt:ConsolidationsPolicyTextBlock", "div", "div", "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0029 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)", "menuCat": "Tables", "order": "29", "role": "http://plyrotech.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables", "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "prt:ConsolidationsPolicyTextBlock", "div", "div", "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "b", "span", "span", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:Revenue", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0003 - Statement - Consolidated Statements of Loss and Comprehensive Loss", "menuCat": "Statements", "order": "3", "role": "http://plyrotech.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss", "shortName": "Consolidated Statements of Loss and Comprehensive Loss", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "b", "span", "span", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": "0", "lang": null, "name": "ifrs-full:CostOfSales", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "ifrs-full:DisclosureOfBusinessCombinationsExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0030 - Disclosure - ACQUISITION (Tables)", "menuCat": "Tables", "order": "30", "role": "http://plyrotech.com/role/BUSINESSACQUISITONTables", "shortName": "ACQUISITION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "ifrs-full:DisclosureOfBusinessCombinationsExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "div", "prt:DisclosureOfPrepaidExpensesExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "prt:DisclosureOfDetailedInformationAboutPrepaidExpensesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0031 - Disclosure - PREPAID EXPENSES (Tables)", "menuCat": "Tables", "order": "31", "role": "http://plyrotech.com/role/PREPAIDEXPENSESTables", "shortName": "PREPAID EXPENSES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "prt:DisclosureOfPrepaidExpensesExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "prt:DisclosureOfDetailedInformationAboutPrepaidExpensesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "div", "div", "div", "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0032 - Disclosure - EQUIPMENT (Tables)", "menuCat": "Tables", "order": "32", "role": "http://plyrotech.com/role/EQUIPMENTTables", "shortName": "EQUIPMENT (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "div", "div", "div", "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0033 - Disclosure - INTANGIBLE ASSETS (Tables)", "menuCat": "Tables", "order": "33", "role": "http://plyrotech.com/role/INTANGIBLEASSETSTables", "shortName": "INTANGIBLE ASSETS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "prt:DisclosureOfDetailedInformationAboutAccountsPayableExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0034 - Disclosure - ACCOUNTS PAYABLE (Tables)", "menuCat": "Tables", "order": "34", "role": "http://plyrotech.com/role/ACCOUNTSPAYABLETables", "shortName": "ACCOUNTS PAYABLE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "prt:DisclosureOfDetailedInformationAboutAccountsPayableExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "prt:DisclosureOfDueToRelatedPartyExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0035 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES (Tables)", "menuCat": "Tables", "order": "35", "role": "http://plyrotech.com/role/RELATEDPARTYTRANSACTIONSTables", "shortName": "RELATED PARTY TRANSACTIONS AND BALANCES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "prt:DisclosureOfDueToRelatedPartyExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "div", "div", "ifrs-full:DisclosureOfIssuedCapitalExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0037 - Disclosure - SHARE CAPITAL (Tables)", "menuCat": "Tables", "order": "36", "role": "http://plyrotech.com/role/SHARECAPITALTables", "shortName": "SHARE CAPITAL (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "ifrs-full:DisclosureOfIssuedCapitalExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "prt:DisclosureOfSupplementalCashFlowInformationExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0038 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Tables)", "menuCat": "Tables", "order": "37", "role": "http://plyrotech.com/role/SUPPLEMENTALCASHFLOWINFORMATIONTables", "shortName": "SUPPLEMENTAL CASH FLOW INFORMATION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "prt:DisclosureOfSupplementalCashFlowInformationExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "prt:DisclosureOfRightOfUseAssetsAndLeaseLiabilityExplanatory", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0039 - Disclosure - RIGHT-OF-USE ASSETS AND LEASE LIABILITY (Tables)", "menuCat": "Tables", "order": "38", "role": "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYTables", "shortName": "RIGHT-OF-USE ASSETS AND LEASE LIABILITY (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "prt:DisclosureOfRightOfUseAssetsAndLeaseLiabilityExplanatory", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "ifrs-full:DisclosureOfExpensesByNatureExplanatory", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfAttributionOfExpensesByNatureToTheirFunctionExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0040 - Disclosure - BREAKDOWN OF EXPENSES (Tables)", "menuCat": "Tables", "order": "39", "role": "http://plyrotech.com/role/BREAKDOWNOFEXPENSESTables", "shortName": "BREAKDOWN OF EXPENSES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "ifrs-full:DisclosureOfExpensesByNatureExplanatory", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfAttributionOfExpensesByNatureToTheirFunctionExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "span", "span", "td", "tr", "table", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20191130_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:Equity", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0004 - Statement - Consolidated Statements of Changes in Shareholders' Equity (Deficit)", "menuCat": "Statements", "order": "4", "role": "http://plyrotech.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity", "shortName": "Consolidated Statements of Changes in Shareholders' Equity (Deficit)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "td", "tr", "table", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20191130_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:Equity", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "div", "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0041 - Disclosure - SEGMENTED INFORMATION (Tables)", "menuCat": "Tables", "order": "40", "role": "http://plyrotech.com/role/SEGMENTEDINFORMATIONTables", "shortName": "SEGMENTED INFORMATION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "div", "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "div", "div", "div", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "prt:DisclosureOfDetailedInformationAboutEffectiveIncomeTaxExpenseRecoveryExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0042 - Disclosure - INCOME TAXES (Tables)", "menuCat": "Tables", "order": "41", "role": "http://plyrotech.com/role/INCOMETAXESTables", "shortName": "INCOME TAXES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "prt:DisclosureOfDetailedInformationAboutEffectiveIncomeTaxExpenseRecoveryExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "b", "b", "span", "span", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:ComprehensiveIncome", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0043 - Disclosure - NATURE OF OPERATIONS AND ABILITY TO CONTINUE AS A GOING CONCERN (Narrative) (Details)", "menuCat": "Details", "order": "42", "role": "http://plyrotech.com/role/NATUREOFOPERATIONSANDABILITYTOCONTINUEASAGOINGCONCERNNarrativeDetails", "shortName": "NATURE OF OPERATIONS AND ABILITY TO CONTINUE AS A GOING CONCERN (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "div", "div", "div", "prt:DisclosureOfNatureOfOperationsAndAbilityToContinueAsGoingConcernExplanatory", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": "0", "lang": null, "name": "ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory", "div", "div", "prt:ConsolidationsPolicyTextBlock", "div", "div", "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130_ifrsfullSignificantInvestmentsInSubsidiariesAxis_prtSubsidiaryMember", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0044 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Disclosure of subsidiaries (Details)", "menuCat": "Details", "order": "43", "role": "http://plyrotech.com/role/SignificantAccountingPoliciesDisclosureOfSubsidiariesDetails", "shortName": "SIGNIFICANT ACCOUNTING POLICIES - Disclosure of subsidiaries (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory", "div", "div", "prt:ConsolidationsPolicyTextBlock", "div", "div", "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130_ifrsfullSignificantInvestmentsInSubsidiariesAxis_prtSubsidiaryMember", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "div", "prt:DisclosureOfUsefulLiveOfAssetsExplanatory", "div", "div", "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory", "div", "div", "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DepreciationMethodPropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0045 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Disclosure of depreciation rates applicable to each category of property and equipment (Detail)", "menuCat": "Details", "order": "44", "role": "http://plyrotech.com/role/SignificantAccountingPoliciesDisclosureOfDepreciationRatesApplicableToEachCategoryOfPropertyAndEquipmentDetail", "shortName": "SIGNIFICANT ACCOUNTING POLICIES - Disclosure of depreciation rates applicable to each category of property and equipment (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "div", "prt:DisclosureOfUsefulLiveOfAssetsExplanatory", "div", "div", "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory", "div", "div", "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DepreciationMethodPropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "span", "p", "div", "div", "div", "div", "div", "ifrs-full:DisclosureOfBusinessCombinationsExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210604_ifrsfullBusinessCombinationsAxis_prtTetraDronesLimitedMember", "decimals": "2", "first": true, "lang": null, "name": "ifrs-full:PercentageOfVotingEquityInterestsAcquired", "reportCount": 1, "unitRef": "pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0046 - Disclosure - ACQUISITION (Narrative) (Details)", "menuCat": "Details", "order": "45", "role": "http://plyrotech.com/role/BUSINESSACQUISITONNarrativeDetail", "shortName": "ACQUISITION (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "div", "div", "div", "div", "div", "ifrs-full:DisclosureOfBusinessCombinationsExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210604_ifrsfullBusinessCombinationsAxis_prtTetraDronesLimitedMember_prtConsiderationPayableDateAxis_prtWithinSevenDaysMember", "decimals": "0", "lang": null, "name": "ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory", "div", "div", "div", "div", "div", "div", "ifrs-full:DisclosureOfBusinessCombinationsExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210604_ifrsfullBusinessCombinationsAxis_prtTetraDronesLimitedMember", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:CashTransferred", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0047 - Disclosure - ACQUISITION - Disclosure of detailed information about purchase price allocation (Details)", "menuCat": "Details", "order": "46", "role": "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutPurchasePriceAllocationDetails", "shortName": "ACQUISITION - Disclosure of detailed information about purchase price allocation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory", "div", "div", "div", "div", "div", "div", "ifrs-full:DisclosureOfBusinessCombinationsExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20210604_ifrsfullBusinessCombinationsAxis_prtTetraDronesLimitedMember", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:CashTransferred", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "span", "span", "span", "span", "p", "div", "prt:DisclosureOfPrepaidExpensesExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20221130", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:AmountsReceivableRelatedPartyTransactions", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0048 - Disclosure - PREPAID EXPENSES (Narrative) (Details)", "menuCat": "Details", "order": "47", "role": "http://plyrotech.com/role/PREPAIDEXPENSESNarrativeDetails", "shortName": "PREPAID EXPENSES (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "span", "span", "p", "div", "prt:DisclosureOfPrepaidExpensesExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20221130", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:AmountsReceivableRelatedPartyTransactions", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "b", "span", "span", "span", "td", "tr", "table", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20221130", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:CurrentPrepaidExpenses", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0049 - Disclosure - PREPAID EXPENSES - Disclosure of prepaid expenses (Details)", "menuCat": "Details", "order": "48", "role": "http://plyrotech.com/role/PREPAIDEXPENSESDisclosureOfPrepaidExpensesDetails", "shortName": "PREPAID EXPENSES - Disclosure of prepaid expenses (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "b", "span", "span", "span", "span", "span", "td", "tr", "table", "div", "prt:DisclosureOfDetailedInformationAboutPrepaidExpensesExplanatory", "div", "prt:DisclosureOfPrepaidExpensesExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20221130_prtPrepaidExpensesAxis_prtAdvertisingAndPromotionsMember", "decimals": "0", "lang": null, "name": "ifrs-full:CurrentPrepaidExpenses", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "span", "span", "td", "tr", "table", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211130", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:PropertyPlantAndEquipment", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0050 - Disclosure - EQUIPMENT - Disclosure of property, plant and equipment (Details)", "menuCat": "Details", "order": "49", "role": "http://plyrotech.com/role/EQUIPMENTDisclosureOfEquipmentDetails", "shortName": "EQUIPMENT - Disclosure of property, plant and equipment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "div", "div", "div", "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember", "decimals": "0", "lang": null, "name": "ifrs-full:DisposalsPropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "b", "span", "span", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:ProfitLoss", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0005 - Statement - Consolidated Statements of Cash Flows", "menuCat": "Statements", "order": "5", "role": "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "b", "span", "span", "td", "tr", "table", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": "0", "lang": null, "name": "ifrs-full:AdjustmentsForSharebasedPayments", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "span", "span", "td", "tr", "table", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20221130", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0051 - Disclosure - INTANGIBLE ASSETS (Narrative) (Details)", "menuCat": "Details", "order": "50", "role": "http://plyrotech.com/role/INTANGIBLEASSETSDetails", "shortName": "INTANGIBLE ASSETS (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "div", "div", "div", "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCustomerrelatedIntangibleAssetsMember", "decimals": null, "lang": "en-US", "name": "ifrs-full:DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "span", "span", "td", "tr", "table", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211130", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0052 - Disclosure - INTANGIBLE ASSETS - Disclosure of detailed information about Intangible assets (Details)", "menuCat": "Details", "order": "51", "role": "http://plyrotech.com/role/IntangibleAssetsDisclosureOfDetailedInformationAboutIntangibleAssetsDetails", "shortName": "INTANGIBLE ASSETS - Disclosure of detailed information about Intangible assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory", "div", "div", "div", "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20201201to20211130_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCustomerrelatedIntangibleAssetsMember", "decimals": "0", "lang": null, "name": "ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "b", "span", "span", "span", "td", "tr", "table", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20221130", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:TradeAndOtherCurrentPayables", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0054 - Disclosure - ACCOUNTS PAYABLE - Disclosure of accounts payable (Details)", "menuCat": "Details", "order": "52", "role": "http://plyrotech.com/role/ACCOUNTSPAYABLEDetails", "shortName": "ACCOUNTS PAYABLE - Disclosure of accounts payable (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "b", "span", "span", "span", "td", "tr", "table", "div", "prt:DisclosureOfDetailedInformationAboutAccountsPayableExplanatory", "div", "div", "div", "div", "div", "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20221130_prtTradeAndOtherPayableAxis_prtProfessionalFeesPayableMember", "decimals": "0", "lang": null, "name": "ifrs-full:TradeAndOtherCurrentPayables", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "span", "p", "div", "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:RevenueFromContractsWithCustomers", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0055 - Disclosure - Deferred Revenue (Narrative) (Details)", "menuCat": "Details", "order": "53", "role": "http://plyrotech.com/role/DeferredRevenueNarrativeDetails", "shortName": "Deferred Revenue (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "div", "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:RevenueFromContractsWithCustomers", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "span", "p", "div", "div", "div", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20221130", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:TradeAndOtherCurrentReceivablesDueFromRelatedParties", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0056 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES (Narrative) (Details)", "menuCat": "Details", "order": "54", "role": "http://plyrotech.com/role/RelatedPartyTransactionsNarrativeDetails", "shortName": "RELATED PARTY TRANSACTIONS AND BALANCES (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "div", "div", "div", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20221130", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:TradeAndOtherCurrentReceivablesDueFromRelatedParties", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "b", "span", "span", "span", "td", "tr", "table", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20221130", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0057 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES - Disclosure of amounts due to directors and officers (Details)", "menuCat": "Details", "order": "55", "role": "http://plyrotech.com/role/RelatedPartyTransactionsDisclosureOfAmountsDueToOfficersDetails", "shortName": "RELATED PARTY TRANSACTIONS AND BALANCES - Disclosure of amounts due to directors and officers (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "b", "span", "span", "td", "tr", "table", "div", "div", "div", "prt:DisclosureOfDueToRelatedPartyExplanatory", "div", "div", "div", "div", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20221130_ifrsfullCategoriesOfRelatedPartiesAxis_srtChiefFinancialOfficerMember", "decimals": "0", "lang": null, "name": "ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "b", "span", "span", "td", "tr", "table", "prt:DisclosureOfConsultingFeesExplanatoryTableTextBlock", "div", "div", "div", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": "0", "first": true, "lang": null, "name": "prt:ConsultingFees", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0058 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES - Disclosure of transactions between related parties (Details)", "menuCat": "Details", "order": "56", "role": "http://plyrotech.com/role/RelatedPartyTransactionsDisclosureOfTransactionsBetweenRelatedPartiesDetails", "shortName": "RELATED PARTY TRANSACTIONS AND BALANCES - Disclosure of transactions between related parties (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "b", "span", "span", "td", "tr", "table", "div", "div", "div", "div", "div", "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "div", "div", "div", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullRelatedPartiesMember", "decimals": "0", "lang": null, "name": "prt:ConsultingFees", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "b", "span", "span", "td", "tr", "table", "div", "div", "div", "div", "prt:DisclosureOfManagementFeesExplanatory", "div", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130_ifrsfullCategoriesOfRelatedPartiesAxis_srtChiefExecutiveOfficerMember", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:KeyManagementPersonnelCompensation", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0059 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES - Disclosure of information about key management personnel (Details)", "menuCat": "Details", "order": "57", "role": "http://plyrotech.com/role/RELATEDPARTYTRANSACTIONSANDBALANCESDisclosureOfInformationAboutKeyManagementPersonnelDetails", "shortName": "RELATED PARTY TRANSACTIONS AND BALANCES - Disclosure of information about key management personnel (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "b", "span", "span", "td", "tr", "table", "div", "div", "div", "div", "prt:DisclosureOfManagementFeesExplanatory", "div", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130_ifrsfullCategoriesOfRelatedPartiesAxis_srtChiefExecutiveOfficerMember", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:KeyManagementPersonnelCompensation", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "b", "span", "span", "td", "tr", "table", "prt:DisclosureOfConsultingFeesExplanatoryTableTextBlock", "div", "div", "div", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": "0", "first": true, "lang": null, "name": "prt:ConsultingFees", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0060 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES - Disclosure of consulting fees (Details)", "menuCat": "Details", "order": "58", "role": "http://plyrotech.com/role/RELATEDPARTYTRANSACTIONSANDBALANCESConsultingFeesDetails", "shortName": "RELATED PARTY TRANSACTIONS AND BALANCES - Disclosure of consulting fees (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "b", "span", "span", "td", "tr", "table", "prt:DisclosureOfConsultingFeesExplanatoryTableTextBlock", "div", "div", "div", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130_ifrsfullCategoriesOfRelatedPartiesAxis_prtCompanyControlledByFormerCorporateSecretaryMember", "decimals": "0", "lang": null, "name": "prt:ConsultingFees", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "span", "span", "p", "div", "div", "ifrs-full:DisclosureOfIssuedCapitalExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0061 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES - Disclosure of information about options granted to the CEO, CFO, the Corporate Secretary, and the Company's directors (Details)", "menuCat": "Details", "order": "59", "role": "http://plyrotech.com/role/RELATEDPARTYTRANSACTIONSANDBALANCESDisclosureOfInformationAboutOptionsGrantedToTheCEOCFOTheCorporateSecretaryAndTheCompanysDirectorsDetails", "shortName": "RELATED PARTY TRANSACTIONS AND BALANCES - Disclosure of information about options granted to the CEO, CFO, the Corporate Secretary, and the Company's directors (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "b", "span", "span", "td", "tr", "table", "div", "div", "div", "div", "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory", "div", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130_ifrsfullCategoriesOfRelatedPartiesAxis_srtChiefExecutiveOfficerMember", "decimals": "INF", "lang": null, "name": "prt:NumberOfOptionsHeld", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "prt:DisclosureOfNatureOfOperationsAndAbilityToContinueAsGoingConcernExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0006 - Disclosure - NATURE OF OPERATIONS AND ABILITY TO CONTINUE AS A GOING CONCERN", "menuCat": "Notes", "order": "6", "role": "http://plyrotech.com/role/NatureOfOperationsAndAbilityToContinueAsGoingConcern", "shortName": "NATURE OF OPERATIONS AND ABILITY TO CONTINUE AS A GOING CONCERN", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "prt:DisclosureOfNatureOfOperationsAndAbilityToContinueAsGoingConcernExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "b", "span", "span", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": "0", "first": true, "lang": null, "name": "prt:PaycheckProtectionProgram", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0062 - Disclosure - GOVERMENT ASSISTANCE RECEIVED (Narrative) (Details)", "menuCat": "Details", "order": "60", "role": "http://plyrotech.com/role/GOVERMENTASSITANCERECEIVEDDetailTextuals", "shortName": "GOVERMENT ASSISTANCE RECEIVED (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "p", "div", "div", "div", "div", "div", "ifrs-full:DisclosureOfGovernmentGrantsExplanatory", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20200504_ifrsfullBorrowingsByNameAxis_prtPaycheckProtectionProgramLoanMember", "decimals": "0", "lang": null, "name": "ifrs-full:Borrowings", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "span", "p", "div", "div", "div", "ifrs-full:DisclosureOfBorrowingsExplanatory", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:BorrowingCostsRecognisedAsExpense", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0063 - Disclosure - LOAN PAYABLE (Narrative) (Details)", "menuCat": "Details", "order": "61", "role": "http://plyrotech.com/role/LOANPAYABLENarrativeDetails", "shortName": "LOAN PAYABLE (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "div", "div", "div", "ifrs-full:DisclosureOfBorrowingsExplanatory", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:BorrowingCostsRecognisedAsExpense", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "span", "p", "div", "div", "ifrs-full:DisclosureOfIssuedCapitalExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20200813", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:NumberOfSharesIssued", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0064 - Disclosure - SHARE CAPITAL (Narrative) (Details)", "menuCat": "Details", "order": "62", "role": "http://plyrotech.com/role/SHARECAPITALNarrativeDetails", "shortName": "SHARE CAPITAL (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "div", "div", "ifrs-full:DisclosureOfIssuedCapitalExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20200501to20200515", "decimals": "INF", "lang": null, "name": "prt:NumberOfUnitsIssued", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory", "div", "div", "ifrs-full:DisclosureOfIssuedCapitalExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211130", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:NumberOfOutstandingShareOptions", "reportCount": 1, "unitRef": "share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0065 - Disclosure - SHARE CAPITAL - Disclosure of number and weighted average exercise prices of share options (Details)", "menuCat": "Details", "order": "63", "role": "http://plyrotech.com/role/ShareCapitalDisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsDetails", "shortName": "SHARE CAPITAL - Disclosure of number and weighted average exercise prices of share options (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory", "div", "div", "ifrs-full:DisclosureOfIssuedCapitalExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20201130", "decimals": "2", "lang": null, "name": "ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019", "reportCount": 1, "unique": true, "unitRef": "CAD_per_Share", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "b", "span", "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory", "div", "div", "ifrs-full:DisclosureOfIssuedCapitalExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20221130", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:NumberOfOutstandingShareOptions", "reportCount": 1, "unitRef": "share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0066 - Disclosure - SHARE CAPITAL - Disclosure of number and weighted average remaining contractual life of outstanding share options (Details)", "menuCat": "Details", "order": "64", "role": "http://plyrotech.com/role/ShareCapitalDisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsDetails", "shortName": "SHARE CAPITAL - Disclosure of number and weighted average remaining contractual life of outstanding share options (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "b", "span", "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory", "div", "div", "ifrs-full:DisclosureOfIssuedCapitalExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20221130", "decimals": "0", "lang": null, "name": "ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement", "reportCount": 1, "unique": true, "unitRef": "share", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "div", "div", "div", "prt:DisclosureOfDetailedInformationAboutWarrantActivityExplanatory", "div", "div", "div", "div", "div", "div", "ifrs-full:DisclosureOfIssuedCapitalExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211130", "decimals": "0", "first": true, "lang": null, "name": "prt:NumberOfOutstandingWarrants", "reportCount": 1, "unitRef": "share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0067 - Disclosure - SHARE CAPITAL - Disclosure of share purchase warrant transactions (Details)", "menuCat": "Details", "order": "65", "role": "http://plyrotech.com/role/ShareCapitalDisclosureOfSharePurchaseWarrantTransactionsDetails", "shortName": "SHARE CAPITAL - Disclosure of share purchase warrant transactions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "div", "div", "div", "prt:DisclosureOfDetailedInformationAboutWarrantActivityExplanatory", "div", "div", "div", "div", "div", "div", "ifrs-full:DisclosureOfIssuedCapitalExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": "0", "lang": null, "name": "prt:NumberOfWarrantsExpired", "reportCount": 1, "unique": true, "unitRef": "share", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "b", "span", "span", "td", "tr", "table", "div", "div", "div", "prt:DisclosureOfDetailedInformationAboutWarrantActivityExplanatory", "div", "div", "div", "div", "div", "div", "ifrs-full:DisclosureOfIssuedCapitalExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20221130", "decimals": "0", "first": true, "lang": null, "name": "prt:NumberOfOutstandingWarrants", "reportCount": 1, "unitRef": "share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0068 - Disclosure - SHARE CAPITAL - Disclosure of number of share purchase warrants outstanding (Details)", "menuCat": "Details", "order": "66", "role": "http://plyrotech.com/role/SHARECAPITALDetails", "shortName": "SHARE CAPITAL - Disclosure of number of share purchase warrants outstanding (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "b", "span", "span", "td", "tr", "table", "div", "prt:DisclosureOfNumberOfSharePurchaseWarrantsOutstandingExplanatory", "div", "div", "div", "div", "div", "div", "div", "ifrs-full:DisclosureOfIssuedCapitalExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "lang": "en-US", "name": "prt:WeightedAverageRemainingContractualLifeForSharePurchaseWarrants", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "span", "p", "div", "div", "div", "div", "div", "div", "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130_ifrsfullTypesOfRisksAxis_ifrsfullCurrencyRiskMember", "decimals": "2", "first": true, "lang": null, "name": "prt:PotentialFluctuationsInFunctionalCurrencyExchangeRate", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0069 - Disclosure - FINANCIAL RISK MANAGEMENT (Narrative) (Details)", "menuCat": "Details", "order": "67", "role": "http://plyrotech.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails", "shortName": "FINANCIAL RISK MANAGEMENT (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "div", "div", "div", "div", "div", "div", "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130_ifrsfullTypesOfRisksAxis_ifrsfullCurrencyRiskMember", "decimals": "2", "first": true, "lang": null, "name": "prt:PotentialFluctuationsInFunctionalCurrencyExchangeRate", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "b", "span", "span", "td", "tr", "table", "div", "div", "prt:DisclosureOfSupplementalCashFlowInformationExplanatory", "div", "div", "div", "div", "div", "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": "0", "first": true, "lang": null, "name": "prt:FairValueOfOptionsExercised", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0070 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION - Disclosure of supplemental cash flow information (Details)", "menuCat": "Details", "order": "68", "role": "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutSupplementalCashFlowInformationDetails", "shortName": "SUPPLEMENTAL CASH FLOW INFORMATION - Disclosure of supplemental cash flow information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "b", "span", "span", "td", "tr", "table", "div", "div", "prt:DisclosureOfSupplementalCashFlowInformationExplanatory", "div", "div", "div", "div", "div", "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": "0", "first": true, "lang": null, "name": "prt:FairValueOfOptionsExercised", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "b", "span", "span", "td", "tr", "table", "prt:DisclosureOfConsultingFeesExplanatoryTableTextBlock", "div", "div", "div", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": "0", "first": true, "lang": null, "name": "prt:ConsultingFees", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0071 - Disclosure - COMMITMENTS AND CONTINGENCIES (Narrative) (Details)", "menuCat": "Details", "order": "69", "role": "http://plyrotech.com/role/COMMITMENTSNarrativeDetail", "shortName": "COMMITMENTS AND CONTINGENCIES (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "div", "div", "div", "ifrs-full:DisclosureOfCommitmentsExplanatory", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": "0", "lang": null, "name": "prt:KeyManagementCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0007 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES", "menuCat": "Notes", "order": "7", "role": "http://plyrotech.com/role/SignificantAccountingPolicies", "shortName": "SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "span", "span", "p", "div", "div", "div", "ifrs-full:DisclosureOfCommitmentsExplanatory", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20181101to20181130_deiLegalEntityAxis_prtPlymouthRockUsaMember", "decimals": null, "first": true, "lang": "en-US", "name": "prt:LeasesTermOfContract", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0072 - Disclosure - RIGHT-OF-USE ASSETS AND LEASE LIABILITY (Narrative) (Details)", "menuCat": "Details", "order": "70", "role": "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetailTextuals", "shortName": "RIGHT-OF-USE ASSETS AND LEASE LIABILITY (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "div", "div", "div", "div", "div", "prt:DisclosureOfRightOfUseAssetsAndLeaseLiabilityExplanatory", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211130_deiLegalEntityAxis_prtPlymouthRockUsaMember", "decimals": "0", "lang": null, "name": "prt:LeasePaymentsDuePerMonthYearThree", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "span", "span", "span", "td", "tr", "table", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211130", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:RightofuseAssets", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0073 - Disclosure - RIGHT-OF-USE ASSETS AND LEASE LIABILITY - Disclosure of continuity of the cost and accumulated amortization of right-of-use assets (Details)", "menuCat": "Details", "order": "71", "role": "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetails", "shortName": "RIGHT-OF-USE ASSETS AND LEASE LIABILITY - Disclosure of continuity of the cost and accumulated amortization of right-of-use assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "div", "div", "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory", "div", "div", "div", "div", "prt:DisclosureOfRightOfUseAssetsAndLeaseLiabilityExplanatory", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20201130", "decimals": "0", "lang": null, "name": "ifrs-full:RightofuseAssets", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "div", "div", "prt:DisclosureOfContinuityOfLeaseLiabilityExplanatory", "div", "div", "div", "div", "prt:DisclosureOfRightOfUseAssetsAndLeaseLiabilityExplanatory", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211130", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:LeaseLiabilities", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0074 - Disclosure - RIGHT-OF-USE ASSETS AND LEASE LIABILITY - Disclosure of continuity of lease liability (Details)", "menuCat": "Details", "order": "72", "role": "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetails1", "shortName": "RIGHT-OF-USE ASSETS AND LEASE LIABILITY - Disclosure of continuity of lease liability (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "div", "div", "prt:DisclosureOfContinuityOfLeaseLiabilityExplanatory", "div", "div", "div", "div", "prt:DisclosureOfRightOfUseAssetsAndLeaseLiabilityExplanatory", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": "0", "lang": null, "name": "prt:AdditionsOfLeaseLiability", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "b", "span", "span", "td", "tr", "table", "div", "div", "ifrs-full:DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory", "div", "div", "div", "div", "prt:DisclosureOfRightOfUseAssetsAndLeaseLiabilityExplanatory", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20221130", "decimals": "0", "first": true, "lang": null, "name": "prt:UndiscountedOperatingLeasePaymentsToBePaid", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0075 - Disclosure - RIGHT-OF-USE ASSETS AND LEASE LIABILITY - Disclosure of minimum lease payments for the lease liabilities (Details)", "menuCat": "Details", "order": "73", "role": "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetails2", "shortName": "RIGHT-OF-USE ASSETS AND LEASE LIABILITY - Disclosure of minimum lease payments for the lease liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "b", "span", "span", "td", "tr", "table", "div", "div", "ifrs-full:DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory", "div", "div", "div", "div", "prt:DisclosureOfRightOfUseAssetsAndLeaseLiabilityExplanatory", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20221130", "decimals": "0", "first": true, "lang": null, "name": "prt:UndiscountedOperatingLeasePaymentsToBePaid", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "b", "span", "span", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:SellingExpense", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0076 - Disclosure - BREAKDOWN OF EXPENSES (Narrative) (Details)", "menuCat": "Details", "order": "74", "role": "http://plyrotech.com/role/BREAKDOWNOFEXPENSESDetailTextuals", "shortName": "BREAKDOWN OF EXPENSES (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R75": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "div", "div", "prt:DisclosureOfContinuityOfLeaseLiabilityExplanatory", "div", "div", "div", "div", "prt:DisclosureOfRightOfUseAssetsAndLeaseLiabilityExplanatory", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:InterestExpenseOnLeaseLiabilities", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0077 - Disclosure - BREAKDOWN OF EXPENSES - Disclosure of breakdown of expenses (Details)", "menuCat": "Details", "order": "75", "role": "http://plyrotech.com/role/BREAKDOWNOFEXPENSESDetails", "shortName": "BREAKDOWN OF EXPENSES - Disclosure of breakdown of expenses (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "b", "span", "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfAttributionOfExpensesByNatureToTheirFunctionExplanatory", "div", "div", "div", "div", "div", "ifrs-full:DisclosureOfExpensesByNatureExplanatory", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130_ifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_ifrsfullSellingGeneralAndAdministrativeExpenseMember", "decimals": "0", "lang": null, "name": "prt:AccountingFees", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "b", "span", "span", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": "0", "first": true, "lang": null, "name": "prt:GainOnDebtForgiveness", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0078 - Disclosure - GAIN ON DEBT FORGIVENESS (Narrative) (Details)", "menuCat": "Details", "order": "76", "role": "http://plyrotech.com/role/GAINONDEBTFORGIVENESSNarrativeDetails", "shortName": "GAIN ON DEBT FORGIVENESS (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "div", "prt:DisclosureOfGainOnDebtForgivenessTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130_ifrsfullBusinessCombinationsAxis_prtTetraDronesLimitedMember", "decimals": "0", "lang": null, "name": "prt:ExcessNetBookValueOfVehicleLoan", "reportCount": 1, "unique": true, "unitRef": "GBP", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "b", "span", "span", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:Revenue", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0079 - Disclosure - SEGMENTED INFORMATION - Disclosure of revenue by geographical location (Details)", "menuCat": "Details", "order": "77", "role": "http://plyrotech.com/role/SEGMENTEDINFORMATIONDetails", "shortName": "SEGMENTED INFORMATION - Disclosure of revenue by geographical location (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "b", "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "div", "div", "div", "div", "div", "div", "div", "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130_ifrsfullGeographicalAreasAxis_countryCA", "decimals": "0", "lang": null, "name": "ifrs-full:Revenue", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "span", "span", "p", "div", "div", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20221130", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0080 - Disclosure - INCOME TAXES (Narrative) (Details)", "menuCat": "Details", "order": "78", "role": "http://plyrotech.com/role/INCOMETAXESDetails", "shortName": "INCOME TAXES (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R79": { "firstAnchor": { "ancestors": [ "b", "span", "span", "td", "tr", "table", "prt:DisclosureOfDetailedInformationAboutEffectiveIncomeTaxExpenseRecoveryExplanatory", "div", "div", "div", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:AccountingProfit", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0081 - Disclosure - INCOME TAXES - Disclosure of detailed information about effective income tax expense (recovery) (Details)", "menuCat": "Details", "order": "79", "role": "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutReconcilesTheExpectedIncomeTaxesExpenseDetails", "shortName": "INCOME TAXES - Disclosure of detailed information about effective income tax expense (recovery) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "b", "span", "span", "td", "tr", "table", "prt:DisclosureOfDetailedInformationAboutEffectiveIncomeTaxExpenseRecoveryExplanatory", "div", "div", "div", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:AccountingProfit", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfBusinessCombinationsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0008 - Disclosure - ACQUISITION", "menuCat": "Notes", "order": "8", "role": "http://plyrotech.com/role/BusinessAcquisiton", "shortName": "ACQUISITION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfBusinessCombinationsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory", "div", "div", "div", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20221130", "decimals": "0", "first": true, "lang": null, "name": "prt:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognisedNoncapitalLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0082 - Disclosure - INCOME TAXES - Disclosure of temporary difference, unused tax losses and unused tax credits (Details)", "menuCat": "Details", "order": "80", "role": "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutUnrecognizedDeductibleTemporaryDifferencesDetails", "shortName": "INCOME TAXES - Disclosure of temporary difference, unused tax losses and unused tax credits (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory", "div", "div", "div", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20221130", "decimals": "0", "first": true, "lang": null, "name": "prt:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognisedNoncapitalLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R81": { "firstAnchor": { "ancestors": [ "span", "span", "p", "div", "div", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20221130", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0083 - Disclosure - INCOME TAXES - Disclosure of non-capital loss carryforwards (Details)", "menuCat": "Details", "order": "81", "role": "http://plyrotech.com/role/IncomeTaxesDisclosureOfNonCapitalLossCarryforwardsDetails", "shortName": "INCOME TAXES - Disclosure of non-capital loss carryforwards (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "prt:DisclosureOfNonCaptialLossCarryforwardsExplanatory", "div", "div", "div", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20221130_prtTaxExpiryPeriodAxis_prtYear2038Member", "decimals": "0", "lang": null, "name": "ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R82": { "firstAnchor": { "ancestors": [ "span", "span", "p", "div", "div", "ifrs-full:DisclosureOfIssuedCapitalExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20200501to20200515", "decimals": "2", "first": true, "lang": null, "name": "prt:PricePerUnitIssued", "reportCount": 1, "unitRef": "CAD_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0084 - Disclosure - SUBSEQUENT EVENTS (Narrative) (Details)", "menuCat": "Details", "order": "82", "role": "http://plyrotech.com/role/SUBSEQUENTEVENTSNarrativeDetail", "shortName": "SUBSEQUENT EVENTS (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "div", "div", "div", "div", "div", "ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory", "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20220301to20220303_ifrsfullCategoriesOfRelatedPartiesAxis_prtDirectorsOfficersEmployeesAndConsultantsMember", "decimals": "0", "lang": null, "name": "ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement", "reportCount": 1, "unique": true, "unitRef": "share", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "prt:DisclosureOfPrepaidExpensesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0009 - Disclosure - PREPAID EXPENSES", "menuCat": "Notes", "order": "9", "role": "http://plyrotech.com/role/PrepaidExpenses", "shortName": "PREPAID EXPENSES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "form20f.htm", "contextRef": "C_20211201to20221130", "decimals": null, "first": true, "lang": "en-US", "name": "prt:DisclosureOfPrepaidExpensesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 92, "tag": { "country_CA": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CANADA", "terseLabel": "Canada [Member]" } } }, "localname": "CA", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://plyrotech.com/role/SEGMENTEDINFORMATIONDetails" ], "xbrltype": "domainItemType" }, "country_GB": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED KINGDOM", "terseLabel": "UK [Member]" } } }, "localname": "GB", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://plyrotech.com/role/SEGMENTEDINFORMATIONDetails" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES", "terseLabel": "USA [Member]" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://plyrotech.com/role/SEGMENTEDINFORMATIONDetails" ], "xbrltype": "domainItemType" }, "dei_AddressTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An entity may have several addresses for different purposes and this domain represents all such types.", "label": "Address Type [Domain]" } } }, "localname": "AddressTypeDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://plyrotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://plyrotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://plyrotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r225", "r226", "r227" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://plyrotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r225", "r226", "r227" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://plyrotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r225", "r226", "r227" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://plyrotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "internationalNameItemType" }, "dei_BusinessContactMember": { "auth_ref": [ "r226", "r227" ], "lang": { "en-us": { "role": { "documentation": "Business contact for the entity", "label": "Business Contact [Member]" } } }, "localname": "BusinessContactMember", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://plyrotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://plyrotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_ContactPersonnelName": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of contact personnel", "label": "Contact Personnel Name" } } }, "localname": "ContactPersonnelName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://plyrotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://plyrotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r226" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://plyrotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r225", "r226", "r227" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://plyrotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://plyrotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://plyrotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://plyrotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r222" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://plyrotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r226" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://plyrotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r228" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://plyrotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://plyrotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://plyrotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://plyrotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://plyrotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://plyrotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://plyrotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityAddressesAddressTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.", "label": "Entity Addresses, Address Type [Axis]" } } }, "localname": "EntityAddressesAddressTypeAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://plyrotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_EntityAddressesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Addresses [Line Items]" } } }, "localname": "EntityAddressesLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://plyrotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_EntityAddressesTable": { "auth_ref": [ "r224" ], "lang": { "en-us": { "role": { "documentation": "Container of address information for the entity", "label": "Entity Addresses [Table]" } } }, "localname": "EntityAddressesTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://plyrotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r224" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://plyrotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://plyrotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://plyrotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://plyrotech.com/role/COMMITMENTSNarrativeDetail", "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetailTextuals", "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r224" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://plyrotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r231" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://plyrotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://plyrotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r224" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://plyrotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://plyrotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r229" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://plyrotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r224" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://plyrotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r224" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://plyrotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://plyrotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r230" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well Known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://plyrotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r225", "r226", "r227" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://plyrotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://plyrotech.com/role/COMMITMENTSNarrativeDetail", "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetailTextuals", "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://plyrotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r223" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://plyrotech.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "exch_BPLC": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "BARCLAYS BANK PLC [Member]", "verboseLabel": "Barclays Bank PLC [Member]" } } }, "localname": "BPLC", "nsuri": "http://xbrl.sec.gov/exch/2022", "presentation": [ "http://plyrotech.com/role/COMMITMENTSNarrativeDetail", "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetailTextuals" ], "xbrltype": "domainItemType" }, "ifrs-full_AccountingProfit": { "auth_ref": [ "r30", "r31" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of profit (loss) for a period before deducting tax expense. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Accounting profit", "negatedLabel": "Net loss before tax and comprehensive loss", "verboseLabel": "Net loss before tax and comprehensive loss" } } }, "localname": "AccountingProfit", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutReconcilesTheExpectedIncomeTaxesExpenseDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember": { "auth_ref": [ "r38", "r47", "r73", "r83", "r86" ], "lang": { "en": { "role": { "documentation": "This member stands for accumulated depreciation, amortisation and impairment. [Refer: Impairment loss; Depreciation and amortisation expense]" } }, "en-us": { "role": { "label": "Accumulated depreciation, amortisation and impairment [member]", "terseLabel": "Accumulated amortization [Member]", "verboseLabel": "Accumulated Depreciation [Member]" } } }, "localname": "AccumulatedDepreciationAmortisationAndImpairmentMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/EQUIPMENTDisclosureOfEquipmentDetails", "http://plyrotech.com/role/IntangibleAssetsDisclosureOfDetailedInformationAboutIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_AccumulatedOtherComprehensiveIncome": { "auth_ref": [ "r237" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 30.0, "parentTag": "ifrs-full_Equity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of accumulated items of income and expense (including reclassification adjustments) that are not recognised in profit or loss as required or permitted by other IFRSs. [Refer: IFRSs [member]; Other comprehensive income]" } }, "en-us": { "role": { "label": "Accumulated other comprehensive income", "verboseLabel": "Accumulated other comprehensive income" } } }, "localname": "AccumulatedOtherComprehensiveIncome", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r235" ], "lang": { "en": { "role": { "documentation": "This member stands for accumulated other comprehensive income. [Refer: Other comprehensive income]" } }, "en-us": { "role": { "label": "Accumulated other comprehensive losses [Member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred": { "auth_ref": [ "r143" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Business combinations [member]]" } }, "en-us": { "role": { "label": "Consideration transferred, acquisition-date fair value", "netLabel": "Consideration payable", "terseLabel": "Fair value of common shares issued", "totalLabel": "Total Consideration", "verboseLabel": "Total Consideration" } } }, "localname": "AcquisitiondateFairValueOfTotalConsiderationTransferred", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/BUSINESSACQUISITONNarrativeDetail", "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdditionalPaidinCapital": { "auth_ref": [ "r237" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 20.0, "parentTag": "ifrs-full_Equity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount received or receivable from the issuance of the entity's shares in excess of nominal value and amounts received from other transactions involving the entity's stock or stockholders." } }, "en-us": { "role": { "label": "Contributed surplus" } } }, "localname": "AdditionalPaidinCapital", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdditionalPaidinCapitalMember": { "auth_ref": [ "r235" ], "lang": { "en": { "role": { "documentation": "This member stands for amounts received from issuance of the entity's shares in excess of nominal value and amounts received from other transactions involving the entity's stock or stockholders." } }, "en-us": { "role": { "label": "Contributed Surplus [Member]" } } }, "localname": "AdditionalPaidinCapitalMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r74" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Additions other than through business combinations, intangible assets other than goodwill", "verboseLabel": "Additions" } } }, "localname": "AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/IntangibleAssetsDisclosureOfDetailedInformationAboutIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment": { "auth_ref": [ "r39" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]" } }, "en-us": { "role": { "label": "Additions other than through business combinations, property, plant and equipment", "verboseLabel": "Additions" } } }, "localname": "AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/EQUIPMENTDisclosureOfEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdditionsToRightofuseAssets": { "auth_ref": [ "r126" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of additions to right-of-use assets. [Refer: Right-of-use assets]" } }, "en-us": { "role": { "label": "Additions to right-of-use assets", "verboseLabel": "Additions" } } }, "localname": "AdditionsToRightofuseAssets", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForAmortisationExpense": { "auth_ref": [ "r249" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows": { "order": 150.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss); Depreciation and amortisation expense]" } }, "en-us": { "role": { "label": "Adjustments for amortisation expense", "verboseLabel": "Amortization expense" } } }, "localname": "AdjustmentsForAmortisationExpense", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForDecreaseIncreaseInInventories": { "auth_ref": [ "r247" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows": { "order": 40.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for decrease (increase) in inventories to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Inventories; Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for decrease (increase) in inventories", "verboseLabel": "Inventories" } } }, "localname": "AdjustmentsForDecreaseIncreaseInInventories", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable": { "auth_ref": [ "r247" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows": { "order": 180.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for decrease (increase) in trade accounts receivable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for decrease (increase) in trade accounts receivable", "terseLabel": "Accounts receivable" } } }, "localname": "AdjustmentsForDecreaseIncreaseInTradeAccountReceivable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForDeferredTaxExpense": { "auth_ref": [ "r249" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows": { "order": 170.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for deferred tax expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Deferred tax expense (income); Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for deferred tax expense", "negatedLabel": "Deferred tax recovery", "positiveLabel": "Income tax expense (recovery)", "totalLabel": "Income tax expense (recovery)", "verboseLabel": "Deferred income tax recovery" } } }, "localname": "AdjustmentsForDeferredTaxExpense", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForImpairmentLossRecognisedInProfitOrLossGoodwill": { "auth_ref": [ "r249" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows": { "order": 100.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for impairment loss on goodwill recognised in profit or loss to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Goodwill; Impairment loss; Impairment loss recognised in profit or loss]" } }, "en-us": { "role": { "label": "Adjustments for impairment loss recognised in profit or loss, goodwill", "negatedLabel": "Impairment of goodwill", "terseLabel": "Impairment of intangible asset" } } }, "localname": "AdjustmentsForImpairmentLossRecognisedInProfitOrLossGoodwill", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossInventories": { "auth_ref": [ "r249" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows": { "order": 110.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for impairment loss (reversal of impairment loss) on inventories recognised in profit or loss to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Inventories; Impairment loss; Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss; Impairment loss (reversal of impairment loss) recognised in profit or loss]" } }, "en-us": { "role": { "label": "Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss, inventories", "verboseLabel": "Write-off of inventory" } } }, "localname": "AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossInventories", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment": { "auth_ref": [ "r249" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows": { "order": 60.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for impairment loss (reversal of impairment loss) on property, plant and equipment recognised in profit or loss to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss; Property, plant and equipment]" } }, "en-us": { "role": { "label": "Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss, property, plant and equipment", "negatedLabel": "Impairment loss recognised in profit or loss, property, plant and equipment", "terseLabel": "Impairment of demo equipment", "verboseLabel": "Impairment" } } }, "localname": "AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable": { "auth_ref": [ "r247" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows": { "order": 220.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for increase (decrease) in trade accounts payable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Accounts payable and accrued liabilities (AdjustmentsForIncreaseDecreaseInTradeAccountPayable)", "terseLabel": "Accounts payable and accrued liabilities" } } }, "localname": "AdjustmentsForIncreaseDecreaseInTradeAccountPayable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForInterestExpense": { "auth_ref": [ "r249" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows": { "order": 120.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for interest expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Interest expense; Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for interest expense", "negatedLabel": "Interest expense", "verboseLabel": "Interest expense" } } }, "localname": "AdjustmentsForInterestExpense", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForReconcileProfitLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in non-cash working capital:" } } }, "localname": "AdjustmentsForReconcileProfitLossAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "ifrs-full_AdjustmentsForSharebasedPayments": { "auth_ref": [ "r248" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for share-based payments", "verboseLabel": "Stock based compensation" } } }, "localname": "AdjustmentsForSharebasedPayments", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains": { "auth_ref": [ "r201", "r248" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows": { "order": 20.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for unrealised foreign exchange losses (gains) to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for unrealised foreign exchange losses (gains)", "negatedLabel": "Foreign exchange loss", "verboseLabel": "Foreign exchange (gain) loss" } } }, "localname": "AdjustmentsForUnrealisedForeignExchangeLossesGains", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AggregatedTimeBandsMember": { "auth_ref": [ "r15", "r119", "r129", "r130", "r151", "r174", "r175", "r176", "r182", "r195", "r210", "r211" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated time bands. It also represents the standard value for the 'Maturity' axis if no other member is used." } }, "en-us": { "role": { "label": "Aggregated time bands [member]" } } }, "localname": "AggregatedTimeBandsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetailTextuals", "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetails2" ], "xbrltype": "domainItemType" }, "ifrs-full_AmortisationExpense": { "auth_ref": [ "r236" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of amortisation expense. Amortisation is the systematic allocation of depreciable amounts of intangible assets over their useful lives." } }, "en-us": { "role": { "label": "Amortisation expense", "terseLabel": "Amortization" } } }, "localname": "AmortisationExpense", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/BREAKDOWNOFEXPENSESDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r76" ], "lang": { "en": { "role": { "documentation": "The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Amortisation, intangible assets other than goodwill", "negatedLabel": "Amortization" } } }, "localname": "AmortisationIntangibleAssetsOtherThanGoodwill", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/IntangibleAssetsDisclosureOfDetailedInformationAboutIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AmountsReceivableRelatedPartyTransactions": { "auth_ref": [ "r56", "r59" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amounts receivable resulting from related party transactions. [Refer: Related parties [member]]" } }, "en-us": { "role": { "label": "Amounts receivable, related party transactions", "terseLabel": "Prepayment to related parties" } } }, "localname": "AmountsReceivableRelatedPartyTransactions", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/PREPAIDEXPENSESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Amounts recognized as of acquisition date for each major class of assets acquired and liabilities assumed [abstract]", "terseLabel": "Net assets acquired (liabilities assumed)", "verboseLabel": "Net identifiable assets (liabilities) acquired" } } }, "localname": "AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutPurchasePriceAllocationDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_ApplicableTaxRate": { "auth_ref": [ "r31" ], "lang": { "en": { "role": { "documentation": "The applicable income tax rate." } }, "en-us": { "role": { "label": "Applicable tax rate", "terseLabel": "Combined statutory tax rate", "verboseLabel": "Statutory tax rate" } } }, "localname": "ApplicableTaxRate", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutReconcilesTheExpectedIncomeTaxesExpenseDetails" ], "xbrltype": "percentItemType" }, "ifrs-full_Assets": { "auth_ref": [ "r13", "r113", "r114", "r115", "r163", "r166" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } }, "en-us": { "role": { "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS", "verboseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "stringItemType" }, "ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis": { "auth_ref": [ "r233", "r236" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Attribution of expenses by nature to their function [axis]" } } }, "localname": "AttributionOfExpensesByNatureToTheirFunctionAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/BREAKDOWNOFEXPENSESDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_BorrowingCostsRecognisedAsExpense": { "auth_ref": [ "r236" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of interest and other costs that an entity incurs in connection with the borrowing of funds that are recognised as an expense." } }, "en-us": { "role": { "label": "Borrowing costs recognised as expense", "verboseLabel": "Borrowing costs" } } }, "localname": "BorrowingCostsRecognisedAsExpense", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/LOANPAYABLENarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_Borrowings": { "auth_ref": [ "r237" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of outstanding funds that the entity is obligated to repay." } }, "en-us": { "role": { "label": "Borrowings", "terseLabel": "Balance as of date", "totalLabel": "Total borrowings", "verboseLabel": "Loan received" } } }, "localname": "Borrowings", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/GOVERMENTASSITANCERECEIVEDDetailTextuals" ], "xbrltype": "monetaryItemType" }, "ifrs-full_BorrowingsByNameAxis": { "auth_ref": [ "r253" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Borrowings by name [axis]" } } }, "localname": "BorrowingsByNameAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/GOVERMENTASSITANCERECEIVEDDetailTextuals" ], "xbrltype": "stringItemType" }, "ifrs-full_BorrowingsByNameMember": { "auth_ref": [ "r253" ], "lang": { "en": { "role": { "documentation": "This member stands for all borrowings when disaggregated by name. It also represents the standard value for the 'Borrowings by name' axis if no other member is used. [Refer: Borrowings]" } }, "en-us": { "role": { "label": "Borrowings by name [member]" } } }, "localname": "BorrowingsByNameMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/GOVERMENTASSITANCERECEIVEDDetailTextuals" ], "xbrltype": "domainItemType" }, "ifrs-full_BorrowingsInterestRate": { "auth_ref": [ "r253" ], "lang": { "en": { "role": { "documentation": "The interest rate on borrowings. [Refer: Borrowings]" } }, "en-us": { "role": { "label": "Borrowings, interest rate", "terseLabel": "Annual interest rate", "verboseLabel": "Interest" } } }, "localname": "BorrowingsInterestRate", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/GOVERMENTASSITANCERECEIVEDDetailTextuals", "http://plyrotech.com/role/LOANPAYABLENarrativeDetails" ], "xbrltype": "percentItemType" }, "ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate": { "auth_ref": [ "r251" ], "calculation": { "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutPurchasePriceAllocationDetails": { "order": 30.0, "parentTag": "ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount recognised as of the acquisition date for borrowings assumed in a business combination. [Refer: Borrowings; Business combinations [member]]" } }, "en-us": { "role": { "label": "Borrowings recognised as of acquisition date", "negatedLabel": "Bank loan", "netLabel": "Bank loan", "verboseLabel": "Loan" } } }, "localname": "BorrowingsRecognisedAsOfAcquisitionDate", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_BottomOfRangeMember": { "auth_ref": [ "r116", "r139", "r176", "r203", "r204", "r253" ], "lang": { "en": { "role": { "documentation": "This member stands for the bottom of a range." } }, "en-us": { "role": { "label": "Bottom of range [member]", "verboseLabel": "Bottom of range [Member]" } } }, "localname": "BottomOfRangeMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutReconcilesTheExpectedIncomeTaxesExpenseDetails", "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_BusinessCombinationsAxis": { "auth_ref": [ "r144" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Business combinations [axis]" } } }, "localname": "BusinessCombinationsAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/BUSINESSACQUISITONNarrativeDetail", "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutPurchasePriceAllocationDetails", "http://plyrotech.com/role/GAINONDEBTFORGIVENESSNarrativeDetails", "http://plyrotech.com/role/LOANPAYABLENarrativeDetails", "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_BusinessCombinationsMember": { "auth_ref": [ "r144" ], "lang": { "en": { "role": { "documentation": "This member stands for transactions or other events in which an acquirer obtains control of one or more businesses. Transactions sometimes referred to as 'true mergers' or 'mergers of equals' are also business combinations as that term is used in IFRS 3." } }, "en-us": { "role": { "label": "Business combinations [member]", "netLabel": "Plymouth Rock USA [Member]", "terseLabel": "Plymouth Rock USA [Member]", "verboseLabel": "Plymouth Rock Technologies Inc. (\"Plymouth Rock USA\") Member" } } }, "localname": "BusinessCombinationsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis": { "auth_ref": [ "r38", "r44", "r73", "r78", "r82", "r83", "r84", "r85", "r86", "r145", "r154", "r155", "r256", "r257" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]" } } }, "localname": "CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/EQUIPMENTDisclosureOfEquipmentDetails", "http://plyrotech.com/role/INTANGIBLEASSETSDetails", "http://plyrotech.com/role/IntangibleAssetsDisclosureOfDetailedInformationAboutIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_CarryingAmountMember": { "auth_ref": [ "r44", "r78", "r82", "r84", "r85", "r145", "r154", "r155", "r219", "r221" ], "lang": { "en": { "role": { "documentation": "This member stands for the amount at which an asset is recognised in the statement of financial position (after deducting any accumulated depreciation or amortisation and accumulated impairment losses). It also represents the standard value for the 'Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount' axis if no other member is used. [Refer: Depreciation and amortisation expense; Impairment loss]" } }, "en-us": { "role": { "label": "Carrying amount [Member]" } } }, "localname": "CarryingAmountMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/EQUIPMENTDisclosureOfEquipmentDetails", "http://plyrotech.com/role/INTANGIBLEASSETSDetails", "http://plyrotech.com/role/IntangibleAssetsDisclosureOfDetailedInformationAboutIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_Cash": { "auth_ref": [ "r250" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of cash on hand and demand deposits. [Refer: Cash on hand]" } }, "en-us": { "role": { "label": "Cash,cash equivalents, and restricted cash", "periodEndLabel": "Cash, end of the period", "periodStartLabel": "Cash, beginning of the period", "verboseLabel": "Cash" } } }, "localname": "Cash", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashAndCashEquivalents": { "auth_ref": [ "r11", "r93", "r108" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 0.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]" } }, "en-us": { "role": { "label": "Cash and cash equivalents", "periodEndLabel": "Cash, end of the year", "periodStartLabel": "Cash, beginning of the year", "verboseLabel": "Cash" } } }, "localname": "CashAndCashEquivalents", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashFlowsFromUsedInFinancingActivities": { "auth_ref": [ "r87", "r95" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows": { "order": 20.0, "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity." } }, "en-us": { "role": { "label": "Net cash provided by financing activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "CashFlowsFromUsedInFinancingActivities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financing Activities" } } }, "localname": "CashFlowsFromUsedInFinancingActivitiesAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "ifrs-full_CashFlowsFromUsedInInvestingActivities": { "auth_ref": [ "r87", "r95" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents." } }, "en-us": { "role": { "label": "Net cash provided by investing activities", "totalLabel": "Net cash provided by (used in) investing activities" } } }, "localname": "CashFlowsFromUsedInInvestingActivities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investing Activities", "terseLabel": "Investing Activities" } } }, "localname": "CashFlowsFromUsedInInvestingActivitiesAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "ifrs-full_CashFlowsFromUsedInOperatingActivities": { "auth_ref": [ "r87", "r95" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows": { "order": 0.0, "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0 } }, "lang": { "en": { "role": { "documentation": "The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]" } }, "en-us": { "role": { "label": "Net cash used in operating activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "CashFlowsFromUsedInOperatingActivities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Provided By (Used In)", "terseLabel": "Cash Provided By (Used In) Operating Activities", "verboseLabel": "Cash Provided By (Used In)" } } }, "localname": "CashFlowsFromUsedInOperatingActivitiesAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities": { "auth_ref": [ "r92" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows": { "order": 0.0, "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The aggregate cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities. [Refer: Subsidiaries [member]]" } }, "en-us": { "role": { "label": "Cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities", "negatedLabel": "Acquisition of business", "negatedNetLabel": "Acquisition of business", "negatedTerseLabel": "Cash flows used in obtaining control of subsidiaries or other businesses", "terseLabel": "Cash flows from losing control of subsidiaries or other businesses", "verboseLabel": "Acquisition of business" } } }, "localname": "CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashOutflowForLeases": { "auth_ref": [ "r125" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow for leases." } }, "en-us": { "role": { "label": "Cash outflow for leases", "negatedLabel": "Lease payment", "negatedTerseLabel": "Payments of lease liabilities", "verboseLabel": "Lease payment" } } }, "localname": "CashOutflowForLeases", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashTransferred": { "auth_ref": [ "r142" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The fair value, at acquisition date, of cash transferred as consideration in a business combination. [Refer: Business combinations [member]]" } }, "en-us": { "role": { "label": "Cash transferred", "verboseLabel": "Cash" } } }, "localname": "CashTransferred", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CategoriesOfRelatedPartiesAxis": { "auth_ref": [ "r58" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Categories of related parties [axis]" } } }, "localname": "CategoriesOfRelatedPartiesAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/COMMITMENTSNarrativeDetail", "http://plyrotech.com/role/LOANPAYABLENarrativeDetails", "http://plyrotech.com/role/RELATEDPARTYTRANSACTIONSANDBALANCESConsultingFeesDetails", "http://plyrotech.com/role/RELATEDPARTYTRANSACTIONSANDBALANCESDisclosureOfInformationAboutKeyManagementPersonnelDetails", "http://plyrotech.com/role/RELATEDPARTYTRANSACTIONSANDBALANCESDisclosureOfInformationAboutOptionsGrantedToTheCEOCFOTheCorporateSecretaryAndTheCompanysDirectorsDetails", "http://plyrotech.com/role/RelatedPartyTransactionsDisclosureOfAmountsDueToOfficersDetails", "http://plyrotech.com/role/RelatedPartyTransactionsDisclosureOfTransactionsBetweenRelatedPartiesDetails", "http://plyrotech.com/role/RelatedPartyTransactionsNarrativeDetails", "http://plyrotech.com/role/SHARECAPITALNarrativeDetails", "http://plyrotech.com/role/SUBSEQUENTEVENTSNarrativeDetail" ], "xbrltype": "stringItemType" }, "ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis": { "auth_ref": [ "r79" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Classes of intangible assets other than goodwill [axis]" } } }, "localname": "ClassesOfIntangibleAssetsOtherThanGoodwillAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/INTANGIBLEASSETSDetails", "http://plyrotech.com/role/IntangibleAssetsDisclosureOfDetailedInformationAboutIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis": { "auth_ref": [ "r45" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Classes of property, plant and equipment [axis]" } } }, "localname": "ClassesOfPropertyPlantAndEquipmentAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/EQUIPMENTDisclosureOfEquipmentDetails", "http://plyrotech.com/role/SignificantAccountingPoliciesDisclosureOfDepreciationRatesApplicableToEachCategoryOfPropertyAndEquipmentDetail" ], "xbrltype": "stringItemType" }, "ifrs-full_ComponentsOfEquityAxis": { "auth_ref": [ "r5" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Components of equity [axis]" } } }, "localname": "ComponentsOfEquityAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity", "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_ComprehensiveIncome": { "auth_ref": [ "r2", "r22", "r98", "r100", "r106", "r202" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners." } }, "en-us": { "role": { "label": "Comprehensive income", "negatedLabel": "Comprehensive loss", "negatedTotalLabel": "NET LOSS AND COMPREHENSIVE LOSS FOR THE YEAR", "netLabel": "Net loss for the year", "positiveTerseLabel": "Net and comprehensive loss for the year", "positiveVerboseLabel": "Net loss for the year", "terseLabel": "Net and comprehensive loss for the year", "totalLabel": "TOTAL COMPREHENSIVE LOSS", "verboseLabel": "Net and comprehensive loss for the year" } } }, "localname": "ComprehensiveIncome", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss", "http://plyrotech.com/role/NATUREOFOPERATIONSANDABILITYTOCONTINUEASAGOINGCONCERNNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ComputerEquipmentMember": { "auth_ref": [ "r242" ], "lang": { "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing computer equipment. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Computer equipment [member]", "terseLabel": "Computer equipment [Member]", "verboseLabel": "Computer [Member]" } } }, "localname": "ComputerEquipmentMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/EQUIPMENTDisclosureOfEquipmentDetails", "http://plyrotech.com/role/SignificantAccountingPoliciesDisclosureOfDepreciationRatesApplicableToEachCategoryOfPropertyAndEquipmentDetail" ], "xbrltype": "domainItemType" }, "ifrs-full_CostOfSales": { "auth_ref": [ "r0", "r27" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 10.0, "parentTag": "ifrs-full_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories." } }, "en-us": { "role": { "label": "Cost of sales" } } }, "localname": "CostOfSales", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary": { "auth_ref": [ "r63", "r66", "r101", "r102" ], "lang": { "en": { "role": { "documentation": "The country in which a subsidiary of the entity is incorporated. [Refer: Subsidiaries [member]]" } }, "en-us": { "role": { "label": "Country of incorporation of subsidiary", "verboseLabel": "Country of Incorporation" } } }, "localname": "CountryOfIncorporationOrResidenceOfSubsidiary", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SignificantAccountingPoliciesDisclosureOfSubsidiariesDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_CurrencyRiskMember": { "auth_ref": [ "r158", "r177", "r178", "r179", "r180" ], "lang": { "en": { "role": { "documentation": "This member stands for a type of market risk representing the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rates. [Refer: Financial instruments, class [member]]" } }, "en-us": { "role": { "label": "Currency risk [member]", "verboseLabel": "Foreign Currency Risk [Member]" } } }, "localname": "CurrencyRiskMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_CurrentAssets": { "auth_ref": [ "r16", "r104", "r202" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 0.0, "parentTag": "ifrs-full_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]" } }, "en-us": { "role": { "label": "Current assets", "totalLabel": "Total current assets" } } }, "localname": "CurrentAssets", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current assets [abstract]", "verboseLabel": "Current assets" } } }, "localname": "CurrentAssetsAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "stringItemType" }, "ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate": { "auth_ref": [ "r251" ], "calculation": { "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutPurchasePriceAllocationDetails": { "order": 60.0, "parentTag": "ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount recognised as of the acquisition date for current assets acquired in a business combination. [Refer: Current assets; Business combinations [member]]" } }, "en-us": { "role": { "label": "Current assets recognised as of acquisition date", "verboseLabel": "Prepaid expenses" } } }, "localname": "CurrentAssetsRecognisedAsOfAcquisitionDate", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentLeaseLiabilities": { "auth_ref": [ "r122" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 20.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current lease liabilities. [Refer: Lease liabilities]" } }, "en-us": { "role": { "label": "Current lease liabilities", "terseLabel": "Lease liabilities", "verboseLabel": "Current portion" } } }, "localname": "CurrentLeaseLiabilities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition", "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentLiabilities": { "auth_ref": [ "r17", "r105", "r202" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 0.0, "parentTag": "ifrs-full_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "Expiry date 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have an unconditional right to defer settlement for at least twelve months after the reporting period.\nEffective 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period." } }, "en-us": { "role": { "label": "Current liabilities", "totalLabel": "Total current liabilities" } } }, "localname": "CurrentLiabilities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current liabilities [abstract]", "verboseLabel": "Current liabilities" } } }, "localname": "CurrentLiabilitiesAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "stringItemType" }, "ifrs-full_CurrentLoansReceivedAndCurrentPortionOfNoncurrentLoansReceived": { "auth_ref": [ "r236" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 30.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current loans received and the current portion of non-current loans received. [Refer: Loans received]" } }, "en-us": { "role": { "label": "Current loans received and current portion of non-current loans received", "positiveTerseLabel": "Loan payable current", "terseLabel": "Current portion of loans payable", "verboseLabel": "Repayment of loan payable" } } }, "localname": "CurrentLoansReceivedAndCurrentPortionOfNoncurrentLoansReceived", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentPrepaidExpenses": { "auth_ref": [ "r236" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 40.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised." } }, "en-us": { "role": { "label": "Prepaid expenses", "terseLabel": "Prepaid expenses", "totalLabel": "Total prepaid expenses", "verboseLabel": "Prepaid expenses" } } }, "localname": "CurrentPrepaidExpenses", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition", "http://plyrotech.com/role/PREPAIDEXPENSESDisclosureOfPrepaidExpensesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentReceivablesFromTaxesOtherThanIncomeTax": { "auth_ref": [ "r238" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 20.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of current receivables from taxes other than income tax. [Refer: Receivables from taxes other than income tax]" } }, "en-us": { "role": { "label": "Sales tax receivable" } } }, "localname": "CurrentReceivablesFromTaxesOtherThanIncomeTax", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentTradeReceivables": { "auth_ref": [ "r188", "r189" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 10.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of current trade receivables. [Refer: Trade receivables]" } }, "en-us": { "role": { "label": "Accounts receivable" } } }, "localname": "CurrentTradeReceivables", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CustomerrelatedIntangibleAssetsMember": { "auth_ref": [ "r244" ], "lang": { "en": { "role": { "documentation": "This member stands for a class of intangible assets representing assets related to customers. Such assets may include customer lists, order or production backlog, customer contracts and related customer relationships as well as non-contractual customer relationships." } }, "en-us": { "role": { "label": "Customer-related intangible assets [member]", "terseLabel": "Customer relationship [Member]" } } }, "localname": "CustomerrelatedIntangibleAssetsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/INTANGIBLEASSETSDetails", "http://plyrotech.com/role/IntangibleAssetsDisclosureOfDetailedInformationAboutIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised": { "auth_ref": [ "r32" ], "calculation": { "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutUnrecognizedDeductibleTemporaryDifferencesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en": { "role": { "documentation": "The amount of deductible temporary differences for which no deferred tax asset is recognised in the statement of financial position. [Refer: Temporary differences [member]]" } }, "en-us": { "role": { "label": "Deductible temporary differences for which no deferred tax asset is recognised", "totalLabel": "Net deferred tax assets", "verboseLabel": "Total unrecognized deductible temporary differences" } } }, "localname": "DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutUnrecognizedDeductibleTemporaryDifferencesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DeferredTaxExpenseIncome": { "auth_ref": [ "r33" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 0.0, "parentTag": "ifrs-full_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of tax expense (income) relating to changes in deferred tax liabilities and deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]" } }, "en-us": { "role": { "label": "Deferred tax expense (income)", "negatedLabel": "Deferred income tax recovery", "positiveLabel": "Income tax expense (recovery)", "totalLabel": "Income tax expense (recovery)", "verboseLabel": "Deferred tax recovery" } } }, "localname": "DeferredTaxExpenseIncome", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DepreciationMethodPropertyPlantAndEquipment": { "auth_ref": [ "r36" ], "lang": { "en": { "role": { "documentation": "The depreciation method used for property, plant and equipment. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Depreciation method, property, plant and equipment", "verboseLabel": "Depreciation method" } } }, "localname": "DepreciationMethodPropertyPlantAndEquipment", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SignificantAccountingPoliciesDisclosureOfDepreciationRatesApplicableToEachCategoryOfPropertyAndEquipmentDetail" ], "xbrltype": "stringItemType" }, "ifrs-full_DepreciationPropertyPlantAndEquipment": { "auth_ref": [ "r42", "r46" ], "lang": { "en": { "role": { "documentation": "The amount of depreciation of property, plant and equipment. [Refer: Depreciation and amortisation expense; Property, plant and equipment]" } }, "en-us": { "role": { "label": "Depreciation, property, plant and equipment", "terseLabel": "Amortization", "verboseLabel": "Depreciation" } } }, "localname": "DepreciationPropertyPlantAndEquipment", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/EQUIPMENTDisclosureOfEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DepreciationRatePropertyPlantAndEquipment": { "auth_ref": [ "r37" ], "lang": { "en": { "role": { "documentation": "The depreciation rate used for property, plant and equipment. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Useful lives or depreciation rates, property, plant and equipment", "verboseLabel": "Depreciation rates" } } }, "localname": "DepreciationRatePropertyPlantAndEquipment", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SignificantAccountingPoliciesDisclosureOfDepreciationRatesApplicableToEachCategoryOfPropertyAndEquipmentDetail" ], "xbrltype": "percentItemType" }, "ifrs-full_DepreciationRightofuseAssets": { "auth_ref": [ "r123" ], "lang": { "en": { "role": { "documentation": "The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]" } }, "en-us": { "role": { "label": "Depreciation, right-of-use assets", "negatedLabel": "Amortization expense", "terseLabel": "Amortization; right-of-use asset" } } }, "localname": "DepreciationRightofuseAssets", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory": { "auth_ref": [ "r254", "r255" ], "lang": { "en": { "role": { "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for business combinations. [Refer: Business combinations [member]]\nEffective 2023-01-01: The description of the entity's material accounting policy information for business combinations. [Refer: Business combinations [member]]" } }, "en-us": { "role": { "label": "Description of accounting policy for business combinations [text block]", "terseLabel": "Business combinations [Policy Text Block]" } } }, "localname": "DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory": { "auth_ref": [ "r254", "r255" ], "lang": { "en": { "role": { "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for earnings per share.\nEffective 2023-01-01: The description of the entity's material accounting policy information for earnings per share." } }, "en-us": { "role": { "label": "Description of accounting policy for earnings per share [text block]", "terseLabel": "Earnings (loss) per share [Policy Text Block]" } } }, "localname": "DescriptionOfAccountingPolicyForEarningsPerShareExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory": { "auth_ref": [ "r254", "r255" ], "lang": { "en": { "role": { "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for financial instruments. [Refer: Financial instruments, class [member]]\nEffective 2023-01-01: The description of the entity's material accounting policy information for financial instruments. [Refer: Financial instruments, class [member]]" } }, "en-us": { "role": { "label": "Description of accounting policy for financial instruments [text block]", "terseLabel": "Financial instruments [Policy Text Block]" } } }, "localname": "DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory": { "auth_ref": [ "r254", "r255" ], "lang": { "en": { "role": { "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for goodwill. [Refer: Goodwill]\nEffective 2023-01-01: The description of the entity's material accounting policy information for goodwill. [Refer: Goodwill]" } }, "en-us": { "role": { "label": "Description of accounting policy for goodwill [text block]", "verboseLabel": "Goodwill [Policy Text Block]" } } }, "localname": "DescriptionOfAccountingPolicyForGoodwillExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants": { "auth_ref": [ "r51" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for government grants, including the methods of presentation adopted in the financial statements. [Refer: Government [member]; Government grants]" } }, "en-us": { "role": { "label": "Description of accounting policy for government grants [text block]", "terseLabel": "Government Grants [Policy Text Block]" } } }, "localname": "DescriptionOfAccountingPolicyForGovernmentGrants", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory": { "auth_ref": [ "r254", "r255" ], "lang": { "en": { "role": { "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for income tax.\nEffective 2023-01-01: The description of the entity's material accounting policy information for income tax." } }, "en-us": { "role": { "label": "Description of accounting policy for income tax [text block]", "verboseLabel": "Income taxes [Policy Text Block]" } } }, "localname": "DescriptionOfAccountingPolicyForIncomeTaxExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory": { "auth_ref": [ "r254", "r255" ], "lang": { "en": { "role": { "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]\nEffective 2023-01-01: The description of the entity's material accounting policy information for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Description of accounting policy for intangible assets other than goodwill [text block]", "verboseLabel": "Intangible assets [Policy Text Block]" } } }, "localname": "DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory": { "auth_ref": [ "r254", "r255" ], "lang": { "en": { "role": { "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for issued capital. [Refer: Issued capital]\nEffective 2023-01-01: The description of the entity's material accounting policy information for issued capital. [Refer: Issued capital]" } }, "en-us": { "role": { "label": "Description of accounting policy for issued capital [text block]", "terseLabel": "Share capital [Policy Text Block]" } } }, "localname": "DescriptionOfAccountingPolicyForIssuedCapitalExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory": { "auth_ref": [ "r254", "r255" ], "lang": { "en": { "role": { "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time.\nEffective 2023-01-01: The description of the entity's material accounting policy information for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time." } }, "en-us": { "role": { "label": "Description of accounting policy for leases [text block]", "verboseLabel": "Leases [Policy Text Block]" } } }, "localname": "DescriptionOfAccountingPolicyForLeasesExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories": { "auth_ref": [ "r49" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for measuring inventories. [Refer: Inventories]" } }, "en-us": { "role": { "label": "Description of accounting policy for measuring inventories [text block]", "terseLabel": "Inventories [Policy Text Block]" } } }, "localname": "DescriptionOfAccountingPolicyForMeasuringInventories", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory": { "auth_ref": [ "r254", "r255" ], "lang": { "en": { "role": { "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for property, plant and equipment. [Refer: Property, plant and equipment]\nEffective 2023-01-01: The description of the entity's material accounting policy information for property, plant and equipment. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Description of accounting policy for property, plant and equipment [text block]", "verboseLabel": "Equipment [Policy Text Block]" } } }, "localname": "DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue": { "auth_ref": [ "r254", "r255" ], "lang": { "en": { "role": { "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for recognising revenue. [Refer: Revenue]\nEffective 2023-01-01: The description of the entity's material accounting policy information for recognising revenue. [Refer: Revenue]" } }, "en-us": { "role": { "label": "Revenue recognition [Policy Text Block]" } } }, "localname": "DescriptionOfAccountingPolicyForRecognitionOfRevenue", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory": { "auth_ref": [ "r254", "r255" ], "lang": { "en": { "role": { "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Share-based payment arrangements [member]]\nEffective 2023-01-01: The description of the entity's material accounting policy information for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Share-based payment arrangements [member]]" } }, "en-us": { "role": { "label": "Description of accounting policy for share-based payment transactions [text block]", "verboseLabel": "Stock-based payment [Policy Text Block]" } } }, "localname": "DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory": { "auth_ref": [ "r254", "r255" ], "lang": { "en": { "role": { "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for transactions with related parties. [Refer: Related parties [member]]\nEffective 2023-01-01: The description of the entity's material accounting policy information for transactions with related parties. [Refer: Related parties [member]]" } }, "en-us": { "role": { "label": "Description of accounting policy for transactions with related parties [text block]", "verboseLabel": "Related party transactions [Policy Text Block]" } } }, "localname": "DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory": { "auth_ref": [ "r254", "r255" ], "lang": { "en": { "role": { "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for warrants. Warrants are financial instruments that give the holder the right to purchase ordinary shares.\nEffective 2023-01-01: The description of the entity's material accounting policy information for warrants. Warrants are financial instruments that give the holder the right to purchase ordinary shares." } }, "en-us": { "role": { "label": "Description of accounting policy for warrants [text block]", "terseLabel": "Share purchase warrants [Policy Text Block]" } } }, "localname": "DescriptionOfAccountingPolicyForWarrantsExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents": { "auth_ref": [ "r94" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy used to determine the components of cash and cash equivalents. [Refer: Cash and cash equivalents]" } }, "en-us": { "role": { "label": "Description of accounting policy for determining components of cash and cash equivalents [text block]", "verboseLabel": "Cash [Policy Text Block]" } } }, "localname": "DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted": { "auth_ref": [ "r140" ], "lang": { "en": { "role": { "documentation": "The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time." } }, "en-us": { "role": { "label": "Expected volatility, share options granted", "verboseLabel": "Volatility" } } }, "localname": "DescriptionOfExpectedVolatilityShareOptionsGranted", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "percentItemType" }, "ifrs-full_DescriptionOfOptionLifeShareOptionsGranted": { "auth_ref": [ "r140" ], "lang": { "en": { "role": { "documentation": "The option life of share options granted." } }, "en-us": { "role": { "label": "Option life, share options granted", "terseLabel": "Term of exercise price of stock options", "verboseLabel": "Expected life" } } }, "localname": "DescriptionOfOptionLifeShareOptionsGranted", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "decimalItemType" }, "ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted": { "auth_ref": [ "r140" ], "lang": { "en": { "role": { "documentation": "The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]" } }, "en-us": { "role": { "label": "Risk free interest rate, share options granted", "verboseLabel": "Risk-free rate" } } }, "localname": "DescriptionOfRiskFreeInterestRateShareOptionsGranted", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "percentItemType" }, "ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r72" ], "lang": { "en": { "role": { "documentation": "Description of useful life used for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Description of useful life, intangible assets other than goodwill", "verboseLabel": "Estimated useful life" } } }, "localname": "DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/INTANGIBLEASSETSDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DilutedEarningsLossPerShare": { "auth_ref": [ "r69", "r70" ], "lang": { "en": { "role": { "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]" } }, "en-us": { "role": { "label": "Diluted earnings (loss) per share", "terseLabel": "LOSS PER SHARE, basic and diluted" } } }, "localname": "DilutedEarningsLossPerShare", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "perShareItemType" }, "ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of attribution of expenses by nature to their function [abstract]" } } }, "localname": "DisclosureOfAttributionOfExpensesByNatureToTheirFunctionAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionExplanatory": { "auth_ref": [ "r233", "r236" ], "lang": { "en": { "role": { "documentation": "The disclosure of attribution of expenses by nature to line items by function in the statement of profit or loss." } }, "en-us": { "role": { "label": "Disclosure of attribution of expenses by nature to their function [text block]", "terseLabel": "Disclosure of breakdown of expenses [Table Text Block]" } } }, "localname": "DisclosureOfAttributionOfExpensesByNatureToTheirFunctionExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/BREAKDOWNOFEXPENSESTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of attribution of expenses by nature to their function [line items]" } } }, "localname": "DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/BREAKDOWNOFEXPENSESDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable": { "auth_ref": [ "r233", "r236" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to attribution of expenses by nature to analysis of expenses by function in the statement of profit or loss." } }, "en-us": { "role": { "label": "Disclosure of attribution of expenses by nature to their function [table]" } } }, "localname": "DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/BREAKDOWNOFEXPENSESDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfBorrowingsExplanatory": { "auth_ref": [ "r232" ], "lang": { "en": { "role": { "documentation": "The disclosure of borrowings. [Refer: Borrowings]" } }, "en-us": { "role": { "label": "Disclosure of borrowings [text block]", "verboseLabel": "LOAN PAYABLE [Text Block]" } } }, "localname": "DisclosureOfBorrowingsExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/LOANPAYABLE" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfBusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about business combination [abstract]" } } }, "localname": "DisclosureOfBusinessCombinationsAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfBusinessCombinationsExplanatory": { "auth_ref": [ "r147" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for business combinations." } }, "en-us": { "role": { "label": "Disclosure of business combinations [text block]", "verboseLabel": "ACQUISITION [Text Block]" } } }, "localname": "DisclosureOfBusinessCombinationsExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/BusinessAcquisiton" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfBusinessCombinationsLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of detailed information about business combination [line items]" } } }, "localname": "DisclosureOfBusinessCombinationsLineItems", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/BUSINESSACQUISITONNarrativeDetail", "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutPurchasePriceAllocationDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfBusinessCombinationsTable": { "auth_ref": [ "r144" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to details of business combinations." } }, "en-us": { "role": { "label": "Disclosure of detailed information about business combination [table]" } } }, "localname": "DisclosureOfBusinessCombinationsTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/BUSINESSACQUISITONNarrativeDetail", "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutPurchasePriceAllocationDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfCashFlowStatementExplanatory": { "auth_ref": [ "r96" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for a statement of cash flows." } }, "en-us": { "role": { "label": "Disclosure of cash flow statement [text block]", "verboseLabel": "SUPPLEMENTAL CASH FLOW INFORMATION [Text Block]" } } }, "localname": "DisclosureOfCashFlowStatementExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SupplementalCashFlowInformation" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfClassesOfShareCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of classes of share capital [abstract]" } } }, "localname": "DisclosureOfClassesOfShareCapitalAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfClassesOfShareCapitalLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of classes of share capital [line items]" } } }, "localname": "DisclosureOfClassesOfShareCapitalLineItems", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfClassesOfShareCapitalTable": { "auth_ref": [ "r20" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to classes of share capital." } }, "en-us": { "role": { "label": "Disclosure of classes of share capital [table]" } } }, "localname": "DisclosureOfClassesOfShareCapitalTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfCommitmentsExplanatory": { "auth_ref": [ "r232" ], "lang": { "en": { "role": { "documentation": "The disclosure of commitments." } }, "en-us": { "role": { "label": "Disclosure of commitments [text block]", "verboseLabel": "COMMITMENTS AND CONTINGENCIES [Text Block]" } } }, "localname": "DisclosureOfCommitmentsExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/Commitments" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about borrowings [abstract]" } } }, "localname": "DisclosureOfDetailedInformationAboutBorrowingsAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory": { "auth_ref": [ "r253" ], "lang": { "en": { "role": { "documentation": "The disclosure of detailed information about borrowings. [Refer: Borrowings]" } }, "en-us": { "role": { "label": "Disclosure of detailed information about borrowings [text block]", "verboseLabel": "Disclosure of loan payable related to the vehicle acquired [Table Text Block]" } } }, "localname": "DisclosureOfDetailedInformationAboutBorrowingsExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/LOANPAYABLETables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of detailed information about borrowings [line items]" } } }, "localname": "DisclosureOfDetailedInformationAboutBorrowingsLineItems", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/GOVERMENTASSITANCERECEIVEDDetailTextuals" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable": { "auth_ref": [ "r253" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to details of borrowings." } }, "en-us": { "role": { "label": "Disclosure of detailed information about borrowings [table]" } } }, "localname": "DisclosureOfDetailedInformationAboutBorrowingsTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/GOVERMENTASSITANCERECEIVEDDetailTextuals" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory": { "auth_ref": [ "r148" ], "lang": { "en": { "role": { "documentation": "The disclosure of detailed information about business combinations. [Refer: Business combinations [member]]" } }, "en-us": { "role": { "label": "Disclosure of detailed information about business combination [text block]", "verboseLabel": "Disclosure of purchase price allocation [Table Text Block]" } } }, "localname": "DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/BUSINESSACQUISITONTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory": { "auth_ref": [ "r79" ], "lang": { "en": { "role": { "documentation": "The disclosure of detailed information about intangible assets. [Refer: Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Disclosure of detailed information about intangible assets [text block]", "terseLabel": "Disclosure of intangible assets [Table Text Block]" } } }, "localname": "DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/INTANGIBLEASSETSTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory": { "auth_ref": [ "r45" ], "lang": { "en": { "role": { "documentation": "The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Disclosure of detailed information about property, plant and equipment [text block]", "verboseLabel": "Disclosure of property, plant and equipment [Table Text Block]" } } }, "localname": "DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/EQUIPMENTTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of disaggregation of revenue from contracts with customers [abstract]" } } }, "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory": { "auth_ref": [ "r173" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for operating segments." } }, "en-us": { "role": { "label": "Disclosure of entity's operating segments [text block]", "terseLabel": "Disclosure of revenue and long-lived assets by geographical location [Table Text Block]" } } }, "localname": "DisclosureOfEntitysReportableSegmentsExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SEGMENTEDINFORMATIONTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfExpensesByNatureExplanatory": { "auth_ref": [ "r232" ], "lang": { "en": { "role": { "documentation": "The disclosure of expenses by nature. [Refer: Expenses, by nature]" } }, "en-us": { "role": { "label": "Disclosure of expenses by nature [text block]", "verboseLabel": "BREAKDOWN OF EXPENSES [Text Block]" } } }, "localname": "DisclosureOfExpensesByNatureExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/BREAKDOWNOFEXPENSES" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfFinancialRiskManagementExplanatory": { "auth_ref": [ "r232" ], "lang": { "en": { "role": { "documentation": "The disclosure of the entity's financial risk management practices and policies." } }, "en-us": { "role": { "label": "Disclosure of financial risk management [text block]", "verboseLabel": "FINANCIAL RISK MANAGEMENT [Text Block]" } } }, "localname": "DisclosureOfFinancialRiskManagementExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/FinancialRiskManagement" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfGovernmentGrantsExplanatory": { "auth_ref": [ "r52" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for government grants." } }, "en-us": { "role": { "label": "Disclosure of government grants [text block]", "verboseLabel": "GOVERNMENT ASSISTANCE RECEIVED [Text Block]" } } }, "localname": "DisclosureOfGovernmentGrantsExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/GOVERMENTASSITANCERECEIVED" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfIncomeTaxExplanatory": { "auth_ref": [ "r35" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for income taxes." } }, "en-us": { "role": { "label": "Disclosure of income tax [text block]", "verboseLabel": "INCOME TAXES [Text Block]" } } }, "localname": "DisclosureOfIncomeTaxExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory": { "auth_ref": [ "r232" ], "lang": { "en": { "role": { "documentation": "The disclosure of information about key management personnel. [Refer: Key management personnel of entity or parent [member]]" } }, "en-us": { "role": { "label": "Disclosure of information about key management personnel [text block]", "terseLabel": "Disclosure of information about key management personnel [Table Text Block]" } } }, "localname": "DisclosureOfInformationAboutKeyManagementPersonnelExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/RELATEDPARTYTRANSACTIONSTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfIntangibleAssetsExplanatory": { "auth_ref": [ "r81" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for intangible assets." } }, "en-us": { "role": { "label": "Disclosure of intangible assets [text block]", "terseLabel": "INTANGIBLE ASSETS [Text Block]" } } }, "localname": "DisclosureOfIntangibleAssetsExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/IntangibleAssets" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of detailed information about intangible assets [line items]" } } }, "localname": "DisclosureOfIntangibleAssetsLineItems", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/INTANGIBLEASSETSDetails", "http://plyrotech.com/role/IntangibleAssetsDisclosureOfDetailedInformationAboutIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfIntangibleAssetsTable": { "auth_ref": [ "r79" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to details of intangible assets." } }, "en-us": { "role": { "label": "Disclosure of detailed information about intangible assets [table]" } } }, "localname": "DisclosureOfIntangibleAssetsTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/INTANGIBLEASSETSDetails", "http://plyrotech.com/role/IntangibleAssetsDisclosureOfDetailedInformationAboutIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfIssuedCapitalExplanatory": { "auth_ref": [ "r232" ], "lang": { "en": { "role": { "documentation": "The disclosure of issued capital. [Refer: Issued capital]" } }, "en-us": { "role": { "label": "Disclosure of issued capital [text block]", "verboseLabel": "SHARE CAPITAL [Text Block]" } } }, "localname": "DisclosureOfIssuedCapitalExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ShareCapital" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory": { "auth_ref": [ "r130" ], "lang": { "en": { "role": { "documentation": "The disclosure of a maturity analysis of operating lease payments. Operating lease is a lease that does not transfer substantially all the risks and rewards incidental to ownership of an underlying asset." } }, "en-us": { "role": { "label": "Disclosure of maturity analysis of operating lease payments [text block]", "verboseLabel": "Disclosure of minimum lease payments for the lease liabilities [Table Text Block]" } } }, "localname": "DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of maturity analysis of operating lease payments [line items]" } } }, "localname": "DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetailTextuals", "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetails2" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable": { "auth_ref": [ "r130" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to the maturity analysis of operating lease payments." } }, "en-us": { "role": { "label": "Disclosure of maturity analysis of operating lease payments [table]" } } }, "localname": "DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetailTextuals", "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetails2" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of nature and extent of risks arising from financial instruments [line items]" } } }, "localname": "DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable": { "auth_ref": [ "r152", "r153" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to the nature and extent of risks arising from financial instruments." } }, "en-us": { "role": { "label": "Disclosure of nature and extent of risks arising from financial instruments [table]" } } }, "localname": "DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of non-adjusting events after reporting period [abstract]" } } }, "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory": { "auth_ref": [ "r28" ], "lang": { "en": { "role": { "documentation": "The disclosure of non-adjusting events after the reporting period. [Refer: Non-adjusting events after reporting period [member]]" } }, "en-us": { "role": { "label": "Disclosure of non-adjusting events after reporting period [text block]", "verboseLabel": "SUBSEQUENT EVENTS [Text Block]" } } }, "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of non-adjusting events after reporting period [line items]" } } }, "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SUBSEQUENTEVENTSNarrativeDetail" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable": { "auth_ref": [ "r28" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to non-adjusting events after the reporting period." } }, "en-us": { "role": { "label": "Disclosure of non-adjusting events after reporting period [table]" } } }, "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SUBSEQUENTEVENTSNarrativeDetail" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory": { "auth_ref": [ "r138" ], "lang": { "en": { "role": { "documentation": "The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Disclosure of number and weighted average exercise prices of share options [text block]", "verboseLabel": "Disclosure of number and weighted average exercise prices of share options [Table Text Block]" } } }, "localname": "DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SHARECAPITALTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]" } } }, "localname": "DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SHARECAPITALDetails", "http://plyrotech.com/role/ShareCapitalDisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable": { "auth_ref": [ "r139" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to the number and weighted average remaining contractual life of outstanding share options." } }, "en-us": { "role": { "label": "Disclosure of number and weighted average remaining contractual life of outstanding share options [table]" } } }, "localname": "DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SHARECAPITALDetails", "http://plyrotech.com/role/ShareCapitalDisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory": { "auth_ref": [ "r6" ], "lang": { "en": { "role": { "documentation": "The disclosure of information that enables users of financial statements to evaluate the entity's objectives, policies and processes for managing capital." } }, "en-us": { "role": { "label": "Disclosure of objectives, policies and processes for managing capital [text block]", "terseLabel": "CAPITAL MANAGEMENT [Text Block]" } } }, "localname": "DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/CapitalManagement" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfOperatingSegmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of operating segments [abstract]" } } }, "localname": "DisclosureOfOperatingSegmentsAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfOperatingSegmentsExplanatory": { "auth_ref": [ "r163" ], "lang": { "en": { "role": { "documentation": "The disclosure of operating segments. [Refer: Operating segments [member]]" } }, "en-us": { "role": { "label": "Disclosure of operating segments [text block]", "verboseLabel": "SEGMENTED INFORMATION [Text Block]" } } }, "localname": "DisclosureOfOperatingSegmentsExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SegmentedInformation" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfOperatingSegmentsLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of operating segments [line items]" } } }, "localname": "DisclosureOfOperatingSegmentsLineItems", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SEGMENTEDINFORMATIONDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfOperatingSegmentsTable": { "auth_ref": [ "r163" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to operating segments." } }, "en-us": { "role": { "label": "Disclosure of operating segments [table]" } } }, "localname": "DisclosureOfOperatingSegmentsTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SEGMENTEDINFORMATIONDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about property, plant and equipment [abstract]" } } }, "localname": "DisclosureOfPropertyPlantAndEquipmentAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/EQUIPMENTDisclosureOfEquipmentDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory": { "auth_ref": [ "r48" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for property, plant and equipment." } }, "en-us": { "role": { "label": "Disclosure of property, plant and equipment [text block]", "verboseLabel": "EQUIPMENT [Text Block]" } } }, "localname": "DisclosureOfPropertyPlantAndEquipmentExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/Equipment" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of detailed information about property, plant and equipment [line items]" } } }, "localname": "DisclosureOfPropertyPlantAndEquipmentLineItems", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/EQUIPMENTDisclosureOfEquipmentDetails", "http://plyrotech.com/role/SignificantAccountingPoliciesDisclosureOfDepreciationRatesApplicableToEachCategoryOfPropertyAndEquipmentDetail" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r45" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to details of property, plant and equipment." } }, "en-us": { "role": { "label": "Disclosure of detailed information about property, plant and equipment [table]" } } }, "localname": "DisclosureOfPropertyPlantAndEquipmentTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/EQUIPMENTDisclosureOfEquipmentDetails", "http://plyrotech.com/role/SignificantAccountingPoliciesDisclosureOfDepreciationRatesApplicableToEachCategoryOfPropertyAndEquipmentDetail" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory": { "auth_ref": [ "r128" ], "lang": { "en": { "role": { "documentation": "The disclosure of quantitative information about right-of-use assets. [Refer: Right-of-use assets]" } }, "en-us": { "role": { "label": "Disclosure of quantitative information about right-of-use assets [text block]", "verboseLabel": "Disclosure of continuity of the cost and accumulated amortization of right-of-use assets [Table Text Block]" } } }, "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory": { "auth_ref": [ "r139" ], "lang": { "en": { "role": { "documentation": "The disclosure of the range of exercise prices for outstanding share options." } }, "en-us": { "role": { "label": "Disclosure of range of exercise prices of outstanding share options [text block]", "verboseLabel": "Disclosure of number and weighted average remaining contractual life of outstanding share options [Table Text Block]" } } }, "localname": "DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SHARECAPITALTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfRelatedPartyExplanatory": { "auth_ref": [ "r60" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for related parties." } }, "en-us": { "role": { "label": "Disclosure of related party [text block]", "terseLabel": "RELATED PARTY TRANSACTIONS AND BALANCES [Text Block]" } } }, "localname": "DisclosureOfRelatedPartyExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory": { "auth_ref": [ "r120", "r121" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for revenue from contracts with customers." } }, "en-us": { "role": { "label": "Disclosure of revenue from contracts with customers [text block]", "terseLabel": "Deferred Revenue [Text Block]" } } }, "localname": "DisclosureOfRevenueFromContractsWithCustomersExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/DeferredRevenue" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory": { "auth_ref": [ "r65", "r68", "r112" ], "lang": { "en": { "role": { "documentation": "The disclosure of subsidiaries. [Refer: Subsidiaries [member]]" } }, "en-us": { "role": { "label": "Disclosure of subsidiaries [text block]", "verboseLabel": "Disclosure of subsidiaries [Table Text Block]" } } }, "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of subsidiaries [line items]" } } }, "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesLineItems", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SignificantAccountingPoliciesDisclosureOfSubsidiariesDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable": { "auth_ref": [ "r65", "r68", "r112" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to subsidiaries." } }, "en-us": { "role": { "label": "Disclosure of subsidiaries [table]" } } }, "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SignificantAccountingPoliciesDisclosureOfSubsidiariesDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory": { "auth_ref": [ "r183" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for significant accounting policies applied by the entity." } }, "en-us": { "role": { "label": "Disclosure of significant accounting policies [text block]", "verboseLabel": "SIGNIFICANT ACCOUNTING POLICIES [Text Block]" } } }, "localname": "DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory": { "auth_ref": [ "r34" ], "lang": { "en": { "role": { "documentation": "The disclosure of types of temporary differences, unused tax losses and unused tax credits. [Refer: Unused tax credits [member]; Unused tax losses [member]; Temporary differences [member]]" } }, "en-us": { "role": { "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [text block]", "verboseLabel": "Disclosure of temporary difference, unused tax losses and unused tax credits [Table Text Block]" } } }, "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/INCOMETAXESTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [line items]" } } }, "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/IncomeTaxesDisclosureOfNonCapitalLossCarryforwardsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable": { "auth_ref": [ "r34" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to temporary differences, unused tax losses and unused tax credits." } }, "en-us": { "role": { "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [table]" } } }, "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/IncomeTaxesDisclosureOfNonCapitalLossCarryforwardsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory": { "auth_ref": [ "r232" ], "lang": { "en": { "role": { "documentation": "The disclosure of trade and other payables. [Refer: Trade and other payables]" } }, "en-us": { "role": { "label": "Disclosure of trade and other payables [text block]", "terseLabel": "ACCOUNTS PAYABLE [Text Block]" } } }, "localname": "DisclosureOfTradeAndOtherPayablesExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/AccountsPayable" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory": { "auth_ref": [ "r57" ], "lang": { "en": { "role": { "documentation": "The disclosure of transactions between the entity and its related parties. [Refer: Related parties [member]]" } }, "en-us": { "role": { "label": "Disclosure of transactions between related parties [text block]", "verboseLabel": "Disclosure of transactions between related parties [Table Text Block]" } } }, "localname": "DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/RELATEDPARTYTRANSACTIONSTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of transactions between related parties [line items]" } } }, "localname": "DisclosureOfTransactionsBetweenRelatedPartiesLineItems", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/RELATEDPARTYTRANSACTIONSANDBALANCESConsultingFeesDetails", "http://plyrotech.com/role/RELATEDPARTYTRANSACTIONSANDBALANCESDisclosureOfInformationAboutKeyManagementPersonnelDetails", "http://plyrotech.com/role/RELATEDPARTYTRANSACTIONSANDBALANCESDisclosureOfInformationAboutOptionsGrantedToTheCEOCFOTheCorporateSecretaryAndTheCompanysDirectorsDetails", "http://plyrotech.com/role/RelatedPartyTransactionsDisclosureOfAmountsDueToOfficersDetails", "http://plyrotech.com/role/RelatedPartyTransactionsDisclosureOfTransactionsBetweenRelatedPartiesDetails", "http://plyrotech.com/role/RelatedPartyTransactionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable": { "auth_ref": [ "r58" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to transactions between related parties." } }, "en-us": { "role": { "label": "Disclosure of transactions between related parties [table]" } } }, "localname": "DisclosureOfTransactionsBetweenRelatedPartiesTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/RELATEDPARTYTRANSACTIONSANDBALANCESConsultingFeesDetails", "http://plyrotech.com/role/RELATEDPARTYTRANSACTIONSANDBALANCESDisclosureOfInformationAboutKeyManagementPersonnelDetails", "http://plyrotech.com/role/RELATEDPARTYTRANSACTIONSANDBALANCESDisclosureOfInformationAboutOptionsGrantedToTheCEOCFOTheCorporateSecretaryAndTheCompanysDirectorsDetails", "http://plyrotech.com/role/RelatedPartyTransactionsDisclosureOfAmountsDueToOfficersDetails", "http://plyrotech.com/role/RelatedPartyTransactionsDisclosureOfTransactionsBetweenRelatedPartiesDetails", "http://plyrotech.com/role/RelatedPartyTransactionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisposalsPropertyPlantAndEquipment": { "auth_ref": [ "r40" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The decrease in property, plant and equipment resulting from disposals. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Disposals, property, plant and equipment", "terseLabel": "Disposal" } } }, "localname": "DisposalsPropertyPlantAndEquipment", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/EQUIPMENTDisclosureOfEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents": { "auth_ref": [ "r90", "r91" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]" } }, "en-us": { "role": { "label": "Effect of exchange rate changes on cash and cash equivalents", "verboseLabel": "Effect of foreign exchange rate changes on cash" } } }, "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalents", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_EmployeeBenefitsExpense": { "auth_ref": [ "r1", "r27", "r185" ], "calculation": { "http://plyrotech.com/role/RelatedPartyTransactionsDisclosureOfTransactionsBetweenRelatedPartiesDetails": { "order": 50.0, "parentTag": "ifrs-full_ServicesReceivedRelatedPartyTransactions", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The expense of all forms of consideration given by an entity in exchange for a service rendered by employees or for the termination of employment." } }, "en-us": { "role": { "label": "Employee benefits expense", "verboseLabel": "Salaries and benefits to CEO" } } }, "localname": "EmployeeBenefitsExpense", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/RelatedPartyTransactionsDisclosureOfTransactionsBetweenRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_EntitysTotalForBusinessCombinationsMember": { "auth_ref": [ "r144", "r146" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Business combinations' axis if no other member is used." } }, "en-us": { "role": { "label": "Entity's total for business combinations [member]" } } }, "localname": "EntitysTotalForBusinessCombinationsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/BUSINESSACQUISITONNarrativeDetail", "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutPurchasePriceAllocationDetails", "http://plyrotech.com/role/GAINONDEBTFORGIVENESSNarrativeDetails", "http://plyrotech.com/role/LOANPAYABLENarrativeDetails", "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_EntitysTotalForRelatedPartiesMember": { "auth_ref": [ "r58" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Categories of related parties' axis if no other member is used." } }, "en-us": { "role": { "label": "Entity's total for related parties [member]", "verboseLabel": "Entity's total for related parties [member]" } } }, "localname": "EntitysTotalForRelatedPartiesMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/COMMITMENTSNarrativeDetail", "http://plyrotech.com/role/LOANPAYABLENarrativeDetails", "http://plyrotech.com/role/RELATEDPARTYTRANSACTIONSANDBALANCESConsultingFeesDetails", "http://plyrotech.com/role/RELATEDPARTYTRANSACTIONSANDBALANCESDisclosureOfInformationAboutKeyManagementPersonnelDetails", "http://plyrotech.com/role/RELATEDPARTYTRANSACTIONSANDBALANCESDisclosureOfInformationAboutOptionsGrantedToTheCEOCFOTheCorporateSecretaryAndTheCompanysDirectorsDetails", "http://plyrotech.com/role/RelatedPartyTransactionsDisclosureOfAmountsDueToOfficersDetails", "http://plyrotech.com/role/RelatedPartyTransactionsDisclosureOfTransactionsBetweenRelatedPartiesDetails", "http://plyrotech.com/role/RelatedPartyTransactionsNarrativeDetails", "http://plyrotech.com/role/SHARECAPITALNarrativeDetails", "http://plyrotech.com/role/SUBSEQUENTEVENTSNarrativeDetail" ], "xbrltype": "domainItemType" }, "ifrs-full_EntitysTotalForSubsidiariesMember": { "auth_ref": [ "r65", "r68", "r112" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Subsidiaries' axis if no other member is used." } }, "en-us": { "role": { "label": "Entity's total for subsidiaries [member]" } } }, "localname": "EntitysTotalForSubsidiariesMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SignificantAccountingPoliciesDisclosureOfSubsidiariesDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_Equity": { "auth_ref": [ "r13", "r18", "r97", "r99", "r113", "r114", "r115" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 10.0, "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities." } }, "en-us": { "role": { "label": "Equity", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance", "totalLabel": "Total shareholders' equity (deficit)", "verboseLabel": "Total shareholders' equity (deficit)" } } }, "localname": "Equity", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity", "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SHAREHOLDERS' EQUITY", "verboseLabel": "SHAREHOLDERS' EQUITY (DEFICIT)" } } }, "localname": "EquityAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "stringItemType" }, "ifrs-full_EquityAndLiabilities": { "auth_ref": [ "r13" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]" } }, "en-us": { "role": { "label": "Equity and liabilities", "totalLabel": "Total liabilities and shareholders' equity (deficit)" } } }, "localname": "EquityAndLiabilities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_EquityMember": { "auth_ref": [ "r5" ], "lang": { "en": { "role": { "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used." } }, "en-us": { "role": { "label": "Equity [Member]" } } }, "localname": "EquityMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity", "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted": { "auth_ref": [ "r140" ], "lang": { "en": { "role": { "documentation": "The percentage of an expected dividend used to calculate the fair value of share options granted." } }, "en-us": { "role": { "label": "Expected dividend as percentage, share options granted", "verboseLabel": "Dividend yield" } } }, "localname": "ExpectedDividendAsPercentageShareOptionsGranted", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "percentItemType" }, "ifrs-full_ExpenseByNatureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OPERATING EXPENSES" } } }, "localname": "ExpenseByNatureAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "ifrs-full_FixturesAndFittingsMember": { "auth_ref": [ "r192" ], "lang": { "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing fixtures and fittings that are not permanently attached to real property. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Fixtures and fittings [member]", "terseLabel": "Furniture [Member]", "verboseLabel": "Furniture [member]" } } }, "localname": "FixturesAndFittingsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SignificantAccountingPoliciesDisclosureOfDepreciationRatesApplicableToEachCategoryOfPropertyAndEquipmentDetail" ], "xbrltype": "domainItemType" }, "ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax": { "auth_ref": [ "r25" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 10.0, "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The gains (losses) recognised in other comprehensive income on exchange differences on the translation of financial statements of foreign operations, net of tax, before reclassification adjustments. [Refer: Other comprehensive income]" } }, "en-us": { "role": { "label": "Gains (losses) on exchange differences on translation, net of tax", "negatedLabel": "Reclassification adjustments on change in value of foreign currency basis spreads, net of tax", "negatedTerseLabel": "Foreign currency translation", "terseLabel": "Foreign currency translation income", "verboseLabel": "Foreign currency translation gain (loss)" } } }, "localname": "GainsLossesOnExchangeDifferencesOnTranslationNetOfTax", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity", "http://plyrotech.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss": { "auth_ref": [ "r7", "r53" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 70.0, "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of exchange differences recognised in profit or loss that arise from foreign currency transactions, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: At fair value [member]; Financial instruments, class [member]]" } }, "en-us": { "role": { "label": "Foreign exchange gain (loss)", "negatedLabel": "Foreign exchange loss", "terseLabel": "Foreign exchange loss", "verboseLabel": "Foreign exchange gain (loss)" } } }, "localname": "GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_GeneralAndAdministrativeExpense": { "auth_ref": [ "r236" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 10.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expense relating to general and administrative activities of the entity." } }, "en-us": { "role": { "label": "General and administrative expense", "terseLabel": "Total", "verboseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/BREAKDOWNOFEXPENSESDetails", "http://plyrotech.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_GeographicalAreasAxis": { "auth_ref": [ "r171", "r194", "r205", "r216" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Geographical areas [axis]" } } }, "localname": "GeographicalAreasAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SEGMENTEDINFORMATIONDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_GeographicalAreasMember": { "auth_ref": [ "r171", "r194", "r205", "r216" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated geographical areas. It also represents the standard value for the 'Geographical areas' axis if no other member is used." } }, "en-us": { "role": { "label": "Geographical areas [member]" } } }, "localname": "GeographicalAreasMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SEGMENTEDINFORMATIONDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_GrossCarryingAmountMember": { "auth_ref": [ "r38", "r73", "r83", "r86", "r145", "r155", "r156", "r209", "r256", "r257" ], "lang": { "en": { "role": { "documentation": "This member stands for the amount at which an asset is recognised before deducting any accumulated depreciation (amortisation) and accumulated impairment losses thereon. [Refer: Depreciation and amortisation expense; Impairment loss]" } }, "en-us": { "role": { "label": "Gross carrying amount [member]", "terseLabel": "Cost [Member]" } } }, "localname": "GrossCarryingAmountMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/EQUIPMENTDisclosureOfEquipmentDetails", "http://plyrotech.com/role/INTANGIBLEASSETSDetails", "http://plyrotech.com/role/IntangibleAssetsDisclosureOfDetailedInformationAboutIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_GrossProfit": { "auth_ref": [ "r186" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 90.0, "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]" } }, "en-us": { "role": { "label": "Gross profit", "terseLabel": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss", "http://plyrotech.com/role/SEGMENTEDINFORMATIONDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed": { "auth_ref": [ "r207", "r208" ], "calculation": { "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutPurchasePriceAllocationDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount recognised as of the acquisition date for net identifiable assets acquired or liabilities assumed in a business combination. [Refer: Business combinations [member]]" } }, "en-us": { "role": { "label": "Identifiable assets acquired (liabilities assumed)", "negatedTerseLabel": "Net identifiable assets acquired", "negatedTotalLabel": "Net assets acquired (liabilities assumed)", "netLabel": "Net identifiable assets acquired (liabilities assumed)", "totalLabel": "Net assets acquired (liabilities assumed)", "verboseLabel": "Net identifiable assets acquired" } } }, "localname": "IdentifiableAssetsAcquiredLiabilitiesAssumed", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ImpairmentLossOnFinancialAssets": { "auth_ref": [ "r184" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 10.0, "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of impairment loss on financial assets. [Refer: Financial assets; Impairment loss]" } }, "en-us": { "role": { "label": "Impairment loss on financial assets", "negatedLabel": "Impairment loss of intangible asset" } } }, "localname": "ImpairmentLossOnFinancialAssets", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r75" ], "lang": { "en": { "role": { "documentation": "The amount of impairment loss recognised in profit or loss for intangible assets other than goodwill. [Refer: Impairment loss recognised in profit or loss; Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Impairment loss recognised in profit or loss, intangible assets other than goodwill", "negatedLabel": "Impairment", "positiveLabel": "Impairment of intangible assets", "terseLabel": "Impairment loss", "verboseLabel": "Impairment" } } }, "localname": "ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/IntangibleAssetsDisclosureOfDetailedInformationAboutIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment": { "auth_ref": [ "r26", "r41" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 20.0, "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": -1.0 } }, "lang": { "en": { "role": { "documentation": "The amount of impairment loss recognised in profit or loss for property, plant and equipment. [Refer: Impairment loss recognised in profit or loss; Property, plant and equipment]" } }, "en-us": { "role": { "label": "Impairment loss recognised in profit or loss, property, plant and equipment", "negatedLabel": "Impairment", "negatedTerseLabel": "Impairment loss of demo equipment", "terseLabel": "Impairment loss of demo equipment", "verboseLabel": "Impairment" } } }, "localname": "ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss", "http://plyrotech.com/role/EQUIPMENTDisclosureOfEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement" } } }, "localname": "IncomeStatementAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_IncomeTaxExpenseContinuingOperations": { "auth_ref": [ "r24", "r29", "r30", "r31", "r62", "r111", "r162" ], "calculation": { "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutReconcilesTheExpectedIncomeTaxesExpenseDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]" } }, "en-us": { "role": { "label": "Tax expense (income)", "negatedLabel": "Deferred tax recovery", "positiveLabel": "Income tax expense (recovery)", "totalLabel": "Income tax expense (recovery)", "verboseLabel": "Deferred tax recovery" } } }, "localname": "IncomeTaxExpenseContinuingOperations", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutReconcilesTheExpectedIncomeTaxesExpenseDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncomeTaxesPaidRefundAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income taxes paid (refund) [abstract]" } } }, "localname": "IncomeTaxesPaidRefundAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents": { "auth_ref": [ "r93" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]" } }, "en-us": { "role": { "label": "Increase in cash", "totalLabel": "Increase (decrease) in cash" } } }, "localname": "IncreaseDecreaseInCashAndCashEquivalents", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding": { "auth_ref": [ "r19" ], "lang": { "en": { "role": { "documentation": "The increase (decrease) in the number of shares outstanding. [Refer: Number of shares outstanding]" } }, "en-us": { "role": { "label": "Shares issued for private placements (Shares)", "terseLabel": "Private placements (Shares)" } } }, "localname": "IncreaseDecreaseInNumberOfSharesOutstanding", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "ifrs-full_IncreaseDecreaseThroughExerciseOfOptions": { "auth_ref": [ "r234" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in equity resulting from the exercise of options." } }, "en-us": { "role": { "label": "Shares issued for options exercised", "terseLabel": "Shares issued for options exercised" } } }, "localname": "IncreaseDecreaseThroughExerciseOfOptions", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity": { "auth_ref": [ "r234" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in equity resulting from the exercise of warrants." } }, "en-us": { "role": { "label": "Increase (decrease) through exercise of warrants, equity", "terseLabel": "Proceeds from warrants exercised", "verboseLabel": "Shares issued for warrants exercised" } } }, "localname": "IncreaseDecreaseThroughExerciseOfWarrantsEquity", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity", "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r77" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in intangible assets other than goodwill resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Increase (decrease) through net exchange differences, intangible assets other than goodwill", "verboseLabel": "Foreign currency translation adjustment" } } }, "localname": "IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/IntangibleAssetsDisclosureOfDetailedInformationAboutIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment": { "auth_ref": [ "r43" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in property, plant and equipment resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Increase (decrease) through net exchange differences, property, plant and equipment", "verboseLabel": "Foreign currency translation adjustment" } } }, "localname": "IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/EQUIPMENTDisclosureOfEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions": { "auth_ref": [ "r4" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]" } }, "en-us": { "role": { "label": "Increase (decrease) through share-based payment transactions, equity", "verboseLabel": "Stock-based compensation" } } }, "localname": "IncreaseDecreaseThroughSharebasedPaymentTransactions", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "ifrs-full_InsuranceExpense": { "auth_ref": [ "r236" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expense arising from purchased insurance." } }, "en-us": { "role": { "label": "Insurance expense", "terseLabel": "Insurance" } } }, "localname": "InsuranceExpense", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/BREAKDOWNOFEXPENSESDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IntangibleAssetsAndGoodwillAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Intangible assets and goodwill [abstract]" } } }, "localname": "IntangibleAssetsAndGoodwillAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_IntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r9", "r78" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 20.0, "parentTag": "ifrs-full_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]" } }, "en-us": { "role": { "label": "Intangible assets other than goodwill", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "positiveLabel": "Intangible assets", "positiveTerseLabel": "Intangible assets", "terseLabel": "Carrying amounts recognized during period", "verboseLabel": "Intangible assets" } } }, "localname": "IntangibleAssetsOtherThanGoodwill", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition", "http://plyrotech.com/role/INTANGIBLEASSETSDetails", "http://plyrotech.com/role/IntangibleAssetsDisclosureOfDetailedInformationAboutIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IntangibleAssetsOtherThanGoodwillMember": { "auth_ref": [ "r79", "r197", "r206" ], "lang": { "en": { "role": { "documentation": "This member stands for intangible assets other than goodwill. It also represents the standard value for the 'Classes of intangible assets other than goodwill' axis if no other member is used. [Refer: Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Intangible assets other than goodwill [Member]", "verboseLabel": "Intangible assets [Member]" } } }, "localname": "IntangibleAssetsOtherThanGoodwillMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/INTANGIBLEASSETSDetails", "http://plyrotech.com/role/IntangibleAssetsDisclosureOfDetailedInformationAboutIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_InterestExpense": { "auth_ref": [ "r110", "r161", "r168" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 40.0, "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expense arising from interest." } }, "en-us": { "role": { "label": "Interest expense", "negatedLabel": "Interest expense", "terseLabel": "Interest and accretion" } } }, "localname": "InterestExpense", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_InterestExpenseOnLeaseLiabilities": { "auth_ref": [ "r124" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of interest expense on lease liabilities. [Refer: Lease liabilities]" } }, "en-us": { "role": { "label": "Interest expense on lease liabilities", "negatedLabel": "Interest expense", "terseLabel": "Interest and accretion", "verboseLabel": "Interest on lease liability" } } }, "localname": "InterestExpenseOnLeaseLiabilities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/BREAKDOWNOFEXPENSESDetails", "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_InterestPayable": { "auth_ref": [ "r236" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of interest recognised as a liability." } }, "en-us": { "role": { "label": "Interest payable" } } }, "localname": "InterestPayable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/LOANPAYABLENarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_InterestRateRiskMember": { "auth_ref": [ "r158", "r177", "r178", "r179", "r180" ], "lang": { "en": { "role": { "documentation": "This member stands for the type of risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. [Refer: Financial instruments, class [member]]" } }, "en-us": { "role": { "label": "Interest rate risk [member]", "verboseLabel": "Interest Rate Risk [Member]" } } }, "localname": "InterestRateRiskMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_Inventories": { "auth_ref": [ "r10", "r50", "r188" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 30.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of current inventories. [Refer: Inventories]" } }, "en-us": { "role": { "label": "Current inventories", "terseLabel": "Inventories" } } }, "localname": "Inventories", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IssueOfEquity": { "auth_ref": [ "r4" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The increase in equity through the issue of equity instruments." } }, "en-us": { "role": { "label": "Shares issued for private placements", "terseLabel": "Private placements" } } }, "localname": "IssueOfEquity", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IssuedCapital": { "auth_ref": [ "r190" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 0.0, "parentTag": "ifrs-full_Equity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The nominal value of capital issued." } }, "en-us": { "role": { "label": "Share capital" } } }, "localname": "IssuedCapital", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IssuedCapitalMember": { "auth_ref": [ "r5" ], "lang": { "en": { "role": { "documentation": "This member stands for a component of equity representing issued capital." } }, "en-us": { "role": { "label": "Issued capital [Member]", "verboseLabel": "Share capital [Member]" } } }, "localname": "IssuedCapitalMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity", "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_KeyManagementPersonnelCompensation": { "auth_ref": [ "r55" ], "calculation": { "http://plyrotech.com/role/RelatedPartyTransactionsDisclosureOfTransactionsBetweenRelatedPartiesDetails": { "order": 0.0, "parentTag": "ifrs-full_ServicesReceivedRelatedPartyTransactions", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]" } }, "en-us": { "role": { "label": "Key management personnel compensation", "terseLabel": "Management fees", "verboseLabel": "Management fees" } } }, "localname": "KeyManagementPersonnelCompensation", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/BREAKDOWNOFEXPENSESDetails", "http://plyrotech.com/role/RELATEDPARTYTRANSACTIONSANDBALANCESDisclosureOfInformationAboutKeyManagementPersonnelDetails", "http://plyrotech.com/role/RelatedPartyTransactionsDisclosureOfTransactionsBetweenRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment": { "auth_ref": [ "r54" ], "calculation": { "http://plyrotech.com/role/RelatedPartyTransactionsDisclosureOfTransactionsBetweenRelatedPartiesDetails": { "order": 40.0, "parentTag": "ifrs-full_ServicesReceivedRelatedPartyTransactions", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]]" } }, "en-us": { "role": { "label": "Share-based payments", "positiveLabel": "Stock-based compensation recognized in profit or loss", "positiveTerseLabel": "Stock-based compensation", "terseLabel": "Expense for the year (vested)", "verboseLabel": "Stock-based compensation" } } }, "localname": "KeyManagementPersonnelCompensationSharebasedPayment", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/BREAKDOWNOFEXPENSESDetails", "http://plyrotech.com/role/RELATEDPARTYTRANSACTIONSANDBALANCESDisclosureOfInformationAboutOptionsGrantedToTheCEOCFOTheCorporateSecretaryAndTheCompanysDirectorsDetails", "http://plyrotech.com/role/RelatedPartyTransactionsDisclosureOfTransactionsBetweenRelatedPartiesDetails", "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember": { "auth_ref": [ "r129", "r130", "r182", "r210", "r212", "r236" ], "lang": { "en": { "role": { "documentation": "This member stands for a time band of later than one year and not later than two years." } }, "en-us": { "role": { "label": "Later than one year and not later than two years [member]", "netLabel": "2021 [Member]", "terseLabel": "December 1, 2021 to November 30, 2022 [Member]", "verboseLabel": "2022 [Member]" } } }, "localname": "LaterThanOneYearAndNotLaterThanTwoYearsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetailTextuals", "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetails2" ], "xbrltype": "domainItemType" }, "ifrs-full_LaterThanOneYearMember": { "auth_ref": [ "r14", "r218", "r220" ], "lang": { "en": { "role": { "documentation": "This member stands for a time band of later than one year." } }, "en-us": { "role": { "label": "Later than one year [member]", "verboseLabel": "December 1, 2020 to November 30, 2021 [Member]" } } }, "localname": "LaterThanOneYearMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetailTextuals" ], "xbrltype": "domainItemType" }, "ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember": { "auth_ref": [ "r129", "r130", "r182", "r210", "r212", "r236" ], "lang": { "en": { "role": { "documentation": "This member stands for a time band of later than three years and not later than four years." } }, "en-us": { "role": { "label": "Later than three years and not later than four years [member]", "verboseLabel": "2024 [Member]" } } }, "localname": "LaterThanThreeYearsAndNotLaterThanFourYearsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetails2" ], "xbrltype": "domainItemType" }, "ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember": { "auth_ref": [ "r129", "r130", "r182", "r210", "r212", "r236" ], "lang": { "en": { "role": { "documentation": "This member stands for a time band of later than two years and not later than three years." } }, "en-us": { "role": { "label": "Later than two years and not later than three years [member]", "terseLabel": "December 1, 2022 to November 30, 2023 [Member]", "verboseLabel": "2023 [Member]" } } }, "localname": "LaterThanTwoYearsAndNotLaterThanThreeYearsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetailTextuals", "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetails2" ], "xbrltype": "domainItemType" }, "ifrs-full_LeaseLiabilities": { "auth_ref": [ "r122" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration." } }, "en-us": { "role": { "label": "Lease liabilities", "periodEndLabel": "Closing balance", "periodStartLabel": "Opening balance", "terseLabel": "Total present value of minimum lease payments", "verboseLabel": "Lease liability" } } }, "localname": "LeaseLiabilities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetails1", "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetails2" ], "xbrltype": "monetaryItemType" }, "ifrs-full_LeaseholdImprovementsMember": { "auth_ref": [ "r242" ], "lang": { "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing improvements to assets held under a lease agreement." } }, "en-us": { "role": { "label": "Leasehold improvements [member]", "terseLabel": "Leasehold Improvement [Member]" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/EQUIPMENTDisclosureOfEquipmentDetails", "http://plyrotech.com/role/SignificantAccountingPoliciesDisclosureOfDepreciationRatesApplicableToEachCategoryOfPropertyAndEquipmentDetail" ], "xbrltype": "domainItemType" }, "ifrs-full_Liabilities": { "auth_ref": [ "r13", "r113", "r114", "r115", "r163", "r167" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 0.0, "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } }, "en-us": { "role": { "label": "Total liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES", "verboseLabel": "LIABILITIES" } } }, "localname": "LiabilitiesAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "stringItemType" }, "ifrs-full_LineItemsByFunctionMember": { "auth_ref": [ "r233", "r236" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value of the \u2018Attribution of expenses by nature to their function' axis if no other member is used." } }, "en-us": { "role": { "label": "Line items by function [member]" } } }, "localname": "LineItemsByFunctionMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/BREAKDOWNOFEXPENSESDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_MaturityAxis": { "auth_ref": [ "r15", "r119", "r129", "r130", "r151", "r157", "r174", "r175", "r176", "r182", "r195", "r210" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Maturity [axis]" } } }, "localname": "MaturityAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetailTextuals", "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetails2" ], "xbrltype": "stringItemType" }, "ifrs-full_MiscellaneousOtherOperatingExpense": { "auth_ref": [ "r236" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of miscellaneous other operating expenses. [Refer: Other operating income (expense)]" } }, "en-us": { "role": { "label": "Miscellaneous other operating expense", "terseLabel": "Transfer agent and filing fees" } } }, "localname": "MiscellaneousOtherOperatingExpense", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/BREAKDOWNOFEXPENSESDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NonadjustingEventsAfterReportingPeriodAxis": { "auth_ref": [ "r28" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Non-adjusting events after reporting period [axis]" } } }, "localname": "NonadjustingEventsAfterReportingPeriodAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SUBSEQUENTEVENTSNarrativeDetail" ], "xbrltype": "stringItemType" }, "ifrs-full_NonadjustingEventsMember": { "auth_ref": [ "r28" ], "lang": { "en": { "role": { "documentation": "This member stands for events that occur between the end of the reporting period and the date when the financial statements are authorised for issue and are indicative of conditions that arose after the reporting period. It also represents the standard value for the 'Non-adjusting events after reporting period' axis if no other member is used." } }, "en-us": { "role": { "label": "Non-adjusting events after reporting period [member]" } } }, "localname": "NonadjustingEventsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SUBSEQUENTEVENTSNarrativeDetail" ], "xbrltype": "domainItemType" }, "ifrs-full_NoncurrentAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-current assets", "verboseLabel": "Non-current assets" } } }, "localname": "NoncurrentAssetsAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "stringItemType" }, "ifrs-full_NoncurrentLeaseLiabilities": { "auth_ref": [ "r122" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 10.0, "parentTag": "ifrs-full_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of non-current lease liabilities. [Refer: Lease liabilities]" } }, "en-us": { "role": { "label": "Non-current lease liabilities", "terseLabel": "Long-term portion", "verboseLabel": "Lease liabilities" } } }, "localname": "NoncurrentLeaseLiabilities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition", "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NoncurrentLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-current liabilities", "verboseLabel": "Non-current liabilities" } } }, "localname": "NoncurrentLiabilitiesAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "stringItemType" }, "ifrs-full_NoncurrentPortionOfNoncurrentLoansReceived": { "auth_ref": [ "r236" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 20.0, "parentTag": "ifrs-full_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The non-current portion of non-current loans received. [Refer: Loans received]" } }, "en-us": { "role": { "label": "Non-current portion of non-current loans received", "terseLabel": "Loan payable", "verboseLabel": "Repayment of loan payable" } } }, "localname": "NoncurrentPortionOfNoncurrentLoansReceived", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NumberOfOutstandingShareOptions": { "auth_ref": [ "r131", "r136", "r139" ], "lang": { "en": { "role": { "documentation": "The number of share options outstanding in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Number of share options outstanding in share-based payment arrangement", "periodEndLabel": "Number of options outstanding, ending balance", "periodStartLabel": "Number of options outstanding, beginning balance", "verboseLabel": "Numbers of options outstanding" } } }, "localname": "NumberOfOutstandingShareOptions", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ShareCapitalDisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsDetails", "http://plyrotech.com/role/ShareCapitalDisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsDetails" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement": { "auth_ref": [ "r137" ], "lang": { "en": { "role": { "documentation": "The number of share options exercisable in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Number of share options exercisable in share-based payment arrangement", "periodEndLabel": "Number of Options outstanding, ending balance", "periodStartLabel": "Number of Options outstanding, beginning balance", "verboseLabel": "Numbers of options exercisable" } } }, "localname": "NumberOfShareOptionsExercisableInSharebasedPaymentArrangement", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ShareCapitalDisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsDetails" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement": { "auth_ref": [ "r134" ], "lang": { "en": { "role": { "documentation": "The number of share options exercised in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Number of share options exercised in share-based payment arrangement", "negatedLabel": "Number of options exercised", "terseLabel": "Shares issued for options exercised (Shares)", "verboseLabel": "Number of share options exercised" } } }, "localname": "NumberOfShareOptionsExercisedInSharebasedPaymentArrangement", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails", "http://plyrotech.com/role/ShareCapitalDisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsDetails" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement": { "auth_ref": [ "r135" ], "lang": { "en": { "role": { "documentation": "The number of share options expired in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Number of share options expired in share-based payment arrangement", "negatedLabel": "Number of options Expired", "terseLabel": "Number of options Expired" } } }, "localname": "NumberOfShareOptionsExpiredInSharebasedPaymentArrangement", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails", "http://plyrotech.com/role/ShareCapitalDisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsDetails" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement": { "auth_ref": [ "r133" ], "lang": { "en": { "role": { "documentation": "The number of share options forfeited in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Number of share options forfeited in share-based payment arrangement", "negatedLabel": "Number of options cancelled", "verboseLabel": "Number of options cancelled" } } }, "localname": "NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails", "http://plyrotech.com/role/ShareCapitalDisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsDetails" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement": { "auth_ref": [ "r132" ], "lang": { "en": { "role": { "documentation": "The number of share options granted in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Number of share options granted in share-based payment arrangement", "negatedLabel": "Number of options exercised", "terseLabel": "Number of Options held", "verboseLabel": "Number of stock options granted" } } }, "localname": "NumberOfShareOptionsGrantedInSharebasedPaymentArrangement", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails", "http://plyrotech.com/role/SUBSEQUENTEVENTSNarrativeDetail", "http://plyrotech.com/role/ShareCapitalDisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsDetails" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfSharesIssued": { "auth_ref": [ "r234" ], "lang": { "en": { "role": { "documentation": "The number of shares issued by the entity." } }, "en-us": { "role": { "label": "Number of shares issued", "negatedLabel": "Share issuance costs", "terseLabel": "Number of shares issued", "totalLabel": "Total number of shares issued", "verboseLabel": "Share issuance costs" } } }, "localname": "NumberOfSharesIssued", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/COMMITMENTSNarrativeDetail", "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "sharesItemType" }, "ifrs-full_NumberOfSharesOutstanding": { "auth_ref": [ "r19" ], "lang": { "en": { "role": { "documentation": "The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]" } }, "en-us": { "role": { "label": "Number of shares outstanding", "periodEndLabel": "Ending Balance (Shares)", "periodStartLabel": "Beginning Balance (Shares)", "verboseLabel": "Number of shares issued and outstanding" } } }, "localname": "NumberOfSharesOutstanding", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity", "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "sharesItemType" }, "ifrs-full_OfficeEquipmentMember": { "auth_ref": [ "r193" ], "lang": { "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing equipment used to support office functions, not specifically used in the production process. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Office equipment [member]", "terseLabel": "Demo equipment [Member]" } } }, "localname": "OfficeEquipmentMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SignificantAccountingPoliciesDisclosureOfDepreciationRatesApplicableToEachCategoryOfPropertyAndEquipmentDetail" ], "xbrltype": "domainItemType" }, "ifrs-full_OperatingExpense": { "auth_ref": [ "r240" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 80.0, "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of all operating expenses." } }, "en-us": { "role": { "label": "Total expenses", "negatedTotalLabel": "Total expenses", "totalLabel": "Total expenses" } } }, "localname": "OperatingExpense", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherIncome": { "auth_ref": [ "r61", "r185", "r186" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 60.0, "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of operating income that the entity does not separately disclose in the same statement or note." } }, "en-us": { "role": { "label": "Other income", "terseLabel": "Other Income" } } }, "localname": "OtherIncome", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities": { "auth_ref": [ "r89" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "Inflows (outflows) of cash, classified as financing activities, that the entity does not separately disclose in the same statement or note." } }, "en-us": { "role": { "label": "Net cash proceeds pursuant to financing activities" } } }, "localname": "OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/NATUREOFOPERATIONSANDABILITYTOCONTINUEASAGOINGCONCERNNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherReceivables": { "auth_ref": [ "r189" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount receivable by the entity that it does not separately disclose in the same statement or note." } }, "en-us": { "role": { "label": "Subscription receivable", "terseLabel": "Subscription receivable" } } }, "localname": "OtherReceivables", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome": { "auth_ref": [ "r30" ], "calculation": { "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutReconcilesTheExpectedIncomeTaxesExpenseDetails": { "order": 40.0, "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that the entity does not separately disclose in the same statement or note. [Refer: Accounting profit; Applicable tax rate]" } }, "en-us": { "role": { "label": "Other tax effects for reconciliation between accounting profit and tax expense (income)", "verboseLabel": "Change in estimates" } } }, "localname": "OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutReconcilesTheExpectedIncomeTaxesExpenseDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PaymentsForDevelopmentProjectExpenditure": { "auth_ref": [ "r245" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow for expenditure related to development projects." } }, "en-us": { "role": { "label": "Payments for development project expenditure", "negatedLabel": "Development expenses on Intangible assets", "verboseLabel": "Development expenses on intangible assets" } } }, "localname": "PaymentsForDevelopmentProjectExpenditure", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities": { "auth_ref": [ "r200" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows": { "order": 0.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]" } }, "en-us": { "role": { "label": "Payments of lease liabilities, classified as financing activities", "negatedLabel": "Lease payments" } } }, "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PercentageOfVotingEquityInterestsAcquired": { "auth_ref": [ "r141" ], "lang": { "en": { "role": { "documentation": "The percentage of voting equity interests acquired in a business combination. [Refer: Business combinations [member]]" } }, "en-us": { "role": { "label": "Percentage of voting equity interests acquired", "verboseLabel": "Percentage of interest acquired" } } }, "localname": "PercentageOfVotingEquityInterestsAcquired", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/BUSINESSACQUISITONNarrativeDetail" ], "xbrltype": "percentItemType" }, "ifrs-full_ProceedsFromExerciseOfOptions": { "auth_ref": [ "r246" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash inflow from the exercise of options." } }, "en-us": { "role": { "label": "Proceeds from exercise of options", "verboseLabel": "Proceeds from exercise of options" } } }, "localname": "ProceedsFromExerciseOfOptions", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProceedsFromIssuingShares": { "auth_ref": [ "r199" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash inflow from issuing shares." } }, "en-us": { "role": { "label": "Common shares issued for cash, net of share issuance costs and subscription receivable", "verboseLabel": "Common shares issued for cash, options and warrants exercised, net of share issuance costs" } } }, "localname": "ProceedsFromIssuingShares", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProfessionalFeesExpense": { "auth_ref": [ "r236" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of fees paid or payable for professional services." } }, "en-us": { "role": { "label": "Professional fees expense", "terseLabel": "Consulting fees", "verboseLabel": "Accounting fees" } } }, "localname": "ProfessionalFeesExpense", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/BREAKDOWNOFEXPENSESDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProfitLoss": { "auth_ref": [ "r3", "r21", "r88", "r98", "r100", "r163", "r165", "r202", "r215", "r217" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows": { "order": 140.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 }, "http://plyrotech.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 0.0, "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]" } }, "en-us": { "role": { "label": "NET AND COMPREHENSIVE LOSS FOR THE YEAR", "negatedLabel": "Net loss", "negatedTotalLabel": "NET LOSS AND COMPREHENSIVE LOSS FOR THE YEAR", "netLabel": "Net loss for the period", "positiveTerseLabel": "Net and comprehensive loss for the year", "positiveVerboseLabel": "Net loss for the year", "terseLabel": "Net and comprehensive loss for the year", "totalLabel": "NET LOSS", "verboseLabel": "Net and comprehensive loss for the year" } } }, "localname": "ProfitLoss", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows", "http://plyrotech.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity", "http://plyrotech.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProfitLossBeforeTax": { "auth_ref": [ "r149", "r185", "r186", "r213", "r214" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 10.0, "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The profit (loss) before tax expense or income. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Loss before income taxes", "negatedTotalLabel": "Loss before income taxes", "totalLabel": "NET LOSS BEFORE INCOME TAX" } } }, "localname": "ProfitLossBeforeTax", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PropertyPlantAndEquipment": { "auth_ref": [ "r8", "r44" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 30.0, "parentTag": "ifrs-full_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period." } }, "en-us": { "role": { "label": "Equipment", "negatedPeriodEndLabel": "Ending balance", "negatedPeriodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance" } } }, "localname": "PropertyPlantAndEquipment", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition", "http://plyrotech.com/role/EQUIPMENTDisclosureOfEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, plant and equipment [abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_PropertyPlantAndEquipmentMember": { "auth_ref": [ "r45", "r197", "r206" ], "lang": { "en": { "role": { "documentation": "This member stands for property, plant and equipment. It also represents the standard value for the 'Classes of property, plant and equipment' axis if no other member is used. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Property, plant and equipment [member]" } } }, "localname": "PropertyPlantAndEquipmentMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/EQUIPMENTDisclosureOfEquipmentDetails", "http://plyrotech.com/role/SignificantAccountingPoliciesDisclosureOfDepreciationRatesApplicableToEachCategoryOfPropertyAndEquipmentDetail" ], "xbrltype": "domainItemType" }, "ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate": { "auth_ref": [ "r207", "r208" ], "calculation": { "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutPurchasePriceAllocationDetails": { "order": 50.0, "parentTag": "ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount recognised as of the acquisition date for plant, property and equipment acquired in a business combination. [Refer: Property, plant and equipment; Business combinations [member]]" } }, "en-us": { "role": { "label": "Property, plant and equipment recognised as of acquisition date", "verboseLabel": "Equipment" } } }, "localname": "PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProportionOfOwnershipInterestInSubsidiary": { "auth_ref": [ "r64", "r67", "r103" ], "lang": { "en": { "role": { "documentation": "The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Subsidiaries [member]]" } }, "en-us": { "role": { "label": "Effective Economic Interest" } } }, "localname": "ProportionOfOwnershipInterestInSubsidiary", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SignificantAccountingPoliciesDisclosureOfSubsidiariesDetails" ], "xbrltype": "percentItemType" }, "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": { "auth_ref": [ "r198" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows": { "order": 20.0, "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Purchase of property, plant and equipment, classified as investing activities", "negatedLabel": "Purchase of equipment" } } }, "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RangeAxis": { "auth_ref": [ "r116", "r139", "r176", "r203", "r204", "r253" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Range [axis]" } } }, "localname": "RangeAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_RangesMember": { "auth_ref": [ "r116", "r139", "r176", "r203", "r204", "r253" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregate ranges. It also represents the standard value for the 'Range' axis if no other member is used." } }, "en-us": { "role": { "label": "Ranges [member]" } } }, "localname": "RangesMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutReconcilesTheExpectedIncomeTaxesExpenseDetails", "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis": { "auth_ref": [ "r139" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Ranges of exercise prices for outstanding share options [axis]" } } }, "localname": "RangesOfExercisePricesForOutstandingShareOptionsAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails", "http://plyrotech.com/role/ShareCapitalDisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember": { "auth_ref": [ "r139" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated ranges of exercise prices for outstanding share options that are meaningful for assessing the number and timing of additional shares that may be issued and the cash that may be received upon exercise of those options. It also represents the standard value for the 'Ranges of exercise prices for outstanding share options' axis if no other member is used. [Refer: Ranges [member]]" } }, "en-us": { "role": { "label": "Ranges of exercise prices for outstanding share options [member]" } } }, "localname": "RangesOfExercisePricesForOutstandingShareOptionsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails", "http://plyrotech.com/role/ShareCapitalDisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_RawMaterialsAndConsumablesUsed": { "auth_ref": [ "r27", "r185" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of raw materials and consumables used in the production process or in the rendering of services. [Refer: Current raw materials]" } }, "en-us": { "role": { "label": "Raw materials and consumables used", "terseLabel": "Materials" } } }, "localname": "RawMaterialsAndConsumablesUsed", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/BREAKDOWNOFEXPENSESDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RelatedPartiesMember": { "auth_ref": [ "r58" ], "lang": { "en": { "role": { "documentation": "This member stands for related parties. Related parties are persons or entities that are related to the entity that is preparing its financial statements (the reporting entity). (a) A person or a close member of that person\u2019s family is related to a reporting entity if that person: (i) has control or joint control over the reporting entity; (ii) has significant influence over the reporting entity; or (iii) is a member of the key management personnel of the reporting entity or of a parent of the reporting entity. (b) An entity is related to a reporting entity if any of the following conditions applies: (i) The entity and the reporting entity are members of the same group (which means that each parent, subsidiary and fellow subsidiary is related to the others). (ii) One entity is an associate or joint venture of the other entity (or an associate or joint venture of a member of a group of which the other entity is a member). (iii) Both entities are joint ventures of the same third party. (iv) One entity is a joint venture of a third entity and the other entity is an associate of the third entity. (v) The entity is a post-employment benefit plan for the benefit of employees of either the reporting entity or an entity related to the reporting entity. If the reporting entity is itself such a plan, the sponsoring employers are also related to the reporting entity. (vi) The entity is controlled or jointly controlled by a person identified in (a). (vii) A person identified in (a)(i) has significant influence over the entity or is a member of the key management personnel of the entity (or of a parent of the entity). (viii) The entity, or any member of a group of which it is a part, provides key management personnel services to the reporting entity or to the parent of the reporting entity. [Refer: Joint ventures [member]; Key management personnel of entity or parent [member]]" } }, "en-us": { "role": { "label": "Related parties [member]", "terseLabel": "Related parties [Member]", "verboseLabel": "Related parties [Member]" } } }, "localname": "RelatedPartiesMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/RELATEDPARTYTRANSACTIONSANDBALANCESDisclosureOfInformationAboutKeyManagementPersonnelDetails", "http://plyrotech.com/role/RELATEDPARTYTRANSACTIONSANDBALANCESDisclosureOfInformationAboutOptionsGrantedToTheCEOCFOTheCorporateSecretaryAndTheCompanysDirectorsDetails", "http://plyrotech.com/role/RelatedPartyTransactionsDisclosureOfTransactionsBetweenRelatedPartiesDetails", "http://plyrotech.com/role/RelatedPartyTransactionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related party transactions [abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_RentalExpense": { "auth_ref": [ "r240" ], "calculation": { "http://plyrotech.com/role/RelatedPartyTransactionsDisclosureOfTransactionsBetweenRelatedPartiesDetails": { "order": 30.0, "parentTag": "ifrs-full_ServicesReceivedRelatedPartyTransactions", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expense recognised on rental activities." } }, "en-us": { "role": { "label": "Rental expense", "terseLabel": "Rent" } } }, "localname": "RentalExpense", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/BREAKDOWNOFEXPENSESDetails", "http://plyrotech.com/role/RelatedPartyTransactionsDisclosureOfTransactionsBetweenRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ResearchAndDevelopmentExpense": { "auth_ref": [ "r80" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 0.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expenditure directly attributable to research or development activities, recognised in profit or loss." } }, "en-us": { "role": { "label": "Research and development expense", "positiveLabel": "Total", "terseLabel": "Research and development", "verboseLabel": "Research and development costs" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/BREAKDOWNOFEXPENSESDetails", "http://plyrotech.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss", "http://plyrotech.com/role/INTANGIBLEASSETSDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RetainedEarnings": { "auth_ref": [ "r190", "r191" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 40.0, "parentTag": "ifrs-full_Equity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "A component of equity representing the entity's cumulative undistributed earnings or deficit." } }, "en-us": { "role": { "label": "Deficit", "negatedLabel": "Accumulated deficit", "verboseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarnings", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition", "http://plyrotech.com/role/NATUREOFOPERATIONSANDABILITYTOCONTINUEASAGOINGCONCERNNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RetainedEarningsMember": { "auth_ref": [ "r5", "r187" ], "lang": { "en": { "role": { "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit." } }, "en-us": { "role": { "label": "Deficit [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "ifrs-full_Revenue": { "auth_ref": [ "r23", "r107", "r149", "r159", "r164", "r169", "r170", "r172", "r185", "r186", "r202" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 0.0, "parentTag": "ifrs-full_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims." } }, "en-us": { "role": { "label": "Revenue", "terseLabel": "Sales" } } }, "localname": "Revenue", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss", "http://plyrotech.com/role/SEGMENTEDINFORMATIONDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RevenueFromContractsWithCustomers": { "auth_ref": [ "r117", "r118" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity\u2019s ordinary activities in exchange for consideration." } }, "en-us": { "role": { "label": "Revenue from contracts with customers", "terseLabel": "Deferred Revenue" } } }, "localname": "RevenueFromContractsWithCustomers", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/DeferredRevenueNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RevenueFromInterest": { "auth_ref": [ "r109", "r160", "r168", "r236" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 30.0, "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of income arising from interest." } }, "en-us": { "role": { "label": "Interest income", "negatedLabel": "Interest income", "verboseLabel": "Interest income" } } }, "localname": "RevenueFromInterest", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RightofuseAssets": { "auth_ref": [ "r127" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 10.0, "parentTag": "ifrs-full_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee." } }, "en-us": { "role": { "label": "Right-of-use assets", "periodEndLabel": "Closing balance", "periodStartLabel": "Opening balance", "terseLabel": "Right of use asset", "verboseLabel": "Right of use asset" } } }, "localname": "RightofuseAssets", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition", "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_SellingExpense": { "auth_ref": [ "r236" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 20.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expense relating to selling activities of the entity." } }, "en-us": { "role": { "label": "Selling expense", "terseLabel": "Selling", "verboseLabel": "Selling expenses" } } }, "localname": "SellingExpense", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/BREAKDOWNOFEXPENSESDetailTextuals", "http://plyrotech.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r240" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expense relating to selling, general and administrative activities of the entity." } }, "en-us": { "role": { "label": "Selling, general and administrative expense", "negatedLabel": "Administrative expenses", "terseLabel": "General office expenses", "totalLabel": "Total selling, general and administrative expense" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/BREAKDOWNOFEXPENSESDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_SellingGeneralAndAdministrativeExpenseMember": { "auth_ref": [ "r233", "r236" ], "lang": { "en": { "role": { "documentation": "This member stands for the amount of expense relating to selling, general and administrative activities of the entity. This member is used to attribute an expense by nature to a functional line item in the statement of profit or loss." } }, "en-us": { "role": { "label": "Selling, general and administrative expense [member]", "verboseLabel": "General and Administrative Expenses [Member]" } } }, "localname": "SellingGeneralAndAdministrativeExpenseMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/BREAKDOWNOFEXPENSESDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_ServicesReceivedRelatedPartyTransactions": { "auth_ref": [ "r196" ], "calculation": { "http://plyrotech.com/role/RelatedPartyTransactionsDisclosureOfTransactionsBetweenRelatedPartiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of services received in related party transactions. [Refer: Related parties [member]]" } }, "en-us": { "role": { "label": "Services received, related party transactions", "totalLabel": "Transactions with related parties", "verboseLabel": "Transactions with related parties" } } }, "localname": "ServicesReceivedRelatedPartyTransactions", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/RelatedPartyTransactionsDisclosureOfTransactionsBetweenRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ShareIssueRelatedCost": { "auth_ref": [ "r234" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of cost related to the issuance of shares." } }, "en-us": { "role": { "label": "Share issue related cost", "negatedLabel": "Share issuance costs", "verboseLabel": "Share issuance costs" } } }, "localname": "ShareIssueRelatedCost", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity", "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ShorttermBorrowings": { "auth_ref": [ "r237" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current borrowings. [Refer: Borrowings]" } }, "en-us": { "role": { "label": "Current borrowings" } } }, "localname": "ShorttermBorrowings", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/LOANPAYABLENarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_SignificantInvestmentsInSubsidiariesAxis": { "auth_ref": [ "r65", "r68", "r112" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Subsidiaries [axis]" } } }, "localname": "SignificantInvestmentsInSubsidiariesAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SignificantAccountingPoliciesDisclosureOfSubsidiariesDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_StatementOfChangesInEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders Equity" } } }, "localname": "StatementOfChangesInEquityAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of financial position [abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss": { "auth_ref": [ "r30" ], "calculation": { "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutReconcilesTheExpectedIncomeTaxesExpenseDetails": { "order": 10.0, "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to expenses not deductible in determining taxable profit (tax loss). [Refer: Accounting profit]" } }, "en-us": { "role": { "label": "Tax effect of expense not deductible in determining taxable profit (tax loss)", "verboseLabel": "Non-deductible items and others" } } }, "localname": "TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutReconcilesTheExpectedIncomeTaxesExpenseDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TaxEffectOfImpairmentOfGoodwill": { "auth_ref": [ "r241" ], "calculation": { "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutReconcilesTheExpectedIncomeTaxesExpenseDetails": { "order": 20.0, "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount representing the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to impairment of goodwill. [Refer: Accounting profit; Goodwill]" } }, "en-us": { "role": { "label": "Tax effect of impairment of goodwill", "terseLabel": "Goodwill impairment" } } }, "localname": "TaxEffectOfImpairmentOfGoodwill", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutReconcilesTheExpectedIncomeTaxesExpenseDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TaxExpenseIncomeAtApplicableTaxRate": { "auth_ref": [ "r30" ], "calculation": { "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutReconcilesTheExpectedIncomeTaxesExpenseDetails": { "order": 0.0, "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The product of the accounting profit multiplied by the applicable tax rate(s). [Refer: Accounting profit; Applicable tax rate]" } }, "en-us": { "role": { "label": "Tax expense (income) at applicable tax rate", "verboseLabel": "Expected income tax (recovery)" } } }, "localname": "TaxExpenseIncomeAtApplicableTaxRate", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutReconcilesTheExpectedIncomeTaxesExpenseDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TopOfRangeMember": { "auth_ref": [ "r116", "r139", "r176", "r203", "r204", "r253" ], "lang": { "en": { "role": { "documentation": "This member stands for top of a range." } }, "en-us": { "role": { "label": "Top of range [member]", "verboseLabel": "Top of range [Member]" } } }, "localname": "TopOfRangeMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutReconcilesTheExpectedIncomeTaxesExpenseDetails", "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_TradeAndOtherCurrentPayables": { "auth_ref": [ "r12" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 0.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]" } }, "en-us": { "role": { "label": "Accounts payable", "positiveTerseLabel": "Accounts payable", "terseLabel": "Accounts payable", "totalLabel": "Total Accounts payable", "verboseLabel": "Accounts payable" } } }, "localname": "TradeAndOtherCurrentPayables", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ACCOUNTSPAYABLEDetails", "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties": { "auth_ref": [ "r239" ], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 40.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current payables due to related parties. [Refer: Related parties [member]; Payables to related parties]" } }, "en-us": { "role": { "label": "Due to related parties", "terseLabel": "Due to directors and officers", "verboseLabel": "Due to related parties" } } }, "localname": "TradeAndOtherCurrentPayablesToRelatedParties", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition", "http://plyrotech.com/role/RelatedPartyTransactionsDisclosureOfAmountsDueToOfficersDetails", "http://plyrotech.com/role/RelatedPartyTransactionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TradeAndOtherCurrentReceivablesDueFromRelatedParties": { "auth_ref": [ "r189" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of current receivables due from related parties. [Refer: Related parties [member]]" } }, "en-us": { "role": { "label": "Due from related parties", "terseLabel": "Due from directors and officers", "verboseLabel": "Due from related parties" } } }, "localname": "TradeAndOtherCurrentReceivablesDueFromRelatedParties", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/RelatedPartyTransactionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate": { "auth_ref": [ "r251" ], "calculation": { "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutPurchasePriceAllocationDetails": { "order": 20.0, "parentTag": "ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount recognised as of the acquisition date for trade and other payables assumed in a business combination. [Refer: Trade and other payables; Business combinations [member]]" } }, "en-us": { "role": { "label": "Trade and other payables recognised as of acquisition date", "negatedLabel": "Accounts payable", "terseLabel": "Accounts payable", "verboseLabel": "Vehicle loan" } } }, "localname": "TradeAndOtherPayablesRecognisedAsOfAcquisitionDate", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TypesOfRisksAxis": { "auth_ref": [ "r150", "r152", "r153", "r177", "r178", "r179", "r181" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Types of risks [axis]" } } }, "localname": "TypesOfRisksAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_TypesOfRisksMember": { "auth_ref": [ "r150", "r152", "r153", "r177", "r178", "r179", "r181" ], "lang": { "en": { "role": { "documentation": "This member stands for all types of risks. It also represents the standard value for the 'Types of risks' axis if no other member is used." } }, "en-us": { "role": { "label": "Risks [member]" } } }, "localname": "TypesOfRisksMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised": { "auth_ref": [ "r32" ], "lang": { "en": { "role": { "documentation": "The amount of unused tax losses for which no deferred tax asset is recognised in the statement of financial position. [Refer: Unused tax losses [member]]" } }, "en-us": { "role": { "label": "Non-capital losses carryforwards", "terseLabel": "Non-capital losses carryforwards", "verboseLabel": "Non-capital loss carryforwards" } } }, "localname": "UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/INCOMETAXESDetails", "http://plyrotech.com/role/IncomeTaxesDisclosureOfNonCapitalLossCarryforwardsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ValueAtRisk": { "auth_ref": [ "r252" ], "lang": { "en": { "role": { "documentation": "The measure of a potential loss exposure as a result of future market movements, based on a specified confidence interval and measurement horizon." } }, "en-us": { "role": { "label": "Value at risk", "terseLabel": "Comprehensive loss due to fluctuations in US dollar against the Canadian dollar" } } }, "localname": "ValueAtRisk", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_VehiclesMember": { "auth_ref": [ "r242" ], "lang": { "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing vehicles used in the entity's operations, specifically to include aircraft, motor vehicles and ships. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Vehicles [member]", "terseLabel": "Vehicles [Member]" } } }, "localname": "VehiclesMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/EQUIPMENTDisclosureOfEquipmentDetails", "http://plyrotech.com/role/SignificantAccountingPoliciesDisclosureOfDepreciationRatesApplicableToEachCategoryOfPropertyAndEquipmentDetail" ], "xbrltype": "domainItemType" }, "ifrs-full_WagesAndSalaries": { "auth_ref": [ "r243" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "A class of employee benefits expense that represents wages and salaries. [Refer: Employee benefits expense]" } }, "en-us": { "role": { "label": "Wages and salaries", "verboseLabel": "Wages, salaries and benefits" } } }, "localname": "WagesAndSalaries", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/BREAKDOWNOFEXPENSESDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019": { "auth_ref": [ "r137" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average exercise price of share options exercisable in share-based payment arrangement", "positiveTerseLabel": "Exercise Price", "terseLabel": "Weighted average exercise price", "verboseLabel": "Weighted average exercise price of share options outstanding and exercisable in share-based payment arrangement" } } }, "localname": "WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ShareCapitalDisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019": { "auth_ref": [ "r134" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average exercise price of share options exercised in share-based payment arrangement", "netLabel": "Exercise price of stock options exercised", "terseLabel": "Weighted average exercise price of share options exercised in share-based payment arrangement", "verboseLabel": "Weighted average exercise price, exercised" } } }, "localname": "WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails", "http://plyrotech.com/role/ShareCapitalDisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019": { "auth_ref": [ "r135" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of share options expired in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average exercise price of share options expired in share-based payment arrangement", "terseLabel": "Weighted average exercise price, Expired" } } }, "localname": "WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails", "http://plyrotech.com/role/ShareCapitalDisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019": { "auth_ref": [ "r133" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of share options forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average exercise price of share options forfeited in share-based payment arrangement", "verboseLabel": "Weighted average exercise price, cancelled" } } }, "localname": "WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails", "http://plyrotech.com/role/ShareCapitalDisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019": { "auth_ref": [ "r132" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average exercise price of share options granted in share-based payment arrangement", "verboseLabel": "Exercise price of stock options granted" } } }, "localname": "WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails", "http://plyrotech.com/role/ShareCapitalDisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019": { "auth_ref": [ "r131", "r136" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average exercise price of share options outstanding in share-based payment arrangement", "periodEndLabel": "Weighted average exercise price, ending balance", "periodStartLabel": "Weighted average exercise price, beginning balance" } } }, "localname": "WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ShareCapitalDisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019": { "auth_ref": [ "r139" ], "lang": { "en": { "role": { "documentation": "The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average remaining contractual life of outstanding share options", "terseLabel": "Weighted average remaining contractual life (year)", "verboseLabel": "Remaining contractual life of stock option" } } }, "localname": "WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails", "http://plyrotech.com/role/ShareCapitalDisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsDetails" ], "xbrltype": "durationItemType" }, "ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019": { "auth_ref": [ "r140" ], "lang": { "en": { "role": { "documentation": "The weighted average share price used as input to the option pricing model to calculate the fair value of share options granted. [Refer: Option pricing model [member]; Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average share price, share options granted", "verboseLabel": "Stock price" } } }, "localname": "WeightedAverageSharePriceShareOptionsGranted2019", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageShares": { "auth_ref": [ "r71" ], "lang": { "en": { "role": { "documentation": "The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor." } }, "en-us": { "role": { "label": "Weighted Average Number of Common Shares Outstanding, Basic and Diluted", "terseLabel": "WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING, basic and diluted" } } }, "localname": "WeightedAverageShares", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "sharesItemType" }, "prt_AccountingFees": { "auth_ref": [], "calculation": { "http://plyrotech.com/role/RelatedPartyTransactionsDisclosureOfTransactionsBetweenRelatedPartiesDetails": { "order": 20.0, "parentTag": "ifrs-full_ServicesReceivedRelatedPartyTransactions", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents amount relate to accounting fees.", "label": "Accounting Fees", "terseLabel": "Accounting and audit fees", "verboseLabel": "Accounting fees" } } }, "localname": "AccountingFees", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/BREAKDOWNOFEXPENSESDetails", "http://plyrotech.com/role/RelatedPartyTransactionsDisclosureOfTransactionsBetweenRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "prt_AccountingStandardsAmendmentsAndInterpretationsNotYetEffectiveExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of accounting policy for accounting standards, amendments and interpretations not yet effective.", "label": "Accounting Standards Amendments And Interpretations Not Yet Effective Explanatory", "verboseLabel": "Accounting standards, amendments and interpretations not yet effective [Policy Text Block]" } } }, "localname": "AccountingStandardsAmendmentsAndInterpretationsNotYetEffectiveExplanatory", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "prt_AcquisitionOfAccountsPayableAndAccruedLiabilities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of acquisition of accounts payable and accrued liabilities.", "label": "Acquisition Of Accounts Payable And Accrued Liabilities", "verboseLabel": "Acquisition of accounts payable and accrued liabilities" } } }, "localname": "AcquisitionOfAccountsPayableAndAccruedLiabilities", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ACCOUNTSPAYABLENarrativeDetail" ], "xbrltype": "monetaryItemType" }, "prt_AdditionsOfLeaseLiability": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the additions of lease liability.", "label": "Additions Of Lease Liability", "verboseLabel": "Additions" } } }, "localname": "AdditionsOfLeaseLiability", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetails1" ], "xbrltype": "monetaryItemType" }, "prt_AdjustmentForConsultingFees": { "auth_ref": [], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows": { "order": 130.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Adjustments for Consulting fees to reconcile profit (loss) to net cash flow from (used in) operating activities.", "label": "Adjustment For Consulting Fees", "terseLabel": "Consulting fees" } } }, "localname": "AdjustmentForConsultingFees", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "prt_AdjustmentOfGainOnDebtForgiveness": { "auth_ref": [], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows": { "order": 70.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount represents adjustment of gain on debt forgiveness.", "label": "Adjustment Of Gain On Debt Forgiveness", "terseLabel": "Gain on debt forgiveness" } } }, "localname": "AdjustmentOfGainOnDebtForgiveness", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "prt_AdjustmentsForAmortizationRightOfUseAsset": { "auth_ref": [], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows": { "order": 160.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Adjustments for amortization of right of use assets to net cash flow from (used in) operating activities.", "label": "Adjustments For Amortization Right Of Use Asset", "verboseLabel": "Amortization, right-of-use asset" } } }, "localname": "AdjustmentsForAmortizationRightOfUseAsset", "nsuri": "http://plyrotech.com/20221130", "xbrltype": "monetaryItemType" }, "prt_AdjustmentsForImpairmentOfDevelopmentAssets": { "auth_ref": [], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows": { "order": 80.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Adjustments for impairment of development assets to net cash flow from (used in) operating activities.", "label": "Adjustments For Impairment Of Development Assets", "verboseLabel": "Impairment of development assets" } } }, "localname": "AdjustmentsForImpairmentOfDevelopmentAssets", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "prt_AdjustmentsForIncreaseDecreaseInAmountsDueFromRelatedParties": { "auth_ref": [], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows": { "order": 200.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Due from related parties", "label": "Adjustments For Increase Decrease In Amounts Due From Related Parties", "terseLabel": "Due from related parties" } } }, "localname": "AdjustmentsForIncreaseDecreaseInAmountsDueFromRelatedParties", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "prt_AdjustmentsForIncreaseDecreaseInAmountsDueToRelatedParties": { "auth_ref": [], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows": { "order": 210.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents amount of adjustments for increase decrease in amounts due to related parties.", "label": "Adjustments For Increase Decrease In Amounts Due To Related Parties", "negatedLabel": "Due to related parties", "verboseLabel": "Due to related parties" } } }, "localname": "AdjustmentsForIncreaseDecreaseInAmountsDueToRelatedParties", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "prt_AdjustmentsForIncreaseDecreaseInDeferredRevenue": { "auth_ref": [], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows": { "order": 50.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The Amount represents adjustments for increase decrease in deferred revenue.", "label": "Adjustments For Increase Decrease In Deferred Revenue.", "terseLabel": "Deferred revenue" } } }, "localname": "AdjustmentsForIncreaseDecreaseInDeferredRevenue", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "prt_AdjustmentsForIncreaseDecreaseInPrepaidExpenses": { "auth_ref": [], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows": { "order": 190.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Prepaid expenses", "label": "Adjustments For Increase Decrease In Prepaid Expenses", "terseLabel": "Prepaid expenses" } } }, "localname": "AdjustmentsForIncreaseDecreaseInPrepaidExpenses", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "prt_AdjustmentsForIncreaseDecreaseInSalesTaxesReceivable": { "auth_ref": [], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows": { "order": 0.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sales tax receivables", "label": "Adjustments For Increase Decrease In Sales Taxes Receivable", "terseLabel": "Sales tax receivable" } } }, "localname": "AdjustmentsForIncreaseDecreaseInSalesTaxesReceivable", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "prt_AdjustmentsOfInterestAndAccretion": { "auth_ref": [], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows": { "order": 30.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Adjustments for interest and accretion to net cash flow from (used in) operating activities.", "label": "Adjustments Of Interest And Accretion", "verboseLabel": "Interest accretion" } } }, "localname": "AdjustmentsOfInterestAndAccretion", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "prt_AdvertisingAndPromotionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information of advertising and promotions.", "label": "Advertising And Promotions [Member]", "terseLabel": "Advertising and promotions [Member]" } } }, "localname": "AdvertisingAndPromotionsMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/PREPAIDEXPENSESDisclosureOfPrepaidExpensesDetails" ], "xbrltype": "domainItemType" }, "prt_AdvertisingCostsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represent the? advertising costs.", "label": "Advertising costs [Member]" } } }, "localname": "AdvertisingCostsMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ACCOUNTSPAYABLEDetails" ], "xbrltype": "domainItemType" }, "prt_AerowaveCorporationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Aerowave Corporation entity.", "label": "Aerowave Corporation [Member]", "verboseLabel": "Aerowave Corporation (\"Aerowave\") [Member]" } } }, "localname": "AerowaveCorporationMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "domainItemType" }, "prt_AggregateLiability": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of aggregate liability.", "label": "Aggregate Liability", "verboseLabel": "Aggregate liability" } } }, "localname": "AggregateLiability", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/COMMITMENTSNarrativeDetail" ], "xbrltype": "monetaryItemType" }, "prt_AmountOfCompensationShareBasedPaymentVested": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of compensation share based payment vested.", "label": "Amount Of Compensation Share Based Payment Vested", "terseLabel": "Amount of compensation share based payment vested" } } }, "localname": "AmountOfCompensationShareBasedPaymentVested", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "prt_AnnualInterestRateOfLease": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the percentage of annual interest rate of lease.", "label": "Annual Interest Rate Of Lease", "verboseLabel": "Annual interest rate of lease" } } }, "localname": "AnnualInterestRateOfLease", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/COMMITMENTSNarrativeDetail", "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetailTextuals" ], "xbrltype": "percentItemType" }, "prt_AnnualLeaseFee": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of annual lease fee.", "label": "Annual Lease Fee", "verboseLabel": "Annual lease fee" } } }, "localname": "AnnualLeaseFee", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/COMMITMENTSNarrativeDetail", "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetailTextuals" ], "xbrltype": "monetaryItemType" }, "prt_AnotherThirdPartyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member is stand for another third party.", "label": "Another Third Party [Member]" } } }, "localname": "AnotherThirdPartyMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/LOANPAYABLENarrativeDetails" ], "xbrltype": "domainItemType" }, "prt_April152020Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It stands for April 15, 2020.", "label": "April 15, 2020 [Member]", "verboseLabel": "Options Vesting April 15, 2020 [Member]" } } }, "localname": "April152020Member", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "domainItemType" }, "prt_ArmsLengthPartyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for arm's length party.", "label": "Arms Length Party [Member]", "verboseLabel": "Arms length party [Member]" } } }, "localname": "ArmsLengthPartyMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/COMMITMENTSNarrativeDetail" ], "xbrltype": "domainItemType" }, "prt_AugustNineTwoZeroTwoSixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "August Nine Two Zero Two Six [Member]", "label": "August Nine Two Zero Two Six [Member]", "terseLabel": "August 9, 2026 [Member]" } } }, "localname": "AugustNineTwoZeroTwoSixMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALDetails" ], "xbrltype": "domainItemType" }, "prt_BankOverdraftMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bank overdraft.", "label": "Bank Overdraft [Member]" } } }, "localname": "BankOverdraftMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ACCOUNTSPAYABLEDetails" ], "xbrltype": "domainItemType" }, "prt_BrokerWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information about broker warrants.", "label": "Broker Warrants [Member]" } } }, "localname": "BrokerWarrantsMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "domainItemType" }, "prt_BusinessAcquisitionRelatedCosts": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.", "label": "Business Acquisition Related Costs", "terseLabel": "Finder's fee for acquisition (Shares)", "verboseLabel": "Finder's fee for acquisition" } } }, "localname": "BusinessAcquisitionRelatedCosts", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "sharesItemType" }, "prt_CancelledPrivatePlacementAmountHeld": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cancelled private placement, amount held.", "label": "Cancelled Private Placement Amount Held", "terseLabel": "Cancelled private placement, amount held" } } }, "localname": "CancelledPrivatePlacementAmountHeld", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "prt_CapitalManagementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Capital Management [Abstract]" } } }, "localname": "CapitalManagementAbstract", "nsuri": "http://plyrotech.com/20221130", "xbrltype": "stringItemType" }, "prt_CashIndebtednessRecognisedAsOfAcquisitionDate": { "auth_ref": [], "calculation": { "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutPurchasePriceAllocationDetails": { "order": 40.0, "parentTag": "ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents amount of cash indebtedness recognised as of acquisition date.", "label": "Cash Indebtedness Recognised As Of Acquisition Date", "negatedLabel": "Cash indebtedness", "verboseLabel": "Cash indebtedness" } } }, "localname": "CashIndebtednessRecognisedAsOfAcquisitionDate", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "prt_CommitmentsAndContingenciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments And Contingencies [Abstract]", "verboseLabel": "Commitments and Contingencies [Abstract]" } } }, "localname": "CommitmentsAndContingenciesAbstract", "nsuri": "http://plyrotech.com/20221130", "xbrltype": "stringItemType" }, "prt_CommonSharesHeldInEscrowAmountReleased": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common shares held in escrow, amount released", "label": "Common Shares Held In Escrow Amount Released", "verboseLabel": "Common shares held in escrow, amount released" } } }, "localname": "CommonSharesHeldInEscrowAmountReleased", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "sharesItemType" }, "prt_CommonSharesHeldInEscrowPercentageReleased": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common shares held in escrow, percentage released", "label": "Common Shares Held In Escrow Percentage Released", "verboseLabel": "Common shares held in escrow, percentage released" } } }, "localname": "CommonSharesHeldInEscrowPercentageReleased", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "percentItemType" }, "prt_CommonSharesIssuedAsCompensationForConsultingFees": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of common shares issued as compensation for consulting fees.", "label": "Common Shares Issued As Compensation For Consulting Fees", "terseLabel": "Common shares issued as compensation for consulting fees" } } }, "localname": "CommonSharesIssuedAsCompensationForConsultingFees", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/RelatedPartyTransactionsNarrativeDetails" ], "xbrltype": "sharesItemType" }, "prt_CompanyControlledByCorporateSecretaryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for company controlled by corporate secretary.", "label": "Company Controlled By Corporate Secretary [Member]", "terseLabel": "Corporate Secretary [Member]", "verboseLabel": "Company controlled by the Corporate Secretary [Member]" } } }, "localname": "CompanyControlledByCorporateSecretaryMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/RelatedPartyTransactionsDisclosureOfAmountsDueToOfficersDetails" ], "xbrltype": "domainItemType" }, "prt_CompanyControlledByFormerCorporateSecretaryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Company controlled by the Former Corporate Secretary.", "label": "Company Controlled By Former Corporate Secretary [Member]", "terseLabel": "Former Corporate Secretary [Member]", "verboseLabel": "Company controlled by the Corporate Secretary [Member]" } } }, "localname": "CompanyControlledByFormerCorporateSecretaryMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/RELATEDPARTYTRANSACTIONSANDBALANCESConsultingFeesDetails", "http://plyrotech.com/role/RELATEDPARTYTRANSACTIONSANDBALANCESDisclosureOfInformationAboutOptionsGrantedToTheCEOCFOTheCorporateSecretaryAndTheCompanysDirectorsDetails" ], "xbrltype": "domainItemType" }, "prt_CompanyControlledByFormerDirectorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Company controlled by former director.", "label": "Company Controlled By Former Director [Member]", "terseLabel": "Director fees paid to Former Director [Member]", "verboseLabel": "Company controlled by former director [Member]" } } }, "localname": "CompanyControlledByFormerDirectorMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/RelatedPartyTransactionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "prt_ConsiderationPayableDateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information of consideration payable date.", "label": "Consideration Payable Date [Axis]" } } }, "localname": "ConsiderationPayableDateAxis", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/BUSINESSACQUISITONNarrativeDetail" ], "xbrltype": "stringItemType" }, "prt_ConsiderationPayableDateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information of consideration payable date.", "label": "Consideration Payable Date [Domain]" } } }, "localname": "ConsiderationPayableDateDomain", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/BUSINESSACQUISITONNarrativeDetail" ], "xbrltype": "domainItemType" }, "prt_ConsolidationsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The description of the entity's accounting policy for consolidation.", "label": "Consolidations [Policy Text Block]", "terseLabel": "Consolidation [Policy Text Block]" } } }, "localname": "ConsolidationsPolicyTextBlock", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "prt_ConsultantAndDirectorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information about consultant and director.", "label": "Consultant And Director [Member]" } } }, "localname": "ConsultantAndDirectorMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "domainItemType" }, "prt_ConsultantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for the consultants.", "label": "Consultant [Member]" } } }, "localname": "ConsultantMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "domainItemType" }, "prt_ConsultingAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for consulting agreement.", "label": "Consulting Agreement [Member]" } } }, "localname": "ConsultingAgreementMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/COMMITMENTSNarrativeDetail" ], "xbrltype": "domainItemType" }, "prt_ConsultingFees": { "auth_ref": [], "calculation": { "http://plyrotech.com/role/RelatedPartyTransactionsDisclosureOfTransactionsBetweenRelatedPartiesDetails": { "order": 10.0, "parentTag": "ifrs-full_ServicesReceivedRelatedPartyTransactions", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents amount relate to consulting fees.", "label": "Consulting fees" } } }, "localname": "ConsultingFees", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/COMMITMENTSNarrativeDetail", "http://plyrotech.com/role/RELATEDPARTYTRANSACTIONSANDBALANCESConsultingFeesDetails", "http://plyrotech.com/role/RelatedPartyTransactionsDisclosureOfTransactionsBetweenRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "prt_CumulativeTranslationAdjustment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the cumulative translation adjustment.", "label": "Cumulative Translation Adjustment", "terseLabel": "Cumulative translation adjustment" } } }, "localname": "CumulativeTranslationAdjustment", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetails" ], "xbrltype": "monetaryItemType" }, "prt_CumulativeTranslationAdjustmentLeaseLiability": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the cumulative translation adjustment lease liability.", "label": "Cumulative Translation Adjustment Lease Liability", "verboseLabel": "Cumulative translation adjustment" } } }, "localname": "CumulativeTranslationAdjustmentLeaseLiability", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetails1" ], "xbrltype": "monetaryItemType" }, "prt_CustomerRelationshipsRecognisedAsOfAcquisitionDate": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents amount of customer relationship amounr recognized.", "label": "Customer Relationships Recognised As Of Acquisition Date", "negatedLabel": "Customer relationships", "verboseLabel": "Customer relationships" } } }, "localname": "CustomerRelationshipsRecognisedAsOfAcquisitionDate", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "prt_December202020Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It stands for December 20, 2020.", "label": "December 20, 2020 [Member]", "verboseLabel": "Options Vesting December 20, 2020 [Member]" } } }, "localname": "December202020Member", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "domainItemType" }, "prt_DecemberOneTwoZeroOneEightToNovemberThreeZeroTwoZeroOneNinePreviousYearMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents December 1, 2018 to November 30, 2019 previous year member.", "label": "December One Two Zero One Eight To November Three Zero Two Zero One Nine Previous Year [Member]", "verboseLabel": "December 1, 2018 to November 30, 2019 [Member]" } } }, "localname": "DecemberOneTwoZeroOneEightToNovemberThreeZeroTwoZeroOneNinePreviousYearMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetailTextuals" ], "xbrltype": "domainItemType" }, "prt_DecemberOneTwoZeroTwoZeroToNovemberThreeZeroTwoZeroTwoOneCurrentYearMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents December 1, 2020 to November 30, 2021 Current year member.", "label": "December One Two Zero Two Zero To November Three Zero Two Zero Two One Current Year [Member]", "verboseLabel": "December 1, 2019 to November 30, 2020 [Member]" } } }, "localname": "DecemberOneTwoZeroTwoZeroToNovemberThreeZeroTwoZeroTwoOneCurrentYearMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetailTextuals" ], "xbrltype": "domainItemType" }, "prt_DeferredRevenue": { "auth_ref": [], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 10.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount represents deferred revenue.", "label": "Deferred Revenue", "terseLabel": "Deferred revenue" } } }, "localname": "DeferredRevenue", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "prt_DemoEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for demo equipment.", "label": "Demo Equipment [Member]", "verboseLabel": "Demo Equipment [Member]" } } }, "localname": "DemoEquipmentMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/EQUIPMENTDisclosureOfEquipmentDetails" ], "xbrltype": "domainItemType" }, "prt_DescriptionOfAccountingPolicyForBasisOfPresentationPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of accounting policy for basis of presentation.", "label": "Description Of Accounting Policy For Basis Of Presentation [Policy Text Block]", "verboseLabel": "Basis of presentation [Policy Text Block]" } } }, "localname": "DescriptionOfAccountingPolicyForBasisOfPresentationPolicyTextBlock", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "prt_DevelopmentCostsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represent the development costs.", "label": "Development costs [Member]" } } }, "localname": "DevelopmentCostsMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ACCOUNTSPAYABLEDetails" ], "xbrltype": "domainItemType" }, "prt_DirectorsOfficersEmployeeAndConsultantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information about directors officers employee and consultants.", "label": "Directors Officers Employee And Consultants [Member]", "verboseLabel": "Directors Officers Employee And Consultants [Member]" } } }, "localname": "DirectorsOfficersEmployeeAndConsultantsMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "domainItemType" }, "prt_DirectorsOfficersEmployeesAndConsultantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for directors, officers, employees, and consultants.", "label": "Directors, Officers, Employees, And Consultants [Member]" } } }, "localname": "DirectorsOfficersEmployeesAndConsultantsMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SUBSEQUENTEVENTSNarrativeDetail" ], "xbrltype": "domainItemType" }, "prt_DisclosureOfCommiitmentsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure Of Commiitments [Table]", "label": "Disclosure Of Commiitments [Table]" } } }, "localname": "DisclosureOfCommiitmentsTable", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/COMMITMENTSNarrativeDetail" ], "xbrltype": "stringItemType" }, "prt_DisclosureOfCommitmentsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure Of Commitments [Line Items]", "label": "Disclosure Of Commitments [Line Items]" } } }, "localname": "DisclosureOfCommitmentsLineItems", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/COMMITMENTSNarrativeDetail" ], "xbrltype": "stringItemType" }, "prt_DisclosureOfConsultingFeesExplanatoryTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of information about consulting fees.", "label": "Disclosure Of Consulting Fees Explanatory [Table Text Block]", "terseLabel": "Disclosure of consulting fees explanatory [Table Text Block]" } } }, "localname": "DisclosureOfConsultingFeesExplanatoryTableTextBlock", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/RELATEDPARTYTRANSACTIONSTables" ], "xbrltype": "textBlockItemType" }, "prt_DisclosureOfContinuityOfLeaseLiabilityExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Entire disclosure related to continuity of lease liability.", "label": "Disclosure Of Continuity Of Lease Liability Explanatory", "verboseLabel": "Disclosure of continuity of lease liability [Table Text Block]" } } }, "localname": "DisclosureOfContinuityOfLeaseLiabilityExplanatory", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYTables" ], "xbrltype": "textBlockItemType" }, "prt_DisclosureOfDetailInformationAboutAccountsPayableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Detail Information About Accounts Payable [Abstract]" } } }, "localname": "DisclosureOfDetailInformationAboutAccountsPayableAbstract", "nsuri": "http://plyrotech.com/20221130", "xbrltype": "stringItemType" }, "prt_DisclosureOfDetailInformationAboutPrepaidExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Detail Information About Prepaid Expenses [Abstract]" } } }, "localname": "DisclosureOfDetailInformationAboutPrepaidExpensesAbstract", "nsuri": "http://plyrotech.com/20221130", "xbrltype": "stringItemType" }, "prt_DisclosureOfDetailedInformationAboutAccountsPayableExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of detailed information about accounts payable.", "label": "Disclosure Of Detailed Information About Accounts Payable Explanatory", "verboseLabel": "Disclosure of accounts payable [Table Text Block]" } } }, "localname": "DisclosureOfDetailedInformationAboutAccountsPayableExplanatory", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ACCOUNTSPAYABLETables" ], "xbrltype": "textBlockItemType" }, "prt_DisclosureOfDetailedInformationAboutEffectiveIncomeTaxExpenseRecoveryExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information about disclosure of detailed information about effective income tax expense recovery explanatory.", "label": "Disclosure Of Detailed Information About Effective Income Tax Expense Recovery Explanatory", "verboseLabel": "Disclosure of detailed information about effective income tax expense (recovery) [Table Text Block]" } } }, "localname": "DisclosureOfDetailedInformationAboutEffectiveIncomeTaxExpenseRecoveryExplanatory", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/INCOMETAXESTables" ], "xbrltype": "textBlockItemType" }, "prt_DisclosureOfDetailedInformationAboutPrepaidExpensesExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of detailed information about prepaid expenses.", "label": "Disclosure Of Detailed Information About Prepaid Expenses Explanatory", "terseLabel": "Disclosure of prepaid expenses [Table Text Block]" } } }, "localname": "DisclosureOfDetailedInformationAboutPrepaidExpensesExplanatory", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/PREPAIDEXPENSESTables" ], "xbrltype": "textBlockItemType" }, "prt_DisclosureOfDetailedInformationAboutWarrantActivityExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of detailed information about warrant activity.", "label": "Disclosure Of Detailed Information About Warrant Activity Explanatory", "verboseLabel": "Disclosure of share purchase warrant transactions [Table Text Block]" } } }, "localname": "DisclosureOfDetailedInformationAboutWarrantActivityExplanatory", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALTables" ], "xbrltype": "textBlockItemType" }, "prt_DisclosureOfDueFromRelatedPartyExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of information about due from related party.", "label": "Disclosure Of Due From Related Party Explanatory", "verboseLabel": "Disclosure of amounts due from directors and officers [Table Text Block]" } } }, "localname": "DisclosureOfDueFromRelatedPartyExplanatory", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/RELATEDPARTYTRANSACTIONSTables" ], "xbrltype": "textBlockItemType" }, "prt_DisclosureOfDueToRelatedPartyExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information related to due to related party.", "label": "Disclosure Of Due To Related Party Explanatory", "verboseLabel": "Disclosure of amounts due to directors and officers [Table Text Block]" } } }, "localname": "DisclosureOfDueToRelatedPartyExplanatory", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/RELATEDPARTYTRANSACTIONSTables" ], "xbrltype": "textBlockItemType" }, "prt_DisclosureOfFinancialRiskManagementExplanatoryAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Financial Risk Management Explanatory [Abstract]" } } }, "localname": "DisclosureOfFinancialRiskManagementExplanatoryAbstract", "nsuri": "http://plyrotech.com/20221130", "xbrltype": "stringItemType" }, "prt_DisclosureOfGainOnDebtForgivenessTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for gain on debt forgiveness.", "label": "Disclosure Of Gain On Debt Forgiveness [Text Block]", "verboseLabel": "GAIN ON DEBT FORGIVENESS [Text Block]" } } }, "localname": "DisclosureOfGainOnDebtForgivenessTextBlock", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/GAINONDEBTFORGIVENESS" ], "xbrltype": "textBlockItemType" }, "prt_DisclosureOfIncomeTaxesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.", "label": "Disclosure Of Income Taxes [Line Items]" } } }, "localname": "DisclosureOfIncomeTaxesLineItems", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutReconcilesTheExpectedIncomeTaxesExpenseDetails" ], "xbrltype": "stringItemType" }, "prt_DisclosureOfIncomeTaxesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule disclosing information about income taxes.", "label": "Disclosure Of Income Taxes [Table]" } } }, "localname": "DisclosureOfIncomeTaxesTable", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutReconcilesTheExpectedIncomeTaxesExpenseDetails" ], "xbrltype": "stringItemType" }, "prt_DisclosureOfInitialIas39ClassificationAndIfrs9ClassificationForAllFinancialInstrumentsExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of detailed information about initial IAS 39 classification and IFRS 9 classification for all financial instruments.", "label": "Disclosure Of Initial Ias 39 Classification And Ifrs 9 Classification For All Financial Instruments Explanatory", "verboseLabel": "Disclosure of initial IAS 39 classification and IFRS 9 classification for all financial instruments explanatory [Table Text Block]" } } }, "localname": "DisclosureOfInitialIas39ClassificationAndIfrs9ClassificationForAllFinancialInstrumentsExplanatory", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables" ], "xbrltype": "textBlockItemType" }, "prt_DisclosureOfManagementFeesExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of information about management fees.", "label": "Disclosure Of Management Fees Explanatory", "verboseLabel": "Disclosure of management fees explanatory [Table Text Block]" } } }, "localname": "DisclosureOfManagementFeesExplanatory", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/RELATEDPARTYTRANSACTIONSTables" ], "xbrltype": "textBlockItemType" }, "prt_DisclosureOfNatureOfOperationsAndAbilityToContinueAsGoingConcernExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The description of the nature of operations and ability to continue as a going concern.", "label": "Disclosure Of Nature Of Operations And Ability To Continue As Going Concern Explanatory", "verboseLabel": "NATURE OF OPERATIONS AND ABILITY TO CONTINUE AS A GOING CONCERN [Text Block]" } } }, "localname": "DisclosureOfNatureOfOperationsAndAbilityToContinueAsGoingConcernExplanatory", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/NatureOfOperationsAndAbilityToContinueAsGoingConcern" ], "xbrltype": "textBlockItemType" }, "prt_DisclosureOfNonCaptialLossCarryforwardsExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information about Disclosure of non-capital loss carryforwards.", "label": "Disclosure Of Non Captial Loss Carryforwards Explanatory", "verboseLabel": "Disclosure of non-capital loss carryforwards [Table Text Block]" } } }, "localname": "DisclosureOfNonCaptialLossCarryforwardsExplanatory", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/INCOMETAXESTables" ], "xbrltype": "textBlockItemType" }, "prt_DisclosureOfNumberOfSharePurchaseWarrantsOutstandingExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of number of share purchase warrants outstanding [Table Text Block]", "label": "Disclosure Of Number Of Share Purchase Warrants Outstanding Explanatory", "terseLabel": "Disclosure of number of share purchase warrants outstanding [Table Text Block]" } } }, "localname": "DisclosureOfNumberOfSharePurchaseWarrantsOutstandingExplanatory", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALTables" ], "xbrltype": "textBlockItemType" }, "prt_DisclosureOfPrepaidExpensesExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of prepaid expenses explanatory.", "label": "Disclosure Of Prepaid Expenses Explanatory", "verboseLabel": "PREPAID EXPENSES [Text Block]" } } }, "localname": "DisclosureOfPrepaidExpensesExplanatory", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/PrepaidExpenses" ], "xbrltype": "textBlockItemType" }, "prt_DisclosureOfRightOfUseAssetsAndLeaseLiabilityExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents right of use assets and lease liability.", "label": "Disclosure Of Right Of Use Assets And Lease Liability Explanatory", "verboseLabel": "RIGHT-OF-USE ASSETS AND LEASE LIABILITY [Text Block]" } } }, "localname": "DisclosureOfRightOfUseAssetsAndLeaseLiabilityExplanatory", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITY" ], "xbrltype": "textBlockItemType" }, "prt_DisclosureOfSignificantAccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Significant Accounting Policies [Abstract]" } } }, "localname": "DisclosureOfSignificantAccountingPoliciesAbstract", "nsuri": "http://plyrotech.com/20221130", "xbrltype": "stringItemType" }, "prt_DisclosureOfSupplementalCashFlowInformationExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information relate to supplemental cash flow.", "label": "Disclosure Of Supplemental Cash Flow Information Explanatory", "verboseLabel": "Disclosure of supplemental cash flow information [Table Text Block]" } } }, "localname": "DisclosureOfSupplementalCashFlowInformationExplanatory", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SUPPLEMENTALCASHFLOWINFORMATIONTables" ], "xbrltype": "textBlockItemType" }, "prt_DisclosureOfUsefulLiveOfAssetsExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents table related to useful live of assets.", "label": "Disclosure Of Useful Live Of Assets Explanatory", "verboseLabel": "Disclosure of depreciation rates applicable to each category of property and equipment [Table Text Block]" } } }, "localname": "DisclosureOfUsefulLiveOfAssetsExplanatory", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables" ], "xbrltype": "textBlockItemType" }, "prt_DroneX1SystemMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents A Millimeter Remote Imaging from Airborne Drone (\"Drone X1 System\") member.", "label": "Drone X1 System [Member]" } } }, "localname": "DroneX1SystemMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/IntangibleAssetsDisclosureOfDetailedInformationAboutIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "prt_DueToFormerShareholderOfTetraMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Due to former shareholder of Tetra.", "label": "Due To Former Shareholder Of Tetra [Member]", "verboseLabel": "Due to former shareholder of Tetra [Member]" } } }, "localname": "DueToFormerShareholderOfTetraMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ACCOUNTSPAYABLEDetails" ], "xbrltype": "domainItemType" }, "prt_DueToRelatedPartyRecognisedAsOfAcquisitionDate": { "auth_ref": [], "calculation": { "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutPurchasePriceAllocationDetails": { "order": 10.0, "parentTag": "ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents amount of due to a related party recognised as of acquisition date.", "label": "Due To Related Party Recognised As Of Acquisition Date", "negatedLabel": "Due to a related party", "verboseLabel": "Due to a related party" } } }, "localname": "DueToRelatedPartyRecognisedAsOfAcquisitionDate", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "prt_EquityIssuancePricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equity issuance, price per share", "label": "Equity Issuance Price Per Share", "terseLabel": "Equity issuance, price per share", "verboseLabel": "Equity issuance, price per share" } } }, "localname": "EquityIssuancePricePerShare", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "perShareItemType" }, "prt_EquityTransactionsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equity transactions", "label": "Equity Transactions [Axis]" } } }, "localname": "EquityTransactionsAxis", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails", "http://plyrotech.com/role/SUBSEQUENTEVENTSNarrativeDetail" ], "xbrltype": "stringItemType" }, "prt_EquityTransactionsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equity transactions", "label": "Equity transactions [Domain]" } } }, "localname": "EquityTransactionsDomain", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails", "http://plyrotech.com/role/SUBSEQUENTEVENTSNarrativeDetail" ], "xbrltype": "domainItemType" }, "prt_EstimatedFairValueOfWarrantsGranted": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents Estimated fair value of warrants granted.", "label": "Estimated Fair Value Of Warrants Granted", "verboseLabel": "Warrants granted, estimated fair value" } } }, "localname": "EstimatedFairValueOfWarrantsGranted", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "prt_ExcessNetBookValueOfVehicleLoan": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of excess net book value of vehicle loan.", "label": "Excess Net Book Value Of Vehicle Loan", "verboseLabel": "Excess net book value of vehicle loan" } } }, "localname": "ExcessNetBookValueOfVehicleLoan", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/GAINONDEBTFORGIVENESSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "prt_ExercisablePeriodOfWarrantsGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents exercisable period of warrants granted.", "label": "Exercisable Period Of Warrants Granted", "verboseLabel": "Exercisable period of warrants granted" } } }, "localname": "ExercisablePeriodOfWarrantsGranted", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "durationItemType" }, "prt_ExercisePriceOfSharePurchaseWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents exercise price of Share purchase warrants.", "label": "Exercise Price Of Share Purchase Warrants", "terseLabel": "Exercise price of share purchase warrants" } } }, "localname": "ExercisePriceOfSharePurchaseWarrants", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "perShareItemType" }, "prt_ExercisePriceZeroPointFiveZeroMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents exercise price 0.50.", "label": "Exercise Price Zero Point Five Zero Member", "verboseLabel": "Exercise Price 0.50 [Member]" } } }, "localname": "ExercisePriceZeroPointFiveZeroMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ShareCapitalDisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsDetails" ], "xbrltype": "domainItemType" }, "prt_ExercisePriceZeroPointFourZeroMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It stands for exercise Price 0.40.", "label": "Exercise Price Zero Point Four Zero Member", "verboseLabel": "Exercise Price 0.40 [Member]" } } }, "localname": "ExercisePriceZeroPointFourZeroMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "domainItemType" }, "prt_ExercisePriceZeroPointOneZeroMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It stands for exercise Price 0.10", "label": "Exercise Price Zero Point One Zero Member", "verboseLabel": "Exercise Price 0.10 [Member]" } } }, "localname": "ExercisePriceZeroPointOneZeroMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "domainItemType" }, "prt_ExercisePriceZeroPointSevenFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise Price Zero Point Seven Five [Member]", "label": "Exercise Price Zero Point Seven Five [Member]", "terseLabel": "Exercise Price 0.75 [Member]" } } }, "localname": "ExercisePriceZeroPointSevenFiveMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ShareCapitalDisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsDetails" ], "xbrltype": "domainItemType" }, "prt_ExercisePriceZeroPointSixZeroMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents exercise price 0.60.", "label": "Exercise Price Zero Point Six Zero Member", "verboseLabel": "Exercise Price 0.60 [Member]" } } }, "localname": "ExercisePriceZeroPointSixZeroMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails", "http://plyrotech.com/role/ShareCapitalDisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsDetails" ], "xbrltype": "domainItemType" }, "prt_ExercisePriceZeroPointSixZeroOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents exercise price of 0.60.", "label": "Exercise Price Zero Point Six Zero One Member", "verboseLabel": "Exercise Price 0.60 [Member]" } } }, "localname": "ExercisePriceZeroPointSixZeroOneMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ShareCapitalDisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsDetails" ], "xbrltype": "domainItemType" }, "prt_ExercisePriceZeroPointThreeZeroMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It stands for exercise Price 0.30.", "label": "Exercise Price Zero Point Three Zero Member", "terseLabel": "Exercise Price 0.30 [Member]" } } }, "localname": "ExercisePriceZeroPointThreeZeroMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "domainItemType" }, "prt_ExpiryDateOfExpiryDateOfSharePurchaseWarrantsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expiry Date of Expiry Date Of Share purchase warrants [Domain]", "label": "Expiry Date Of Expiry Date Of Share Purchase Warrants [Domain]" } } }, "localname": "ExpiryDateOfExpiryDateOfSharePurchaseWarrantsDomain", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALDetails", "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "domainItemType" }, "prt_ExpiryDateOfSharePurchaseWarrantsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expiry Date Of Share purchase warrants [Axis]", "label": "Expiry Date Of Share Purchase Warrants [Axis]" } } }, "localname": "ExpiryDateOfSharePurchaseWarrantsAxis", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALDetails", "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "stringItemType" }, "prt_ExpiryDateOfStockOptionsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Expiry Date Of Stock Options [Axis]" } } }, "localname": "ExpiryDateOfStockOptionsAxis", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ShareCapitalDisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsDetails" ], "xbrltype": "stringItemType" }, "prt_ExpiryDateOfStockOptionsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Expiry Date Of Stock Options [Domain]" } } }, "localname": "ExpiryDateOfStockOptionsDomain", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ShareCapitalDisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsDetails" ], "xbrltype": "domainItemType" }, "prt_ExpiryDateOfStockOptionsJanuaryOneFiveTwoZeoTwoFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information about expiry date January 15, 2024.", "label": "Expiry Date Of Stock Options January One Five Two Zeo Two Four [Member]", "verboseLabel": "January 15, 2024 [Member]" } } }, "localname": "ExpiryDateOfStockOptionsJanuaryOneFiveTwoZeoTwoFourMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ShareCapitalDisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsDetails" ], "xbrltype": "domainItemType" }, "prt_ExpiryDateOfStockOptionsJanuaryTwoOneTwoZeroTwoSixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expiry Date Of Stock Options January Two One Two Zero Two Six [Member]", "label": "Expiry Date Of Stock Options January Two One Two Zero Two Six [Member]", "terseLabel": "January 21, 2026 [Member]" } } }, "localname": "ExpiryDateOfStockOptionsJanuaryTwoOneTwoZeroTwoSixMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ShareCapitalDisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsDetails" ], "xbrltype": "domainItemType" }, "prt_ExpiryDateOfStockOptionsJuneOneZeroTwoZeroTwoSixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expiry Date Of Stock Options June One Zero Two Zero Two Six [Member]", "label": "Expiry Date Of Stock Options June One Zero Two Zero Two Six [Member]", "terseLabel": "June 10, 2026 [Member]" } } }, "localname": "ExpiryDateOfStockOptionsJuneOneZeroTwoZeroTwoSixMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ShareCapitalDisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsDetails" ], "xbrltype": "domainItemType" }, "prt_ExpiryDateOfStockOptionsMarchTwoZeroTwoZeroTwoFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information about expiry date March 20, 2024.", "label": "Expiry Date Of Stock Options March Two Zero Two Zero Two Four [Member]", "verboseLabel": "March 20, 2024 [Member]" } } }, "localname": "ExpiryDateOfStockOptionsMarchTwoZeroTwoZeroTwoFourMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ShareCapitalDisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsDetails" ], "xbrltype": "domainItemType" }, "prt_ExpiryDateOfStockOptionsNovemberTwoEightTwoZeroTwoFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information about expiry date November 28, 2024.", "label": "Expiry Date Of Stock Options November Two Eight Two Zero Two Four [Member]", "verboseLabel": "November 28, 2024 [Member]" } } }, "localname": "ExpiryDateOfStockOptionsNovemberTwoEightTwoZeroTwoFourMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ShareCapitalDisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsDetails" ], "xbrltype": "domainItemType" }, "prt_ExtendedTermOfAgreement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents extended additional term of agreement.", "label": "Extended Term Of Agreement", "terseLabel": "Extended additional term of lease agreement" } } }, "localname": "ExtendedTermOfAgreement", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetailTextuals" ], "xbrltype": "durationItemType" }, "prt_FairValueOfAgentWarrantsGranted": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents information related to fair value of agent warrants granted.", "label": "Fair Value Of Agent Warrants Granted", "verboseLabel": "Fair value of warrants granted" } } }, "localname": "FairValueOfAgentWarrantsGranted", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "prt_FairValueOfFindersUnitsIssued": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of finders units issued.", "label": "Fair Value Of Finders Units Issued", "terseLabel": "Fair value of finders units issued" } } }, "localname": "FairValueOfFindersUnitsIssued", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "prt_FairValueOfOptionsCancelledAndExpired": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represent the fair value of options cancelled and expired", "label": "Fair Value Of Options Cancelled And Expired", "verboseLabel": "Fair value of options cancelled and expired" } } }, "localname": "FairValueOfOptionsCancelledAndExpired", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "prt_FairValueOfOptionsExercised": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of options exercised.", "label": "Fair Value Of Options Exercised", "verboseLabel": "Fair value of options exercised" } } }, "localname": "FairValueOfOptionsExercised", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "prt_FairValueOfOptionsGrantedAndVested": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the fair value of options granted and vested.", "label": "Fair Value Of Options Granted And Vested", "terseLabel": "Fair value of options granted and vested" } } }, "localname": "FairValueOfOptionsGrantedAndVested", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "prt_FairValueOfStockOption": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represent the fair value of stock option.", "label": "Fair Value Of Stock Option", "terseLabel": "Fair value of stock option" } } }, "localname": "FairValueOfStockOption", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "prt_FairValueOfWarrantsEstimatedDividendYieldRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents percentage of dividend yield rate.", "label": "Fair Value Of Warrants Estimated Dividend Yield Rate", "verboseLabel": "Fair value of warrants estimated dividend yield rate" } } }, "localname": "FairValueOfWarrantsEstimatedDividendYieldRate", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "percentItemType" }, "prt_FairValueOfWarrantsEstimatedPriceVolatilityRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents percentage of fair value of warrants estimated volatility rate.", "label": "Fair Value Of Warrants Estimated Price Volatility Rate", "verboseLabel": "Fair value of warrants estimated price volatility rate" } } }, "localname": "FairValueOfWarrantsEstimatedPriceVolatilityRate", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "percentItemType" }, "prt_FairValueOfWarrantsEstimatedRiskFreeRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents percentage of risk-free rate.", "label": "Fair Value Of Warrants Estimated Risk Free Rate", "verboseLabel": "Fair value of warrants estimated risk free rate" } } }, "localname": "FairValueOfWarrantsEstimatedRiskFreeRate", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "percentItemType" }, "prt_FairValueOfWarrantsExercised": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents information related to fair value of warrants exercised.", "label": "Fair Value Of Warrants Exercised", "terseLabel": "Fair value of warrants exercised" } } }, "localname": "FairValueOfWarrantsExercised", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "prt_FairValueOfWarrantsExpectedLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents fair value of warrants expected life.", "label": "Fair Value Of Warrants Expected Life", "verboseLabel": "Fair value of warrants, expected life" } } }, "localname": "FairValueOfWarrantsExpectedLife", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "durationItemType" }, "prt_FindersFeesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Finder's Fees", "label": "Finder's Fees [Member]" } } }, "localname": "FindersFeesMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "domainItemType" }, "prt_FirstTrancheMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information regarding first tranche.", "label": "First Tranche [Member]", "terseLabel": "First Tranche [Member]", "verboseLabel": "First Tranche" } } }, "localname": "FirstTrancheMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "domainItemType" }, "prt_FormerCfoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for former CFO.", "label": "Former Cfo [Member]", "terseLabel": "Company controlled by the Former CFO [Member]", "verboseLabel": "Former CFO [Member]" } } }, "localname": "FormerCfoMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/RELATEDPARTYTRANSACTIONSANDBALANCESDisclosureOfInformationAboutKeyManagementPersonnelDetails", "http://plyrotech.com/role/RELATEDPARTYTRANSACTIONSANDBALANCESDisclosureOfInformationAboutOptionsGrantedToTheCEOCFOTheCorporateSecretaryAndTheCompanysDirectorsDetails", "http://plyrotech.com/role/RelatedPartyTransactionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "prt_FundsToBeReturnedToInvestorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represent the? funds to be returned to investors.", "label": "Funds to be returned to investors [Member]" } } }, "localname": "FundsToBeReturnedToInvestorsMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ACCOUNTSPAYABLEDetails" ], "xbrltype": "domainItemType" }, "prt_FurnitureMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing furniture.", "label": "Furniture [Member]", "verboseLabel": "Furniture [Member]" } } }, "localname": "FurnitureMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/EQUIPMENTDisclosureOfEquipmentDetails" ], "xbrltype": "domainItemType" }, "prt_GainOnDebtForgiveness": { "auth_ref": [], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 0.0, "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount represents gain on debt forgiveness.", "label": "Gain On Debt Forgiveness", "terseLabel": "Gain on debt forgiveness" } } }, "localname": "GainOnDebtForgiveness", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss", "http://plyrotech.com/role/GAINONDEBTFORGIVENESSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "prt_GainOnDebtForgivenessAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Gain On Debt Forgiveness [Abstract]" } } }, "localname": "GainOnDebtForgivenessAbstract", "nsuri": "http://plyrotech.com/20221130", "xbrltype": "stringItemType" }, "prt_GainOnDebtForgivenessLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.", "label": "Gain On Debt Forgiveness [Line Items]" } } }, "localname": "GainOnDebtForgivenessLineItems", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/GAINONDEBTFORGIVENESSNarrativeDetails" ], "xbrltype": "stringItemType" }, "prt_GainOnDebtForgivenessTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule disclosing information related to gain on debt forgiveness.", "label": "Gain On Debt Forgiveness [Table]" } } }, "localname": "GainOnDebtForgivenessTable", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/GAINONDEBTFORGIVENESSNarrativeDetails" ], "xbrltype": "stringItemType" }, "prt_GovernmentAssistanceReceivedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Government Assistance Received [Abstract]" } } }, "localname": "GovernmentAssistanceReceivedAbstract", "nsuri": "http://plyrotech.com/20221130", "xbrltype": "stringItemType" }, "prt_IncreaseDecreaseInNumberOfSharesOutstandingThroughExerciseOfOptions": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares issued for options exercised (Shares)", "label": "Increase (Decrease ) In Number Of Shares Outstanding Through Exercise Of Options", "terseLabel": "Shares issued for options exercised (Shares)", "verboseLabel": "Number of share options exercised" } } }, "localname": "IncreaseDecreaseInNumberOfSharesOutstandingThroughExerciseOfOptions", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "prt_IncreaseDecreaseInNumberOfSharesOutstandingThroughExerciseOfWarrant": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents amount related to shares issued for warrants exercised.", "label": "Increase Decrease In Number Of Shares Outstanding Through Exercise Of Warrant", "verboseLabel": "Shares issued for warrants exercised (Shares)" } } }, "localname": "IncreaseDecreaseInNumberOfSharesOutstandingThroughExerciseOfWarrant", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "prt_IncreaseDecreaseSharesThroughFinderFee": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents number of share related to Finder's fee - acquisition.", "label": "Increase Decrease Shares Through Finder Fee", "verboseLabel": "Shares issued to finders (Shares)" } } }, "localname": "IncreaseDecreaseSharesThroughFinderFee", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "prt_IncreaseDecreaseThroughExplorationAndEvaluationAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Shares issued for exploration and evaluation assets", "label": "Increase Decrease Through Exploration And Evaluation Assets", "terseLabel": "Shares issued for exploration and evaluation assets" } } }, "localname": "IncreaseDecreaseThroughExplorationAndEvaluationAssets", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "prt_IncreaseDecreaseThroughExplorationAndEvaluationAssetsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares issued for exploration and evaluation assets (Shares)", "label": "Increase Decrease Through Exploration And Evaluation Assets Shares", "terseLabel": "Shares issued for exploration and evaluation assets (Shares)" } } }, "localname": "IncreaseDecreaseThroughExplorationAndEvaluationAssetsShares", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "sharesItemType" }, "prt_IncreaseDecreaseThroughFairValueExerciseOfWarrantsEquity": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) in equity resulting from fair value exercise of warrants.", "label": "Increase Decrease Through Fair Value Exercise Of Warrants Equity", "terseLabel": "Fair value of warrants exercised" } } }, "localname": "IncreaseDecreaseThroughFairValueExerciseOfWarrantsEquity", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "prt_IncreaseDecreaseThroughFairValueOfAgentWarrantsExercised": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Information about increase decrease through fair Value of agent warrants exercised.", "label": "Increase Decrease Through Fair Value Of Agent Warrants Exercised", "verboseLabel": "Fair value of agent warrants exercised" } } }, "localname": "IncreaseDecreaseThroughFairValueOfAgentWarrantsExercised", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "prt_IncreaseDecreaseThroughFairValueOfBrokerWarrantsGranted": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of increase (decrease) through fair value of broker warrants granted.", "label": "Increase Decrease Through Fair Value Of Broker Warrants Granted", "terseLabel": "Fair value of broker warrants granted" } } }, "localname": "IncreaseDecreaseThroughFairValueOfBrokerWarrantsGranted", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "prt_IncreaseDecreaseThroughFairValueOfOptionsExercised": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents amount related to fair value of options exercised.", "label": "Increase Decrease Through Fair Value Of Options Exercised", "verboseLabel": "Fair value of options exercised" } } }, "localname": "IncreaseDecreaseThroughFairValueOfOptionsExercised", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "prt_IncreaseDecreaseThroughFinderFee": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents amount related to finder's fees.", "label": "Increase Decrease Through Finder Fee", "verboseLabel": "Shares issued to finders" } } }, "localname": "IncreaseDecreaseThroughFinderFee", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "prt_IncreaseDecreaseThroughPaymentsToFinders": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of increase (decrease) through payments to finders.", "label": "Increase Decrease Through Payments To Finders", "terseLabel": "Cash paid to finders" } } }, "localname": "IncreaseDecreaseThroughPaymentsToFinders", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "prt_IncreaseDecreaseThroughSharesIssuedForAcquisition": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents number of share issued for acqusition of company.", "label": "Increase Decrease Through Shares Issued For Acquisition", "terseLabel": "Shares issued", "verboseLabel": "Shares issued for acquisition (Shares)" } } }, "localname": "IncreaseDecreaseThroughSharesIssuedForAcquisition", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "sharesItemType" }, "prt_IncreaseDecreaseThroughSharesIssuedForCompensationShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the increase decrease through shares issued for compensation, shares.", "label": "Increase Decrease Through Shares Issued For Compensation, Shares", "terseLabel": "Shares issued as compensation (Shares)", "verboseLabel": "Common shares issued as compensation for consulting fees" } } }, "localname": "IncreaseDecreaseThroughSharesIssuedForCompensationShares", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity", "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "sharesItemType" }, "prt_IncreaseDecreaseThroughSharesIssuedForCompensationValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the increase decrease through shares issued for compensation, value.", "label": "Increase Decrease Through Shares Issued For Compensation, Value", "terseLabel": "Shares issued as compensation", "verboseLabel": "Value of common shares issued as compensation for consulting fees" } } }, "localname": "IncreaseDecreaseThroughSharesIssuedForCompensationValue", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity", "http://plyrotech.com/role/RelatedPartyTransactionsNarrativeDetails", "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "prt_IncreaseDecreaseThroughSharesIssuedFromServiceValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents increase decrease through shares issued from service value.", "label": "Increase Decrease Through Shares Issued From Service Value", "terseLabel": "Shares issued from services" } } }, "localname": "IncreaseDecreaseThroughSharesIssuedFromServiceValue", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "prt_IncreaseDecreaseThroughSharesIssuedFromServicesShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Increase Decrease Through Shares Issued From Services Shares", "label": "Increase Decrease Through Shares Issued From Services Shares", "terseLabel": "Shares issued from services (Shares)" } } }, "localname": "IncreaseDecreaseThroughSharesIssuedFromServicesShares", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "prt_IncreaseDecreaseThroughSharesToBeIssued": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represent the amount of increase decrease through shares to be issued.", "label": "Increase Decrease Through Shares To Be Issued", "verboseLabel": "Shares to be issued" } } }, "localname": "IncreaseDecreaseThroughSharesToBeIssued", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "prt_InsuranceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Insurance.", "label": "Insurance [Member]" } } }, "localname": "InsuranceMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/PREPAIDEXPENSESDisclosureOfPrepaidExpensesDetails" ], "xbrltype": "domainItemType" }, "prt_InterestRateIncreaseInDefaultLoanPayments": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to interest rate increase in default loan payments.", "label": "Interest Rate Increase In Default Loan Payments", "terseLabel": "Interest rate increase in default loan payments" } } }, "localname": "InterestRateIncreaseInDefaultLoanPayments", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/LOANPAYABLENarrativeDetails" ], "xbrltype": "percentItemType" }, "prt_ItemsNotAffectingCashAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Items Not Affecting Cash [abstract]", "terseLabel": "Items not affecting cash:" } } }, "localname": "ItemsNotAffectingCashAbstract", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "prt_January152020Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It stands for January 15, 2020.", "label": "January 15, 2020 [Member]", "verboseLabel": "Options Vesting January 15, 2020 [Member]" } } }, "localname": "January152020Member", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "domainItemType" }, "prt_January152021Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It stands for January 15, 2021.", "label": "January 15, 2021 [Member]", "verboseLabel": "Options Vesting January 15, 2021 [Member]" } } }, "localname": "January152021Member", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "domainItemType" }, "prt_JanuaryTwentyNineTwoZeroTwoSixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "January Twenty Nine Two Zero Two Six [Member]", "label": "January Twenty Nine Two Zero Two Six [Member]", "terseLabel": "January 29, 2026 [Member]" } } }, "localname": "JanuaryTwentyNineTwoZeroTwoSixMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALDetails" ], "xbrltype": "domainItemType" }, "prt_July152020Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It stands for July 15, 2020.", "label": "July 15, 2020 [Member]", "verboseLabel": "Options Vesting July 15, 2020 [Member]" } } }, "localname": "July152020Member", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "domainItemType" }, "prt_June202020Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It stands for June 20, 2020.", "label": "June 20, 2020 [Member]", "verboseLabel": "Options Vesting June 20, 2020 [Member]" } } }, "localname": "June202020Member", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "domainItemType" }, "prt_June202021Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It stands for June 20, 2021.", "label": "June 20, 2021 [Member]", "verboseLabel": "Options Vesting June 20, 2021 [Member]" } } }, "localname": "June202021Member", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "domainItemType" }, "prt_KeyManagementCompensationExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of key management compensation expense.", "label": "Key Management Compensation Expense", "terseLabel": "Key management compensation" } } }, "localname": "KeyManagementCompensationExpense", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/COMMITMENTSNarrativeDetail" ], "xbrltype": "monetaryItemType" }, "prt_LaborExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the amount recognised as labor.", "label": "Labor Expense", "terseLabel": "Labor" } } }, "localname": "LaborExpense", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/BREAKDOWNOFEXPENSESDetails" ], "xbrltype": "monetaryItemType" }, "prt_LatterOfOutstandingLoan": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of latter of outstanding loan.", "label": "Latter Of Outstanding Loan", "verboseLabel": "Latter of outstanding loan" } } }, "localname": "LatterOfOutstandingLoan", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/LOANPAYABLENarrativeDetails" ], "xbrltype": "monetaryItemType" }, "prt_LeasePayments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of lease payments.", "label": "Lease Payments", "terseLabel": "Monthly lease payment" } } }, "localname": "LeasePayments", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/COMMITMENTSNarrativeDetail", "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetailTextuals" ], "xbrltype": "monetaryItemType" }, "prt_LeasePaymentsDuePerMonthNextTwelveMonths": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of monthly lease payments for next twelve months.", "label": "Lease Payments Due Per Month Next Twelve Months", "terseLabel": "Monthly lease payment, next twelve months" } } }, "localname": "LeasePaymentsDuePerMonthNextTwelveMonths", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/COMMITMENTSNarrativeDetail", "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetailTextuals" ], "xbrltype": "monetaryItemType" }, "prt_LeasePaymentsDuePerMonthYearFour": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of monthly lease payments year four.", "label": "Lease Payments Due Per Month Year Four", "verboseLabel": "Monthly lease payment, year four" } } }, "localname": "LeasePaymentsDuePerMonthYearFour", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetailTextuals" ], "xbrltype": "monetaryItemType" }, "prt_LeasePaymentsDuePerMonthYearThree": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of monthly lease payments year three.", "label": "Lease Payments Due Per Month Year Three", "verboseLabel": "Monthly lease payment, year three" } } }, "localname": "LeasePaymentsDuePerMonthYearThree", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetailTextuals" ], "xbrltype": "monetaryItemType" }, "prt_LeasePaymentsDuePerMonthYearTwo": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of monthly lease payments year two.", "label": "Lease Payments Due Per Month Year Two", "terseLabel": "Monthly lease payment, year two" } } }, "localname": "LeasePaymentsDuePerMonthYearTwo", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/COMMITMENTSNarrativeDetail", "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetailTextuals" ], "xbrltype": "monetaryItemType" }, "prt_LeasesTermOfContract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the term period of lease contracts.", "label": "Leases Term Of Contract", "terseLabel": "Term of lease" } } }, "localname": "LeasesTermOfContract", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/COMMITMENTSNarrativeDetail", "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetailTextuals" ], "xbrltype": "durationItemType" }, "prt_LegalFee": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.", "label": "Legal Fee", "terseLabel": "Legal fees" } } }, "localname": "LegalFee", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/BREAKDOWNOFEXPENSESDetails" ], "xbrltype": "monetaryItemType" }, "prt_LicenseExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of license expense.", "label": "License Expense", "terseLabel": "license fee" } } }, "localname": "LicenseExpense", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/COMMITMENTSNarrativeDetail" ], "xbrltype": "monetaryItemType" }, "prt_LicenseFeeAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for license fee agreement.", "label": "License Fee Agreement [Member]" } } }, "localname": "LicenseFeeAgreementMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/COMMITMENTSNarrativeDetail" ], "xbrltype": "domainItemType" }, "prt_LoansPayableDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "n/a", "label": "Loans Payable Disclosure [Abstract]" } } }, "localname": "LoansPayableDisclosureAbstract", "nsuri": "http://plyrotech.com/20221130", "xbrltype": "stringItemType" }, "prt_LoansPayableLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.", "label": "Loans Payable [Line Items]" } } }, "localname": "LoansPayableLineItems", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/LOANPAYABLENarrativeDetails" ], "xbrltype": "stringItemType" }, "prt_LoansPayableTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule disclosing information related to loans payable.", "label": "Loans Payable [Table]" } } }, "localname": "LoansPayableTable", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/LOANPAYABLENarrativeDetails" ], "xbrltype": "stringItemType" }, "prt_March202020Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It stands for March 20, 2020.", "label": "March 20, 2020 [Member]", "verboseLabel": "Options Vesting March 20, 2020 [Member]" } } }, "localname": "March202020Member", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "domainItemType" }, "prt_March202021Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It stands for March 20, 2021.", "label": "March 20, 2021 [Member]", "verboseLabel": "Options Vesting March 20, 2021 [Member]" } } }, "localname": "March202021Member", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "domainItemType" }, "prt_MayFifteenTwoZeroTwoTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "May Fifteen Two Zero Two Two [Member]", "label": "May Fifteen Two Zero Two Two [Member]", "terseLabel": "May 15, 2022 [Member]" } } }, "localname": "MayFifteenTwoZeroTwoTwoMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALDetails" ], "xbrltype": "domainItemType" }, "prt_MonthlyRentExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents amount related to monthly rent.", "label": "Monthly Rent Expenses", "verboseLabel": "Monthly rent expenses" } } }, "localname": "MonthlyRentExpenses", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetailTextuals" ], "xbrltype": "monetaryItemType" }, "prt_NatureOfOperationsAndAbilityToContinueAsGoingConcernAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nature Of Operations And Ability To Continue As Going Concern Abstract" } } }, "localname": "NatureOfOperationsAndAbilityToContinueAsGoingConcernAbstract", "nsuri": "http://plyrotech.com/20221130", "xbrltype": "stringItemType" }, "prt_NewIfrsStandardsThatAreEffectiveForCurrentYearExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of new IFRS standards that are effective for the current year.", "label": "New Ifrs Standards That Are Effective For Current Year Explanatory", "terseLabel": "New IFRS standards that are effective for the current year [Policy Text Block]" } } }, "localname": "NewIfrsStandardsThatAreEffectiveForCurrentYearExplanatory", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "prt_NonBrokeredPrivatePlacementFinancingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Non-brokered private placement financing [Member]", "label": "Non Brokered Private Placement Financing [Member]", "terseLabel": "Non-brokered private placement financing [Member]" } } }, "localname": "NonBrokeredPrivatePlacementFinancingMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails", "http://plyrotech.com/role/SUBSEQUENTEVENTSNarrativeDetail" ], "xbrltype": "domainItemType" }, "prt_NonCashFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non Cash Financing Activities [Abstract]", "verboseLabel": "Non-cash financing activities" } } }, "localname": "NonCashFinancingActivitiesAbstract", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutSupplementalCashFlowInformationDetails" ], "xbrltype": "stringItemType" }, "prt_NonCashInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information related to fair value of options exercised.", "label": "Non Cash Investing Activities [Abstract]", "verboseLabel": "Non-cash investing activities:" } } }, "localname": "NonCashInvestingActivitiesAbstract", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutSupplementalCashFlowInformationDetails" ], "xbrltype": "stringItemType" }, "prt_NotesToFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Notes to Financial Statements [Abstract]", "label": "Notes to Financial Statements [Abstract]" } } }, "localname": "NotesToFinancialStatementsAbstract", "nsuri": "http://plyrotech.com/20221130", "xbrltype": "stringItemType" }, "prt_November302020Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It stands for November 30, 2020 .", "label": "November 30, 2020 [Member]", "verboseLabel": "Options Vesting November 30, 2020 [Member]" } } }, "localname": "November302020Member", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "domainItemType" }, "prt_November302021Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It stands for November 30, 2021.", "label": "November 30, 2021 [Member]", "verboseLabel": "Options Vesting November 30, 2021 [Member]" } } }, "localname": "November302021Member", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "domainItemType" }, "prt_NumberOfFindersInvolvedInPrivatePlacement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents number of finders involved in the private placement.", "label": "Number Of Finders Involved In Private Placement", "verboseLabel": "Number of finders involved in private placement" } } }, "localname": "NumberOfFindersInvolvedInPrivatePlacement", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "integerItemType" }, "prt_NumberOfFindersWarrantsIssuedAsPercentageOfUnitsIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents number of finders warrants issued as a percentage of units issued.", "label": "Number Of Finders Warrants Issued As Percentage Of Units Issued", "verboseLabel": "Percentage of number of warrant units issued" } } }, "localname": "NumberOfFindersWarrantsIssuedAsPercentageOfUnitsIssued", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "percentItemType" }, "prt_NumberOfOptionsHeld": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of options held.", "label": "Number Of Options Held", "terseLabel": "Number of Options held" } } }, "localname": "NumberOfOptionsHeld", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/RELATEDPARTYTRANSACTIONSANDBALANCESDisclosureOfInformationAboutOptionsGrantedToTheCEOCFOTheCorporateSecretaryAndTheCompanysDirectorsDetails", "http://plyrotech.com/role/RelatedPartyTransactionsNarrativeDetails" ], "xbrltype": "sharesItemType" }, "prt_NumberOfOutstandingWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants outstanding in share-based payment arrangement at beginning of period.", "label": "Number Of Outstanding Warrants", "periodEndLabel": "Warrants outstanding, ending balance", "periodStartLabel": "Warrants outstanding, beginning balance", "terseLabel": "Numbers of warrants outstanding", "verboseLabel": "Number of Warrants outstanding and exercisable" } } }, "localname": "NumberOfOutstandingWarrants", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALDetails", "http://plyrotech.com/role/ShareCapitalDisclosureOfSharePurchaseWarrantTransactionsDetails" ], "xbrltype": "decimalItemType" }, "prt_NumberOfRemainingShareOptionsGrantedInShareBasedPaymentArrangement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of remaining share options granted in share based payment arrangement.", "label": "Number Of Remaining Share Options Granted In Share Based Payment Arrangement", "terseLabel": "Number of remaining share options granted in share based payment arrangement" } } }, "localname": "NumberOfRemainingShareOptionsGrantedInShareBasedPaymentArrangement", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "sharesItemType" }, "prt_NumberOfUnitsIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of units issued.", "label": "Number Of Units Issued", "terseLabel": "Number of units issued" } } }, "localname": "NumberOfUnitsIssued", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "sharesItemType" }, "prt_NumberOfUnitsIssuedForPrivatePlacement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents number of units issued for private placement.", "label": "Number Of Units Issued For Private Placement", "positiveLabel": "Number of units issued", "terseLabel": "Shares issued for private placement, shares", "verboseLabel": "Number of units issued for private placement" } } }, "localname": "NumberOfUnitsIssuedForPrivatePlacement", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails", "http://plyrotech.com/role/SUBSEQUENTEVENTSNarrativeDetail" ], "xbrltype": "decimalItemType" }, "prt_NumberOfWarrantsExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents number of warrants exercised.", "label": "Number Of Warrants Exercised", "negatedLabel": "Warrants exercised", "negatedTerseLabel": "Number of warrants exercised", "netLabel": "Number of warrants exercised", "terseLabel": "Number of share purchase warrants exercised", "verboseLabel": "Warrants exercised" } } }, "localname": "NumberOfWarrantsExercised", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails", "http://plyrotech.com/role/ShareCapitalDisclosureOfSharePurchaseWarrantTransactionsDetails" ], "xbrltype": "sharesItemType" }, "prt_NumberOfWarrantsExpired": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information about number of warrants expired.", "label": "Number Of Warrants Expired", "negatedLabel": "Warrants expired" } } }, "localname": "NumberOfWarrantsExpired", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ShareCapitalDisclosureOfSharePurchaseWarrantTransactionsDetails" ], "xbrltype": "decimalItemType" }, "prt_NumberOfWarrantsGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information about number of warrants granted.", "label": "Number Of Warrants Granted", "terseLabel": "Warrants granted", "verboseLabel": "Number of warrants granted" } } }, "localname": "NumberOfWarrantsGranted", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails", "http://plyrotech.com/role/ShareCapitalDisclosureOfSharePurchaseWarrantTransactionsDetails" ], "xbrltype": "decimalItemType" }, "prt_October152020Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It stands for October 15, 2020.", "label": "October 15, 2020 [Member]", "verboseLabel": "Options Vesting October 15, 2020 [Member]" } } }, "localname": "October152020Member", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "domainItemType" }, "prt_OtherComprehensiveIncomeLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss) [abstract]", "terseLabel": "OTHER COMPREHENSIVE INCOME", "verboseLabel": "OTHER COMPREHENSIVE INCOME (LOSS)" } } }, "localname": "OtherComprehensiveIncomeLossAbstract", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "prt_OtherPayableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represent the other payables.", "label": "Other Payable [Member]", "terseLabel": "Others [Member]" } } }, "localname": "OtherPayableMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ACCOUNTSPAYABLEDetails" ], "xbrltype": "domainItemType" }, "prt_OthersIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "OTHER INCOME", "label": "Others Income Abstract", "verboseLabel": "OTHER INCOME (EXPENSES)" } } }, "localname": "OthersIncomeAbstract", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "prt_OthersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information of prepaid other expenses.", "label": "Others [Member]" } } }, "localname": "OthersMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/PREPAIDEXPENSESDisclosureOfPrepaidExpensesDetails" ], "xbrltype": "domainItemType" }, "prt_PaycheckProtectionProgram": { "auth_ref": [], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 50.0, "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of paycheck protection program.", "label": "Paycheck Protection Program", "terseLabel": "Paycheck protection program" } } }, "localname": "PaycheckProtectionProgram", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfLossAndComprehensiveLoss", "http://plyrotech.com/role/GOVERMENTASSITANCERECEIVEDDetailTextuals" ], "xbrltype": "monetaryItemType" }, "prt_PaycheckProtectionProgramLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Paycheck Protection Program Loan.", "label": "Paycheck Protection Program Loan [Member]", "verboseLabel": "CARES Act Paycheck Protection Program Loan (\"PPP Loan\") [Member]" } } }, "localname": "PaycheckProtectionProgramLoanMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/GOVERMENTASSITANCERECEIVEDDetailTextuals" ], "xbrltype": "domainItemType" }, "prt_PayrollMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member is stand for Payroll.", "label": "Payroll [Member]" } } }, "localname": "PayrollMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ACCOUNTSPAYABLEDetails" ], "xbrltype": "domainItemType" }, "prt_PercentageOfCommonSharesReservedForIssuance": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents percentage of common shares reserved for issuance.", "label": "Percentage Of Common Shares Reserved For Issuance", "verboseLabel": "Percentage of common shares reserved for issuance" } } }, "localname": "PercentageOfCommonSharesReservedForIssuance", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "percentItemType" }, "prt_PercentageOfFindersFeesOfCash": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents percentage of finder's fees of cash.", "label": "Percentage Of Finders Fees Of Cash", "verboseLabel": "Percentage of finders fees of cash" } } }, "localname": "PercentageOfFindersFeesOfCash", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "percentItemType" }, "prt_PlymouthRockTechnologiesUKLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Plymouth Rock Technologies UK Limited.", "label": "Plymouth Rock Technologies U K Limited [Member]", "terseLabel": "PRT UK [Member]" } } }, "localname": "PlymouthRockTechnologiesUKLimitedMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/COMMITMENTSNarrativeDetail" ], "xbrltype": "domainItemType" }, "prt_PlymouthRockUsaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Plymouth Rock USA.", "label": "Plymouth Rock Usa [Member]", "terseLabel": "PRT USA [Member]" } } }, "localname": "PlymouthRockUsaMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/COMMITMENTSNarrativeDetail", "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetailTextuals" ], "xbrltype": "domainItemType" }, "prt_PotentialFluctuationsInFunctionalCurrencyExchangeRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represent the potential fluctuations in functional currency exchange rate.", "label": "Potential Fluctuations In Functional Currency Exchange Rate", "verboseLabel": "Potential fluctuations in functional currency exchange rate" } } }, "localname": "PotentialFluctuationsInFunctionalCurrencyExchangeRate", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/FINANCIALRISKMANAGEMENTNarrativeDetails" ], "xbrltype": "percentItemType" }, "prt_PremisesInPlymouthMassachusettsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Premises in Plymouth Massachusetts.", "label": "Premises In Plymouth Massachusetts [Member]", "verboseLabel": "Plymouth, Massachusetts [Member]" } } }, "localname": "PremisesInPlymouthMassachusettsMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/COMMITMENTSNarrativeDetail" ], "xbrltype": "domainItemType" }, "prt_PrepaidExpensesAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information of prepaid expenses.", "label": "Prepaid Expenses [Axis]" } } }, "localname": "PrepaidExpensesAxis", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/PREPAIDEXPENSESDisclosureOfPrepaidExpensesDetails" ], "xbrltype": "stringItemType" }, "prt_PrepaidExpensesDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information of prepaid expenses.", "label": "Prepaid Expenses [Domain]" } } }, "localname": "PrepaidExpensesDomain", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/PREPAIDEXPENSESDisclosureOfPrepaidExpensesDetails" ], "xbrltype": "domainItemType" }, "prt_PrepaidExpensesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Prepaid Expenses [Line Items]" } } }, "localname": "PrepaidExpensesLineItems", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/PREPAIDEXPENSESDisclosureOfPrepaidExpensesDetails" ], "xbrltype": "stringItemType" }, "prt_PrepaidExpensesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting prepaid expenses.", "label": "Prepaid Expenses [Table]" } } }, "localname": "PrepaidExpensesTable", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/PREPAIDEXPENSESDisclosureOfPrepaidExpensesDetails" ], "xbrltype": "stringItemType" }, "prt_PrepaymentToRelatedParty": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represent the amount of prepayment ?to related party.", "label": "Prepayment To Related Party", "verboseLabel": "Prepayment to related party" } } }, "localname": "PrepaymentToRelatedParty", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/RelatedPartyTransactionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "prt_PricePerUnitIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents price per unit issued.", "label": "Price Per Unit Issued", "terseLabel": "Price per unit issued" } } }, "localname": "PricePerUnitIssued", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails", "http://plyrotech.com/role/SUBSEQUENTEVENTSNarrativeDetail" ], "xbrltype": "perUnitItemType" }, "prt_PrivatePlacementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private Placements", "label": "Private Placements [Member]", "terseLabel": "Private Placements [Member]" } } }, "localname": "PrivatePlacementsMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails", "http://plyrotech.com/role/SUBSEQUENTEVENTSNarrativeDetail" ], "xbrltype": "domainItemType" }, "prt_ProceedsFromLoansReceivable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of proceeds from loans receivable.", "label": "Proceeds From Loans Receivable", "verboseLabel": "Proceeds from loans receivable" } } }, "localname": "ProceedsFromLoansReceivable", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/LOANPAYABLENarrativeDetails" ], "xbrltype": "monetaryItemType" }, "prt_ProceedsFromUnitsIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents proceeds from units issued.", "label": "Proceeds From Units Issued", "verboseLabel": "Proceeds from units issued" } } }, "localname": "ProceedsFromUnitsIssued", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails", "http://plyrotech.com/role/SUBSEQUENTEVENTSNarrativeDetail" ], "xbrltype": "monetaryItemType" }, "prt_ProfessionalFeesPayableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represent the professional fees payable.", "label": "Professional Fees Payable [Member]", "verboseLabel": "Professional fees [Member]" } } }, "localname": "ProfessionalFeesPayableMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ACCOUNTSPAYABLEDetails" ], "xbrltype": "domainItemType" }, "prt_PurchasesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchases.", "label": "Purchases [Member]" } } }, "localname": "PurchasesMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ACCOUNTSPAYABLEDetails" ], "xbrltype": "domainItemType" }, "prt_RecognitionUponAdoptionLeaseLiability": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the recognition upon adoption lease liability.", "label": "Recognition Upon Adoption Lease Liability", "terseLabel": "Recognition upon adoption of IFRS 16" } } }, "localname": "RecognitionUponAdoptionLeaseLiability", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetails1" ], "xbrltype": "monetaryItemType" }, "prt_RecognitionUponAdoptionRightOfUseAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the recognition upon adoption right of use assets.", "label": "Recognition Upon Adoption Right Of Use Assets", "verboseLabel": "Recognition upon adoption of IFRS 16" } } }, "localname": "RecognitionUponAdoptionRightOfUseAssets", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetails" ], "xbrltype": "monetaryItemType" }, "prt_RemainingAcquisitionRelatedCost": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of remaining acquisition related cost.", "label": "Remaining Acquisition Related Cost", "verboseLabel": "Remaining acquisition related cost" } } }, "localname": "RemainingAcquisitionRelatedCost", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/GAINONDEBTFORGIVENESSNarrativeDetails", "http://plyrotech.com/role/LOANPAYABLENarrativeDetails" ], "xbrltype": "monetaryItemType" }, "prt_RentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information of prepaid rent.", "label": "Rent [Member]" } } }, "localname": "RentMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ACCOUNTSPAYABLEDetails", "http://plyrotech.com/role/PREPAIDEXPENSESDisclosureOfPrepaidExpensesDetails" ], "xbrltype": "domainItemType" }, "prt_RepaymentsOfProceedsFromBorrowingsClassifiedAsFinancingActivities": { "auth_ref": [], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows": { "order": 20.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash outflows and inflows from borrowings classified as financing activities.", "label": "Repayments Of Proceeds From Borrowings Classified As Financing Activities", "negatedLabel": "Loan payable", "negatedTerseLabel": "Repayments of borrowings" } } }, "localname": "RepaymentsOfProceedsFromBorrowingsClassifiedAsFinancingActivities", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "prt_ResearchAndDevelopmentExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents research and development expense member.", "label": "Research And Development Expenses [Member]", "verboseLabel": "Research and Development [Member]" } } }, "localname": "ResearchAndDevelopmentExpensesMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/BREAKDOWNOFEXPENSESDetails" ], "xbrltype": "domainItemType" }, "prt_RightOfUseAssetsAndLeaseLiabilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Right Of Use Assets And Lease Liability [Abstract]" } } }, "localname": "RightOfUseAssetsAndLeaseLiabilityAbstract", "nsuri": "http://plyrotech.com/20221130", "xbrltype": "stringItemType" }, "prt_SecondTrancheMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Second Tranche [Member]" } } }, "localname": "SecondTrancheMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "domainItemType" }, "prt_SeptemberThirtyTwoZeroTwoTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "September Thirty Two Zero Two Two [Member]", "label": "September Thirty Two Zero Two Two [Member]", "terseLabel": "September 30, 2022 [Member]" } } }, "localname": "SeptemberThirtyTwoZeroTwoTwoMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALDetails" ], "xbrltype": "domainItemType" }, "prt_ShareIssuanceCosts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represent the amount of share issuance costs.", "label": "Share Issuance Costs", "verboseLabel": "Share issuance costs" } } }, "localname": "ShareIssuanceCosts", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "prt_ShareIssuedForPrivatePlacementShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share issued for private placement, shares", "label": "Share Issued For Private Placement Shares", "terseLabel": "Share issued for private placement, shares" } } }, "localname": "ShareIssuedForPrivatePlacementShares", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "sharesItemType" }, "prt_SharePurchaseWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information about share purchase warrant.", "label": "Share Purchase Warrant [Member]" } } }, "localname": "SharePurchaseWarrantMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "domainItemType" }, "prt_SharePurchaseWarrantsExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents exercise price of Share purchase warrants.", "label": "Share Purchase Warrants Exercise Price", "verboseLabel": "Exercise Price" } } }, "localname": "SharePurchaseWarrantsExercisePrice", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALDetails", "http://plyrotech.com/role/ShareCapitalDisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsDetails" ], "xbrltype": "perShareItemType" }, "prt_SharesHeldInEscrow": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares held in escrow", "label": "Shares Held In Escrow", "verboseLabel": "Shares held in escrow" } } }, "localname": "SharesHeldInEscrow", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "sharesItemType" }, "prt_SharesIssuedForAcquisitionsValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Shares issued for acquisitions, value", "label": "Shares Issued For Acquisitions Value", "terseLabel": "Shares issued for acquisition", "verboseLabel": "Shares issued for acquisitions, value" } } }, "localname": "SharesIssuedForAcquisitionsValue", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "prt_SharesIssuedForConsultingServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of share issued for consulting services.", "label": "Shares Issued For Consulting Services", "verboseLabel": "Shares issued for consulting services" } } }, "localname": "SharesIssuedForConsultingServices", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutSupplementalCashFlowInformationDetails", "http://plyrotech.com/role/RelatedPartyTransactionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "prt_SharesIssuedForConsultingServicesShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This element represents shares issued for consulting services.", "label": "Shares Issued For Consulting Services, Shares", "terseLabel": "Shares issued for consulting services (shares)", "verboseLabel": "Shares issued for consulting services" } } }, "localname": "SharesIssuedForConsultingServicesShares", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/RelatedPartyTransactionsNarrativeDetails" ], "xbrltype": "sharesItemType" }, "prt_SharesIssuedForExplorationAndEvaluationsAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents information related to shares issued for exploration and evaluations assets.", "label": "Shares Issued For Exploration And Evaluations Assets", "verboseLabel": "Shares issued for exploration and evaluations assets" } } }, "localname": "SharesIssuedForExplorationAndEvaluationsAssets", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "prt_SharesIssuedForFinders": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represent the amount of shares issued for finders", "label": "Shares Issued For Finders", "verboseLabel": "Shares issued for finders" } } }, "localname": "SharesIssuedForFinders", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "prt_SharesIssuedForFindersFeesShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares issued for finder's fees, shares", "label": "Shares Issued For Finders Fees Shares", "verboseLabel": "Shares issued for finder's fees, shares" } } }, "localname": "SharesIssuedForFindersFeesShares", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "sharesItemType" }, "prt_SharesIssuedForFindersFeesValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Shares issued for finder's fees, value", "label": "Shares Issued For Finders Fees Value", "terseLabel": "Shares issued for finder's fees, value", "verboseLabel": "Shares issued for finder's fees, value" } } }, "localname": "SharesIssuedForFindersFeesValue", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "prt_SharesIssuedForOptionsExercised": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represent the amount of shares issued for options exercised.", "label": "Shares Issued For Options Exercised", "verboseLabel": "Shares issued for options exercised" } } }, "localname": "SharesIssuedForOptionsExercised", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "prt_SharesIssuedForPrivatePlacementValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Shares issued for private placement, value", "label": "Shares Issued For Private Placement Value", "terseLabel": "Shares issued for private placement, value", "verboseLabel": "Shares issued for private placement, value" } } }, "localname": "SharesIssuedForPrivatePlacementValue", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "prt_SharesIssuedForServices": { "auth_ref": [], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows": { "order": 90.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount represents adjustment on shares issued for services", "label": "Shares Issued For Services", "terseLabel": "Shares issued for services" } } }, "localname": "SharesIssuedForServices", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "prt_SharesIssuedForWarrantsExercised": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represent the amount of shares issued for warrants exercised.", "label": "Shares Issued For Warrants Exercised", "verboseLabel": "Shares issued for warrants exercised" } } }, "localname": "SharesIssuedForWarrantsExercised", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "prt_SharesIssuedPerSharesForAcquisitions": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents issued price per share for acquisitions.", "label": "Shares Issued Per Shares For Acquisitions", "verboseLabel": "Price per share issued for acquisitions" } } }, "localname": "SharesIssuedPerSharesForAcquisitions", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "perShareItemType" }, "prt_SharesToBeIssued": { "auth_ref": [], "calculation": { "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition": { "order": 10.0, "parentTag": "ifrs-full_Equity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents amount related to shares issued.", "label": "Shares To Be Issued", "verboseLabel": "Shares to be issued" } } }, "localname": "SharesToBeIssued", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "prt_SharesToBeIssuedForAcquisitionOfInventory": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represent the amount of shares to be issued for acquisition of inventory.", "label": "Shares To Be Issued For Acquisition Of Inventory", "terseLabel": "Shares to be issued to acquisition of inventory", "verboseLabel": "Shares to be issued for acquisition of inventory" } } }, "localname": "SharesToBeIssuedForAcquisitionOfInventory", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "prt_SharesToBeIssuedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares to be issued.", "label": "Shares To Be Issued [Member]", "terseLabel": "Shares to be issued [Member]" } } }, "localname": "SharesToBeIssuedMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "prt_ShoeScannerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "a compact microwave radar system for scanning shoe's (\"Shoe-Scanner\") member.", "label": "Shoe Scanner [Member]" } } }, "localname": "ShoeScannerMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/IntangibleAssetsDisclosureOfDetailedInformationAboutIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "prt_SignificantAccountingJudgmentsEstimatesAndAssumptions": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information regarding Significant accounting judgments, estimates and assumptions.", "label": "Significant Accounting Judgments Estimates And Assumptions", "verboseLabel": "Significant accounting judgments, estimates and assumptions [Policy Text Block]" } } }, "localname": "SignificantAccountingJudgmentsEstimatesAndAssumptions", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "prt_StatementsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Statements [Line Items]", "label": "Statements Line Items" } } }, "localname": "StatementsLineItems", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity", "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "stringItemType" }, "prt_StatementsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Statements [Table]", "label": "Statements Table" } } }, "localname": "StatementsTable", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity", "http://plyrotech.com/role/ConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "stringItemType" }, "prt_StockIssuedDuringPeriodNumberOfSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Stock Issued During Period, Number Of Shares, Issued For Services", "terseLabel": "Number of shares issued for services" } } }, "localname": "StockIssuedDuringPeriodNumberOfSharesIssuedForServices", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "sharesItemType" }, "prt_StockIssuedDuringPeriodValueOfIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.", "label": "Stock Issued During Period, Value Of Issued For Services", "terseLabel": "Value of shares issued for services" } } }, "localname": "StockIssuedDuringPeriodValueOfIssuedForServices", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "prt_SubscriptionReceivedReclassifiedToAccountsPayableAndAccruedLiabilities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents subscription received reclassified to accounts payable and accrued liabilities.", "label": "Subscription Received Reclassified To Accounts Payable And Accrued Liabilities", "verboseLabel": "Subscription received reclassified to accounts payable and accrued liabilities" } } }, "localname": "SubscriptionReceivedReclassifiedToAccountsPayableAndAccruedLiabilities", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "prt_SubscriptionsReceivedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Subscriptions received.", "label": "Subscriptions Received [Member]", "terseLabel": "Subscriptions received [Member]" } } }, "localname": "SubscriptionsReceivedMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "prt_SubsequentEventsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Events [Member]", "verboseLabel": "Subsequent Events [Member]" } } }, "localname": "SubsequentEventsMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SUBSEQUENTEVENTSNarrativeDetail" ], "xbrltype": "domainItemType" }, "prt_SubsidiaryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents subsidiary member.", "label": "Subsidiary [Member]", "terseLabel": "Plymouth Rock Technologies Inc. (\"Plymouth Rock USA\")", "verboseLabel": "Plymouth Rock USA [Member]" } } }, "localname": "SubsidiaryMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SignificantAccountingPoliciesDisclosureOfSubsidiariesDetails" ], "xbrltype": "domainItemType" }, "prt_SubsidiaryOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents subsidiary one member.", "label": "Subsidiary One [Member]", "terseLabel": "Plymouth Rock UK [Member]", "verboseLabel": "PRT UK [Member]" } } }, "localname": "SubsidiaryOneMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SignificantAccountingPoliciesDisclosureOfSubsidiariesDetails" ], "xbrltype": "domainItemType" }, "prt_SubsidiaryTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents subsidiary two member.", "label": "Subsidiary Two [Member]", "terseLabel": "Tetra Drones [Member]" } } }, "localname": "SubsidiaryTwoMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SignificantAccountingPoliciesDisclosureOfSubsidiariesDetails" ], "xbrltype": "domainItemType" }, "prt_SupplementalCashFlowsInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flows Information Abstract" } } }, "localname": "SupplementalCashFlowsInformationAbstract", "nsuri": "http://plyrotech.com/20221130", "xbrltype": "stringItemType" }, "prt_TaxEffectOfChangeInDeferredTaxAssetNotRecognized": { "auth_ref": [], "calculation": { "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutReconcilesTheExpectedIncomeTaxesExpenseDetails": { "order": 50.0, "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to change in deferred tax asset not recognized.", "label": "Tax Effect Of Change In Deferred Tax Asset Not Recognized", "verboseLabel": "Change in deferred tax assets not recognized" } } }, "localname": "TaxEffectOfChangeInDeferredTaxAssetNotRecognized", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutReconcilesTheExpectedIncomeTaxesExpenseDetails" ], "xbrltype": "monetaryItemType" }, "prt_TaxEffectOfPermanentDifferences": { "auth_ref": [], "calculation": { "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutReconcilesTheExpectedIncomeTaxesExpenseDetails": { "order": 30.0, "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount that represents the tax effect of permanent differences.", "label": "Tax Effect Of Permanent Differences", "verboseLabel": "Permanent differences" } } }, "localname": "TaxEffectOfPermanentDifferences", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutReconcilesTheExpectedIncomeTaxesExpenseDetails" ], "xbrltype": "monetaryItemType" }, "prt_TaxExpiryPeriodAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the tax expiry period.", "label": "Tax Expiry Period [Axis]" } } }, "localname": "TaxExpiryPeriodAxis", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/IncomeTaxesDisclosureOfNonCapitalLossCarryforwardsDetails" ], "xbrltype": "stringItemType" }, "prt_TaxExpiryPeriodDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the tax expiry period.", "label": "Tax Expiry Period [Domain]" } } }, "localname": "TaxExpiryPeriodDomain", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/IncomeTaxesDisclosureOfNonCapitalLossCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "prt_TermOfLeaseAgreement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents term of lease agreement.", "label": "Term of lease agreement" } } }, "localname": "TermOfLeaseAgreement", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetailTextuals" ], "xbrltype": "durationItemType" }, "prt_TetraDronesLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information of Tetra Drones Limited.", "label": "Tetra Drones Limited [Member]", "verboseLabel": "Tetra [Member]" } } }, "localname": "TetraDronesLimitedMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/BUSINESSACQUISITONNarrativeDetail", "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutPurchasePriceAllocationDetails", "http://plyrotech.com/role/GAINONDEBTFORGIVENESSNarrativeDetails", "http://plyrotech.com/role/LOANPAYABLENarrativeDetails" ], "xbrltype": "domainItemType" }, "prt_ThirdPartyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member is stand for third party.", "label": "Third Party [Member]" } } }, "localname": "ThirdPartyMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/LOANPAYABLENarrativeDetails" ], "xbrltype": "domainItemType" }, "prt_TradeAndOtherPayableAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information of trade and other payable.?", "label": "Trade And Other Payable [Axis]" } } }, "localname": "TradeAndOtherPayableAxis", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ACCOUNTSPAYABLEDetails" ], "xbrltype": "stringItemType" }, "prt_TradeAndOtherPayableDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information of trade and other payable.?", "label": "Trade And Other Payable [Domain]" } } }, "localname": "TradeAndOtherPayableDomain", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ACCOUNTSPAYABLEDetails" ], "xbrltype": "domainItemType" }, "prt_TradeAndOtherPayableLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Trade And Other Payable [Line Items]" } } }, "localname": "TradeAndOtherPayableLineItems", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ACCOUNTSPAYABLEDetails" ], "xbrltype": "stringItemType" }, "prt_TradeAndOtherPayableTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information of trade and other payable.", "label": "Trade And Other Payable [Table]" } } }, "localname": "TradeAndOtherPayableTable", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ACCOUNTSPAYABLEDetails" ], "xbrltype": "stringItemType" }, "prt_TransferAgentAndFilingFeesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Transfer agent and filing fees.", "label": "Transfer Agent And Filing Fees [Member]", "terseLabel": "Transfer agent and filing fees [Member]" } } }, "localname": "TransferAgentAndFilingFeesMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/PREPAIDEXPENSESDisclosureOfPrepaidExpensesDetails" ], "xbrltype": "domainItemType" }, "prt_TypesOfArrangementsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Types Of Arrangements [Axis]", "label": "Types Of Arrangements [Axis]" } } }, "localname": "TypesOfArrangementsAxis", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/COMMITMENTSNarrativeDetail" ], "xbrltype": "stringItemType" }, "prt_TypesOfArrangementsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Types Of Arrangements [Domain]", "label": "Types Of Arrangements [Domain]" } } }, "localname": "TypesOfArrangementsDomain", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/COMMITMENTSNarrativeDetail" ], "xbrltype": "domainItemType" }, "prt_UndiscountedInterestExpenseOnLeaseLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents amount related to interest expense on lease liabilities.", "label": "Undiscounted Interest Expense On Lease Liabilities", "negatedLabel": "Less: Interest expense on lease liabilities", "verboseLabel": "Less: Interest expense on lease liabilities" } } }, "localname": "UndiscountedInterestExpenseOnLeaseLiabilities", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetails2" ], "xbrltype": "monetaryItemType" }, "prt_UndiscountedOperatingLeasePaymentsToBePaid": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of undiscounted operating lease payments to be paid. Operating lease is a lease that does not transfer substantially all the risks and rewards incidental to ownership of an underlying asset.", "label": "Undiscounted Operating Lease Payments To Be Paid", "verboseLabel": "Minimum lease payments for lease liabilities" } } }, "localname": "UndiscountedOperatingLeasePaymentsToBePaid", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/RIGHTOFUSEASSETSANDLEASELIABILITYDetails2" ], "xbrltype": "monetaryItemType" }, "prt_UnrecognizedDeductibleTemporaryDifferencesForCapitalLosses": { "auth_ref": [], "calculation": { "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutUnrecognizedDeductibleTemporaryDifferencesDetails": { "order": 10.0, "parentTag": "ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized deductible temporary differences for capital losses.", "label": "Unrecognized Deductible Temporary Differences For Capital Losses", "verboseLabel": "Capital losses" } } }, "localname": "UnrecognizedDeductibleTemporaryDifferencesForCapitalLosses", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutUnrecognizedDeductibleTemporaryDifferencesDetails" ], "xbrltype": "monetaryItemType" }, "prt_UnrecognizedDeductibleTemporaryDifferencesForEquipment": { "auth_ref": [], "calculation": { "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutUnrecognizedDeductibleTemporaryDifferencesDetails": { "order": 20.0, "parentTag": "ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of unrecognized deductible temporary differences for equipment.", "label": "Unrecognized Deductible Temporary Differences For Equipment", "verboseLabel": "Equipment" } } }, "localname": "UnrecognizedDeductibleTemporaryDifferencesForEquipment", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutUnrecognizedDeductibleTemporaryDifferencesDetails" ], "xbrltype": "monetaryItemType" }, "prt_UnrecognizedDeductibleTemporaryDifferencesForIntangibleAssets": { "auth_ref": [], "calculation": { "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutUnrecognizedDeductibleTemporaryDifferencesDetails": { "order": 40.0, "parentTag": "ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized deductible temporary differences for intangible assets.", "label": "Unrecognized Deductible Temporary Differences For Intangible Assets", "verboseLabel": "Intangible assets" } } }, "localname": "UnrecognizedDeductibleTemporaryDifferencesForIntangibleAssets", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutUnrecognizedDeductibleTemporaryDifferencesDetails" ], "xbrltype": "monetaryItemType" }, "prt_UnrecognizedDeductibleTemporaryDifferencesForShareIssuanceCosts": { "auth_ref": [], "calculation": { "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutUnrecognizedDeductibleTemporaryDifferencesDetails": { "order": 30.0, "parentTag": "ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of unrecognized deductible temporary differences for share issuance costs.", "label": "Unrecognized Deductible Temporary Differences For Share Issuance Costs", "verboseLabel": "Share issuance costs" } } }, "localname": "UnrecognizedDeductibleTemporaryDifferencesForShareIssuanceCosts", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutUnrecognizedDeductibleTemporaryDifferencesDetails" ], "xbrltype": "monetaryItemType" }, "prt_UnrecognizedDeductibleTemporaryDifferencesforOtherAssets": { "auth_ref": [], "calculation": { "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutUnrecognizedDeductibleTemporaryDifferencesDetails": { "order": 50.0, "parentTag": "ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents amount related to unrecognized deductible temporary difference for other assets.", "label": "Unrecognized Deductible Temporary Differencesfor Other Assets", "verboseLabel": "Others" } } }, "localname": "UnrecognizedDeductibleTemporaryDifferencesforOtherAssets", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutUnrecognizedDeductibleTemporaryDifferencesDetails" ], "xbrltype": "monetaryItemType" }, "prt_UnrelatedPartyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Unrelated Party.", "label": "Unrelated Party [Member]", "terseLabel": "Unrelated party [Member]" } } }, "localname": "UnrelatedPartyMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/COMMITMENTSNarrativeDetail" ], "xbrltype": "domainItemType" }, "prt_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognisedNoncapitalLossCarryforwards": { "auth_ref": [], "calculation": { "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutUnrecognizedDeductibleTemporaryDifferencesDetails": { "order": 0.0, "parentTag": "ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents amount of non-capital loss carryforwards.", "label": "Unused Tax Losses For Which No Deferred Tax Asset Recognised Noncapital Loss Carryforwards", "verboseLabel": "Non-capital loss" } } }, "localname": "UnusedTaxLossesForWhichNoDeferredTaxAssetRecognisedNoncapitalLossCarryforwards", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutUnrecognizedDeductibleTemporaryDifferencesDetails" ], "xbrltype": "monetaryItemType" }, "prt_VATPayableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "VAT Payable.", "label": "V A T Payable [Member]", "terseLabel": "VAT Payable [Member]" } } }, "localname": "VATPayableMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ACCOUNTSPAYABLEDetails" ], "xbrltype": "domainItemType" }, "prt_VehicleLoanRecognisedAsOfAcquisitionDate": { "auth_ref": [], "calculation": { "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutPurchasePriceAllocationDetails": { "order": 0.0, "parentTag": "ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents amount of vehicle loan recognised as of acquisition date.", "label": "Vehicle Loan Recognised As Of Acquisition Date", "negatedLabel": "Vehicle loan", "terseLabel": "Principal", "verboseLabel": "Vehicle loan" } } }, "localname": "VehicleLoanRecognisedAsOfAcquisitionDate", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "prt_VestingPeriodAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Vesting Period [Axis]", "verboseLabel": "Vesting Period [Axis]" } } }, "localname": "VestingPeriodAxis", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "stringItemType" }, "prt_VestingPeriodDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Vesting Period [Domain]", "verboseLabel": "Vesting Period [Domain]" } } }, "localname": "VestingPeriodDomain", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "domainItemType" }, "prt_WarrantsGrantedExercisablePeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents Warrants granted, exercisable period.", "label": "Warrants Granted Exercisable Period", "verboseLabel": "Warrants granted, exercisable period" } } }, "localname": "WarrantsGrantedExercisablePeriod", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "durationItemType" }, "prt_WeightedAverageExercisePriceOfWarrantsExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It represents as a amount of warrants exercised.", "label": "Weighted Average Exercise Price Of Warrants Exercised", "terseLabel": "Warrant exercise price", "verboseLabel": "Weighted average exercise price of warrants exercised" } } }, "localname": "WeightedAverageExercisePriceOfWarrantsExercised", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails", "http://plyrotech.com/role/ShareCapitalDisclosureOfSharePurchaseWarrantTransactionsDetails" ], "xbrltype": "perShareItemType" }, "prt_WeightedAverageExercisePriceOfWarrantsExpired": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents warrant exercise price of warrant expired", "label": "Weighted Average Exercise Price Of Warrants Expired", "verboseLabel": "Weighted average exercise price of warrants expired" } } }, "localname": "WeightedAverageExercisePriceOfWarrantsExpired", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/ShareCapitalDisclosureOfSharePurchaseWarrantTransactionsDetails" ], "xbrltype": "perShareItemType" }, "prt_WeightedAverageExercisePriceOfWarrantsGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It represents as a amount of warrants granted.", "label": "Weighted Average Exercise Price Of Warrants Granted", "terseLabel": "Weighted average exercise price of warrants granted", "verboseLabel": "Exercise price of warrants granted" } } }, "localname": "WeightedAverageExercisePriceOfWarrantsGranted", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALNarrativeDetails", "http://plyrotech.com/role/SUBSEQUENTEVENTSNarrativeDetail", "http://plyrotech.com/role/ShareCapitalDisclosureOfSharePurchaseWarrantTransactionsDetails" ], "xbrltype": "perShareItemType" }, "prt_WeightedAverageExercisePriceOfWarrantsOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average exercise price of warrants outstanding in share-based payment arrangement at beginning of period.", "label": "Weighted Average Exercise Price Of Warrants Outstanding", "periodEndLabel": "Weighted average exercise price, ending balance", "periodStartLabel": "Weighted average exercise price, beginning balance", "terseLabel": "Weighted average exercise price" } } }, "localname": "WeightedAverageExercisePriceOfWarrantsOutstanding", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALDetails", "http://plyrotech.com/role/ShareCapitalDisclosureOfSharePurchaseWarrantTransactionsDetails" ], "xbrltype": "perShareItemType" }, "prt_WeightedAverageRemainingContractualLifeForSharePurchaseWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents weighted average remaining contractual life for share purchase warrants.", "label": "Weighted Average Remaining Contractual Life For Share Purchase Warrants", "verboseLabel": "Weighted average remaining contractual life (year)" } } }, "localname": "WeightedAverageRemainingContractualLifeForSharePurchaseWarrants", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/SHARECAPITALDetails" ], "xbrltype": "durationItemType" }, "prt_WiTiMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents Wi-Fi radar techniques for threat detection screening in Wi-Fi enabled zones in buildings and places, such as airports, shopping malls, schools and sports venues (\"Wi-Ti\").", "label": "Wi Ti [Member]" } } }, "localname": "WiTiMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/IntangibleAssetsDisclosureOfDetailedInformationAboutIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "prt_WithinOneTwentyDaysMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents payment date within 120 days.", "label": "Within One Twenty Days [Member]", "verboseLabel": "Amount (paid) within 120 days [Member]" } } }, "localname": "WithinOneTwentyDaysMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/BUSINESSACQUISITONNarrativeDetail" ], "xbrltype": "domainItemType" }, "prt_WithinOneTwentyDaysOfThirdInstalmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents payment within 120 days of third installment.", "label": "Within One Twenty Days Of Third Instalment [Member]", "verboseLabel": "Remaining balance [Member]" } } }, "localname": "WithinOneTwentyDaysOfThirdInstalmentMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/BUSINESSACQUISITONNarrativeDetail" ], "xbrltype": "domainItemType" }, "prt_WithinSevenDaysMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information of payment within 7 days.", "label": "Within Seven Days [Member]", "verboseLabel": "Amount (paid) within 7 days [Member]" } } }, "localname": "WithinSevenDaysMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/BUSINESSACQUISITONNarrativeDetail" ], "xbrltype": "domainItemType" }, "prt_WithinTwentyOneDaysMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents payment date within 21 days.", "label": "Within Twenty One Days [Member]", "verboseLabel": "Amount (paid) within 21 days [Member]" } } }, "localname": "WithinTwentyOneDaysMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/BUSINESSACQUISITONNarrativeDetail" ], "xbrltype": "domainItemType" }, "prt_WithoutRestrictionInExchangeAnnualFee": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of without restriction in exchange annual fee.", "label": "Without Restriction In Exchange Annual Fee", "verboseLabel": "Without restriction in exchange annual fee" } } }, "localname": "WithoutRestrictionInExchangeAnnualFee", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/COMMITMENTSNarrativeDetail" ], "xbrltype": "monetaryItemType" }, "prt_Year2031Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents expiry year 2031.", "label": "Year 2031 [Member]", "verboseLabel": "2031 [Member]" } } }, "localname": "Year2031Member", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/IncomeTaxesDisclosureOfNonCapitalLossCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "prt_Year2032Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents expiry year 2032.", "label": "Year 2032 [Member]", "verboseLabel": "2032 [Member]" } } }, "localname": "Year2032Member", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/IncomeTaxesDisclosureOfNonCapitalLossCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "prt_Year2033Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents expiry year 2033.", "label": "Year 2033 [Member]", "verboseLabel": "2033 [Member]" } } }, "localname": "Year2033Member", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/IncomeTaxesDisclosureOfNonCapitalLossCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "prt_Year2034Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents expiry year 2034.", "label": "Year 2034 [Member]", "verboseLabel": "2034 [Member]" } } }, "localname": "Year2034Member", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/IncomeTaxesDisclosureOfNonCapitalLossCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "prt_Year2035Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents expiry year 2035.", "label": "Year 2035 [Member]", "verboseLabel": "2035 [Member]" } } }, "localname": "Year2035Member", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/IncomeTaxesDisclosureOfNonCapitalLossCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "prt_Year2036Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents expiry year 2036.", "label": "Year 2036 [Member]", "verboseLabel": "2036 [Member]" } } }, "localname": "Year2036Member", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/IncomeTaxesDisclosureOfNonCapitalLossCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "prt_Year2037Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents expiry year 2037.", "label": "Year 2037 [Member]", "verboseLabel": "2037 [Member]" } } }, "localname": "Year2037Member", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/IncomeTaxesDisclosureOfNonCapitalLossCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "prt_Year2038Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents expiry year 2038.", "label": "Year 2038 [Member]", "verboseLabel": "2038 [Member]" } } }, "localname": "Year2038Member", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/IncomeTaxesDisclosureOfNonCapitalLossCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "prt_Year2039Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents expiry year 2039.", "label": "Year 2039 [Member]", "verboseLabel": "2039 [Member]" } } }, "localname": "Year2039Member", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/IncomeTaxesDisclosureOfNonCapitalLossCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "prt_YearTwoZeroFourOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents expiry year 2041.", "label": "Year Two Zero Four One [Member]", "verboseLabel": "2041 [Member]" } } }, "localname": "YearTwoZeroFourOneMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/IncomeTaxesDisclosureOfNonCapitalLossCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "prt_YearTwoZeroFourTwoMemberMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents expiry year 2042.", "label": "Year Two Zero Four Two Member [Member]", "verboseLabel": "2042 [Member]" } } }, "localname": "YearTwoZeroFourTwoMemberMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/IncomeTaxesDisclosureOfNonCapitalLossCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "prt_YearTwoZeroFourZeroMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents expiry year 2040.", "label": "Year Two Zero Four Zero [Member]", "verboseLabel": "2040 [Member]" } } }, "localname": "YearTwoZeroFourZeroMember", "nsuri": "http://plyrotech.com/20221130", "presentation": [ "http://plyrotech.com/role/IncomeTaxesDisclosureOfNonCapitalLossCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "srt_ChiefExecutiveOfficerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Chief Executive Officer [Member]", "netLabel": "Company controlled by CEO [Member]", "terseLabel": "CEO [Member]", "verboseLabel": "CEO of the Company [Member]" } } }, "localname": "ChiefExecutiveOfficerMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://plyrotech.com/role/RELATEDPARTYTRANSACTIONSANDBALANCESDisclosureOfInformationAboutKeyManagementPersonnelDetails", "http://plyrotech.com/role/RELATEDPARTYTRANSACTIONSANDBALANCESDisclosureOfInformationAboutOptionsGrantedToTheCEOCFOTheCorporateSecretaryAndTheCompanysDirectorsDetails", "http://plyrotech.com/role/RelatedPartyTransactionsDisclosureOfAmountsDueToOfficersDetails" ], "xbrltype": "domainItemType" }, "srt_ChiefFinancialOfficerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Chief Financial Officer [Member]", "terseLabel": "Former CFO [Member]", "verboseLabel": "Company controlled by the CFO [Member]" } } }, "localname": "ChiefFinancialOfficerMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://plyrotech.com/role/RELATEDPARTYTRANSACTIONSANDBALANCESDisclosureOfInformationAboutKeyManagementPersonnelDetails", "http://plyrotech.com/role/RelatedPartyTransactionsDisclosureOfAmountsDueToOfficersDetails" ], "xbrltype": "domainItemType" }, "srt_DirectorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Director [Member]", "terseLabel": "Directors [Member]", "verboseLabel": "Director [Member]" } } }, "localname": "DirectorMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://plyrotech.com/role/COMMITMENTSNarrativeDetail", "http://plyrotech.com/role/RELATEDPARTYTRANSACTIONSANDBALANCESConsultingFeesDetails", "http://plyrotech.com/role/RELATEDPARTYTRANSACTIONSANDBALANCESDisclosureOfInformationAboutOptionsGrantedToTheCEOCFOTheCorporateSecretaryAndTheCompanysDirectorsDetails", "http://plyrotech.com/role/RelatedPartyTransactionsDisclosureOfAmountsDueToOfficersDetails", "http://plyrotech.com/role/RelatedPartyTransactionsNarrativeDetails", "http://plyrotech.com/role/SHARECAPITALNarrativeDetails", "http://plyrotech.com/role/SUBSEQUENTEVENTSNarrativeDetail" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://plyrotech.com/role/DisclosureOfDetailedInformationAboutReconcilesTheExpectedIncomeTaxesExpenseDetails" ], "xbrltype": "stringItemType" } }, "unitCount": 10 } }, "std_ref": { "r0": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "103", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_103&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r1": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "104", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_104&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r10": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_g&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r100": { "Clause": "ii", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "1", "Paragraph": "32", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2022-en-r&anchor=para_32_a_ii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r101": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "12", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_12_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r102": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "19B", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_19B_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r103": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "19B", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_19B_c&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r104": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r105": { "Clause": "iii", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r106": { "Clause": "ix", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r107": { "Clause": "v", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r108": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "B13", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r109": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "B13", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B13_e&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r11": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r110": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "B13", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B13_f&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r111": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "B13", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r112": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "B4", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B4_a&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r113": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "13", "Paragraph": "93", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_93_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r114": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "13", "Paragraph": "93", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_93_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r115": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "13", "Paragraph": "93", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_93_e&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r116": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "14", "Paragraph": "33", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=14&code=ifrs-tx-2022-en-r&anchor=para_33_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r117": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "15", "Paragraph": "113", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&anchor=para_113_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r118": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "15", "Paragraph": "114", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&anchor=para_114&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r119": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "15", "Paragraph": "120", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&anchor=para_120_b_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r12": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "k", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_k&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r120": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "15", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IFR15_g110-129_IFRS15_g110-129_TI", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r121": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "15", "Section": "Presentation", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IFRS15_g105-109__IFRS15_g105-109_TI", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r122": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "16", "Paragraph": "47", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_47_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r123": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "16", "Paragraph": "53", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_53_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r124": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "16", "Paragraph": "53", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_53_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r125": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "16", "Paragraph": "53", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_53_g&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r126": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "16", "Paragraph": "53", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_53_h&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r127": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "16", "Paragraph": "53", "Subparagraph": "j", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_53_j&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r128": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "16", "Paragraph": "53", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_53&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r129": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "16", "Paragraph": "94", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_94&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r13": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "55", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_55&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r130": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "16", "Paragraph": "97", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_97&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r131": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_b_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r132": { "Clause": "ii", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_b_ii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r133": { "Clause": "iii", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_b_iii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r134": { "Clause": "iv", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_b_iv&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r135": { "Clause": "v", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_b_v&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r136": { "Clause": "vi", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_b_vi&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r137": { "Clause": "vii", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_b_vii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r138": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r139": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_d&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r14": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "61", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_61_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r140": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "2", "Paragraph": "47", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_47_a_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "3", "Paragraph": "B64", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2022-en-r&anchor=para_B64_c&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "3", "Paragraph": "B64", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2022-en-r&anchor=para_B64_f_i&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "3", "Paragraph": "B64", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2022-en-r&anchor=para_B64_f&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "3", "Paragraph": "B64", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2022-en-r&anchor=para_B64&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "3", "Paragraph": "B67", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2022-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "3", "Paragraph": "B67", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2022-en-r&anchor=para_B67&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "3", "Section": "Disclosures", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IFRS03_g59-63__IFRS03_g59-63_TI", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "3", "Section": "Disclosures application of paragraphs 59 and 61", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2022-en-r&doctype=Appendix&subtype=B&dita_xref=IFRS03_gB64-B67__IFRS03_gB64-B67_TI", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "5", "Paragraph": "33", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2022-en-r&anchor=para_33_b_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "61", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_61&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r150": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "21C", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_21C&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "23B", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_23B_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "33", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_33&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_34&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "35H", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_35H&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "35I", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_35I&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "35M", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_35M&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "42E", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_42E_e&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Section": "Defined terms", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&doctype=Appendix&subtype=A&dita_xref=IFRS07_APPA__IFRS07_APPA_TI", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "23", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_23_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_66&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r160": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "23", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_23_c&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "23", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_23_d&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "23", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_23_h&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "23", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_23&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "28", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "28", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "28", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_c&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "28", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_d&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "28", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_e&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "32", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_32&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "69", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_69&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r170": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "33", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_33_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "33", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_33&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_34&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IFRS08_g20-24__IFRS08_g20-24_TI", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "109", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_109&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "109A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_109A&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "120", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_120&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "124", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_124&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "125", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_125&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "127", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_127&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "78", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_e&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r180": { "Clause": "ii", "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "128", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_128_a_ii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "128", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_128_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "132", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_132_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "IssueDate": "2022-03-24", "Name": "IAS", "Note": "Expiry date 2023-01-01", "Number": "1", "Paragraph": "117", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_117&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Expiry date 2023-01-01", "Number": "7", "Paragraph": "20", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_20_e&doctype=Standard&book=b", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "102", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_102&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r186": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "103", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_103&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r187": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "108", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_108&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r188": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "68", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_68&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r189": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "78", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r19": { "Clause": "iv", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "79", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_79_a_iv&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r190": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "78", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_e&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r191": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "IG6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_IG6&doctype=Implementation%20Guidance", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r192": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "16", "Paragraph": "37", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_37_g&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r193": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "16", "Paragraph": "37", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_37_h&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r194": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "19", "Paragraph": "138", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_138_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r195": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "19", "Paragraph": "147", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_147_c&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r196": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "24", "Paragraph": "21", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&anchor=para_21_c&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r197": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "36", "Paragraph": "127", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2022-en-r&anchor=para_127&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r198": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "16", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_16_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r199": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "17", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_17_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r2": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "106", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r20": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "79", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_79_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r200": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "17", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_17_e&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r201": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Section": "A Statement of cash flows for an entity other than a financial institution", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_A__IAS07_IE_A_TI", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r202": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "B10", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r203": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "13", "Paragraph": "B6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_B6&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r204": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "13", "Paragraph": "IE63", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_IE63&doctype=Illustrative%20Examples", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r205": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "15", "Paragraph": "B89", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&anchor=para_B89_b&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r206": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "16", "Paragraph": "53", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_53&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r207": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "3", "Paragraph": "B64", "Subparagraph": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2022-en-r&anchor=para_B64_i&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r208": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "3", "Paragraph": "IE72", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2022-en-r&anchor=para_IE72&doctype=Illustrative%20Examples", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r209": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "35N", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_35N&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r21": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "81A", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_81A_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r210": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "B11", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_B11&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r211": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "B35", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_B35&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r212": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "IG31A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_IG31A&doctype=Implementation%20Guidance", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r213": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "23", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_23&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r214": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "28", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r215": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "113", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_113_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r216": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "96", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_96_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r217": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Effective on first application of IFRS 9", "Number": "4", "Paragraph": "39L", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2022-en-b&anchor=para_39L_e&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r218": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Expiry date 2023-01-01", "Number": "7", "Paragraph": "37", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_37_a&doctype=Standard&book=b", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r219": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Expiry date 2023-01-01", "Number": "7", "Paragraph": "37", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_37_b&doctype=Standard&book=b", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r22": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "81A", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_81A_c&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r220": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Expiry date 2023-01-01", "Number": "7", "Paragraph": "IG28", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG28_d&doctype=Implementation%20Guidance&book=b", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r221": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Expiry date 2023-01-01", "Number": "7", "Paragraph": "IG29", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG29_a&doctype=Implementation%20Guidance&book=b", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r222": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r223": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r224": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r225": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r226": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r227": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r228": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r229": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r23": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "82", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_82_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r230": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r231": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r232": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "10", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_10_e&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r233": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "104", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_104&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r234": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "106", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106_d&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r235": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "108", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_108&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r236": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "112", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_112_c&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r237": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "55", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_55&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r238": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "78", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r239": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "78", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r24": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "82", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_82_d&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r240": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "85", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_85&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r241": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "12", "Paragraph": "81", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_81_c_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r242": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "16", "Paragraph": "37", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_37&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r243": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "19", "Paragraph": "9", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_9&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r244": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "38", "Paragraph": "119", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_119&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r245": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "16", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_16&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r246": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "17", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_17&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r247": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "20", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_20_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r248": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "20", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_20_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r249": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "20", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_20&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r25": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "91", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_91_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r250": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_45&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r251": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "3", "Paragraph": "B64", "Subparagraph": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2022-en-r&anchor=para_B64_i&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r252": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "41", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_41&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r253": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_7&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r254": { "IssueDate": "2022-03-24", "Name": "IAS", "Note": "Effective 2023-01-01", "Number": "1", "Paragraph": "117", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_117&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r255": { "IssueDate": "2022-03-24", "Name": "IAS", "Note": "Expiry date 2023-01-01", "Number": "1", "Paragraph": "117", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-b&anchor=para_117_b&doctype=Standard&forcepdf=true", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r256": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Expiry date 2023-01-01", "Number": "7", "Paragraph": "37", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_37_b&doctype=Standard&book=b", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r257": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Expiry date 2023-01-01", "Number": "7", "Paragraph": "IG29", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG29&doctype=Implementation%20Guidance&book=b", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r26": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "98", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_98_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "99", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_99&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "10", "Paragraph": "21", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2022-en-r&anchor=para_21&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "12", "Paragraph": "79", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_79&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "106", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106_d_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r30": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "12", "Paragraph": "81", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_81_c_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Clause": "ii", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "12", "Paragraph": "81", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_81_c_ii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "12", "Paragraph": "81", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_81_e&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Clause": "ii", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "12", "Paragraph": "81", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_81_g_ii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "12", "Paragraph": "81", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_81_g&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "12", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IAS12_g79-88__IAS12_g79-88_TI", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "16", "Paragraph": "73", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_73_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "16", "Paragraph": "73", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_73_c&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "16", "Paragraph": "73", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_73_d&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "16", "Paragraph": "73", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_73_e_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Clause": "iii", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "106", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106_d_iii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r40": { "Clause": "ii", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "16", "Paragraph": "73", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_73_e_ii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Clause": "v", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "16", "Paragraph": "73", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_73_e_v&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Clause": "vii", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "16", "Paragraph": "73", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_73_e_vii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Clause": "viii", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "16", "Paragraph": "73", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_73_e_viii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "16", "Paragraph": "73", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_73_e&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "16", "Paragraph": "73", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_73&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "16", "Paragraph": "75", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_75_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "16", "Paragraph": "75", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_75_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "16", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IAS16_g73-79__IAS16_g73-79_TI", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r49": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "2", "Paragraph": "36", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2022-en-r&anchor=para_36_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r5": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "106", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r50": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "2", "Paragraph": "36", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2022-en-r&anchor=para_36_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r51": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "20", "Paragraph": "39", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=20&code=ifrs-tx-2022-en-r&anchor=para_39_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r52": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "20", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=20&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IAS20_g39-39__IAS20_g39-39_TI", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r53": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "21", "Paragraph": "52", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2022-en-r&anchor=para_52_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r54": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "24", "Paragraph": "17", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&anchor=para_17_e&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r55": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "24", "Paragraph": "17", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&anchor=para_17&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r56": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "24", "Paragraph": "18", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&anchor=para_18_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r57": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "24", "Paragraph": "18", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&anchor=para_18&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r58": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "24", "Paragraph": "19", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&anchor=para_19&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r59": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "24", "Paragraph": "20", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&anchor=para_20&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r6": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "134", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_134&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r60": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "24", "Section": "Disclosures", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IAS24_g13-24__IAS24_g13-24_TI", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r61": { "Clause": "iv", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "26", "Paragraph": "35", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2022-en-r&anchor=para_35_b_iv&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r62": { "Clause": "viii", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "26", "Paragraph": "35", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2022-en-r&anchor=para_35_b_viii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r63": { "Clause": "ii", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "27", "Paragraph": "16", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_16_b_ii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r64": { "Clause": "iii", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "27", "Paragraph": "16", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_16_b_iii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r65": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "27", "Paragraph": "16", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_16_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r66": { "Clause": "ii", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "27", "Paragraph": "17", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_17_b_ii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r67": { "Clause": "iii", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "27", "Paragraph": "17", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_17_b_iii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r68": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "27", "Paragraph": "17", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_17_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r69": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "33", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2022-en-r&anchor=para_66&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r7": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "35", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_35&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r70": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "33", "Paragraph": "67", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2022-en-r&anchor=para_67&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r71": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "33", "Paragraph": "70", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2022-en-r&anchor=para_70_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r72": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "38", "Paragraph": "118", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_118_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r73": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "38", "Paragraph": "118", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_118_c&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r74": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "38", "Paragraph": "118", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_118_e_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r75": { "Clause": "iv", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "38", "Paragraph": "118", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_118_e_iv&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r76": { "Clause": "vi", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "38", "Paragraph": "118", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_118_e_vi&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r77": { "Clause": "vii", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "38", "Paragraph": "118", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_118_e_vii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r78": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "38", "Paragraph": "118", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_118_e&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r79": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "38", "Paragraph": "118", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_118&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r8": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r80": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "38", "Paragraph": "126", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_126&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r81": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "38", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IAS38_g118-128__IAS38_g118-128_TI", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r82": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "40", "Paragraph": "76", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2022-en-r&anchor=para_76&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r83": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "40", "Paragraph": "79", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2022-en-r&anchor=para_79_c&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r84": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "40", "Paragraph": "79", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2022-en-r&anchor=para_79_d&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r85": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "41", "Paragraph": "50", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2022-en-r&anchor=para_50&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r86": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "41", "Paragraph": "54", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2022-en-r&anchor=para_54_f&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r87": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "10", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_10&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r88": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "18", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_18_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r89": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "21", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_21&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r9": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_c&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r90": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "25", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_25&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r91": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "28", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_28&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r92": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "39", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_39&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r93": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_45&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r94": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "46", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_46&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r95": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "50", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_50_d&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r96": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Section": "Presentation of a statement of cash flows", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IAS07_g10-17__IAS07_g10-17_TI", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r97": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "1", "Paragraph": "24", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2022-en-r&anchor=para_24_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r98": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "1", "Paragraph": "24", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2022-en-r&anchor=para_24_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r99": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "1", "Paragraph": "32", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2022-en-r&anchor=para_32_a_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" } }, "version": "2.2" } ZIP 110 0001062993-23-010706-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001062993-23-010706-xbrl.zip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